SEARCH

Search Details

KAKEJI Yoshihiro
Graduate School of Medicine / Faculty of Medical Sciences
Professor

Researcher basic information

■ Research Keyword
  • Gastroenterology
  • ロボット医学
  • 消化器外科学
■ Research Areas
  • Life sciences / Digestive surgery
■ Committee History
  • 2006, 日本胃癌学会, 評議員, 日本胃癌学会
  • 2005, 日本癌治療学会, 評議員, 日本癌治療学会
  • 2003, American Society of Clinical Oncology (ASCO), -, American Society of Clinical Oncology (ASCO)
  • 2003, 日本消化器癌発生学会, 評議員, 日本消化器癌発生学会
  • 2003, 日本食道学会, 評議員, 日本食道学会
  • 2002, 日本サイトメトリー学会, 評議員, 日本サイトメトリー学会

Research activity information

■ Paper
  • Taishi Hata, Hiroyuki Yamamoto, Masataka Ikeda, Hiroaki Nagano, Ichiro Takemasa, Takeshi Naitoh, Norikazu Yamada, Mamoru Uemura, Hidetoshi Eguchi, Yoshihiro Kakeji, Ken Shirabe, Yuichiro Doki
    Springer Science and Business Media LLC, Dec. 2024, Surgery Today
    Scientific journal

  • Masashi Takeuchi, Hideki Endo, Taizo Hibi, Ryo Seishima, Yusuke Takemura, Hiroyuki Yamamoto, Hiromichi Maeda, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masayuki Watanabe, Hiroyuki Daiko, Takushi Yasuda, Makoto Yamasaki, Masaki Mori, Hiroya Takeuchi, Ken Shirabe, Yuko Kitagawa
    Springer Science and Business Media LLC, Dec. 2024, Esophagus, 22(1) (1), 37 - 46
    Scientific journal

  • RIKUYA TORIGOE, TARO OSHIKIRI, HIRONOBU GOTO, YASUHUMI KOTERAZAWA, RYUICHIRO SAWADA, TARO IKEDA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA, YOSHIHIRO KAKEJI
    Anticancer Research USA Inc., Dec. 2024, Anticancer Research, 44(12) (12), 5485 - 5493
    Scientific journal

  • Hiroki Yokoo, Shingo Kanaji, Taro Ikeda, Yasufumi Koterazawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Elsevier BV, Dec. 2024, Journal of Gastrointestinal Surgery, 101934 - 101934
    Scientific journal

  • Hiroshi Saiga, Taro Oshikiri, Hironobu Goto, Yasufumi Koterazawa, Takashi Kato, Yukari Adachi, Toshitatsu Takao, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yuzo Kodama, Yoshihiro Kakeji
    Elsevier BV, Dec. 2024, Journal of Gastrointestinal Surgery, 28(12) (12), 2001 - 2007
    Scientific journal

  • Yasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, Yuki Azumi, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    Abstract Background Esophagectomy with lymphadenectomy is the primary treatment for esophageal squamous cell carcinoma (ESCC). However, intensive dissection of lymph nodes (LNs) along the recurrent laryngeal nerve (RLN) is associated with RLN palsy and pulmonary complications leading to poor survival. Therefore, this study aimed identify the risk factors for LNs metastasis along the RLN in patients with ESCC. Methods The present study included 168 patients with lower thoracic esophageal and esophagogastric junction (EGJ) squamous cell carcinoma who underwent esophagectomy with total mediastinal lymphadenectomy at Kobe University Hospital. Left/Right cervical paraesophageal (101 L/R), left/right recurrent nerve (106 recL/R), and left tracheobronchial LNs (106 tbL) were defined as LNs along the RLN. We evaluated the pathological distance between the proximal tumor boundary and the EGJ using images of the fixed specimen (PB‐EGJ length). Results LN metastasis along the RLN was observed in 19 (11%) patients. The percentage of patients with a longer PB‐EGJ length and cLNs metastasis was higher in the LNs metastasis along the RLN positive‐group than in the RLN‐negative group (p = 0.0075 and p = 0.013, respectively). The incidence of LNs metastasis along the RLN was 0% (95% confidence interval [CI] = 0–7.7%) when the PB‐EGJ length was <4 cm. Univariate analysis showed that patients with cLNs metastasis negative had a low risk for LNs metastasis along the RLN (odds ratio = 0.26 and 95% CI = 0.083–0.82). Conclusions Patients with a PB‐EGJ length <4 cm and negative for cLNs metastasis may be candidates for the omission of lymphadenectomy along the RLN.
    Wiley, Nov. 2024, World Journal of Surgery
    Scientific journal

  • Masaki Imai, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Yoshihiro Kakeji
    Abstract Developmental cyst is occasionally seen in children but are less common in adults. Complete removal of developmental cyst is necessary because there are risk of infection, squamous cell carcinoma, and recurrence due to incomplete resection. The best approach for resection of developmental cyst is still controversial. Although transsacral approach, open abdominal approach, or a combination of both have been often employed to date, reports of laparoscopic surgery have been appearing in recent years. We performed laparoscopic surgery for four patients with this disease: (i) 29‐year‐old woman with epidermoid cyst; (ii) 21‐year‐old woman with dermoid cyst; (iii) 55‐year‐old woman with epidermoid cyst; and (iv) 77‐year‐old woman with epidermoid cyst. No perioperative complications occurred and no recurrence has developed so far in any patients. Laparoscopic surgery can be considered as one of the optimal treatment options for developmental cyst.
    Wiley, Nov. 2024, Asian Journal of Endoscopic Surgery, 18(1) (1)
    Scientific journal

  • 第79回 日本消化器外科学会総会
    長谷川 寛, 掛地 吉弘
    Nov. 2024, 臨牀消化器内科, 39(12) (12), 1528, Japanese

  • Takashi Nakanishi, Yu-ichiro Koma, Shoji Miyako, Rikuya Torigoe, Hiroki Yokoo, Masaki Omori, Keitaro Yamanaka, Nobuaki Ishihara, Shuichi Tsukamoto, Takayuki Kodama, Mari Nishio, Manabu Shigeoka, Hiroshi Yokozaki, Yoshihiro Kakeji
    Cancer-associated fibroblasts (CAFs) are a key component of the tumor microenvironment and significantly contribute to the progression of various cancers, including esophageal squamous cell carcinoma (ESCC). Our previous study established a direct co-culture system of human bone marrow-derived mesenchymal stem cells (progenitors of CAFs) and ESCC cell lines, which facilitates the generation of CAF-like cells and enhances malignancy in ESCC cells. In this study, we further elucidated the mechanism by which CAFs promote ESCC progression using cDNA microarray analysis of monocultured ESCC cells and those co-cultured with CAFs. We observed an increase in the expression and secretion of amphiregulin (AREG) and the expression and phosphorylation of its receptor EGFR in co-cultured ESCC cells. Moreover, AREG treatment of ESCC cells enhanced their survival and migration via the EGFR-Erk/p38 MAPK signaling pathway. Immunohistochemical analysis of human ESCC tissues showed a positive correlation between the intensity of AREG expression at the tumor-invasive front and the expression level of the CAF marker FAP. Bioinformatics analysis confirmed significant upregulation of AREG in ESCC compared with normal tissues. These findings suggest that AREG plays a crucial role in CAF-mediated ESCC progression and could be a novel therapeutic target for ESCC.
    MDPI AG, Oct. 2024, Cells, 13(20) (20), 1733 - 1733
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Ryuichiro Sawada, Yasufumi Koterazawa, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Yoshihiro Kakeji
    Springer Science and Business Media LLC, Sep. 2024, Surgery Today
    Scientific journal

  • Hironobu Goto, Taro Oshikiri, Yasufumi Koterazawa, Ryuichiro Sawada, Taro Ikeda, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Springer Science and Business Media LLC, Sep. 2024, Esophagus, 22(1) (1), 59 - 67
    Scientific journal

  • Yoshihiro Kakeji, Hiroyuki Yamamoto, Masayuki Watanabe, Koji Kono, Hideki Ueno, Yuichiro Doki, Yuko Kitagawa, Hiroya Takeuchi, Ken Shirabe, Yasuyuki Seto
    Abstract Esophagectomy for esophageal cancer is a highly invasive gastrointestinal surgical procedure. The National Clinical Database (NCD) of Japan, initiated in 2011, has compiled real-world data on esophagectomy, one of nine major gastroenterological surgeries. This review examines outcomes after esophagectomy analyzed using the Japanese big databases. Certification systems by the Japanese Society of Gastroenterological Surgery (JSGS) and the Japan Esophageal Society (JES) have shown that institutional certification has a greater impact on short-term surgical outcomes than surgeon certification. Minimally invasive esophagectomy has emerged as a viable alternative to open esophagectomy, although careful patient selection is crucial, especially for elderly patients with advanced tumors. The NCD has significantly contributed to the assessment and enhancement of surgical quality and short-term outcomes, while studies based on Comprehensive Registry of Esophageal Cancer in Japan (CRECJ) have provided data on patient characteristics, treatments, and long-term outcomes. The JES has conducted various questionnaire-based retrospective clinical reviews in collaboration with authorized institutions certified by JES. The Diagnosis Procedure Combination (DPC) database provides administrative claims data including itemized prices for surgical, pharmaceutical, laboratory, and other inpatient services. Analyzing these nationwide databases can offer precise insights into surgical quality for esophageal cancer, potentially leading to improved treatment outcomes.
    Lead, Springer Science and Business Media LLC, Aug. 2024, Esophagus, 21(4) (4), 411 - 418
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Kengo Kuriyama, Osamu Shiraishi, Takanori Kurogochi, Tetsuya Abe, Hiroshi Sato, Hiroshi Miyata, Yoshihiko Kawaguchi, Yusuke Sato, Hiroaki Nagano, Shinsuke Takeno, Masanobu Nakajima, Kentaro Matsuo, Kentaro Murakami, Katsushi Takebayashi, Sohei Matsumoto, Tomoyuki Okumura, Yoshihiro Kakeji, Koji Kono, Nobuhiko Oridate, Yasushi Toh, Hiroya Takeuchi, Yukio Katori
    Springer Science and Business Media LLC, Aug. 2024, Esophagus
    Scientific journal

  • Ryo Yamamoto, Shinya Hirakawa, Hisateru Tachimori, Tadashi Matsuoka, Hirotoshi Kikuchi, Hiroshi Hasegawa, Ken Shirabe, Yoshihiro Kakeji, Hirofumi Kawakubo, Yuko Kitagawa, Junichi Sasaki
    Background: Perforated peptic ulcer (PPU) causes peritonitis and requires surgery based on disease severity. This study aimed to develop and validate a severity scale for PPU with generalized peritonitis. Materials and methods: This retrospective cohort study used a nationwide multi-center surgical database (2013–2020). Patients aged >15 years who underwent surgery for PPU with generalized peritonitis were included and categorized into the derivation (2013–2018) and two validation (2019 and 2020) cohorts. Possible severity predictors were selected via a literature review, and Lasso models were developed to predict severe postoperative adverse events with 2000 bootstrapping. Final variables for the scoring system were determined based on inclusion frequency (≥90%) in the Lasso models. Discrimination and accuracy were evaluated using c-statistics and calibration plots. Cutoff values for minimal postoperative adverse events were examined using negative predictive values. Results: Among 12,513 patients included (1,202 underwent laparoscopic surgery), 533 (5.9%), 138 (7.6%), and 117 (6.9%) in the derivation and two validation cohorts experienced postoperative adverse events. Age, dyspnea at rest, preoperative sepsis, III/IV/V of American Society of Anesthesiologists physical status, and albumin and creatinine were selected for the final model. A 0–11 scoring system was developed with c-statistics of 0.812–0.819. Cutoff value was determined as 5, which predicted <3% probability of postoperative adverse events regardless of type of surgery. Conclusions: A score of <5 predicts minimal risks for postoperative adverse events and therefore would be clinically useful to determine type of surgery. Further studies are needed to validate the score.
    Ovid Technologies (Wolters Kluwer Health), Aug. 2024, International Journal of Surgery
    Scientific journal

  • National Clinical Detabase からみる食道癌術後合併症と手術死亡率
    掛地 吉弘, 渡邊 雅之, 河野 浩二, 上野 秀樹, 土岐 祐一郎, 北川 雄光, 竹内 裕也, 調 憲, 瀬戸 泰之
    Lead, Aug. 2024, 臨床外科, 79(8) (8), 840 - 844
    Scientific journal

  • JUNKO MUKOHYAMA, MINORI KOIZUMI, KIMIHIRO YAMASHITA, AKIHIDE YOSHIMI, DAI SHIDA, YOSHIHIRO KAKEJI
    Anticancer Research USA Inc., Jul. 2024, Anticancer Research, 44(8) (8), 3553 - 3556
    Scientific journal

  • Sono Ito, Yusuke Kinugasa, Shinichi Yamauchi, Hiroyuki Sato, Akihiro Hirakawa, Soichiro Ishihara, Akio Shiomi, Yukihide Kanemitsu, Takeshi Suto, Hiroki Takahashi, Michio Itabashi, Manabu Shiozawa, Masaya Hiyoshi, Takaya Kobatake, Koji Komori, Hiroyuki Egi, Heita Ozawa, Tomohiro Yamaguchi, Ryo Inada, Masaaki Ito, Yasumitsu Hirano, Akinobu Furutani, Yoshitaka Tanabe, Hideki Ueno, Masayuki Ohue, Koya Hida, Kazushige Kawai, Eiji Sunami, Hideyuki Ishida, Kay Uehara, Jun Watanabe, Masanori Hotchi, Atsushi Ishibe, Yasumasa Takii, Junichiro Hiro, Masakatsu Numata, Ichiro Takemasa, Takeshi Kato, Yoshihiro Kakeji, Akira Hirata, Yoichi Ajioka
    BACKGROUND: The significance of resection of paraaortic lymph node metastasis in colorectal cancer is controversial. OBJECTIVE: To clarify the prognosis of colorectal cancer after paraaortic lymph node metastasis resection. DESIGN: Multicenter retrospective study. SETTINGS: Thirty-six institutions in Japan participated in this study. PATIENTS: Patients with resected and pathologically proven paraaortic lymph node metastasis of CRC between 2010 and 2015. DATA SOURCES: Database and medical records at each institution. MAIN OUTCOME MEASURES: Overall survival after paraaortic lymph node metastasis resection, recurrence-free survival, and recurrence patterns after R0 resection of paraaortic lymph node metastasis. RESULTS: A total of 133 patients were included in the primary analysis population in this study. The 5-year overall survival rate (95% confidence interval [CI]) was 41.0% (32.0, 49.8), and the median survival (95% CI) was 4.1 (3.4, 4.7) years. Independent prognostic factors for overall survival were the pathological T stage (pT4 vs. pT1– 3, adjusted hazard ratio [aHR]: 1.91, p = 0.006), other organ metastasis (present vs. absent, aHR: 1.98, p = 0.005), time to metastases (synchronous vs. metachronous, aHR: 2.02, p = 0.02), and number of paraaortic lymph node metastasis (≥3 vs. <3, aHR: 2.13, p = 0.001). The 5-year recurrence-free survival rate (95% CI) was 21.1% (13.5, 29.7), with a median (95% CI) of 1.2 (0.9, 1.4) years. The primary tumor location (left- vs. right-sided colon, aHR: 4.77, p = 0.01; rectum vs. right-sided colon, aHR: 5.27, p = 0.006), other organ metastasis (present vs. absent, aHR: 1.90, p = 0.03), number of paraaortic lymph node metastasis (≥3 vs. <3, aHR: 2.20, p = 0.001), and hospital volume (<10 vs. ≥10, aHR: 2.18, p = 0.02) were identified as independent prognostic factors for recurrence-free survival. Paraaortic lymph node recurrence was the most common at 33.3%. LIMITATIONS: Selection bias cannot be ruled out because of the retrospective nature of the study. CONCLUSIONS: Less than three paraaortic lymph node metastasis was a favorable prognostic factor for both overall survival and recurrence-free survival. However, paraaortic lymph node metastases were considered to be a systemic disease and the significance of resection was limited. See Video Abstract.
    Ovid Technologies (Wolters Kluwer Health), Jul. 2024, Diseases of the Colon & Rectum
    Scientific journal

  • Takao Tsuneki, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Yasufumi Koterazawa, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Yoshihiro Kakeji
    Springer Science and Business Media LLC, Jun. 2024, Surgery Today
    Scientific journal

  • Naoto Shirakami, Shingo Kanaji, Atsushi Shimada, Tomosuke Mukoyama, Ryuichiro Sawada, Hitoshi Harada, Tomonori Tanaka, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Abstract Background Herein, we report a case of gastric antrum cancer with multiple invasions to other organs that was completely cured with laparoscopic distal gastrectomy after preoperative chemotherapy in a patient with poor general condition. Case presentation An 80-year-old male patient was diagnosed with anemia during follow-up for cerebral lacunar infarction at another hospital. He was diagnosed with advanced-stage gastric antrum cancer and was referred to our hospital. On esophagogastroduodenoscopy, type 2 advanced-stage gastric cancer was detected at the greater curvature of the antrum, and the biopsy results revealed tubular adenocarcinoma. Contrast-enhanced computed tomography scan revealed multiple invasions to other organs, thick gastric wall with contrast effect, and superior mesenteric vein tumor thrombus. However, there was no evidence of distant metastasis on positron emission tomography/computed tomography scan. The clinical diagnosis was stage IVA gastric cancer. Pancreatoduodenectomy with portal vein resection could be important at this point. However, preoperative chemotherapy with S-1 and oxaliplatin was administered instead of performing extended surgery because the patient had poor general condition (performance status score of 3). The patient received three cycles of preoperative chemotherapy at the hospital along with rehabilitation and nutritional management with oral nutritional supplements. After treatment, the performance status score of the patient improved from 3 to 1. Furthermore, in terms of clinical therapeutic effect, the patient achieved partial response. Hence, laparoscopic distal gastrectomy with D2 lymph node dissection and partial transverse colectomy was performed. After surgery, the patient was admitted for oral intake on postoperative day 6 and was discharged on postoperative day 21. Based on the histopathological examination, gastric cancer had disappeared, and there were no evident malignant findings. Therefore, gastric cancer was classified as grade 3 according to the histological treatment efficacy criteria. The patient did not present with recurrence at 2 years after surgery. Conclusions By actively administering preoperative chemotherapy, minimally invasive radical surgery with maximum preservation of the surrounding organs can be performed for locally far advanced-stage gastric cancer in older patients with poor general condition.
    Springer Science and Business Media LLC, Jun. 2024, Surgical Case Reports, 10(1) (1)
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, Takeshi Sano, Wataru Ichikawa, Yoshihiro Kakeji, Yu Sunakawa, Masahiro Takeuchi, Masashi Fujii
    Springer Science and Business Media LLC, Jun. 2024, Gastric Cancer, 27(5) (5), 1157 - 1157
    Scientific journal

  • Shingo Kanaji, Naoki Urakawa, Hitoshi Harada, Atsushi Shimada, Yasufumi Koterazawa, Ryuichiro Sawada, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    Springer Science and Business Media LLC, Jun. 2024, Langenbeck's Archives of Surgery, 409(1) (1)
    Scientific journal

  • 安藤 嘉子, 高橋 新, 藤井 誠, 長谷川 寛, 木村 聡元, 山本 博之, 田嶋 哲也, 西口 幸雄, 掛地 吉弘, 宮田 浩章, 北川 雄光
    日本ストーマ・排泄リハビリテーション学会, Jun. 2024, 日本ストーマ・排泄リハビリテーション学会誌, 40(2) (2), 46 - 61, Japanese

  • Yasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    Springer Science and Business Media LLC, May 2024, Surgical Endoscopy, 38(7) (7), 3625 - 3635
    Scientific journal

  • 小寺澤 康文, 後藤 裕信, 掛地 吉弘
    (株)日本臨床社, May 2024, 日本臨床, 82(増刊3 食道癌2024) (増刊3 食道癌2024), 532 - 536, Japanese

  • Masashi Takeuchi, Taizo Hibi, Ryo Seishima, Yusuke Takemura, Hiromichi Maeda, Genta Toshima, Noriyuki Ishida, Naoki Miyazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Ken Shirabe, Yuko Kitagawa
    Abstract Background Due to the coronavirus disease 2019 (COVID‐19) pandemic, cancer screening, diagnosis, and treatment have changed. This study aimed to investigate the impact of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection prior to gastroenterological cancer surgeries on postoperative complications using data from a nationwide database in Japan. Methods Data on patients who underwent surgery for cancer including esophageal, gastric, colon, rectal, liver, and pancreatic cancer between July 1, 2019, and September 300, 2022, from real‐world sources in Japan were analyzed. The association between preoperative SARS‐CoV‐2 infection and short‐term postoperative outcomes was evaluated. A similar analysis stratified according to the interval from SARS‐CoV‐2 infection to surgery (<4 vs. >4 weeks) was conducted. Results In total, 60 604 patients were analyzed, and 227 (0.4%) patients were diagnosed with SARS‐CoV‐2 infection preoperatively. The median interval from SARS‐CoV‐2 infection to surgery was 25 days. Patients diagnosed with SARS‐CoV‐2 infection preoperatively had a significantly higher incidence of pneumonia (odds ratio: 2.05; 95% confidence interval: 1.05–3.74; p = 0.036) than those not diagnosed with SARS‐CoV‐2 infection based on the exact logistic regression analysis adjusted for the characteristics of the patients. A similar finding was observed in patients who had SARS‐CoV‐2 infection <4 weeks before surgery. Conclusions Patients with a history of SARS‐CoV‐2 infection had a significantly higher incidence of pneumonia. This finding can be particularly valuable for countries that have implemented strict regulations in response to the COVID‐19 pandemic and have lower SARS‐CoV‐2 infection‐related mortality rates.
    Wiley, May 2024, Annals of Gastroenterological Surgery, 8(5) (5), 942 - 951
    Scientific journal

  • Shoji Miyako, Yu-ichiro Koma, Takashi Nakanishi, Shuichi Tsukamoto, Keitaro Yamanaka, Nobuaki Ishihara, Yuki Azumi, Satoshi Urakami, Masaki Shimizu, Takayuki Kodama, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    Elsevier BV, May 2024, The American Journal of Pathology, 194(5) (5), 828 - 848
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Akihiko Soyama, Hiroyuki Yamamoto, Susumu Eguchi, Atsushi Nanashima, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
    Abstract Background Although curative resection with vascular reconstruction improves the prognosis of blood‐invading locally advanced hepatobiliary tumors, the mortality and morbidity of the procedure remains unclear. This study aimed to clarify the risk factors associated with mortality and morbidity in patients undergoing liver resection with vascular reconstruction. Methods This retrospective observational study included 1215 patients undergoing hepatectomy of more than one section with vascular reconstruction, except for left lateral sectionectomy registered in the National Clinical Database (NCD) between 2015 and 2019. The rates of surgical mortality and relevant clinical factors were evaluated. Results Among the four types of vascular reconstruction, portal venous reconstruction was frequently performed in 724 patients (59.6% of the enrolled patients). Surgical mortality was 8.1%. Patients with hepatic artery reconstruction had the highest surgical mortality rate of 15.8%. In other types of reconstruction, surgical mortality was 9.1% in the portal vein, 5.2% in inferior vena cava, and 4.9% in hepatic vein. Factors significantly associated with surgical mortality include age, sex (male), preoperative comorbidity (American Society of Anesthesiologists grade >3, respiratory distress, diabetes, preoperative pneumonia, weight loss, and obstructive jaundice), poorer liver functional reserve (indocyanine green retention rate at 15 min and prothrombin time/international normalized ratio >1.1) and accompanying biliary reconstruction. Conclusions The NCD revealed the detailed status of liver resection combined with vascular reconstruction in Japan. Based on the results of this analysis, understanding the factors that influence the outcome and postoperative course of each procedure will provide patients with accurate information and opportunities to improve future outcomes.
    Wiley, Apr. 2024, Journal of Hepato-Biliary-Pancreatic Sciences, 31(7) (7), 425 - 436
    Scientific journal

  • Hironobu Goto, Taro Oshikiri, Takashi Kato, Yoshiaki Nagatani, Yohei Funakoshi, Yasufumi Koterazawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Hironobu Minami, Yoshihiro Kakeji
    Background In Japan, preoperative adjuvant chemotherapy followed by surgical resection is the standard treatment for patients with locally advanced esophageal squamous cell carcinoma. However, the risk of recurrence after surgical resection remains high. Although a randomized controlled trial evaluating the efficacy of nivolumab, a fully human monoclonal anti-programmed death 1 antibody, as postoperative adjuvant therapy after neoadjuvant chemoradiotherapy and surgery established its superior efficacy as adjuvant therapy, the efficacy for patients who received preoperative adjuvant chemotherapy has not been demonstrated. This study aims to elucidate the efficacy and safety of nivolumab as postoperative adjuvant therapy for patients with esophageal squamous cell carcinoma after preoperative adjuvant chemotherapy with docetaxel and cisplatin plus 5-fluorouracil followed by surgical resection. Methods This study is a multi-institutional, single-arm, Phase II trial. We plan to recruit 130 esophageal squamous cell carcinoma patients, who have undergone preoperative adjuvant chemotherapy with docetaxel and cisplatin plus 5-fluorouracil followed by surgical resection. If the patient did not have a pathological complete response, nivolumab is started as a postoperative adjuvant therapy within 4–16 weeks after surgery. The nivolumab dose is 480 mg/day every four weeks. Nivolumab is administered for up to 12 months. The primary endpoint is disease-free survival; the secondary endpoints are overall survival, distant metastasis-free survival, and incidence of adverse events. Discussion To our knowledge this study is the first trial establishing the efficacy of nivolumab as postoperative adjuvant therapy for patients with esophageal squamous cell carcinoma after preoperative adjuvant chemotherapy with docetaxel and cisplatin plus 5-fluorouracil followed by surgical resection. In Japan, preoperative adjuvant chemotherapy followed by surgery is a well-established standard treatment for resectable, locally advanced esophageal squamous cell carcinoma. Therefore, developing an effective postoperative adjuvant therapy has been essential for improving oncological outcomes.
    Public Library of Science (PLoS), Apr. 2024, PLOS ONE, 19(4) (4), e0299742 - e0299742
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Tatsuya Orimo, Shinya Hirakawa, Akinobu Taketomi, Hisateru Tachimori, Taro Oshikiri, Hiroaki Miyata, Yoshihiro Kakeji, Ken Shirabe
    Abstract Aim We evaluated the morbidity and mortality associated with liver surgery in Japan and developed a risk model for liver resection using information from a national database. Methods We retrospectively reviewed 73 861 Japanese patients who underwent hepatectomy between 2014 and 2019, using information from the National Clinical Database (NCD) registrations. The primary endpoints were 30 days and in‐hospital mortality, and the secondary endpoints were postoperative complications. Logistic regression risk models for postoperative morbidity and mortality after hepatectomy were constructed based on preoperative clinical parameters and types of liver resection, and validated using a bootstrapping method. Results The 30‐day and in‐hospital mortality rates were 0.9% and 1.7%, respectively. Trisectionectomy, hepatectomy for gallbladder cancer, hepatectomy for perihilar cholangiocarcinoma, and poor activities of daily living were statistically significant risk factors with high odds ratios for both postoperative morbidity and mortality. Internal validations indicated that the c‐indices for 30‐day and in‐hospital mortality were 0.824 and 0.839, respectively. Conclusions We developed a risk model for liver resection by using a national surgical database that can predict morbidity and mortality based on preoperative factors.
    Wiley, Apr. 2024, Annals of Gastroenterological Surgery, 8(5) (5), 896 - 916
    Scientific journal

  • Shimpei Ogawa, Hideki Endo, Masahiro Yoshida, Tomomitsu Tsuru, Michio Itabashi, Hiroyuki Yamamoto, Yoshihiro Kakeji, Hideki Ueno, Yuko Kitagawa, Taizo Hibi, Akinobu Taketomi, Norihiko Ikeda, Masaki Mori
    Abstract Aim To examine the potential negative effects of the COVID‐19 pandemic on short‐term postoperative outcomes of emergency surgery for gastroduodenal perforation in Japan. Methods A total of 7973 cases of gastroduodenal perforation from 2019 to 2021 were retrieved from the National Clinical Database (NCD), which includes >95% of surgical cases in Japan. Data were analyzed nationally and in subgroups for subjects in areas with high infection levels (HILs). Postoperative 30‐d mortality, surgical mortality, and complications (Clavien–Dindo (CD) grade ≥3) were examined. Months were considered to have significantly high or low mortality or complication rates, if the 95% confidence interval (CI) of the standardized mortality (morbidity) ratio (SMR) does not contain 1. Results Nationally, data from 2019 vs 2020 and 2021 showed 30‐d mortality of 175 (6.7%) vs 398 (7.4%), surgical mortality of 250 (9.5%) vs 537 (10.1%), and complications (CD ≥3) of 558 (21.2%) vs 1163 (21.8%). Among these data, the only significantly high SMR was found for complications in July 2020 (1.36 [95% CI: 1.001–1.80]). In areas with HILs, data from 2019 vs 2020 and 2021 indicated 30‐d mortality of 91 (6.3%) vs 215 (7.3%), surgical mortality of 135 (9.4%) vs 294 (10.0%), and complications (CD ≥3) of 304 (21.1%) vs (23.1%). In these data, no month had a significantly high SMR. Conclusion The COVID‐19 pandemic had few negative effects on outcomes after surgery for gastroduodenal perforation. These findings suggest that the emergency system for gastroduodenal perforation in Japan was generally maintained during the pandemic.
    Wiley, Apr. 2024, Annals of Gastroenterological Surgery, 8(5) (5), 795 - 806
    Scientific journal

  • Naoya Sato, Shinya Hirakawa, Shigeru Marubashi, Hisateru Tachimori, Taro Oshikiri, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa
    Abstract Aim The existing predictive risk models for the surgical outcome of acute diffused peritonitis (ADP) need renovation by adding relevant variables such as ADP's definition or causative etiology to pursue outstanding data collection reflecting the real world. We aimed to revise the risk models predicting mortality and morbidities of ADP using the latest Japanese Nationwide Clinical Database (NCD) variable set. Methods Clinical dataset of ADP patients who underwent surgery, and registered in the NCD between 2016 and 2019, were used to develop a risk model for surgical outcomes. The primary outcome was perioperative mortality. Results After data cleanup, 45 379 surgical cases for ADP were derived for analysis. The perioperative and 30‐day mortality were 10.6% and 7.2%, respectively. The prediction models have been created for the mortality and 10 morbidities associated with the mortality. The top five relevant predictors for perioperative mortality were age >80, advanced cancer with multiple metastases, platelet count of <50 000/mL, serum albumin of <2.0 g/dL, and unknown ADP site. The C‐indices of perioperative and 30‐day mortality were 0.859 and 0.857, respectively. The predicted value calculated with the risk models for mortality was highly fitted with the actual probability from the lower to the higher risk groups. Conclusions Risk models for postoperative mortality and morbidities with good predictive performance and reliability were revised and validated using the recent real‐world clinical dataset. These models help to predict ADP surgical outcomes accurately and are available for clinical settings.
    Wiley, Apr. 2024, Annals of Gastroenterological Surgery, 8(4) (4), 711 - 727
    Scientific journal

  • 島田 淳司, 山崎 悠太, 金治 新悟, 掛地 吉弘
    金原出版(株), Apr. 2024, 手術, 78(5) (5), 769 - 775, Japanese

  • Natsuko Yamauchi, Mako Otsuka, Tomohiro Ishikawa, Yoshihiro Kakeji, Akira Kikuchi, Atsuhiro Masuda, Yuzo Kodama, Yasuhiro Minami, Koki Kamizaki
    Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most refractory cancers with the worst prognosis. Although several molecules are known to be associated with the progression of PDAC, the molecular mechanisms underlying the progression of PDAC remain largely elusive. The Ror‐family receptors, Ror1 and Ror2, which act as a receptor(s) for Wnt‐family ligands, particularly Wnt5a, are involved in the progression of various types of cancers. Here, we show that higher expression of Ror1 and Wnt5b, but not Ror2, are associated with poorer prognosis of PDAC patients, and that Ror1 and Wnt5b are expressed highly in a type of PDAC cell lines, PANC‐1 cells. Knockdown of either Ror1 or Wnt5b in PANC‐1 cells inhibited their proliferation significantly in vitro, and knockout of Ror1 in PANC‐1 cells resulted in a significant inhibition of tumor growth in vivo. Furthermore, we show that Wnt5b‐Ror1 signaling in PANC‐1 cells promotes their proliferation in a cell‐autonomous manner by modulating our experimental setting in vitro. Collectively, these findings indicate that Wnt5b‐Ror1 signaling might play an important role in the progression of some if not all of PDAC by promoting proliferation.
    Wiley, Mar. 2024, Genes to Cells
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yusuke Takemura, Hideki Endo, Taizo Hibi, Yutaka Nakano, Ryo Seishima, Masashi Takeuchi, Hiroyuki Yamamoto, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa
    Abstract Aim The coronavirus disease 2019 (COVID‐19) pandemic greatly impacted medical resources such as cancer screening, diagnosis, and treatment given to people for various diseases. We surveyed the impacts of the pandemic on the incidence of complications and mortality following pancreaticoduodenectomy for pancreatic cancer in Japan. Methods Data on patients who underwent pancreaticoduodenectomy for pancreatic cancer were extracted from the Japanese National Clinical Database (NCD) between 2018 and 2021. The number of the pancreaticoduodenectomy for pancreatic cancer were obtained and then the morbidity and mortality rates were evaluated using a standardized morbidity/mortality ratio (SMR), which is the ratio of the observed number of incidences to the expected number of incidences calculated by the risk calculator previously developed by the NCD. Results This study included 22 255 cases. The number of pancreaticoduodenectomies exhibited an increasing trend even during the COVID‐19 pandemic. The mean observed incidence rates of Grade C pancreatic fistula and Clavien–Dindo grade ≥4 complications, and the 30‐day mortality and surgical mortality rates were 0.8%, 1.8%, 0.8% and 0.9%, respectively. The standardized morbidity ratios did not increase during the COVID‐19 pandemic. The standardized mortality ratios remained within the range of variations observed before the COVID‐19 pandemic. Conclusion The increasing trend in the number of pancreaticoduodenectomies and favorable short‐term outcomes even in the COVID‐19 pandemic suggest the medical care for pancreatic cancer in Japan functioned well during the pandemic.
    Wiley, Mar. 2024, Annals of Gastroenterological Surgery, 8(5) (5), 877 - 887
    Scientific journal

  • コンピュータ外科学の進歩
    掛地 吉弘
    Mar. 2024, 日本コンピュータ外科学会誌, 25(4) (4), 273

  • 外科医労働環境改善委員会の活動
    掛地 吉弘
    Mar. 2024, 日本外科学会雑誌, 125(2) (2), 96

  • Souya Nunobe, Hideki Endo, Michitaka Honda, Masayuki Watanabe, Hiroyuki Yamamoto, Shingo Kanaji, Yoshihiro Kakeji, Yasuhiro Kodera, Yuko Kitagawa
    Springer Science and Business Media LLC, Feb. 2024, Surgery Today
    Scientific journal

  • Yusuke Takemura, Hideki Endo, Taizo Hibi, Yutaka Nakano, Ryo Seishima, Masashi Takeuchi, Hiroyuki Yamamoto, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa
    Abstract Aim The coronavirus disease 2019 (COVID‐19) pandemic has significantly impacted the allocation of medical resources, including cancer screening, diagnosis, and treatment. We aimed to investigate the effects of the pandemic on morbidity and mortality following hepatectomy for hepatocellular carcinoma (HCC). Methods We identified patients who underwent hepatectomy for HCC between 2018 and 2021 from the Japanese National Clinical Database (NCD). The number of surgical cases, the use of intensive care units, and the incidence of morbidity were assessed. The standardized morbidity / mortality ratio (SMR) was used to evaluate the rates of morbidity (bile leakage and pneumonia) and mortality in each month, which compares the observed incidence to the expected incidence calculated by the NCD's risk calculator. Results The study included a total of 10 647 cases. The number of patients undergoing hepatectomy for HCC gradually decreased. The proportion of patients aged 80 years or older increased and that of cases with T1 stage decreased. The proportion of patients who were admitted to the intensive care unit did not change between the pre‐ and postpandemic period. The mean actual incidence rates of bile leakage, pneumonia, 30‐day mortality, and surgical mortality were 9.2%, 2.3%, 1.4%, and 2.1%, respectively. The SMR for the mortalities and morbidities in each month did not increase mostly throughout the COVID‐19 pandemic. Conclusions The present study showed the decreasing number of resected cases for HCC, while the surgical safety for hepatectomy was enough to be maintained by managing medical resources in Japan.
    Wiley, Feb. 2024, Hepatology Research
    Scientific journal

  • 愛甲 丞, 隈丸 拓, 山下 裕玄, 金治 新悟, 絹川 直子, 掛地 吉弘, 北川 雄光, 瀬戸 泰之
    (一社)日本消化器外科学会, Feb. 2024, 日本消化器外科学会雑誌, 57(2) (2), 51 - 59, Japanese

  • 安達 祐里, 押切 太郎, 後藤 裕信, 加藤 喬, 堀川 学, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 谷 明穂, 児玉 良典, 伊藤 智雄, 掛地 吉弘
    (一社)日本消化器外科学会, Feb. 2024, 日本消化器外科学会雑誌, 57(2) (2), 67 - 74, Japanese

  • 金治 新悟, 掛地 吉弘
    (株)南江堂, Feb. 2024, 外科, 86(2) (2), 127 - 132, Japanese

  • 金治 新悟, 掛地 吉弘
    (株)南江堂, Feb. 2024, 外科, 86(2) (2), 127 - 132, Japanese

  • Jun Okui, Kengo Nagashima, Satoru Matsuda, Yasunori Sato, Akihiko Okamura, Hirofumi Kawakubo, Manabu Muto, Yoshihiro Kakeji, Koji Kono, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki, Takeo Bamba, Takashi Fukuda, Hitoshi Fujiwara, Shinsuke Sato, Kazuhiro Noma, Hiroshi Miyata, Takeo Fujita, Yuko Kitagawa
    Abstract Background Overall survival is considered as one of the most important endpoints of treatment efficacy but often requires long follow-up. This study aimed to determine the validity of recurrence-free survival as a surrogate endpoint for overall survival in patients with surgically resectable advanced oesophageal squamous cell carcinoma (OSCC). Methods Patients with OSCC who received neoadjuvant cisplatin and 5-fluorouracil, or docetaxel, cisplatin and 5-fluorouracil, at 58 Japanese oesophageal centres certified by the Japan Esophageal Society were reviewed retrospectively. The correlation between recurrence-free and overall survival was assessed using Kendall's τ. Results The study included 3154 patients. The 5-year overall and recurrence-free survival rates were 56.6 and 47.7% respectively. The primary analysis revealed a strong correlation between recurrence-free and overall survival (Kendall's τ 0.797, 95% c.i. 0.782 to 0.812) at the individual level. Subgroup analysis showed a positive relationship between a more favourable pathological response to neoadjuvant chemotherapy and a higher τ value. In the meta-regression model, the adjusted R2 value at the institutional level was 100 (95% c.i. 40.2 to 100)%. The surrogate threshold effect was 0.703. Conclusion There was a strong correlation between recurrence-free and overall survival in patients with surgically resectable OSCC who underwent neoadjuvant chemotherapy, and this was more pronounced in patients with a better response to neoadjuvant chemotherapy.
    Oxford University Press (OUP), Jan. 2024, British Journal of Surgery, 111(2) (2)
    Scientific journal

  • Tomonori Akagi, Hideki Endo, Masafumi Inomata, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, Hiroyuki Yamamoto, Yoshihiro Kakeji, Yuko Kitagawa, Akinobu Taketomi, Masaki Mori
    Abstract Background The COVID‐19 outbreak made conventional medical care impossible, forcing changes in both healthcare providers and patients. In Japan, COVID‐19 infection began spreading in earnest in 2020 and exploded in 2021. There was concern that the medical impact of COVID‐19 in 2021 would differ from that in 2020. We aimed to clarify the impact of COVID‐19 on mortality and anastomotic leakage in laparoscopic surgery for gastric cancer and rectal cancer in Japan using the National Clinical Database (NCD). Methods We collected data from patients who underwent laparoscopic distal gastrectomy (LDG) and laparoscopic low anterior resection (LLAR) from January 2018 to December 2021 from the NCD, a web‐based surgical registration system in Japan. The number of surgical cases, monthly incidence of mortality and morbidity (anastomotic leakage), standardized mortality ratio (SMR), and standardized morbidity‐leakage ratio (SMLR [ratio of observed patients to expected patients calculated using the risk calculator established in the NCD]) were evaluated. Results The numbers of LDG and LLAR cases continued to decline in the first year of the pandemic in 2020 and were as low in 2021 as in 2020. Although the numbers of robot‐assisted LDG and LLAR cases increased, the growth rate was lower than the rate of increase prior to the pandemic. Mortality and anastomotic leakage, two of the most important complications, as assessed by SMR and SMLR, did not worsen during the pandemic in comparison to the pre‐pandemic period. Conclusions Laparoscopic surgeries were performed safely in Japan and were not affected by the COVID‐19 pandemic.
    Wiley, Jan. 2024, Annals of Gastroenterological Surgery, 8(3) (3), 521 - 529
    Scientific journal

  • Hiromichi Maeda, Hideki Endo, Nao Ichihara, Hiroaki Miyata, Hiroshi Hasegawa, Kinji Kamiya, Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuyuki Seto, Hiroki Yamaue, Masakazu Yamamoto, Yuko Kitagawa, Sunao Uemura, Kazuhiro Hanazaki
    Springer Science and Business Media LLC, Jan. 2024, Langenbeck's Archives of Surgery, 409(1) (1)
    Scientific journal

  • Takeshi Yamada, Hideki Endo, Hiroshi Hasegawa, Yoshihiro Kakeji, Hiroyuki Yamamoto, Hiroaki Miyata, Koki Otsuka, Akihisa Matsuda, Hiroshi Yoshida, Yuko Kitagawa
    Abstract Background Anemia has negative effects on long‐term outcomes of rectal cancer patients; however, its status as a risk factor for severe complications is disputed. Perioperative risks may differ based on the severity of pre‐surgical anemia; nonetheless, no previous study has investigated these differences. This study identified risks of severe postoperative complications in rectal cancer patients based on severity of their pre‐surgical anemia. Materials and Methods This study enrolled patients who underwent low anterior resection for rectal cancer and were registered in the Japanese National Clinical Database (NCD) between 2017 and 2019. Anemia severity was categorized into three levels: mild, moderate, and severe. A logistic regression model was applied to calculate the risk‐adjusted odds ratio (OR) of severe complications after surgery. Results This study analyzed a cohort of 51 765 rectal cancer patients who underwent low anterior resection. Results showed that severe complications occurred in 10.9% of patients and were significantly more frequent in patients with anemia (13.6%) than those with normal hemoglobin levels (9.2%). Risk‐adjusted ORs of severe complications in the severe, moderate, and mild anemia groups versus the normal group for males were 1.19 (95% confidence interval [CI]: 0.89–1.58), 1.47 (1.34–1.62), and 1.21 (1.12–1.31), respectively. Those for females were 1.39 (0.90–2.15), 1.64 (1.37–1.97), and 1.36 (1.16–1.58), respectively. Conclusions According to this large cohort study, pre‐surgical anemia significantly increases the risk of severe postoperative complications in rectal cancer patients. Even mild anemia presents a significant risk.
    Wiley, Jan. 2024, Annals of Gastroenterological Surgery, 8(3) (3), 471 - 480
    Scientific journal

  • YUKI AZUMI, SHINGO KANAJI, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI, YOSHIHIRO KAKEJI
    Background/Aim: The relationship between gastric cancer and oral health has been reported in several studies. This study aimed to determine the relationship between the postoperative prognosis of gastric cancer and oral health using preoperative tooth loss as a simple index. Patients and Methods: We conducted a single-center retrospective cohort study. Patients were divided into two groups according to the number of tooth losses. The survival curve was constructed using the Kaplan–Meier method. We also performed univariate and multivariate analyses of overall survival based on Cox proportional hazard regression to determine prognostic factors. Results: A total of 191 patients were divided into two groups: those with seven or more tooth losses and those with less than seven tooth losses. The three-year overall survival rate was 71.5% in the group with seven or more tooth losses and 87.0% in the group with less than seven tooth losses. The group with seven or more tooth losses had a significantly lower overall survival rate compared to the group with less than seven tooth losses (p=0.0014). However, in multivariate analysis, tooth loss was not identified as an independent prognostic factor whereas age, clinical T stage, CEA level, and serum albumin level were independent poor prognostic factors. Conclusion: Preoperative tooth loss was not a prognostic factor for gastric cancer after gastrectomy, but tooth loss may be a simple and useful method for evaluating frailty in patients.
    Anticancer Research USA Inc., Jan. 2024, Cancer Diagnosis & Prognosis, 4(1) (1), 51 - 56
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 小松 昇平, 岡田 健次, 掛地 吉弘, 國久 智成, 尾藤 祐子, 眞庭 謙昌, 福本 巧
    (株)医学書院, Jan. 2024, 臨床外科, 79(1) (1), 44 - 47, Japanese

  • 後藤 裕信, 小寺澤 康文, 加藤 喬, 押切 太郎, 掛地 吉弘
    (株)日本臨床社, Jan. 2024, 日本臨床, 82(増刊1 ロボット支援手術) (増刊1 ロボット支援手術), 163 - 169, Japanese

  • TAKASHI NAKANISHI, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, SHINGO KANAJI, TARO OSHIKIRI, YOSHIHIRO KAKEJI
    Anticancer Research USA Inc., Dec. 2023, Anticancer Research, 44(1) (1), 229 - 237
    Scientific journal

  • Yasufumi Koterazawa, Taro Oshikiri, Hironobu Goto, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Springer Science and Business Media LLC, Dec. 2023, Annals of Surgical Oncology, 31(4) (4), 2482 - 2489
    Scientific journal

  • Takashi Kato, Taro Oshikiri, Yasufumi Koterazawa, Hironobu Goto, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Springer Science and Business Media LLC, Dec. 2023, Surgery Today
    Scientific journal

  • 都 鍾智, 松田 武, 加藤 喬, 清水 将来, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 山下 公大, 押切 太郎, 掛地 吉弘
    (株)癌と化学療法社, Dec. 2023, 癌と化学療法, 50(13) (13), 1370 - 1373, Japanese

  • 中西 崇, 長谷川 寛, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    (株)癌と化学療法社, Dec. 2023, 癌と化学療法, 50(13) (13), 1374 - 1377, Japanese

  • 消化管腫瘍の新展開 2021～2023
    掛地 吉弘, 伊東 文生, 片岡 洋望, 佐竹 悠良
    Lead, Dec. 2023, 日本消化管学会雑誌, 7(1) (1), 43 - 51

  • TOMOSUKE MUKOYAMA, SHINGO KANAJI, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI, YOSHIHIRO KAKEJI
    Anticancer Research USA Inc., Nov. 2023, Anticancer Research, 43(12) (12), 5649 - 5656
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Yoshihiro Kakeji, Koji Kono, Yuko Kitagawa, Hiroya Takeuchi
    Springer Science and Business Media LLC, Nov. 2023, Esophagus, 21(1) (1), 2 - 10
    Scientific journal

  • Shimpei Ogawa, Hideki Endo, Masahiro Yoshida, Tomomitsu Tsuru, Michio Itabashi, Hiroyuki Yamamoto, Yoshihiro Kakeji, Hideki Ueno, Yuko Kitagawa, Taizo Hibi, Akinobu Taketomi, Norihiko Ikeda, Masaki Mori
    Abstract Aim Possible negative effects of the COVID‐19 pandemic on short‐term postoperative outcomes for colorectal perforation in Japan were examined in this study. Methods The National Clinical Database (NCD) is a large‐scale database including more than 95% of surgical cases in Japan. We analyzed 13 107 cases of colorectal perforation from 2019 to 2021. National data were analyzed, and subgroup analyses were conducted for subjects in prefectures with high infection levels (HILs) and metropolitan areas (Tokyo Met. and Osaka Pref.). Postoperative 30‐day mortality, surgical mortality, and postoperative complications (Clavien–Dindo grade ≥3) were examined. Months were considered to have significantly high or low mortality or complication rates, if the 95% confidence interval (CI) of the standardized mortality (morbidity) ratio (SMR) does not contain 1. Results In the NCD, postoperative 30‐day mortality occurred in 1371 subjects (10.5%), surgical mortality in 1805 (13.8%), and postoperative complications in 3950 (30.1%). Significantly higher SMRs were found for 30‐day mortality in November 2020 (14.6%, 1.39 [95% CI: 1.04–1.83]) and February 2021 (14.6%, 1.48 [95% CI: 1.10–1.96]), and for postoperative complications in June 2020 (37.3%, 1.28 [95% CI: 1.08–1.52]) and November 2020 (36.4%, 1.21 [95% CI: 1.01–1.44]). The SMRs for surgical mortality were not significantly high in any month. In prefectures with HILs and large metropolitan areas, there were few months with significantly higher SMRs. Conclusions The COVID‐19 pandemic had limited negative effects on postoperative outcomes in patients with colorectal perforation. These findings suggest that the emergency system for colorectal perforation in Japan was generally maintained during the pandemic.
    Wiley, Nov. 2023, Annals of Gastroenterological Surgery, 8(3) (3), 450 - 463
    Scientific journal

  • Hiroyuki Yamamoto, Atsushi Nashimoto, Isao Miyashiro, Hiroaki Miyata, Yasushi Toh, Mitsukazu Gotoh, Yasuhiro Kodera, Yoshihiro Kakeji, Yasuyuki Seto
    Springer Science and Business Media LLC, Nov. 2023, Surgery Today, 54(5) (5), 459 - 470
    Scientific journal

  • Yuki Azumi, Yu-ichiro Koma, Shuichi Tsukamoto, Yu Kitamura, Nobuaki Ishihara, Keitaro Yamanaka, Takashi Nakanishi, Shoji Miyako, Satoshi Urakami, Kohei Tanigawa, Takayuki Kodama, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    Tumor-associated macrophages (TAMs), one of the major components of the tumor microenvironment, contribute to the progression of esophageal squamous cell carcinoma (ESCC). We previously established a direct co-culture system of human ESCC cells and macrophages and reported the promotion of malignant phenotypes, such as survival, growth, and migration, in ESCC cells. These findings suggested that direct interactions between cancer cells and macrophages contribute to the malignancy of ESCC, but its underlying mechanisms remain unclear. In this study, we compared the expression levels of the interferon-induced genes between mono- and co-cultured ESCC cells using a cDNA microarray and found that interferon-inducible protein 16 (IFI16) was most significantly upregulated in co-cultured ESCC cells. IFI16 knockdown suppressed malignant phenotypes and also decreased the secretion of interleukin-1α (IL-1α) from ESCC cells. Additionally, recombinant IL-1α enhanced malignant phenotypes of ESCC cells through the Erk and NF-κB signaling. Immunohistochemistry revealed that high IFI16 expression in human ESCC tissues tended to be associated with disease-free survival and was significantly associated with tumor depth, lymph node metastasis, and macrophage infiltration. The results of this study reveal that IFI16 is involved in ESCC progression via IL-1α and imply the potential of IFI16 as a novel prognostic factor for ESCC.
    MDPI AG, Nov. 2023, Cells, 12(22) (22), 2603 - 2603
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Itaru Endo, Arata Takahashi, Hisateru Tachimori, Hiroaki Miyata, Yuki Homma, Takafumi Kumamoto, Ryusei Matsuyama, Yoshihiro Kakeji, Yuko Kitagawa, Yasuyuki Seto
    Abstract Aim We explored institutional factors in Japan associated with lower operative mortality and failure‐to‐rescue (FTR) rates for eight major gastrointestinal procedures. Methods A 22‐item online questionnaire was sent to 2119 institutional departments (IDs) to examine the association between institutional factors and operative mortality and FTR rates. IDs were classified according to the number of annual surgeries, board certification status, and locality. In addition, the top 20% and bottom 20% of IDs were identified based on FTR rates and matched with the results of the questionnaire survey. Factors associated with operative mortality were selected by multivariate analysis. Results Of the 1083 IDs that responded to the questionnaire, 568 (213 382 patients) were included in the analysis. Operative morbidity, operative mortality, and FTR rates in the top 20% and bottom 20% of IDs were 13.1% and 8.4% (p < 0.001), 0.52% and 4.3% (p < 0.001), and 4.0% and 51.2% (p < 0.001), respectively. Based on the patients' background characteristics, the top 20% of IDs handled more advanced cases. No significant difference in locality was seen between better or worse hospital FTR rates, but fewer esophagectomies, hepatectomies, and pancreatoduodenectomies were performed in depopulated areas. Six items were found to be associated with operative mortality by multivariate logistic analysis. Only 50 (8.8%) IDs met all five factors related to better FTR rates. Conclusions The present findings indicate that several hospital factors surrounding surgical treatment, characterized by abundant human resources, are closely related to better postoperative recovery from severe complications.
    Wiley, Oct. 2023, Annals of Gastroenterological Surgery, 8(2) (2), 342 - 355
    Scientific journal

  • Atsushi Shimada, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    Abstract There has been no reliable marker for predicting oncological outcomes in patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy (NACRT). We retrospectively analyzed 73 patients with LARC who underwent curative surgery after NACRT. The modified Glasgow prognostic score (mGPS) was assessed after NACRT, and clinical outcomes were compared between the high (mGPS = 1 or 2; n = 23) and low (mGPS = 0; n = 50) groups. Body mass index was significantly higher in the low mGPS group. The 5-year disease-free survival (DFS) rate was significantly worse in the high mGPS group than that in the low mGPS group (36.7% vs. 76.6%, p = 0.002). Univariate and multivariate analyses of DFS revealed that mGPS was the most significant predictor (p < 0.001). mGPS appears to be a reliable predictor of oncological outcomes in patients with LARC undergoing NACRT.
    Springer Science and Business Media LLC, Oct. 2023, Scientific Reports, 13(1) (1)
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 医学生に対する外科勧誘のアプローチ
    小松 昇平, 岡田 健次, 掛地 吉弘, 國久 智成, 尾藤 祐子, 眞庭 謙昌, 福本 巧
    Oct. 2023, 臨床外科, 78(10) (10), 1272 - 1276

  • Fumihiro Terasaki, Shinya Hirakawa, Hisateru Tachimori, Teiichi Sugiura, Atsushi Nanashima, Shohei Komatsu, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
    Abstract Background The aim of this study was to analyze the nationwide surgical outcome of a left trisectionectomy (LT) and to identify the perioperative risk factors associated with its morbidity. Methods Cases of LT for hepato‐biliary malignancies registered at the Japanese National Clinical Database between 2013 and 2019 were retrospectively reviewed. Statistical analyses were performed to identify the perioperative risk factors associated with a morbidity of Clavien–Dindo classification (CD) ≥III. Results Left trisectionectomy was performed on 473 and 238 cases of biliary and nonbiliary cancers, respectively. Morbidity of CD ≥III and V occurred in 45% and 5% of cases with biliary cancer, respectively, compared with 26% and 2% of cases with nonbiliary cancer, respectively. In multivariable analyses, biliary cancer was significantly associated with a morbidity of CD ≥III (odds ratio, 1.87; p = .018). In subgroup analyses for biliary cancer, classification of American Society of Anesthesiologists physical status (ASA‐PS) 2, portal vein resection (PVR), and intraoperative blood loss ≥30 mL/kg were significantly associated with a morbidity of CD ≥III. Conclusions Biliary cancer induces severe morbidity after LT. The ASA‐PS classification, PVR, and intraoperative blood loss indicate severe morbidity after LT for biliary cancer.
    Wiley, Sep. 2023, Journal of Hepato-Biliary-Pancreatic Sciences, 30(12) (12), 1304 - 1315
    Scientific journal

  • Shigeki Yamaguchi, Hideki Endo, Hiroyuki Yamamoto, Toshiyuki Mori, Takeyuki Misawa, Masafumi Inomata, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa, Masahiko Watanabe, Yoshiharu Sakai
    BACKGROUND: There are few studies on the impact of a colorectal-specific technically certified surgeon on good surgical outcomes for laparoscopic low anterior resection in the real world. OBJECTIVE: To evaluate the short-term outcomes of laparoscopic low anterior resection with the participation of a certified colorectal surgeon. DESIGN: This was a retrospective cohort study using a Japanese nationwide database. SETTING: This study was conducted as a project for the Japan Society of Endoscopic Surgery and the Japanese Society of Gastroenterological Surgery. PATIENTS: This study included 41,741 patients listed in the National Clinical Database who underwent laparoscopic low anterior resection performed by certified, noncertified, and colorectal-specific certified surgeons, according to the Endoscopic Surgical Skill Qualification System, from 2016 to 2018. MAIN OUTCOME MEASURES: Operative mortality rate and anastomotic leak rate were the primary outcome measures. RESULTS: Overall 30-day mortality and operative mortality were 0.2% and 0.3%, respectively, without significant differences between all kinds of certified and noncertified surgeon groups. Overall anastomotic leak rate was 9.3%, with a significant difference between the 2 groups. Colorectal- and stomach-certified groups had lower 30-day mortality and operative mortality than the biliary-certified and noncertified groups. The anastomotic leak rate was the lowest in the colorectal-certified group. Based on a logistic regression analysis using the risk-adjusted model, operative mortality was significantly higher in the biliary-certified group than in the colorectal-certified group. Moreover, anastomotic leak rate was significantly lower in the colorectal-certified group than in the stomach-certified and noncertified groups. LIMITATIONS: This study was a retrospective study, and there was a possibility of different definitions of anastomotic leak due to the use of a nationwide database. CONCLUSIONS: The participation of a colorectal-specific certified surgeon may decrease the risk of operative mortality and anastomotic leak for laparoscopic low anterior resection. CIRUJANO COLORRECTAL ALTAMENTE CALIFICADO PROVOCA RESULTADOS QUIRÚRGICOS FAVORABLES A CORTO PLAZO PARA LA RESECCIÓN ANTERIOR BAJA LAPAROSCÓPICA: EVALUACIÓN DE LA BASE DE DATOS NACIONAL JAPONESA ANTECEDENTES: Hay pocos estudios sobre el impacto de un cirujano certificado técnicamente especializado en cáncer colorrectal con un buen resultado quirúrgico para la resección anterior baja laparoscópica en el mundo real. OBJETIVO: Evaluar los resultados a corto plazo de la resección anterior baja laparoscópica con la participación de un cirujano colorrectal certificado. DISEÑO: Este fue un estudio de cohorte retrospectivo que utilizó una base de datos nacional japonesa. AJUSTE: Este estudio se realizó como un proyecto para la Sociedad Japonesa de Cirugía Endoscópica y la Sociedad Japonesa de Cirugía Gastroenterológica. PACIENTES: este estudio incluyó a 41 741 pacientes incluidos en la base de datos clínica nacional que se sometieron a una resección anterior baja laparoscópica realizada por cirujanos certificados, no certificados y certificados específicamente colorrectales, según el Sistema de calificación de habilidades quirúrgicas endoscópicas de 2016 a 2018. PRINCIPALES MEDIDAS DE RESULTADO: La tasa de mortalidad operatoria y la tasa de fuga anastomótica fueron los resultados primarios. RESULTADOS: La mortalidad general a los 30 días y la mortalidad operatoria fueron del 0,2 % y el 0,3 %, respectivamente, sin diferencias significativas entre los grupos de todos los tipos de cirujanos certificados y no certificados. La tasa global de fuga anastomótica fue del 9,3 %, con una diferencia significativa entre los dos grupos. Los grupos con certificación colorrectal y estomacal tuvieron una mortalidad a los 30 días y una mortalidad operatoria más bajas que los grupos con certificación biliar y sin certificación. La tasa de fuga anastomótica fue la más baja en el grupo certificado colorrectal. Con base en un análisis de regresión logística utilizando el modelo ajustado por riesgo, la mortalidad operatoria fue significativamente más alta en el grupo con certificación biliar que en el grupo con certificación colorrectal. Además, la tasa de fuga anastomótica fue significativamente más baja en el grupo con certificación colorrectal que en los grupos con certificación estomacal y sin certificación. LIMITACIONES: Este estudio fue retrospectivo y existía la posibilidad de diferentes definiciones de fuga anastomótica debido al uso de una base de datos nacional. CONCLUSIONES: La participación de un cirujano certificado en video específico colorrectal puede disminuir el riesgo de mortalidad operatoria y fuga anastomótica para la resección anterior baja laparoscópica. (Traducción—Dr. Mauricio Santamaria)
    Ovid Technologies (Wolters Kluwer Health), Sep. 2023, Diseases of the Colon & Rectum, 66(12) (12), e1217 - e1224
    Scientific journal

  • 【免疫療法を支える基礎研究】深層学習アルゴリズムを基盤としたイメージングサイトメトリーによる大腸癌腫瘍免疫微小環境の解析
    山下 公大, 長坂 暢, 安達 祐里, 阿部 智喜, 掛地 吉弘
    Sep. 2023, 癌と化学療法, 50(9) (9), 955 - 957

  • Ryo Seishima, Hideki Endo, Taizo Hibi, Masashi Takeuchi, Yutaka Nakano, Hiroyuki Yamamoto, Hiroaki Miyata, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa
    Abstract Aim The Coronavirus Disease 2019 (COVID‐19) pandemic affected the allocation of various medical resources to several areas, including intensive care units (ICUs). However, currently, its impact on the short‐term postoperative outcomes of gastrointestinal cancer surgeries remains unclear. We aimed to evaluate the impact of the pandemic on the incidence of complications occurring after low anterior resection in patients with rectal cancer in Japan. Methods Data from the Japanese National Clinical Database between 2018 and 2021 were retrospectively examined. The primary outcome of the study was the postoperative morbidity and mortality rates before and after COVID‐19 pandemic. Moreover, the postoperative ICU admission rate was assessed. Morbidity and mortality rates were also assessed using a standardized morbidity/mortality ratio (SMR, the ratio of the actual number of incidences to the expected number of incidences calculated by the risk calculator). Results This study included 74 181 patients, including 43 663 (58.9%) from COVID‐19 epidemic areas. The mean actual incidences of anastomotic leakage (AL) and pneumonia during the study period were 9.2% and 0.9%, respectively. The SMRs of these complications did not increase during the pandemic but those of AL declined gradually. The mean 30‐day mortality and operative mortality rates were 0.3% and 0.5%, respectively. Moreover, SMRs did not change significantly in the pandemic or regional epidemic status. The ICU admission rate temporarily decreased, especially in the epidemic areas. Conclusion Although the pandemic temporarily decreased the ICU admission rate, its impact on short‐term outcomes following low anterior resection in patients with rectal cancer was insignificant in Japan.
    Wiley, Aug. 2023, Annals of Gastroenterological Surgery, 8(1) (1), 107 - 113
    Scientific journal

  • Yoshihiro Kakeji
    Wiley, Aug. 2023, Annals of Gastroenterological Surgery, 7(5) (5), 694 - 695
    Scientific journal

  • Yasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, Takeshi Sano, Wataru Ichikawa, Yoshihiro Kakeji, Yu Sunakawa, Masahiro Takeuchi, Masashi Fujii
    PURPOSE: A phase III trial comparing S-1 and docetaxel with S-1 alone as postoperative chemotherapy for pathologically Stage III gastric cancer was conducted and clarified the superiority of the doublet in terms of 3-year relapse-free survival as the primary endpoint (67.7% versus 57.4%, hazard ratio [HR] 0.715, 95% confidence interval [CI] 0.587-0.871; p = 0.0008). This final report analyzed 5-year survival outcomes along with the incidence and pattern of late recurrences. PATIENTS AND METHODS: Patients with histologically confirmed Stage III gastric cancer who underwent gastrectomy with D2 lymphadenectomy were randomly assigned to receive adjuvant chemotherapy with either S-1 plus docetaxel or S-1 alone. The same 912 patients who were evaluated for 3-year survival outcomes in the previous report were analyzed. RESULTS: Five-year overall survival rate of the S-1 plus docetaxel group (67.91%) was significantly superior to that in the S-1 group (60.27%; HR 0.752, 95% CI 0.613-0.922; p = 0.0059). The incidence of late recurrence at > 3 years after randomization was similar in both groups (7.3% versus 7.2%). Peritoneal dissemination was the most common pattern of late recurrence. Addition of docetaxel significantly suppressed relapse through the lymphatic (6.8% [95% CI 4.52-9.17] versus 15% [95% CI 11.76-18.30]; p < 0.0001) and hematogenous (10.2% [95% CI 7.37-12.94] versus 15.7% [95% CI 12.36-19.01]; p < 0.0137) pathways throughout the 5 years of follow-up. CONCLUSION: The survival benefit of postoperative chemotherapy with S-1 and docetaxel in terms of 5-year overall survival rate was confirmed for patients with pathologically Stage III gastric cancer, although late recurrences were not prevented.
    Aug. 2023, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, English, Domestic magazine
    Scientific journal

  • Satoru Matsuda, Yuko Kitagawa, Jun Okui, Akihiko Okamura, Hirofumi Kawakubo, Ryo Takemura, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki
    OBJECTIVE: This study aimed to validate the prognostic significance of stratification using pathological stage and response to neoadjuvant chemotherapy with a nationwide database from an authorized institute by the Japan Esophageal Society. BACKGROUND: We proposed the combined criteria using pStage and pathological response. Conducting a validation study using an expanded cohort in the clinical setting would be valuable since it was developed using retrospective data collection. METHODS: Patients with esophageal squamous cell carcinoma who underwent subtotal esophagectomy at 85 authorized institutes were retrospectively reviewed for esophageal cancer between 2010 and 2015. The prognostic value of the pathological response was evaluated within the same pStage. Moreover, risk stratification was developed to predict cancer-specific survival (CSS). RESULTS: The pathological response showed significant stratification of CSS in 3761 patients included in this analysis. We classified the patients into 7 groups as survival was significantly different between responders and nonresponders under the stratification with pStage, excluding pStage I comprising pStage 0-I/II responder/II nonresponder/III responder/III nonresponder/IV responder/IV nonresponder with the 5-year CSS of 83.7%/75.8%/68.9%/59.8%/44.4%/40.7%/23.1%, respectively. Furthermore, the area under the curve was significantly higher under the new classification than in the pStage alone ( P <0.001). CONCLUSIONS: The prognostic value of classification using pStage and the pathological response was successfully validated using real-world data in Japan. This result would guide appropriate treatment for patients with esophageal squamous cell carcinoma who received neoadjuvant chemotherapy followed by esophagectomy.
    Aug. 2023, Annals of surgery, 278(2) (2), e234-e239, English, International magazine
    Scientific journal

  • Takeru Matsuda, Yoshihiro Kakeji
    Aug. 2023, Journal of the American College of Surgeons, 237(2) (2), 396 - 396, English, International magazine

  • Tomoki Abe, Kimihiro Yamashita, Toru Nagasaka, Mitsugu Fujita, Kyousuke Agawa, Masayuki Ando, Tomosuke Mukoyama, Kota Yamada, Souichiro Miyake, Masafumi Saito, Ryuichiro Sawada, Hiroshi Hasegawa, Takeru Matsuda, Takashi Kato, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Hiroaki Yanagimoto, Taro Oshikiri, Tetsuo Ajiki, Takumi Fukumoto, Yoshihiro Kakeji
    BACKGROUND/AIM: In pathology, the digitization of tissue slide images and the development of image analysis by deep learning have dramatically increased the amount of information obtainable from tissue slides. This advancement is anticipated to not only aid in pathological diagnosis, but also to enhance patient management. Deep learning-based image cytometry (DL-IC) is a technique that plays a pivotal role in this process, enabling cell identification and counting with precision. Accurate cell determination is essential when using this technique. Herein, we aimed to evaluate the performance of our DL-IC in cell identification. MATERIALS AND METHODS: Cu-Cyto, a DL-IC with a bit-pattern kernel-filtering algorithm designed to help avoid multi-counted cell determination, was developed and evaluated for performance using tumor tissue slide images with immunohistochemical staining (IHC). RESULTS: The performances of three versions of Cu-Cyto were evaluated according to their learning stages. In the early stage of learning, the F1 score for immunostained CD8+ T cells (0.343) was higher than the scores for non-immunostained cells [adenocarcinoma cells (0.040) and lymphocytes (0.002)]. As training and validation progressed, the F1 scores for all cells improved. In the latest stage of learning, the F1 scores for adenocarcinoma cells, lymphocytes, and CD8+ T cells were 0.589, 0.889, and 0.911, respectively. CONCLUSION: Cu-Cyto demonstrated good performance in cell determination. IHC can boost learning efficiencies in the early stages of learning. Its performance is expected to improve even further with continuous learning, and the DL-IC can contribute to the implementation of precision oncology.
    Aug. 2023, Anticancer research, 43(8) (8), 3755 - 3761, English, International magazine
    Scientific journal

  • Junko Mukohyama, Kyosuke Agawa, Kimihiro Yamashita, Takeru Matsuda, Masahiro Shinoda, Osamu Itano, Yoshihiro Kakeji
    BACKGROUND/AIM: Colorectal cancer (CRC) with reduced expression of the homeobox transcription factor CDX2, a master gene essential for the development and maintenance of the intestinal tract, is known as a poor prognosis subtype of CRC. The recurrence rate is high in patients with CDX2low CRC. However, the prognostic significance of CDX2 in advanced CRC is unclear. This study aimed to elucidate the prognostic significance of CDX2 in unresectable metastatic CRC (mCRC). PATIENTS AND METHODS: Twenty-nine patients with unresectable mCRC who underwent primary site resection at the Kobe University Hospital during a 6-year period from January 2008 to January 2015 were included. The tissues from those patients were immunohistochemically stained with anti-CDX2 antibody (clone: CDX2-88). The patients were divided into CDX2high CRC group and CDX2low CRC group and their prognoses were analyzed. RESULTS: There were no clear differences in background between the two groups. A low CDX2 expression was associated with reduced overall survival (37.67 months vs. 25.32 months, p=0.03) and tended to associate with reduced progression-free survival (17.4 months vs. 12.9 months, p=0.37). Two patients received chemotherapy after resection of the primary lesion and obtained pathological complete response. CONCLUSION: CDX2 expression might be a possible prognostic biomarker for unresectable mCRC.
    Aug. 2023, Anticancer research, 43(8) (8), 3763 - 3767, English, International magazine
    Scientific journal

  • Tomoki Abe, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Takashi Kato, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. In recent years, the proportion of patients diagnosed with CRC at younger ages has increased. The clinicopathological features and oncological outcomes in younger patients with CRC remain controversial. We aimed to analyze the clinicopathological features and oncological outcomes in younger patients with CRC. METHODS: We examined 980 patients who underwent surgery for primary colorectal adenocarcinoma between 2006 and 2020. Patients were divided into two cohorts: younger (< 40 years old) and older (≥ 40 years old). RESULTS: Of the 980 patients, 26 (2.7%) were under the age of 40 years. The younger group had more advanced disease (57.7% vs. 36.6%, p = 0.031) and more cases beyond the transverse colon (84.6% vs. 65.3%, p = 0.029) than the older group. Adjuvant chemotherapy was administered more frequently in the younger group (50% vs. 25.8%, p < 0.01). Relapse-free survival and overall survival were similar between the groups at all stages. Moreover, in stages II and III they were also comparable, regardless of the administration of adjuvant chemotherapy. CONCLUSIONS: Younger patients with CRC have a prognosis equivalent to that of older patients. Further studies are needed to establish the optimal treatment strategies for these patients.
    Jul. 2023, International journal of colorectal disease, 38(1) (1), 191 - 191, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Satoru Matsuda, Yuko Kitagawa, Ryo Takemura, Jun Okui, Akihiko Okamura, Hirofumi Kawakubo, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki
    OBJECTIVE: We aimed to evaluate the efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy over cisplatin and 5-fluorouracil (CF) in patients with surgically resectable advanced esophageal squamous cell carcinoma (ESCC), using real-world data from 85 esophageal centers. BACKGROUND: JCOG1109 trial, which assessed the superiority of DCF over CF, and the superiority of chemoradiotherapy with CF over CF alone demonstrated the significant survival advantage of neoadjuvant DCF in overall survival (OS) over CF for ESCC. METHODS: The ESCC patients who received neoadjuvant CF or DCF at 85 Japanese esophageal centers certified by the Japan Esophageal Society were retrospectively reviewed. After propensity score (PS) matching, the OS and recurrence-free survival were compared between CF and DCF. RESULTS: We initially enrolled 4781 patients. After data cleaning and PS matching using pretreatment variables, 1074 patients for each group were selected for subsequent analysis. There was no significant difference in the incidence of postoperative pneumonia and anastomotic leakage. In the survival analysis, OS was significantly longer in DCF group than CF group (hazard ratio, 0.868; 95% confidence interval, 0.770-0.978; P =0.02), as well as recurrence-free survival (hazard ratio, 0.850; 95% confidence interval, 0.761-0.949; P =0.004). The survival advantage of DCF was not observed in patients with 76 years old or older. CONCLUSIONS: Neoadjuvant DCF therapy showed a remarkable survival advantage in surgically resectable ESCC patients, especially in patients who were 75 years old or younger. The current real-world evidence will encourage recommendations for DCF as a standard regimen in neoadjuvant chemotherapy-based treatment strategy for ESCC.
    Jul. 2023, Annals of surgery, 278(1) (1), e35-e42, English, International magazine
    Scientific journal

  • Satoru Matsuda, Yuko Kitagawa, Jun Okui, Akihiko Okamura, Hirofumi Kawakubo, Ryo Takemura, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki
    BACKGROUND: The prognostic impact of docetaxel, cisplatin, and 5-FU (DCF) reported in JCOG1109 was successfully validated using real-world data in patients < 75 years old. However, DCF was not reported to be beneficial in elderly patients with a relatively higher postoperative complication incidence. This study aimed to clarify the impact of postoperative complications on the prognosis of ESCC and the difference in the magnitude of the impact by age and regimen. METHODS: Patients with esophageal squamous cell carcinoma (ESCC) who underwent subtotal esophagectomy at 85 authorized institutes were retrospectively reviewed from 2010 to 2015. The prognostic impact of postoperative anastomotic leakage (AL) and pneumonia on survival was evaluated. The prognostic value of the postoperative complications was assessed by stratifying patients according to age and neoadjuvant chemotherapy regimen. RESULTS: Patients with AL, pneumonia, and infectious complications (ICs: a combination of pneumonia and AL) showed significantly worse overall survival (OS). IC served as a negative prognostic factor of OS and recurrence-free survival, and its negative prognostic impact was more evident in patients aged > 75 years. When the patients were further stratified by chemotherapeutic regimens, using the CF/IC(-) group as a reference, the DCF/IC (+) group showed significantly shorter OS in patients aged > 75 years with a hazard ratio (HR) of 2.551. The HR of the CF/IC (+) group was 1.503. CONCLUSIONS: The negative impact of postoperative complications on survival was confirmed in this nationwide study. Furthermore, its magnitude was higher in elderly patients who received triplet chemotherapy.
    Jul. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(3) (3), 445 - 454, English, Domestic magazine
    Scientific journal

  • Yoshihiro Mise, Shinya Hirakawa, Hisateru Tachimori, Yoshihiro Kakeji, Yuko Kitagawa, Shohei Komatsu, Atsushi Nanashima, Masafumi Nakamura, Itaru Endo, Akio Saiura
    BACKGROUND: Centralization of complex surgeries has made little progress when it only considers the minimum number of surgical procedures. We aim to assess the impact of certification system of Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) on centralization and surgical quality of advanced hepato-pancreatic-biliary (HPB) surgery. METHODS: The National Clinical Database was used to review 20 111 patients who underwent pancreatoduodenectomy (PD) and 9666 who underwent advanced hepatectomy defined as hepatectomy of more than one section during 2019 and 2020. JSHPBS certifies hospitals based on the annual number of advanced HPB surgeries and the surgical quality. Minimum numbers of surgeries for board-certified A and B institutions are 50 and 30, respectively. Short-term outcomes were compared among institutions. RESULTS: In 2020, 69.4% (7007/10090) and 72.9% (3433/4710) of patients underwent PD and advanced hepatectomy at board-certified institutions. In-hospital mortality rates after PD was 0.9% at certified A institutions, 1.4% at B institutions, and 2.7% at non-certified institutions (p < .001). The odds ratio (OR) of risk-adjusted mortality after PD compared with non-certified institutions was 0.39 (confidence interval [CI]: 0.30-0.50, p < .001) at certified A institutions, and 0.54 at certified B institutions (CI: 0.40-0.73, p < .001). In-hospital mortality rates after advanced hepatectomy was 1.7% at certified A institutions, 2.3% at B institutions, and 3.2% at non-certified institutions (p < .001). The OR of risk-adjusted mortality after advanced hepatectomy compared with non-certified institutions was 0.57 at certified A institutions (CI: 0.41-0.78, p < .001). CONCLUSION: The volume- and quality-controlled certification system of JSHBPS reduces surgical mortality after advanced HPB surgeries.
    Jul. 2023, Journal of hepato-biliary-pancreatic sciences, 30(7) (7), 851 - 862, English, Domestic magazine
    Scientific journal

  • Yutaka Miyawaki, Hisateru Tachimori, Yasuaki Nakajima, Hiroshi Sato, Naoto Fujiwara, Kenro Kawada, Hiroaki Miyata, Shinichi Sakuramoto, Hideaki Shimada, Masayuki Watanabe, Yoshihiro Kakeji, Yuichiro Doki, Yuko Kitagawa
    BACKGROUND: Cervical esophageal cancer accounts for a small proportion of all esophageal cancers. Therefore, studies examining this cancer include a small patient cohort. Most patients with cervical esophageal cancer undergo reconstruction using a gastric tube or free jejunum after esophagectomy. We examined the current status of postoperative morbidity and mortality of cervical esophageal cancer based on big data. METHODS: Based on the Japan National Clinical Database, 807 surgically treated patients with cervical esophageal cancer were enrolled between January 1, 2016, and December 31, 2019. Surgical outcomes were retrospectively reviewed for each reconstructed organ using gastric tubes and free jejunum. RESULTS: The incidence of postoperative complications related to reconstructed organs was higher in the gastric tube reconstruction (17.9%) than in the free jejunum (6.7%) for anastomotic leakage (p < 0.01), but not significantly different for reconstructed organ necrosis (0.4% and 0.3%, respectively). The incidence rates of overall morbidity, pneumonia, 30-day reoperation, tracheal necrosis, and 30-day mortality using these reconstruction methods were 64.7% and 59.7%, 16.7% and 11.1%, 9.3% and 11.4%, 2.2% and 1.6%, and 1.2% and 0.0%, respectively. Only pneumonia was more common in the gastric tube reconstruction group (p = 0.03), but was not significantly different for any other complication. CONCLUSIONS: The incidence of overall morbidities and reoperation, especially anastomotic leakage after gastric tube reconstruction, suggested a necessity for further improvement. However, the incidence of fatal complications, such as tracheal necrosis or reconstructed organ necrosis, was low for both reconstruction methods, and the mortality rate was acceptable as a means of radical treatment.
    Jul. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(3) (3), 427 - 434, English, Domestic magazine
    Scientific journal

  • Satoru Matsuda, Yuko Kitagawa, Jun Okui, Akihiko Okamura, Hirofumi Kawakubo, Ryo Takemura, Koji Kono, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki
    BACKGROUND: Our previous study reported the prognostic significance of endoscopic response (ER) evaluation, defined ER, and revealed ER as an independent prognostic factor of overall survival (OS) and recurrence-free survival (RFS) for esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemotherapy (NAC) and surgery. The present study aimed to validate the prognostic impact of ER using a nationwide database from the authorized institute for board-certified esophageal surgeons by the Japan Esophageal Society. METHODS: This study retrospectively reviewed patients with ESCC who underwent subtotal esophagectomy at 85 authorized institutes for esophageal cancer from 2010 to 2015. Patients were classified as ER when the tumor size was markedly reduced post-NAC compared to pre-NAC. The correlation between OS and RFS was investigated. RESULTS: Of 4781 patients initially enrolled, 3636 were selected for subsequent analysis. Of them, 642 (17.7%) patients were classified as the ER group. Patients with ER showed significantly better OS and RFS. Subgroup analysis revealed the statistical difference in OS and RFS in cStage II and III, while the magnitude of survival difference between ER and non-ER was not evident in cStage I and IV. The percentage of ER varied from 46 to 87% among groups when institutions were classified into 3 subgroups based on the hospital volume, which would indicate the interinstitutional inconsistency. CONCLUSIONS: The prognostic impact of ER was validated using a nationwide database. Standardization of ER evaluation is required to improve the interinstitutional consistency and clinical validity of the ER evaluation.
    Jul. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(3) (3), 455 - 464, English, Domestic magazine
    Scientific journal

  • Manabu Horikawa, Taro Oshikiri, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Jul. 2023, Annals of surgical oncology, 30(7) (7), 4056 - 4057, English, International magazine
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    BACKGROUND: Although neoadjuvant treatment (NAT) has become the standard of care for patients with locally advanced esophageal cancer, the risk of recurrence remains high. The risk must be predicted accurately, so that appropriate adjuvant therapy can be planned. We aimed to develop a model predicting recurrence of esophageal squamous cell carcinoma (ESCC) in patients who received NAT before esophagectomy. METHODS: This nationwide study included 3874 patients from 85 institutions. Patients who underwent NAT and then surgery for ESCC were eligible. We developed a Cox proportional hazards model and created a nomogram to predict disease recurrence after NAT and curative esophagectomy. RESULTS: Of the patients, 268 (6.9%), 1280 (33.0%), 2006 (51.8%), and 320 (8.3%) had clinical stage I, II, III, and IV tumors, respectively. The 5-year recurrence rate was 45.1% (95% confidence interval 43.4%-46.7%). Multivariable analysis revealed that body mass index, type of neoadjuvant treatment, primary tumor location, operative blood loss, pathological tumor stage, pathological therapeutic effect, and leakage were independently associated with disease recurrence. Using 13 commonly measured perioperative variables, we created a predictive nomogram, and the area under the curve was 0.783 (95% confidence interval 0.766-0.800). This nomogram was also adequately validated internally and had excellent calibration capacity (calibration slope, 0.992). CONCLUSIONS: The model developed in this study adequately predicted ESCC recurrence in patients who underwent NAT and then esophagectomy. Further research with this nomogram is needed to assess the effect of adjuvant therapy in patients at high risk for recurrence.
    Jul. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(3) (3), 465 - 473, English, Domestic magazine
    Scientific journal

  • Manabu Horikawa, Taro Oshikiri, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND: Retrosternal reconstruction has lower risks for severe postoperative morbidities, such as gastro-tracheal fistula or esophageal hiatal hernia. We have previously reported the laparoscopic retrosternal route creation (LRRC) method, but its safety and efficacy remain unclear. METHODS: In total, 374 patients with esophageal carcinoma who underwent minimally invasive McKeown esophagectomy in the prone position between 2010 and 2021 were retrospectively reviewed. We performed a propensity score-matched analysis with the simple, nearest-neighbor method and no calipers to compare postoperative outcomes and reconstructed gastric conduit functionality between patients who underwent LRRC and counterparts who underwent posterior mediastinal reconstruction. RESULTS: After matching, 62 patients were included in the laparoscopic retrosternal group (LR group) or posterior mediastinal group (PM group). No significant differences were observed between the groups, apart from the number of robot-assisted surgeries, the extent of lymph node dissection, and the method of cervical anastomosis. There were no significant differences in the incidence of Clavien-Dindo grade ≥ 2 complications. Gastro-tracheal fistula (n = 1) and esophageal hiatal hernia (n = 2) occurred in the PM group but not in the LR group. There were no differences in the incidence of pulmonary embolism between the groups (5% vs. 5%). The postoperative anastomotic stenosis rate was similar (16% vs. 27%, p = 0.192). Endoscopic findings of reflux esophagitis (modified Los Angeles classification ≥ M) at 1 year after surgery were significantly better in the LR group (p = 0.037). CONCLUSIONS: LRRC for gastric conduit reconstruction is safe and valuable. It is associated with good reconstructed gastric conduit function.
    Jul. 2023, Annals of surgical oncology, 30(7) (7), 4044 - 4053, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Shingo Kanaji, Naoki Urakawa, Tomosuke Mukoyama, Hitoshi Harada, Takashi Kato, Hironobu Goto, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND/AIM: There are several concerns about oncological contamination and technical difficulty in the laparoscopic approach for locally advanced gastric cancer. We aimed to determine the safety and usefulness of laparoscopic gastrectomy for patients with advanced gastric cancer with tumor depth greater than serosal invasion. PATIENTS AND METHODS: Sixty-two laparoscopic and 82 laparotomy gastric cancer cases surgically diagnosed as serosal or other organ invasions intraoperatively between 2011 and 2021 were included. The laparoscopic and open gastrectomy results were compared by propensity score matching using stage, preoperative chemotherapy, curative resection, surgical technique, and age as explanatory variables and laparoscopy and open resection as outcome variables. RESULTS: No difference in median operative time (341 vs. 386 minutes, p=0.24) was observed, but median blood loss (0 vs. 510 ml, p<0.001) and blood transfusion requirement (9.5 vs. 43%, p<0.001) were lower in the laparoscopic group. No difference was observed between the two groups regarding complications. Furthermore, 3-year overall survival was also similar (43 vs. 42%, p=0.74). CONCLUSION: The laparoscopic surgery results are comparable to those of open surgery in treating gastric cancer with T4a or greater depth. In addition, it is minimally invasive with less blood loss, making it a standard approach.
    Jul. 2023, Anticancer research, 43(7) (7), 3145 - 3152, English, International magazine
    Scientific journal

  • Hidefumi Shiroshita, Hideki Endo, Masafumi Inomata, Tomonori Akagi, Hiroyuki Yamamoto, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa, Akinobu Taketomi, Masaki Mori
    AIM: This study aimed to evaluate the impact of the coronavirus disease (COVID-19) pandemic on elective endoscopic surgeries in Japan using the National Clinical Database. METHODS: We retrospectively analyzed the clinicopathological factors and surgical outcomes of laparoscopic cholecystectomy (LC), laparoscopic distal gastrectomy (LDG), and laparoscopic low anterior resection (LLAR) and compared the monthly numbers of each procedure performed in 2020 with those in 2018 and 2019. The degree of infection in prefectures was classified into low and high groups. RESULTS: In 2020, the number of LCs (except for acute cholecystitis) was 76 079 (93.0% of that in 2019), the number of LDGs was 14 271 (85.9% of that in 2019), and the number of LLARs was 19 570 (88.1% of that in 2019). Although the number of robot-assisted LDG and LLAR cases increased in 2020, the growth rate was mild compared with that in 2019. There was little difference in the number of cases in the degree of infection in the prefectures. The numbers of LC, LDG, and LLAR cases decreased from May to June and recovered gradually. In late 2020, the proportion of T4 and N2 cases of gastric cancer and the number of T4 cases of rectal cancer increased compared with those in 2019. There was little difference between the proportions of postoperative complications and mortality in the three procedures between 2019 and 2020. CONCLUSION: The number of endoscopic surgeries decreased in 2020 as a result of the COVID-19 pandemic. However, the procedures were performed safely in Japan.
    Jul. 2023, Annals of gastroenterological surgery, 7(4) (4), 572 - 582, English, Domestic magazine
    Scientific journal

  • Taro Oshikiri, Hironobu Goto, Takashi Kato, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Yasuhiro Fujino, Masahiro Tominaga, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND: The effect of lymphadenectomy around the recurrent laryngeal nerve (RLN) in open oesophagectomy was demonstrated with the Efficacy Index (EI). However, it remains unclear whether this effect exists for minimally invasive esophagectomy (MIE) in the prone position. The purpose of this study is to clarify the upper mediastinal lymphadenectomy contributes to improved prognosis in patients with esophageal squamous cell carcinoma. STUDY DESIGN: This study included 339 patients with esophageal squamous cell carcinoma treated with MIE in the prone position at Kobe University or Hyogo Cancer Center from 2010 to 2015. EI for each station, correlations between metastatic L/Ns around the left RLN and RLN palsy, and survival of patients with and without upper mediastinal lymphadenectomy were investigated. RESULTS: Among 297 patients treated with upper mediastinal lymphadenectomy, Clavien- Dindo grade > II left RLN palsy occurred in 59 patients (20%). Overall, EIs for the right RLN (7.4) and left RLN (6.6) were higher than EIs for other stations. For patients with upper-third or middle-third tumors, the trend was stronger. Left RLN palsy was more likely in patients with metastatic L/Ns around the left RLN than in those without (44% vs. 15%, P < 0.0001).After propensity score-matching, 42 patients were included in each group with and without upper mediastinal lymphadenectomy. In survival analyses, the 5-year overall survival (OS) were 55% vs. 35% and cause-specific survival (CSS) rates were 61% vs. 43% for the patients with and without upper mediastinal lymphadenectomy respectively. Significant differences were confirmed in survival curves (OS; P = 0.03 and CSS; P = 0.04, respectively). CONCLUSIONS: Upper mediastinal lymphadenectomy contributes to improved prognosis with high EIs in MIE in the prone position.
    Jun. 2023, Journal of the American College of Surgeons, English, International magazine
    Scientific journal

  • Mitsuhiko Ota, Hiroshi Saeki, Hideo Uehara, Yoshiko Matsuda, Satoshi Tsutsumi, Tetsuya Kusumoto, Hisateru Yasui, Yasunari Ubukata, Shohei Yamaguchi, Hiroyuki Orita, Naoki Izawa, Saburo Kakizoe, Mototsugu Shimokawa, Tomoharu Yoshizumi, Yoshihiro Kakeji, Masaki Mori, Eiji Oki
    BACKGROUND: Gastrectomy with D2 dissection and adjuvant chemotherapy is the standard treatment for locally advanced gastric cancer (LAGC) in Asia. However, administering chemotherapy with sufficient intensity after gastrectomy is challenging. Several trials demonstrated the efficacy of neoadjuvant chemotherapy (NAC). However, limited studies explored the feasibility of NAC-SOX for older patients with LAGC. This phase II study (KSCC1801) evaluated the safety and efficacy of NAC-SOX in patients with LAGC aged ≥ 70 years. METHODS: Patients received three cycles of SOX130 (oxaliplatin 130 mg/m2 on day 1, oral S-1 40-60 mg twice daily for two weeks every three weeks) as NAC, followed by gastrectomy with lymph node dissection. The primary endpoint was the dose intensity (DI). The secondary endpoints were safety, R0 resection rate, pathological response rate (pRR), overall survival, and relapse-free survival. RESULTS: The median age of 26 enrolled patients was 74.5 years. The median DI in NAC-SOX130 was 97.2% for S-1 and 98.3% for oxaliplatin. Three cycles of NAC were administered in 25 patients (96.2%), of whom 24 (92.3%) underwent gastrectomy with lymphadenectomy. The R0 resection rate was 92.3% and the pRR (≥ grade 1b) was 62.5%. The major adverse events (≥ grade 3) were neutropenia (20.0%), thrombocytopenia (11.5%), anorexia (11.5%), nausea (7.7%), and hyponatremia (7.7%). Postoperative complications of abdominal infection, elevated blood amylase, and bacteremia occurred in one patient each. Severe diarrhea and dehydration caused one treatment-related death. CONCLUSIONS: NAC-SOX130 is a feasible therapy for older patients, although systemic management and careful monitoring of adverse events are necessary.
    Jun. 2023, International journal of clinical oncology, English, Domestic magazine
    Scientific journal

  • Masashi Takeuchi, Hideki Endo, Taizo Hibi, Ryo Seishima, Yutaka Nakano, Hiroyuki Yamamoto, Hiroaki Miyata, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa
    BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic had adversely impacted cancer screening, diagnosis, and treatment. We investigated the change in medical resource, such as the intensive care unit use, and short-term outcomes after esophagectomy during the pandemic. METHODS: Data of patients who underwent esophagectomy for esophageal cancer registered in the National Clinical Database (NCD) in Japan from January 2018 to December 2021 were analyzed. The time series change in the number of surgical cases; usage of intensive care unit; incidence of morbidity and mortality; standardized mortality and morbidity ratio (SMR) for 30-days mortality; surgical mortality; and morbidities for pneumonia, sepsis, unplanned intubation, and anastomotic leakage were evaluated. RESULTS: The annual number of patients undergoing esophagectomy remained similar from 2018 to 2021. The negative impact of the pandemic on medical resources was strongly identified in the patients from an epidemic area where there is a higher cumulative number of infections per population as compared to all prefectures. The proportions of patients admitted to the intensive care unit were 91.4%, 93.0%, 91.6%, and 90.5% in 2018, 2019, 2020, and 2021, respectively. Moreover, 93.3%, 94.0%, 92.0%, and 90.9% patients who underwent surgery in an epidemic area were admitted to the intensive care unit in 2018, 2019, 2020, and 2021, respectively. However, the morbidity and mortality rates during the pandemic did not worsen according to the SMR values. CONCLUSIONS: Esophagectomy was performed during the pandemic despite limited medical resources by a systematic endeavor of the entire surgical department in Japan, without increasing the incidence rate of worse outcome.
    Jun. 2023, Esophagus : official journal of the Japan Esophageal Society, English, Domestic magazine
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    Jun. 2023, Annals of surgical oncology, English, International magazine
    Scientific journal

  • Kazushige Kawai, Shinya Hirakawa, Hisateru Tachimori, Taro Oshikiri, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa
    INTRODUCTION: We previously developed risk models for mortality and morbidity after low anterior resection using a nationwide Japanese database. However, the milieu of low anterior resection in Japan has undergone drastic changes since then. This study aimed to construct risk models for 6 short-term postoperative outcomes after low anterior resection, i.e., in-hospital mortality, 30-day mortality, anastomotic leakage, surgical site infection except for anastomotic leakage, overall postoperative complication rate, and 30-day reoperation rate. METHODS: This study enrolled 120,912 patients registered with the National Clinical Database, who underwent low anterior resection between 2014 and 2019. Multiple logistic regression analyses were performed to generate predictive models of mortality and morbidity using preoperative information, including the TNM stage. RESULTS: We developed new risk prediction models for the overall postoperative complication and 30-day reoperation rates for low anterior resection, which were absent from the previous version. The concordance indices for each endpoint were: 0.82 for in-hospital mortality, 0.79 for 30-day mortality, 0.64 for anastomotic leakage, 0.62 for surgical site infection besides anastomotic leakage, 0.63 for complications, and 0.62 for reoperation. The concordance indices of all four models included in the previous version showed improvement. CONCLUSION: This study successfully updated the risk calculators for predicting mortality and morbidity after low anterior resection using a model based on vast nationwide Japanese data.
    Jun. 2023, Digestive surgery, English, International magazine
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    Jun. 2023, Annals of surgical oncology, English, International magazine
    Scientific journal

  • 金治 新悟, 掛地 吉弘
    (株)医学書院, Jun. 2023, 臨床外科, 78(6) (6), 696 - 702, Japanese

  • 【食道・胃・大腸癌の最新情報】胃癌 胃がん内視鏡治療の進歩
    阪口 博哉, 児玉 裕三, 掛地 吉弘
    大道学館出版部, Jun. 2023, 臨牀と研究, 100(6) (6), 694 - 698, Japanese

  • Hironobu Goto, Taro Oshikiri, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Jun. 2023, Annals of surgical oncology, 30(6) (6), 3803 - 3804, English, International magazine
    Scientific journal

  • Takeyuki Misawa, Hideki Endo, Toshiyuki Mori, Shigeki Yamaguchi, Masafumi Inomata, Hiroyuki Yamamoto, Yoshiharu Sakai, Yoshihiro Kakeji, Hiroaki Miyata, Yuko Kitagawa
    BACKGROUND: Proficiency of the operating surgeon is one of the most critical factors potentially associated with reductions in complications and surgery-related mortality. With video-rating systems having shown potential for assessing laparoscopic surgeons' proficiency, the Endoscopic Surgical Skill Qualification System (ESSQS) was developed by the Japan Society for Endoscopic Surgery to subjectively assess the proficiency of laparoscopic surgeons by rating applicants' non-edited case videos. We conducted a study to evaluate how ESSQS skill-qualified (SQ) surgeon involvement influences short-term outcomes of laparoscopic gastrectomy performed for gastric cancer. METHODS: Data from the National Clinical Database regarding laparoscopic distal and total gastrectomy performed for gastric cancer between January 2016 and December 2018 were analyzed. Operative mortality, defined as 30-day mortality or 90-day in-hospital mortality, and anastomotic leakage rates were compared per involvement vs. non-involvement of an SQ surgeon. Outcomes were also compared per involvement of a gastrectomy-, colectomy-, or cholecystectomy-qualified surgeon. The association between the area of qualification and operative mortality/anastomotic leakage was also analyzed with a generalized estimating equation logistic regression model used to account for patient-level risk factors and institutional differences. RESULTS: Of 104,093 laparoscopic distal gastrectomies, 52,143 were suitable for inclusion in the study; 30,366 (58.2%) were performed by an SQ surgeon. Of 43,978 laparoscopic total gastrectomies, 10,326 were suitable for inclusion; 6501 (63.0%) were performed by an SQ surgeon. Gastrectomy-qualified surgeons outperformed non-SQ surgeons in terms of both operative mortality and anastomotic leakage. They also outperformed cholecystectomy- and colectomy-qualified surgeons in terms of operative mortality or anastomotic leakage in distal and total gastrectomy, respectively. CONCLUSION: The ESSQS appears to discriminate laparoscopic surgeons who can be expected to achieve significantly improved gastrectomy outcomes.
    Jun. 2023, Surgical endoscopy, 37(6) (6), 4627 - 4640, English, International magazine
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    BACKGROUND: Although neoadjuvant treatment has become the standard of care for patients with locally advanced esophageal cancer, previous studies comparing neoadjuvant chemotherapy (NAC) and neoadjuvant chemoradiotherapy (NACRT) have demonstrated inconclusive results. METHODS: Our study cohort included 3978 patients from 85 institutions. Those who underwent NAC or NACRT followed by surgery for esophageal squamous cell carcinoma (ESCC) were eligible for inclusion. We used the inverse probability of treatment weighting (IPTW) method to compare the outcomes between NAC and NACRT. RESULTS: Among the 3978 patients, 3777 (94.9%) received NAC and 201 (5.1%) received NACRT. After IPTW adjustment, the NACRT group had more patients with pathologically downstaged diseases and significantly better pathological response compared with the NAC group (p < 0.001); however, 5-year overall survival (OS), recurrence-free survival (RFS), and regional recurrence-specific survival (RRSS) were comparable between the groups. Subgroup analysis stratifying patients according to cT category showed that among cT1-2 patients, those in the NACRT group had significantly longer 5-year OS, RFS, and RRSS than those in the NAC group (P = 0.024, < 0.001, and 0.020, respectively). In contrast, no significant differences were observed among cT3-4a patients. The competing risks regression model showed comparable subdistribution hazard ratios for 10-year cancerous and noncancerous deaths between the NAC and NACRT groups. CONCLUSIONS: Compared with NAC, NACRT for ESCC did not promote better survival despite better therapeutic effects and did not increase noncancerous deaths.
    Jun. 2023, Annals of surgical oncology, English, International magazine
    Scientific journal

  • Masashi Takeuchi, Hideki Endo, Taizo Hibi, Ryo Seishima, Yutaka Nakano, Hiroyuki Yamamoto, Hiroaki Miyata, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa
    Abstract Background The coronavirus disease 2019 (COVID‐19) pandemic had resulted in either failure to provide required medical resources or delayed treatment for gastric cancer patients. This study aimed to investigate the impact of COVID‐19 on the incidence of postoperative complications using a nationwide Japanese database of patients undergoing distal gastrectomy for gastric cancer. Methods We collected the data of patients who underwent distal gastrectomy from January 2018 to December 2021 from the National Clinical Database (NCD), a web‐based surgical registration system in Japan. The number of surgical cases, the use of intensive care units, and the incidence of morbidity per month were analyzed. We also calculated the standardized mortality ratio (SMR), defined as the ratio of the number of observed patients to the expected number of patients calculated using the risk calculator established in the NCD, for several morbidities, including pneumonia, sepsis, 30‐day mortality, and surgical mortality. Results A decrease of 568 gastrectomies was observed from April 2020 to May 2020. Although the absolute number of patients admitted to intensive care units had declined since 2020, the proportion of patients admitted to the ICU did not change before and after the pandemic. Mortality and critical morbidity (such as pneumonia and sepsis) rates were not worse during the pandemic compared to pre‐pandemic periods per the SMR. Conclusions Surgical management was conducted adequately through the organized efforts of the entire surgery department in our country even in a pandemic during which medical resources and staff may have been limited.
    Wiley, May 2023, Annals of Gastroenterological Surgery, 7(6) (6), 887 - 895
    Scientific journal

  • 【がん診療における層別化医療の現状と今後の展望】胃がんにおける層別化医療の現状と今後の展望
    掛地 吉弘
    (一社)日本外科学会, May 2023, 日本外科学会雑誌, 124(3) (3), 253 - 260, Japanese

  • Taro Oshikiri, Hodaka Numasaki, Junya Oguma, Yasushi Toh, Masayuki Watanabe, Manabu Muto, Yoshihiro Kakeji, Yuichiro Doki
    BACKGROUND: The thoracic duct (TD) plays an important role in nutrition and immunity but is often resected with the esophagus when dissecting surrounding lymph nodes in patients with esophageal squamous cell carcinoma (ESCC). We examined whether indiscriminate TD resection improved the prognosis of patients with ESCC treated with neoadjuvant chemoradiotherapy (NACRT) followed by esophagectomy. METHODS: A total of 440 patients treated with NACRT followed by esophagectomy between 2007 and 2012 were analyzed using data from the Comprehensive Registry of Esophageal Cancer in Japan. The propensity score-matched TD resection and TD preservation groups were compared in terms of short- and long-term outcomes. RESULTS: After matching, there were 85 patients in both groups. No significant differences were found between groups in either overall survival or cause-specific survival rates at 5 years: 44.2% and 49.0% in the TD resection group, and 39.8% and 47.2% in the TD preservation group, respectively. Furthermore, the number of retrieved mediastinal lymph nodes was significantly greater in the TD resection group than in the TD preservation group (26 vs. 15, p < 0.0001). In contrast, TD resection was associated with metastasis to a significantly greater number of distant organs than TD preservation (49 vs. 32, p = 0.049). CONCLUSIONS: TD resection did not contribute to improved survival in patients with ESCC but did lead to metastases in more organs than TD preservation. Consequently, indiscriminate TD resection might be avoided in patients with ESCC treated with NACRT followed by esophagectomy.
    May 2023, Annals of surgical oncology, 30(5) (5), 2691 - 2698, English, International magazine
    Scientific journal

  • Taro Oshikiri, Hodaka Numasaki, Junya Oguma, Yasushi Toh, Masayuki Watanabe, Manabu Muto, Yoshihiro Kakeji, Yuichiro Doki
    May 2023, Annals of surgical oncology, 30(5) (5), 2699 - 2700, English, International magazine
    Scientific journal

  • Taro Oshikiri, Hodaka Numasaki, Junya Oguma, Yasushi Toh, Masayuki Watanabe, Manabu Muto, Yoshihiro Kakeji, Yuichiro Doki
    May 2023, Annals of surgical oncology, 30(5) (5), 2701 - 2702, English, International magazine
    Scientific journal

  • Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND: Although transanal total mesorectal excision (TaTME) is a promising treatment for low rectal cancer, it is considered technically demanding, and the number of cases required to become proficient in TaTME remains unknown. The purpose of this study was to assess the TaTME learning curve based on the total mesorectal excision completion time. STUDY DESIGN: This retrospective analysis comprised 128 individuals who received TaTME between September 2016 and December 2021. The cumulative sum method was used to generate the learning curve. The duration of the procedure from the beginning to the end of the circumferential rendezvous was used to define the total mesorectal excision completion time. RESULTS: The learning curve consists of 3 phases: phase I (learning phase: cases 1 to 38), phase II (consolidation phase: cases 39 to 70), and phase III (maturing phase: cases 71 to 128). As the phases varied, both the overall operative time and total mesorectal excision completion time decreased considerably. Through the 3 phases of TaTME, intraoperative adverse events decreased, and in phase III, none occurred. Only 1 instance of local recurrence occurred during phase III, and none occurred during phase I or II. CONCLUSIONS: After 70 operations, the surgeon could join the mastery phase of TaTME based on the total mesorectal excision completion time. After the mastering phase began, there were no intraoperative negative occurrences. From the beginning, the oncological safety could be guaranteed.
    May 2023, Journal of the American College of Surgeons, 236(5) (5), 1054 - 1063, English, International magazine
    Scientific journal

  • Yoshihiko Maehara, Eiji Oki, Mitsuhiko Ota, Norifumi Harimoto, Koji Ando, Ryota Nakanishi, Tetsuro Kawazoe, Yoshiaki Fujimoto, Kentaro Nonaka, Hiroyuki Kitao, Makoto Iimori, Kunio Makino, Teiji Takechi, Takeshi Sagara, Kazutaka Miyadera, Kazuaki Matsuoka, Hiroshi Tsukihara, Yuki Kataoka, Takeshi Wakasa, Hiroaki Ochiiwa, Yoshihiro Kamahori, Eriko Tokunaga, Hiroshi Saeki, Tomoharu Yoshizumi, Yoshihiro Kakeji, Ken Shirabe, Hideo Baba, Mitsuo Shimada
    Prof. Setsuro Fujii achieved significant results in the field of drug discovery research in Japan. He developed nine well-known drugs: FT, UFT, S-1 and FTD/TPI are anticancer drugs, while cetraxate hydrochloride, camostat mesilate, nafamostat mesilate, gabexate mesilate and pravastatin sodium are therapeutic drugs for various other diseases. He delivered hope to patients with various diseases across the world to improve their condition. Even now, drug discovery research based on Dr. Fujii's ideas is continuing.
    May 2023, International journal of clinical oncology, 28(5) (5), 613 - 624, English, Domestic magazine
    Scientific journal

  • Yoshiki Kajiwara, Arata Takahashi, Hideki Ueno, Yoshihiro Kakeji, Hiroshi Hasegawa, Susumu Eguchi, Takanori Goi, Akio Saiura, Akira Sasaki, Shuji Takiguchi, Hiroya Takeuchi, Chie Tanaka, Masaji Hashimoto, Naoki Hiki, Akihiko Horiguchi, Satoru Matsuda, Tsunekazu Mizushima, Shigeru Marubashi, Mitsukazu Gotoh, Hiroyuki Konno, Hiroyuki Yamamoto, Hiroaki Miyata, Yasuyuki Seto, Yuko Kitagawa
    AIM: The National Clinical Database (NCD) of Japan is a nationwide data entry system for surgery, and it marked its 10th anniversary in 2020. The aim was to present the 2020 annual report of gastroenterological surgery of the NCD. METHODS: The data of the surgical procedures stipulated by the training curriculum for board-certified surgeons of the Japanese Society of Gastroenterological Surgery in the NCD from 2011 to 2020 were summarized. RESULTS: In total, 5 622 845 cases, including 593 088 cases in 2020, were extracted from the NCD. The total number of gastroenterological surgeries increased gradually in these 10 years, except for the year 2020 due to the COVID-19 pandemic. The annual number of surgeries of each organ, except the pancreas and liver, decreased by 0.4%-13.1% in 2020 compared to 2019. The surgical patients were consistently aging, with more than 20% of all gastroenterological surgeries in 2020 involving patients aged 80 years or older. The participation of board-certified surgeons increased for each organ (75.9%-95.7% in 2020). The rates of endoscopic surgery also increased constantly. Although the incidences of postoperative complications of each organ increased by 0.7%-7.9% in these 10 years, postoperative mortality rates decreased by 0.2%-1.5%. CONCLUSIONS: We present here the short-term outcomes of each gastroenterological operative procedure in 2020. This review of the 10-years of NCD data of gastroenterological surgery revealed a consistent increase of the number of surgeries (except for in 2020), especially endoscopic procedures, and aging of the Japanese population. The good safety of Japanese gastroenterological surgeries was also indicated.
    May 2023, Annals of gastroenterological surgery, 7(3) (3), 367 - 406, English, Domestic magazine
    Scientific journal

  • Hiromichi Maeda, Hideki Endo, Hiroyuki Yamamoto, Hiroaki Miyata, Masaya Munekage, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Kazuhiro Yoshida, Hiroki Yamaue, Masakazu Yamamoto, Yuko Kitagawa, Mori Masaki, Kazuhiro Hanazaki
    AIM: This study aimed to investigate the effect of the coronavirus disease pandemic on the number of surgeries for gastroenterological cancer cases in Japan. METHODS: The data recorded in the National Clinical Database of Japan between 2018 and 2020 were utilized for this study. Five specific surgeries for primary cancers and surgery for acute diffuse peritonitis were considered the primary endpoints. We divided the study period into the prepandemic and postpandemic (after April 2020) periods and examined the number of surgeries in relation to clinical factors. RESULTS: Overall, 228 860 surgeries were analyzed. Among the five primary cancer surgeries, the number of distal gastrectomies for gastric cancer decreased the most (to 81.0% of the monthly number in the prepandemic period), followed by that of low anterior resections for rectal cancer (91.4%). In contrast, the number of pancreaticoduodenectomies for pancreatic cancer increased by 7.1%, while that of surgeries for peritonitis remained stable. This trend was observed nationwide. We also noted a marked reduction in the number of distal gastrectomy (to 72.5%), low anterior resection (84.0%), and esophagectomy (88.8%) procedures for T1 tumors. The noncurative resection rate and mortalities were low despite the increased proportion of T4 tumors and older patients. CONCLUSION: A marked reduction in surgeries for gastric and rectal cancers with early T factors may reflect prioritization of surgeries and reduction in cancer screenings. Although the quality of the surgery was maintained in terms of reduced mortalities and morbidities, the long-term effects of this pandemic should be monitored.
    May 2023, Annals of gastroenterological surgery, 7(3) (3), 407 - 418, English, Domestic magazine
    Scientific journal

  • Hiroshi Hasegawa, Takeru Matsuda, Kimihiro Yamashita, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: Narrow pelvis, tumor diameter, and obesity have been reported as clinical variables correlated with the difficulty of conventional laparoscopic low anterior resection (Lap-LAR). A two-team transanal total mesorectal excision (TaTME) approach where the transabdominal and TaTME are performed simultaneously might reduce the difficulty associated with these factors. This study aimed to clarify the factors associated with the longer time required for TME (TME time) in conventional Lap-LAR and a two-team approach for TaTME. METHODS: We analyzed 52 patients with rectal carcinoma treated with Lap-LAR and 35 patients treated with TaTME. We performed simple linear regression analysis to assess the association between TME time and bony pelvic size using 3D pelvimetry, longest tumor diameter, and body mass index (BMI). RESULTS: Linear regression analysis demonstrated a highly significant association between TME time and obstetric conjugate (R2  = 0.098, P = .024) and BMI (R2  = 0.307, P < .001) in the Lap-LAR group, while no significant association was observed in the TaTME group. Male patients, who had a narrower bony pelvis and higher BMI than female patients, had longer TME time than female patients in the Lap-LAR group (213 minutes vs 172 minutes, P = .021), while the TME time of male and female patients did not differ in the TaTME group (122 minutes vs 108 minutes, P = .451). The TME time in the TaTME group was significantly shorter than that in the Lap-LAR group (121 minutes vs 197 minutes, P < .001). CONCLUSION: A two-team TaTME approach provided a shorter TME time compared to conventional Lap-LAR, regardless of pelvic size and BMI.
    Apr. 2023, Asian journal of endoscopic surgery, 16(2) (2), 189 - 196, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Satoru Matsuda, Yuko Kitagawa, Hirofumi Kawakubo, Jun Okui, Akihiko Okamura, Ryo Takemura, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki
    BACKGROUND: We previously reported that postoperative recurrence in responders occurred in the regional field mostly as a solitary lesion without distant failure. However, further validation is necessary due to the low percentage of pathological responders, especially those with pCR. This study aimed to validate the prognostic impact of pathological response and the distribution of residual tumors in pathological responders using a nationwide database from 85 Japanese esophageal centers. METHODS: We retrospectively reviewed patients with esophageal squamous cell carcinoma (ESCC) who underwent subtotal esophagectomy at 85 authorized institutes for esophageal cancer between 2010 and 2015. The recurrence free survival (RFS), overall survival (OS), and recurrent tumor patterns were compared among the pathological responses. RESULTS: Of 4781 patients initially enrolled, 3840 were selected for subsequent analysis, including 237 patients with pathological complete response (pCR, 6%). The RFS and OS were significantly correlated with pathological response. When the recurrence pattern was classified into regional or distant recurrence, the incidence of distant failure was significantly lower in patients with pCR in cT1/2. Three percent of all patients with pCR in cT1/2 encountered postoperative recurrence in distant organs. CONCLUSION: The prognostic impact of pathological response was reproduced in the nationwide data. pCR in ESCC patients with cT1/2 provides a favorable prognosis with less incidence of distant failure. This finding may contribute to selecting appropriate candidates for an organ preservation approach based on the response to induction therapy.
    Apr. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(2) (2), 205 - 214, English, Domestic magazine
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    BACKGROUND: Neoadjuvant treatment has become the standard of care for patients with advanced esophageal cancer. However, few studies have elucidated the clinical factors that predict response to neoadjuvant therapy in a large multicenter cohort. We aimed to develop a predictive model of therapeutic effect in patients with esophageal squamous cell carcinoma (SCC) who received neoadjuvant treatment. METHODS: This nationwide study included 4078 patients from 85 institutions. Patients who received neoadjuvant treatment followed by surgery for esophageal SCC were eligible. We developed a logistic regression model to predict good pathological therapeutic effects, and a predictive nomogram was generated by applying the logistic regression formula. RESULTS: Among neoadjuvant regimens, cisplatin plus 5-fluorouracil (CF) was the most frequently used (60.2%), followed by docetaxel plus CF (DCF, 27.4%), CF with radiotherapy (CF-RT, 4.5%), adriamycin plus CF (3.6%), nedaplatin plus 5-fluorouracil (0.9%), and DCF-RT (0.5%). Multivariable analysis revealed that male sex, advanced cT category, and increased pretherapeutic SCC antigen level were independently associated with not achieving a good therapeutic effect. Moreover, intensified neoadjuvant regimens were independently associated with favorable therapeutic effects; DCF-RT elicited the best therapeutic effect, followed by CF-RT and DCF. A predictive model including nine commonly measured preoperative variables was generated, and the area under the curve was 0.679 (95% confidence interval: 0.658-0.700). This nomogram was also adequately validated internally. CONCLUSIONS: The model developed in this study was validated and predicts the therapeutic effect in patients with esophageal SCC who received neoadjuvant treatment. This model might contribute to individualized treatment strategies.
    Apr. 2023, Annals of surgical oncology, 30(4) (4), 2176 - 2185, English, International magazine
    Scientific journal

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    Apr. 2023, Annals of surgical oncology, 30(4) (4), 2186 - 2187, English, International magazine
    Scientific journal

  • Hironobu Goto, Taro Oshikiri, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND: Esophagectomy for esophageal carcinoma is associated with higher morbidity and mortality rates than other gastrointestinal surgeries. Smoking is an established risk factor for postoperative complications after esophagectomy. This study aimed retrospectively to investigate the impact of smoking status on short- and long-term outcomes for patients undergoing thoracoscopic esophagectomy in the prone position (TEP) for esophageal carcinoma. METHODS: In this study, 234 patients with esophageal carcinoma who underwent TEP between 2012 and 2020 were divided into two groups based on smoking status (current or non-current smokers and the Brinkman index) by patients' declarations. Postoperative complications (Clavien-Dindo classification grade ≥2), overall survival (OS), and disease-free survival (DFS) were compared between smoking statuses. RESULTS: The rates of postoperative complications did not differ significantly between the two groups (current smoker vs non-current smoker; Brinkman index ≥800 vs <800). The rate of postoperative pneumonia was higher in the combination group of current and higher Brinkman index (≥800) smokers than in the other group (25.0 % vs 11.8 %; P = 0.036). Multivariate analysis showed that smoking status was an independent risk factor for postoperative pneumonia (hazard ratio, 0.41; 95 % confidence interval, 0.18-0.93; P = 0.037). According to the long-term outcomes, no significant differences in OS and DFS were observed between the smoking statuses. CONCLUSIONS: The combination of current smoking and heavy smoking history is a risk factor for postoperative pneumonia in patients who have esophageal carcinoma treated with TEP, although no correlation was observed between the long-term outcomes and smoking status.
    Apr. 2023, Annals of surgical oncology, 30(4) (4), 2202 - 2211, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, Yuichiro Doki
    Apr. 2023, Annals of surgical oncology, 30(4) (4), 2188 - 2189, English, International magazine
    Scientific journal

  • Masayuki Ando, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: Laparoscopic surgery for low rectal cancer is often challenging. Transanal total mesorectal excision (TaTME) and robotic surgery have been introduced to overcome the technical difficulties in laparoscopic surgery and achieve more favorable outcomes. Hybrid robotic surgery, which combines TaTME with the abdominal robotic approach, incorporates the advantages of each of these surgical techniques and might achieve less invasive and safer surgery. This study evaluated the safety and feasibility of hybrid robotic surgery with TaTME (hybrid TaTME). METHODS: We retrospectively reviewed 162 TaTME cases performed at our department from September 2016 to May 2022. Among them, 92 cases of conventional TaTME and 30 of hybrid TaTME were eligible. We used propensity score matching analysis (PSM) to adjust for patients' characteristics and compared the short-term outcomes of the two treatment groups. RESULTS: Twenty-seven cases in each group were extracted using PSM. The operation time in hybrid TaTME was comparable to that in conventional TaTME. There was no significant difference in the postoperative hospital stay between the two groups. Other intra- and post-operative outcomes were also comparable between the two groups. Furthermore, no significant differences were observed between the two groups in the curative resection and recurrence rates. CONCLUSION: Hybrid TaTME for low rectal cancer was as favorable as conventional TaTME in producing satisfactory short-term outcomes. However, furthermore, larger-scale studies conducted over longer study periods are needed to evaluate the validity of the findings.
    Mar. 2023, Langenbeck's archives of surgery, 408(1) (1), 129 - 129, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 井上 大志, 大村 篤史, 中井 秀和, 阪口 和憲, 岡田 翼, 白木 宏長, 岩橋 大輔, 長谷川 翔太, 長命 俊也, 濱口 真里, 河野 敦則, 辻本 貴紀, 村上 優, 幸田 陽次郎, 山中 勝弘, 井上 武, 岡田 健次, 長谷川 寛, 中村 哲, 掛地 吉弘
    兵庫県外科医会, Mar. 2023, 兵庫県外科医会会誌, 57, 42 - 45, Japanese

  • Jun Watanabe, Yukihide Kanemitsu, Hirokazu Suwa, Yoshihiro Kakeji, Soichiro Ishihara, Eiji Shinto, Heita Ozawa, Takeshi Suto, Junichiro Kawamura, Fumihiko Fujita, Michio Itabashi, Masayuki Ohue, Hideyuki Ike, Kenichi Sugihara
    AIM: There have been no reports of searching for metastases to lymph nodes along the accessory middle colic artery (aMCA). The aim of this study was to investigate the metastasis rate of the aMCA for splenic flexural colon cancer. METHODS: Patients with histologically proven colon carcinoma located in the splenic flexure, clinically diagnosed as stage I-III were eligible for this study. Patients were retrospectively and prospectively enrolled. The primary endpoint was frequency of lymph node metastasis to the aMCA (station 222-acc and 223-acc). The secondary endpoint was the frequency of lymph node metastasis to the middle colic artery (MCA) (station 222-lt and 223) and left colic artery (LCA) (station 232 and 253). RESULTS: Between January 2013 and February 2021, a total of 153 consecutive patients were enrolled. The location of the tumor was 58% in the transverse colon and 42% in the descending colon. Lymph node metastases were observed in 49 cases (32%). The presence of aMCA rate was 41.8% (64 cases). The metastasis rates of stations 221, 222-lt, and 223 were 20.0%, 1.6%, and 0%, and stations 231, 232, and 253 were 21.4%, 1.0%, and 0%, respectively. The metastasis rates of stations 222-acc and 223-acc were 6.3% (95% confidence interval: 1.7%-15.2%) and 3.7% (95% confidence interval: 0.1%-19%), respectively. CONCLUSIONS: This study identified the distribution of lymph node metastases from splenic flexural colon cancer. If the aMCA is present, this vessel should be targeted for dissection, taking into account the frequency of lymph node metastasis.
    Mar. 2023, Annals of gastroenterological surgery, 7(2) (2), 265 - 271, English, Domestic magazine
    Scientific journal

  • Takuya Kudo, Shingo Kanaji, Hitoshi Harada, Yasushi Ohmura, Ryuichiro Sawada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: This study aimed to compare motions of the laparoscope tip during a laparoscopic task in a training box using a recent joystick-guided robotic scope holder to those manipulated by human scopists. We hypothesized that laparoscopic manipulation could be positively affected by robotic scope holders due to the elimination of unintentional movement. METHODS: Twelve surgeons participated as operators, and eight medical doctors participated in this study. Among the human scopists, five were trained surgeons and three were novices who had no experience with laparoscopic surgery. A validated laparoscopic task was used to evaluate the path length of the laparoscope tip using an optical position tracker and operative time. The operators performed the designated camera task under three different laparoscopic manipulations: using a joystick-guided robotic scope holder, expert human scopists, and novice scopists. RESULTS: The median path lengths (cm) of the laparoscopic tip were 94.0, 110.0, and 122.2 in the robotic scope holder, expert, and novice groups, respectively. The path lengths in the robotic scope holder group were significantly shorter than those in the other groups (P < .01). The median operative times (seconds) were 136.6, 66.4, and 62.3 in the robotic scope holder, expert, and novice groups, respectively. The operative time of the robotic scope holder group was significantly longer than that of the other groups (P < .001). CONCLUSION: A robotic scope holder can provide shorter camera movement owing to the stable holding and intentional scope manipulation by the operator, although it requires a longer operative time than a human assistant.
    Feb. 2023, Surgical innovation, 15533506231157039 - 15533506231157039, English, International magazine
    Scientific journal

  • 金治 新悟, 掛地 吉弘
    (一社)日本外科感染症学会, Feb. 2023, 日本外科感染症学会雑誌, 19(4-5) (4-5), 374 - 379, Japanese

  • Susumu Kunisawa, Haku Ishida, Hiroshi Ikai, Hiroaki Nagano, Toshiyoshi Fujiwara, Hideki Ohdan, Yoshiyuki Fujiwara, Yoshitsugu Tajima, Tomio Ueno, Yoshinori Fujiwara, Mitsuo Shimada, Yasuyuki Suzuki, Yuji Watanabe, Kazuhiro Hanazaki, Yoshihiro Kakeji, Hiraku Kumamaru, Arata Takahashi, Hiroaki Miyata, Yuichi Imanaka
    PURPOSE: A research subgroup was established by the Japanese Society of Gastroenterological Surgery to improve the health care quality in the Chushikoku area of Western Japan. METHODS: The records of four surgical procedures were extracted from the Japanese National Clinical Database and analyzed retrospectively to establish the association between hospital characteristics, defined using a combination of hospital case-volume and patients' hospital travel distance, and the incidences of perioperative complications of ≥ Grade 3 of the Clavien-Dindo classification after gastroenterological surgery. RESULTS: This study analyzed 11,515 cases of distal gastrectomy for gastric cancer, 4,705 cases of total gastrectomy for gastric cancer, 4,996 cases of right hemicolectomy for colon cancer, and 5,243 cases of lower anterior resection for rectal cancer, with composite outcome incidences of 5.6%, 10.2%, 5.5%, and 10.7%, respectively. After adjusting for patient characteristics and surgical procedures, no association was identified between the hospital category and surgical outcomes. CONCLUSION: The findings of our study of the Chushikoku region did not provide positive support for the consolidation and centralization of hospitals, based solely on hospital case volume. Our grouping was unique in that we included patient travel distance in the analysis, but further investigations from other perspectives are needed.
    Feb. 2023, Surgery today, 53(2) (2), 214 - 222, English, Domestic magazine
    Scientific journal

  • Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Masako Utsumi, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND: Although lateral pelvic lymph node dissection (LLND) might be an effective approach for patients with rectal cancer with lateral lymph node metastasis, it is technically challenging because of the anatomical complexity and location of the deep pelvis. An assistance by transanal approach might be useful for a successful LLND. METHODS: From September 2016 to May 2021, 39 patients with low rectal cancer underwent transanal total mesorectal excision with LLND. Among them, 18 patients underwent LLND using a conventional laparoscopic approach alone, while the remaining 21 underwent LLND using both conventional and transanal approaches. Their clinical outcomes were retrospectively compared. RESULTS: The operation time for LLND on each side was significantly shorter in the transanal group (105 min vs. 54 min, P < 0.001). The intraoperative blood loss was also significantly less in the transanal group (40 g vs. 0 g, P = 0.031). The rate of overall postoperative complications ≥ grade II according to the Clavien-Dindo classification was significantly less in the transanal group (66.7% vs. 28.6%, odds ratio: 5.000, 95% confidence intervals: 1.313-19.047, P = 0.040). The number of harvested lateral lymph nodes in both groups was similar (8.5 vs. 8, P = 0.544). CONCLUSION: The transanal approach for LLND reduced operative time, blood loss, and morbidity compared with the conventional approach alone in a cohort of patients with rectal cancer.
    Feb. 2023, Surgical endoscopy, 37(2) (2), 1562 - 1568, English, International magazine
    Scientific journal

  • Shoji Miyako, Takeru Matsuda, Yu-Ichiro Koma, Takahiro Koide, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    Although a therapeutic response to neoadjuvant chemoradiotherapy (NACRT) is important to improve oncological outcomes after surgery in patients with locally advanced rectal cancer, there is no reliable predictor for this. The Wnt/β-catenin signal is known to be crucial for the tumorigenesis of colorectal cancer. This study aimed to investigate the association of Wnt/β-catenin signal activation with a pathological response to NACRT. The immunohistochemical expression of nuclear and membranous β-catenin was analyzed in biopsy samples obtained from 60 patients with locally advanced rectal cancer who received curative surgery following NACRT. The association of Wnt/β-catenin signal activation with their clinical outcomes was investigated. Notably, the body mass index of these patients was significantly higher in the low nuclear β-catenin expression group. Moreover, patients in the high nuclear β-catenin expression group tended to have more advanced disease and a higher rate of positive vascular invasion than those in the low expression group. Furthermore, the rate of good histological responses was significantly higher in the low nuclear β-catenin expression group (72% vs. 37.1%, p < 0.01). Overall, relapse-free survival tended to be better in patients with low nuclear/high membranous β-catenin expression (n = 9) than in other individuals (n = 51) (p = 0.093 and p = 0.214, respectively). Activation of the Wnt/β-catenin signal pathway represented by nuclear β-catenin accumulation was significantly associated with a poor response to NACRT in patients with rectal cancer. Analysis of nuclear β-catenin accumulation before starting treatment might help predict the therapeutic response to NACRT.
    Jan. 2023, Biomedicines, 11(1) (1), English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yu Kitamura, Yu-Ichiro Koma, Kohei Tanigawa, Shuichi Tsukamoto, Yuki Azumi, Shoji Miyako, Satoshi Urakami, Takayuki Kodama, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    High infiltration of tumor-associated macrophages (TAMs), which contribute to the progression of several cancer types, is correlated with poor prognosis of esophageal squamous cell carcinoma (ESCC). In addition to the previously reported increase in migration and invasion, ESCC cells co-cultured directly with macrophages exhibited enhanced survival and growth. Furthermore, interleukin-related molecules are associated with ESCC; however, the precise mechanism underlying this association is unclear. Therefore, we explored the role of interleukin-related molecules in ESCC progression. A cDNA microarray analysis of monocultured and co-cultured ESCC cells revealed that the interleukin 7 receptor (IL-7R) was upregulated in ESCC cells co-cultured with macrophages. Overexpression of IL-7R promoted the survival and growth of ESCC cells by activating the Akt and Erk1/2 signaling pathways. The IL-7/IL-7R axis also contributed to the promotion of ESCC cell migration via the Akt and Erk1/2 signaling pathways. Furthermore, immunohistochemistry showed that ESCC patients with high IL-7R expression in cancer nests exhibited a trend toward poor prognosis in terms of disease-free survival, and showed significant correlation with increased numbers of infiltrating macrophages and cancer-associated fibroblasts. Therefore, IL-7R, which is upregulated when directly co-cultured with macrophages, may contribute to ESCC progression by promoting the development of various malignant phenotypes in cancer cells.
    Jan. 2023, Cancers, 15(2) (2), English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Akira Sasaki, Hisateru Tachimori, Yuji Akiyama, Taro Oshikiri, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa
    PURPOSE: Postoperative complications after esophagectomy can be severe or fatal and impact the patient's postoperative quality of life and long-term outcomes. The aim of the present study was to develop the best possible model for predicting mortality and complications based on the Japanese Nationwide Clinical Database (NCD). METHODS: Data registered in the NCD, on 32,779 patients who underwent esophagectomy via a thoracic approach for malignant esophageal tumor between January, 2012 and December, 2017, were used to create a risk model. RESULTS: The 30-day mortality rate after esophagectomy was 1.0%, and the operative mortality rate was 2.3%. Postoperative complications included pneumonia (13.8%), anastomotic leakage (13.2%), recurrent laryngeal nerve palsy (11.1%), atelectasis (4.9%), and chylothorax (2.5%). Postoperative artificial respiration for over 48 h was required by 7.8% of the patients. Unplanned intubation within 30 postoperative days was performed in 6.2% of the patients. C-indices evaluated using the test data were 0.694 for 30-day mortality and 0.712 for operative mortality. CONCLUSIONS: We developed a good risk model for predicting 30-day mortality and operative mortality after esophagectomy based on the NCD. This risk model will be useful for the preoperative prediction of 30-day mortality and operative mortality, obtaining informed consent, and deciding on the optimal surgical procedure for patients with preoperative risks for mortality.
    Jan. 2023, Surgery today, 53(1) (1), 73 - 81, English, Domestic magazine
    Scientific journal

  • Kentaro Murakami, Yasunori Akutsu, Hiroaki Miyata, Yasushi Toh, Takeshi Toyozumi, Yoshihiro Kakeji, Yasuyuki Seto, Hisahiro Matsubara
    BACKGROUND: With the aging of society and increasingly longer of life expectancy, elderly patients with esophageal cancer are more commonly encountered. This study aimed to identify the risk factors for operative mortality after esophagectomy in elderly patients. METHODS: We used data from the National Clinical Database of Japan. After cleaning the data, 10,633 records obtained from 861 hospitals were analyzed. A risk model for operative mortality was developed using risk factors from the entire study population. Then, odds ratios (OR) were compared between age categories using this risk model. RESULTS: In this study, 1959 (18.4%) patients were ≥ 75 years (defined as "elderly" in this study). Eighteen variables, including T4b, N2-N3, and M1 in the TNM classification, were included in the risk model for operative mortality. The ORs increased in age categories < 65, 65-74, and ≥ 75 years for N2-N3 (1.172, 1.200, and 1.588, respectively), and M1 (2.189, 3.164, and 4.430, respectively). Based on these results, we also focused on residual tumors, which are caused by extensive tumor development. The operative mortality in the elderly group with residual tumors increased to more than twice than that in the non-elderly groups (15.9 vs. 5.5 or 6.5%) and was much higher than that in elderly patients without residual tumors (15.9 vs. 4.6%). CONCLUSION: We should carefully select the treatment for elderly patients with highly advanced tumors, which result in N2-N3 and M1, to avoid unfavorable short-term outcomes. In addition, R0 resection is important in preventing operative mortality among elderly patients.
    Jan. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(1) (1), 39 - 47, English, Domestic magazine
    Scientific journal

  • Akihiko Okamura, Hideki Endo, Masayuki Watanabe, Hiroyuki Yamamoto, Hirotoshi Kikuchi, Shingo Kanaji, Yasushi Toh, Yoshihiro Kakeji, Yuichiro Doki, Yuko Kitagawa
    BACKGROUND: Two prominent patient positions during thoracoscopic esophagectomy are the left lateral decubitus position (LP) and the prone position (PP). However, whether the patient position during thoracoscopic esophagectomy influences short-term outcomes, especially postoperative pneumonia, remains unclear. We aimed to elucidate the impact of patient position on the occurrence of postoperative pneumonia. METHODS: We analyzed 9850 patients who underwent oncologic thoracoscopic esophagectomies between 2016 and 2019 from the National Clinical Database. We compared the short-term outcomes between the LP and PP groups, and the primary outcome measure was the incidence of postoperative pneumonia. RESULTS: This study included 2637 (26.8%) and 7213 (73.2%) patients in the LP and the PP groups, respectively. The baseline characteristics of the two groups were well-balanced. Compared with the LP group, the PP group had a longer operative time and less blood loss. There were no significant differences in the incidences of postoperative pneumonia, recurrent laryngeal nerve palsy, anastomotic leakage, severe complications, and reoperation between the groups. Meanwhile, prolonged ventilation and surgery-related mortality occurred more frequently in the LP than in the PP group (P < 0.001 and 0.046, respectively). After multivariable adjustment, the patient position did not significantly influence the incidence of postoperative pneumonia (odds ratio 0.91, 95% confidence interval 0.80-1.04). CONCLUSIONS: Although prolonged ventilation and surgery-related mortality occurred more frequently in the LP group than in the PP group, the patient position did not significantly influence the occurrence of postoperative pneumonia.
    Jan. 2023, Esophagus : official journal of the Japan Esophageal Society, 20(1) (1), 48 - 54, English, Domestic magazine
    Scientific journal

  • Naoki Urakawa, Shingo Kanaji, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND/AIM: Neoadjuvant chemotherapy (NAC) for advanced gastric cancer (GC) and esophagogastric junction cancer (EGC) is expected to effectively control the tumor; however, histological tumor response and immune function markers as prognostic factors for NAC remain unknown. This study assessed the prognostic significance of histological response and immune function markers in patients undergoing NAC for GC and EGC. PATIENTS AND METHODS: Forty-two patients who underwent NAC followed by surgical resection for operable advanced GC or EGC from January 2007 to December 2019 were divided into two groups based on histological response. Overall survival (OS), tumor response, and immune function markers, such as the neutrophil/lymphocyte ratio (NLR), were the outcomes analyzed. RESULTS: The 5-year OS for Grade 2b-3 (n=10, responder group) according to the Japanese Gastric Cancer Classification was 72.0% with a favorable prognosis, compared with 33.3% for Grade 0-1a (n=18), and 46.8% for Grade 1b-2a (n=14) in the non-responder group. There was no significant difference in the background between the two groups regarding clinical status or immune function markers. In a multivariate analysis of immune function markers, the NLR value before NAC was significantly associated with prognosis (p=0.048). Patients with an NLR value <3.4 had a favorable OS (p=0.03). CONCLUSION: Histological response scores for Grade 2b or higher may help predict a favorable prognosis for patients undergoing NAC for advanced GC and EGC. The outcomes may be further improved by considering NLR values.
    2023, In vivo (Athens, Greece), 37(1) (1), 378 - 384, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Hiroshi Hasegawa, Takeru Matsuda, Kimihiro Yamashita, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: Rectal or anal canal adenocarcinoma with inguinal lymph node metastasis (ILNM) is rare and is associated with poor prognostic outcomes. This study aimed to elucidate the clinical significance of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for rectal or anal canal adenocarcinoma with clinically suspected ILNM. METHODS: This study enrolled 15 consecutive patients who underwent neoadjuvant therapy and curative resection for rectal or anal canal adenocarcinoma with clinically suspected ILNM between 2005 and 2019 at a single institution. Inguinal lymph node dissection was selectively performed on the side of suspected metastasis before neoadjuvant therapy. Short- and long-term outcomes were retrospectively reviewed. RESULTS: Out of the15 patients, 11 were treated with neoadjuvant chemoradiation, three with chemotherapy, and one with chemoradiation followed by chemotherapy. Fluorodeoxyglucose (FDG)-positron emission tomography (PET) scans were performed after neoadjuvant therapy in 14 patients. Five patients had negative FDG accumulation in inguinal lymph nodes on FDG-PET scan, and their inguinal lymph nodes were also pathologically negative for metastasis. Of the nine patients who had positive FDG accumulation, four had pathologically positive inguinal lymph nodes. Seven patients (46.7%) had inguinal seroma postoperatively. Five-year-overall survival was 77.5%, and 5-year-relapse-free survival was 64.2%. No patient had a recurrence in the inguinal region. CONCLUSION: In patients with rectal or anal canal adenocarcinoma associated with clinical ILNM, radical resection with neoadjuvant therapy provides a good long-term survival.
    Dec. 2022, Langenbeck's archives of surgery, 408(1) (1), 2 - 2, English, International magazine
    Scientific journal

  • Kota Yamada, Masafumi Saito, Masayuki Ando, Tomoki Abe, Tomosuke Mukoyama, Kyosuke Agawa, Akihiro Watanabe, Shiki Takamura, Mitsugu Fujita, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji, Kimihiro Yamashita
    Obesity, a known risk factor for various types of cancer, reduces the number and function of cytotoxic immune cells in the tumor immune microenvironment (TIME). However, the impact of obesity on CD4+ T cells remains unclear. Therefore, this study aimed to clarify the impact of obesity on CD4+ T cells in the TIME. A tumor-bearing obese mouse model was established by feeding with 45% high-fat diet (HFD), followed by inoculation with a colon cancer cell line MC38. Tumor growth was significantly accelerated compared to that in mice fed a control diet. Tumor CD4+ T cells showed a significant reduction in number and an increased expression of programmed death-1 (PD-1), and decreased CD107a expression and cytokine such as IFN-γ and TNF-α production, indicating dysfunction. We further established CD4+ T cell-depleted HFD-fed model mice, which showed reduced tumor infiltration, increased PD-1 expression in CD8+ T cells, and obesity-induced acceleration of tumor growth in a CD4+ T cell-dependent manner. These findings suggest that the reduced number and dysfunction of CD4+ T cells due to obesity led to a decreased anti-tumor response of both CD4+ and CD8+ T cells to ultimately accelerate the progression of colorectal cancer. Our findings may elucidate the pathogenesis for poor outcomes of colorectal cancer associated with obesity.
    Dec. 2022, Cells, 12(1) (1), English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 山田 康太, 裏川 直樹, 金治 新悟, 澤田 隆一郎, 原田 仁, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    (株)癌と化学療法社, Dec. 2022, 癌と化学療法, 49(13) (13), 1711 - 1713, Japanese

  • Hironobu Goto, Taro Oshikiri, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND: Many patients with esophageal squamous cell carcinoma (ESCC) have obstructive ventilatory disorder (OVD), which is considered a risk factor for postoperative pneumonia. It has been reported that thoracoscopic esophagectomy in the prone position (TEP) is less invasive and is associated with fewer postoperative respiratory complications compared with open esophagectomy. This matched-cohort study aimed to elucidate the safety and oncologic outcomes of ESCC patients with OVD who undergo TEP. METHODS: In this matched-cohort study, 237 patients with ESCC who underwent TEP between 2010 and 2018 were divided into two groups based on forced expiratory volume in 1 s/forced vital capacity. Postoperative complications (Clavien-Dindo classification grade II or higher), overall survival (OS), and disease-free survival (DFS) were compared between the two groups. RESULTS: Based on their propensity scores, 75 patients with normal respiratory function (NRF) and 75 with OVD were selected. The rates of postoperative pneumonia were not significantly different between the two groups (NRF group vs OVD group: 18.7% vs 18.7%; P = 1.000). The rates of recurrent laryngeal nerve palsy and anastomotic leakage were also not significantly different (NRF group vs OVD group: 12.0% vs 18.7%, P = 0.365; 18.7% vs 18.7%, P = 1.000). The 5-year OS and DFS rates in the NRF vs OVD groups were 66.2% vs 54.9% and 63.5% vs 52.9%, respectively, with no significant differences (P = 0.421, 0.197). CONCLUSIONS: TEP can be safely performed on ESCC patients with OVD and can result in an oncological efficiency equal to that of the NRF group.
    Dec. 2022, Surgical endoscopy, 36(12) (12), 8834 - 8842, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Hiraku Kumamaru, Yoshihiro Kakeji, Kiyohide Fushimi, Koichi Benjamin Ishikawa, Hiroyuki Yamamoto, Hideki Hashimoto, Minoru Ono, Tadashi Iwanaka, Shigeru Marubashi, Mitsukazu Gotoh, Yasuyuki Seto, Yuko Kitagawa, Hiroaki Miyata
    PURPOSE: To assess the increase in hospital costs associated with postoperative complications after lower anterior resection (LAR) for rectal cancer. METHODS: The subjects of this retrospective analysis were patients who underwent elective LAR surgery between April, 2015 and March, 2017, collected from a Japanese nationwide gastroenterological surgery registry linked to hospital-based claims data. We evaluated total and category-specific hospitalization costs based on the level of postoperative complications categorized using the Clavien-Dindo (CD) classification. We assessed the relative increase in hospital costs, adjusting for preoperative factors and hospital case volume. RESULTS: We identified 15,187 patients (mean age 66.8) treated at 884 hospitals. Overall, 71.8% had no recorded complications, whereas 7.6%, 10.8%, 9.0%, 0.6%, and 0.2% had postoperative complications of CD grades I-V, respectively. The median (25th-75th percentiles) hospital costs were $17.3 K (16.1-19.3) for the no-complications group, and $19.1 K (17.3-22.2), $21.0 K (18.5-25.0), $27.4 K (22.4-33.9), $41.8 K (291-618), and $22.7 K (183-421) for the CD grades I-V complication groups, respectively. The multivariable model identified that complications of CD grades I-V were associated with 11%, 21%, 61%, 142%, and 70% increases in in-hospital costs compared with no complications. CONCLUSIONS: Postoperative complications and their severity are strongly associated with increased hospital costs and health-care resource utilization. Implementing strategies to prevent postoperative complications will improve patients' clinical outcomes and reduce hospital care costs substantially.
    Dec. 2022, Surgery today, 52(12) (12), 1766 - 1774, English, Domestic magazine
    Scientific journal

  • [A Case of Pathological Complete Response after Conversion Surgery for HER2-Positive Advanced Gastric Cancer with Multiple Distant Metastases].
    Kota Yamada, Naoki Urakawa, Shingo Kanaji, Ryuichiro Sawada, Hitoshi Harada, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    The patient is a 70's man. Esophagogastroduodenoscopy and contrast-enhanced CT scan of the abdomen revealed gastric cancer, 2 liver metastases, and peritoneal dissemination. He was diagnosed with unresectable advanced gastric cancer and received 5 courses of chemotherapy(CapeOX plus T-mab). The primary tumor size had reduced, and liver metastases and peritoneal dissemination were not detectable, so laparoscopic distal gastrectomy and partial hepatectomy were performed. Histopathological findings revealed no viable cancer cells in either the primary tumor or the hepatic resection site, and the histological response was Grade 3. The patient has been recurrence-free for 6 months since the surgery. Even in Stage Ⅳ gastric cancer with multiple distant metastases, long-term survival may be expected by conversion surgery after response to chemotherapy.
    Dec. 2022, Gan to kagaku ryoho. Cancer & chemotherapy, 49(13) (13), 1711 - 1713, Japanese, Domestic magazine
    Scientific journal

  • NCDデータから紡ぐ外科学の進歩 消化管領域におけるNCD研究の利活用
    掛地 吉弘, 丸橋 繁, 上野 秀樹, 北川 雄光, 瀬戸 泰之, 宮田 裕章, 今野 弘之, 後藤 満一
    (一社)日本外科学会, Nov. 2022, 日本外科学会雑誌, 123(6) (6), 589 - 591, Japanese

  • NCDデータから紡ぐ外科学の進歩 肝胆膵領域におけるNCDデータ解析研究とACS-NSQIPから学ぶ外科医療成績向上へのステップ
    丸橋 繁, 掛地 吉弘, 上野 秀樹, 北川 雄光, 瀬戸 泰之, 遠藤 格, 宮田 裕章, 今野 弘之, 後藤 満一
    (一社)日本外科学会, Nov. 2022, 日本外科学会雑誌, 123(6) (6), 592 - 595, Japanese

  • Yoshihiro Kakeji, Takashi Ishikawa, Satoshi Suzuki, Kohei Akazawa, Tomoyuki Irino, Isao Miyashiro, Hiroyuki Ono, Haruhisa Suzuki, Satoshi Tanabe, Shigenori Kadowaki, Kei Muro, Takeo Fukagawa, Souya Nunobe, Takeyuki Wada, Hitoshi Katai, Yasuhiro Kodera
    BACKGROUND: The nationwide registry of the Japanese Gastric Cancer Association collected data of surgically resected cases of gastric cancer between 2001 and 2013. These retrospective analyses aimed to delineate tumor characteristics, surgical history, and survival distribution. METHODS: Data from 254,706 patients with primary gastric cancer were included. The 5-year survival rates were calculated for various subsets of prognostic factors. RESULTS: The number of patients over 70 years old increased from 2001 to 2013. The frequency with which laparoscopic gastrectomy was opted for increased dramatically (from 3.5 to 40.8%) in 13 years. We focused on the patients registered between 2010 and 2013, for whom data collection was based on the 3rd edition of the Japanese classification and guidelines. Five-year overall survival (OS) rate among 92,305 patients with resected tumors was 70.6%. The 5-year OS rates of patients with pathological stage IA, IB, IIA, IIB, IIIA, IIIB, IIIC, and IV disease were 89.6%, 83.2%, 77.6%, 68.1%, 59.3%, 45.6%, 29.9%, and 14.0%, respectively. CONCLUSION: Our detailed analysis highlights the historical changes in outcomes of surgically treated gastric malignancies in Japan, and provides robust dataset for future analysis.
    Nov. 2022, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 25(6) (6), 1082 - 1093, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Shingo Kanaji, Yoshinori Morita, Takuya Kudo, Kouta Yamada, Takashi Kato, Arata Sakai, Toshitatsu Takao, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Takashi Toyonaga, Yuzo Kodama, Yoshihiro Kakeji
    PURPOSE: No study has focused on the safety and feasibility of our previously developed open-window suturing technique to close mucosal defects on the pancreatic side after endoscopic submucosal dissection from the opened duodenal wall. This study aimed to evaluate the safety and usefulness of laparoscopic endoscopic cooperative surgery for duodenal tumors for treating superficial non-ampullary duodenal epithelial tumors on the pancreatic side of the duodenum. METHODS: This retrospective study included 61 consecutive patients who underwent surgery during August 2014-November 2021. After dissection when the tumor was on the pancreatic side, we sutured the mucosal defect from the opened duodenal wall. A preoperative endoscopic pancreatic stent was placed for tumors within 1 cm of the ampulla of Vater. The surgical outcomes were compared between tumors on the pancreatic and non-pancreatic sides. RESULTS: There were 27 and 34 patients with tumors on the pancreatic and non-pancreatic sides, respectively. The patient characteristics were similar. Preoperative pancreatic stents were placed in four patients in the pancreatic side group. The median operative time was significantly longer on the pancreatic side than in the non-pancreatic side group (241 vs. 209 min, P = 0.02). In one patient in the pancreatic side group, an intraoperative injury of the ampulla of Vater was successfully treated with intraoperative management. There were no significant differences in the incidence of postoperative grade II or higher complications between the groups. CONCLUSIONS: Laparoscopic endoscopic cooperative surgery for duodenal tumors for treating superficial non-ampullary duodenal epithelial tumors on the pancreatic side is safe and feasible.
    Nov. 2022, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 26(11) (11), 2266 - 2273, English, International magazine
    Scientific journal

  • Natsuko Yamauchi, Takeru Matsuda, Ryuichiro Sawad, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND/AIM: Although survival in cases with early recurrence after curative resection of colorectal cancer has been persistently poor, the risk factors for early recurrence remain unknown. PATIENTS AND METHODS: A total of 1,043 patients with stage I-III colorectal cancer underwent curative resection at Kobe University Hospital between April 2007 and September 2020. Of these, 122 patients developed recurrence: 57 had early recurrence (<1 year after surgery) and 65 patients had late recurrence (≥1 year after surgery). The clinicopathological features were compared between the groups and the risk factors for early recurrence were analyzed. RESULTS: Overall survival both from the date of recurrence and from the date of surgery were significantly worse in the early recurrence group. The proportion of the patients with ≥100 g of intraoperative blood loss, blood transfusion, and postoperative complications were significantly higher in the early recurrence group. R0 resection was achieved more frequently in the late recurrence group. Multivariate analysis revealed that no adjuvant chemotherapy, elevated preoperative CA19-9, blood transfusion, and the occurrence of the postoperative complication were independent risk factors for early recurrence. CONCLUSION: Early recurrence after curative resection of colorectal cancer was associated with worse overall survival. Adjuvant chemotherapy might be beneficial for patients with risk factors of early recurrence to improve prognosis.
    Nov. 2022, Anticancer research, 42(11) (11), 5553 - 5559, English, International magazine
    Scientific journal

  • Tatsuto Nishigori, Nao Ichihara, Kazutaka Obama, Ichiro Uyama, Hiroaki Miyata, Masafumi Inomata, Yoshihiro Kakeji, Yuko Kitagawa, Yoshiharu Sakai
    AIM: The National Health Insurance system has reimbursed robotic gastrointestinal surgery since April 2018 in Japan. Additionally, strict facility and surgeon standards were established by the government and the academic society. This study aimed to evaluate the prevalence and safety of robotic surgery using a Japanese nationwide web-based database. METHODS: Patients who underwent the following robotic surgeries for malignant tumors in 2018 were included: esophagectomy (RE), total gastrectomy (RTG), distal gastrectomy (RDG), proximal gastrectomy (RPG), low anterior resection (RLAR), and rectal resections other than RLAR (RRR). The number of cases and surgical mortality rates each month were calculated to evaluate the prevalence and safety of robotic procedures. RESULTS: A total of 3281 patients underwent robotic gastrointestinal surgery. The monthly number of robotic surgeries nearly doubled in April 2018 when they were initially reimbursed by the National Health Insurance system. Operative mortality rates were 0.9%, 0.4%, 0.2%, and 2.8% for RE (n = 330), RTG (n = 239), RDG (n = 1167), and RPG (n = 109), respectively. No mortality was observed in RLAR (n = 1062) or RRR (n = 374). CONCLUSION: Robotic surgery for gastrointestinal malignant tumors was safely introduced into daily clinical practice along with rigorous surgeon and facility standards in Japan.
    Nov. 2022, Annals of gastroenterological surgery, 6(6) (6), 746 - 752, English, Domestic magazine
    Scientific journal

  • 金治 新悟, 掛地 吉弘
    (株)医学書院, Oct. 2022, 臨床外科, 77(11) (11), 58 - 64, Japanese

  • Tomoki Abe, Taro Oshikiri, Hironobu Goto, Takashi Kato, Manabu Horikawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Oct. 2022, Annals of surgical oncology, 29(11) (11), 6867 - 6868, English, International magazine
    Scientific journal

  • Tomoki Abe, Taro Oshikiri, Hironobu Goto, Takashi Kato, Manabu Horikawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Yoshihiro Kakeji
    BACKGROUND: Multidisciplinary treatment combining neoadjuvant treatment (NAT) and surgery has slightly improved the prognosis of patients with esophageal squamous cell carcinoma (ESCC). Although various biomarkers targeting nutrition and inflammation are associated with cancer prognosis, most studies have focused on conditions prior to NAT. Developing real-time and sensitive biomarkers that monitor changes in systemic conditions during NAT is important. We established a novel nutritional and inflammatory index, represented as the albumin to derived neutrophil-to-lymphocyte ratio (Alb-dNLR), and calculated the change in Alb-dNLR (ΔAlb-dNLR) during neoadjuvant chemotherapy (nCT). In this study, we aimed to evaluate whether ΔAlb-dNLR is associated with prognosis in patients with ESCC. METHODS: We investigated 172 patients who underwent nCT before esophagectomy between April 2010 and March 2018. The dNLR was calculated as the ratio of neutrophil count to (white blood cell count - neutrophil count), Alb-dNLR was calculated by dividing the serum albumin level by the dNLR, and ΔAlb-dNLR was evaluated by dividing the post-Alb-dNLR by the pre-Alb-dNLR. Patients were divided into 'high' and 'low' groups according to the ΔAlb-dNLR. RESULTS: Thirty-nine patients (22.7%) had a low ΔAlb-dNLR (≤ 0.8), and the 5-year overall survival (OS) rates in patients with low and high ΔAlb-dNLR were 38.1% and 53.6%, respectively (p = 0.0072). Multivariate analyses demonstrated that estimated blood loss (p = 0.044), pathological T stage (p = 0.0005), pathological N stage (p = 0.017), and ΔAlb-dNLR (p = 0.005) were independent prognostic factors for OS. CONCLUSIONS: ΔAlb-dNLR is a useful prognostic factor for OS in patients with ESCC receiving nCT.
    Oct. 2022, Annals of surgical oncology, 29(11) (11), 6860 - 6866, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Tomoki Abe, Taro Oshikiri, Hironobu Goto, Takashi Kato, Manabu Horikawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Oct. 2022, Annals of surgical oncology, 29(11) (11), 6869 - 6870, English, International magazine
    Scientific journal

  • Yasuaki Nakajima, Hisateru Tachimori, Yutaka Miyawaki, Naoto Fujiwara, Kenro Kawada, Hiroshi Sato, Hiroaki Miyata, Shinichi Sakuramoto, Hideaki Shimada, Masayuki Watanabe, Yoshihiro Kakeji, Yuichiro Doki, Yuko Kitagawa
    BACKGROUND: One upside of cervical esophageal carcinoma is that radical surgery can be performed by laryngectomy, even for tumors with tracheal invasion. However, this approach drastically reduces the quality of life, such as by losing the vocal function. Cervical esophageal carcinoma is rare, and no comprehensive reports have described the current state of surgery. Using a Japanese nationwide web-based database, we analyzed the surgical outcomes of cervical esophageal carcinoma to evaluate the impact of larynx-preserving surgery. METHODS: Based on the Japan National Clinical Database, 215 surgically treated cases of cervical esophageal carcinoma between January 1, 2018, and December 31, 2019, were enrolled. Clinical outcomes were compared between the larynx-preserved group and the laryngectomy group. RESULTS: Ninety-four (43.7%) patients underwent larynx-preserving surgery. A total of 177 (82.3%) patients underwent free jejunum reconstruction. More T4b patients and more patients who underwent preoperative radiotherapy were in the laryngectomy group. There were no significant differences in the frequency and the severity of morbidities between the two groups. However, in the laryngectomy group, in-hospital death within 30 days after surgery was observed in 1 patient, and the postoperative hospital stay was significantly longer (P = 0.030). In the larynx-preserved group, recurrent nerve paralysis was observed in 24.5%. Re-operation (35.3%, P = 0.016), re-intubation (17.6%, P = 0.019) and tracheal necrosis (17.6%, P = 0.028) were significantly more frequent in patients who underwent pharyngolaryngectomy with total esophagectomy and gastric tube reconstruction than in others. CONCLUSION: Larynx-preserving surgery was therefore considered to be feasible because it was equivalent to laryngectomy regarding the short-term surgical outcomes.
    Oct. 2022, Esophagus : official journal of the Japan Esophageal Society, 19(4) (4), 569 - 575, English, Domestic magazine
    Scientific journal

  • Tomosuke Mukoyama, Shingo Kanaji, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    The risk factors for delayed gastric emptying (DGE) following gastrectomy are unclear. This study aimed to investigate the risk factors for DGE and the severity of DGE. We retrospectively evaluated 412 patients who underwent gastrectomy for gastric cancer between 2011 and 2019. The cases were classified into the DGE (n = 27) and non-DGE (n = 385) groups; the DGE group was further classified into two subgroups based on nasogastric tube insertion as an indicator of severity. For determining the relationship between resected stomach volume and DGE, we calculated the area of each surgical specimen using the ImageJ software. Female sex (odds ratio [OR] 2.55; 95% confidence interval [CI] 1.09-5.93; P = 0.03), diabetes (OR 2.38; 95% CI 1.02-5.57; P = 0.03), and distal gastric tumors (OR 2.61; 95% CI 1.10-6.19; P = 0.02) were identified as independent risk factors by multivariate analysis. The duration of hospital stay was longer in the DGE group than in the non-DGE group (29 vs. 15 days, P < 0.01). Overall, 24 cases of DGE (89%) were found in more than 1 week following surgery. No correlation was observed between clinical features and the severity of DGE. The resected area in the DGE group was significantly larger than that in the non-DGE group (198.0 vs. 173.9 cm2, P = 0.03). In conclusion, DGE was frequently observed in females and in patients with diabetes and distal gastric tumors. Most of the DGE cases occurred after 7-14 days of surgery, patients who are discharged early should be informed to seek hospitalization if they have symptoms caused by DGE.
    Sep. 2022, Scientific reports, 12(1) (1), 15903 - 15903, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Emiko Kono, Urara Isozumi, Sachiyo Nomura, Kae Okoshi, Hiroyuki Yamamoto, Hiroaki Miyata, Itaru Yasufuku, Hiromichi Maeda, Junichi Sakamoto, Kazuhisa Uchiyama, Yoshihiro Kakeji, Kazuhiro Yoshida, Yuko Kitagawa
    Importance: Women are vastly underrepresented in surgical leadership and management in Japan. The lack of equal opportunities for surgical training is speculated to be the main reason for this disparity; however, this hypothesis has not been investigated thus far. Objective: To examine gender disparity in the number of surgical experiences among Japanese surgeons. Design, Setting, and Participants: This retrospective, multicenter cross-sectional study used data from the National Clinical Database, which contains more than 95% of all surgical procedures in Japan. Participants included male and female gastroenterological surgeons who performed appendectomy, cholecystectomy, right hemicolectomy, distal gastrectomy, low anterior resection, and pancreaticoduodenectomy between January 1, 2013, and December 31, 2017. Exposures: Differences in the number of surgical experiences between male and female surgeons. Main Outcomes and Measures: The primary outcomes were the total number of operations and number of operations per surgeon by gender and years of experience. Data were analyzed from March 18 to August 31, 2021. Results: Of 1 147 068 total operations, 83 354 (7.27%) were performed by female surgeons and 1 063 714 (92.73%) by male surgeons. Among the 6 operative procedures, the percentage of operations performed by female surgeons were the highest for appendectomy (n = 20 648 [9.83%]) and cholecystectomy (n = 41 271 [7.89%]) and lowest for low anterior resection (n = 4507 [4.57%]) and pancreaticoduodenectomy (n = 1329 [2.64%]). Regarding the number of operations per surgeon, female surgeons had fewer surgical experiences for all 6 types of operations in all years after registration, except for appendectomy and cholecystectomy in the first 2 years after medical registration. The largest gender disparity for each surgical procedure was 3.17 times more procedures for male vs female surgeons for appendectomy (at 15 years after medical registration), 4.93 times for cholecystectomy (at 30-39 years), 3.65 times for right hemicolectomy (at 30-39 years), 3.02 times for distal gastrectomy (at 27-29 years), 6.75 times for low anterior resection (at 27-29 years), and 22.2 times for pancreaticoduodenectomy (at 30-39 years). Conclusions and Relevance: This cross-sectional study found that female surgeons had less surgical experience than male surgeons in Japan, and this gap tended to widen with an increase in years of experience, especially for medium- and high-difficulty operations. Gender disparity in surgical experience needs to be eliminated, so that female surgeons can advance to leadership positions.
    Sep. 2022, JAMA surgery, 157(9) (9), e222938, English, International magazine
    Scientific journal

  • 【これ一冊ですべて網羅!消化器の吻合方法】総論 吻合法の基礎 器械吻合
    金治 新悟, 長谷川 寛, 掛地 吉弘
    (株)へるす出版, Aug. 2022, 消化器外科, 45(8) (8), 851 - 857, Japanese

  • 押切 太郎, 後藤 裕信, 加藤 喬, 掛地 吉弘
    金原出版(株), Aug. 2022, 手術, 76(9) (9), 1475 - 1488, Japanese

  • Taro Oshikiri, Hironobu Goto, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yasuhiro Fujino, Masahiro Tominaga, Yoshihiro Kakeji
    BACKGROUND: The eighth edition of the American Joint Committee on Cancer (AJCC) tumor node metastasis (AJCC-TNM 8th) system adopted the newly separate post-neoadjuvant pathologic stage group (ypTNM). However, it is not compatible with the Japanese pathologic classification after neoadjuvant chemotherapy (JPN-CT-pTNM). The aim of this study is to clarify the subjects of the AJCC-ypTNM 8th and propose a unification of the AJCC and Japanese systems to create novel AJCC-CT-pTNM 8th. METHODS: Participants were 304 esophageal squamous cell carcinoma (ESCC) patients who underwent neoadjuvant chemotherapy followed by 3 stage esophagectomy between 2010 and 2019. Predictive probabilities of pN, pM in AJCC-ypTNM 8th and JPN-CT-pTNM 11th systems were evaluated to propose novel system. RESULTS: In training data from 234 patients, the overall survival rate was statistically better for ypStage IIIA than ypStage II (P = 0.040) resulting in staging inversion in AJCC-ypTNM 8th. Predictive probability of pathological N status in AJCC-ypTNM 8th (Akaike Information Criterion: AIC = 979.53) was superior to that in JPN-CT-pTNM 11th (AIC = 999.07). In AJCC-ypTNM 8th, 71% (15/21) of ypM1 diseases were supraclavicular lymph nodes (No. 104 L/N as regional in JPN-CT-pTNM 11th) metastases with considerably good prognosis. The predictive probability of the novel AJCC-CT-pTNM 8th [unification of ypStage II and IIIA, conversion of supraclavicular L/Ns metastases from ypM to ypN] (AIC = 1054.24) was superior to that of the existing AJCC-ypTNM 8th (AIC = 1070.74). The feasibility of novel system was validated using test data from 70 patients. CONCLUSIONS: Unification of the AJCC and Japanese systems yields a simpler and more precise predictive system after neoadjuvant chemotherapy.
    Aug. 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 48(8) (8), 1760 - 1767, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Toshiyuki Mori, Hideki Endo, Takeyuki Misawa, Shigeki Yamaguchi, Yoshihiro Sakamoto, Masafumi Inomata, Yoshiharu Sakai, Yoshihiro Kakeji, Hiroaki Miyata, Yuko Kitagawa, Masahiko Watanabe
    OBJECTIVE: The Endoscopic Surgical Skill Qualification System (ESSQS) was developed by the Japan Society for Endoscopic Surgery as a means of subjectively assessing the proficiency of laparoscopic surgeons. We conducted a study to evaluate how involvement of an ESSQS skill-qualified (SQ) surgeon influences short-term outcomes of laparoscopic cholecystectomy performed for acute cholecystitis. Previous reports suggest that assessment of the video-rating system is a potential tool to discriminate laparoscopic surgeons' proficiency and top-rated surgeons face less surgical mortality and morbidity in bariatric surgery. METHODS: Data from the National Clinical Database regarding laparoscopic cholecystectomy performed for acute cholecystitis between January 2016 and December 2018 were analyzed. Outcomes were compared between patients grouped according to involvement vs. non-involvement of an SQ surgeon. Outcomes were also compared between patients grouped according to whether their operation was performed by biliary tract-, stomach-, or colon-qualified surgeon. RESULTS: Of the 309,998 laparoscopic cholecystectomies during the study period, 65,295 were suitable for inclusion in the study and 13,670 (20.9%) were performed by an SQ surgeon. Patients' clinical characteristics did not differ between groups. Thirty-day mortality was significantly lower in the SQ group (0.1%) 16/13,670 than in the non-SQ group (0.2%) 140/51,625 (P = 0.001). Thirty-day mortality was [0.1% (9/7173)] in the biliary tract-qualified group, [0.2% (5/3527)] in the stomach-qualified group, and [0.1% (2/3240)] in the colon-qualified group. CONCLUSION: Surgeons with ESSQS certification outperform the non-skilled surgeons in terms of surgical mortality in 30 and 90 days. Further verification of the value of the ESSQS is warranted and similar systems may be needed in countries across the world to ensure patient safety and control the quality of surgical treatments.
    Aug. 2022, Surgical endoscopy, 36(8) (8), 5956 - 5963, English, International magazine
    Scientific journal

  • Masaki Kaibori, Nao Ichihara, Hiroaki Miyata, Yoshihiro Kakeji, Atsushi Nanashima, Yuko Kitagawa, Hiroki Yamaue, Masakazu Yamamoto, Itaru Endo
    BACKGROUND/PURPOSE: Laparoscopic (repeat) liver resection (LRLR) is a well-established liver tumor treatment. However, since its outcomes and comparison with open repeat liver resection (ORLR) in recurrent liver cancer remain inadequately studied, this study then aimed to compare their short-term outcomes for liver cancers (hepatocellular carcinoma, intrahepatic cholangiocellular carcinoma, and metastatic liver cancer). METHODS: Repeat liver resection cases between 2013 and 2017 from Japan's National Clinical Database were extracted. We used propensity score matching (PSM) to compare the proportion of patients with postoperative complications of Clavien-Dindo classification grade II or higher (CD2+) (primary endpoint), as well as the operative time, intraoperative bleeding volume, and intraoperative transfusion implementation rate (secondary endpoints). RESULTS: Of 2902 patients (ORLR, 2476; LRLR, 426), 712 (356 per type) with comparable backgrounds remained via PSM. Before and after PSM, the postoperative CD2+ complication rate was significantly lower in the LRLR group, who had shorter operative time, smaller intraoperative bleeding volume, and lower intraoperative transfusion rate, than in the ORLR group (after matching, 7.6% vs 18.3%, P < 0.0001). CONCLUSIONS: LRLR showed better short-term outcomes than ORLR, making it a safer and more effective liver cancer treatment.
    Aug. 2022, Journal of hepato-biliary-pancreatic sciences, 29(8) (8), 833 - 842, English, Domestic magazine
    Scientific journal

  • Shingo Kanaji, Satoshi Suzuki, Masashi Yamamoto, Kohei Tanigawa, Hitoshi Harada, Naoki Urakawa, Ryuichiro Sawada, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: Despite the increasing incidence of adenocarcinoma of the esophagogastric junction, laparoscopic proximal gastrectomy with lower esophagectomy (PGLE) is not widely accepted owing to the lack of standardized reconstruction techniques. In this study, we developed a new reconstruction method named y-shaped overlap esophagogastric tube reconstruction, which reproduces an angle of His and a pseudo-fornix, to be used in laparoscopic transhiatal PGLE. This study aimed to determine the feasibility of this novel reconstruction method. METHODS: This retrospective study included the analysis of short- and mid-term surgical outcomes of 30 consecutive patients with Siewert type II esophagogastric junction adenocarcinoma who underwent laparoscopic PGLE with y-shaped overlap esophagogastric tube reconstruction from April 2015 to August 2020. A novel method was used to form a 6-cm pseudo-fornix and an angle of His using the distal esophagus and a long gastric tube. RESULTS: The median operation time was 369 min, and the median blood loss was 28 mL. The median follow-up period after surgery was 37 months. Although two patients experienced postoperative anastomotic leakage, none of the patients developed stenosis. One patient experienced moderate reflux symptoms, whereas four patients developed moderate reflux esophagitis based on the 1-year follow-up endoscopic examination; the condition of all patients could be efficiently controlled with medication. CONCLUSION: The short- and mid-term surgical outcomes of y-shaped overlap esophagogastric tube reconstruction reflected the feasibility of this simple technique and suggested its potential utility as a reconstruction alternative for Siewert type II tumors.
    Aug. 2022, Langenbeck's archives of surgery, 407(5) (5), 1881 - 1890, English, International magazine
    Scientific journal

  • Kota Yamada, Naoki Urakawa, Shingo Kanaji, Hiroshi Hasegawa, Masashi Yamamoto, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Satoshi Suzuki, Yoshihiro Kakeji
    In recent years, the usefulness of neoadjuvant chemotherapy for resectable advanced gastric cancer, particularly stage III, has been reported. Preoperative staging is mainly determined by computed tomography (CT), and the usefulness of 18F-fluoro-2-deoxyglucose positron emission tomography/CT (FDG-PET/CT) for gastric cancer has been limited in usefulness. The study aimed to evaluate the usefulness of FDG-PET/CT in preoperative diagnosis of advanced gastric cancer. We retrospectively enrolled 113 patients with gastric cancer who underwent preoperative FDG-PET/CT. All patients underwent gastrectomy with lymph-node dissection. The maximum standardized uptake value (SUVmax) of the primary tumor (T-SUVmax) and lymph nodes (N-SUVmax) were measured for all patients. The cutoff values of T-SUVmax for pathological T3/4 from receiver operating characteristic analysis were 8.28 for differentiated and 4.32 for undifferentiated types. The T-SUVmax and N-SUVmax cutoff values for pathological lymph-node metastasis were 4.32 and 1.82, respectively. Multivariate analysis showed that T-SUVmax for differentiated types was a significant predictor of pathological T3/4, and N-SUVmax was a significant predictor of lymph-node metastasis. In conclusion, the SUVmax of FDG-PET/CT was a useful predictor of pathological T3/4 and lymph-node metastasis in gastric cancer. The diagnosis by preoperative FDG-PET/CT is promising to contribute a more accurate staging of gastric cancer than by CT scan alone.
    Jul. 2022, Scientific reports, 12(1) (1), 11370 - 11370, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Hiromichi Maeda, Hideki Endo, Nao Ichihara, Hiroaki Miyata, Hiroshi Hasegawa, Kinji Kamiya, Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuyuki Seto, Hiroki Yamaue, Masakazu Yamamoto, Yuko Kitagawa, Sunao Uemura, Kazuhiro Hanazaki
    BACKGROUND: The association between weekend interventions and poor outcomes is termed the "weekend effect." This retrospective study investigated whether the weekend effect exists in the surgical treatment of acute diffuse peritonitis due to gastrointestinal perforation. METHODS: Patients (n = 16,209) who underwent operation for acute diffuse peritonitis during 2016-2017 were included and grouped depending on the perforation site. Using 23 variables, we performed hierarchical logistic regression analysis and calculated odds ratios for surgical mortality. RESULTS: Surgical mortality rates were 8.8%, 15.0%, and 14.1% for patients with gastroduodenal, small bowel, and large bowel perforations, respectively. Unadjusted odds ratios for surgical mortality differed significantly on Wednesdays only for patients with large bowel perforation (odds ratio: 0.772, 95% confidence interval: 0.613-0.972, P = 0.03). However, there was no significant difference in adjusted odds ratios. CONCLUSION: The quality of emergency surgical treatment is uniform in Japan throughout the week in terms of mortality.
    Jul. 2022, American journal of surgery, 224(1 Pt B) (1 Pt B), 546 - 551, English, International magazine
    Scientific journal

  • Takuya Kudo, Taro Oshikiri, Hironobu Goto, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND: Postoperative complications affect long-term prognosis in patients with esophageal squamous cell carcinoma (ESCC). Although a comprehensive estimator can predict long-term prognosis, the Clavien-Dindo classification system, a widely used approach to evaluate complications, assesses each complication individually. We aimed to clarify the utility of the comprehensive complication index (CCI) on predicting the overall survival (OS) of patients with ESCC following minimally invasive esophagectomy (MIE). METHODS: This was a retrospective study of patients undergoing MIE for ESCC in the prone position between January 2011 and December 2018. Multivariate analyses using the Cox proportional hazards model were performed to determine independent risk factors for OS. RESULTS: The study cohort included 229 patients who were categorized into patients with CCI values of ≥ 33.7 (CCI high) and < 33.7 (CCI low) by receiver-operating characteristic (ROC) curve analysis. There were no significant differences between the two groups according to clinicopathological factors, such as sex, age, tumor location, tumor depth, lymph node metastasis, and neoadjuvant chemotherapy. The intraoperative transfusion rate in the CCI high group was significantly higher than in the CCI low group. The 5 year OS rate was significantly lower in the CCI high group than in the CCI low group (49.5% vs. 65.7%, p = 0.030). By multivariate analyses, age, tumor depth, lymph node metastasis, and the CCI were independent predictors of OS. CONCLUSIONS: Comprehensive assessment of postoperative complications using the CCI was useful in predicting OS of patients undergoing MIE for the ESCC.
    Jul. 2022, Esophagus : official journal of the Japan Esophageal Society, 19(3) (3), 410 - 416, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Mitsuhiko Ota, Masaru Morita, Masahiko Ikebe, Yuichiro Nakashima, Manabu Yamamoto, Hisahiro Matsubara, Yoshihiro Kakeji, Yuichiro Doki, Yasushi Toh
    BACKGROUND: Survivors of esophageal cancer post-esophagectomy may sometimes develop gastric tube cancer (GTC). However, its clinical characteristics have not been elucidated. We conducted a retrospective nationwide survey of GTCs to clarify them. METHODS: A questionnaire on GTCs was sent by e-mail and mail to 116 institutions certified by the Japan Esophageal Society. A total of 608 GTC cases diagnosed and treated between 2001 and 2015 were registered from 62 institutions. RESULTS: The median age at diagnosis was 71 years, with 88.9% being diagnosed with stage I. Sixty percent of GTC cases were in the anal third of the gastric tube and 79.7% were differentiated adenocarcinomas. The median interval between esophagectomy and GTC diagnosis was 6 years, with approximately 25% of patients being diagnosed more than 10 years later. The 5-year overall survivals (5-OSs) after endoscopic and surgical treatments for GTC were 75.9% and 52.7%, respectively. Patients whose GTC was diagnosed without symptoms or by regular follow-up examination showed better 5-OSs compared to others (69.7% vs. 41.2%, p < 0.0001; and 71.4% vs. 41.8%, p < 0.0001, respectively). The prognosis of GTC cases diagnosed within 2 years of the preceding upper gastrointestinal endoscopy (UGI) was better than that in cases diagnosed longer than 2 years (5-OS: 73.4% vs. 48.8%, p < 0.05). CONCLUSION: This nationwide survey revealed the clinicopathological features of GTCs for the first time. Early detection is important in improving the prognosis of GTC, and it is recommended that UGI endoscopy be continued every 2 years for 10 or more years after esophagectomy.
    Jul. 2022, Esophagus : official journal of the Japan Esophageal Society, 19(3) (3), 384 - 392, English, Domestic magazine
    Scientific journal

  • 裏川 直樹, 原田 仁, 金治 新悟, 掛地 吉弘
    (株)南江堂, Jun. 2022, 外科, 84(7) (7), 715 - 718, Japanese

  • Kota Itamoto, Hiraku Kumamaru, Susumu Aikou, Koichi Yagi, Hiroharu Yamashita, Sachiyo Nomura, Hiroaki Miyata, Shinji Kuroda, Toshiyoshi Fujiwara, Shunsuke Endo, Yuko Kitagawa, Yoshihiro Kakeji, Yasuyuki Seto
    PURPOSE: Centralization of high-risk surgeries has become a widespread strategy. However, whether or not the hospital volume affects the outcomes of common surgeries remains unclear. This study explored the association between hospital volume and short-term outcomes of common surgeries, as represented by appendectomy, cholecystectomy, and pneumothorax surgery, by analyzing data from a Japanese nationwide database. METHODS: All hospitals were categorized into four groups (very low-, low-, high-, and very high-volume) according to the annual hospital volume of all gastrointestinal surgeries or all respiratory surgeries in 2017. Patient demographic data and surgical outcomes were evaluated across hospital volume categories. RESULTS: We analyzed 2392 facilities which performed 771,182 gastrointestinal surgeries, and 992 facilities which performed 98,656 respiratory surgeries. Short-term outcomes of patients who underwent appendectomy (n = 50,568), cholecystectomy (n = 104,262), and pneumothorax surgery (n = 11,723) were evaluated. The incidences of postoperative complications, reoperation, and readmission were similar among the groups. Multivariable logistic regression analyses revealed hospital volume to have no association with these short-term outcomes. CONCLUSION: Analyses of a Japanese nationwide database revealed that the hospital volume was not associated with short-term outcomes of appendectomy, cholecystectomy, and pneumothorax surgery. These common surgical procedures may not require centralization into high-volume hospitals.
    Jun. 2022, Surgery today, 52(6) (6), 941 - 952, English, Domestic magazine
    Scientific journal

  • Akihiro Watanabe, Taro Oshikiri, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Daisuke Makiura, Yoshihiro Kakeji
    BACKGROUND: Minimally invasive esophagectomy (MIE) for esophageal cancer patients with sarcopenia is associated with a high risk of perioperative complications; however, the relationship between sarcopenia and the survival of esophageal cancer patients remains controversial. In this study, we aimed to develop a stratifying marker for sarcopenia to precisely predict patients' prognosis. METHODS: We retrospectively studied 135 patients who underwent thoracoscopic esophagectomy at Kobe University Hospital from 2011 to 2015 and who were preoperatively diagnosed with or without sarcopenia based on the Asian Working Group for Sarcopenia index. Creatinine levels and albumin as measures of skeletal muscle volume and nutritional status, respectively, were used to develop a marker to be used for stratifying sarcopenic patients based on prognosis. RESULTS: Of the 135 patients, 35 were diagnosed with sarcopenia and 100 were not. We combined the creatinine and albumin levels (Cr × Alb) as a stratifying marker for sarcopenia, and extracted sarcopenic patients with values below the Cr × Alb cut-off as the actual sarcopenic group. The 5-year overall survival (OS) rates of the actual and non-actual sarcopenic groups were 28.9% and 58.9%, respectively (p = 0.0005), and the 5-year disease-free survival rate of the actual sarcopenic group was 34.1%, and 62.8% (p = 0.0106) for the non-actual sarcopenic group. This stratified sarcopenia model was an independent prognostic factor and was superior to sarcopenia alone for OS. CONCLUSIONS: In patients undergoing MIE, preoperative measurement of Cr × Alb may be a prognostic stratification marker for patients with sarcopenia.
    Jun. 2022, Annals of surgical oncology, 29(6) (6), 3670 - 3681, English, International magazine
    Scientific journal

  • Shigeo Hisamori, Junko Mukohyama, Sanjay Koul, Takanori Hayashi, Michael Evan Rothenberg, Masao Maeda, Taichi Isobe, Luis Enrique Valencia Salazar, Xin Qian, Darius Michael Johnston, Dalong Qian, Kaiqin Lao, Naoya Asai, Yoshihiro Kakeji, Vincenzo Alessandro Gennarino, Debashis Sahoo, Piero Dalerba, Yohei Shimono
    BACKGROUND: MicroRNAs (miRNAs) are key regulators of stem cell functions, including self-renewal and differentiation. In this study, we aimed to identify miRNAs that are upregulated during terminal differentiation in the human colon epithelium, and elucidate their role in the mechanistic control of stem cell properties. METHODS: "Bottom-of-the-crypt" (EPCAM+/CD44+/CD66alow) and "top-of-the-crypt" (EPCAM+/CD44neg/CD66ahigh) epithelial cells from 8 primary colon specimens (6 human, 2 murine) were purified by flow cytometry and analyzed for differential expression of 335 miRNAs. The miRNAs displaying the highest upregulation in "top-of-the-crypt" (terminally differentiated) epithelial cells were tested for positive correlation and association with survival outcomes in a colon cancer RNA-seq database (n = 439 patients). The two miRNAs with the strongest "top-of-the-crypt" expression profile were evaluated for capacity to downregulate self-renewal effectors and inhibit in vitro proliferation of colon cancer cells, in vitro organoid formation by normal colon epithelial cells and in vivo tumorigenicity by patient-derived xenografts (PDX). RESULTS: Six miRNAs (miR-200a, miR-200b, miR-200c, miR-203, miR-210, miR-345) were upregulated in "top-of-the-crypt" cells and positively correlated in expression among colon carcinomas. Overexpression of the three miRNAs with the highest inter-correlation coefficients (miR-200a, miR-200b, miR-200c) associated with improved survival. The top two over-expressed miRNAs (miR-200c, miR-203) cooperated synergistically in suppressing expression of BMI1, a key regulator of self-renewal in stem cell populations, and in inhibiting proliferation, organoid-formation and tumorigenicity of colon epithelial cells. CONCLUSION: In the colon epithelium, terminal differentiation associates with the coordinated upregulation of miR-200c and miR-203, which cooperate to suppress BMI1 and disable the expansion capacity of epithelial cells.
    Jun. 2022, Journal of gastroenterology, 57(6) (6), 407 - 422, English, Domestic magazine
    Scientific journal

  • Takahiro Koide, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Yoshihiro Kakeji, Takashi Aoi
    Intestinal metaplasia is related to gastric carcinogenesis. Previous studies have suggested the important role of CDX2 in intestinal metaplasia, and several reports have shown that the overexpression of CDX2 in mouse gastric mucosa caused intestinal metaplasia. However, no study has examined the induction of intestinal metaplasia using human gastric mucosa. In the present study, to produce an intestinal metaplasia model in human gastric mucosa in vitro, we differentiated human-induced pluripotent stem cells (hiPSC) to gastric organoids, followed by the overexpression of CDX2 using a tet-on system. The overexpression of CDX2 induced, although not completely, intestinal phenotypes and the enhanced expression of many, but not all, intestinal genes and previously reported intestinal metaplasia-related genes in the gastric organoids. This model can help clarify the mechanisms underlying intestinal metaplasia and carcinogenesis in human gastric mucosa and develop therapies to restitute precursor conditions of gastric cancer to normal mucosa.
    May 2022, iScience, 25(5) (5), 104314 - 104314, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Masako Utsumi, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    Although transperineal minimally invasive abdominoperineal resection (tp-APR) based on the concept of transanal total mesorectal excision has recently been used for rectal cancer, the operative procedure has not been standardized to date due to its technical difficulty. The tp-APR procedure used by the authors for a male patient with low rectal cancer is presented in this video.
    May 2022, Annals of surgical oncology, 29(5) (5), 3065 - 3065, English, International magazine
    Scientific journal

  • Daiki Okamoto, Natsuko Yamauchi, Gosuke Takiguchi, Michiru Nishita, Yoshihiro Kakeji, Yasuhiro Minami, Koki Kamizaki
    Accumulating evidence demonstrates that bone marrow (BM)-derived mesenchymal stem cells (MSCs) play critical roles in regulating progression of various types of cancer. We have previously shown that Wnt5a-Ror2 signaling in MSCs induces expression of CXCL16, and that CXCL16 secreted from MSCs then binds to its cognate receptor CXCR6 on the surface of an undifferentiated gastric cancer cell line MKN45 cells, eventually leading to proliferation and migration of MKN45 cells. However, it remains unclear about a possible involvement of another (other) cytokine(s) in regulating progression of gastric cancer. Here, we show that CXCL16-CXCR6 signaling is also activated in MSCs through cell-autonomous machinery, leading to upregulated expression of CCL5. We further show that CCR1 and CCR3, receptors of CCL5, are expressed on the surface of MKN45 cells, and that CCL5 secreted from MSCs promotes migration of MKN45 cells presumably via its binding to CCR1/CCR3. These data indicate that cell-autonomous CXCL16-CXCR6 signaling activated in MSCs upregulates expression of CCL5, and that subsequent activation of CCL5-CCR1/3 signaling in MKN45 cells through intercellular machinery can promote migration of MKN45 cells. Collectively, these findings postulate the presence of orchestrated chemokine signaling emanated from MSCs to regulate progression of undifferentiated gastric cancer cells.
    May 2022, Genes to cells : devoted to molecular & cellular mechanisms, 27(5) (5), 368 - 375, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Takashi Kato, Taro Oshikiri, Hironobu Goto, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND/AIM: Esophageal squamous cell carcinoma (ESCC) is a deadly malignant disease. This study examined whether the platelet-to-lymphocyte ratio (PLR) can be used as a biomarker to evaluate prognosis in patients with advanced ESCC following neoadjuvant chemotherapy (NAC) and undergoing minimally invasive esophagectomy (MIE). PATIENTS AND METHODS: We examined 174 patients between January 2010 and December 2015 at the Kobe University. Of these, 121 were treated with NAC. The PLR cutoff was determined through receiver-operating characteristic curve analysis. Univariate and multivariate analyses were conducted to identify prognostic factors for overall survival (OS). RESULTS: The PLR cutoff for OS in 121 patients was 169.6. Patients with PLR ≥169.6 had worse 5-year OS rates (31.1%) than those with a PLR <169.6 (61.1%, p=0.001). Multivariate analysis revealed that a PLR of ≥169.6 was an independent factor for poor prognosis. CONCLUSION: PLR is an independent prognostic factor for patients with ESCC after NAC and MIE.
    May 2022, Anticancer research, 42(5) (5), 2775 - 2782, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Nobuaki Hoshino, Hideki Endo, Koya Hida, Hiraku Kumamaru, Hiroshi Hasegawa, Teruhide Ishigame, Yuko Kitagawa, Yoshihiro Kakeji, Hiroaki Miyata, Yoshiharu Sakai
    Background: Elective laparoscopic surgery is now widely accepted in the treatment of abdominal diseases because of its minimal invasiveness and rapid postoperative recovery. It is also used in the emergency setting for the diagnosis and treatment of acute diffuse peritonitis regardless of the causative disease. However, the value of laparoscopy in acute diffuse peritonitis remains unclear. In this study we aimed to show trends in the use of laparoscopy over time and compare the real-world performance of laparoscopic surgery with that of open surgery for acute diffuse peritonitis due to gastrointestinal perforation. Methods: We extracted data from the National Clinical Database, a nationwide surgery registration system in Japan, for patients with a diagnosis of acute diffuse peritonitis due to gastroduodenal or colorectal perforation between 2016 and 2019. Trends in the use of laparoscopy over time were identified. Patient characteristics, laboratory findings, surgical findings, and postoperative complications were compared between laparoscopic surgery and open surgery. Results: Patients in poor condition and those with abnormal laboratory findings tended to undergo open surgery. Anesthesia time and operating time were longer for laparoscopic surgery in patients with gastroduodenal perforation but shorter in those with colorectal perforation. Fewer complications occurred in patients who underwent laparoscopic surgery. The number of institutions where laparoscopic surgery was performed and the proportion of the use of laparoscopy at each institution increased over time. Conclusion: The use of laparoscopy is becoming common in surgery for acute diffuse peritonitis due to gastrointestinal perforation. This approach may be a useful option for acute diffuse peritonitis.
    May 2022, Annals of gastroenterological surgery, 6(3) (3), 430 - 444, English, Domestic magazine
    Scientific journal

  • 外科医獲得にむけた神戸大学外科学講の取り組み
    小松 昇平, 岡田 健次, 掛地 吉弘, 谷野 裕一, 尾藤 祐子, 眞庭 謙昌
    (一社)日本外科学会, Apr. 2022, 日本外科学会定期学術集会抄録集, 122回, SP - 8, Japanese

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Ryuichiro Sawada, Naoki Urakawa, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    Mar. 2022, Diseases of the colon and rectum, 65(3) (3), e175, English, International magazine
    Scientific journal

  • Satoshi Suzuki, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND/AIM: This study aimed to examine the efficacy of surgical intervention after chemotherapy for stage IV gastric cancer and the predictors of survival after surgical intervention. PATIENTS AND METHODS: Forty-three gastric cancer patients who had only one type of incurable factor (e.g., para-aortic lymph node metastasis) and had undergone initial chemotherapy, underwent chemotherapy alone (CX group; n=25), palliative gastrectomy (PS group; n=8), and conversion surgery (CS group; n=10). Their therapeutic outcomes were compared. RESULTS: The CS group had significantly higher 2-year overall survival rates (80%) than the CX group (25%), whose prognosis was similar to that of the PS group (23%; p<0.001). Pathological complete response of para-aortic lymph node or peritoneal metastases was an independent predictor of survival after surgery, as was >6 months of chemotherapy. CONCLUSION: CS may improve the prognosis of patients with stage IV gastric cancer in whom chemotherapy can achieve pathological disappearance of the metastatic lesions.
    Mar. 2022, Anticancer research, 42(3) (3), 1541 - 1546, English, International magazine
    Scientific journal

  • Yoshiko Ando, Arata Takahashi, Makoto Fujii, Hiroshi Hasegawa, Toshimoto Kimura, Hiroyuki Yamamoto, Tetsuya Tajima, Yukio Nishiguchi, Yoshihiro Kakeji, Hiroaki Miyata, Yuko Kitagawa
    Background and Aim: In Japan, the actual number of stoma constructions and stoma closures is not known. The aim of this study was to conduct a survey to determine the number of gastrointestinal stoma constructions and closures in Japan. Methods: Enrolled participants comprised patients undergoing selected gastrointestinal surgeries who were recorded in the National Clinical Database. This database uses the "Common Items for Gastrointestinal Surgeons." These procedures were formulated by the Japanese Society of Gastroenterological Surgery during 2013-2018. Results: According to the National Clinical Database, a total of 154,323 gastrointestinal stomas were constructed between January 1, 2013 and December 31, 2018. By procedure, there were 78,723 cases of stoma construction, 39,653 of abdominoperineal resection, 2470 total pelvic exenteration procedures, and 33,572 Hartmann's procedures. The ratio of stoma closures to stoma constructions increased annually in patients under 70 y of age but not in older patients. Approximately 35% of total colectomies, 60% of proctocolectomies, and 20% of low anterior resections were accompanied by stoma construction. The number of patients with rectal cancer who underwent colostomy increased gradually during the study period and the number who underwent stoma construction increased among older patients. Conclusion: The number of cases of gastrointestinal stoma construction has increased gradually in Japan, and the proportion of older patients is increasing each year. The purposes and surgical techniques for stoma construction are diverse and are expected to increase in Japan, a super-aged society.
    Mar. 2022, Annals of gastroenterological surgery, 6(2) (2), 212 - 226, English, Domestic magazine
    Scientific journal

  • 進行胃がんに対する腹腔鏡下幽門側胃切除術の長期成績－KLASS-02試験－
    掛地 吉弘
    Feb. 2022, GI Cancer Cutting Edge, 3(3) (3), 6, Japanese
    Scientific journal

  • Naoki Urakawa, Shingo Kanaji, Satoshi Suzuki, Ryuichiro Sawada, Hitoshi Harada, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND: This study aimed to identify prognostic factors for adenocarcinoma of the esophagogastric junction (AEG) in Siewert type II and characterize the population whose prognosis is expected to improve. PATIENTS AND METHODS: We retrospectively reviewed a database of 68 AEG type II patients who had undergone surgical curative resection without preoperative treatment. RESULTS: Although patients with pathological N0 (pN0) showed favorable 3-year disease-free survival (91%), patients with pN1-3 had poor outcomes (42%, 23%, and 10%). Multivariate analyses showed that the only independent prognostic factor was lymph node metastasis, and that tumor depth (cT3-4) and tumor size (≥4 cm) were correlated closely with lymph node metastasis. CONCLUSION: Surgical curative resection without preoperative treatment is insufficient to treat AEG type II with lymph node metastasis. Among AEG patients, those with the high-risk factors of preoperative tumor depth (T3-4) or/and size (≥4 cm) might need intensive multimodal treatment, including perioperative adjuvant chemotherapy.
    Feb. 2022, Anticancer research, 42(2) (2), 1051 - 1057, English, International magazine
    Scientific journal

  • Yasunori Otowa, Shingo Kanaji, Yoshihiro Kakeji
    Feb. 2022, Endoscopy international open, 10(2) (2), E226, English, International magazine
    Scientific journal

  • Tomoki Abe, Taro Oshikiri, Hironobu Goto, Takashi Kato, Manabu Horikawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    Jan. 2022, Annals of surgical oncology, English, International magazine
    Scientific journal

  • Takuya Kudo, Shingo Kanaji, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND/AIM: The safety of gastrectomy for patients receiving antithrombotic agents remains unclear. This retrospective cohort study sought to compare outcomes between patients who did and did not receive antithrombotic agents. PATIENTS AND METHODS: This single-center retrospective cohort study included 548 patients who underwent gastrectomy for primary gastric adenocarcinoma from January 2011 to December 2019. The surgical outcomes were compared between two groups according to whether they received antithrombotic therapy (n=121) or not (n=427). RESULTS: Among the entire cohort, the patients in the antithrombotic therapy group were significantly older than those who did not receive this therapy and had significantly higher postoperative complication rates than those who did not (33.1% vs. 23.9%; p=0.046). However, after propensity score matching, no significant difference in the postoperative complication rate was observed between the two groups. CONCLUSION: Despite having a high risk for postoperative complications, patients receiving antithrombotic therapy can safely undergo gastric resection.
    2022, Cancer diagnosis & prognosis, 2(2) (2), 210 - 215, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Susumu Miura, Tomoyuki Wakahara, Saya Yamauchi, Yuki Yasuhara, Hideyo Mukubo, Kiyonori Kanemitsu, Takeshi Iwasaki, Mitsuru Sasako, Yoshihiro Kakeji
    INTRODUCTION: The drain amylase concentration (dAmy-C) is a useful marker for predicting pancreatic fistula after gastric cancer surgery. However, dAmy-C might be reduced in cases of high drainage volume. Therefore, we hypothesized that we could accurately assess the amount of amylase leaked from the pancreas by multiplying dAmy-C by the daily drainage volume. In this study, we investigated the clinical utility of the amount of drain amylase (A-dAmy: concentration × volume) for predicting pancreatic fistula. We investigated the clinical utility of the combination of dAmy-C and A-dAmy for predicting pancreatic fistula. METHODS: We investigated patients who underwent gastrectomy for gastric cancer at Yodogawa Christian Hospital between 2012 and 2020. The optimal cutoff levels of dAmy-C and A-dAmy on postoperative day 1 for predicting Clavien-Dindo (CD) grade II or higher pancreatic fistula was calculated using receiver operating characteristic (ROC) curves. We calculate the positive predictive value and negative predictive value for predicting pancreatic fistula using these cutoff levels. RESULTS: A total of 448 patients were eligible for analysis. Twenty-two patients experienced CD grade II or higher pancreatic fistula. ROC curves identified 1,615 IU/L as the optimal cutoff level of dAmy-C, predicting pancreatic fistula. When the simple cutoff level of dAmy-C was 1,600 IU/L, the positive predictive value for was 22.8%, and the negative predictive value was 99.7%. ROC curves identified 177.52 IU as the optimal cutoff level of A-dAmy predicting pancreatic fistula. When the simple cutoff level of A-dAmy was 177 IU, the positive predictive value was 21.2%, and the negative predictive value was 99.7%. Using these two cutoff levels together, the positive predictive value was 34.4%, and the negative predictive value was 99.7%. CONCLUSION: A-dAmy could predict and exclude pancreatic fistula after gastrectomy as with dAmy-C. The combination of dAmy-C and A-dAmy predict pancreatic fistula more accurately than dAmy-C alone.
    2022, Oncology, 100(7) (7), 363 - 369, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Takuya Kudo, Takeru Matsuda, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Taro Oshikiri, Yoshihiro Kakeji
    Situs inversus totalis (SIT) is a rare condition in which the internal organ's position is a mirror image of normal anatomy. Although several investigators reported laparoscopic surgery for colorectal cancer in patients with SIT, it is considered difficult even for an experienced surgeon because of the mirror position. We show a case report of laparoscopic sigmoidectomy with the splenic flexure mobilization (SFM) procedure in SIT. A 79-year-old woman with SIT was referred to our hospital for a locally advanced sigmoid cancer (cT3N1M0, cStageIIIB). We safely performed the laparoscopic sigmoidectomy with SFM, as shown in detail below. No postoperative complication occurred, and the patient is in good health with no recurrences 30 months after surgery, as of the writing this report. We propose three critical points; checking the CT angiography to understand the anatomy; using flip-horizontal video of "normal" laparoscopic sigmoidectomy to confirm an unfamiliar situation; adding the epigastric trocar to make SFM procedures safe and comfortable.
    Jan. 2022, Asian journal of endoscopic surgery, 15(1) (1), 168 - 171, English, Domestic magazine

  • Makoto Sohda, Hiroshi Saeki, Hiroyuki Kuwano, Makoto Sakai, Akihiko Sano, Takehiko Yokobori, Tatsuya Miyazaki, Yoshihiro Kakeji, Yasushi Toh, Yuichiro Doki, Hisahiro Matsubara
    BACKGROUND: Surgical treatment is usually required for Boerhaave's syndrome (post-emetic esophageal perforation), and the technique should be chosen based on the local infection status and patient's general condition. This study was performed to examine the current status of surgical treatment of Boerhaave's syndrome in Japan. METHODS: Ninety-five patients with Boerhaave's syndrome who underwent surgical treatment from January 2010 to December 2015, obtained from a national survey were retrospectively analyzed. The details of each surgical treatment and the type of treatment performed according to the patients' characteristics were examined. RESULTS: Primary closure was performed in 75 (78.9%) patients, T-tube insertion in 15 (15.8%), and esophagectomy in 5 (5.3%). The length of the postoperative stay was significantly shorter in patients who underwent primary closure (p = 0.0011). Esophagectomy tended to be performed more often in patients with a long perforation and was performed significantly more often in patients with a high C-reactive protein concentration (p = 0.0118). The postoperative hospital stay was significantly longer in patients with leakage of the primary closure site (p < 0.0001). As a result, leakage of the primary closure site was significantly correlated with a long duration from symptom onset to patient presentation (p = 0.042), diagnostic imaging of the intrathoracic perforation (p = 0.013), and abscess formation in the mediastinal cavity (p = 0.006). CONCLUSIONS: Selection of an appropriate surgical procedure may contribute to reduced mortality rates in patients with esophageal rupture. With regard to primary closure, it is necessary to understand that leaks are likely to occur in patients with a long duration from symptom onset to presentation or with severe intrathoracic/mediastinal inflammation, and to select an appropriate surgical procedure in consideration of the degree of invasiveness and QOL.
    Jan. 2022, Esophagus : official journal of the Japan Esophageal Society, 19(1) (1), 175 - 181, English, Domestic magazine
    Scientific journal

  • Kensuke Kudou, Hiroshi Saeki, Yuichiro Nakashima, Yasue Kimura, Eiji Oki, Masaki Mori, Mototsugu Shimokawa, Yoshihiro Kakeji, Yasushi Toh, Yuichiro Doki, Hisahiro Matsubara
    BACKGROUND: Several studies have reported the efficacy of resection for recurrent lesions. However, they involved a limited number of subjects. This study aimed to identify a subset of patients who benefit from surgical resection of recurrent lesions after curative esophagectomy for esophageal squamous cell carcinoma. METHODS: Clinicopathological features of 186 patients with esophageal squamous cell carcinoma who underwent surgical treatment for postoperative recurrent lesions at 37 accredited institutions of the Japanese Esophageal Society were evaluated. RESULTS: The most common recurrence site was the lymph node (106 cases; 58.6%), followed by the lung (40 cases; 22.1%). Univariate analyses revealed that pN 0-1 at esophagectomy (P = 0.0348), recurrence-free interval of ≥ 550 days (P = 0.0306), R0 resection (P < 0.0001), and absence of severe complications after resection for recurrent lesions (Clavien-Dindo grade < IIIa) (P = 0.0472) were associated with better overall survival after surgical resection. According to multivariate analyses, pN 0-1 (P = 0.0146), lung metastasis (P = 0.0274), recurrence-free interval after curative esophagectomy of ≥ 550 days (P = 0.0266), R0 resection (P = 0.0009), and absence of severe complications after resection for recurrent lesions (Clavien-Dindo grade < IIIa) (P = 0.0420) were independent predictive factors for better overall survival. CONCLUSIONS: Surgical resection of recurrent esophageal squamous cell carcinoma lesions is a useful option, especially for cases involving lower pN stage, lung metastasis, long recurrence-free intervals after esophagectomy, and technically resectable lesions. Surgical risks should be minimized as much as possible.
    Jan. 2022, Esophagus : official journal of the Japan Esophageal Society, 19(1) (1), 57 - 68, English, Domestic magazine
    Scientific journal

  • Akihiro Watanabe, Kimihiro Yamashita, Mitsugu Fujita, Akira Arimoto, Masayasu Nishi, Shiki Takamura, Masafumi Saito, Kota Yamada, Kyosuke Agawa, Tomosuke Mukoyama, Masayuki Ando, Shingo Kanaji, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    (1) Background: Cancer vaccines are administered to induce cytotoxic CD8+ T cells (CTLs) specific for tumor antigens. Invariant natural killer T (iNKT) cells, the specific T cells activated by α-galactosylceramide (α-GalCer), play important roles in this process as they are involved in both innate and adaptive immunity. We developed a new cancer vaccine strategy in which dendritic cells (DCs) were loaded with an exogenous ovalbumin (OVA) protein by electroporation (EP) and pulsed with α-GalCer. (2) Methods: We generated bone marrow-derived DCs from C57BL/6 mice, loaded full-length ovalbumin proteins to the DCs by EP, and pulsed them with α-GalCer (OVA-EP-galDCs). The OVA-EP-galDCs were intravenously administered to C57BL/6 mice as a vaccine. We then investigated subsequent immune responses, such as the induction of iNKT cells, NK cells, intrinsic DCs, and OVA-specific CD8+ T cells, including tissue-resident memory T (TRM) cells. (3) Results: The OVA-EP-galDC vaccine efficiently rejected subcutaneous tumors in a manner primarily dependent on CD8+ T cells. In addition to the OVA-specific CD8+ T cells both in early and late phases, we observed the induction of antigen-specific TRM cells in the skin. (4) Conclusions: The OVA-EP-galDC vaccine efficiently induced antigen-specific antitumor immunity, which was sustained over time, as shown by the TRM cells.
    Dec. 2021, Cancers, 14(1) (1), English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Kohei Tanigawa, Shuichi Tsukamoto, Yu-Ichiro Koma, Yu Kitamura, Satoshi Urakami, Masaki Shimizu, Masataka Fujikawa, Takayuki Kodama, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    Tumor-associated macrophages are associated with more malignant phenotypes of esophageal squamous cell carcinoma (ESCC) cells. Previously, using an indirect co-culture assay of ESCC cells and macrophages, the authors identified several factors associated with ESCC progression. Here, a direct co-culture assay of ESCC cells and macrophages was established, which more closely simulated the actual cancer microenvironment. Direct co-cultured ESCC cells had significantly increased migration and invasion abilities, and phosphorylation levels of Akt and p38 mitogen-activated protein kinase (MAPK) compared with monocultured ESCC cells. According to a cDNA microarray analysis between monocultured and co-cultured ESCC cells, both the expression and release of S100 calcium binding protein A8 and A9 (S100A8 and S100A9), which commonly exist and function as a heterodimer (herein, S100A8/A9), were significantly enhanced in co-cultured ESCC cells. The addition of recombinant human S100A8/A9 protein induced migration and invasion of ESCC cells via Akt and p38 MAPK signaling. Both S100A8 and S100A9 silencing suppressed migration, invasion, and phosphorylation of Akt and p38 MAPK in co-cultured ESCC cells. Moreover, ESCC patients with high S100A8/A9 expression exhibited significantly shorter disease-free survival (P = 0.005) and cause-specific survival (P = 0.038). These results suggest that S100A8/A9 expression and release in ESCC cells are enhanced by direct co-culture with macrophages and that S100A8/A9 promotes ESCC progression via Akt and p38 MAPK signaling pathways.
    Dec. 2021, The American journal of pathology, 192(3) (3), 536 - 552, English, International magazine
    Scientific journal

  • Taro Oshikiri, Hodaka Numasaki, Junya Oguma, Yasushi Toh, Masayuki Watanabe, Manabu Muto, Yoshihiro Kakeji, Yuichiro Doki
    OBJECTIVE: To clarify whether routine thoracic duct (TD) resection improves the prognosis of patients with esophageal cancer after radical esophagectomy. SUMMARY BACKGROUND DATA: Although TD resection can cause nutritional disadvantage and immune suppression, it has been performed for the resection of surrounding lymph nodes. METHODS: We analyzed 12,237 patients from the Comprehensive Registry of Esophageal Cancer in Japan who underwent esophagectomy between 2007 and 2012. TD resection and preservation groups were compared in terms of prognosis, perioperative outcomes, and initial recurrent patterns using strict propensity score matching. Particularly, the year of esophagectomy and history of primary cancer of other organs were added as covariates. RESULTS: Following propensity score matching, 1638 c-Stage I-IV patients participated in each group. The five-year overall survival and cause-specific survival rates were 57.5% and 55.2% in the TD-resected group and 65.6% and 63.4% in the TD-preserved group, respectively, without significant differences. The TD-resected group had significantly more retrieved mediastinal nodes (30 vs. 21, P < 0.0001) and significantly fewer lymph node recurrence (376 vs. 450, P = 0.0029) compared with the TD-preserved group. However, the total number of distant metastatic organs was significantly greater in TD-resected group than in the TD-preserved group (499 vs. 421, P = 0.0024). CONCLUSIONS: TD resection did not improve survival in patients with esophageal cancer. Despite having retrieved more lymph nodes, TD resection caused distant metastases in more organs compared to TD preservation. Hence, prophylactic TD resection should not be recommended in patients with esophageal cancer.
    Dec. 2021, Annals of surgery, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Gosuke Takiguchi, Naoki Urakawa, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Despite the increasing utilization of transanal total mesorectal excision as a promising approach for low rectal cancer, the feasibility and safety of transperineal minimally invasive abdominoperineal resection (tp-APR) remain unclear. METHODS: In total, 25 patients who underwent tp-APR between April 2017 and May 2020 (tp-APR group) and 27 patients who underwent conventional laparoscopic APR between May 2009 and September 2016 (lap-APR group) for low rectal cancer were enrolled in this retrospective study. Clinical outcomes were compared between the groups before and after propensity score matching. The primary outcome was the incidence of the overall postoperative complications with Clavien-Dindo grade II or above. Standardized technique of tp-APR was also demonstrated. RESULTS: On comparison, operative time, intraoperative blood loss, and overall postoperative complications with Clavien-Dindo grade II or above were significantly less in the tp-APR group both before and after propensity score matching. The rates of urinary disturbance and perineal wound infection were significantly less in the tp-APR group after matching. Further, postoperative hospital stay was significantly shorter in the tp-APR group both before and after matching. However, pathological outcomes did not differ between the groups before and after matching. There has been no local recurrence in the tp-APR group with a median follow-up period of 18 months. CONCLUSION: Standardized tp-APR for low rectal cancer is feasible and seems superior to conventional laparoscopic APR in terms of short-term outcomes. Further larger-scale studies with a longer follow-up period are required to evaluate oncological outcomes.
    Dec. 2021, Surgical endoscopy, 35(12) (12), 7236 - 7245, English, International magazine
    Scientific journal

  • Takashi Kato, Taro Oshikiri, Hironobu Goto, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: One of the primary treatment for resectable advanced esophageal squamous cell cancer (ESCC) is neoadjuvant chemotherapy (NAC) followed by minimally invasive esophagectomy (MIE). Because the neutrophil-to-lymphocyte ratio (NLR) is a widely reported prognostic factor in several cancers, we investigated whether the preoperative NLR is a biomarker in ESCC patients treated with NAC and MIE. METHODS: In this study, we investigated 174 ESCC patients who underwent MIE from January 2010 to December 2015, including 121 patients who received NAC. The cutoff value of the NLR was analyzed using the receiver operating characteristic curve. Multivariate analyses were performed to clarify independent prognostic factors for overall survival (OS). RESULTS: The cutoff value of the NLR for OS in 121 patients who received NAC was 2.5 ng/ml, and the area under the curve was 0.63026 (p = 0.0127). The 5-year OS rate was 64% in those with an NLR <2.5 and 39% in those with an NLR ≥2.5. According to multivariate analysis, NLR ≥2.5, pathological T, pathological N, and intraoperative blood loss of >415 ml were independent poor prognostic factors. CONCLUSIONS: NLR is a biomarker of prognosis in ESCC patients who undergo MIE after NAC.
    Dec. 2021, Journal of surgical oncology, 124(7) (7), 1022 - 1030, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Naoki Urakawa, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Yoshihiro Kakeji
    INTRODUCTION: Although lateral pelvic lymph node dissection is considered as a treatment option for advanced rectal cancer, it is technically demanding. Recently, the transanal approach for total mesorectal excision has become increasingly used. In this Technical Note, we describe lateral pelvic lymph node dissection using a 2-team method that was assisted by the transanal approach. TECHNIQUE: First, the lateral pelvic area was entered from the anal side by dissection between the S4 sacral splanchnic nerve and levator ani muscle. Then, the fatty tissues including the obturator compartment and the distal part of the internal iliac compartment were separated from the inferior and superior vesical vessels and the bladder wall. Next, the fatty tissues were separated from the lateral pelvic wall. The obturator nerve was isolated and preserved, whereas the obturator vessels were resected at their peripheral end. Then, the fatty tissues were dissected from the bottom plane. Finally, the fatty tissues were dissected from the ventral bladder wall and were completely isolated from the obturator nerve in cooperation with the transabdominal team. RESULTS: The 2-team method shortened the operative time dramatically and decreased mental and physical burden on the operators during lateral dissection. Assistance with the transanal approach helped with a secure and effective dissection, especially of the most distal parts, such as around the internal pudendal and inferior vesical arteries, because substantial skill is required for the transabdominal approach alone. CONCLUSIONS: This procedure is useful for the safe and effective performance of lateral pelvic lymph node dissection for patients with rectal cancer.
    Dec. 2021, Diseases of the colon and rectum, 64(12) (12), e719-e724, English, International magazine
    Scientific journal

  • Tomoki Abe, Taro Oshikiri, Hironobu Goto, Takashi Kato, Manabu Horikawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji
    BACKGROUND: Multidisciplinary treatment for esophageal squamous cell carcinoma (ESCC) has improved outcomes, but the prognosis for ESCC remains poor. Nutritional and inflammatory indicators are reported to be associated with cancer prognosis. The combination of albumin and the derived neutrophil-to-lymphocyte ratio (Alb-dNLR) score was established to measure the immune system and nutritional status. The authors hypothesized that the Alb-dNLR score could be a new reliable prognostic factor for ESCC patients. METHODS: The study evaluated 269 patients who underwent esophagectomy between April 2010 and March 2018, including 185 patients who received neoadjuvant chemotherapy. The Alb-dNLR score was calculated using serum albumin and the dNLR. The dNLR was calculated as neutrophils to (leukocyte-neutrophil count). The cutoff values of the albumin and dNLR for overall survival (OS) were determined using the receiver operating characteristic curve. Patients were divided into "high" and "low" groups according to the Alb-dNLR score. RESULTS: A high Alb-dNLR score was found in 61 cases (22.7%). The 5-year OS was 34% in the high Alb-dNLR group and 66.2% in the low Alb-dNLR group (p < 0.0001). The 5-year cause-specific survival (CSS) was 51.5% in the high Alb-dNLR group and 74.7% in the low Alb-dNLR group (p < 0.0001). Multivariate analyses demonstrated that the Alb-dNLR score was an independent prognostic factor for OS (hazard ratio [HR], 2.198; 95% confidence interval [CI], 1.460-3.263; p = 0.0002) and CSS (HR, 1.733; 95% CI, 1.035-2.835; p = 0.0371). CONCLUSIONS: The Alb-dNLR score is an extremely useful, easy-to-use parameter to predict OS and CSS for ESCC patients.
    Nov. 2021, Annals of surgical oncology, 29(4) (4), 2663 - 2671, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yuta Yamazaki, Shingo Kanaji, Takuya Kudo, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshito Otake, Yoshinobu Sato, Yoshihiro Kakeji
    BACKGROUND: Whether surgical device usage in laparoscopic gastrectomy differs with respect to operator's skill levels is unknown. Further, device usage analysis using artificial intelligence has not been reported to date. Herein, we compared the patterns of surgical device usage during laparoscopic gastrectomy for gastric cancer among surgeons at different skill levels. The data of device usage was acquired from laparoscopic video recordings using an automated surgical-instrument detection system. METHODS: In total, 100 video recordings of infrapyloric lymphadenectomy and 33 of D2 suprapancreatic lymphadenectomy during laparoscopic gastrectomy for gastric cancer were analyzed in this retrospective study. The system's accuracy was evaluated by comparing the automatic and the manual usage time. Surgical device usage patterns were compared between qualified and nonqualified surgeons of The Japan Society for Endoscopic Surgery Endoscopic Surgical Skill Qualification System. RESULTS: For every device, the automatic detection time and manual detection time were consistent with each other. In infrapyloric lymphadenectomy, the usage time proportions of dissector forceps and clip applier were higher among nonqualified operators than among qualified operators (dissector, 5.1% vs. 2.3%, P < 0.001; clip applier, 1.6% vs. 1.3%, P < 0.01). In suprapancreatic lymphadenectomy, the usage time proportions of energy devices, clip applier, and grasper forceps were significantly different (energy devices, 59.6% vs. 50.6%, P < 0.001; clip applier, 1.4% vs. 0.9%, P < 0.001; only grasper forceps; 18.3% vs. 27.9%, P = 0.022). CONCLUSIONS: Quantitative analysis of laparoscopic device usage using the automated surgical device detection system showed that the patterns of device usage during laparoscopic gastrectomy differed depending on surgeons' skill levels. These differences could suggest how the qualified and nonqualified surgeons performed the procedures.
    Nov. 2021, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 26(5) (5), 1006 - 1014, English, International magazine
    Scientific journal

  • 各疾患登録とNCDの課題と将来 胃がん登録の現状とNCDへの実装
    掛地 吉弘, 日本胃癌学会登録委員会
    (一社)日本外科学会, Nov. 2021, 日本外科学会雑誌, 122(6) (6), 719 - 721, Japanese

  • Taro Oshikiri, Hironobu Goto, Manabu Horikawa, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Yoshihiro Kakeji
    Nov. 2021, Annals of surgical oncology, 28(12) (12), 7258 - 7258, English, International magazine
    Scientific journal

  • Taro Oshikiri, Hironobu Goto, Manabu Horikawa, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Yoshihiro Kakeji
    BACKGROUND: Esophagectomy with lymphadenectomy is the principal treatment for localized esophageal cancer. Conventional minimally invasive esophagectomy (C-MIE) in prone position has spread worldwide as it is less invasive. However, its efficacy remains controversial. Robot-assisted MIE (RAMIE) can have more advantages than C-MIE. Therefore, the current study aimed to validate whether RAMIE is associated with lower incidence of left recurrent laryngeal nerve (RLN) palsy compared with C-MIE in prone position. PATIENTS AND METHODS: In total, 404 patients with esophageal carcinoma underwent MIE (353 C-MIEs and 51 RAMIEs) in prone position at Kobe University between 2010 and 2020. Then, propensity score matching was performed, and results showed that 51 patients should be included in each group. Thereafter, the perioperative outcomes between the two groups were compared. RESULTS: The RAMIE group had a significantly longer operative time than the C-MIE group (P < 0.0001). However, the number of lymph nodes resected along the left RLN was similar in both groups. Moreover, the incidence of left RLN palsy was significantly lower in the RAMIE group than in the C-MIE [Clavien-Dindo classification grade II; 0 (0%) versus 32 (9%), P = 0.022 in entire cohort, and 0 (0%) versus 5 (10%), P = 0.022 in matched cohort. Esophagectomy Complications Consensus Group definitions type I; 8 (16%) versus 101 (29%), P = 0.041 in entire cohort and 8 (16%) versus 18 (35%) in matched cohort, P = 0.023]. CONCLUSION: RAMIE is superior to C-MIE in prone position in decreasing the incidence of left RLN palsy.
    Nov. 2021, Annals of surgical oncology, 28(12) (12), 7249 - 7257, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Masako Utsumi, Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Kyosuke Agawa, Naoki Urakawa, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Yoshihiro Kakeji
    PURPOSE: There has been an increase in the percentage of elderly patients with colorectal cancer (CRC). However, few studies have reported the short- and long-term outcomes of laparoscopic surgery for elderly patients with CRC aged over 80 years. METHODS: This study included 529 patients who underwent laparoscopic resection for clinical stage 0-III CRC at Kobe University Hospital between January 2010 and December 2018. Propensity score matching (PSM) was used to create balanced cohorts of the elderly (aged ≥ 80, n = 113) and the non-elderly (aged < 80, n = 113). Their clinical outcomes were compared after PSM. RESULTS: After matching, carcinoembryonic antigen (CEA) level was higher in the non-elderly group, and adjuvant chemotherapy was less frequently employed in the elderly group. D3 dissection was performed more frequently and the number of the harvested lymph nodes tended to be larger in the non-elderly group. There was no significant difference in the rates of postoperative complications, reoperation within 30 days, and 30-day mortality between the groups. The 5-year relapse-free survival rate was not statistically different between the two groups (77.3% for the non-elderly vs. 62.7% for the elderly, p = 0.13). The multivariate analyses for the whole cohort showed that the factors of sex, tumor location, operation time, and conversion to open surgery, but not the age, were significant predictors of postoperative complications. CONCLUSION: Laparoscopic surgery for colorectal cancer patients aged over 80 years is technically and oncologically safe.
    Nov. 2021, International journal of colorectal disease, 36(11) (11), 2519 - 2528, English, International magazine
    Scientific journal

  • Daiki Okamoto, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Hironobu Goto, Naoki Urakawa, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    BACKGROUND: Lateral pelvic lymph node metastasis impairs the oncological outcomes of patients with rectal cancer. Although lateral pelvic lymph node dissection (LLND) might be an effective procedure for such patients, the associated risk factors for postoperative complications are unknown. PATIENTS AND METHODS: The operative outcomes of 21 patients undergoing unilateral LLND and 26 patients undergoing bilateral LLND for rectal cancer were compared. The risk factors for complications were evaluated using a logistic regression model. RESULTS: Univariate and multivariate analyses revealed that a longer operative time (≥480 min) was the most important risk factor for grade II or more postoperative complications according to the Clavien-Dindo classification (odds ratio=6.58; 95% confidence interval=1.35-32.1; p=0.020). A bilateral procedure was not a significant risk factor for postoperative complications. CONCLUSION: Surgeons should make efforts to shorten the operative time to reduce the risk of postoperative complications.
    Nov. 2021, Anticancer research, 41(11) (11), 5599 - 5604, English, International magazine
    Scientific journal

  • Kazumasa Horie, Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Masako Utsumi, Naoki Urakawa, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
    INTRODUCTION: Recently, sarcopenia has been reported to be associated with poor postoperative outcomes in various cancers. However, its clinical significance for rectal cancer patients undergoing neoadjuvant chemoradiotherapy (NACRT) followed by surgery remains unknown. MATERIALS AND METHODS: This study included 46 patients with locally advanced rectal cancer who underwent curative surgery after NACRT. Sarcopenia was assessed by measuring the cross-sectional psoas muscle area (PA) at L3 and total bilateral psoas muscle volume (PV). Patients with a lower PV or PA value than the median were assigned to the sarcopenia group while others were assigned to the non-sarcopenia group. Clinical outcomes were then compared between groups. RESULTS: The sarcopenia group included 22 patients. The rate of overall postoperative complications did not differ between groups. Five-year relapse-free survival (RFS) was significantly lower in the sarcopenia group when sarcopenia was assessed by PV after NACRT (44.0% vs. 82.6%, P = 0.00494). In contrast, RFS did not differ between groups when sarcopenia was assessed by PA. Multivariable analysis identified PV after NACRT as the most significant risk factor for RFS (hazard ratio 4.00; 95% CI 1.27-12.66, P = 0.018). CONCLUSION: Sarcopenia assessed by total PV after NACRT may be an accurate and reliable predictor of poor oncological outcomes in rectal cancer patients.
    Oct. 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 48(4) (4), 850 - 856, English, International magazine
    Scientific journal

  • Koichi Suda, Hiroyuki Yamamoto, Tatsuto Nishigori, Kazutaka Obama, Yukie Yoda, Makoto Hikage, Susumu Shibasaki, Tsuyoshi Tanaka, Yoshihiro Kakeji, Masafumi Inomata, Yuko Kitagawa, Hiroaki Miyata, Masanori Terashima, Hirokazu Noshiro, Ichiro Uyama
    BACKGROUND: Robotic gastrectomy (RG) has increased since being covered by universal health insurance in 2018. However, to ensure patient safety the operating surgeon and facility must meet specific requirements. We aimed to determine whether RG has been safely implemented under the requirements for universal health insurance in Japan. METHODS: Data of consecutive patients with primary gastric cancer who underwent minimally invasive total or distal gastrectomy-performed by a surgeon certified by the Japan Society for Endoscopic Surgery (JSES) endoscopic surgical skill qualification system (ESSQS) between October 2018 and December 2019-were extracted from the gastrointestinal surgery section of the National Clinical Database (NCD). The primary outcome was morbidity over Clavien-Dindo classification grade IIIa. Patient demographics and hospital volume were matched between RG and laparoscopic gastrectomy (LG) using propensity score-matched analysis (PSM), and the short-term outcomes of RG and LG were compared. RESULTS: After PSM, 2671 patients who underwent RG and 2671 who underwent LG were retrieved (from a total of 9881), and the standardized difference of all the confounding factors reduced to 0.07 or less. Morbidity rates did not differ between the RG and LG patients (RG, 4.9% vs. LG, 3.9%; p = 0.084). No difference was observed in 30-day mortality (RG, 0.2% vs. LG, 0.1%; p = 0.754). The reoperation rate was greater following RG (RG, 2.2% vs. LG, 1.2%; p = 0.004); however, the duration of postoperative hospitalization was shorter (RG, 10 [8-13] days vs. LG, 11 [9-14] days; p < 0.001). CONCLUSIONS: Insurance-covered RG has been safely implemented nationwide.
    Oct. 2021, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 25(2) (2), 438 - 449, English, Domestic magazine
    Scientific journal

  • 金治 新悟, 裏川 直樹, 鷹尾 俊達, 森田 圭紀, 豊永 高史, 掛地 吉弘
    金原出版(株), Oct. 2021, 手術, 75(11) (11), 1673 - 1677, Japanese

  • Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research
    Suto H, Funakoshi Y, Nagatani Y, Imamura Y, Toyoda M, Kiyota N, Matsumoto H, Tanaka S, Takai R, Hasegawa H, Yamashita K, Matsuda T, Kakeji Y, Minami H
    Oct. 2021, J Cancer Res Ther, 17(6) (6), 1358 - 1369
    [Refereed]

  • Taro Oshikiri, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    Oct. 2021, Annals of surgical oncology, 28(11) (11), 6339 - 6340, English, International magazine
    Scientific journal

  • Shuji Okamoto, Yasunori Otowa, Ryosuke Fujinaka, Keisuke Arai, Koichi Murata, Yasuhiko Mii, Keitaro Kakinoki, Shigeteru Oka, Shingo Kanaji, Yoshihiro Kakeji, Daisuke Kuroda
    INTRODUCTION: The closure of the appendiceal stump is a crucial part of a laparoscopic appendectomy, and an endoloop or endostapler is generally used. The endoloop can be more cost effective than the endostapler. However, reports have shown that the endoloop has a higher postoperative abdominal abscess rate than the endostapler in complicated appendicitis. At our institution, we perform a purse-string suture after ligating by endoloop to reduce postoperative abdominal abscess risk. This study aimed to clarify whether this method could reduce the incidence of postoperative abdominal abscess compared with the endostapler. METHODS: Patients with acute appendicitis were classified into the purse-string suture group (n = 149) and the endostapler group (n = 82). Postoperative outcomes were compared after propensity score matching (n = 47). RESULTS: No significant difference was found between the two groups in terms of the patient characteristics and postoperative complications, including abdominal abscess. However, the purse-string suture group had more drain placement and a shorter hospital stay than the endostapler group (P = .04 and P = .02, respectively). In patients with complicated appendicitis, there was less drain placement and a shorter hospital stay in the purse-string suture group than in the endostapler group (P < .01 and P < .01, respectively). This might have reflected the difficulty of the operation. All postoperative abdominal abscesses occurred in complicated appendicitis cases. CONCLUSIONS: Endoloop with additional purse-string suture had a lower incidence of abscess than previous reports of using endoloop alone. Moreover, the postoperative abdominal abscess rate is similar between the two closure methods.
    Oct. 2021, Asian journal of endoscopic surgery, 14(4) (4), 775 - 781, English, Domestic magazine
    Scientific journal

  • Manabu Horikawa, Taro Oshikiri, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Retrosternal reconstruction is associated with a lower risk of mediastinitis, gastro-tracheal fistula, and hiatal hernia. Historically, traumatic manual creation of the retrosternal tunnel has been performed using one's fist. We report a novel and atraumatic laparoscopic procedure to create the retrosternal route. METHODS: We have laparoscopically created the retrosternal route in 25 thoracoscopic, mediastinoscopic, or robot-assisted minimally invasive esophagectomies since August 2019. Specifically, a peritoneal incision is started at the dorsal side of the xiphoid process. Through a 12-mm port inserted slightly to the right of and superior to the umbilical camera port, we dissect loose connective tissues from the caudal to the cranial side using behind the sternum and inside the internal thoracic vessels as landmarks. The time required to create the route was calculated. Then, the cumulative sum (CUSUM) method and the simple moving average of five cases were used to evaluate the learning curve of this novel procedure. Operative outcomes were analyzed according to the learning curve results and also compared with 25 cases of postmediastinal reconstruction counterparts. RESULTS: Twenty-five patients were divided into the early group (six patients) and late group (19 patients) based on the peak of the CUSUM chart. The time required for route creation was 28.5 min (median) in the early and 15 min in the late group, indicating a significant difference (P = 0.038). The overall incidence of pleural injury was 20% (5 of 25 patients), with no significant difference between the groups. There was no significant difference in the incidence of perioperative complications. Also, there were no significant differences in perioperative complications or gastric conduit functions 1 year after surgery between the retrosternal and the postmediastinal reconstruction. CONCLUSION: Laparoscopic creation of a retrosternal route for gastric conduit reconstruction is safe and feasible and has a short learning curve.
    Sep. 2021, Surgical endoscopy, 36(4) (4), 2680 - 2687, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Sunao Uemura, Hideki Endo, Nao Ichihara, Hiroaki Miyata, Hiromichi Maeda, Hiroshi Hasegawa, Kinji Kamiya, Yoshihiro Kakeji, Kazuhiro Yoshida, Seto Yasuyuki, Hiroki Yamaue, Masakazu Yamamoto, Yuko Kitagawa, Kazuhiro Hanazaki
    BACKGROUND/PURPOSE: The day of the week can impact medical treatment outcomes; however, few large-scale, disease-specific studies have focused on the association between the day of the week and mortality in patients after pancreatoduodenectomy for pancreatic head cancer. METHODS: Data were obtained from the National Clinical Database. Twenty-two clinical variables were adopted for hierarchal logistic regression modeling to determine adjusted odds ratios (ORs) for surgical mortality after elective pancreatoduodenectomy. RESULTS: The 30-day mortality and surgical mortality rates were 1.0% and 1.7%, respectively (n = 29 720). Surgeries were performed the least on Fridays (13.4%) compared with other weekdays. Crude rates of severe postoperative complications (mean, 14.1%; range, 13.5%-14.8%) and pancreatic fistulas (mean, 10.0%; range, 9.6%-10.3%) remained stable throughout the week. Unadjusted/adjusted ORs did not significantly differ between Friday and Monday (0.868, 95% CI: 0.636-1.173, P = .365, and 0.928, 95% CI: 0.668-1.287, P = .653, respectively), and results were similar for the remaining weekdays. Nineteen independent factors were associated with surgical mortality. CONCLUSIONS: The rate of perioperative mortality for elective pancreatoduodenectomy is low in Japan, with no evidence of disparities in surgical mortality rates between weekdays.
    Sep. 2021, Journal of hepato-biliary-pancreatic sciences, 29(7) (7), 778 - 784, English, Domestic magazine
    Scientific journal

  • T Matsuyama, H Endo, H Yamamoto, I Takemasa, K Uehara, T Hanai, H Miyata, T Kimura, H Hasegawa, Y Kakeji, M Inomata, Y Kitagawa, Y Kinugasa
    BACKGROUND: Robot-assisted laparoscopic surgery has several advantages over conventional laparoscopy. However, population-based comparative studies for low anterior resection are limited. This article aimed to compare peri-operative results of robot-assisted low anterior resection (RALAR) and laparoscopy. METHODS: This retrospective cohort study used data from patients treated with RALAR or conventional laparoscopic low anterior resection (CLLAR) between October 2018 and December 2019, as recorded in the Japanese National Clinical Database, a data set registering clinical information, perioperative outcomes, and mortality. Of note, the registry does not include information on the tumour location (centimetres from the anal verge) and diverting stoma creation. Perioperative outcomes, including rate of conversion to open surgery, were compared between RALAR and CLLAR groups. Confounding factors were adjusted for using propensity score matching. RESULTS: Of 21 415 patients treated during the study interval, 20 220 were reviewed. Two homogeneous groups of 2843 patients were created by propensity score matching. The conversion rate to open surgery was significantly lower in the RALAR group than in the CLLAR group (0.7 versus 2.0 per cent; P < 0.001). The RALAR group had a longer operating time (median: 352 versus 283 min; P < 0.001), less intraoperative blood loss (15 versus 20 ml; P < 0.001), a lower in-hospital mortality rate (0.1 versus 0.5 per cent; P = 0.007), and a shorter postoperative hospital stay (median: 13 versus 14 days; P < 0.001) compared with the CLLAR group. The CLLAR group had a lower rate of readmission within 30 days (2.4 versus 3.3 per cent; P = 0.045). CONCLUSION: These data highlight the reduced conversion rate, in-hospital mortality rate, intraoperative blood loss, and length of postoperative hospital stay for rectal cancer surgery in patients treated using robot-assisted laparoscopic surgery compared with laparoscopic low anterior resection.
    Sep. 2021, BJS open, 5(5) (5), English, International magazine
    Scientific journal

  • Hirotoshi Kikuchi, Hideki Endo, Hiroyuki Yamamoto, Soji Ozawa, Hiroaki Miyata, Yoshihiro Kakeji, Hisahiro Matsubara, Yuichiro Doki, Yuko Kitagawa, Hiroya Takeuchi
    BACKGROUND: Esophagectomy followed by gastric conduit reconstruction is a standard surgical procedure for esophageal cancer. However, there is no evidence of the superiority or inferiority of the posterior mediastinal (PM) versus the retrosternal (RS) reconstruction route with regard to short-term outcomes after esophagectomy. We aimed to elucidate whether the reconstruction route can affect the short-term outcomes after esophagectomy followed by gastric conduit reconstruction. METHODS: We reviewed the clinical data of patients who underwent esophagectomy between 2016 and 2018 from the Japanese National Clinical Database. This study included 9786 patients who underwent gastric conduit reconstruction through the PM or RS route with cervical anastomosis. RESULTS: Of the 9786 patients analyzed, 3478 and 6308 underwent gastric conduit reconstruction thorough the PM and RS routes, respectively. The incidence of anastomotic leak and surgical site infection (SSI) was significantly lower in the PM group than in the RS group (11.7% vs 13.8%, P = .005 and 8.4% vs 14.9%, P < .001, respectively), while the incidence of pneumonia was higher in the PM group (13.7% vs 12.2%, P = .040). Generalized estimating equation logistic regression analysis revealed a higher risk of anastomotic leak and SSI (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.15-1.51; P < .001 and OR, 2.06; 95% CI, 1.78-2.38; P < .001, respectively) and a lower risk of pneumonia (OR, 0.86; 95% CI, 0.75-0.98; P = .028) in the RS group than in the PM group. CONCLUSION: The findings of this study will help surgeons to design the reconstruction route following esophagectomy.
    Wiley, Sep. 2021, Annals of Gastroenterological Surgery, 6(1) (1), 46 - 53, English, Domestic magazine
    Scientific journal

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Gosuke Takiguchi, Naoki Urakawa, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    Sep. 2021, Surgical endoscopy, 36(5) (5), 3676 - 3676, English, International magazine

  • 鈴木 知志, 裏川 直樹, 金治 新悟, 掛地 吉弘
    金原出版(株), Sep. 2021, 手術, 75(10) (10), 1519 - 1524, Japanese

  • 掛地 吉弘, 原田 仁, 裏川 直樹, 金治 新悟
    (株)自然科学社, Sep. 2021, 医学と薬学, 78(10) (10), 1167 - 1173, Japanese

  • Yoshihiro Hiramatsu, Hiraku Kumamaru, Hirotoshi Kikuchi, Shiyori Usune, Kinji Kamiya, Hiroaki Miyata, Hiroyuki Konno, Yoshihiro Kakeji, Yuko Kitagawa, Hiroya Takeuchi
    Aim: Preoperative inflammation-based Glasgow prognostic score (GPS) is a useful tool for predicting long-term prognosis in cancer patients. However, its association with postoperative short-term outcomes remains unknown. The aim of this study is to investigate the association between GPS and postoperative morbidity and mortality among patients undergoing surgery for various gastrointestinal malignancies. Methods: Using the Japanese National Clinical Database, we analyzed the records of 312 357 patients with gastrointestinal malignancy who underwent six typical elective surgeries, including esophagectomy, distal gastrectomy, total gastrectomy, right hemicolectomy, low anterior resection, and pancreaticoduodenectomy, between January 2015 and December 2018. We assigned GPS of 0, 1, or 2 to patients with no, one, or both decreased albumin and elevated C-reactive protein levels, respectively. We investigated the relationship of GPS with operative morbidity and mortality for each procedure with adjustments for patients' demographics, preoperative status, comorbidities, and cancer stages. Results: Crude operative morbidity was significantly higher for GPS 1 and 2 than GPS 0 patients in all procedures except pancreaticoduodenectomy. The postoperative length of hospital stay was significantly longer for GPS 1 and 2 patients in all procedures (P < .001). Operative mortality was also higher for GPS 1 and 2 patients in all procedures. The associations remained significant after adjustments for potential confounders of age, sex, physical status, tumor classification, use of preoperative therapy, and comorbidities. Conclusion: This nationwide study provides solid evidence on the strong association between GPS and postoperative outcomes.
    Sep. 2021, Annals of gastroenterological surgery, 5(5) (5), 659 - 668, English, Domestic magazine
    Scientific journal

  • Taro Oshikiri, Yoshihiro Kakeji
    Sep. 2021, Annals of surgical oncology, 28(9) (9), 4928 - 4928, English, International magazine
    Scientific journal

  • Shingo Kanaji, Yuta Yamazaki, Takuya Kudo, Hitoshi Harada, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    PURPOSE: We conducted a prospective clinical control study to identify the best imaging technology among three-dimensional (3-D) high-definition (HD) stereovision and two-dimensional (2-D) ultra-high-resolution (4 K) technology and confirm their effects on surgical outcomes of laparoscopic gastrectomy for gastric cancer. METHODS: From April 2018 to August 2019, 50 patients were randomly classified into two groups based on the imaging technology (3-D/HD group = 25, 2-D/4 K = 25). After excluding eight patients based on laparoscopic findings, 42 patients were analyzed (3-D/HD group = 21, 2-D/4 K = 21). The primary endpoint was the operative time; the secondary endpoints were blood loss, postoperative infectious complications, and postoperative hospital stay. RESULTS: The patients' backgrounds were similar (sex, age, body mass index [BMI], stage, procedure, and extent of lymph node dissection). There were no significant differences in operative time (252 vs. 238 min, P = 0.70), total blood loss, postoperative infectious complications, and postoperative hospital stay between the two groups. However, video analysis of surgeries revealed a significantly shortened median operative time (18 vs. 25 min, P = 0.04) in the suturing step with 3-D/HD; the median number of camera cleaning procedures during suprapancreatic lymph node dissection was significantly lower with 2-D/4 K than with 3-D/HD (n = 4.4 vs. 2.8, P = 0.02). CONCLUSION: 3-D/HD and 2-D/4 K laparoscopic radical gastrectomies provide similar surgical outcomes. However, the 3-D monitor reduces suturing time during reconstruction, while the 4 K monitor reduces the number of camera cleaning procedures during lymphadenectomy. TRIAL REGISTRATION: Registered in the University Hospital Medical Information Network Clinical Trials Registry (identification number 000029227).
    Aug. 2021, Langenbeck's archives of surgery, 407(1) (1), 105 - 112, English, International magazine
    Scientific journal

  • Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi, Takeshi Sano, Wataru Ichikawa, Sang-Woong Lee, Kazushige Shibahara, Toshio Shikano, Masato Kataoka, Atsushi Ishiguro, Hitoshi Ojima, Yoshinori Sakai, Nobuyuki Musha, Tsunenobu Takase, Taisei Kimura, Masahiro Takeuchi, Masashi Fujii
    PURPOSE: The second planned interim analysis (median follow-up 12.5 months) in a phase III trial of postoperative adjuvant chemotherapy for stage III gastric cancer revealed significant improvement in relapse-free survival (RFS) for S-1 plus docetaxel over S-1 alone. Although enrollment was terminated on the recommendation of the independent data and safety monitoring committee, we continued follow-up and herein report on 3-year RFS, the primary endpoint. PATIENTS AND METHODS: Patients with histologically confirmed stage III gastric cancer who underwent gastrectomy with D2 lymphadenectomy were randomly assigned to receive adjuvant chemotherapy with either S-1 plus docetaxel or S-1 alone. In the S-1 plus docetaxel group, S-1 was given orally for 2 weeks followed by 1 week of rest for seven courses, and docetaxel was given intravenously on day 1 of the second to seventh courses. The combination therapy was followed by S-1 monotherapy for up to 1 year. RESULTS: The 3-year RFS rate of the S-1 plus docetaxel group was 67.7%. This was significantly superior to that of 57.4% in the S-1 group (hazard ratio [HR] 0.715, 95% CI 0.587-0.871, P = 0.0008). This translated into a significant benefit in the 3-year overall survival (OS) rate in the S-1 plus docetaxel group (77.7% versus 71.2%, HR 0.742, 95% CI 0.596-0.925, P = 0.0076). CONCLUSION: On 3-year follow-up data, postoperative adjuvant therapy with S-1 plus docetaxel was confirmed to improve both RFS and OS and can be recommended as a standard of care for patients with stage III gastric cancer treated by D2 dissection.
    Aug. 2021, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 25(1) (1), 188 - 196, English, Domestic magazine
    Scientific journal

  • Kohei Tanigawa, Shingo Kanaji, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji
    PURPOSE: Laparoscopic local resection for gastrointestinal stromal tumors (GISTs) near the esophagogastric junction (EGJ) increases the risk of injuring the EGJ. We investigated the safety of laparoscopic local resection for GISTs near the EGJ according to the distance from the EGJ to the tumor edge. METHODS: We retrospectively evaluated 40 patients who had undergone laparoscopic local resection for GISTs near the EGJ between January 2009 and December 2019. After excluding 1 patient who had undergone right colectomy at the same time, 39 patients were classified according to distance of the GIST from the EGJ in the Near group (0-2.0 cm; n = 16) and the Far group (2.1-5.0 cm; n = 23). RESULTS: We found no marked differences in the operation time, blood loss, length of postoperative hospital stay, or postoperative complication rate in the two groups. Anastomotic leakage occurred with a tumor located on the EGJ. Three tumors recurred in the Near group, and all of them were located on the EGJ. CONCLUSION: Except for GISTs located on the EGJ, laparoscopic local resection for GISTs near the EGJ can be performed safely with few postoperative complications and a low risk of recurrence.
    Jul. 2021, Surgery today, 52(3) (3), 395 - 400, English, Domestic magazine
    Scientific journal

  • 松田 武, 掛地 吉弘
    金原出版(株), Jul. 2021, 手術, 75(8) (8), 1259 - 1267, Japanese

  • Satoshi Suzuki, Shingo Kanaji, Naoki Urakawa, Gosuke Takiguchi, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Yoshihiro Kakeji
    Aim: The outcomes of gastrectomy for gastric cancer in patients at each severity of chronic kidney disease (CKD) remain unknown. Methods: We retrospectively analyzed the outcomes of 560 patients who underwent distal or total gastrectomy for gastric cancer between 2009 and 2018. We classified the patients into four groups based on estimated glomerular filtration rate: stage 1/2 (normal to mild, n = 375), stage 3a (mild to moderate, n = 122), stage 3b (moderate to severe, n = 43), and stage 4/5 (severe to end-stage, n = 20) CKD. The relationship between CKD stage and the incidence of postoperative morbidity was analyzed. Results: CKD was a predictor of overall morbidity independent of age, gender, American Society of Anesthesiologists Performance Status, pulmonary comorbidity, extent of lymphadenectomy, and operation time in a multivariate analysis. The incidences of overall and severe morbidity were significantly increased with CKD progression (both P < .001). Compared to stage 1/2 CKD, the odds of overall morbidity were significantly elevated in stage 3a (odds ratio [OR] 1.87, P = .007), stage 3b (OR 3.86, P < .001), and stage 4/5 (OR 8.60, P < .001). The risk of procedure-related morbidity was strikingly increased in stage 3b (OR 2.93, P = .004). The risk of procedure-unrelated morbidity elevated markedly in stage 3a (OR 2.77, P = .001). A significant graded association between CKD progression and overall morbidity was also revealed in elderly patients (P = .001). Conclusions: The severity of CKD predicts the likelihood and type of morbidity after gastrectomy and can guide surgical decision-making for patients with gastric cancer.
    Jul. 2021, Annals of gastroenterological surgery, 5(4) (4), 519 - 527, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 【消化器外科とAI】AIを用いた腹腔鏡下胃癌手術における手術器具自動認識システムの開発と利用
    山崎 悠太, 金治 新悟, 掛地 吉弘
    (株)へるす出版, Jun. 2021, 消化器外科, 44(7) (7), 1193 - 1202, Japanese

  • 堀江 和正, 押切 太郎, 瀧口 豪介, 中村 哲, 掛地 吉弘
    金原出版(株), Jun. 2021, 手術, 75(7) (7), 1153 - 1159, Japanese

  • 【消化器癌;診断と治療のすべて】消化器癌の診断・病期分類・治療・成績 胃癌 集学的治療
    金治 新悟, 裏川 直樹, 掛地 吉弘
    (株)へるす出版, May 2021, 消化器外科, 44(6) (6), 705 - 708, Japanese

  • 安藤 正恭, 長谷川 寛, 掛地 吉弘
    (株)メディカ出版, Apr. 2021, 消化器ナーシング, (2021春季増刊) (2021春季増刊), 154 - 155, Japanese

  • 安藤 正恭, 長谷川 寛, 掛地 吉弘
    (株)メディカ出版, Apr. 2021, 消化器ナーシング, (2021春季増刊) (2021春季増刊), 156 - 157, Japanese

  • 安藤 正恭, 長谷川 寛, 掛地 吉弘
    (株)メディカ出版, Apr. 2021, 消化器ナーシング, (2021春季増刊) (2021春季増刊), 158 - 159, Japanese

  • 安藤 正恭, 長谷川 寛, 掛地 吉弘
    (株)メディカ出版, Apr. 2021, 消化器ナーシング, (2021春季増刊) (2021春季増刊), 160 - 161, Japanese

  • Taro Oshikiri, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Given the worldwide popularization of conventional minimally invasive esophagectomy (C-MIE), robot-assisted MIE (RAMIE) can be expected to provide a finer procedure. However, controversy remains regarding whether RAMIE is superior to C-MIE in preventing recurrent laryngeal nerve (RLN) palsy. Considering the shallow learning curve for RAMIE, a novel procedure for lymphadenectomy along the RLN during RAMIE is needed. METHODS: Based on a logical and simple understanding of the left upper mediastinum anatomy, the authors developed a novel "modified bascule method" for RAMIE that could simplify lymphadenectomy along the left RLN and prevent it from being touched and stretched. Between 2018 and 2020, 46 patients with esophageal carcinoma underwent RAMIE using this method at Kobe University. RESULTS: The modified bascule method was used to perform RAMIE for 29 men and 17 women with a median age of 67 years (range, 49-82 years). The median thoracoscopic procedure time was 438 min (range, 344-625 min), and the median console time was 351 min (range 273-518 min). The study harvested a median of 24 (range, 8-34) lymph nodes from the thoracic portion and 4 (range, 0-10) lymph nodes from along the left RLN. The mortality rate was 0%. Postoperative left RLN palsy classified as Clavien-Dindo (C-D) grade 1 or higher was observed for 9 patients (19%), whereas grade 2 or higher was not seen (0%). Pneumonia and anastomotic leakage rates higher than C-D grade 2 were respectively 13% and 19%. CONCLUSIONS: The novel modified bascule method for RAMIE can promote feasible lymphadenectomy along the left RLN even when performed during the learning period.
    Mar. 2021, Annals of surgical oncology, English, International magazine
    Scientific journal

  • R Seishima, H Miyata, K Okabayashi, H Hasegawa, M Tsuruta, K Shigeta, M Monno, Y Yamashita, M Inomata, G Wakabayashi, Y Kakeji, Y Kitagawa, M Watanabe
    BACKGROUND: This study aimed to analyse the perioperative results from a national dataset of rectal cancer resections in elderly patients. METHODS: The clinical records of patients undergoing rectal cancer surgery between 2012 and 2014 were retrieved from the Japanese National Clinical Database and analysed retrospectively. Patients were categorized according to age and those 80 years or older were defined as elderly. Subgroups were also defined according to the surgical approach (laparoscopy versus open surgery). The short-term outcomes, including mortality, anastomotic leak, surgical site infections and medical complications were compared between subgroups. RESULTS: Of 56 175 patients undergoing rectal cancer surgery, some 6717 patients were elderly and laparoscopy was performed in 46.8 per cent of the sample. When comparing laparoscopy and open surgery in elderly patients, the operative mortality rate (1.5 versus 2.8 per cent; P < 0.001), the incidence of anastomotic leakage (5.2 versus 6.5 per cent; P = 0.026), surgical site infections (6.0 versus 8.0 per cent; P = 0.001), pneumonia (1.4 versus 2.5 per cent; P = 0.001), renal failure (0.7 versus 1.3 per cent; P = 0.016) and cardiac events (0.3 versus 0.8 per cent; P = 0.008) were lower for laparoscopy than for open surgery. The overall complication rate in elderly patients (19.5 per cent) was comparable to that in the younger group (P = 0.07). However, incidence of systemic complications was significantly higher in elderly than in younger patients (all P < 0.001). CONCLUSION: Laparoscopy was safe and feasible in elderly patients compared with open surgery. However, the rates of systemic complications were significantly higher than in younger patients.
    Mar. 2021, BJS open, 5(2) (2), English, International magazine
    Scientific journal

  • Arata Takahashi, Hiroyuki Yamamoto, Yoshihiro Kakeji, Shigeru Marubashi, Mitsukazu Gotoh, Yasuyuki Seto, Hiroaki Miyata
    PURPOSE: This study compared the quality of healthcare before and after implementation of a policy restructuring the healthcare delivery system and estimated the impact of centralization. METHODS: We used the National Clinical Database to study patients undergoing esophagectomies from 2011 to 2016. We compared the effect of centralization based on the patient background, surgical mortality, and year of surgery. Difference-in-difference methods based on the generalized estimating equation logistic regression model were used for before-and-after comparisons after adjusting for patient-level expected surgical mortality. RESULTS: In total, 34,640 cases were identified. More cases with risk factors were noted in ultra-low-volume hospitals, where 38.4% of cases in underpopulated areas were treated, than in higher volume facilities, and the operative mortality, readmission within 30 days and length of stay were worse among patients treated in these hospitals. In centralized prefectures, the number of cases per hospital increased over time (7.2 in 2011 to 9.5 in 2016) while the crude operative mortality tended to decrease (3.4% in 2011 to 1.8% in 2016). The difference-in-difference estimator was 0.856 (95% confidence interval: 0.639-1.147, p = 0.298). CONCLUSION: The centralization of ultra-low-volume hospitals did not lead to a deterioration in the quality of care but rather an improving trend.
    Mar. 2021, Surgery today, English, Domestic magazine
    Scientific journal

  • NCDデータを用いた、本邦での腹腔鏡下直腸手術の年齢別短期成績の検討
    岡林 剛史, 長谷川 博俊, 清島 亮, 茂田 浩平, 松井 信平, 宮田 裕章, 山下 裕一, 猪股 雅史, 若林 剛, 掛地 吉弘, 渡邊 昌彦, 北川 雄光
    (一社)日本内視鏡外科学会, Mar. 2021, 日本内視鏡外科学会雑誌, 25(7) (7), SP5 - 2, Japanese

  • ロボット支援消化管手術の普及と安全性に関するNational Clinical Databaseを用いた解析
    小濱 和貴, 錦織 達人, 一原 直昭, 宇山 一朗, 猪股 雅史, 渡邊 昌彦, 掛地 吉弘, 瀬戸 泰之, 宮田 裕章, 坂井 義治
    (一社)日本内視鏡外科学会, Mar. 2021, 日本内視鏡外科学会雑誌, 25(7) (7), SP5 - 4, English

  • Kyosuke Agawa, Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Gosuke Takiguchi, Naoki Urakawa, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND/AIM: The safety of neoadjuvant chemoradiotherapy (NACRT) combined with total mesorectal excision (TME) and selective lateral pelvic lymph node dissection (LLND) is unclear in elderly patients with locally advanced rectal cancer (LARC). PATIENTS AND METHODS: Forty-two patients with LARC underwent TME and selective LLND following NACRT at Kobe University Hospital. The clinical outcomes were retrospectively compared between the elderly (aged ≥70 years, n=13) and non-elderly patients (aged <70, n=29). RESULTS: Twelve of the thirteen elderly patients could complete NACRT. Although the overall rate of postoperative complications did not differ between the groups, abdominal wound infection and deep vein thrombosis developed more frequently in the elderly group. The length of the postoperative hospital stay was similar. Three-year overall survival and 3-year relapse-free survival rates were similar between the groups. CONCLUSION: Selective LLND after NACRT is safe for elderly patients with LARC.
    Mar. 2021, Anticancer research, 41(3) (3), 1677 - 1682, English, International magazine
    Scientific journal

  • Hiroki Sakamoto, Yu-Ichiro Koma, Nobuhide Higashino, Takayuki Kodama, Kohei Tanigawa, Masaki Shimizu, Masataka Fujikawa, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    Cancer-associated fibroblasts (CAFs) contribute to the progression of various cancers. Previously, we reported the significance of CAFs in esophageal squamous cell carcinoma (ESCC); however, the functions of CAFs in the ESCC microenvironment remain unknown. To investigate CAFs' function, we established an indirect coculture assay between human bone marrow-derived mesenchymal stem cells (MSCs) and ESCC cells. Cocultured MSCs expressed more fibroblast activation protein, one of the markers of CAFs, compared with monocultured MSCs. Therefore, we defined cocultured MSCs as CAF-like cells. To identify molecules associated with the ESCC progression in CAFs, we conducted a cDNA microarray analysis on monocultured MSCs and CAF-like cells to compare their gene expression profiles. We found that SERPINE1, which encodes plasminogen activator inhibitor-1 (PAI-1), was more abundant in CAF-like cells than in monocultured MSCs, and the PAI-1 derived from CAF-like cells induced the abilities of migration and invasion in both ESCC cells and macrophages by the Akt and Erk1/2 signaling pathways via the low-density lipoprotein receptor-related protein 1 (LRP1), which is a PAI-1 receptor. Based on immunohistochemistry assays of ESCC tissues, higher expression levels of PAI-1 and LRP1 were correlated with poor prognosis in ESCC patients. These results suggest that the PAI-1/LRP1 axis contributes to the progression of ESCC, making it a potential target for ESCC therapy.
    Mar. 2021, Laboratory investigation; a journal of technical methods and pathology, 101(3) (3), 353 - 368, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Masaaki Iwatsuki, Hiroyuki Yamamoto, Hiroaki Miyata, Yoshihiro Kakeji, Kazuhiro Yoshida, Hiroyuki Konno, Yasuyuki Seto, Hideo Baba
    BACKGROUND: Despite interest in surgeon and hospital volume effects on total gastrectomy (TG), clinical significance has not been confirmed in a large-scale population. This study aimed at clarifying the association of surgeon and hospital volume on postoperative mortality after TG for gastric cancer among Japanese patients in National Clinical Database (NCD). METHODS: Between 2011 and 2015, we retrospectively extracted data on TG for gastric cancer from the NCD. The primary outcome was operative mortality. We divided surgeon volume as the number of TGs performed by a patient's surgeon in the previous year: S1 (0-2 cases), S2 (3-9), S3 (10-25), S4 (26-79) and hospital volume by the number of TGs performed in the previous year: H1 (0-11 cases), H2 (12-26), H3 (27-146). We calculated the 95% confidence interval (CI) for the mortality rate based on odds ratios (OR) estimated from a hierarchical logistic regression model. RESULTS: We analyzed 71,307 patients at 2051 institutions. Low-volume surgeons and hospitals had significantly older and poorer-risk patients with various comorbidities. The operative mortality rate decreased with surgeon volume, 2.5% in S1 and 0.6% in S4. The operative mortality was 3.1% in H1, 1.7% in H2, and 1.2% in H3. After risk adjustment for surgeon, hospital volume and patient characteristics, hospital volume was significantly associated with operative morality (H3: OR = 0.53, 95% CI 0.43-0.63). CONCLUSIONS: We demonstrate hospital volume has an impact on postoperative mortality after TG in a nationwide population study. These findings suggest centralization may improve outcomes after TG.
    Mar. 2021, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 24(2) (2), 526 - 534, English, Domestic magazine
    Scientific journal

  • Kazuhiko Mori, Kotaro Sugawara, Susumu Aikou, Hideomi Yamashita, Keishi Yamashita, Mariko Ogura, Keisho Chin, Masayuki Watanabe, Hisahiro Matsubara, Yasushi Toh, Yoshihiro Kakeji, Yasuyuki Seto
    BACKGROUND: Chemoradiotherapy is an alternative to surgery for esophageal cancer, with a putatively equivalent outcome. However, disease recurrence after a complete response is common and if follow-up surveillance detects recurrence, salvage treatments for potentially curable disease must follow. METHODS: We conducted a nation-wide questionnaire survey of institutions in Japan certified by the Japanese Esophageal Society to investigate outcomes of primary thoracic esophageal cancer patients initially treated by chemoradiotherapy with complete response diagnoses. The primary endpoint was overall survival, the secondary endpoint disease recurrence. Outcomes of patients who had undergone salvage treatments were also investigated. Cases were excluded from analysis if endoscopic study, endoscopic biopsy, or computed tomography data were lacking. RESULTS: At 41 institutes 544 case records were collected; valid data on 392 patients were obtained; 5-year survival was 74.8%, 5-year disease-free survival, 66.8%. Clinical staging before treatment significantly affected both overall and disease-free survival rates, but differences between adjoining stages were unexpectedly small. The primary relapse site was classified as primary site (n = 58), regional lymph nodes (n = 36), or distant disease (n = 34). Salvage treatments with curative intent (surgery, endoscopic treatments, and additional radiation) were performed on 38, 23, and 4 cases; 5-year survival after esophagectomy (n = 22), endoscopic treatment (n = 23), and lymphadenectomy (n = 9) was 47.4%, 70.9%, and 33.3%, respectively. CONCLUSIONS: A quarter of patients developed recurrent disease, mostly locoregional, after complete response. Complete response patients with originally advanced stage disease had fair clinical outcomes; salvage treatments after locoregional recurrence achieved modest long-term survival.
    Feb. 2021, Esophagus : official journal of the Japan Esophageal Society, English, Domestic magazine
    Scientific journal

  • Makoto Sohda, Hiroyuki Kuwano, Hiroshi Saeki, Tatsuya Miyazaki, Makoto Sakai, Yoshihiro Kakeji, Yasushi Toh, Yuichiro Doki, Hisahiro Matsubara
    BACKGROUND: Esophageal neuroendocrine carcinoma (ENEC) is an extremely rare type of tumor characterized by a high malignant potential, rapid growth, and poor prognosis. Because the standard therapy for ENEC has been poorly defined, we herein aimed to attain a clear view of the current state of treatment for ENEC by performing a large-scale, multicenter study. METHODS: We conducted a questionnaire-based, retrospective clinical review of 142 patients with ENEC treated at 37 hospitals accredited by the Japan Esophageal Society from January 2010 to December 2015. RESULTS: The most frequent main treatment performed was an operation, followed by chemoradiotherapy, chemotherapy, and endoscopic submucosal dissection. Among the 67 patients who underwent surgery, 28 (19.7%) were not accurately diagnosed with NEC or a combined NEC tumor by pretreatment biopsy. The 5-year overall survival rate of all patients was 33.2%. Among patients with Stages III and IV disease, the prognosis was significantly better in patients who underwent chemoradiotherapy than in patients who underwent other treatments. Among patients with Stages I and II disease, however, there was no difference in survival rates between those who underwent surgery and chemoradiotherapy. CONCLUSIONS: This nationwide survey is a valuable report of the current status of treatment of ENEC in a limited number of cases experienced at each participating institution. The survival benefit obtained from surgery was considered to be limited, especially for Stages III and IV ENEC. Accurate pretreatment histological diagnosis is essential to determine the most appropriate treatment strategy for patients with ENEC.
    Feb. 2021, Journal of gastroenterology, English, Domestic magazine
    Scientific journal

  • Ryo Takai, Yohei Funakoshi, Hirotaka Suto, Yoshiaki Nagatani, Yoshinori Imamura, Masanori Toyoda, Kimikazu Yakushijin, Naomi Kiyota, Ken-Ichi Harada, Kimihiro Yamashita, Yoshihiro Kakeji, Hironobu Minami
    BACKGROUND/AIM: Biomarkers for immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) are required. We encountered a patient whose skin irAE fluctuated in parallel with serum soluble interleukin-2 receptor (sIL-2R). PATIENTS AND METHODS: We examined 15 patients with cancer who received ICIs. Serum sIL-2R levels before and during ICI treatment were measured. The sIL-2R levels of preserved serum samples from another five patients who developed grade 3 irAEs were measured. RESULTS: Twelve patients showed no significant changes in sIL-2R levels during ICI treatment. Baseline serum sIL-2R levels in three patients increased beyond the normal range before the second cycle. These three patients had grade ≥2 irAEs at the second cycle treatment visit, supporting our hypothesis. Furthermore, at diagnosis of irAEs, the sIL-2R levels of all preserved samples from patients with grade 3 irAEs were significantly elevated. CONCLUSION: Serum sIL-2R is a promising biomarker for the diagnosis of irAEs.
    Feb. 2021, Anticancer research, 41(2) (2), 1021 - 1026, English, International magazine
    Scientific journal

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Masataka Fujikawa, Hiroki Sakamoto, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Although transanal total mesorectal excision (ta-TME) is adopted for rectal cancer surgery by an increasing number of surgeons, it is still technically challenging. We have employed a lateral-first approach for ta-TME to overcome technical difficulties. However, its outcomes and advantage over conventional laparoscopic TME remain unclear. METHODS: Thirty-five consecutive patients who underwent ta-TME using a lateral-first approach (the ta-TME group) and 53 consecutive patients who underwent conventional laparoscopic TME (the lap-TME group) for low rectal cancer were included. Propensity score matching (PSM) was used to create balanced cohorts of ta-TME (n = 28) and lap-TME (n = 28). Their clinical outcomes were compared after PSM. RESULTS: The operative time and intraoperative blood loss were significantly lower in the ta-TME group than in the lap-TME group (P = 0.042 and P < 0.001, respectively). Postoperative complications ≥ Clavien-Dindo grade II were significantly less and postoperative hospital stay was significantly shorter in the ta-TME group (35.7% vs. 78.6%, P = 0.003, and 18 days vs. 32 days, P < 0.001, respectively). The distal margin was significantly larger in the ta-TME when excluding the abdominoperineal resection cases (20 mm vs. 10 mm, P = 0.032). The positive radial margin was observed in 2 of 28 patients (7.1%) in the ta-TME group. CONCLUSIONS: Ta-TME using a lateral-first approach is feasible and may offer several advantages over lap-TME in terms of short-term outcomes. It might be an alternative safe approach for ta-TME. To confirm the oncological superiority of this surgery, further study in a larger population and for a longer follow-up period is warranted.
    Feb. 2021, Surgical endoscopy, 35(2) (2), 971 - 978, English, International magazine
    Scientific journal

  • Yoshihiro Kakeji, Hiroyuki Yamamoto, Hideki Ueno, Susumu Eguchi, Itaru Endo, Akira Sasaki, Shuji Takiguchi, Hiroya Takeuchi, Masaji Hashimoto, Akihiko Horiguchi, Tadahiko Masaki, Shigeru Marubashi, Kazuhiro Yoshida, Hiroaki Miyata, Hiroyuki Konno, Mitsukazu Gotoh, Yuko Kitagawa, Masaki Mori, Yasuyuki Seto
    The National Clinical Database (NCD) of Japan was established in 2010 with the board certification system. A joint committee of 16 gastroenterological surgery database-affiliated organizations has been nurturing this nationwide database and utilizing its data for various analyses. Stepwise board certification systems have been validated by the NCD and are used to improve the surgical outcomes of patients. The use of risk calculators based on risk models can be particularly helpful for establishing appropriate and less invasive surgical treatments for individual patients. Data obtained from the NCD reflect current developments in the surgical approaches used in hospitals, which have progressed from open surgery to endoscopic and robot-assisted procedures. An investigation of the data acquired by the NCD could answer some relevant clinical questions and lead to better surgical management of patients. Furthermore, excellent surgical outcomes can be achieved through international comparisons of the national databases worldwide. This review examines what we have learned from the NCD of gastroenterological surgery and discusses what future developments we can expect.
    Feb. 2021, Surgery today, 51(2) (2), 187 - 193, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Taro Oshikiri, Gosuke Takiguchi, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: During the past decade, minimally invasive esophagectomy (MIE) for esophageal cancer has been adopted worldwide with expectations of lower invasiveness. However, the rate of postoperative pneumonia, which is an independent risk factor for oncological prognosis in esophageal cancer, remains high. The aim of this retrospective follow-up study is to clarify whether there is a strong correlation between recurrent laryngeal nerve (RLN) palsy and postoperative pneumonia in MIE. METHODS: This retrospective follow-up study included 209 patients with esophageal cancer who underwent thoracoscopic esophagectomy in the prone position (TEP) at Kobe University between 2011 and 2018. Inclusion criteria included age 18-85 years; cT1-3, cN0-3 disease; upper mediastinal lymphadenectomy; and ability to undergo simultaneous esophagectomy and reconstruction of the gastric conduit or pedicled jejunum. Univariate and multivariate logistic regression were conducted to identify independent risk factors for pneumonia. RESULTS: Among 209 TEPs, pneumonia of Clavien-Dindo classification grade > II occurred in 44 patients (21%). In the pneumonia positive and negative groups, there were significant differences in age (67.9 ± 7.5 vs. 64.9 ± 8.6 years), 3-field lymph node dissection [27 (61%) vs. 67 (41%)], transfusion [20 (45%) vs. 41 (25%)], left RLN palsy [19 (43%) vs. 18 (11%)], and any RLN palsy [20 (45%) vs. 18 (11%)]. In multivariate analysis, any RLN palsy was associated with a higher incidence of pneumonia [odds ratio (OR), 6.210; 95% confidence interval (CI), 2.728-14.480; P < 0.0001]. In addition, age was associated with a higher incidence of pneumonia (OR, 1.049; 95% CI, 1.001-1.103; P = 0.046). Changes in the rate of any RLN palsy over time were quite similar to changes in the incidence of pneumonia. CONCLUSION: There is a strong correlation between RLN palsy and pneumonia in MIE for esophageal cancer. Prevention of RLN palsy may reduce the incidence of pneumonia, leading to better oncological prognosis.
    Feb. 2021, Surgical endoscopy, 35(2) (2), 837 - 844, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Sonoko Ishida, Masayuki Akita, Kohei Fujikura, Masato Komatsu, Ryuichiro Sawada, Hisayuki Matsumoto, Jun Saegusa, Tomoo Itoh, Yoshihiro Kakeji, Yoh Zen
    The gene mutation profiles of gastric neuroendocrine neoplasms are incompletely understood. The purpose of this study was to characterize the molecular pathology of poorly differentiated neuroendocrine carcinoma (NEC) and mixed neuroendocrine‒non-neuroendocrine neoplasm (MiNEN) of the stomach. Surgical cases of gastric NEC (n = 7) and MiNEN (n = 6) were examined by clinical review, immunohistochemistry, microsatellite instability (MSI) analysis and whole-exome sequencing. NEC cases consisted of small- (n = 2) and large-cell types (n = 4). All cases of MiNEN were histologically composed of large-cell type NEC and tubular adenocarcinoma. Whole-exome sequencing analysis detected recurrent mutations in TP53 in 8 cases (62%), and they were more frequently observed in MiNEN than in NEC (100% vs. 29%). Frameshift mutations of APC were observed in two cases of MiNEN. One case of large-cell type NEC had a frameshift mutation with loss of heterozygosity in RB1. The other mutated genes (e.g., ARID1 and KRAS) were detected in a single case each. A high level of MSI was confirmed in one case of MiNEN, which harbored mutations in two well-differentiated neuroendocrine tumor (NET)-related genes (MEN1 and ATRX1). In cases of MiNEN, two histological components shared mutations in TP53, APC and ZNF521, whereas alterations in CTNNB1, KMT2C, PTEN and SPEN were observed in neuroendocrine components only. In conclusion, TP53 is a single, frequently mutated gene in gastric NEC and MiNEN, and alterations in other genes are less common, resembling the mutation profiles of gastric adenocarcinomas. Gene mutations frequently observed in well-differentiated NET were uncommon but not entirely exclusive.
    Jan. 2021, Human pathology, 110, 1 - 10, English, International magazine, Co-authored internationally
    Scientific journal

  • Masataka Fujikawa, Yu-Ichiro Koma, Masayoshi Hosono, Naoki Urakawa, Kohei Tanigawa, Masaki Shimizu, Takayuki Kodama, Hiroki Sakamoto, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    Tumor-associated macrophages (TAMs) promote tumor progression. The number of infiltrating TAMs is associated with poor prognosis in esophageal squamous cell carcinoma (ESCC) patients; however, the mechanism underlying this phenomenon is unclear. Our previous cDNA microarray analysis had revealed that the expression of chemokine (C-C motif) ligand 1 (CCL1) is up-regulated in peripheral blood monocyte-derived macrophages stimulated using conditioned media from ESCC cells (TAM-like macrophages). In this study, we evaluated the role of CCL1 in ESCC progression. We confirmed that CCL1 is overexpressed in TAM-like macrophages, and that CCR8, a CCL1 receptor, is expressed on ESCC cell surface. TAM-like macrophages significantly enhanced the motility of ESCC cells, and neutralizing antibodies against CCL1 or CCR8 suppressed this increased motility. Recombinant human CCL1 promoted ESCC cell motility via the Akt/proline-rich Akt substrate of 40 kDa/mammalian target of rapamycin pathway. Phosphatidylinositol 3-kinase or Akt inhibitors, CCR8 silencing, and neutralizing antibody against CCR8 could significantly suppress these effects. The overexpression of CCL1 in stromal cells or CCR8 in ESCC cells was significantly associated with poor overall survival (P = 0.002 or P = 0.009, respectively) and disease-free survival (P = 0.009 or P = 0.047, respectively) in ESCC patients. These results indicated that the interaction between stromal CCL1 and CCR8 on cancer cells promotes ESCC progression via the Akt/proline-rich Akt substrate of 40 kDa/mammalian target of rapamycin pathway, providing novel therapeutic targets.
    Jan. 2021, The American journal of pathology, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Polymicrobial Solitary Retroperitoneal Abscess Due to Sigmoid Colon Perforation.
    Yuta Takase, Young-Min Yang, Koichi Kitagawa, Yuzo Nakano, Susumu Miura, Taro Oshikiri, Yoshihiro Kakeji, Katsumi Shigemura, Masato Fujisawa
    We treated an 85-year-old man with an abscess perforating into the retroperitoneal space from the sigmoid colon, with retroperitoneal drainage combined with antibiotics. CT showed no abscess formation in the intraperitoneal space. The patient consulted a doctor with a chief complaint of left-side low back pain and fever. He was first diagnosed with bacteremia due to Escherichia coli and close examination by CT revealed a retroperitoneal abscess. On referral to our hospital, we determined by CT that the cause of abscess formation was perforation of the intestine into the retroperitoneal space and spreading into the psoas muscle compartment. We then performed colostomy and abscess drainage through the retroperitoneal space to prevent the abscess disseminating into the intraperitoneal space. The abscess and necrotic tissue cultures were polymicrobial, including Enterobacteriaceae and Bacteroides spp. The abscess almost disappeared after drainage, and the patient's general condition gradually improved. The retroperitoneal abscess did not relapse by follow-up CT. In conclusion, this rare case presented with perforation of the intestine (Sigmoid colon) disseminated only to the retroperitoneal space without no intraperitoneal space abscess formation. We performed drainage only by a retroperitoneal approach without entering the intraperitoneal space.
    Jan. 2021, The Kobe journal of medical sciences, 66(4) (4), E149-E152, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yu Kitamura, Taro Oshikiri, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yasuhiro Fujino, Masahiro Tominaga, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Esophageal squamous cell cancer (ESCC) is one of the deadliest cancers in the world. Esophagectomy remains the principal treatment, and minimally invasive esophagectomy (MIE) has been performed worldwide. This study aimed to clarify whether the lymph node ratio (LNR), defined as the ratio of metastatic lymph nodes (LNs) to examined, is a prognostic factor for ESCC after MIE. METHODS: This study included 327 MIEs with the patient in the prone position at two institutions from 2010 to 2015. Cox proportional hazards regression analyses using clinicopathologic characteristics and the LNR were performed for the pN1 patients and the whole cohort. RESULTS: In the multivariate analysis for all stages, independent prognostic factors were depth of tumor invasion (P < 0.0001), LNR (P = 0.014), operative time (P = 0.003), and pneumonia (P = 0.012). In the analysis of the pN1 subgroup, the optimum LNR cutoff level for overall survival (OS) was 9 based on receiver operation characteristic analysis. The LNR was significantly associated with depth of tumor invasion (P = 0.004) and number of metastatic LNs (P < 0.0001). The OS curve for the group with an LNR of 9 or higher was significantly worse than for the group with an LNR lower than 9 (P < 0.001). Multivariate analyses demonstrated that the LNR is a unique independent prognostic factor for the pN1 subgroup (hazard ratio, 6.811; 95% confidence interval, 2.009-23.087; P = 0.002). CONCLUSIONS: The LNR is an independent prognostic factor in ESCC after MIE. Especially for patients with pN1 status, the LNR is more useful than the number of metastatic LNs for predicting survival outcome.
    Jan. 2021, Annals of surgical oncology, English, International magazine
    Scientific journal

  • Satoshi Suzuki, Shingo Kanaji, Naoki Urakawa, Gosuke Takiguchi, Hiroshi Hasegawa, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Yoshihiro Kakeji
    BACKGROUND/AIM: Adenocarcinoma of the esophagogastric junction (AEG) is refractory even when curative resection is followed by adjuvant chemotherapy. This study evaluated the efficacy of neoadjuvant chemotherapy (NAC) using an oral fluoropyrimidine-platinum regimen for AEG. PATIENTS AND METHODS: Out of 35 patients with locally advanced AEG who underwent curative resection, 21 who underwent surgery first and 14 who received NAC were retrospectively compared in terms of survival. RESULTS: The NAC regimens comprised of S-1 or capecitabine plus oxaliplatin or cisplatin; trastuzumab was added to six borderline resectable cases. The downstaging rate was 50% and the pathological response rate including complete response (29%) was 50%. The three-year relapse-free survival in the NAC group was significantly superior than the surgery-first group (78% vs. 22%, p=0.011). The NAC group had a significantly longer median survival time than the surgery-first group (NR vs. 29 months, p=0.032). CONCLUSION: NAC using an oral fluoropyrimidine-platinum regimen may provide survival benefit in AEG.
    2021, Cancer diagnosis & prognosis, 1(3) (3), 185 - 191, English, International magazine
    Scientific journal

  • 掛地 吉弘, 長谷川 寛, 金治 新悟, 北川 雄光
    医学図書出版(株), Jan. 2021, 泌尿器外科, 34(1) (1), 47 - 53, Japanese

  • 泌尿器外科 特集 National Clinical Database の現状
    掛地 吉弘, 長谷川 寛, 金治 新悟, 北川 雄光
    Jan. 2021, 消化器外科領域におけるNational Clinical Databaseの活用, 34(1) (1), 47 - 53, Japanese
    [Refereed]
    Scientific journal

  • Makoto Sohda, Hiroshi Saeki, Hiroyuki Kuwano, Makoto Sakai, Akihiko Sano, Takehiko Yokobori, Tatsuya Miyazaki, Yoshihiro Kakeji, Yasushi Toh, Yuichiro Doki, Hisahiro Matsubara
    BACKGROUND: n our previous nationwide survey report on esophageal perforation, we proposed the existence of cases with idiopathic esophageal perforation at a certain rate. AIMS: To elucidate the clinical characteristics of idiopathic esophageal perforation, we performed a comparative analysis between cases with idiopathic type and post-emetic type esophageal perforation. METHODS: This study enrolled 139 patients with esophageal perforation (post-emetic type: idiopathic type = 115:24) as the subjects of nationwide survey on esophageal perforation. We conducted detailed studies on chief complaints, inflammatory responses, initial diagnosis, location and situation of the perforation site, time to therapeutic intervention, and prognosis between the two groups. RESULTS: Compared with post-emetic type, cases of idiopathic type tended to exhibit rear-side perforation (p = 0.052) and significantly less presented chest pain (p = 0.002). Consequently, cases of idiopathic type significantly missed to diagnose as esophageal perforation compared with post-emetic type (p = 0.042). With regard to inflammatory response, cases of post-emetic type experienced hyperthermia compared with idiopathic type (p = 0.033). On the other hand, cases of idiopathic type exhibited significantly higher level of C-reactive protein than post-emetic type (p = 0.004). In addition, it took longer time until starting treatment in the cases of idiopathic type (p < 0.0001) and the cases of idiopathic type showed significantly worse prognosis than the cases of post-emetic type (p = 0.009). CONCLUSION: This study first focused on the characteristics of idiopathic esophageal perforation that have been included in so-called Boerhaave's syndrome. The pathophysiology of the idiopathic type should be separately understood from post-emetic type, because the diagnostic and prognostic features largely differ.
    Jan. 2021, Esophagus : official journal of the Japan Esophageal Society, English, Domestic magazine
    Scientific journal

  • Yoshihiro Kakeji
    Jan. 2021, Annals of gastroenterological surgery, 5(1) (1), 5 - 6, English, Domestic magazine
    Link to Kobe Univ. Repository (Kernel)

  • Yoshihiro Kakeji, Taro Oshikiri, Gosuke Takiguchi, Shingo Kanaji, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki
    Esophageal cancer has a poor prognosis despite the fact that surgical techniques have been advanced and optimized, and systemic multimodality approaches have progressed recently. Adding chemotherapy, radiotherapy, and immunotherapy to the basic surgical approach have been shown to have therapeutic benefit for esophageal cancer. This review describes the latest development of chemoradiotherapy, chemotherapy, and immunotherapy, which have contributed to the reduction in esophageal cancer growth and improved the survival of patients. Chemoradiation is a treatment option for resectable esophageal cancer to preserve the esophagus for patients who cannot tolerate surgery. Moreover, a combination of chemoradiotherapy and salvage surgery could extend the survival of patients. The effects of a triplet chemotherapy regimen are currently being verified in some Phase III studies for unresectable advanced/recurrent esophageal cancer. In addition, with the great promise of immune checkpoint inhibitors, strategies that incorporate the use of immunotherapy may shift from the metastatic setting to the neoadjuvant/adjuvant setting as a result of clinical trials. More precise comprehension of the molecular biology of esophageal cancer is expected to further control disease progression using multimodality treatments in the future.
    Jan. 2021, Esophagus : official journal of the Japan Esophageal Society, 18(1) (1), 25 - 32, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yuta Yamazaki, Shingo Kanaji, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    PURPOSE: This study was conducted to determine whether establishing the proximal resection line using India ink tattooing can ensure safe resection margins during totally laparoscopic distal gastrectomy. METHODS: This retrospective study included 81 patients who underwent totally laparoscopic distal gastrectomy for gastric cancer on the lower two-thirds of the stomach. The proximal resection margins were analyzed with respect to the macroscopic type and clinical T stage, and the intraoperative appearance of the stain on the serosa was classified by reviewing surgical videos. RESULTS: R0 resection was performed in all patients. The rates of the intended margins were 89.2% in patients without a frozen section diagnosis and 84.2% in patients with differentiated type lesions who underwent a frozen section diagnosis; however, most patients with undifferentiated advanced lesions failed to achieve the intended resection margins. Intraoperative appearance revealed that 85.2% of patients had localized type stains, whereas 11.1% had widespread-type stains. CONCLUSIONS: Our procedure to determine the proximal resection line in totally laparoscopic distal gastrectomy is oncologically safe. However, careful observation of the resected specimen and a frozen section analysis should be performed for undifferentiated advanced lesions.
    Jan. 2021, Surgery today, 51(1) (1), 111 - 117, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Yasufumi Koterazawa, Taro Oshikiri, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Patients often experience severe weight loss after oesophagectomy. Enteral nutrition via a feeding jejunostomy tube (FT) is commonly practised. This study aimed to assess the effect of severe weight loss postoperatively and enteral nutrition via an FT on long-term prognosis after oesophagectomy. METHODS: This study analysed 317 patients who underwent minimally invasive oesophagectomy at Kobe University Hospital and Hyogo Cancer Center from 2010 to 2015. The patients' body weight was evaluated at 3 months postoperatively. They were organised into the severe weight loss (n = 65) and moderate weight loss (n = 252) groups. Furthermore, they were categorised into the FT group (184 patients who had an FT placed during oesophagectomy) and no-FT group (133 patients without FT). Patients (119 per group) matched for the FT and no-FT groups were identified via propensity score matching. RESULTS: The 5-year overall survival (OS) rate in the severe weight loss group was significantly lower (p = 0.024). In the multivariate analysis, tumour invasion depth (pT3-4), preoperative therapy and severe weight loss had a worse OS (hazard ratio = 1.89; 95% confidence interval = 1.12-3.17, hazard ratio = 2.11; 95% confidence interval = 1.25-3.54, hazard ratio = 1.82; 95% confidence interval = 1.02-3.524, respectively). No significant differences in the number of severe weight loss patients and OS were found between the FT and no-FT groups. CONCLUSION: Severe weight loss is significantly associated with poor OS. In addition, enteral nutrition via an FT did not improve the severe weight loss and OS.
    Dec. 2020, BMC gastroenterology, 20(1) (1), 407 - 407, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 掛地 吉弘
    (公財)上原記念生命科学財団, Dec. 2020, 上原記念生命科学財団研究報告集, 34, 1 - 6, Japanese

  • Akihiko Okamura, Hiroyuki Yamamoto, Masayuki Watanabe, Hiroaki Miyata, Shingo Kanaji, Kinji Kamiya, Yoshihiro Kakeji, Yuichiro Doki, Yuko Kitagawa
    OBJECTIVE: To elucidate the association between preoperative hemoglobin A1c (HbA1c) levels and short-term outcomes after oncologic esophagectomy. SUMMARY BACKGROUND DATA: Although diabetes mellitus (DM) is associated with an increased risk of postoperative morbidity in several types of surgery, the association of DM with short-term outcomes after esophagectomy has shown conflicting results. METHODS: We analyzed 15801 patients who underwent oncologic esophagectomy between 2015 and 2017 from the National Clinical Database. We evaluated the associations between preoperative HbA1c levels and short-term outcomes, using multivariable logistic regression and restricted cubic spline models. RESULTS: The cohort included 12074, 1361, 1097, 909, and 360 patients with HbA1c levels of ≤5.9%, 6.0%-6.4%, 6.5%-6.9%, 7.0%-7.9%, and ≥8.0%, respectively. There were value-dependent associations between HbA1c values and odds ratios (ORs) for anastomotic leakage (AL), surgical site infections (SSIs), pneumonia, and composite outcomes. Compared with the HbA1c category of ≤5.9%, the categories of 7.0%-7.9% and ≥8.0% were at higher risk for AL (P <0.001 and 0.031, respectively), the category of ≥8.0% was at higher risk for SSIs (P = 0.001), the categories of 6.5%-6.9% and 7.0%-7.9% were at higher risk for pneumonia (P = 0.016 and 0.002, respectively), and the categories of 7.0-7.9 and ≥ 8.0% were at higher risk for composite outcomes (P < 0.001 and 0.001, respectively). CONCLUSIONS: Preoperative HbA1c levels are associated with the risk of postoperative complications following esophagectomy, and the threshold values differed among the outcomes. Preoperative HbA1c is useful in predicting the risk of postoperative complications.
    Nov. 2020, Annals of surgery, English, International magazine
    Scientific journal

  • Takuya Kudo, Taro Oshikiri, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    PURPOSE: Minimally invasive esophagectomy (MIE) has been increasingly used, but many reports have stated that recurrent laryngeal nerve (RLN) palsy after MIE is a major complication associated with postoperative pneumonia. Prevention of RLN palsy clearly has been a challenging task. The study aim was to determine if a three-dimensional (3-D) stereoscopic vision system can reduce the RLN palsy rate after MIE. METHODS: This was a retrospective study of MIE (McKeown esophagectomy) using a 3-D or 2-D stereoscopic vision system to treat 358 patients in the prone position between April 2010 and March 2019. The patients who underwent 3-D MIE (3-D group) or 2-D MIE (2-D group) were matched by using propensity score matching. After matching, the perioperative outcomes were compared between the groups. RESULTS: After propensity score matching, 154 patients were analyzed (77 patients, 3-D group; 77 patients, 2-D group). There were no significant differences in the patients' baseline characteristics in the matched cohort. There were no significant differences in the rates of pneumonia (Clavien-Dindo (C-D) grade ≥ II, 3-D vs. 2-D, 11 (14%) vs. 12 (16%)), anastomotic leakage (C-D grade ≥ II, 10 (13%) vs. 18 (23%)) and mortality. The rates of left RLN palsy (C-D grade ≥ IIIa, 1 (1.3%) vs. 7 (9.1%), P = 0.029), right RLN palsy (C-D grade ≥ I, 2 (3%) vs. 8 (10%), P = 0.049), comprehensive complication index (CCI®) (8.5 vs. 14.3, P = 0.011), and postoperative hospital stay period (median: 25 vs. 30 days, P = 0.034) were significantly lower in the 3-D group than in the 2-D group, respectively. CONCLUSIONS: In MIE, the 3-D viewing system was one of the factors that reduced postoperative morbidities such as the rates of each RLN palsy and CCI®, leading to shorter postoperative hospital stay.
    Nov. 2020, Langenbeck's archives of surgery, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Natsuko Yamauchi, Takashi Ito, Hiroki Matsuoka, Teruhiro Chohno, Hiroshi Hasegawa, Yoshihiro Kakeji, Takamasa Ohnishi
    BACKGROUND: Lipomas are the most common cause of intussusception in adults. To our knowledge, however, no cases of lipoma and ectopic gastric mucosa with gastritis cystica profunda (GCP) have been reported. We report a case of intussusception caused by a small intestinal lipoma with ectopic gastric mucosa containing GCP-component cells within the inverted Meckel's diverticulum. CASE PRESENTATION: A female in her 40s underwent computed tomography for postoperative follow-up of left breast cancer. A tumor, suspected to be a lipoma, was found in the ileum. Since there were no symptoms, the patient underwent regular follow-up. However, gradual enlargement was observed, and surgery was recommended due to the risk of intussusception. After reduction via the Hutchinson technique, laparoscopically assisted partial resection of the small intestine was performed due to suspicion that the tumor was causing intussusception starting from the ileum. Histopathologic examinations revealed proliferation of mature adipose tissue in the subserosal layer, which was diagnosed as lipoma. Furthermore, adipose tissue was found in the stem area and accordingly, we diagnosed lipoma associated with the inverted Meckel's diverticulum. Moreover, gastric mucosa-like crypt epithelium and proper glandular tissue were identified in the mucosal membrane at the area of onset, and signs of gastric pit dilatation over the submucosa and crypt epithelium hyperplasia were observed. Diagnosis was ectopic gastric mucosa containing GCP component tissue. CONCLUSIONS: Intussusception in the small intestine complicated with lipoma and ectopic gastric mucosa with GCP within the Meckel's diverticulum has not been reported, demonstrating the rarity of our case.
    Springer Science and Business Media LLC, Nov. 2020, Surgical case reports, 6(1) (1), 286 - 286, English, International magazine
    Scientific journal

  • Takeru Matsuda, Hideki Endo, Masafumi Inomata, Hiroshi Hasegawa, Hiraku Kumamaru, Hiroaki Miyata, Yoshiharu Sakai, Yoshihiro Kakeji, Yuko Kitagawa, Masahiko Watanabe
    Aim: The advantages of laparoscopic right hemicolectomy over open surgery for colon cancer in general clinical practice are debated, as evidenced by the continued use of open surgery in a significant proportion of patients worldwide. This study aimed to assess and compare the clinical outcome of laparoscopic and open right hemicolectomy for colon cancer using data from the Japanese National Clinical Database. Methods: A total of 72 299 patients who underwent laparoscopic (n = 46 084) and open (n = 26 215) right hemicolectomy for colon cancer between 2014 and 2018 were enrolled in this retrospective study. Short-term outcome was compared between groups using propensity score matching analysis. Results: The incidence of overall postoperative morbidity ≥ Clavien-Dindo classification grade 3 was significantly higher in the open surgery group than the laparoscopic group (4.7% vs 3.2%, P < .001). The incidence of most individual morbidities, including surgical site infection, anastomotic leakage, and ileus, was higher in the open surgery group. Short-term outcomes, including intraoperative blood loss, postoperative hospital stay, reoperation rate, 30-day mortality, and in-hospital mortality, were superior in the laparoscopic group, except for operative time. Subgroup analyses showed that the incidence of postoperative morbidity was lower in the laparoscopic group for all prespecified subgroups. Conclusion: Laparoscopic right hemicolectomy has an advantage over open surgery for colon cancer with respect to short-term outcome.
    Nov. 2020, Annals of gastroenterological surgery, 4(6) (6), 693 - 700, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Tomonori Akagi, Hideki Endo, Masafumi Inomata, Hiroyuki Yamamoto, Toshiyuki Mori, Kazuyuki Kojima, Hiroya Kuroyanagi, Yoshiharu Sakai, Kentaro Nakajima, Hidefumi Shiroshita, Tsuyoshi Etoh, Yoshihisa Saida, Seiichiro Yamamoto, Hirotoshi Hasegawa, Hideki Ueno, Yoshihiro Kakeji, Hiroaki Miyata, Yuko Kitagawa, Masahiko Watanabe
    Aim: This study aimed to evaluate the association between surgeons certified via the Endoscopic Surgical Skill Qualification System (ESSQS) of the Japan Society for Endoscopic Surgery (JSES) and surgical outcomes of laparoscopic distal gastrectomy (LDG) and laparoscopic low anterior resection (LLAR). Methods: Japanese National Clinical Database data on the patients undergoing LDG and LLAR between 2014-2016 were analyzed retrospectively. The proportion of cases performed by ESSQS-certified surgeons was calculated for each procedure, and clinicopathological factors with or without participation of ESSQS-certified surgeons as an operator were assessed. Then, effects of operations performed by ESSQS-certified surgeons on short-term patient outcomes were analyzed using generalized estimating equations logistic regression analysis. Results: There were 110 610 and 65 717 patients who underwent LDG and LLAR, respectively. The operations performed by ESSQS-certified surgeons in each procedure totaled 28 467 (35.3%) and 12 866 (31.2%), respectively. A multivariable logistic regression model showed that odds ratios of mortality for LDG and LLAR performed by ESSQS-certified surgeons were 0.774 (95% CI, 0.566-1.060, P = 0.108) and 0.977 (0.591-1.301, P = 0.514), respectively. Odds ratios for secondary endpoints of anastomotic leakage in LDG and LLAR performed by ESSQS-certified surgeons were 0.835 (95% CI, 0.723-0.964, P = 0.014) and 0.929 (0.860-1.003, P = 0.059), respectively, whereas that of ileus/bowel obstruction for LLAR performed by ESSQS-certified surgeons was 1.265 (1.132-1.415, P < 0.001). There were no significant associations between the two operations performed by ESSQS-certified surgeons and other factors such as mortality and overall complications. Conclusions: ESSQS certification did not affect postoperative mortality following LDG and LLAR, but annual experience of laparoscopic surgery was associated with it. ESSQS certification may contribute to favorable outcomes regarding anastomotic leakage following LDG and LLAR.
    Nov. 2020, Annals of gastroenterological surgery, 4(6) (6), 721 - 734, English, Domestic magazine
    Scientific journal

  • Machiko Nagata, Takeru Matsuda, Hiroshi Hasegawa, Masako Utsumi, Kimihiro Yamashita, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Omentoplasty is sometimes used to prevent perineal wound complications after abdominoperineal resection (APR) following neoadjuvant chemoradiotherapy (NACRT). However, recent studies have raised some controversy about its clinical benefit. PATIENTS AND METHODS: Outcomes for rectal cancer patients who received APR after NACRT were retrospectively compared between the groups with omentoplasty (n=28) and without omentoplasty (n=14). RESULTS: The operative time was significantly longer in the omentoplasty group (575 vs. 404 min, p<0.001). Laparoscopic surgery was performed more frequently in the omentoplasty group. Perineal wound problems including dehiscence and infection were significantly reduced in the omentoplasty group (46.4% vs. 78.6%, p<0.001). Univariate and multivariate analyses revealed that omentoplasty was the most important factor in reducing perineal wound complications (odds ratio=0.020, 95% confidence intervaI=0.001-0.393; p=0.001). CONCLUSION: Omentoplasty was useful in reducing perineal wound complications after APR following NACRT.
    Nov. 2020, Anticancer research, 40(11) (11), 6539 - 6543, English, International magazine
    Scientific journal

  • Hitoshi Katai, Takashi Ishikawa, Kohei Akazawa, Takeo Fukagawa, Yoh Isobe, Isao Miyashiro, Ichiro Oda, Shunichi Tsujitani, Hiroyuki Ono, Satoshi Tanabe, Souya Nunobe, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: No guidelines are available for defining the extent of lymph node (LN) dissection in patients with remnant gastric carcinoma (RGC). Hence, this retrospective study aimed to determine the optimal extent of LN dissection in patients with RGC. METHODS: We retrospectively evaluated the therapeutic outcomes of node dissection for RGC from a nationwide registry. When the metastatic rate or 5-year survival rate exceeded 10%, dissection was recommended. We calculated the dissection index by multiplying the incidence of metastasis at that nodal station by the 5-year survival rate of patients with metastasis at the station. A dissection index of > 1.0 was considered significant. RESULTS: We included 1133 patients with RGC (T2-T4 tumor) who had undergone distal gastrectomy as the primary surgery for the evaluation of the survival benefit of nodal dissection. Any regional node station was considered significant. When the primary surgery was for malignant disease, the index was high for Nos. 3 (10.2), 7 (9.5), 1 (7.1), and 9 (8.0) nodes. For nodes at the splenic hilum, the index value was 4.4, which was higher than that for the perigastric nodes (Nos. 4sa and 4sb). The index for No. 10 nodes was the highest (10.5) when tumors involved a greater curvature. CONCLUSIONS: The therapeutic strategy for RGC remains the same, regardless of the histology of the primary disease during the initial surgery. Total gastrectomy and dissection of the perigastric LNs (Nos. 1-4), suprapancreatic LNs (Nos. 7-9 and 11), and LNs at the splenic hilum (No. 10) are justified.
    Nov. 2020, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 23(6) (6), 1091 - 1101, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Shingo Kanaji, Ryohei Watanabe, Pietro Mascagni, Fabian Trauzettel, Takeshi Urade, Fabio Longo, Ludovica Guerriero, Silvana Perretta, Bernard Dallemagne, Yoshihiro Kakeji, Jacques Marescaux
    BACKGROUND: Three-dimensional (3-D) high-definition (HD) stereovision and two-dimensional (2-D) ultra-high-resolution (4K) monitors have recently become available for laparoscopic surgery. The aim of this study was to compare laparoscopic performance between inexperienced participants using 3-D/HD and 2-D/4K monitors and those using conventional 2-D/HD monitors. METHODS: The study enrolled 66 participants with no previous surgical experience or medical training. They were randomly divided into three equal groups, each using a different type of monitor (2-D/HD, 2-D/4K, or 3-D/HD), to perform three phantom tasks using a laparoscopic simulator: Task 1, touching markers on a non-flat surface; Task 2, bimanual peg transfer; and Task 3, passing a straight rod through a loop. Each task was performed three times. The performance scores (operative time, path length of the forceps, and technical errors) were compared for each monitor type and by age group (< 30 vs. > 30 years). RESULTS: For all three tasks, scores using the 3-D monitor were significantly better than those using either 2-D monitor, with no difference between the 2-D/4K and 2-D/HD monitors. Using the 2-D monitors, the performance of Task 3 by the participants > 30 years was worse than that by the younger participants; however, there was no difference between the age groups when using the 3-D monitor. CONCLUSION: Participants with no prior experience using a 3-D monitor showed better laparoscopic performance than those using 2-D monitors, even with 4K resolution. This improvement was more marked in older participants, suggesting a greater loss of depth perception in a 2-D environment.
    Nov. 2020, Surgical endoscopy, 34(11) (11), 5083 - 5091, English, International magazine, Co-authored internationally
    [Refereed]
    Scientific journal

  • Yasuhide Kofunato, Arata Takahashi, Mitsukazu Gotoh, Yoshihiro Kakeji, Yasuyuki Seto, Hiroyuki Konno, Hiraku Kumamaru, Hiroaki Miyata, Shigeru Marubashi
    OBJECTIVES: To investigate the effect of geriatric variables on five newly added outcomes and create risk models for predicting these outcomes. SUMMARY BACKGROUND DATA: Because there is a current lack of geriatric research focusing on geriatric outcomes using a national surgical database in Japan, there is a need to investigate outcomes associated with major gastroenterological surgery using these data. METHODS: This multicenter prospective cohort study was conducted at 26 surgery departments across 21 institutions in Japan using the National Clinical Database (NCD) surgical registry. In total, 22 new geriatric variables were imported from the ACS NSQIP geriatric pilot study. The following five geriatric outcomes were defined: 1) postoperative delirium, 2) physical function on postoperative day 30, 3) fall risk on discharge, 4) discharge other than home with social service, and 5) functional decline on discharge, and geriatric risk prediction models for major gastroenterological surgery were created. RESULTS: Between January 2018 and December 2018, data on 3,981 procedures from seven major gastroenterological surgeries were collected and analyzed. Older age and preoperative geriatric variables (Origin status from home, History of dementia, Use of mobility aid, Fall history, and Not competent on admission) were strongly associated with postoperative outcomes. Geriatric risk prediction models for these outcomes were created, with C-statistic values ranging from 0.74 to 0.90, demonstrating model validity and sufficiency of fit. CONCLUSIONS: The risk models for the newly defined five geriatric outcomes that we created can be used in the decision-making process or provision of care in geriatric patients.
    Oct. 2020, Annals of surgery, 275(6) (6), 1112 - 1120, English, International magazine
    Scientific journal

  • S Ashina, A Sakai, A Masuda, M Tsujimae, T Kobayashi, Y Shiomi, H Shiomi, S Kanaji, T Itoh, Y Kakeji, Y Kodama
    Wiley, Oct. 2020, Journal of Gastroenterology and Hepatology, 35(10) (10), 1667 - 1667, English, International magazine
    Scientific journal

  • Yasufumi Koterazawa, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Yoshihiro Kakeji, Takashi Aoi
    In the original publication of the article, the following errors were noted and corrected in this correction.
    Oct. 2020, Journal of gastroenterology, 55(10) (10), 1010 - 1011, English, Domestic magazine

  • Masamichi Mizuma, Hiroyuki Yamamoto, Hiroaki Miyata, Mitsukazu Gotoh, Michiaki Unno, Tooru Shimosegawa, Yasushi Toh, Yoshihiro Kakeji, Yasuyuki Seto
    PURPOSES: The aim of this study was to clarify the impact of a board certification system and the implementation of clinical practice guidelines for pancreatic cancer (PC) on the mortality of pancreaticoduodenectomy in Japan. METHODS: By a web questionnaire survey via the National Clinical Database (NCD) for departments participating in the NCD, quality indicators (QIs) related to the treatment for PC, namely the board certification systems of various societies and the adherence to clinical practice guidelines for PC, were investigated between October 2014 and January 2015. A multivariable logistic regression analysis was performed to evaluate the relationship between the QIs and mortality of pancreaticoduodenectomy. RESULTS: Of 1415 departments that registered at least 1 pancreaticoduodenectomy between 2013 and 2014 in NCD, 631 departments (44.6%), which performed pancreaticoduodenectomy for a total of 11,684 cases, answered the questionnaire. The mortality of pancreaticoduodenectomy was positively affected by the board certification systems of the Japanese Society of Gastroenterological Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Gastroenterology, and Japanese Society of Medical Oncology as well as by institutions that used magnetic resonance imaging of ≥ 3 T for the diagnosis of PC in principle. CONCLUSIONS: The measurement of the appropriate QIs is suggested to help improve the mortality in pancreaticoduodenectomy. Masamichi Mizuma and Hiroyuki Yamamoto equally contributed.
    Oct. 2020, Surgery today, 50(10) (10), 1297 - 1307, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Yo-Ichi Yamashita, Hiroyuki Yamamoto, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa, Hiroki Yamaue, Masakazu Yamamoto, Hideo Baba
    BACKGROUND/PURPOSE: The aim of this study was to identify risk factors for bile leakage in hepatic resections without biliary reconstructions using the large Japanese national clinical database (NCD). METHODS: A total of 10 102 patients who had undergone hepatic resection involving more than one segment without biliary reconstructions for hepatocellular carcinoma during 2015-2017 were enrolled. Risk factors for bile leakage, with special reference to the type of hepatic resection, were identified by multivariable logistic regression analysis. RESULTS: Bile leakage occurred in 726 patients (7.2%). Risk factors for bile leakage were as follows: male sex (odds ratio [OR] 1.28, 95% confidence interval [CI] 1.04-1.58), diabetes mellitus (+) (OR 1.19, 95% CI 1.01-1.39), hemoglobin <10 g/dL (OR 1.4, 95% CI 1.02-1.93), albumin <3.5 g/dL (OR 1.3, 95% CI 1.03-1.63), central bisectionectomy (OR 3.8, 95% CI 2.81-5.13), left trisectionectomy (OR 3.6, 95% CI 2.10-6.15), right anterior sectionectomy (OR 2.07, 95% CI 1.58-2.72), and S5 or S8 segmentectomy (OR 1.33, 95% CI 1.00-1.77). CONCLUSION: Central bisectionectomy, left trisectionectomy, and right anterior sectionectomy are high-risk types of hepatic resection for bile leakage.
    Sep. 2020, Journal of hepato-biliary-pancreatic sciences, English, Domestic magazine
    Scientific journal

  • Y Sugita, T Nakamura, R Sawada, G Takiguchi, N Urakawa, H Hasegawa, M Yamamoto, S Kanaji, Y Matsuda, K Yamashita, T Matsuda, T Oshikiri, S Suzuki, Y Kakeji
    The number of elderly patients with esophageal cancer has increased in recent years. The use of thoracoscopic esophagectomy has also increased, and its minimal invasiveness is believed to contribute to postoperative outcomes. However, the short- and long-term outcomes in elderly patients remain unclear. This study aimed to elucidate the safety and feasibility of minimally invasive esophagectomy in elderly patients. This retrospective study included 207 patients who underwent radical thoracoscopic esophagectomy for thoracic esophageal squamous cell carcinoma at Kobe University Hospital between 2005 and 2014. Patients were divided into non-elderly (<75 years) and elderly (≥75 years) groups. A propensity score matching analysis was performed for sex and clinical T and N stage, with a total of 29 matched pairs. General preoperative data, surgical procedures, intraoperative data, postoperative complications, in-hospital death, cancer-specific survival, and overall survival were compared between groups. The elderly group was characterized by lower preoperative serum albumin levels and higher American Society of Anesthesiologists grade. Intraoperative data and postoperative complications did not differ between the groups. The in-hospital death rate was 4% in the elderly group, which did not significantly differ from the non-elderly group. Cancer-specific survival was similar between the two groups. Although overall survival tended to be poor in the elderly group, it was not significantly worse than that of the non-elderly group. In conclusion, the short- and long-term outcomes of minimally invasive esophagectomy in elderly versus non-elderly patients were acceptable. Minimally invasive esophagectomy is a safe and feasible modality for elderly patients with appropriate indications.
    Sep. 2020, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, English, International magazine
    Scientific journal

  • 後藤 満一, 丸橋 繁, 一原 直昭, 掛地 吉弘, 宮田 裕章, 武冨 紹信, 江川 裕人, 高田 泰次, 梅下 浩司, 瀬戸 泰之
    (株)医学書院, Sep. 2020, 臨床外科, 75(9) (9), 1056 - 1061, Japanese

  • Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Masako Utsumi, Yoshihiro Kakeji
    Laparoscopic right hemicolectomy (LRH) is utilized worldwide as one of the standard surgical treatments for right-sided colon cancer. However, there have been issues concerning its applicability, techniques, and trend. The present study aimed to elucidate the current status and trend of LRH by reviewing literature focusing on important issues associated with this surgery. Based on previous studies, LRH most likely provides better short-term outcomes and similar oncological outcomes compared to open surgery. Despite the increasing use of robotic approach in this surgery, it seems to have always been associated with longer operative times and greater hospital cost with limited advantage. Intracorporeal anastomosis seems to improve short-term outcomes, such as quicker recovery of bowel function, compared to extracorporeal anastomosis. However, it does not contribute to shorter hospital stay. With regard to dissection technique, various approaches, and landmarks have been advocated to overcome the technical difficulty in LRH. This difficulty is likely to be caused by anatomical variation, especially in venous structures. The superiority of one approach or landmark over another is still argued about due to the lack of large-scale prospective studies. However, deep understanding both of anatomical variation and characteristics of each approach would be of extreme importance to minimize adverse effects and maximize patient benefit after LRH.
    Sep. 2020, Annals of gastroenterological surgery, 4(5) (5), 521 - 527, English, Domestic magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Nobuaki Hoshino, Hideki Endo, Koya Hida, Nao Ichihara, Yoshimitsu Takahashi, Hiroshi Hasegawa, Toshimoto Kimura, Yuko Kitagawa, Yoshihiro Kakeji, Hiroaki Miyata, Takeo Nakayama, Yoshiharu Sakai
    Background: Emergency gastrointestinal surgery, although rare, is known for its high mortality and morbidity. However, the risks of emergency surgery for gastrointestinal cancer have not been investigated in depth. This study aimed to investigate the impact of emergency surgery on mortality and morbidity in patients with gastrointestinal cancers and to identify associated risk factors. Methods: We extracted data from the National Clinical Database, a nationwide surgery registration system in Japan, for patients with gastrointestinal cancer who underwent esophageal resection, total gastrectomy, distal gastrectomy, right hemicolectomy, or low anterior resection between 2012 and 2017. The impacts of emergency surgery on 30-day mortality and incidence of overall postoperative complications were compared with those of non-emergency surgery. Risk factors for mortality and overall postoperative complications were then sought in patients who underwent emergency surgery. Results: Thirty-day mortality and incidence of overall postoperative complications were significantly higher in emergency surgeries for gastric, colon, and rectal cancers than in non-emergency surgeries (odds ratios 4.86-6.98 and 1.68-2.18, respectively; all P < .001). Various risk factors were identified in the group that underwent emergency surgery, including preoperative sepsis and lower body mass index. Some of the risk factors were common to all types of surgery and others were specific to a certain type of surgery. Conclusion: The actual risk of emergency surgery and the risk factors for overall postoperative complications in emergency cases are shown to serve as a reference for postoperative management. Emergency surgery had an additional burden on patients depending on the type of surgery.
    Sep. 2020, Annals of gastroenterological surgery, 4(5) (5), 549 - 561, English, Domestic magazine
    Scientific journal

  • ACS-NSQIPに学ぶ、外科医療成績向上に向けた取り組み
    丸橋 繁, 掛地 吉弘, 宮田 裕章, 瀬戸 泰之, 北川 雄光, Hu Lina, Ko Clifford, 後藤 満一
    (一社)日本外科学会, Aug. 2020, 日本外科学会定期学術集会抄録集, 120回, SP - 2, Japanese

  • 佐藤 直哉, 丸橋 繁, 掛地 吉弘, 武富 紹信, 高田 泰次, 梅下 浩司, 江川 裕人, 大段 秀樹, 瀬戸 泰之, 後藤 満一
    (一社)日本消化器外科学会, Aug. 2020, 日本消化器外科学会雑誌, 53(8) (8), 617 - 626, Japanese

  • Yasufumi Koterazawa, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Yoshihiro Kakeji, Takashi Aoi
    BACKGROUND: The esophagus is known to be derived from the foregut. However, the mechanisms regulating this process remain unclear. In particular, the details of the human esophagus itself have been poorly researched. In this decade, studies using human induced pluripotent stem cells (hiPSCs) have proven powerful tools for clarifying the developmental biology of various human organs. Several studies using hiPSCs have demonstrated that retinoic acid (RA) signaling promotes the differentiation of foregut into tissues such as lung and pancreas. However, the effect of RA signaling on the differentiation of foregut into esophagus remains unclear. METHODS: We established a novel stepwise protocol with transwell culture and an air-liquid interface system for esophageal epithelial cell (EEC) differentiation from hiPSCs. We then evaluated the effect of all-trans retinoic acid (ATRA), which is a retinoic acid receptor (RAR)α, RARβ and RARγ agonist, on the differentiation from the hiPSC-derived foregut. Finally, to identify which RAR subtype was involved in the differentiation, we used synthetic agonists and antagonists of RARα and RARγ, which are known to be expressed in esophagus. RESULTS: We successfully generated stratified layers of cells expressing EEC marker genes that were positive for lugol staining. The enhancing effect of ATRA on EEC differentiation was clearly demonstrated with quantitative reverse transcription polymerase chain reaction, immunohistology, lugol-staining and RNA sequencing analyses. RARγ agonist and antagonist enhanced and suppressed EEC differentiation, respectively. RARα agonist had no effect on the differentiation. CONCLUSION: We revealed that RARγ activation promotes the differentiation of hiPSCs-derived foregut into EECs.
    Aug. 2020, Journal of gastroenterology, 55(8) (8), 763 - 774, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Daiki Okamoto, Takeru Matsuda, Akihiro Watanabe, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Shigeo Hara, Yoshihiro Kakeji
    The Japanese Journal of Gastroenterological Surgery, Jul. 2020, The Japanese Journal of Gastroenterological Surgery, 53(7) (7), 598 - 604
    Scientific journal

  • 膵全摘術の現状と展望 National clinical databaseによる膵全摘術の術後重症合併症リスクモデル
    橋本 大輔, 水間 正道, 隈丸 拓, 宮田 裕章, 近本 亮, 五十嵐 久人, 糸井 隆夫, 江川 新一, 児玉 裕三, 里井 壯平, 濱田 晋, 水元 一博, 山上 裕機, 山本 雅一, 掛地 吉弘, 瀬戸 泰之, 馬場 秀夫, 海野 倫明, 下瀬川 徹, 岡崎 和一
    (一社)日本膵臓学会, Jul. 2020, 膵臓, 35(3) (3), A119 - A119, Japanese

  • エキスパートの治療法 症例から考える 4型胃癌の治療方針
    掛地 吉弘
    (株)メディカルレビュー社, Jul. 2020, 胃がんperspective, 11(2) (2), 124 - 127, Japanese

  • National Clinical Databaseから何が引き出せるか
    掛地 吉弘, 長谷川 寛, 金治 新悟
    Jul. 2020, 外科臨床に役立つ統計学, 82(8) (8), 830 - 835, Japanese
    [Refereed]
    Scientific journal

  • Hiroshi Hasegawa, Takeru Matsuda, Akira Arimoto, Kimihiro Yamashita, Masayasu Nishi, Nobuhisa Takase, Masayoshi Hosono, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    PURPOSE: The influence of anastomotic leakage on long-term survival in patients with rectal cancer is debatable. The aim of this study was to evaluate relationships between anastomotic leakage and long-term survival. METHODS: In this multicenter retrospective cohort study, 395 consecutive stage I to III rectal cancer patients underwent anterior resection between 2007 and 2012. Five-year overall survival, 5-year disease-free survival, and 5-year local recurrence-free survival were compared between patients with leakage (Leakage (+)) and patients without leakage (Leakage (-)). RESULTS: Of 395 patients, 50 (12.7%) had anastomotic leakage. Of these 50, 34 (68.0%) required urgent surgery and 16 (32.0%) could be managed by watchful waiting or with percutaneous drainage. The median follow-up period was 62.6 months. Five-year overall survival did not differ between the two groups (Leakage (+) 93.8% vs. Leakage (-) 89.0%, P = 0.121). Five-year disease-free survival also did not differ between the two groups (81.6% vs. 80.3%, P = 0.731), and neither did 5-year local recurrence-free survival (91.9% vs. 86.1%, P = 0.206). In a multivariable Cox regression model, BMI > 25, preoperative CA19-9 > 37, pathological T stage, pathological N stage, and circumferential resection margin (CRM) positive were independent predictors of disease-free survival. Moreover, pathological T stage, pathological N stage, and CRM positive were the only independent predictors of overall survival and local recurrence-free survival. Anastomotic leakage was not a risk factor for overall survival, disease-free survival, or local recurrence-free survival. CONCLUSION: Anastomotic leakage is not associated with a significant decrease in long-term survival in rectal cancer patients.
    Jul. 2020, International journal of colorectal disease, 35(7) (7), 1243 - 1253, English, International magazine
    [Refereed]
    Scientific journal

  • Sohda M, Kuwano H, Sakai M, Miyazaki T, Kakeji Y, Toh Y, Matsubara H
    OBJECTIVE: To get a clear view of the current state of treatment for esophageal perforation in Japan. Esophagus perforations are the most serious gastrointestinal tract perforations and are associated with high morbidity and mortality. The optimal treatment choice remains unknown. METHODS: We conducted a retrospective clinical review of 182 esophageal perforation cases at 108 hospitals accredited by the Japanese Esophageal Society between January 2010 and December 2015. RESULTS: We found that 20.9% of patients were incorrectly diagnosed initially. We observed mediastinum emphysema in 83.5% of patients, and serious abscess formations of the mediastinum and intrathoracic cavity in 38.6% and 29.6%, respectively. The lower esophagus was the most commonly perforated site (77.7%). Management of esophageal perforations included nonoperative treatment in 20 patients (11%) and operative treatment in 162 patients (89%). The overall mortality rate was 6.9%. The survivors had significantly shorter times from symptom appearance to visit (p = 0.0016), and from time to visit to diagnosis confirmation (p = 0.0011). Moreover, patients older than 65 years, white blood cells less than 3000/mm3, C-reactive protein > 10 mg/L, or abscesses in the thoracic cavity showed significantly higher mortality than others. CONCLUSION: Shortening the time from onset to the start of treatment contributes to reduce mortality in patients with esophageal perforation. Moreover, strict medical treatment is necessary to lower the mortality rate of elderly patients with strong inflammation and abscesses in the thoracic cavity.
    Jul. 2020, Esophagus : official journal of the Japan Esophageal Society, 17(3) (3), 230 - 238, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Yuta Yamazaki, Shingo Kanaji, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    PURPOSE: Skeletal muscle loss after gastrectomy can worsen patients' quality of life and prognosis. Laparoscopic gastrectomy is less invasive than open gastrectomy and has become commonly performed. However, the degree of skeletal muscle loss after laparoscopic procedures remains unclear. We herein report the degree and risk factors of psoas muscle loss after laparoscopic gastrectomy for gastric cancer. METHODS: The total psoas area (TPA) on computed tomography of 50 consecutive patients who underwent laparoscopic total gastrectomy (LTG) and 167 consecutive patients who underwent laparoscopic distal gastrectomy (LDG) for gastric cancer was retrospectively evaluated at one postoperative year. The TPA loss was compared between LDG and LTG and univariate and multivariate analyses were performed to identify the risk factors for TPA loss > 10%. RESULTS: The median TPA decrease rate was 5.9% in the LDG group and 15.6% in the LTG group. LTG and postoperative respiratory complications were independent factors associated with a severe TPA loss of > 10%. In the LTG group, no independent factors were identified in a multivariate analysis. In the LDG group, postoperative complications were identified as an independent risk factor for TPA loss > 10%. CONCLUSIONS: Laparoscopic gastrectomy leads to postoperative TPA loss, especially in patients who underwent LTG and had postoperative respiratory complications. Postoperative complications after LDG were also a risk factor for TPA loss.
    Jul. 2020, Surgery today, 50(7) (7), 693 - 702, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Eiji Fukuoka, Takeru Matsuda, Hiroshi Hasegawa, Kimihiro Yamashita, Akira Arimoto, Gosuke Takiguchi, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    INTRODUCTION: Laparoscopic surgery has become popular for colorectal cancer treatment in recent years. However, its success rate even among high-risk patients remains debatable. The present study aims to compare the short- and long-term outcomes between laparoscopic and open surgeries in the American Society of Anesthesiologists (ASA) classes 3 and 4 patients with colorectal cancer. METHODS: This was a single-center, retrospective, cohort study performed at a university hospital, with 78 patients suffering from colorectal cancer who underwent surgery in ASA classes 3 and 4 as respondents. Patient and tumor characteristics, operative outcomes, and prognoses were factors compared between the open and laparoscopic groups. RESULTS: Compared with the open group, laparoscopic group had longer operation time (median 287.5 vs 204.5 minutes, P = .001), less operative blood loss (median 40 vs 240 mL, P = .020), and fewer postoperative complications (24% vs 55%, P = .011). In addition, operative approach (open vs laparoscopic) served as an independent factor for the occurrence of postoperative complications [HR = 3.963 (1.344-12.269), P = .013]. In terms of overall survival and recurrence-free survival (P = .171 and .087, respectively), no significant difference was found between the two groups. CONCLUSION: Laparoscopic surgery is thus associated with more favorable short-time outcomes and could be adopted as treatment even for colorectal cancer ASA class 3 and 4 patients.
    Jul. 2020, Asian journal of endoscopic surgery, 13(3) (3), 336 - 342, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Naoya Yoshida, Hiroyuki Yamamoto, Hideo Baba, Hiroaki Miyata, Masayuki Watanabe, Yasushi Toh, Hisahiro Matsubara, Yoshihiro Kakeji, Yasuyuki Seto
    OBJECTIVE: We aimed to elucidate whether minimally invasive esophagectomy (MIE) can be safely performed by reviewing the Japanese National Clinical Database. SUMMARY OF BACKGROUND DATA: MIE is being increasingly adopted, even for advanced esophageal cancer that requires various preoperative treatments. However, the superiority of MIE's short-term outcomes compared with those of open esophagectomy (OE) has not been definitively established in general clinical practice. METHODS: This study included 24,233 esophagectomies for esophageal cancer conducted between 2012 and 2016. Esophagectomy for clinical T4 and M1 stages, urgent esophagectomy, 2-stage esophagectomy, and R2 resection were excluded. The effects of preoperative treatment and surgery on short-term outcomes were analyzed using generalized estimating equations logistic regression analysis. RESULTS: MIE was superior or equivalent to OE in terms of the incidence of most postoperative morbidities and surgery-related mortality, regardless of the type of preoperative treatment. Notably, MIE performed with no preoperative treatment was associated with significantly less incidence of any pulmonary morbidities, prolonged ventilation ≥48 hours, unplanned intubation, surgical site infection, and sepsis. However, reoperation within 30 days in patients with no preoperative treatment was frequently observed after MIE. The total surgery-related mortality rates of MIE and OE were 1.7% and 2.4%, respectively (P < 0.001). Increasing age, low preoperative activities of daily living, American Society of Anesthesiologists physical status ≥3, diabetes mellitus requiring insulin use, chronic obstructive pulmonary disease, congestive heart failure, creatinine ≥1.2 mg/dL, and lower hospital case volume were identified as independent risk factors for surgery-related mortality. CONCLUSIONS: The results suggest that MIE can replace OE in various situations from the perspective of short-term outcome.
    Jul. 2020, Annals of surgery, 272(1) (1), 118 - 124, English, International magazine
    [Refereed]
    Scientific journal

  • Kazumasa Horie, Taro Oshikiri, Yu Kitamura, Masaki Shimizu, Yuta Yamazaki, Hiroki Sakamoto, Sonoko Ishida, Yasufumi Koterazawa, Taro Ikeda, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    INTRODUCTION: Recent advances in the treatment for esophageal cancer have improved the prognosis after esophagectomy, but they have led to an increased incidence of gastric tube cancer. In most patients who underwent retrosternal reconstruction, median sternotomy is performed; it is associated with a risk of postoperative bleeding and osteomyelitis, and pain often negatively affects respiration. Here, we report the first case of thoracoscopic retrosternal gastric conduit resection in the supine position (TRGR-S). MATERIALS AND SURGICAL TECHNIQUE: A 75-year-old male patient was placed in the supine position. Four ports were placed in the left chest wall. The gastric tube was separated from the epicardium, sternum, and left brachiocephalic vein. Because of adhesions between the gastric tube and the right pleura, combined resection of the right pleura was performed. The dorsal side of the gastric tube was dissected before the ventral side, enabling the gastric tube to be suspended from the back of the sternum and, thus, making it easier to expose the surgical field. Next, pedicled jejunal reconstruction via the presternal route was performed. There were no postoperative complications. The pathological diagnosis was signet ring cell carcinoma (pT1b, pN0, M0, pStage I), indicating R0 resection. DISCUSSION: TRGR-S does not require sternotomy, reducing the risk of postoperative bleeding and osteomyelitis. In the presence of adhesions, TRGR-S is safe and provides a good surgical view. It is also reliable procedure for resection of retrosternal gastric tube cancer, and it is ergonomic for surgeons.
    Jul. 2020, Asian journal of endoscopic surgery, 13(3) (3), 461 - 464, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yuta Yamazaki, Shingo Kanaji, Hitoshi Harada, Masayasu Nishi, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Taro Oshikiri, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    INTRODUCTION: Three-dimensional (3D) laparoscopic vision can improve depth perception. However, it is a question whether 3D vision can improve motion in the depth direction. The aim of this study was to compare the impact of 3D vision on forceps motion in the depth and horizontal directions. METHODS: All data were obtained from our previous two studies, where, in total, 40 novices and 20 moderately experienced surgeons participated. A simple phantom task was performed in a training box. The participants were randomly assigned to two groups. Specifically, one group performed the task five times initially under a two-dimensional (2D) system, and the other group started under a 3D system. Both groups then performed the same task five times under the alternative system. Performances were recorded by an optical position tracker. We separately evaluated forceps motion in the x-, y-, and z-axis directions. RESULTS: Compared with the findings for 2D vision, the forceps path lengths were significantly decreased among novices and moderately experienced surgeons in almost all tasks under 3D vision. In a comparison of the path length ratio (3D/2D) in each direction, larger reduction was observed for the depth direction among novices, whereas no significant directional difference was noted among moderately experienced surgeons. CONCLUSIONS: For novices, 3D laparoscopic vision improves depth perception and may give shorter forceps movement in the depth direction even for simple tasks.
    Jul. 2020, Asian journal of endoscopic surgery, 13(3) (3), 265 - 271, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Taichi Tamura, Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Takumi Fukumoto, Yoshihiro Kakeji
    Retroperitoneal cellular angiofibroma (RCA) is very rare, and the optimal treatment for RCA has not been established. We report the case of RCA in a 58-year-old man who underwent curative laparoscopy-assisted resection. Preoperative computed tomography showed heterogeneous enhancement of the 7 cm diameter tumor in the pelvis. A smaller (2.3 cm) mass was also detected in the small intestine. The preoperative diagnosis was peritoneal metastasis of the gastrointestinal tumor of the small intestine. The pelvic tumor was laparoscopically mobilized from the rectum, the left ureter, and the left internal iliac vessels. The tumor was excised by detachment from the urinary bladder in laparotomy. The pathological diagnosis was RCA. The tumor had not recurred by the 1-year follow-up. The laparoscopic approach thus might be useful for resection of RCA.
    Jul. 2020, Asian journal of endoscopic surgery, 13(3) (3), 431 - 434, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Matsuda T, Yamashita K, Hasegawa H, Arimoto A, Watanabe A, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    Jun. 2020, Diseases of the colon and rectum, 63(6) (6), 859 - 859, English, International magazine
    [Refereed]
    Scientific journal

  • Koji Ando, Yasunori Emi, Nobutomo Miyanari, Akihito Tsuji, Kenji Sakai, Terumitsu Sawai, Hiroshi Imamura, Shinichiro Mori, Shoji Tokunaga, Eiji Oki, Hiroshi Saeki, Yoshihiro Kakeji, Yoshito Akagi, Hideo Baba, Yoshihiko Maehara, Masaki Mori
    BACKGROUND: Adjuvant chemotherapy is an accepted treatment to improve survival rates in patients with stage III colon cancer, and regimens including oxaliplatin have been shown to be superior to those containing 5-FU alone. The purpose of this study was to examine the efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) as adjuvant chemotherapy for patients with stage III colon cancer following curative resection. METHODS: Patients with colon cancer who underwent curative resection were enrolled and received oral S-1 40-60 mg twice daily on days 1-14 every 3 weeks plus intravenous oxaliplatin 130 mg/m2 on day 1 for eight courses. The primary endpoint was 3-year disease-free survival rate. Secondary endpoints were the rate of treatment completion, adverse events, relative dose intensity, and overall survival. RESULTS: Between February 2014 and December 2014, 89 patients were enrolled. One patient was excluded from the analysis because of ineligibility, and the remaining 88 patients were included. The rate of protocol treatment completion was 72.3%. The relative dose intensity of S-1 and oxaliplatin was 72% and 76.3%, respectively. Hematological severe adverse events (Grade 3/4) were neutropenia (21.3%) and thrombocytopenia (15.7%). The most frequent symptom was diarrhea (Grade 3/4: 5.6%). The incidence of grade 2 neuropathy has decreased from 8.1 to 2.7% after 3 years of the therapy. Three-year disease-free survival rate was 73.9% (95% CI 63.8-81.9), and 3-year overall survival rate was 94.3% (95% CI 86.8-97.6) CONCLUSIONS: C-SOX is a safe and feasible adjuvant chemotherapy regimen in patients with stage III colon cancer undergoing curative resection.
    Jun. 2020, International journal of clinical oncology, 25(6) (6), 1115 - 1122, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Naoki Shibuya, Yoshihiro Kakeji, Yohei Shimono
    Cancer cells with cancer stem cell (CSC) properties initiate both primary tumor formation and metastases at distant sites. Acquisition of CSC properties is highly associated with epigenetic alterations, including those mediated by microRNAs (miRNAs). We have previously established the breast cancer patient-derived tumor xenograft (PDX) mouse model in which CSC marker CD44+ cancer cells formed spontaneous microscopic metastases in the liver. In this PDX mouse, we found that the expression levels of 3 miRNAs (miR-25, miR-93, and miR-106b) in the miR-106b-25 cluster were much lower in the CD44+ human cancer cells metastasized to the liver than those at the primary site. Constitutive overexpression of miR-93 suppressed invasive ability and 3D-organoid formation capacity of breast cancer cells in vitro and significantly suppressed their metastatic ability to the liver in vivo. Wiskott-Aldrich syndrome protein family member 3 (WASF3), a regulator of both cytoskeleton remodeling and CSC properties, was identified as a functional target of miR-93: overexpression of miR-93 reduced the protein level of WASF3 in breast cancer cells and WASF3 rescued the miR-93-mediated suppression of breast cancer cell invasion. These findings suggest that miR-93 functions as a metastasis suppressor by suppressing both invasion ability and CSC properties in breast cancers.
    Jun. 2020, Cancer science, 111(6) (6), 2093 - 2103, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Shimura Y, Kanaji S, Urakawa N, Yamamoto M, Utsumi M, Takiguchi G, Hasegawa H, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    BACKGROUND: We report a rare case of gastrointestinal stromal tumors (GISTs) in Carney's triad, successfully treated using laparoscopic gastrectomy with lymph node dissection after chemotherapy. CASE PRESENTATION: A 21-year-old woman presented to our hospital for treatment of recurrent GISTs. The patient had been admitted for treatment 11 years prior, with black stools being the chief presenting complaint at that time. On examination at that time, multiple submucosal tumors in the pyloric antrum and multiple pulmonary tumors had been observed. She underwent open partial gastrectomy, and the diagnosis of GISTs was confirmed. She was administered tyrosine kinase inhibitors to treat lung metastases from 2 months after surgery. Due to the increasing size of the lung tumors, a right upper lobectomy was performed 9 years after the index gastric surgery. Histopathological examination of the lung specimen, in combination with re-examination of the gastric specimens, was indicative of incomplete-type Carney's triad. Eleven years after the index gastric surgery, multiple GISTs were observed in her entire stomach. Tumor biopsy revealed a succinate dehydrogenase deficiency, confirming the diagnosis of recurrent GISTs. For treatment, the patient underwent laparoscopic completion gastrectomy, with D1 plus lymph node dissection. CONCLUSION: This is a first case report of completion gastrectomy performed laparoscopically for the treatment of GISTs associated with incomplete-type Carney's triad. The recurrent GISTs developed over a protracted period of 11 years from the index gastric surgery to tumor recurrence.
    May 2020, Surgical case reports, 6(1) (1), 112 - 112, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Kobayashi H, Yamamoto H, Miyata H, Gotoh M, Kotake K, Sugihara K, Toh Y, Kakeji Y, Seto Y.
    Aim: To investigate the effectiveness of the institutional medical structure and of the implemented clinical practice guidelines for improving colon cancer surgical outcomes. Methods: We conducted a web-based questionnaire survey among departments registered at the National Clinical Database in Japan from October 2014 to January 2015 to assess the association between quality indicators (QIs), including structure and process indicators (clinical practice guideline adherence), and the risk-adjusted odds ratio for operative mortality (AOR) after right hemicolectomy for colorectal cancer during the study period. Results: Among the 2064 departments registering at least one colorectal surgery during the study period, we obtained responses from 814 departments (39.4%). Our analysis on data from 22 816 patients with right hemicolectomy demonstrated that three structural QIs (certification of training hospitals by the Japanese Society of Gastroenterological Surgery and the presences of board-certified gastroenterological and colorectal surgeons) were associated with significantly lower AOR (P < .001, P = .02, and P = .05, respectively). The "performed at the doctor's discretion" answer was associated with poorer short-term outcomes in six process QIs than other answers. Conclusion: The board certification system for gastroenterological and colorectal surgeons and the adherence to the clinical guidelines improve the operative mortality after right hemicolectomy. It is desired to clarify the most suitable QIs to reduce the operative mortality after colorectal surgery.
    May 2020, Annals of gastroenterological surgery, 4(3) (3), 283 - 293, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Kakeji Y, Takahashi A, Hasegawa H, Ueno H, Eguchi S, Endo I, Sasaki A, Takiguchi S, Takeuchi H, Hashimoto M, Horiguchi A, Masaki T, Marubashi S, Yoshida K, Gotoh M, Konno H, Yamamoto H, Miyata H, Seto Y, Kitagawa Y, National Clinical Database
    The National Clinical Database (NCD) of Japan grew rapidly, harvesting over 11 million cases of data between 2011 and 2018 from more than 5000 facilities. This is the Report of the NCD based upon gastrointestinal surgery information in 4 420 175 cases from 2011 to 2018. More than 70% of all gastrointestinal surgeries were performed at certified institutions, and the percentage of surgeries performed at certified institutions was particularly high for the esophagus (93.8% in 2018), liver (89.4%), pancreas (91.3%), and spleen (86.9%). Also, more than 70% of the surgeries were performed with the participation of the board-certified surgeon. As the patients have been getting older, the morbidities have been increasing. However, the mortalities have been kept at a low level. The rates of endoscopic surgery have been increasing year by year, especially high in low anterior resection (67.0%) and esophagectomy (61.0%). Nationwide, this database is surely expecting to ensure the quality of board certification system and surgical outcomes in gastroenterological surgery.
    May 2020, Annals of gastroenterological surgery, 4(3) (3), 250 - 274, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • D. Hashimoto, M. Mizuma, H. Kumamaru, H. Miyata, A. Chikamoto, H. Igarashi, T. Itoi, S. Egawa, Y. Kodama, S. Satoi, S. Hamada, K. Mizumoto, H. Yamaue, M. Yamamoto, Y. Kakeji, Y. Seto, H. Baba, M. Unno, T. Shimosegawa, K. Okazaki
    May 2020, BRITISH JOURNAL OF SURGERY, 107(6) (6), 734 - 742, English, International magazine
    [Refereed]
    Scientific journal

  • Akihito Kitao, Shinichiro Kawamoto, Keiji Kurata, Ikuyo Hayakawa, Takashi Yamasaki, Hiroshi Matsuoka, Yasuo Sumi, Yoshihiro Kakeji, Toyomi Kamesaki, Hironobu Minami
    Autoimmune hemolytic anemia (AIHA) is a rare comorbidity in colorectal cancer (CRC) and has an unknown etiology. Previously, we described an AIHA case secondary to CRC with ectopic band 3 expression. Herein, we investigated ectopic band 3 expression and erythrocyte membrane-bound IgG in a CRC cohort. Between September 2016 and August 2018, 50 patients with CRC and 26 healthy controls were enrolled in the present study. The expression of band 3 and SLC4A1 mRNA was observed in 97% of CRC surgical specimens. Although clinical AIHA was not observed in any patient with CRC, a direct antiglobulin test was positive in 10 of the patients in the CRC group (p = 0.01). Flow cytometry revealed significantly increased erythrocyte membrane-bound IgG among patients with CRC compared to healthy controls (mean ± standard deviation; 38.8 ± 4.7 vs. 29.9 ± 15.6, p = 0.012). Normocytic anemia was observed, including in cases negative for fecal occult blood, suggesting a shortened erythrocyte life-span due to increased membrane-bound IgG. Immunoprecipitation revealed increased anti-band 3 autoantibodies in patients' sera. Mouse experiments recapitulated this phenomenon. We also confirmed that band 3 expression is controlled by 5'AMP-activated protein kinase under hypoxic conditions. These findings increase our understanding of the etiology of cancer-related anemia.
    May 2020, International journal of hematology, 111(5) (5), 657 - 666, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yuta Yamazaki, Shingo Kanaji, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yuta Hiasa, Yoshito Otake, Yoshinobu Sato, Yoshihiro Kakeji
    BACKGROUND: The common use of laparoscopic intervention produces impressive amounts of video data that are difficult to review for surgeons wishing to evaluate and improve their skills. Therefore, a need exists for the development of computer-based analysis of laparoscopic video to accelerate surgical training and assessment. We developed a surgical instrument detection system for video recordings of laparoscopic gastrectomy procedures. This system, the use of which might increase the efficiency of the video reviewing process, is based on the open source neural network platform, YOLOv3. STUDY DESIGN: A total of 10,716 images extracted from 52 laparoscopic gastrectomy videos were included in the training and validation data sets. We performed 200,000 iterations of training. Video recordings of 10 laparoscopic gastrectomies, independent of the training and validation data set, were analyzed by our system, and heat maps visualizing trends of surgical instrument usage were drawn. Three skilled surgeons evaluated whether each heat map represented the features of the corresponding operation. RESULTS: After training, the testing data set precision and sensitivity (recall) was 0.87 and 0.83, respectively. The heat maps perfectly represented the devices used during each operation. Without reviewing the video recordings, the surgeons accurately recognized the type of anastomosis, time taken to initiate duodenal and gastric dissection, and whether any irregular procedure was performed, from the heat maps (correct answer rates ≥ 90%). CONCLUSIONS: A new automated system to detect manipulation of surgical instruments in video recordings of laparoscopic gastrectomies based on the open source neural network platform, YOLOv3, was developed and validated successfully.
    May 2020, Journal of the American College of Surgeons, 230(5) (5), 725 - 732, English, International magazine
    [Refereed]
    Scientific journal

  • Taro Oshikiri, Gosuke Takiguchi, Susumu Miura, Hironobu Goto, Dai Otsubo, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Yasuhiro Fujino, Masahiro Tominaga, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    In the original article, there are errors in Fig. 1. Following is the corrected figure.
    Apr. 2020, Annals of surgical oncology, English, International magazine
    [Refereed]

  • Shingo Kanaji, Yoshinori Morita, Yuta Yamazaki, Yasunori Otowa, Toshitatsu Takao, Shinwa Tanaka, Naoki Urakawa, Masashi Yamamoto, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Takashi Toyonaga, Yuzo Kodama, Yoshihiro Kakeji
    OBJECTIVE: Laparoscopic endoscopic cooperative surgery for duodenal tumors (D-LECS) has been developed to prevent duodenal leakage by reinforcing the endoscopic submucosal dissection site. However, there has been no prospective trial showing the feasibility of D-LECS. Herein, we conducted a single-arm confirmatory trial to evaluate the safety of D-LECS for non-ampullary superficial duodenal neoplasms. METHODS: This prospective single-center single-arm confirmatory trial analyzed patients with non-ampullary superficial duodenal neoplasms who underwent D-LECS. The primary endpoint was the incidence of any postoperative leakage occurring on the duodenal wall within 1 month postoperatively. The planned sample size was 20 patients, considering a threshold of 28% and one-sided alpha value of 5%. RESULTS: Between January 2015 and September 2018, 20 eligible patients were enrolled. Sixteen tumors were located in the second portion, three in the first portion, and one in the third portion of the duodenal region. The median operative time was 225 (134-361) min and the median blood loss was 0 (0-150) mL. Curative resection (R0) with negative margins was achieved in 19 cases. One case of postoperative leakage and one case of bleeding of grade 2 according to the Clavien-Dindo classification were observed in this series. The median duration of postoperative hospital stay was 9 (5-12) days. No local recurrence was observed in any patient during the median follow-up of 15.0 (12.0-38.0) months. CONCLUSIONS: This trial confirmed the safety and feasibility of D-LECS for non-ampullary superficial duodenal neoplasms with respect to the low incidence of postoperative duodenal leakage.
    Apr. 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, English, International magazine
    [Refereed]
    Scientific journal

  • Yuri Ito, Isao Miyashiro, Takashi Ishikawa, Kohei Akazawa, Keisuke Fukui, Hitoshi Katai, Souya Nunobe, Ichiro Oda, Yoh Isobe, Shunichi Tsujitani, Hiroyuki Ono, Satoshi Tanabe, Takeo Fukagawa, Satoshi Suzuki, Yoshihiro Kakeji, Mitsuru Sasako, Anton Bilchik, Manabu Fujita
    BackgroundAlthough the incidence and mortality have decreased, gastric cancer (GC) is still a public health issue globally. An international study reported higher survival in Korea and Japan than other countries, including the US. We examined the determinant factors of the high survival in Japan, compared with the US.MethodsWe analysed data on 78,648 cases from the nationwide GC registration project, the Japanese Gastric Cancer Association (JGCA), from 2004-2007 and compared them with 16,722 cases from the Surveillance, Epidemiology, and End Results Program (SEER), a US population-based cancer registry data from 2004-2010. We estimated five-year relative survival and applied a multivariate excess hazard model to compare the two countries, considering the effect of number of lymph nodes (LNs) examined.ResultsFive-year relative survival in Japan was 81.0%, compared with 45.0% in the US. After controlling for confounding factors, we still observed significantly higher survival in Japan. Among N2 patients, a higher number of LNs examined showed better survival in both countries. Among N3 patients, the relationship between number of LNs examined and differences in survival between the two countries disappeared.ConclusionAlthough the wide differences in GC survival between Japan and US can be largely explained by differences in the stage at diagnosis, the number of LNs examined may also help to explain the gaps between two countries, which is related to stage migration.
    Apr. 2020, Journal of epidemiology, 31(4) (4), 241 - 248, English, Domestic magazine, Co-authored internationally
    [Refereed]
    Scientific journal

  • 山崎 悠太, 裏川 直樹, 掛地 吉弘
    (株)メディカ出版, Apr. 2020, 消化器ナーシング, 25(4) (4), 305 - 311, Japanese
    [Refereed]
    Scientific journal

  • Taro Ikeda, Michiru Nishita, Kyoka Hoshi, Takashi Honda, Yoshihiro Kakeji, Yasuhiro Minami
    Bone marrow-derived mesenchymal stem or stromal cells (MSC) have been shown to be recruited to various types of tumor tissues, where they interact with tumor cells to promote their proliferation, survival, invasion and metastasis, depending on the type of the tumor. We have previously shown that Ror2 receptor tyrosine kinase and its ligand, Wnt5a, are expressed in MSC, and Wnt5a-Ror2 signaling in MSC induces expression of CXCL16, which, in turn, promotes proliferation of co-cultured MKN45 gastric cancer cells via the CXCL16-CXCR6 axis. However, it remains unclear how CXCL16 regulates proliferation of MKN45 cells. Here, we show that knockdown of CXCL16 in MSC by siRNA suppresses not only proliferation but also migration of co-cultured MKN45 cells. We also show that MSC-derived CXCL16 or recombinant CXCL16 upregulates expression of Ror1 through activation of STAT3 in MKN45 cells, leading to promotion of proliferation and migration of MKN45 cells in vitro. Furthermore, co-injection of MSC with MKN45 cells in nude mice promoted tumor formation in a manner dependent on expression of Ror1 in MKN45 cells, and anti-CXCL16 neutralizing antibody suppressed tumor formation of MKN45 cells co-injected with MSC. These results suggest that CXCL16 produced through Ror2-mediated signaling in MSC within the tumor microenvironment acts on MKN45 cells in a paracrine manner to activate the CXCR6-STAT3 pathway, which, in turn, induces expression of Ror1 in MKN45 cells, thereby promoting tumor progression.
    Apr. 2020, Cancer science, 111(4) (4), 1254 - 1265, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Nobuhide Higashino, Takeru Matsuda, Hiroshi Hasegawa, Kimihiro Yamashita, Hiroki Sakamoto, Masataka Fujikawa, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND/AIM: To investigate the outcomes of laparoscopic surgery in colorectal cancer patients with dialysis. PATIENTS AND METHODS: Fourteen dialysis (dialysis group) and 567 non-dialysis (non-dialysis group) patients who underwent laparoscopic and open surgery for colorectal cancer between April 2008 and December 2015 were included. Short-term and long-term outcomes were compared between the groups. A 1:2 propensity score matching was performed to compare long-term outcomes. RESULTS: All the dialysis patients underwent laparoscopic surgery. There were no significant differences in operative outcomes and postoperative short-term outcomes between the two groups. In the whole cohort, overall survival of dialysis patients was shorter than that in the non-dialysis ones (p=0.020), while disease-free survival did not differ between the two groups. After matching, there was no significant difference between the groups in overall or disease-free survival. CONCLUSION: Laparoscopic colorectal cancer surgery for dialysis patients seems safe and feasible and associates with comparable short-term outcome and recurrence rate to non-dialysis patients.
    Apr. 2020, Anticancer research, 40(4) (4), 2165 - 2170, English, International magazine
    [Refereed]
    Scientific journal

  • Shinwa Tanaka, Hirofumi Abe, Ryusuke Ariyoshi, Hiroya Sakaguchi, Taro Oshikiri, Tetsu Nakamura, Yoshiko Nakano, Yoshinori Morita, Takashi Toyonaga, Eiji Umegaki, Hiroshi Yokozaki, Yoshihiro Kakeji, Yuzo Kodama
    Apr. 2020, JGH open : an open access journal of gastroenterology and hepatology, 4(2) (2), 309 - 311, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Daisuke Ban, Minoru Tanabe, Hiraku Kumamaru, Hiroyuki Nitta, Yuichiro Otsuka, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa, Hironori Kaneko, Go Wakabayashi, Hiroki Yamaue, Masakazu Yamamoto
    OBJECTIVE: To investigate the frequency of laparoscopic liver resection (LLR) nationwide in Japan. BACKGROUND: LLR was initially limited to basic liver resection, but is becoming more common in advanced liver resection. METHODS: Retrospective observational study of 148,507 patients registered in the National Clinical Database 2011-2017. Excluded: liver resection with biliary and vascular reconstruction. RESULTS: LLR or open liver resection (OLR) was performed in 1848 (9.9%) and 16,888 (90.1%) patients, respectively, in 2011, whereas in 2017, LLR had increased to 24.8% and OLR decreased to 75.2% of resections (5648 and 17,099 patients, respectively). There was an annual increasing trend of LLR, starting at 9.9%, then 13.8%, 17.3%, 21.2%, 18.1%, 21.0%, and finally 24.8% in 2017. Basic LLR became more common, up to 30.8% of LR in 2017. Advanced LLR increased from 3.3% of all resections in 2011 to 10.8% in 2017. Throughout the years observed, there were fewer complications in LLR than OLR. Operative mortality was 3.6% for both advanced LLR and OLR in 2011, and decreased to 1.0% and 2.0%, respectively, in 2017. Mortality for both basic LLR and basic OLR were low and did not change throughout the study, at 0.5% and 1.6%, respectively, in 2011 and 0.5% and 1.1%, in 2017. CONCLUSIONS: LLR has rapidly become widespread in Japan. Basic LLR is now a standard option, and advanced LLR, while not as common yet, has been increasing year by year. LLR has been safely developed with low mortality and complications rate relative to OLR.
    Mar. 2020, Annals of surgery, English, International magazine
    [Refereed]
    Scientific journal

  • 山本 将士, 金治 新悟, 裏川 直樹, 鈴木 知志, 掛地 吉弘
    金原出版(株), Mar. 2020, 手術, 74(4) (4), 510 - 514, Japanese
    [Refereed]
    Scientific journal

  • Kohei Nakata, Hiroyuki Yamamoto, Hiroaki Miyata, Yoshihiro Kakeji, Yasuyuki Seto, Hiroki Yamaue, Masakazu Yamamoto, Masafumi Nakamura
    BACKGROUND: This study aimed to define an objective evidence-based threshold of high-volume hospitals (HVHs) for pancreatoduodenectomy (PD) using nationwide data systems. METHODS: A total of 36,453 patients underwent PD in 1,499 hospitals from 2012 to 2015 were collected from the National Clinical Database in Japan. Restricted cubic spline model with risk adjustment was used for definition of an objective evidence-based threshold of HVHs. RESULTS: The restricted cubic spline curve of 30-day and in-hospital mortality showed a continuous decrease with an increase in hospital volume and plateau phase of mortality was detected between approximately 30 and 50 PDs/year. On the basis of this curve, we defined hospitals ≥30 PDs/year as HVHs and ≤29 PDs/year as non-HVHs. We also sub-classified hospitals <5, 5-29, 30-49, and ≥50 PDs/year as low-volume, intermediate-volume, high-volume, and very high-volume hospitals using the spline curve. The odds ratio (OR) of risk-adjusted mortality decreased as hospital volume increased, with an OR of 0.34 for HVHs and 0.26 for very HVHs compared with low-volume hospitals. CONCLUSIONS: We consider that this concept is applicable to other high-risk procedures for reducing mortality after these procedures, which could improve medical care and health services.
    Mar. 2020, Journal of hepato-biliary-pancreatic sciences, 27(3) (3), 107 - 113, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Susumu Miura, Tetsu Nakamura, Takumi Hasegawa, Yukiko Miura, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Satoshi Suzuki, Masaya Akashi, Yoshihiro Kakeji
    BACKGROUND: Oral health is associated with various diseases, including cancer. Tooth loss is a simple and objective index of oral health. OBJECTIVE: The purpose of this study was to investigate the association between preoperative tooth loss and esophageal cancer prognosis after esophagectomy. METHODS: This study included 191 patients who underwent esophagectomy for esophageal cancer after perioperative dental evaluation and oral care at Kobe University Hospital from April 2011 to March 2016. Patients were divided into two groups: Group A (tooth loss < 7) and Group B (tooth loss ≥ 7). Three-year overall survival (OS) and multivariate analysis were performed, along with subgroup analysis for elderly patients (age ≥ 65 years). RESULTS: The 3-year OS rate was 68.1% in Group A (104 patients) and 49.2% in Group B (87 patients). Group A had significantly higher OS than Group B (p = 0.002), and there were no significant differences in sex and clinical T or N stage between the two groups. However, the mean age of Group A was younger than that of Group B (64.2 vs. 68.5 years; p = 0.0002). Among elderly patients, the 3-year OS rate was 68.2% in Group A (55 patients) and 45.1% in Group B (65 patients) [p = 0.003]. Multivariate analysis that included age demonstrated that tooth loss is an independent prognostic factor (hazard ratio 1.87, 95% confidence interval 1.22-2.87), in addition to clinical T stage and preoperative serum albumin. CONCLUSION: Tooth loss is an independent prognostic factor for esophageal cancer after esophagectomy.
    Mar. 2020, Annals of surgical oncology, 27(3) (3), 683 - 690, English, International magazine
    [Refereed]
    Scientific journal

  • Takeru Matsuda, Hiroshi Hasegawa, Kimihiro Yamashita, Tomoko Tanaka, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Yasuo Sumi, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: Laparoscopic lateral pelvic lymph node dissection (LLND) has been reported to be feasible; however, studies comparing the outcomes of laparoscopic LLND with that of open LLND following preoperative chemoradiotherapy (CRT) are limited. METHODS: Between November 2005 and October 2017, 38 patients with locally advanced rectal cancer underwent total mesorectal excision and LLND following preoperative CRT at Kobe University Hospital. The data of the patients who underwent open LLND (OP group, n = 19) and laparoscopic LLND (LAP group, n = 19) were retrospectively collected and compared. RESULTS: The operative time was significantly longer in the LAP group compared with that in the OP group. However, the volume of blood loss was significantly higher, and transfusion was more frequently performed in the OP group than in the LAP group. The number of LLNs harvested in the LAP group was significantly higher than that in the OP group. The prevalence of perineal wound infection and bowel obstruction was significantly higher in the OP group than in the LAP group. However, no significant differences were observed between the groups in terms of 5-year overall survival, relapse-free survival, and local recurrence-free survival. CONCLUSIONS: Laparoscopic LLND is feasible and safe for patients with rectal cancer who were treated with preoperative CRT. Compared with open LLND, laparoscopic LLND might have several advantages such as higher yields of dissected LLNs and lower incidences of perineal wound infection and bowel obstruction.
    Mar. 2020, Surgical endoscopy, 34(3) (3), 1425 - 1431, English, International magazine
    [Refereed]
    Scientific journal

  • Souya Nunobe, Ichiro Oda, Takashi Ishikawa, Kohei Akazawa, Hitoshi Katai, Yoh Isobe, Isao Miyashiro, Shunichi Tsujitani, Hiroyuki Ono, Satoshi Tanabe, Takeo Fukagawa, Satoshi Suzuki, Yoshihiro Kakeji
    BACKGROUND: The proportion of elderly patients undergoing surgery for gastric cancer is increasing. However, limited number of therapeutic outcomes in the elderly has been reported. Here we examined the surgical results based on a nationwide survey of elderly patients who underwent surgery for Stage I gastric cancer. METHODS: Data from 68,353 Stage I patients who underwent gastrectomy between 2001 and 2007 were retrospectively collected. The accumulated data were reviewed and analyzed by the Japanese Gastric Cancer Association registration committee. We first classified the patients as those aged ≤ 74 years and ≥ 75 years. We further classified those patients aged ≥ 75 years into groups by 5-year increments to examine their short- and long-term postoperative outcomes. RESULTS: Patients aged ≥ 75 years accounted for 46.5%. The 30-day mortality rate was < 0.7% for any age group, but for those aged ≥ 75 years, the 60-day and 90-day mortality rates were 0.9-2.3% and 1.2-5.1%, respectively. An examination of long-term survival indicated that, as the class of age increased, the 5-year overall survival (OS) was 47.0-93.1% and disease-specific survival (DSS) was 91.4-98.2%, respectively. Although high DSS rates of ≥ 90% were found for all age groups, OS only accounted for ≤ 82% of patients aged ≥ 75 years. CONCLUSION: Among elderly patients with Stage I gastric cancer, deaths due to other diseases were frequently observed in the long term. Thus, for elderly patients, it may be appropriate to reconsider the treatment strategy with respect to the balance between the invasiveness of the treatment and the prognosis.
    Mar. 2020, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 23(2) (2), 328 - 338, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Mikito Inokuchi, Hiraku Kumamaru, Masatoshi Nakagawa, Hiroaki Miyata, Yoshihiro Kakeji, Yasuyuki Seto, Kazuyuki Kojima
    BACKGROUND: Laparoscopic gastrectomy (LG) is an established minimally invasive procedure for gastric cancer. However, it is controversial whether LG is useful for patients with poor physical status classified into higher classes of the American Society of Anesthesiologists physical status (ASA-PS) classification. The aim of this study was to determine the feasibility of LG in patients with ASA-PS class ≥ 3. METHODS: We extracted data for a total of 28,160 patients with an ASA-PS class ≥ 3 who underwent distal or total gastrectomy for gastric cancer between January 2013 and December 2017 from the National Clinical Database Japan society for gastroenterological surgery registry. We developed a propensity score model from baseline demographics and comorbidities and matched patients undergoing LG to those undergoing open gastrectomy (OG) using a 1:1 ratio. Mortality and morbidities (within 30 days and in-hospital) were compared between the 6998 matched patient pairs. RESULTS: In-hospital mortality was significantly lower in patients undergoing LG than in those undergoing OG (2.3% vs. 3.0%, p = 0.01), while the 30-day mortality was similar (1.6% vs. 1.5%). The length of hospital stay was significantly shorter in the LG group (median, 14 days vs. 17 days, p < 0.001). The LG group had a significantly lower incidence of postoperative complications in patients with any grade complication (20.3% vs. 22.5%, p = 0.002) as well as those with ≥ grade 3 complications (8.7% vs. 9.8%, p = 0.03). CONCLUSION: LG was associated with decreased in-hospital mortality and a lower incidence of several postoperative complications when compared to OG among patients with poor physical condition.
    Mar. 2020, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 23(2) (2), 310 - 318, English, Domestic magazine
    [Refereed]
    Scientific journal

  • 第1章消化器外科総論 10.保険診療とビックデータ 22）National Clinical Database
    掛地 吉弘
    Lead, 株式会社杏林社, Feb. 2020, 消化器外科専門医の心得, 上, 91 - 93, Japanese
    [Refereed]
    Scientific journal

  • Masafumi Saito, Shigeaki Inoue, Kimihiro Yamashita, Yoshihiro Kakeji, Takumi Fukumoto, Joji Kotani
    Aging is a grave problem in sepsis, and T cell exhaustion is the main cause of sepsis-induced immunosuppression. Sepsis- and aging-induced T cell exhaustion is related to secondary infection with a poor long-term outcome in the elderly. However, the trend, impact, and mechanism of T cell exhaustion are still unclear. Interleukin (IL)-15 improves survival rate of septic mice via its antiapoptotic effect on T cells; however, it is still unclear how IL-15 reverses prolonged T cell exhaustion in aged septic mice. The purpose of this study was to clarify the trend of sepsis-induced T cell exhaustion and whether IL-15 prevents aging-induced persistent T cell exhaustion in septic mice. Preserved cecal slurry was injected intraperitoneally into young (6-week-old) and aged mice (18-24-month-old) 4 times, to induce clinically relevant repeated sepsis. IL-15 (1.5 μg) or phosphate-buffered saline was injected subcutaneously 3 times, body weight was serially measured, and peripheral blood cells from their cheek were serially collected for 50 days. Sepsis-induced T cell exhaustion was significantly severe in aged mice than in young mice and was accompanied with decreased naive CD4 and CD8 T cells (P < 0.01) and increased expression of program death 1 on T cell (P < 0.01) and regulatory T cell population (P < 0.01). IL-15 significantly improved sepsis-induced T exhaustion, with significantly increased numbers of natural killer cells and macrophages, and significantly enhanced phagocytosis activity in aged septic mice (P < 0.05). It decreased the long-term mortality associated with sepsis survivors by improving T cell exhaustion over an extended duration and also ameliorated aging-induced persistent T cell exhaustion in septic mice.
    Feb. 2020, Shock (Augusta, Ga.), 53(2) (2), 228 - 235, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yasufumi Koterazawa, Taro Oshikiri, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    Esophagectomy for esophageal cancer is a highly invasive procedure, and a feeding jejunostomy tube (FJT) is routinely placed to ensure adequate enteral nutrition. However, the effect of perioperative short-term FJT placement remains controversial, and the aim of this study was to assess risks and benefits of routine FJT placement during esophagectomy and to determine parameters that can identify patients needing long-term FJT. This retrospective study included 393 patients who had undergone esophagectomy with gastric tube reconstruction via the posterior mediastinal route at the Kobe University Hospital and the Hyogo Cancer Center between April 2010 and December 2017. Propensity score matching was used to identify matched patients (139 per group) in the FJT and no-FJT groups. The incidence of postoperative complications and weight loss (3 months post-procedure) was compared in the matched cohort and significant risk factors predicting the need for long-term FJT placement in the whole cohort were identified. In the matched cohort, while weight loss was not different between the FJT and no-FJT groups (11% vs. 10%), the incidence of small bowel obstruction in the FJT group (11.5%) was significantly higher than that in the no-FJT group (0%). Multivariate analysis revealed that age (≥75 years), preoperative therapy, anastomosis leakage, and pulmonary complications were independent risk factors for long-term FJT placement. Routine placement of an FJT during esophagectomy increases small bowel obstruction and does not result in better nutritional status, suggesting that selective long-term FJT placement in high-risk patients should be considered.
    Jan. 2020, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 33(1) (1), English, International magazine
    [Refereed]
    Scientific journal

  • Taro Ikeda, Shingo Kanaji, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    Objectives: Dissection of the No. 11p lymph nodes is technically challenging because of variations in anatomical landmarks. This study aimed to determine the accuracy and efficacy of predicting the dorsal landmark of No. 11p lymph node using three-dimensional computed tomography simulation. Methods: Laparoscopic gastrectomy with No. 11p lymph node dissection with preoperative simulation using three-dimensional computed tomography was performed in 24 patients at our institution from October 2016 to May 2018. Initially, preoperative three-dimensional computed tomography findings with operative videos in these 24 patients were compared. The dorsal landmark was defined as an anatomical structure behind the splenic artery on preoperative three-dimensional computed tomography and operative videos. The dorsal landmark of No. 11p lymph node was divided into four types: (1) splenic vein type, (2) splenic vein and pancreas type, (3) pancreas type, and (4) unclear type. Then, to investigate the efficacy of three-dimensional computed tomography, we compared the clinical and pathological features and surgical outcomes of nine patients who underwent preoperative three-dimensional computed tomography simulation (three-dimensional computed tomography group) and 23 patients who did not undergo three-dimensional computed tomography simulation from August 2014 to September 2016 (non-three-dimensional computed tomography group). All procedures were performed by one surgeon certified by the Endoscopic Surgical Skill Qualification System in Japan. Results: The concordance rate between three-dimensional computed tomography and operative videos of the dorsal landmark using three-dimensional computed tomography was 79% (19/24). The operative time of No. 11p lymph node dissection was significantly shorter in the three-dimensional computed tomography group than in the non-three-dimensional computed tomography group (7.7 versus 15.8 min, P = 0.044). Conclusion: The accuracy of predicting the dorsal landmark of No. 11p lymph node using three-dimensional computed tomography was extremely high. Preoperative simulation with three-dimensional computed tomography was useful in shortening the operative time of No. 11p lymph node dissection.
    2020, SAGE open medicine, 8, 2050312120936918 - 2050312120936918, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Satoru Motoyama, Hiroyuki Yamamoto, Hiroaki Miyata, Masahiko Yano, Takushi Yasuda, Masaichi Ohira, Yoshiaki Kajiyama, Yasushi Toh, Masayuki Watanabe, Yoshihiro Kakeji, Yasuyuki Seto, Yuichiro Doki, Hisahiro Matsubara
    BACKGROUND: In 2009, the Japan Esophageal Society (JES) established a system for certification of qualified surgeons as "Board Certified Esophageal Surgeons" (BCESs) or institutes as "Authorized Institutes for Board Certified Esophageal Surgeons" (AIBCESs). We examined the short-term outcomes after esophagectomy, taking into consideration the certifications statuses of the institutes and surgeons. METHODS: This study investigated patients who underwent esophagectomy for thoracic esophageal cancer and who were registered in the Japanese National Clinical Database (NCD) between 2015 and 2017. Using hierarchical multivariable logistic regression analysis adjusted for patient-level risk factors, we determined whether the institute's or surgeon's certification status had greater influence on surgery-related mortality or postoperative complications. RESULTS: Enrolled were 16,752 patients operated on at 854 institutes by 1879 surgeons. There were significant differences in the backgrounds and incidences of postoperative complications and surgery-related mortality rates between the 11,162 patients treated at AIBCESs and the 5590 treated at Non-AIBCESs (surgery-related mortality rates: 1.6% vs 2.8%). There were also differences between the 6854 patients operated on by a BCES and the 9898 treated by a Non-BCES (1.7% vs 2.2%). Hierarchical logistic regression analysis revealed that surgery-related mortality was significantly lower among patients treated at AIBCESs. The institute's certification had greater influence on short-term surgical outcomes than the operating surgeon's certification. CONCLUSIONS: The certification system for surgeons and institutes established by the JES appears to be appropriate, as indicated by the improved surgery-related mortality rate. It also appears that the JES certification system contributes to a more appropriate medical delivery system for thoracic esophageal cancer in Japan.
    Jan. 2020, Esophagus : official journal of the Japan Esophageal Society, 17(1) (1), 41 - 49, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Oshikiri T, Takiguchi G, Miura S, Takase N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda Y, Matsuda T, Nakamura T, Suzuki S, Kakeji Y.
    BACKGROUND: Esophagectomy with extended lymphadenectomy remains the mainstay of treatment for localized esophageal cancer. Currently, transthoracic and abdominal esophagectomy with cervical anastomosis (McKeown esophagectomy) is a frequently used technique in Japan. However, cervical anastomosis is still an invasive procedure with a high incidence of anastomotic leakage. The use of a drainage tube to treat anastomotic leakage is effective, but the routine placement of a closed suction drain around the anastomosis at the end of the operation remains controversial. The objective of this study is to evaluate the postoperative anastomotic leakage rate, duration to oral intake, hospital stay, and analgesic use with nonplacement of a cervical drainage tube as an alternative to placement of a cervical drainage tube. METHODS: This is an investigator-initiated, investigator-driven, open-label, randomized controlled parallel-group, noninferiority trial. All adult patients (aged ≥20 and ≤85 years) with histologically proven, surgically resectable (cT1-3 N0-3 M0) squamous cell carcinoma, adenosquamous cell carcinoma, or basaloid squamous cell carcinoma of the intrathoracic esophagus, and European Clinical Oncology Group performance status 0, 1, or 2 are assessed for eligibility. Patients (n = 110) with resectable esophageal cancer who provide informed consent in the outpatient clinic are randomized to either nonplacement of a cervical drainage tube (n = 55) or placement of a cervical drainage tube (n = 55). The primary outcome is the percentage of Clavien-Dindo grade 2 or higher anastomotic leakage. DISCUSSION: This is the first randomized controlled trial comparing nonplacement versus placement of a cervical drainage tube during McKeown esophagectomy with regards to the usefulness of a drain for anastomotic leakage. If our hypothesis is correct, nonplacement of a cervical drainage tube will be recommended because it is associated with a similar anastomotic leakage rate but less pain than placement of a cervical drainage tube. TRIAL REGISTRATION: UMIN-CTR, 000031244. Registered on 1 May 2018.
    Dec. 2019, Trials, 20(1) (1), 758 - 758, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 虫垂腺癌術後に吻合部再発と診断された神経内分泌癌の1例(原著論文)
    渡部 晃大, 山下 公大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    Dec. 2019, 癌と化学療法, 46(13) (13), 2327 - 2329, Japanese
    [Refereed]
    Scientific journal

  • Miura S, Kakeji Y
    Dec. 2019, Annals of surgical oncology, 26(Suppl 3) (Suppl 3), 817 - 817, English, International magazine
    [Refereed]

  • Oshikiri Y, Kakeji Y
    Dec. 2019, Annals of surgical oncology, 26(Suppl 3) (Suppl 3), 814 - 814, English, International magazine
    [Refereed]

  • Tatara T, Suzuki S, Kanaji S, Yamamoto M, Matsuda Y, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y
    AIM: Total lymphocyte count in preoperative peripheral blood is associated with prognosis in various cancers. The predictive value of preoperative total lymphocyte count for survival was assessed in older gastric cancer patients after gastrectomy. METHODS: A total of 200 gastric cancer patients aged ≥75 years who underwent curative resection from 2000 to 2014 were included in this retrospective study. The cut-off value of total lymphocyte count in preoperative peripheral blood was determined using receiver operating characteristic curve analysis, and the association with prognosis was examined. RESULTS: The cut-off value of total lymphocyte count was 1462/μL, and 94 patients were classified as low total lymphocyte count patients and 106 patients were classified as high total lymphocyte count patients. In univariate analysis, American Society of Anesthesiologists score ≥3, Charlson Comorbidity Index ≥3, total lymphocyte count <1462/μL, stage III, open approach, total gastrectomy, splenectomy and infectious complication were significantly associated with overall survival. In multivariate analysis, total lymphocyte count <1462/μL (P = 0.003), American Society of Anesthesiologists score ≥3 (P = 0.01) and stage III (P = 0.017) were independent prognostic factors. Low total lymphocyte count significantly reduced overall survival in stage I (P = 0.037) and II (P = 0.009) patients, but not stage III patients (P = 0.29). CONCLUSION: Total lymphocyte count in preoperative peripheral blood can predict postoperative survival of older patients with relatively early-stage gastric cancer. Geriatr Gerontol Int 2019; 19: 1215-1219.
    Dec. 2019, Geriatrics & gerontology international, 19(12) (12), 1215 - 1219, English, Domestic magazine
    [Refereed]
    Scientific journal

  • 外科医とがん登録-NCDから見えてきたわが国のがん治療の実態- 5.胃がん登録
    掛地 吉弘
    Nov. 2019, 日本外科学会雑誌, 120(6) (6), 652 - 656, Japanese
    [Refereed]
    Scientific journal

  • Oshikiri T, Takiguchi G, Miura S, Goto H, Otsubo D, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Fujino Y, Tominaga M, Nakamura T, Suzuki S, Kakeji Y
    PURPOSE: Esophagectomy with extended lymphadenectomy remains the mainstay of treatment for localized esophageal squamous cell carcinoma (ESCC). Thoracic duct (TD) resection has been recommended as part of extended lymphadenectomy, although its merits are unclear. The aim of this two-institutional, matched-cohort study is to clarify whether TD resection improves prognosis in esophagectomy for ESCC. PATIENTS AND METHODS: In this two-institutional, matched-cohort study of 399 patients with ESCC who underwent McKeown esophagectomy between 2010 and 2014, the primary outcomes were overall survival (OS), disease-free survival (DFS), and cause-specific survival (CSS). Secondary outcomes were perioperative results and recurrence patterns. RESULTS: Based on a propensity score, 122 TD-resected or 122 TD-preserved patients in all stages were selected (median follow-up 4.5 years). The 5-year OS, DFS, and CSS rates in the TD-resected versus TD-preserved groups were 49% versus 60%, 53% versus 57%, and 58% versus 70%, respectively, without any significant differences. Operative time for the thoracic procedure was significantly longer and the number of retrieved mediastinal nodes was significantly higher in the TD-resected group (P = 0.009 and 0.005, respectively). The rates of chylothorax and left recurrent laryngeal nerve (RLN) palsy were significantly higher in the TD-resected group (P = 0.041 and 0.018, respectively). There were no significant differences in rates of local or distant metastases between the two groups. CONCLUSIONS: TD resection does not contribute to improve OS, DFS, or CSS in ESCC but increases incidence of chylothorax and left RLN palsy. Prophylactic TD resection should be avoided in esophagectomy for ESCC.
    Nov. 2019, Annals of surgical oncology, 26(12) (12), 4053 - 4061, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Mukohyama J, Isobe T, Hu Q, Hayashi T, Watanabe T, Maeda M, Yanagi H, Qian X, Yamashita K, Minami H, Mimori K, Sahoo D, Kakeji Y, Suzuki A, Dalerba P, Shimono Y
    miRNAs are key players in the integrated regulation of cellular processes and shape many of the functional properties that define the "cancer stem cell" (CSC) phenotype. Little is known, however, about miRNAs that regulate such properties in human colorectal carcinoma. In this study, we compared the expression levels of 754 miRNAs between paired samples of EpCAM+/CD44+ cancer cells (enriched in CSCs) and EpCAM+/CD44neg cancer cells (with CSC depletion) sorted in parallel from human primary colorectal carcinomas and identified miR-221 as the miRNA that displayed the highest level of preferential expression in EpCAM+/CD44+ cancer cells. High levels of miR-221 expression were associated with Lgr5+ cells in mouse colon crypts and reduced survival in patients with colorectal carcinoma. Constitutive overexpression of miR-221 enhanced organoid-forming capacity of both conventional colorectal carcinoma cell lines and patient-derived xenografts (PDX) in vitro. Importantly, constitutive downregulation of miR-221 suppressed organoid-forming capacity in vitro and substantially reduced the tumorigenic capacity of CSC populations from PDX lines in vivo. Finally, the most abundant splicing isoform of the human Quaking (QKI) gene, QKI-5, was identified as a functional target of miR-221; overexpression of miR-221-reduced QKI-5 protein levels in human colorectal carcinoma cells. As expected, overexpression of QKI-5 suppressed organoid-forming capacity in vitro and tumorigenic capacity of colorectal carcinoma PDX cells in vivo. Our study reveals a mechanistic link between miR-221 and QKI and highlights their key role in regulating CSC properties in human colorectal cancer. SIGNIFICANCE: These findings uncover molecular mechanisms underlying the maintenance of cancer stem cell properties in colon cancer.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/20/5151/F1.large.jpg.
    Oct. 2019, Cancer research, 79(20) (20), 5151 - 5158, English, International magazine
    [Refereed]
    Scientific journal

  • 完全腹腔鏡下手術における切離ラインの決定
    金治 新悟, 山崎 悠太, 掛地 吉弘
    Oct. 2019, 臨床外科, 74(10) (10), 1164 - 1168, Japanese
    [Refereed]
    Scientific journal

  • Shibuya N, Matsuda T, Yamashita K, Hasegawa H, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    BACKGROUND/AIM: To clarify the usefulness of intraoperative colonoscopy (CS) for preventing postoperative anastomotic leakage and bleeding in rectal cancer surgery. PATIENTS AND METHODS: The data of rectal cancer patients who underwent circular-stapled anastomosis from January 2008 to December 2016 were compared between 162 patients who received intraoperative CS (the CS group) and 23 patients who did not receive intraoperative CS (the non-CS group). RESULTS: Anastomotic leakage rate in the CS group (8.6%) was similar to that in the non-CS group (4.3%) (p=0.70). Postoperative anastomotic bleeding rate was also similar between the CS and non-CS groups (2.4% vs. 0%, p=0.50). Although a positive air leak test was observed in two patients in the CS group, no postoperative leakage developed by adding intraoperative treatment. CONCLUSION: Although intraoperative CS did not significantly reduce the incidence of postoperative anastomotic leakage or bleeding, it can be useful for certain cases.
    Oct. 2019, Anticancer research, 39(10) (10), 5761 - 5765, English, International magazine
    [Refereed]

  • Ueta K, Matsuda T, Yamashita K, Hasegawa H, Mukohyama J, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    BACKGROUND/AIM: To investigate the impact of inguinal lymph node dissection (ILND) following neoadjuvant chemoradiotherapy (NACRT) for rectal cancer patients with ILN metastasis. PATIENTS AND METHODS: Forty-three patients with rectal cancer underwent NACRT followed by curative surgery between January 2005 and December 2016. Seven patients underwent ILND after NACRT for clinically-positive ILN metastasis (ILND (+) group), while the remaining 36 did not receive ILND for clinically negative ILN metastasis (ILND (-) group). Their outcomes were retrospectively analyzed. RESULTS: Only one patient in the ILND (+) group had a local recurrence at six years after surgery. The 5-year recurrence-free survival was 100% and 65.4% in the ILND (+) and ILND (-) groups, respectively (p=0.09), and the 5-year overall survival was 100% and 83.2%, respectively (p=0.32). CONCLUSION: ILND following NACRT seems effective for rectal cancer patients with ILN metastasis.
    Oct. 2019, Anticancer research, 39(10) (10), 5767 - 5772, English, International magazine
    [Refereed]

  • Arimoto A, Matsuda T, Hasegawa H, Yamashita K, Nakamura T, Sumi Y, Suzuki S, Kakeji Y
    INTRODUCTION: Anatomical evaluation of the splenic flexure vein is essential for complete mesocolic excision with central vascular ligation when treating patients with splenic flexure cancer. Although there have been several studies relating to the arterial branches of the splenic flexure, very limited data are available regarding the variation in venous anatomy in this region. METHODS: Sixty-six patients with colorectal cancer who underwent preoperative 3-D CT between April 2016 and April 2017 were included in this retrospective study. The pattern of the venous drainage of the splenic flexure and its association with the inferior border of the pancreas were evaluated. RESULTS: The inferior mesenteric vein flowed into the splenic vein in 32 patients (48.5%), into the superior mesenteric vein in 27 patients (40.9%), and into the confluence of splenic vein and superior mesenteric vein in 7 patients (10.6%). The splenic flexure vein joined the inferior mesenteric vein in 62 patients (93.9%), the splenic vein in 2 patients (3.0%), and the middle colic vein in 2 patients (3.0%). The splenic flexure vein flowed into the inferior mesenteric vein below the level of the inferior border of the pancreas in 58 patients (90.6%) and above it in 4 patients (6.3%). CONCLUSION: Preoperative evaluation of the venous pattern of the splenic flexure on 3-D CT is useful before complete mesocolic excision with central vascular ligation to avoid intraoperative bleeding during splenic flexure cancer surgery.
    Oct. 2019, Asian journal of endoscopic surgery, 12(4) (4), 412 - 416, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Hosono M, Matsuda T, Yamashita K, Hasegawa H, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Sumi Y, Suzuki S, Kakeji Y
    INTRODUCTION: Although a self-expanding metallic stent (SEMS) or a transnasal or transanal decompression tube is sometimes used as a bridge to surgery in patients with obstructive colorectal cancer, the optimal decompression procedure to achieve successful laparoscopic surgery remains unclear. METHODS: Forty-two patients with obstructive colorectal cancer who were preoperatively decompressed by using SEMS (the SEMS group, n = 20) or a decompression tube (the DT group, n = 22) between January 2010 and February 2017 were included in this retrospective study. RESULTS: In the SEMS group, 20 patients (100%) were able to eat and 17 patients (85%) were able to undergo total colonoscopy preoperatively, but no patients could do so in the DT group (P < 0.01 and P < 0.01, respectively). The serum albumin level increased in the time between admission and just before surgery in five patients in the SEMS groups (25%), whereas it decreased in all patients in the DT group (P = 0.037). Laparoscopic surgery was performed more frequently in the SEMS groups (19 patients, 95%) than in the DT group (13 patients, 59.1%) (P = 0.018). Primary anastomosis without stoma was also achieved more frequently in the SEMS groups (19 patients, 95%) than in the DT group (15 patients, 68.2%) (P = 0.047). Anastomotic leakage did not occur in the SEMS group, but it did occur in one patient in the DT group. The recurrence-free survival rate did not differ between the groups (median follow-up period: 21 months). CONCLUSION: In patients with obstructive colorectal cancer, SEMS appears to be more effective than a decompression tube as a preoperative treatment to achieve successful laparoscopic resection without stoma.
    Oct. 2019, Asian journal of endoscopic surgery, 12(4) (4), 401 - 407, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Miura S, Nakamura T, Miura Y, Takiguchi G, Takase N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Suzuki S, Kakeji Y
    BACKGROUND: Several studies have suggested that thoracoscopic esophagectomy (TE) in the prone position (TEP) may be more feasible than TE in the lateral position (TEL); however, few studies have compared long-term survival between the two procedures. We evaluated whether TEP is oncologically equivalent to TEL. METHODS: Surgical outcomes of TEs performed from January 2006 to December 2013 at our hospital were retrospectively analyzed. Propensity score matching was used to control for confounding factors. RESULTS: TE was performed in 200 patients diagnosed with esophageal squamous cell carcinoma; 78 patients were matched in two procedures. The mean thoracic operative time in TEL was shorter than in TEP (228.9 min vs. 299.1 min; p < 0.001); however, the mean thoracic blood loss in TEL was higher than in TEP (186.9 ml vs. 76.5 ml; p < 0.001). The mean number of thoracic lymph nodes harvested in TEL was lower than in TEP (23.5 vs. 26.9; p < 0.05), and the pulmonary complication rate in TEL was higher than in TEP (30.8% vs. 15.4%; p < 0.05). The 5-year overall survival rates in pathological stage I (81.2% vs. 81.6%; p = 0.82), stage II (65.3% vs. 80.9%; p = 0.21), stage III (26.7% vs. 24.2%; p = 0.86) and all stages (63.6% vs. 62.3%; p = 0.88), and the 5-year progression-free survival rates in pathological stage I (78.0% vs. 81.8%; p = 0.54), stage II (53.5% vs. 77.6%; p = 0.13), stage III (10.5% vs. 12.8%; p = 0.81) and all stages (53.6% vs. 57.9%; p = 0.50) were not significantly different between the two procedures. CONCLUSION: TEP and TEL provide equal oncological efficiency.
    Oct. 2019, Annals of surgical oncology, 26(11) (11), 3736 - 3744, English, International magazine
    [Refereed]
    Scientific journal

  • Sasaki S, Oki E, Saeki H, Shimose T, Sakamoto S, Hu Q, Kudo K, Tsuda Y, Nakashima Y, Ando K, Akagi Y, Kakeji Y, Baba H, Maehara Y
    BACKGROUND: Sarcopenia or degenerative loss of skeletal muscle mass is related to poor prognosis in patients with cancer. This study aimed to clarify the clinical significance of skeletal muscle loss (SML) during chemotherapy for metastatic colorectal cancer (mCRC). METHODS: A total of 249 patients who were secondarily registered in a pooled database of mCRC patients with the first-line systemic chemotherapy and prospectively enrolled in six clinical trials of Kyushu Study Group of Clinical Cancer were included in this study. Skeletal muscle area was calculated from computed tomography images before and 3 and 6 months after treatment. Baseline sarcopenia and SML (cut-off value = 9%) were evaluated. RESULTS: Baseline sarcopenia was observed in 135 of 219 patients who were evaluated before treatment. They tended to be male; older; and have lower body mass index, lower visceral and subcutaneous fat contents, and a lower waist circumference (P < 0.01); however, baseline sarcopenia was not associated with prognosis. SML at 3 months was associated with an incidence of adverse events (P = 0.01), poor objective response rate (ORR) (P < 0.01), and poor progression-free survival (PFS) (P = 0.03), and it was an independent predictive factor for poor ORR (P < 0.01) and PFS (P = 0.04). CONCLUSION: SML at 3 months after systemic chemotherapy for mCRC was associated with poor treatment response. Thus, clarifying the importance of SML prevention guarantees a more effective chemotherapy.
    Oct. 2019, International journal of clinical oncology, 24(10) (10), 1204 - 1213, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y
    BACKGROUND: It remains unknown how much institutional medical structure and process of implementation of clinical practice guidelines for esophageal cancers can improve quality of surgical outcome in Japan. METHODS: A web-based questionnaire survey was performed for departments registered in the National Clinical Database in Japan from October 2014 to January 2015. Quality indicators (QIs) including structure and process indicators (clinical practice guideline adherence) were evaluated on the risk-adjusted odds ratio for operative mortality (AOR) of the patients using registered cases in the database who underwent esophagectomy and reconstruction in 2013 and 2014. RESULTS: Among 916 departments which registered at least one esophagectomy case during the study period, 454 departments (49.6%) responded to the questionnaire. Analyses of 6661 cases revealed that two structure QIs (certification of training hospitals by Japan Esophageal Society and presence of board-certified esophageal surgeons) were associated with significantly lower AOR (p < 0.001 and p = 0.005, respectively). One highly recommended process QI regarding preoperative chemotherapy had strong tendency to associate with lower AOR (p = 0.053). In two process QIs, the answer "performed at the doctor's discretion" showed a significant negative impact on prognosis, suggesting importance of institutional uniformity. CONCLUSIONS: The medical institutional structure of board-certified training sites for esophageal surgeons and of participation of board-certified esophageal surgeons improves surgical outcome in Japan. Establishment of appropriate QIs and their uniform implementation would be crucial for future quality improvement of medical care in esophagectomy.
    Oct. 2019, Esophagus : official journal of the Japan Esophageal Society, 16(4) (4), 362 - 370, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Goto H, Kanaji S, Otsubo D, Oshikiri T, Yamamoto M, Nakamura T, Suzuki S, Fujino Y, Tominaga M, Kakeji Y
    PURPOSE: Completion gastrectomy (CG) is a common procedure for remnant gastric cancer (RGC). However, partial gastrectomy for gastric cancer has several benefits compared to total gastrectomy in terms of the quality of life. In this study, we evaluated the feasibility and advantage of subtotal resection of the remnant stomach (SR) for clinical stage IA RGC. METHODS: A total of 43 patients who underwent gastrectomy for clinical stage IA RGC were included. CG and SR were performed on 27 (62.8%) and 16 patients (37.2%), respectively. The short- and long-term outcomes, including the nutritional status, after CG and SR for clinical stage IA RGC were compared between the two groups. RESULTS: There were no significant differences in pathological stage or incidence of postoperative complications between the two groups. The decrease in body weight, body mass index, and serum albumin level was significantly lower in the SR group than in the CG group (P < 0.001, P = 0.025, and 0.008). In the SR group, there was no recurrence at the remaining lymph nodes or gastric stump. The 5-year overall survival rate was 87.8% in the CG group and 86.1% in the SR group, without a significant difference between the two groups (P = 0.959). CONCLUSIONS: The present study showed the noninferiority of SR to CG based on surgical and oncological outcomes for clinical stage IA RGC. Furthermore, SR has an advantage over CG in terms of postoperative nutritional status. Therefore, SR could be an alternative elective treatment option for early RGC located around the anastomotic site.
    Sep. 2019, Langenbeck's archives of surgery, 404(6) (6), 753 - 760, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Koterazawa Y, Oshikiri T, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y
    BACKGROUND: Esophagectomy with three-field lymph node dissection is common, but the effects of cervical lymph node dissection on overall survival in patients with thoracic esophageal cancer remain controversial. Recently, we performed thoracoscopic esophagectomy and superior mediastinum and paracervical esophageal lymph nodes could have been effectively dissected from the thoracic cavity. This study assessed the risks and benefits of prophylactic supraclavicular lymph node dissection in patients who underwent thoracoscopic esophagectomy. METHODS: This retrospective study included 294 patients who underwent thoracoscopic esophagectomy at Kobe University Hospital and Hyogo Cancer Center between April 2010 and December 2015. Patients in the two-field (paracervical esophageal lymph nodes were dissected from the thoracic cavity) and three-field lymph node dissection groups were matched using propensity score matching. We compared overall survival and the incidence of postoperative complications in the matched cohort and assessed the estimated efficacy of additional lymphadenectomy for supraclavicular lymph node recurrence in the entire cohort. RESULTS: In the matched cohort, overall survival was not significantly different between the two groups, but the incidence of recurrent laryngeal nerve palsy was significantly higher in the 3FL group than in the 2FL group. In the entire cohort, 162 patients underwent a two-field lymph node dissection; 11 experienced supraclavicular nodal recurrence. We performed additional supraclavicular lymph node dissection in three patients without systemic metastasis, all of whom are alive without any other recurrence. CONCLUSIONS: Prophylactic cervical lymph nodes dissection in thoracoscopic esophagectomy does not improve long-term survival but does increase the risk of postoperative complications.
    Sep. 2019, Annals of surgical oncology, 26(9) (9), 2899 - 2904, English, International magazine
    [Refereed]
    Scientific journal

  • Hirata K, Imamura M, Fujiwara T, Fukui T, Furukawa T, Gotoh M, Hakamada K, Ishiguro M, Kakeji Y, Konno H, Miyata H, Mori M, Okita K, Sato M, Shibata A, Takemasa I, Unno M, Yokoi K, Nishidate T, Nishiyama M
    BACKGROUND: The current status of site-specific cancer registry has not been elucidated, but sufficient system is found in some societies. The purpose of this study was to clear the present condition of site-specific cancer registries in Japan and to suggest for the improvement. METHODS: The questionnaire was conducted by the study group of the Ministry of Health, Labor, and Welfare. It consisted of 38 questions, conflicts of interest, clinical research method, informed consent and funding for registry. We distributed this questionnaire to 28 academic societies, which had published the clinical practice guideline(s) assessed under Medical Information Network Distribution Service (MINDS). RESULTS: The concept of the importance in assessment for medical quality by the data of the site-specific cancer registry was in good consensus. But the number of the society with the mature registry was limited. The whole-year registry with the scientific researches in the National Clinical Database (NCD) and in the Translational Research Informatics Center (TRI) might seem to be in success, because assured enhancement may be estimated. Now, academic societies have the structural factors, i.e., the financial limitation in the registry maintenance and the data analysis, and in the difficulty of employment of the researchers with skill and talent. CONCLUSIONS: To manage the site-specific cancer registry effectively, the scientific registry system will be essentially important. Each academic society had much experienced highly qualified clinical researches in past. Accordingly, the scientific suggestion and co-operation should be of great importance for the improvement.
    Sep. 2019, International journal of clinical oncology, 24(9) (9), 1161 - 1168, English, Domestic magazine
    [Refereed]
    Scientific journal

  • National Clinical Databaseにおける鼠径部ヘルニア手術 Annual Report 2011-2017
    宮崎 恭介, 早川 哲史, 稲葉 毅, 上村 佳央, 川原田 陽, 嶋田 元, 諏訪 勝仁, 宋 圭男, 諸冨 嘉樹, 長江 逸郎, サシーム・パウデル, 松原 猛人, 柵瀬 信太郎, 松本 純夫, 福地 絵梨子, 宮田 裕章, 掛地 吉弘, 瀬戸 泰之
    Aug. 2019, 日本ヘルニア学会誌, 5(2) (2), 3 - 9, Japanese
    [Refereed]
    Scientific journal

  • Fukuoka E, Yamashita K, Tanaka T, Sawada R, Sugita Y, Arimoto A, Fujita M, Takiguchi G, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    BACKGROUND/AIM: The aim of this study was to investigate PD-L1 expression and its association with prognosis in esophageal squamous cell carcinoma (ESCC) before and after neoadjuvant chemotherapy (5-fluorouracil and cisplatin, NAC-FP). PATIENTS AND METHODS: Using a database of 69 ESCC patients, we analyzed PD-L1 expression on tumor cells (TCs) and immune cells (ICs), as well as the density of CD8+ tumor-infiltrating lymphocytes (TILs) in pretreatment biopsy specimens-versus-surgical specimens after resection. We determined the prognostic significance of these factors. RESULTS: The fraction of ESCC containing ICs expressing PD-L1 and having a high CD8+ TIL density was significantly increased after neoadjuvant treatment. However, PD-L1 expression on TCs or ICs, and CD8+ TIL density, was not significantly associated with patient survival in ESCC patients. CONCLUSION: NAC-FP induced PD-L1 expression on ICs and CD8+ TILs in ESCC patients. This finding suggests that PD-1/PD-L1 blockade could be combined with NAC-FP to treat ESCC patients.
    Aug. 2019, Anticancer research, 39(8) (8), 4539 - 4548, English, International magazine
    [Refereed]
    Scientific journal

  • Kubota K, Aoki T, Kumamaru H, Shiraki T, Miyata H, Seto Y, Kakeji Y, Yamamoto M
    BACKGROUND: The aim of the present study was to clarify the association between preoperative liver function and complications after hepatectomy. METHODS: The study included 11,686 patients registered in the National Clinical Database for 2015 for whom data on indocyanine green at 15 min (ICG15) and hepatectomy were available. The patients were divided into four groups: group A (ICG15 <10%; n = 5,661), group B (ICG15 10% to <20%; n = 4,381), group C (ICG15 20% to <30%; n = 1,173) and group D (ICG15 >30%; n = 463). Hepatectomy procedures were classified as partial resection (n = 3,934), systematic subsegmentectomy (n = 2,055), monosectionectomy (n = 2,043), bisectionectomy (n = 2,993) and trisectionectomy (n = 208). Complications were classified using the Clavien-Dindo classification (CD) and evaluated by ICG15 category and procedure type. RESULTS: Complications more severe than CD III increased significantly as the operation time lengthened and the intraoperative bleeding volume increased (P < 0.001). ICG15 category was positively associated with operative death, >CD III complications, surgical site infection (SSI), liver failure, and intractable ascites for many of the major hepatectomy procedures, but not with bile leakage. More complications were observed in patients outside the Makuuchi criteria than in those within the criteria. CONCLUSIONS: Operation time and intraoperative bleeding volume are significantly associated with severe postoperative complications in patients undergoing hepatectomy. ICG15 is a good indicator predictive of operative death, >CD III complications, SSI, liver failure and intractable ascites.
    Aug. 2019, Journal of hepato-biliary-pancreatic sciences, 26(8) (8), 331 - 340, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Matsuda T, Hasegawa H, Yamashita K, Takase N, Takiguchi G, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    BACKGROUND: Laparoscopic complete mesocolic excision (CME) for hepatic or splenic flexural colon cancer is considered technically demanding. The double (hepatic and splenic) flexural colon cancers are rare, and the laparoscopic CME procedure for such disease is not standardized. METHODS: This video presents laparoscopic CME for double (hepatic and splenic) flexural colon cancers using a medial and cranial approach. RESULTS: The patient was a 60-year-old woman with the diagnosis of splenic flexure cancer (cT4N1M0) and hepatic flexure cancer (cT3N0M0). Laparoscopic subtotal colectomy was performed. First, the left colic artery was divided at its origin, and the inferior mesenteric vein also was divided at the same level. The descending mesocolon was widely separated from the retroperitoneal tissues using a medial approach. Then, lymph node dissection along the surgical trunk was performed using a cranial approach. Finally, the transverse mesocolon was divided at the inferior border of the pancreas, and CME was achieved. The specimen was extracted through a small incision at the umbilicus, and side-to-side ileo-sigmoid anastomosis was performed extracorporeally. CONCLUSIONS: The approach presented in the video might be useful for standardization of laparoscopic CME for double flexural colon cancers.
    Aug. 2019, Annals of surgical oncology, 26(8) (8), 2516 - 2516, English, International magazine
    [Refereed]
    Scientific journal

  • Honda M, Kumamaru H, Etoh T, Miyata H, Yamashita Y, Yoshida K, Kodera Y, Kakeji Y, Inomata M, Konno H, Seto Y, Kitano S, Watanabe M, Hiki N
    BACKGROUND: Laparoscopic gastrectomy (LG) might have greater clinical benefits for elderly patients as less invasive surgery; however, there is still little evidence to support its benefit. We evaluated the surgical outcomes of elderly patients in a nationwide prospective cohort study. METHODS: One hundred and sixty-nine participating institutions were identified by stratified random sampling, and were adjusted for hospital volume, type and location. During 1 year from 2014 to 2015, consecutive patients who underwent gastrectomy for gastric cancer were prospectively enrolled. 'Elderly' was defined as ≥ 75 years of age, based on the prevalence of comorbidities and the activities of daily living of patients of this age. We compared the surgical outcomes of LG to those of open gastrectomy (OG) in non-elderly and elderly patients. The primary outcome was the incidence of severe morbidities (Grade ≥ 3). RESULTS: Eight thousand nine hundred and twenty-seven patients were enrolled [non-elderly, n = 6090 (OG, n = 2602; LG, n = 3488); elderly, n = 2837 (OG, n = 1471; LG, n = 1366)]. Grade ≥ 3 complications occurred in 161 (10.9%) patients who underwent OG and 98 (7.2%) who underwent LG (p < 0.001). After adjusting for confounding factors, we confirmed that laparoscopic surgery was not an independent risk factor (odds ratio = 0.81, 0.60-1.09). OG was associated with a significantly longer median length of postoperative stay in comparison to LG (16 versus 12 days, p < 0.001). There were no significant differences in the incidence of other postoperative comorbidities. CONCLUSION: The safety of LG in elderly patients was demonstrated. LG shortened the length of postoperative hospital stay.
    Jul. 2019, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 22(4) (4), 845 - 852, English, Domestic magazine
    [Refereed]
    Scientific journal

  • [Practical Use of National Clinical Database in Cancer Treatment].
    Yoshihiro Kakeji
    The National Clinical Database(NCD)started its registration in 2011 as the parent body ofthe database system linked to the board-certification system. Risk models of mortality or morbidity for 9 procedures in gastroenterological surgery have been established, and feedback reports to participants have been implemented. The NCD can provide data on each facility's severity-adjusted clinical performance, which can be compared with national or prefectural data. The NCD's huge stock of data also provides important information about operations on such topics as association between the participation of boardcertified surgeons and operative mortality, or the impact of hospital volume on risk-adjusted mortality. Breast cancer registry or pancreas cancer registry had been implemented into NCD in 2012, and several cancer registries have been implemented. With high level ofcompleteness ofthe registration, addition oflong term prognosis ofthe patients with cancer to NCD will improve cancer treatment nationwide.
    Jul. 2019, Gan to kagaku ryoho. Cancer & chemotherapy, 46(7) (7), 1087 - 1092, Japanese, Domestic magazine
    [Refereed]
    Scientific journal

  • Aoki T, Matsuda T, Hasegawa H, Yamashita K, Sumi Y, Ishida R, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    PURPOSE: The surgical indication of laparoscopic surgery for pT4 colon cancer remains to be established because only a few studies have investigated the short- and long-term outcomes of laparoscopic surgery for them to date. Therefore, we aimed to elucidate the validity of laparoscopic surgery for them. METHODS: We retrospectively analyzed 81 patients with pT4 colon cancer who underwent surgical resection with a curative intent at Kobe University Hospital from January 2007 to December 2015. The short- and long-term outcomes were compared between the propensity score-matched patients who underwent laparoscopic colectomy (LAP group, n = 25) and those who underwent open colectomy (OP group, n = 25). RESULTS: Intraoperative blood loss was significantly less in the LAP group than in the OP group (p = 0.029). Operative time, R0 resection rate, and morbidity did not significantly differ between the two groups. The 5-year overall survival (OS) and the 5-year recurrence-free survival (RFS) did not significantly differ between the propensity score-matched groups. Univariate and multivariate analyses of the entire cohort showed the surgical approach (LAP vs OP) selected was not a significant prognostic factor for OS or RFS. CONCLUSIONS: The short and the long-term outcomes were similar between the LAP and OP groups. Laparoscopic surgery might be a safe and feasible option for pT4 colon cancer patients.
    Jul. 2019, International journal of colorectal disease, 34(7) (7), 1259 - 1265, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Sawada R, Maehara R, Oshikiri T, Nakamura T, Itoh T, Kodama Y, Kakeji Y, Zen Y
    The present study aimed to elucidate the clinicopathological significance of molecular alterations in MDM2 in esophageal squamous cell carcinoma (ESCC). A total of 399 resected cases of ESCC were examined by dual-color in situ hybridization for MDM2 and immunohistochemistry for p53 using tissue microarrays. Clinicopathological features were correlated with the MDM2 status. Among 362 cases with a successful dual-color in situ hybridization analysis, 19 (5%) and 13 (4%) had MDM2 amplification and chromosome 12 polysomy, respectively, and these were examined as an MDM2-positive group. A comparison between amplified and polysomic cases revealed that the latter were more strongly associated with preoperative chemotherapy than the former. Sixteen (50%) of 32 MDM2-positive cases had positive results in all tissue cores examined, indicating diffuse MDM2 alterations. Cases with the diffuse alteration of MDM2 were characterized by an advanced pT stage and extensive vascular infiltration. The relationship between MDM2 copy number increases and p53 mutations was weak, with the overexpression of p53 being similarly detected in MDM2-positive and MDM2-negative cases (59% versus 49%; P = .267). Overall survival was shorter in patients with MDM2-positive ESCC than in those without MDM2 alterations (P = .033). The poor prognostic value of MDM2 alterations became more obvious when only diffusely altered cases were counted (P = .005). In conclusion, the present study revealed that MDM2 copy number increases occurred in 9% of ESCC cases, and MDM2 alterations, particularly diffuse abnormalities, were associated with a poor prognosis. MDM2-altered ESCC may achieve beneficial effects from MDM2-targeted therapy.
    Jul. 2019, Human pathology, 89(89) (89), 1 - 9, English, International magazine
    [Refereed]
    Scientific journal

  • Hiroshi Hasegawa, Arata Takahashi, Yoshihiro Kakeji, Hideki Ueno, Susumu Eguchi, Itaru Endo, Akira Sasaki, Shuji Takiguchi, Hiroya Takeuchi, Masaji Hashimoto, Akihiko Horiguchi, Tadahiko Masaki, Shigeru Marubashi, Kazuhiro Yoshida, Hiroyuki Konno, Mitsukazu Gotoh, Hiroaki Miyata, Yasuyuki Seto
    Background: The Japanese National Clinical Database (NCD) is a large-scale, nationwide, web-based data entry system that is linked to the surgical board certification system and covers almost all surgical cases carried out in Japan. Aim: To evaluate outcomes according to the gastroenterological section of the NCD. Methods: The 115 surgical procedures stipulated by the "Training Curriculum for Board-Certified Surgeons in Gastroenterology" were registered from 2011 to 2017. The number of surgeries, preoperative comorbidities, and short-term outcomes were compared between registration periods. Results: In total, 3 818 414 cases have been registered. More than 70% of all surgeries were carried out at certified institutions. The annual number of cases has been increasing year after year, and the aged population has also been increasing. Although the rates of preoperative comorbidities and postoperative complications have been increasing, the postoperative mortality rate has remained relatively low; in 2017, the 30-day mortality rate was 1.0% among those who underwent esophagectomy, 0.7% among those who underwent distal gastrectomy, 1.1% among those who underwent total gastrectomy, 1.3% among those who underwent right hemicolectomy, 0.5% among those who underwent low anterior resection, 1.3% among those who underwent hepatectomy, and 1.3% among those who underwent pancreaticoduodenectomy. The annual rate of endoscopic surgery dramatically increased over 7 years between 2011 and 2017, especially for low anterior resection (29.5%-62.6%) and esophagectomy (31.0%-56.1%). Conclusion: This database is expected to ensure the quality of the board-certification system and surgical outcomes in gastroenterological surgery.
    Jul. 2019, Annals of gastroenterological surgery, 3(4) (4), 426 - 450, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Miura S, Oshikiri T, Miura Y, Takiguchi G, Takase N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    Mirror image is one of the most difficult situations that the assistant surgeon encounters in laparoscopic colorectal surgery. The aim of the present study was to investigate whether task performance with mirror images improves by changing the position of the monitor and the rotation angle of the camera. Twenty-four surgeons performed the task under different conditions: Coaxial image (C), Mirror image (M), Mirror image + Monitor on the left side of participants (M + Mon), Mirror image + Camera rotated 90 degrees to the right (M + Cam), and Mirror image + Monitor on the left side + Camera rotated to the right (M + Mon + Cam) in a training box. The outcome measure was the mean time for completing the task. The mean time for completing the task, in decreasing order, was M (111.4 ± 58.9 seconds) > M + Mon (70.5 ± 29.4 seconds) > M + Cam (47.1 ± 17.1 seconds) > M + Mon + Cam (33.4 ± 10.3 seconds) > C (20.5 ± 3.5 seconds). (multivariable analysis of variance (MANOVA), p = 7.9 × 10-7) Task performance with mirror images improved by changing the monitor positioning and camera rotation angle. This novel method is a simple way to overcome mirror image in laparoscopic colorectal surgery.
    Jun. 2019, Scientific reports, 9(1) (1), 8371 - 8371, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 【消化管術後合併症-発症要因と対応】 胃術後食物停滞の発症要因,予防対策と対応
    池田 太郎, 金治 新悟, 永田 真知子, 青木 丈明, 山本 将士, 掛地 吉弘
    Jun. 2019, 外科, 81(6月7号) (6月7号), 716 - 720, Japanese
    [Refereed]
    Scientific journal

  • Higashino N, Koma Y, Hosono M, Takase N, Okamoto M, Kodaira H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H
    Esophageal squamous cell carcinoma (ESCC) is a highly aggressive tumor with frequent recurrence even after curative resection. The tumor microenvironment, which consists of non-cancer cells, such as cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs), was recently reported to promote several cancers, including ESCC. However, the role of CAF as a coordinator for tumor progression in ESCC remains to be elucidated. In our immunohistochemical investigation of ESCC tissues, we observed that the intensity of expression of two CAF markers-alpha smooth muscle actin (αSMA) and fibroblast activation protein (FAP)-in the tumor stroma was significantly correlated with the depth of tumor invasion, lymph node metastasis, advanced pathological stage, and poor prognosis. We co-cultured human bone marrow-derived mesenchymal stem cells (MSCs) with ESCC cells and confirmed the induction of FAP expression in the co-cultured MSCs. These FAP-positive MSCs (which we defined as CAF-like cells) promoted the cell growth and migration of ESCC cells and peripheral blood mononuclear cell-derived macrophage-like cells. CAF-like cells induced the M2 polarization of macrophage-like cells. A cytokine array and ELISA revealed that CAF-like cells secreted significantly more CCL2, Interleukin-6, and CXCL8 than MSCs. These cytokines promoted the migration of tumor cells and macrophage-like cells. The silencing of FAP in CAF-like cells attenuated cytokine secretion. We compared cell signaling of MSCs, CAF-like cells, and FAP-silenced CAF-like cells; PTEN/Akt and MEK/Erk signaling were upregulated and their downstream targets, NF-κB and β-catenin, were also activated with FAP expression. Silencing of FAP attenuated these effects. Cytokine secretion from CAF-like cells were attenuated by inhibitors against these signaling pathways. These findings indicate that the collaboration of CAFs with tumor cells and macrophages plays a pivotal role in tumor progression, and that FAP expression is responsible for the tumor promotive and immunosuppressive phenotypes of CAFs.
    Jun. 2019, Laboratory investigation; a journal of technical methods and pathology, 99(6) (6), 777 - 792, English, International magazine
    [Refereed]
    Doctoral thesis

  • 胃癌補助化学療法の現状と展望
    掛地 吉弘
    Lead, Jun. 2019, 週間 日本医事新報, 4963(6月2号) (6月2号), 46 - 47, Japanese
    [Refereed]
    Scientific journal

  • Tanaka T, Matsuda T, Hasegawa H, Yamashita K, Nakamura T, Suzuki S, Kakeji Y
    BACKGROUND: To perform a safe and precise laparoscopic surgery for the splenic flexure cancer, it is important for surgeons to gain a preoperative understanding of the running of the feeding artery of the splenic flexure. We evaluated the blood supply to the splenic flexure by using preoperative three-dimensional computed tomography (3D-CT). METHOD: We retrospectively analyzed a total of 88 patients with colorectal cancer who underwent preoperative 3D-CT at our institutions between April 2016 and June 2017. RESULTS: The arterial blood supply to the splenic flexure was divided into four patterns as follows: type 1, the left branch of the middle colic artery (MCA) with common trunk and the left colic artery (LCA) (n = 48, 54.5%); type 2, the left branch of the MCA with independent origin and the LCA (n = 8, 9.1%); type3, the accessory-MCA (A-MCA) and the LCA (n = 27, 30.7%); and type4, the LCA alone (n = 5, 5.7%). The MCA had the common trunk of the right and left branches in the majority of cases (85.2%). The right and left branches of the MCA arose separately from the superior mesenteric artery (SMA) in 8 of 88 patients (9.1%). CONCLUSIONS: The arterial patterns of the splenic flexure were classified into four patterns by using preoperative 3D-CT. The A-MCA existed in 30% of the patients in this study. These information should be helpful to perform the optimal surgery for the splenic flexure cancer.
    Jun. 2019, International journal of colorectal disease, 34(6) (6), 1047 - 1051, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M
    PURPOSE: S-1 is a standard postoperative adjuvant chemotherapy for patients with stage II or III gastric cancer in Asia. Neoadjuvant or perioperative strategies dominate in Western countries, and docetaxel has recently shown significant survival benefits when combined with other standard regimens in advanced cancer and perioperative settings. PATIENTS AND METHODS: This randomized phase III study was designed to prove the superiority of postoperative S-1 plus docetaxel over S-1 alone for R0 resection of pathologic stage III gastric cancer. The sample size of 1,100 patients was necessary to detect a 7% increase in 3-year relapse-free survival as the primary end point (hazard ratio, 0.78; 2-sided α = .05; β = .2). RESULTS: The second interim analysis was conducted when the number of events reached 216 among 915 enrolled patients (median follow-up, 12.5 months). Analysis demonstrated the superiority of S-1 plus docetaxel (66%) to S-1 (50%) for 3-year relapse-free survival (hazard ratio, 0.632; 99.99% CI, 0.400 to 0.998; stratified log-rank test, P < .001), and enrollment was terminated as recommended by the independent data and safety monitoring committee. Incidences of grade 3 or greater adverse events, particularly neutropenia and leukopenia, were higher in the S-1 plus docetaxel group, but all events were manageable. CONCLUSION: Addition of docetaxel to S-1 is effective with few safety concerns in patients with stage III gastric cancer. The present findings may also be applicable in countries in which perioperative adjuvant chemotherapy or chemoradiation is not standard.
    May 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(15) (15), 1296 - 1304, English, International magazine
    [Refereed]
    Scientific journal

  • 特集 食道癌手術の最前線─合併症ゼロを目指した私の秘訣 腹臥位アプローチによる胸腔鏡下食道癌根治術─上縦隔郭清手技を中心に
    押切 太郎, 瀧口 豪介, 三浦 晋, 中村 哲, 掛地 吉弘
    May 2019, 手術, 73(6) (6), 837 - 848, Japanese
    [Refereed]
    Scientific journal

  • Oshikiri T, Takiguchi G, Miura S, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y
    PURPOSE: In esophageal squamous cell carcinoma (ESCC), lymph nodes (LNs) around the subcarina and main bronchi are thought to be highly involved. Therefore, complete dissection of these LNs with preservation of the pulmonary branches of the vagus nerves, which control important pulmonary functions, is recommended. The aim of this retrospective study was to investigate the feasibility of reliable method for lymphadenectomy around the subcarina and main bronchi, named the medial approach, during thoracoscopic esophagectomy in the prone position (TEP). METHODS: This was a case-matched control study of patients who underwent TEP for ESCC. The fundamental concept in this method is to first exfoliate the LNs around the subcarina and main bronchi from the pericardium. Developing the operative field contributes to visualizing and preserving the pulmonary branches of the right vagus nerve. Twenty-three patients who underwent the medial approach and 23 patients who underwent the conventional approach were selected by the use of propensity score matching to compare the operative outcomes. RESULTS: The medial approach significantly reduced operative time for procedure (16 ± 3 vs 30 ± 6 min, p < 0.0001) and operative blood loss (123 ± 108 vs 207 ± 162 ml, p = 0.046) comparing with conventional approach. The incidence of postoperative pneumonia was lower in the medial approach group (4%) than in the conventional approach group (15%) (p = 0.069). CONCLUSIONS: The medial approach for lymphadenectomy around the subcarina and both main bronchi during TEP is technically safe and feasible in shorting the operative time with possibility to reduce postoperative pneumonia.
    May 2019, Langenbeck's archives of surgery, 404(3) (3), 359 - 367, English, International magazine
    [Refereed]
    Scientific journal

  • 高齢者胃癌の外科治療
    鈴木 知志, 金治 新悟, 山本 将士, 松田 佳子, 杉田 裕, 掛地 吉弘
    Apr. 2019, 癌の臨床, 64(4) (4), 257 - 264, Japanese
    [Refereed]
    Scientific journal

  • Kanaji S, Takahashi A, Miyata H, Marubashi S, Kakeji Y, Konno H, Gotoh M, Seto Y
    PURPOSES: To evaluate the reliability of data collected from the gastroenterological section of the National Clinical Database of Japan (NCD), which began registrations in 2011 with ten surgical subspecialty societies. METHODS: During 2014 and 2015, 1,136,700 cases involving 115 procedures at 4374 hospitals were registered in the gastroenterological surgery section of the NCD. After a test audit using the 2014 data, 17 hospitals were selected for the first audit and data verification for 2015. The data accuracy of patient demographics, surgical outcomes, and processes was assessed using 45 items from the cases registered, in comparison with the medical records. RESULTS: In the first audit of the 2015 data, case registration accuracy verification involved 338 patients (99.4% of the extracted cases). The data accuracy with the maximum postoperative variables was > 95%. Accuracy of the mortality and status 30 days after the surgery was high (> 99%) with a sensitivity of 1.00 and a specificity of 1.00. Among the six complications studied, the recorded cases had high specificity but lower sensitivity (0.70-0.89). CONCLUSIONS: We verified the data from the gastroenterological section of the NCD and found high accuracy of data entry.
    Apr. 2019, Surgery today, 49(4) (4), 328 - 333, English, Domestic magazine
    [Refereed]

  • Aoki T, Nishita M, Sonoda J, Ikeda T, Kakeji Y, Minami Y
    Collective invasion is an important strategy of cancers of epithelial origin, including colorectal cancer (CRC), to infiltrate efficiently into local tissues as collective cell groups. Within the groups, cells at the invasive front, called leader cells, are highly polarized and motile, thereby providing the migratory traction that guides the follower cells. However, its underlying mechanisms remain unclear. We have previously shown that signaling emanating from the receptor tyrosine kinase Ror2 can promote invasion of human osteosarcoma cells and that intraflagellar transport 20 (IFT20) mediates its signaling to regulate Golgi structure and transport. Herein, we investigated the role of Ror2 and IFT20 in collective invasion of CRC cells, where Ror2 expression is either silenced or nonsilenced. We show by cell biological analyses that IFT20 promotes collective invasion of CRC cells, irrespective of expression and function of Ror2. Intraflagellar transport 20 is required for organization of Golgi-associated, stabilized microtubules, oriented toward the direction of invasion in leader cells. Our results also indicate that IFT20 promotes reorientation of the Golgi apparatus toward the front side of leader cells. Live cell imaging of the microtubule plus-end binding protein EB1 revealed that IFT20 is required for continuous polarized microtubule growth in leader cells. These results indicate that IFT20 plays an important role in collective invasion of CRC cells by regulating organization of Golgi-associated, stabilized microtubules and Golgi polarity in leader cells.
    Apr. 2019, Cancer science, 110(4) (4), 1306 - 1316, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Suzuki S, Kanaji S, Yamamoto M, Oshikiri T, Nakamura T, Kakeji Y
    BACKGROUND: Preoperative nutritional status is considered to affect the short-term and long-term outcomes of cancer patients. The clinical value of the controlling nutritional status (CONUT) score in elderly patients undergoing gastrectomy for gastric cancer remains unknown. METHODS: This study reviewed 211 elderly patients aged 75 years or over who underwent curative resection for gastric cancer from 2000 to 2015. Patients were grouped according to the preoperative CONUT score into those with normal nutrition (75 patients), light malnutrition (100 patients) and moderate or severe malnutrition (36 patients). The predictive value of the CONUT score for postoperative morbidity and survival was assessed. RESULTS: Impaired nutrition was associated with cardiovascular disease (P = 0.012) and chronic kidney disease (P = 0.014), and worsened malnutrition was linked to advanced age (P = 0.004), decreased body mass index (P = 0.008) and advanced disease stage (P = 0.01). Multivariate analysis showed the CONUT score as an independent predictor of procedure-unrelated infectious morbidity (odds ratio, 2.36; 95% confidence interval [CI], 0.99-5.40; P = 0.046). Patients with a higher CONUT score had significantly shorter overall survival in both stage I and stage II/III gastric cancer (P = 0.044 and P = 0.007, respectively) and reduced cancer-specific survival in stage II/III (P = 0.003) The CONUT score was a strong predictors of overall survival (hazard ratio [HR], 2.12; 95% CI, 1.18-3.69; P = 0.012) and cancer-specific survival (HR, 3.75; 95% CI, 1.30-10.43; P = 0.015) independent of disease stage. CONCLUSIONS: The preoperative CONUT score is a simple and promising predictor of postoperative procedure-unrelated infectious morbidity and prognosis in elderly gastric cancer patients.
    Apr. 2019, World journal of surgery, 43(4) (4), 1076 - 1084, English, International magazine
    [Refereed]
    Scientific journal

  • Tatara T, Kanaji S, Suzuki S, Ishida R, Hasegawa H, Yamamoto M, Matsuda Y, Yamashita K, Oshikiri T, Matsuda T, Nakamura T, Sumi Y, Kakeji Y
    BACKGROUND: Single-incision laparoscopic surgery (SILS) has recently been used for the management of gastrointestinal stromal tumors (GIST). Here, the feasibility and effectiveness of SILS for GIST and indications for SILS according to tumor location were investigated. CASE PRESENTATION: From July 2009 to May to 2013, a total of 14 patients underwent SILS for GIST. In 14 patients, 5 patients had tumor near the esophagogastric junction, 4 patients on the lesser curvature, 2 patients on the anterior wall, 2 patients on the posterior wall, and 1 patient on the greater curvature. The surgery of one patient with lesser curvature tumor was converted to conventional laparoscopic surgery because of technical difficulties. Another patient required re-operation because of a posterior wall tumor causing gastric obstruction. There was no complication in patients with tumors on the anterior wall and greater curvature. CONCLUSIONS: Because SILS for GISTs located mainly on the anterior wall was feasible, SILS may be considered the most appropriate type of laparoscopic surgery for GISTs in this location. However, for GISTs on the posterior wall or with lesser curvature, which require more complex management, SILS is challenging and should be carefully adapted.
    Mar. 2019, Surgical case reports, 5(1) (1), 50 - 50, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Oshikiri T, Takiguchi G, Miura S, Takase N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda Y, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    Esophagectomy with extended lymphadenectomy remains the mainstay of treatment for localized esophageal cancer. However, it is one of the most invasive procedures with high morbidity. To reduce invasiveness, minimally invasive esophagectomy (MIE), which includes thoracoscopic, laparoscopic, mediastinoscopic, and robotic surgery, is becoming popular worldwide. Thoracoscopic esophagectomy in the prone position is ergonomic for the surgeon and has better perioperative arterial oxygen pressure/fraction of inspired oxygen (P/F) ratio. Thoracoscopic esophagectomy in the left decubitus position is easy to introduce because it is similar to standard right posterolateral open esophagectomy (OE) in position. It has a relatively short operative time. Laparoscopic approach could potentially have a substantial effect on pneumonia prevention under the condition of thoracotomy. Mediastinoscopic surgery has the potential to reduce pulmonary complications because it can avoid a transthoracic procedure. In robotic surgery, in the future, less recurrent laryngeal nerve palsy will be expected as a result of polyarticular fine maneuvering without human tremors. In studies comparing MIE with OE, mediastinoscopic surgery and robotic surgery are usually not included; these studies show that MIE has a longer operative time and less blood loss than OE. MIE is particularly beneficial in reducing postoperative respiratory complications such as atelectasis, despite no dramatic decrease in pneumonia. Reoperation might occur more frequently with MIE. There is no significant difference in mortality rate between MIE and OE. It is important to recognize that the advantages of MIE, particularly "less invasiveness", can be of benefit at facilities with experienced medical personnel.
    Mar. 2019, Annals of gastroenterological surgery, 3(2) (2), 138 - 145, English, Domestic magazine
    [Refereed]
    Link to Kobe Univ. Repository (Kernel)

  • Lee D, Matsuda T, Yamashita K, Hasegawa H, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Fukumoto T, Kakeji Y
    AIM: To evaluate the clinical significance of lateral pelvic lymph node (LLN) size in predicting pathological metastasis and prognosis in rectal cancer treated with preoperative chemoradiotherapy (CRT) followed by surgery. PATIENTS AND METHODS: Fifty-two patients with rectal cancer who underwent curative surgery after preoperative CRT were included. Fifteen patients underwent total mesorectal excision (TME) alone, while 37 patients underwent TME with LLN dissection for clinical LLN metastasis. RESULTS: Pathological metastasis was identified in seven (2.6%) out of 270 resected LLNs in six (16.2%) out of 37 patients. The cut-off value of the short-axis diameter was 7.0 mm before and 6.0 mm after CRT. The 5-year recurrence-free survival rate was significantly higher in patients with LLNs <7.0 mm than in those with LLNs ≥7.0 mm (85.7% versus 56.8%, p=0.038). CONCLUSION: Short-axis diameter of LLNs of 7.0 mm seems to be an optimal cut-off value before CRT for predicting pathological metastasis and prognosis.
    Feb. 2019, Anticancer research, 39(2) (2), 993 - 998, English, International magazine
    [Refereed]
    Scientific journal

  • Shigeru Marubashi, Naoaki Ichihara, Yoshihiro Kakeji, Hiroaki Miyata, Akinobu Taketomi, Hiroto Egawa, Yasutsugu Takada, Koji Umeshita, Yasuyuki Seto, Mitsukazu Gotoh
    Aim: A comprehensive description of morbidity and mortality risk factors for post liver transplant has not been available to date. In this study, we established real-time risk models of postoperative morbidities and mortality in liver transplant recipients using two Japanese nationwide databases. Methods: Data from two Japanese nationwide databases were combined and used for this study. We developed real-time prognostic models for morbidity and mortality from a derivation cohort (n = 1472) and validated the findings with an independent cohort (n = 395). Preoperative variables (C1), preoperative and intraoperative variables (C2), and all variables including postoperative morbidities within 30 days (C3) were analyzed to evaluate the independent risk factors for postoperative morbidity and mortality. Results: We established real-time risk models for morbidity and mortality. Areas under the curve (AUC) of C1 and C2 risk models for mortality were 0.74 (0.63-0.82) and 0.79 (0.69-0.86), respectively. Multivariate logistic analysis using C3 showed that hemoglobin <10 g/dL, operative time (hours), and five postoperative morbidities (prolonged ventilation >48 hours, coma >24 hours, renal dysfunction, postoperative systemic sepsis, and serum total bilirubin ≥10 mg/dL) represented independent risk factors for mortality (AUC = 0.87, 95% confidence interval [CI]: 0.78-0.93). Conclusions: Real-time risk models of postoperative morbidities and mortality at various perioperative time points in liver transplant recipients were established. These novel approaches may improve postoperative outcomes of liver transplant recipients. Furthermore, these real-time risk models may be applicable to other surgical procedures.
    Jan. 2019, Annals of gastroenterological surgery, 3(1) (1), 75 - 95, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Iwatsuki M, Yamamoto H, Miyata H, Kakeji Y, Yoshida K, Konno H, Seto Y, Baba H
    BACKGROUND: Despite interest in surgeon and hospital volume effects on distal gastrectomy, clinical significance has not been confirmed in a large-scale population. We studied to clarify the effects of surgeon and hospital volume on postoperative mortality after distal gastrectomy for gastric cancer among Japanese patients in a nationwide web-based data entry system. METHODS: We extracted data on distal gastrectomy for gastric cancer from the National Clinical Database between 2011 and 2015. The primary outcome was operative mortality. Hospital volume was divided into 3 tertiles: low (1-22 cases per year), medium (23-51) and high (52-404). Surgeon volume was divided into the 5 groups: 0-3, 4-10, 11-20, 21-50, 51 + cases per year. We calculated the 95% confidence interval (CI) for the mortality rate based on odds ratios (ORs) estimated from a hierarchical logistic regression model. RESULTS: We analyzed 145,523 patients at 2182 institutions. Operative mortality was 1.9% in low-, 1.0% in medium- and 0.5% in high-volume hospitals. The operative mortality rate decreased definitively with surgeon volume, 1.6% in the 0-3 group and 0.3% in the 51 + group. After risk adjustment for surgeon and hospital volume and patient characteristics, hospital volume was significantly associated with operative morality (medium: OR 0.64, 95% CI 0.56-0.73, P < 0.001; high: OR 0.42, 95% CI 0.35-0.51, P < 0.001). CONCLUSIONS: We demonstrate that hospital volume can have a crucial impact on postoperative mortality after distal gastrectomy compared with surgeon volume in a nationwide population study. These findings suggest that centralization may improve outcomes after distal gastrectomy.
    Jan. 2019, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 22(1) (1), 190 - 201, English, Domestic magazine
    [Refereed]

  • Kodera Y, Yoshida K, Kumamaru H, Kakeji Y, Hiki N, Etoh T, Honda M, Miyata H, Yamashita Y, Seto Y, Kitano S, Konno H
    BACKGROUND: Although laparoscopic total gastrectomy (LTG) is considered a technically demanding procedure with safety issues, it has been performed in several hospitals in Japan. Data from a nationwide web-based data entry system for surgical procedures (NCD) that started enrollment in 2011 are now available for analysis. METHODS: A retrospective cohort study was conducted using data from 32,144 patients who underwent total gastrectomy and were registered in the NCD database between January 2012 and December 2013. Mortality and morbidities were compared between patients who received LTG and those who underwent open total gastrectomy (OTG) in the propensity score-matched Stage I cohort and Stage II-IV cohort. RESULTS: There was no significant difference in mortality rate between LTG and OTG in both cohorts. Operating time was significantly longer in LTG while the blood loss was smaller. In the Stage I cohort, LTG, performed in 33.6% of the patients, was associated with significantly shorter hospital stay but significantly higher incidence of readmission, reoperation, and anastomotic leakage (5.4% vs. 3.6%, p < 0.01). In the Stage II-IV cohort, LTG was performed in only 8.8% of the patients and was associated with significantly higher incidence of leakage (5.7% vs. 3.6%, p < 0.02) although the hospital stay was shorter (15 days vs. 17 days, p < 0.001). CONCLUSION: LTG was more discreetly introduced than distal gastrectomy, but remained a technically demanding procedure as of 2013. This procedure should be performed only among the well-trained and informed laparoscopic team.
    Jan. 2019, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 22(1) (1), 202 - 213, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Yamashita K, Matsuda T, Hasegawa H, Mukohyama J, Arimoto A, Tanaka T, Yamamoto M, Matsuda Y, Kanaji S, Nakamura T, Sumi Y, Suzuki S, Kakeji Y
    Neoadjuvant chemoradiotherapy (nCRT) has been widely used as a multidisciplinary approach for stage II/III rectal cancer. However, its safety and efficacy are controversial because previous studies have shown conflicting outcomes. The present review aimed to elucidate the benefits and limitations of nCRT for patients with rectal cancer. Future perspectives of nCRT are also described. No recent randomized trials have been able to show a survival benefit, although many studies have demonstrated good local control with the use of fluoropyrimidine (e.g. 5-fluorouracil [FU] or capecitabine)-based nCRT. Addition of oxaliplatin (OX) to FU-based nCRT might improve overall survival by preventing distant metastasis, as shown in recent meta-analyses. However, control of adverse effects is an important concern with this treatment. New treatment strategies such as nonoperative management (watch and wait policy) and total neoadjuvant therapy (TNT) are promising, but the establishment of reliable diagnostic methods of metastasis is essential. Development of new biomarkers is also necessary to select patients who are more likely to benefit from nCRT.
    Jan. 2019, Annals of gastroenterological surgery, 3(1) (1), 24 - 33, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 高齢者胃癌に対する標準治療
    山口和也, 朴成和, 長島文夫, Kakeji Yoshihiro
    Jan. 2019, 胃がんperspective, 10(2) (2), 5 - 13, Japanese
    [Refereed]
    Scientific journal

  • Otowa Y, Nakamura T, Yamazaki Y, Takiguchi G, Nakagawa A, Yamamoto M, Kanaji S, Matsuda T, Oshikiri T, Suzuki S, Kakeji Y
    PURPOSE: The prognosis of esophageal cancer is dismal, and the 3-year overall survival of cStage III does not reach 50.0%. C-reactive protein (CRP) is a well-known protein that reflects the short- and long-term operative outcomes of esophageal cancer. However, since elevated CRP levels are often observed in cStage III esophageal cancer, whether or not CRP still reflects the prognosis is unclear. METHODS: Eighty-four patients who were diagnosed with cStage III esophageal cancer and underwent R0/1 operation from January 2007 to December 2014 were retrospectively evaluated. RESULTS: The mean age was 66.8 years, and the majority of patients were male. The median preoperative and postoperative CRP levels were 0.15 and 1.47 mg/dl, respectively. A majority of the patients underwent thoracoscopic surgery, and the median blood loss and operation duration were 456 ml and 11.6 h, respectively. Forty-six patients (54.8%) died during the observation period, and the 3-year overall survival was 52.4%. A multivariate analysis showed that the preoperative CRP level, postoperative albumin level, blood loss, and complications were independent prognostic factors. A multiple linear regression analysis showed that an elevated postoperative CRP level was affected by the operation duration and preoperative CRP levels. CONCLUSIONS: These findings suggest that the preoperative CRP level is a prognostic factor for cStage III esophageal cancer and that postoperative elevation in the CRP level is affected by the operation duration.
    Jan. 2019, Surgery today, 49(1) (1), 90 - 95, English, Domestic magazine
    [Refereed]
    Scientific journal

  • 【機能性消化管疾患診療の実際】 嚥下障害・つまり感があれば器質性疾患に注意(解説/特集)
    小寺澤 康文, 中村 哲, 掛地 吉弘
    Jan. 2019, 日本医師会雑誌, 147(10) (10), 1996 - 1996, Japanese
    [Refereed]
    Scientific journal

  • 無菌法（消毒法および減菌法）
    掛地 吉弘
    Jan. 2019, 標準外科学, 15(1) (1), 53 - 59, Japanese
    [Refereed]
    Scientific journal

  • 嚥下障害・つまり感があれば器質性疾患に注意
    小寺澤 康文, 中村 哲, 掛地 吉弘
    Jan. 2019, 日本医師会雑誌, 147(10) (10), 1996 - 1996, Japanese
    [Refereed]
    Scientific journal

  • Initial verification of data from a clinical database of gastroenterological surgery in Japan.
    Kanaji S, Takahashi A, Miyata H, Marubashi S, Kakeji Y, Konno H, Gotoh M, Seto Y
    Jan. 2019, Surg Today., 49(1) (1), 90 - 95, English
    [Refereed]
    Scientific journal

  • Mass-Forming Deep Pseudodiverticulosis of the Esophagus With 18F-Fluorodeoxyglucose Uptake
    Sawada R, Oshikiri Taro, Nakamura Tetsu, Yamamoto Masashi, Matsuda Takeru, Sumi Y, Itoh T, Zen Y, Suzuki Satoshi, Kakeji Yoshihiro
    Dec. 2018, Ann Thorac Surg, 106(6) (6), e309 - e311, English
    [Refereed]
    Scientific journal

  • PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer
    Ueta K, Otowa Y, Kakeji Yoshihiro, Hirashima M
    Nov. 2018, Anticancer Res, 38(11) (11), 6139 - 6145, English
    [Refereed]
    Scientific journal

  • The effect on surgical skills of expert surgeons using 3D/HD and 2D/4K resolution monitors in laparoscopic phantom tasks
    Harada H, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Y, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    Oct. 2018, Surg Endosc, 32(10) (10), 4228 - 4234, English
    [Refereed]
    Scientific journal

  • Surgery: To what extent can we operate
    Kakeji Yoshihiro
    Oct. 2018, ANN GASTROENTEROL SURG, 2(6) (6), 398 - 399, English
    [Refereed]
    Scientific journal

  • Optimal Surgery for Mid-Transverse Colon Cancer: Laparoscopic Extended Right Hemicolectomy Versus Laparoscopic Transverse Colectomy
    Matsuda Takeru, Sumi Y, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    Oct. 2018, World J Surg, 42(10) (10), 3398 - 3404, English
    [Refereed]
    Scientific journal

  • 【食道癌(第2版)-基礎・臨床研究の進歩-】 食道癌の疫学 Big dataからみる食道癌 食道癌全国登録とNCD
    Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    Oct. 2018, 日本臨床, 76(増刊8 食道癌) (増刊8 食道癌), 54 - 59, Japanese

  • Significance of Additional Gastrectomy Including Endoscopic Submucosal Dissection Scar for Gastric Cancer
    Ishida R, Kanaji Shingo, Maehara R, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Y, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    Sep. 2018, Anticancer Res, 38(9) (9), 5289 - 5294, English
    [Refereed]
    Scientific journal

  • Koterazawa Y, Nakamura T, Oshikiri T, Kanaji S, Tanaka S, Ishida T, Yamashita K, Matsuda T, Morita Y, Suzuki S, Kakeji Y
    PURPOSE: Endoscopic submucosal dissection (ESD) is widely used to treat esophageal cancer, but some patients require additional treatment due to the possibility of lymph node metastasis. The aim of this study was to elucidate the clinical outcomes of these additional treatments. METHODS: The study included 59 patients who developed superficial esophageal squamous cell carcinoma after noncurative ESD treated between 2005 and 2016, of whom 28 underwent esophagectomy and 31 received chemoradiotherapy (CRT). RESULTS: The median follow-up periods were 45 months in the esophagectomy group and 41 months in the CRT group. The overall survival did not differ significantly between the groups (P = 0.46). However, there were no recurrences in the esophagectomy group, and the disease-specific survival rate was significantly higher in this group (P = 0.042). Among the patients at high risk for recurrence due to massive tumor invasion (≥ SM2) with lymphovascular invasion (esophagectomy group, six patients; CRT group, ten patients), none in the esophagectomy group had recurrence, whereas four in the CRT group died of esophageal cancer (P = 0.031). CONCLUSION: The overall survival did not differ significantly between the groups. However, compared with CRT, esophagectomy provided more favorable disease control for patients with massive tumor invasion (≥ SM2) with lymphovascular invasion.
    Aug. 2018, Surgery today, 48(8) (8), 783 - 789, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Recent updates in perioperative chemotherapy and recurrence pattern of gastric cancer
    Kanaji Shingo, Suzuki Satoshi, Matsuda Yoshiko, Hasegawa Hiroshi, Yamamoto Masashi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Nakamura Tetsu, Sumi Y, Kakeji Yoshihiro
    Aug. 2018, ANN GASTROENTEROL SURG, 2(6) (6), 400 - 405, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas
    Sawada R, Ku Y, Akita M, Otani K, Fujikura K, Itoh T, Ajiki Tetsuo, Fukumoto Takumi, Kakeji Yoshihiro, Zen Y
    Aug. 2018, Histopathology, 73(2) (2), 259 - 272, English
    [Refereed]
    Scientific journal

  • 【腹膜播種治療の今】 胃癌腹膜播種に対しての化学療法
    Kakeji Yoshihiro, 原田仁, 三浦晋, Matsuda Yoshiko, Yamamoto Masashi, Kanaji Shingo, Suzuki Satoshi
    Aug. 2018, 癌の臨床, 64(2号) (2号), 83 - 89, Japanese
    [Refereed]

  • Immunosuppression Induced by Perioperative Peritonitis Promotes Lung Metastasis
    Arimoto A, Yamashita Kimihiro, Hasegawa Hiroshi, Sugita Y, Fukuoka E, Tanaka T, Suzuki Satoshi, Kakeji Yoshihiro
    Jul. 2018, Anticancer Res, 38(7) (7), 4333 - 4338, English
    [Refereed]
    Scientific journal

  • Application of iNKT Cell-targeted Active Immunotherapy in Cancer Treatment
    Yamashita Kimihiro, Arimoto A, Nishi M, Tanaka T, Fujita M, Fukuoka E, Sugita Y, Nakagawa A, Hasegawa Hiroshi, Suzuki Satoshi, Kakeji Yoshihiro
    Jul. 2018, Anticancer Res, 38(7) (7), 4233 - 4239, English
    [Refereed]
    Scientific journal

  • Strategy for esophageal non-epithelial tumors based on a retrospective analysis of a single facility
    Aoki T, Nakamura Tetsu, Oshikiri Taro, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Sumi Y, Suzuki Satoshi, Kakeji Yoshihiro
    Jun. 2018, Esophagus, English
    [Refereed]
    Scientific journal

  • 用語解説 有茎空腸再建術
    坂本浩輝, Nakamura Tetsu, Kakeji Yoshihiro
    Jun. 2018, 日本気管食道科学会会報, 69(3号) (3号), 221 - 223, Japanese

  • Tatara T, Mukohara T, Shimono Y, Yamasaki T, Imamura Y, Funakoshi Y, Toyoda M, Kiyota N, Takao S, Kono S, Kakeji Y, Minami H
    BACKGROUND AND OBJECTIVES: To explore whether lymphocytes in sentinel lymph nodes (SLNs) are highly exposed to tumor neoantigens and thus express high level of programmed death 1 (PD-1), we examined PD-1 expression in SLNs and non-sentinel regional lymph nodes (non-SLNs) in breast cancer. METHODS: We performed PD-1 immunohistochemistry in two cohorts: 40 metastasis-negative SLNs including 10 patients for each subtype (luminal A-like, luminal B-like, HER2, and triple negative breast cancer [TNBC]); and 25 pairs of metastasis-positive SLNs and non-SLNs (10 luminal A-like, 10 luminal B-like, and 5 TNBC). RESULTS: Among 40 metastasis-negative SLNs, 34 and 6 samples were PD-1 intensity grade 1 (low) and 2 (high), respectively. PD-1 intensity correlated with PD-1-positive lymphocyte numbers (P = 0.005); TNBC had the highest PD-1 lymphocyte numbers among all subtypes. The median PD-1-positive lymphocyte number was higher in SLNs than non-SLNs. In most cases, more lymphocytes in SLNs expressed PD-1 than those in non-SLNs (P < 0.0001). CONCLUSIONS: TNBC had the greatest PD-1 expression among all subtypes, and metastasis-positive SLNs had more PD-1-positive lymphocytes than downstream non-SLNs. These data suggested that lymphocytes in SLNs are activated following exposure to tumor neoantigens and thus tumor specific, and could be utilized as a biomarker platform.
    May 2018, Journal of surgical oncology, 117(6) (6), 1131 - 1136, English, International magazine
    [Refereed]
    Scientific journal

  • 3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture.
    Tatara T, Mukohara T, Tanaka R, Shimono Y, Funakoshi Y, Imamura Y, Toyoda M, Kiyota N, Hirai M, Kakeji Y, Minami H
    BACKGROUND: Our hypothesis was that three-dimensional (3D) culture better represents differential in vivo responses to trastuzumab between PIK3CA-wild-type (wt) and mutant (mt) cell lines than does two-dimensional (2D) culture. MATERIALS AND METHODS: Apoptosis and cell signaling proteins were evaluated in response to trastuzumab with and without BKM120, a pan-phosphatidylinositol 3-kinase (PI3K) inhibitor, using western blot analysis of four breast cancer cell lines with human epidermal growth factor receptor 2 (HER2) amplification. RESULTS: Increased expression of cleaved poly (ADP-ribose) polymerase (PARP) was observed only in 3D-cultured PIK3CA-wt lines in response to trastuzumab, but not in 2D-cultured PIK3CA-wt or PIK3CA-mt lines. Decrease in the ratio of phosphorylated (p-)AKT to AKT in response to trastuzumab was more profound in PIK3CA-wt cells than in PIK3CA-mt cells in 3D culture, while the difference between PIK3CA genotypes was less apparent in 2D culture. Treatment with BKM120 and trastuzumab resulted in a stronger increase in cleaved PARP than either treatment alone. CONCLUSION: 3D Culture appears to better represent trastuzumab-induced apoptosis and resistance to trastuzumab associated with PIK3CA mutation.
    May 2018, Anticancer research, 38(5) (5), 2831 - 2839, English, International magazine
    [Refereed]
    Scientific journal

  • Trastuzumab Capecitabine Cisplatin療法により治癒切除し得た胃癌腹膜転移の1例
    松田佑輔, Suzuki Satoshi, 前原律子, Matsuda Yoshiko, Kanaji Shingo, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, 角泰雄, Nakamura Tetsu, Kakeji Yoshihiro
    Apr. 2018, 癌と化学療法, 45(4号) (4号), 709 - 711, Japanese
    [Refereed]
    Scientific journal

  • The Depth from the Skin to the Celiac Artery Measured Using Computed Tomography is a Simple Predictive Index for Longer Operation Time During Laparoscopic Distal Gastrectomy
    Goto H, KANAJI SHINGO, Yasuda T, OSHIKIRI TARO, YAMAMOTO MASASHI, Matsuda T, NAKAMURA TETSU, Suzuki S, Fujino Y, Tominaga M, KAKEJI YOSHIHIRO
    Apr. 2018, World J Surg, 42(4) (4), 1065 - 1072, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer
    Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    Apr. 2018, Int J Colorectal Dis, 33(4) (4), 367 - 374, English
    [Refereed]
    Scientific journal

  • Curative Gastrectomy with Perioperative Chemotherapy Improves the Survival for Unresectable Gastric Cancer
    Otowa Y, Suzuki Satoshi, Kanaji Shingo, Harada H, Tanaka T, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    Apr. 2018, Anticancer Res, 38(4) (4), 2363 - 2368, English
    [Refereed]
    Scientific journal

  • Standardizing procedures improves and homogenizes short-term outcomes after minimally invasive esophagectomy
    Oshikiri Taro, Nakamura Tetsu, HasegawaH, YamamotoM, KanajiS, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, FujinoY, TominagaM, Suzuki Satoshi, Kakeji Yoshihiro
    Mar. 2018, Langenbecks Arch Surg, English
    [Refereed]
    Scientific journal

  • S-1/CDDP療法後に手術を施行し長期予後を得ている胃癌腹膜播種の1例
    Matsuda Yoshiko, Nakamura Tetsu, 植田康司, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    Mar. 2018, 癌と化学療法, 45(3) (3), 471 - 473, Japanese
    [Refereed]
    Scientific journal

  • Anatomical and embryological perspectives in laparoscopic complete mesocoloic excision of splenic flexure cancers
    Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    Mar. 2018, Surg Endosc, 32(3) (3), 1202 - 1208, English
    [Refereed]
    Scientific journal

  • The learning effect of using stereoscopic vision in the early phase of laparoscopic surgical training for novices
    Harada H, Kanaji S, Nishi M, Otake Y, Hasegawa H, Yamamoto M, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Sumi Y, Nakamura T, Suzuki S, Sato Y, Kakeji Y
    Feb. 2018, Surg Endosc, 32(2) (2), 582 - 588, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Makimura D, Ono R, Inoue J, Fukuta A, Kashiwa M, Miura Y, Oshikiri T, Nakamura T, Kakeji Y, Sakai Y
    BACKGROUND: Although sarcopenia increases postoperative complications following esophagectomy, its effects on prognosis remain unclear. This study was performed to identify the effect of sarcopenia on 90-day unplanned readmission and overall survival (OS) after esophagectomy. METHODS: Ninety-eight patients with esophageal cancer who underwent esophagectomy were enrolled in this study. Unplanned readmission was defined as any emergent hospitalization within 90 days after discharge. Sarcopenia, defined as low muscle mass plus low muscle strength and/or low physical performance according to the Asian consensus definition, was assessed prior to esophagectomy. Multivariate logistic regression analysis was performed to identify factors that contributed to 90-day unplanned readmission. OS was estimated using the Kaplan-Meier method, and a Cox proportional hazards model was used to assess the relationship between sarcopenia and OS. RESULTS: Thirty-one patients (31.6%) were diagnosed with sarcopenia. The 90-day unplanned readmission rate was significantly higher in patients with sarcopenia than those without (42.9% vs. 16.4%, respectively; p = 0.01). Multivariable logistic regression analysis showed that sarcopenia was an independent predictor of 90-day unplanned readmission [odds ratio 3.71, 95% confidence interval (CI) 1.29-11.05; p = 0.02], and the log-rank test showed that sarcopenia was associated with OS (p = 0.01). Moreover, sarcopenia was a significant predictor of OS after adjustment for age, sex, and pathological stage (hazard ratio 2.35, 95% CI 1.21-4.54; p = 0.01). CONCLUSIONS: Sarcopenia is a risk factor for 90-day unplanned readmission and OS following esophagectomy. Assessment of sarcopenia could help to identify patients at higher risk of a poor prognosis after esophagectomy.
    Feb. 2018, Annals of surgical oncology, 25(2) (2), 456 - 464, English, International magazine
    [Refereed]
    Scientific journal

  • Recent updates in the surgical treatment of colorectal cancer
    Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Oshikiri Taro, Hosono M, Higashino N, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Nakamura Tetsu, Suzuki Satoshi, Sumi Y, Kakeji Yoshihiro
    Feb. 2018, ANN GASTROENTEROL SURG, 2(2) (2), 129 - 136, English
    [Refereed]
    Link to Kobe Univ. Repository (Kernel)

  • Saeki H, Emi Y, Oki E, Tokunaga S, Kakeji Y, Akagi Y, Baba H, Baba E, Maehara Y, Kyushu Study, group of Clinical Cancer, KSC
    BACKGROUND: Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no Japanese clinical data on an oxaliplatin dose of 130 mg/m2. The current research involves a single-arm, prospective, phase II clinical trial to examine the efficacy and safety of oxaliplatin + S-1 with an oxaliplatin dose of 130 mg/m2 to treat HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy in Japan. METHODS/DESIGN: The primary endpoint of this trial will be the response rate, and the secondary endpoints will be the safety profile of oxaliplatin + S-1, progression-free survival, the response rate in subjects under the age of 75, overall survival, time to treatment failure, duration of treatment, time to failure of strategy, and dose intensity. The threshold response rate is 45% and the expected response rate is 60%. Assuming that a one-tailed score test will be performed with an α of 0.05, 68 patients are needed to ensure a statistical power of 80%. Planned enrollment is 70 subjects and the total duration of this trial is expected to be 3 years. DISCUSSION: Since replacing cisplatin with oxaliplatin should provide the same level of therapeutic efficacy while limiting adverse events and simplifying treatment, oxaliplatin + S-1 may be increasingly used to treat gastric cancer in Japan. Verifying the efficacy and safety of oxaliplatin + S-1 with an oxaliplatin dose of 130 mg is an important task that the current trial has set out to achieve. TRIAL REGISTRATION: The protocol was registered at the website of the University Hospital Medical Information Network (UMIN), Japan (protocol ID UMIN000017550) on May 29, 2015. The details are available at the following web address: http://www.umin.ac.jp/ctr/ .
    Jan. 2018, BMC cancer, 18(1) (1), 57 - 57, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Kakeji Y, Takahashi A, Udagawa H, Unno M, Endo I, Kunisaki C, Taketomi A, Tangoku A, Masaki T, Marubashi S, Yoshida K, Gotoh M, Konno H, Miyata H, Seto Y
    The National Clinical Database (NCD) of Japan started its registration in 2011 and over 9 000 000 cases from more than 5000 facilities were registered over a 6-year period. This is the report of NCD based upon gastrointestinal surgery information in excess of 3 200 000 cases from 2011 to 2016 adding data of complications. About 70% of all gastrointestinal surgeries were carried out at certified institutions, and the percentage of surgeries done at certified institutions was particularly high for the esophagus (92.4% in 2016), liver (88.4%), pancreas (89.8%), and spleen (86.8%). The percentage of anesthesiologist participation was more than 90% for almost all organs, except 85.7% for the rectum and anus. Approximately, more than two-thirds of the surgeries were carried out with the participation of a board-certified surgeon. Although patients have been getting older, mortalities have not been increasing. There were differences in the incidence of complications according to organ site and procedure. Remarkably, mortality rates of low anterior resection were very low, and those of hepatectomy and acute diffuse peritonitis surgery have been gradually decreasing. Although the complication rates were gradually increasing for esophagectomy or pancreaticoduodenectomy, the mortality rates for these procedures were decreasing. Nationwide, this database is expected to ensure the quality of the board-certification system and surgical outcomes in gastroenterological surgery.
    Jan. 2018, Annals of gastroenterological surgery, 2(1) (1), 37 - 54, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yoshida K, Honda M, Kumamaru H, Kodera Y, Kakeji Y, Hiki N, Etoh, Miyata H, Yamashita Y, Seto Y, Kitano S, Konno H
    To clarify the safety profile of laparoscopic distal gastrectomy (LDG) for gastric cancer patients, the short-term outcome of LDG was compared to that of open distal gastrectomy (ODG) by propensity score matching using data from the Japanese National Clinical Database (NCD). We conducted a retrospective cohort study of patients undergoing distal gastrectomy between January 2012 and December 2013. Using the data for 70 346 patients registered in the NCD, incidences of mortality and morbidities were compared between LDG patients and ODG patients in the propensity score matched stage I patients (ODG: n = 14 386, LDG: n = 14 386) and stage II-IV patients (ODG: n = 3738, LDG: n = 3738), respectively. There was no significant difference in mortality rates between LDG and ODG at all stages. Operating time was significantly longer in LDG compared to ODG, whereas blood loss and incidences of superficial surgical site infection (SSI), deep SSI, and wound dehiscence were significantly higher in ODG at all stages. Interestingly, pancreatic fistula was found significantly more often in LDG (1%) compared to ODG (0.8%) (P = .01) in stage I patients; however, it was not different in stage II-IV patients. The length of postoperative stay was significantly longer in patients undergoing ODG compared to LDG at all stages. LDG in general practice might be a feasible therapeutic option in patients with both advanced gastric cancer and those with early gastric cancer in Japan.
    Jan. 2018, Annals of gastroenterological surgery, 2(1) (1), 55 - 64, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Mukohyama J, Sumi Y, Kanemitsu K, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    INTRODUCTION: Primary appendiceal cancer with fistula formation is extremely rare. We report a case of a patient with appendiceal cancer invading the ileum who underwent successful laparoscopic ileocecal resection. PRESENTATION OF CASE: A 76-year-old man who presented with fever and abdominal pain was diagnosed with acute appendicitis and received antibiotics at a local hospital. After a few days, he was referred to our hospital because of an abnormality found in the colonoscopy, which was an oozing ulcer in the terminal ileum. Laparoscopic ileocecal resection was performed with a preoperative diagnosis of ileal cancer. The tumor adhered to the right internal inguinal ring. We dissected the right spermatic cord involved in the tumor. The resected specimen revealed a fistula between the appendiceal orifice and ileac ulcer. Histopathological examination revealed a well differentiated tubular adenocarcinoma. We made the diagnosis of appendiceal cancer with an ileal fistula because the ileal ulcer was derived from the appendiceal site. DISCUSSION: Most cases of appendiceal cancer with a fistula undergo laparotomy, but in selected cases, laparoscopic resection should be considered a feasible, safe, and curative procedure. Our patient underwent laparoscopic ileocecal resection, whereby the tumor and other organs with invasion were resected successfully with a negative surgical margin. CONCLUSION: This is the first case report of appendiceal cancer with an ileal fistula successfully treated with laparoscopic resection. Laparoscopic ileocecal resection can be applied for appendiceal cancers with a fistula by experienced surgeons with careful consideration.
    2018, International journal of surgery case reports, 52, 120 - 124, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Yamazato T, Nakamura T, Abe N, Yokawa K, Ikeno Y, Koda Y, Henmi S, Nakai H, Gotake Y, Matsueda T, Inoue T, Tanaka H, Kakeji Y, Okita Y
    Jan. 2018, J Thorac Cardiovasc Surg, 155(1) (1), 32 - 40, English
    [Refereed]
    Scientific journal

  • SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation
    Maehara R, Fujikura K, Takeuchi K, Akita M, Abe-Suzuki S, Karbanova J, Corbeil D, Itoh T, Kakeji Y, Zen Y
    Jan. 2018, Mod Pathol, 31(1) (1), 83 - 92, English
    [Refereed]
    Scientific journal

  • Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study
    Hiki N, Honda M, Etoh T, Yoshida K, Kodera Y, Kakeji Y, Kumamaru H, Miyata H, Yamashita Y, Inomata M, Konno H, Seto Y, Kitano S
    Jan. 2018, Gastric Cancer, 21(1) (1), 162 - 170, English
    [Refereed]
    Scientific journal

  • Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007)
    Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Nunobe S, Kakeji Y, Nashimoto A, Registration Committee of the Japanese Gastric Cancer Association.
    Jan. 2018, Gastric Cancer, 21(1) (1), 144 - 154, English
    [Refereed]
    Scientific journal

  • Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M
    Dec. 2017, SURGERY TODAY, 47(12) (12), 1539 - 1540, English
    [Refereed]

  • Nakagawa A, Nakamura T, Oshikiri T, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Sumi Y, Suzuki S, Kakeji Y
    Dec. 2017, ANNALS OF SURGICAL ONCOLOGY, 24(13) (13), 3934 - 3946, English
    [Refereed]
    Scientific journal

  • Morbidity and mortality from a propensity score-matched, prospective cohort study of laparoscopic versus open total gastrectomy for gastric cancer: data from a nationwide web-based database
    Etoh T, Honda M, Kumamaru H, Miyata H, Yoshida K, Kodera Y, Kakeji Y, Inomata M, Konno H, Seto Y, Kitano S, Hiki N
    Dec. 2017, Surg Endosc, English
    [Refereed]
    Scientific journal

  • C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer
    Otowa Y, Nakamura T, Yamamoto M, Kanaji S, Matsuda Y, Matsuda T, Oshikiri T, Sumi Y, Suzuki S, Kakeji Y
    Dec. 2017, Dis Esophagus, 30(12) (12), 1 - 5, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Otowa Y, Kanaji S, Morita Y, Suzuki S, Yamamoto M, Matsuda Y, Matsuda T, Oshikiri T, Nakamura T, Kawara F, Tanaka S, Ishida T, Toyonaga T, Azuma T, Kakeji Y
    Background and study aims  Endoscopic submucosal dissection (ESD) for duodenal tumors results in a high delayed perforation rate due to the thinness of the duodenal wall. In most cases with perforation after duodenal ESD, additional surgery is needed due to severe peritonitis. A newly developed procedure, laparoscopic endoscopic cooperative surgery for duodenal tumors (D-LECS), may help to avoid perforation after ESD. In our institution, patients with superficial non-ampullary duodenal epithelial tumors (SNADET) smaller than 50 mm which could not have en-bloc resection by endoscopic mucosal resection were treated with D-LECS. After a laparoscopic exposure of anterior duodenal wall of second portion, ESD was performed. Laparoscopic suturing from the serosal side of ESD site was performed for reinforcement. There were neither postoperative leakage nor other complications. Therefore, D-LECS can be performed safely and prevent perforation after ESD for SNADET. D-LECS could be selected as a treatment for SNADET which can be cured by ESD.
    Nov. 2017, Endoscopy international open, 5(11) (11), E1153-E1158 - E1158, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells
    Hosono M, Koma Yuichiro, Takase N, Urakawa N, Higashino N, Suemune K, Kodaira H, Nishio Mari, Shigeoka Manabu, Kakeji Yoshihiro, Yokozaki Hiroshi
    Nov. 2017, Oncotarget, 8(62) (62), 106071 - 106088, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    Nov. 2017, ANNALS OF SURGICAL ONCOLOGY, 24(12) (12), 3673 - 3673, English
    [Refereed]
    Scientific journal

  • 裏川直樹, Kanaji Shingo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    Nov. 2017, 手術, 71(12) (12), 1645 - 1649, Japanese

  • 癌免疫カンファレンスルーム(第3回) 免疫抑制のメカニズム
    Yamashita Kimihiro, 田中智子, 有本聡, Kakeji Yoshihiro
    Nov. 2017, 消化器外科, 40(12) (12), 1681 - 1668, Japanese
    [Refereed]

  • 【分子標的療法は外科治療をどう変えるか】 大腸癌
    Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Kakeji Yoshihiro
    Nov. 2017, 日本外科学会雑誌, 118(6) (6), 639 - 645, Japanese
    [Refereed][Invited]

  • Ishida R, Koyanagi-Aoi M, Oshima N, Kakeji Y, Aoi T
    Oct. 2017, MOLECULAR CANCER RESEARCH, 15(10) (10), 1455 - 1466, English
    [Refereed]
    Scientific journal

  • Is Laparoscopic Distal Gastrectomy a Feasible Procedure for Elderly Patients With Gastric Cancer
    Kanaji S, Kakeji Y
    Oct. 2017, J Invest Surg, English
    [Refereed]
    Scientific journal

  • Mukohyama J, Shimono Y, Minami H, Kakeji Y, Suzuki A
    Oct. 2017, CANCERS, 9(10) (10), English
    [Refereed]
    Link to Kobe Univ. Repository (Kernel)

  • Kakeji Yoshihiro, 瀬戸泰之
    Oct. 2017, 臨床外科, 72(10) (10), 1248 - 1253, Japanese

  • Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M
    Sep. 2017, SURGERY TODAY, 47(9) (9), 1060 - 1071, English
    [Refereed]
    Scientific journal

  • Nakamura T, Yamamoto M, Yamazato T, Kanaji S, Takahashi H, Inoue T, Oshikiri T, Tanaka H, Suzuki S, Okita Y, Kakeji Y
    Sep. 2017, DISEASES OF THE ESOPHAGUS, 30(9) (9), 1 - 7, English
    [Refereed]
    Scientific journal

  • Kanaji S, Suzuki S, Yamamoto M, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Sumi Y, Kakeji Y
    Sep. 2017, ANNALS OF SURGICAL ONCOLOGY, 24(9) (9), 2727 - 2727, English
    [Refereed]
    Scientific journal

  • Long-term impact of postoperative pneumonia after curative gastrectomy for elderly gastric cancer patients
    Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Y, Nakamura Tetsu, Kakeji Yoshihiro
    Sep. 2017, ANN GASTROENTEROL SURG, 2(1) (1), 72 - 78, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Arimoto A, Hasegawa H, Sugiyama H, Yamashita K, Matsuda T, Tominaga M, Sumi Y, Suzuki S, Kakeji Y
    Aug. 2017, ANTICANCER RESEARCH, 37(8) (8), 4195 - 4198, English
    [Refereed]
    Scientific journal

  • Oshikiri T, Nakamura T, Miura Y, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda Y, Matsuda T, Sumi Y, Suzuki S, Kakeji Y
    Aug. 2017, ANNALS OF SURGICAL ONCOLOGY, 24(8) (8), 2302 - 2302, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 青木丈明, Matsuda Takeru, Hasegawa Hiroshi, Yamashita Kimihiro, Kakeji Yoshihiro
    Aug. 2017, 手術, 71(9) (9), 1335 - 1340, Japanese
    [Refereed]

  • Tanaka T, Fujita M, Hasegawa H, Arimoto A, Nishi M, Fukuoka E, Sugita Y, Matsuda T, Sumi Y, Suzuki S, Kakeji Y, Yamashita K
    Jul. 2017, ANTICANCER RESEARCH, 37(7) (7), 3863 - 3869, English
    [Refereed]
    Scientific journal

  • Kondo H, Shimono Y, Mukohyama J, Tanaka Y, Shibuya N, Minami H, Kakeji Y, Suzuki A
    Jul. 2017, ANTICANCER RESEARCH, 37(7) (7), 3885 - 3890, English
    [Refereed]
    Scientific journal

  • Minami K, Morita M, Emi Y, Okamoto M, Tanaka E, Nagata S, Touyama T, Ohgaki K, Tanaka T, Okumura H, Suenaga T, Tokunaga S, Oki E, Kakeji Y, Akagi Y, Baba H, Natsugoe S, Maehara Y, Kyushu Study, Group of Clinical Cancer, KSC
    Jun. 2017, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22(3) (3), 505 - 510, English
    [Refereed]
    Scientific journal

  • iPS細胞を巡る最新の動向と今後の研究展開 人工癌幹細胞と癌オルガノイドを用いた癌幹細胞研究
    AOI TAKASHI, 石田 諒, OGAWA HIROYUKI, AOI MICHIYO, KAKEJI YOSHIHIRO, MANIWA YOSHIMASA
    Jun. 2017, Cytometry Research, 27(Suppl) (Suppl), 36, Japanese
    Research society

  • α-galactosylceramide付加細胞投与によるNKT細胞活性化を介した抗腫瘍免疫療法
    西将康, Yamashita Kimihiro, Hasegawa Hiroshi, 田中智子, 有本聡, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 掛地吉弘
    May 2017, Cytometry research, 27(1) (1), 7 - 12, Japanese
    [Refereed]
    Scientific journal

  • Matsuda T, Iwasaki T, Hirata K, Tsugawa D, Sugita Y, Ishida S, Kanaji S, Kakeji Y
    May 2017, GASTRIC CANCER, 20(3) (3), 548 - 552, English
    [Refereed]
    Scientific journal

  • Nishi M, Kanaji S, Otake Y, Harada H, Yamamoto M, Oshikiri T, Nakamura T, Suzuki S, Suzuki Y, Hiasa Y, Sato Y, Kakeji Y
    May 2017, SURGERY, 161(5) (5), 1334 - 1340, English
    [Refereed]
    Scientific journal

  • Aoki S, Miyata H, Gotoh M, Motoi F, Kumamaru H, Konno H, Wakabayashi G, Kakeji Y, Mori M, Seto Y, Unno M
    May 2017, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(5) (5), 243 - 251, English
    [Refereed]
    Scientific journal

  • Shimono Yohei, 渋谷尚樹, 向山順子, 西村建徳, 後藤典子, Minami Hironobu, Kakeji Yoshihiro, 鈴木聡
    May 2017, Cytometry Research, 27(1号) (1号), 33 - 39, Japanese
    [Refereed]

  • 消化器外科医からみた大動脈食道瘻の治療戦略－その食道切除術と再建術
    Nakamura Tetsu, 押切太郎, Kakeji Yoshihiro
    Apr. 2017, 手術, 71(5) (5), 773 - 780, Japanese
    [Refereed]
    Scientific journal

  • Oshikiri T, Nakamura T, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Suzuki S, Kakeji Y
    Apr. 2017, ANNALS OF SURGICAL ONCOLOGY, 24(4) (4), 1018 - 1018, English
    [Refereed]
    Scientific journal

  • Oshikiri T, Yasuda T, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y
    Mar. 2017, SURGERY TODAY, 47(3) (3), 313 - 319, English
    [Refereed]
    Scientific journal

  • Otsubo D, Nakamura T, Yamamoto M, Kanaji S, Kanemitsu K, Yamashita K, Imanishi T, Oshikiri T, Sumi Y, Suzuki S, Kuroda D, Kakeji Y
    Mar. 2017, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 31(3) (3), 1136 - 1141, English
    [Refereed]
    Scientific journal

  • Oshikiri T, Nakamura T, Miura Y, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Suzuki S, Kakeji Y
    Mar. 2017, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 31(3) (3), 1496 - 1504, English
    [Refereed]
    Scientific journal

  • 掛地吉弘, 宇田川晴司, 海野倫明, 遠藤格, 國崎主税, 武冨紹信, 丹黒章, 正木忠彦, 丸橋繁, 吉田和弘, 渡邉聡明, 後藤満一, 今野弘之, 高橋新, 宮田裕章, 宮田裕章, 瀬戸泰之
    2017, 日本消化器外科学会雑誌(Web), 50(2) (2), 166‐176(J‐STAGE), Japanese

  • スーパーピクセルと畳み込みニューラルネットワークを用いた腹腔鏡下手術における術具領域セグメンテーション(原著論文)
    日朝祐太, 中谷聡志, 大竹義人, 原田仁, Kanaji Shingo, Kakeji Yoshihiro, 佐藤嘉伸
    2017, 日本医用画像工学会大会予稿集, 36, 133 - 137, Japanese
    [Refereed]
    Scientific journal

  • 川崎健太郎, 安積靖友, 藤原英利, 廣吉基己, 石井正之, 野田雅史, Kakeji Yoshihiro, 冨田尚裕
    Jan. 2017, 日本内視鏡外科学会雑誌, 22(1) (1), 34, Japanese
    [Refereed]
    Scientific journal

  • Akiyama S, Saeki H, Nakashima Y, Iimori M, Kitao H, Oki E, Oda Y, Nakabeppu Y, Kakeji Y, Maehara Y
    Jan. 2017, CANCER MEDICINE, 6(1) (1), 258 - 266, English
    [Refereed]
    Scientific journal

  • Satake H, Iwatsuki M, Uenosono Y, Shiraishi T, Tanioka H, Saeki H, Sugimachi K, Kitagawa D, Shimokawa M, Oki E, Emi Y, Kakeji Y, Tsuji A, Akagi Y, Natsugoe S, Baba H, Maehara Y, Kyushu Study, Group of Clinical Cancer
    Jan. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79(1) (1), 147 - 153, English
    [Refereed]
    Scientific journal

  • Takase N, Yamashita K, Sumi Y, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Koma Y, Komatsu M, Sasaki R, Kakeji Y
    Jan. 2017, WORLD JOURNAL OF CLINICAL CASES, 5(1) (1), 18 - 23, English
    [Refereed]
    Scientific journal

  • Matsuda T, Iwasaki T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    Jan. 2017, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 32(1) (1), 139 - 141, English
    [Refereed]
    Scientific journal

  • Tsuji Y, Baba H, Takeda K, Kobayashi M, Oki E, Gotoh M, Yoshida K, Shimokawa M, Kakeji Y, Aiba K.
    2017, EXPERT OPINION ON PHARMACOTHERAPY, 18(8) (8), 753 - 758, English
    [Refereed]
    Scientific journal

  • 胃癌 1.病因論
    Kakeji Yoshihiro
    2017, 日本外科学会雑誌, 118(2) (2), 207 - 209, Japanese

  • Successful resection of giant esophageal liposarcoma by endoscopic submucosal dissection combined with surgical retrieval: a case report and literature review
    TakiguchiG, Nakamura Tetsu, OtowaY, TomonoA, Kanaji Shingo, Oshikiri Taro, Suzuki Satoshi, IshidaT, Kakeji Yoshihiro
    Dec. 2016, Surg Case Rep, 2(1) (1), 90, English
    [Refereed]
    Scientific journal

  • Successful laparoscopic distal gastrectomy with D2 lymph node dissection preserving the common hepatic artery branched from the left gastric artery for advanced gastric cancer with an Adachi type VI (group 26) vascular anomaly
    GotoH, YasudaT, Oshikiri Taro, ImanishiT, YamashitaH, OyamaM, KakinokiK, OharaT, SendoH, FujinoY, TominagaM, Kakeji Yoshihiro
    Dec. 2016, Surg Case Rep, 2(1) (1), 55, English
    [Refereed]
    Scientific journal

  • 鼠径リンパ節転移を伴う進行直腸癌に対する術前化学放射線療法 手術による局所制御効果
    植田康司, Yamashita Kimihiro, 角泰雄, 金光聖哲, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    Nov. 2016, 癌と化学療法, 43(12号) (12号), 1443 - 1445, Japanese
    [Refereed]
    Scientific journal

  • 亜全胃温存膵頭十二指腸切除により切除し得た卵巣原発線維肉腫再発の1例
    水本拓也, 外山博近, 浅利貞毅, 後藤直大, 寺井祥雄, 白川幸代, 南野佳英, Ajiki Tetsuo, 木戸正浩, 松本拓, 田中基文, Nakamura Tetsu, 福本巧, Kakeji Yoshihiro, Ku Yonson
    Nov. 2016, 癌と化学療法, 43(12号) (12号), 2193 - 2195, Japanese
    [Refereed]
    Scientific journal

  • MakiuraD, OnoR, InoueJ, KashiwaM, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro, Sakai Yoshitada, MiuraY
    Nov. 2016, J Geriatr Oncol, English
    [Refereed]
    Scientific journal

  • Pathological Complete Response after Preoperative Chemotherapy with a Regimen Containing Trastuzumab in Esophagogastric Junction Adenocarcinoma: A Case Report
    AraiK, Kanaji Shingo, OkamotoD, MaeharaR, Yamamoto Masashi, Nakamura Tetsu, Suzuki Satoshi, JimboN, MorinagaY, ItohT, Kakeji Yoshihiro
    Nov. 2016, Int Surg, English
    [Refereed]
    Scientific journal

  • 【周囲神経・血管・リンパ節までまるわかり!外科ナース・研修医のための消化器の手術&臓器のはたらき】 (3章)胃 胃の働きと解剖
    田中智子, Kanaji Shingo, Yamamoto Masashi, Suzuki Satoshi, Kakeji Yoshihiro
    Oct. 2016, 消化器外科Nursing, (2016秋季増刊) (2016秋季増刊), 60 - 70, Japanese

  • 【周囲神経・血管・リンパ節までまるわかり!外科ナース・研修医のための消化器の手術&臓器のはたらき】 (3章)胃 だから胃手術後はどう注意する?
    田中智子, Kanaji Shingo, Yamamoto Masashi, Suzuki Satoshi, Kakeji Yoshihiro
    Oct. 2016, 消化器外科Nursing, (2016秋季増刊) (2016秋季増刊), 71 - 74, Japanese

  • Oshikiri Taro, YasudaT, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, SumiY, Nakamura Tetsu, FujinoY, TominagaM, Suzuki Satoshi, Kakeji Yoshihiro
    Sep. 2016, Langenbecks Arch Surg, 401(6) (6), 797 - 804, English
    [Refereed]
    Scientific journal

  • NCDの活用 デバイスラグ解消に向けて NCDを基盤とした消化器外科領域の前向き研究への課題
    後藤満一, Kakeji Yoshihiro, 宮田裕章, 瀬戸泰之, 日本消化器外科学会データベース委員会
    Sep. 2016, 日本外科学会雑誌, 117(5号) (5号), 465 - 467, Japanese
    [Refereed]
    Scientific journal

  • TakaseN, Koma Yuichiro, UrakawaN, Nishio Mari, AraiN, AkiyamaH, ShigeokaM, Kakeji Yoshihiro, Yokozaki Hiroshi
    Sep. 2016, Cancer Lett, 380(1) (1), 47 - 58, English
    [Refereed]
    Scientific journal

  • Totally laparoscopic total gastrectomy in a patient with situs inversus totalis
    HaradaH, Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Yamashita Kimihiro, ImanishiT, SUMI YASUO, Nakamura Tetsu, TanakaK, Kakeji Yoshihiro
    Aug. 2016, Int Surg, English
    [Refereed]
    Scientific journal

  • Junko Mukohyama, Dai Iwakiri, Yoh Zen, Toru Mukohara, Hironobu Minami, Yoshihiro Kakeji, Yohei Shimono
    Aug. 2016, ONCOTARGET, 7(31) (31), 50150 - 50160, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • KanemitsuK, SumiY, Yamashita Kimihiro, YmamotoM, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, ToyokawaA, Kakeji Yoshihiro
    Aug. 2016, Surg Laparosc Endosc Percutan Tech, 26(4) (4), 343 - 346, English
    [Refereed]
    Scientific journal

  • OkiE, TokunagaS, EmiY, KusumotoT, YamamotoM, FukuzawaK, TakahashiI, IshigamiS, TsujiA, HigashiH, NakamuraT, SaekiH, ShirabeK, Kakeji Yoshihiro, SakaiK, BabaH, NishimakiT, NatsugoeS, MaeharaY
    Jul. 2016, Gastric Cancer, 19(3) (3), 976, English
    [Refereed]
    Scientific journal

  • Liver Injury After Invariant NKT Cell Activation by Free Alpha-galactosylceramide and Alpha-galactosylceramide-loaded Dendritic Cells
    Hasegawa Hiroshi, Yamashita Kimihiro, OtsuboD, Kakeji Yoshihiro
    Jul. 2016, Anticancer Res, 36(7) (7), 3667 - 72, English
    [Refereed]
    Scientific journal

  • Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer
    Yamashita Kimihiro, Hasegawa Hiroshi, FujitaM, NishiM, TanakaT, ArimotoA, Suzuki Satoshi, KamigakiT, Kakeji Yoshihiro
    Jul. 2016, Anticancer Res, 36(7) (7), 3659 - 65, English
    [Refereed]
    Scientific journal

  • Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells
    MukohyamaJ, Shimono Yohei, Yamashita Kimihiro, SumiY, MukoharaT, MinamiH, Kakeji Yoshihiro
    Jul. 2016, Anticancer Res, 36(7) (7), 3679 - 86, English
    [Refereed]
    Scientific journal

  • OkiE, MurataA, YoshidaK, MaedaK, IkejiriK, MunemotoY, SasakiK, MatsudaC, KotakeM, SuenagaT, MatsudaH, EmiY, Kakeji Yoshihiro, BabaH, HamadaC, SajiS, MaeharaY
    Jul. 2016, Ann Oncol, 27(7) (7), 1266 - 1272, English
    [Refereed]
    Scientific journal

  • 5-Fluorouracil(5-FU)の効果増強を目指した創薬の歴史と取り組み
    前原喜彦, 沖英次, 佐伯浩司, 徳永えり子, 北尾洋之, 飯森真人, 新美晋一郎, 片岡裕貴, 江見泰徳, Kakeji Yoshihiro, 馬場秀夫, 白坂哲彦
    Jul. 2016, 癌と化学療法, 43(7号) (7号), 845 - 854, Japanese
    [Refereed]
    Scientific journal

  • OtowaY, MoriwakiK, SanoK, ShirakabeM, YonemuraS, ShibuyaM, RossantJ, SudaT, Kakeji Yoshihiro, Hirashima Masanori
    Jun. 2016, Sci Rep, 6, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • オキサリプラチンの10年間の軌跡
    Kanaji Shingo, 沖英次, 佐伯浩司, 北尾洋之, 前原喜彦, Kakeji Yoshihiro
    Jun. 2016, 癌と化学療法, 43(6号) (6号), 715 - 722, Japanese
    [Refereed]

  • オキサリプラチンと5-FU併用による抗腫瘍効果の分子機序
    北尾洋之, 清成信一, 飯森真人, 新美晋一郎, 片岡裕貴, 秋山真吾, 枝廣圭太郎, 中西良太, 徳永えり子, 佐伯浩司, 沖英次, Kanaji Shingo, Kakeji Yoshihiro, 前原喜彦
    Jun. 2016, 癌と化学療法, 43(6号) (6号), 707 - 714, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 大腸のしくみとはたらき 腸閉塞(イレウス)とはどのような症状?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 30 - 31, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 大腸のしくみとはたらき 大腸を切除したら体はどうなるの?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 28 - 29, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 大腸のしくみとはたらき 大腸は体のどこにある? どんな構造をしているの?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 24 - 25, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 大腸のしくみとはたらき 大腸のはたらきは?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 26 - 27, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 食道のしくみとはたらき 食道を切除したら体はどうなるの?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 12 - 13, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 食道のしくみとはたらき 食道は体のどこにある? どんな構造をしているの?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 8 - 9, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 食道のしくみとはたらき 食道のはたらきは?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 10 - 11, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 食道のしくみとはたらき 術後逆流性食道炎とはどのような症状?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 14 - 15, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 胃のしくみとはたらき 十二指腸の構造とはたらきは?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 22 - 23, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 胃のしくみとはたらき 胃を切除したら体はどうなるの?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 20 - 21, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 胃のしくみとはたらき 胃は体のどこにある? どんな構造をしているの?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 16 - 17, Japanese

  • 【でっかくド～ン!オールカラー図解でみるみるわかる 新人ナースのための消化器外科 術前術後ケアQ&A102】 (1章)消化器臓器のしくみとはたらきQ&A 胃のしくみとはたらき 胃のはたらきは?
    前原律子, Nakamura Tetsu, Kanaji Shingo, 金光聖哲, 角泰雄, Kakeji Yoshihiro
    Apr. 2016, 消化器外科Nursing, (2016春季増刊) (2016春季増刊), 18 - 19, Japanese

  • 松岡正造, 牧原夏子, 生橋義之, 蛯名康彦, 白川得朗, 山崎友維, Suzuki Satoshi, 角泰雄, Kakeji Yoshihiro, 山田秀人
    Mar. 2016, 日本産科婦人科内視鏡学会雑誌, 31(2) (2), 469, Japanese
    [Refereed]
    Scientific journal

  • OtowaY, Nakamura Tetsu, TakiguchiG, YamamotoM, Kanaji Shingo, ImanishiT, Oshikiri Taro, Suzuki Satoshi, TanakaK, Kakeji Yoshihiro
    Mar. 2016, Eur J Surg Oncol, 42(3) (3), 407 - 411, English
    [Refereed]
    Scientific journal

  • Nobutomo Miyanari, Yasunori Emi, Akihito Tsuji, Kenji Sakai, Hideaki Anai, Hiroaki Takeshita, Hiroshi Imamura, Shinichiro Mori, Takayuki Shimose, Eiji Oki, Hiroshi Saeki, Yoshihiro Kakeji, Yoshito Akagi, Hideo Baba, Yoshihiko Maehara
    Feb. 2016, JOURNAL OF CLINICAL ONCOLOGY, 34(4) (4), English
    [Refereed]

  • Taro Oshikiri, Takashi Yasuda, Kentaro Kawasaki, Hitoshi Harada, Masato Oyama, Hiroshi Hasegawa, Tadayuki Ohara, Hiroyoshi Sendo, Tetsu Nakamura, Yasuhiro Fujino, Masahiro Tominaga, Yoshihiro Kakeji
    Feb. 2016, SURGERY, 159(2) (2), 459 - 466, English
    [Refereed]
    Scientific journal

  • Takiguchi G, Nishita M, Kurita K, Kakeji Y, Minami Y
    2016, Cancer Sci., 107(3) (3), 290, English
    [Refereed]
    Doctoral thesis

  • Otowa Y, Nakamura T, Takiguchi G, Tomono A, Yamamoto M, Kanaji S, Imanishi T, Suzuki S, Tanaka K, Itoh T, Kakeji Y
    2016, Dis Esophagus., 29(2) (2), 146, English
    [Refereed]
    Scientific journal

  • GotoH, YasudaT, Oshikiri Taro, Kanaji Shingo, KawasakiK, ImanishiT, OyamaM, KakinokiK, OharaT, SendoH, FujinoY, TominagaM, Kakeji Yoshihiro
    Jan. 2016, Asian J Endosc Surg, 9(2) (2), 121, English
    [Refereed]
    Scientific journal

  • 田中智子, Yamashita Kimihiro, 大坪大, 有本聡, 西将康, Hasegawa Hiroshi, 山本将士, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, 角泰雄, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    2016, Cytometry research, 26(2) (2), 27 - 31, Japanese
    [Refereed]

  • 石田諒, Kakeji Yoshihiro, 青井貴之
    2016, Cytometry research, 26(2) (2), 7 - 13, Japanese
    [Refereed]

  • Hasegawa Hiroshi, Yamashita Kimihiro, 西将康, 田中智子, 有本聡, Matsuda Takeru, 角泰雄, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    2016, Cytometry research, 26(2) (2), 21 - 25, Japanese
    [Refereed]

  • TakiguchiG, Nishita Michiru, KuritaK, Kakeji Yoshihiro, Minami Yasuhiro
    Dec. 2015, Cancer Sci, 107(3) (3), 297, English
    [Refereed]
    Scientific journal

  • OkiE, EmiY, MiyamotoY, KabashimaA, HigashiH, OgataY, IkebeM, SaekiH, TokunagaS, ShirabeK, BeppuT, UchidaS, TakatsukiM, SakodaM, EguchiS, AkagiY, Kakeji Yoshihiro, BabaH, NatsugoeS, MaeharaY, KyushuStudyGroupofClinicalCancer(KSCC
    Dec. 2015, Ann Surg Oncol, 22, 1067 - 1074, English
    [Refereed]
    Scientific journal

  • OkiE, EmiY, MiyamotoY, KabashimaA, HigashiH, OgataY, IkebeM, SaekiH, TokunagaS, ShirabeK, BeppuT, UchidaS, TakatsukiM, SakodaM, EguchiS, AkagiY, Kakeji Yoshihiro, BabaH, NatsugoeS, MaeharaY, KyushuStudyGroupofClinicalCancer(KSCC
    Dec. 2015, Ann Surg Oncol, 22, 1067 - 1074, English
    [Refereed]
    Scientific journal

  • MatsudaT, IwasakiT, HirataK, TsugawaD, SugitaY, SumiY, Kakeji Yoshihiro
    Dec. 2015, Ann Surg Oncol, 22, 335, English
    [Refereed]
    Scientific journal

  • MatsudaT, IwasakiT, MitsutsujiM, HirataK, TsugawaD, SugitaY, ShimadaE, Kakeji Yoshihiro
    Dec. 2015, Ann Surg Oncol, 22, 355, English
    [Refereed]
    Scientific journal

  • 食道癌根治切除後再発に対してSalvage Chemoradiotherapy(CRT)により長期生存が得られた1例
    Yamamoto Masashi, 奥野達哉, 今西達也, Kanaji Shingo, Yamashita Kimihiro, Kim Kiyonori, 角泰雄, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    Nov. 2015, 癌と化学療法, 42(12号) (12号), 1457 - 1459, Japanese
    [Refereed]
    Scientific journal

  • クローン病長期寛解後に同時性多発大腸癌を発症した1例
    裏川直樹, 山下公大, Kim Kiyonori, 角泰雄, Suzuki Satoshi, Kakeji Yoshihiro
    Nov. 2015, 癌と化学療法, 42(12号) (12号), 2202 - 2204, Japanese
    [Refereed]
    Scientific journal

  • SadahiroS, TsuchiyaT, SasakiK, KondoK, KatsumataK, NishimuraG, Kakeji Yoshihiro, BabaH, SatoS, KodaK, YamaguchiY, MoritaT, MatsuokaJ, UsukiH, HamadaC, KodairaS
    Nov. 2015, Ann Oncol, 26(11) (11), 2274 - 2280, English
    [Refereed]
    Scientific journal

  • MatsusakaS, NashimotoA, NishikawaK, MikiA, MiwaH, YamaguchiK, YoshikawaT, OchiaiA, MoritaS, SanoT, KoderaY, Kakeji Yoshihiro, SakamotoJ, SajiS, YoshidaK
    Nov. 2015, Gastric Cancer, 19(3) (3), 851, English
    [Refereed]
    Scientific journal

  • 【外科修練医必修 新外科専門医到達のための特別講義】 麻酔科学 硬膜外麻酔の原理
    向山順子, Obata Norihiko, 溝渕知司, Kakeji Yoshihiro
    Nov. 2015, 外科, 77(12号) (12号), 1452 - 1455, Japanese

  • OtowaY, Yamashita Kimihiro, Kim Kiyonori, SumiY, YamamotoM, Kanaji Shingo, ImanishiT, Nakamura Tetsu, Suzuki Satoshi, TanakaK, Kakeji Yoshihiro
    Oct. 2015, Onco Targets Ther, 8, 3169 - 3173, English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • NK細胞浸潤がヒト乳がん異種移植マウスの腫瘍増殖に与える影響
    向山順子, Shimono Yohei, 船越洋平, Kono Seishi, Yamashita Kimihiro, 向原徹, 高尾信太郎, 南博信, Kakeji Yoshihiro
    Oct. 2015, 癌と化学療法, 42(10号) (10号), 1252 - 1255, Japanese
    [Refereed]
    Scientific journal

  • 【化学放射線療法の現況と展望】 食道癌に対する化学放射線療法の現況と展望
    青木丈明, Nakamura Tetsu, Kakeji Yoshihiro
    Oct. 2015, 癌と化学療法, 42(10号) (10号), 1148 - 1151, Japanese

  • Kakeji Yoshihiro, KurodaD, Nakamura Tetsu, Suzuki Satoshi, YamamotoM, Kanaji Shingo, ImanishiT, TanakaK
    Sep. 2015, BMC Res Notes, 8(1) (1), English
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Kanaji Shingo, Suzuki Satoshi, Nakamura Tetsu, TomonoA, UrakawaN, Kakeji Yoshihiro
    Sep. 2015, Int Surg, 100(9-10) (9-10), 1326 - 1331, English
    [Refereed]
    Scientific journal

  • TomonoA, Yamashita Kimihiro, Kim Kiyonori, SumiY, YamamotoM, Kanaji Shingo, ImanishiT, Nakamura Tetsu, Suzuki Satoshi, TanakaK, Kakeji Yoshihiro
    Sep. 2015, Int J Clin Oncol, 21(2) (2), 349, English
    [Refereed]
    Scientific journal

  • TanabeK, FujiiM, NishikawaK, KunisakiC, TsujiA, MatsuhashiN, TakaganeA, OhnoT, KawaseT, KochiM, YoshidaK, Kakeji Yoshihiro, IchikawaW, ChinK, TerashimaM, TakeuchiM, NakajimaT, JACCROGC, tudygroup
    Sep. 2015, Ann Oncol, 26(9) (9), 1916 - 1922, English
    [Refereed]
    Scientific journal

  • Kanaji Shingo, OhyamaM, YasudaT, SendoH, Suzuki Satoshi, KawasakiK, TanakaK, FujinoY, TominagaM, Kakeji Yoshihiro
    Sep. 2015, Surg Today, 46(7) (7), 820, English
    [Refereed]
    Scientific journal

  • 【胃がん治療戦略のUp to Date】 胃癌における機能温存手術
    Suzuki Satoshi, Kanaji Shingo, 山本将士, 裏川直樹, 友野絢子, Nakamura Tetsu, 田中賢一, Kakeji Yoshihiro
    Sep. 2015, 癌の臨床, 61(4号) (4号), 283 - 287, Japanese

  • Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation
    OtsuboD, Yamashita Kimihiro, FujitaM, NishiM, KimuraY, HasegawaH, Suzuki Satoshi, Kakeji Yoshihiro
    Aug. 2015, Anticancer Res, 35(8) (8), 4425 - 31, English
    [Refereed]
    Scientific journal

  • MatsusakaS, NashimotoA, NishikawaK, MikiA, MiwaH, YamaguchiK, YoshikawaT, OchiaiA, MoritaS, SanoT, KoderaY, Kakeji Yoshihiro, SakamotoJ, SajiS, YoshidaK
    Aug. 2015, Gastric Cancer, 19(3) (3), 851, English
    [Refereed]
    Scientific journal

  • Urakawa N, Utsunomiya S, Nishio M, Shigeoka M, Takase N, Arai N, Kakeji Yoshihiro, Koma Yuichiro, Yokozaki Hiroshi
    May 2015, Lab Invest, 95(5) (5), 491 - 503, English
    [Refereed]
    Scientific journal

  • Suzuki Satoshi, Nakamura Tetsu, Imanishi Tatsuya, Kanaji S, Yamamoto M, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Tanaka Kenichi, Kuroda D, Kakeji Yoshihiro
    May 2015, Ann Surg Oncol, 22(5) (5), 1548 - 1554, English
    [Refereed]
    Scientific journal

  • 癌の遺伝子診断・治療
    Yamashita Kimihiro, 西将康, Kakeji Yoshihiro
    Apr. 2015, 消化器外科学レビュー, 16, 186, Japanese
    [Refereed]
    Scientific journal

  • Topic: Inguinal Hernia - Unsolved problem in the daily practice
    YasuoS, KenichiY, UenoN, ArimotoA, HosonoM, YoshikawaT, ToyokawaA, Kakeji Yoshihiro, TsaiY, TsaiC, SulJ, LimM, ParkJ, JangCE, SantilliO, TripoloniD, SantilliH, NardelliN, GrecoA, EstevezM, SakuraiS, RyuS, CesanaG, CiccareseF, UccelliM, Gra
    Apr. 2015, Hernia, 19(Suppl 1) (Suppl 1), S293 - 304, English
    [Refereed]
    Scientific journal

  • Urakawa N, Utsunomiya S, NISHIO MARI, SHIGEOKA MANABU, TAKASE NOBUHISA, Arai N, KAKEJI YOSHIHIRO, KOMA YUICHIRO, YOKOZAKI HIROSHI
    Apr. 2015, Lab. Invest, 95(5) (5), 491 - 503, English
    [Refereed]
    Scientific journal

  • Matsuda T, Iwasaki T, Mitsutsuji M, Hirata K, Maekawa Y, Tanaka T, Shimada E, Kakeji Yoshihiro
    Apr. 2015, Surg Endosc, 29(4) (4), 1001, English
    [Refereed]
    Scientific journal

  • Otowa Y, Nakamura Tetsu, Takiguchi G, Urakawa N, Ishida R, Imanishi T, Suzuki Satoshi, Tanaka K, Kuroda D, Kakeji Yoshihiro
    Mar. 2015, Oncol Lett, 9(6) (6), 2583 - 2585, English
    [Refereed]
    Scientific journal

  • Shigeoka M, Urakawa N, Nishio M, Takase N, Utsunomiya S, Akiyama H, Kakeji Yoshihiro, Komori T, Koma Yuichiro, Yokozaki Hiroshi
    Mar. 2015, Cancer Med, 4(3) (3), 437 - 446, English
    [Refereed]
    Scientific journal

  • Tomono A, Nakamura Tetsu, Otowa Y, Imanishi Tatsuya, Tanaka Yugo, Maniwa Yoshimasa, Kakeji Yoshihiro
    Feb. 2015, Ann Thorac Cardiovasc Surg, 21(3) (3), 289 - 292, English
    [Refereed]
    Scientific journal

  • Ikuo Takahashi, Mototugu Shimokawa, Yasunori Emi, Hiroaki Tanioka, Takeshi Shiraishi, Eiji Oki, Hiroshi Saeki, Akihito Tsuji, Sumiya Ishigami, Yoshihiro Kakeji, Hideo Baba, Shoji Natsugoe, Yoshihiko Maehara
    Jan. 2015, JOURNAL OF CLINICAL ONCOLOGY, 33(3) (3), English
    [Refereed]

  • Tetsuji Sawada, Masakazu Yashiro, Kazuhiro Sentani, Naohide Oue, Wataru Yasui, Kohji Miyazaki, Keita Kai, Sachio Fushida, Takashi Fujimura, Masaichi Ohira, Yoshihiro Kakeji, Shoji Natsugoe, Ken Shirabe, Sachiyo Nomura, Yutaka Shimada, Naohiro Tomita, Kosei Hirakawa, Yoshihiko Maehara
    Jan. 2015, GASTRIC CANCER, 18(1) (1), 119 - 128, English
    [Refereed]
    Scientific journal

  • 新薬展望2015 第III部 治療における最近の新薬の位置付け「薬効別」 ～新薬の広場～ 消化器癌治療薬
    裏川 直樹, 金光 聖哲, Kakeji Yoshihiro
    Jan. 2015, 医薬ジャーナル, 51(S-1) (S-1), 147 - 155, Japanese
    [Refereed]
    Scientific journal

  • Matsuda T, Iwasaki T, Mitsutsuji M, Hirata K, Maekawa Y, Tsugawa D, Sugita Y, Shimada E, Kakeji Yoshihiro
    Jan. 2015, Surg Endosc, 29(11) (11), 3386 - 3391, English
    [Refereed]
    Scientific journal

  • Sumi Yasuo, Yamashita Kimihiro, Kim Kiyonori, Masashi Yamamoto, Shingo Kanaji, Tatsuya Imanishi, Nakamura Tetsu, Suzuki Satoshi, Kenichi Tanaka, Kakeji Yoshihiro
    Jan. 2015, Indian J Surg, 77, 1462 - 1465, English
    [Refereed]
    Scientific journal

  • Oki E, Emi Y, Kojima H, Higashijima J, Kato T, Miyake Y, Kon M, Ogata Y, Takahashi K, Ishida H, Saeki H, Sakaguchi Y, Yamanaka T, Kono T, Tomita N, Baba H, Shirabe K, Kakeji Yoshihiro, Maehara Y
    Jan. 2015, Int J Clin Oncol, 20(4) (4), 775, English
    [Refereed]
    Scientific journal

  • Matsuda T, Iwasaki T, Mitsutsuji M, Hirata K, Maekawa Y, Tsugawa D, Sugita Y, Sumi Yasuo, Shimada E, Kakeji Yoshihiro
    Jan. 2015, Langenbecks Arch Surg, 400(1) (1), 113 - 117, English
    [Refereed]
    Scientific journal

  • Tomono A, Itoh T, Yanagita E, Imagawa N, Kakeji Yoshihiro
    Jan. 2015, Medicine (Baltimore), 94(4) (4), e501, English
    [Refereed]
    Scientific journal

  • Assessment of surgical treatment and postoperative nutrition in gastric cancer patients older than 80 years
    Nakanoko T, Kakeji Yoshihiro, Ando K, Nakashima Y, Ohgaki K, Kimura Y, Saeki H, Oki E, Morita M, Maehara Y
    Jan. 2015, Anticancer Res, 35(1) (1), 511 - 5, English
    [Refereed]
    Scientific journal

  • 胃がん治療戦略のUp to Date 胃癌における機能温存手術
    Suzuki Satoshi, Kakeji Yoshihiro
    Jan. 2015, メディカル朝日, 44(1号) (1号), 34 - 35, Japanese

  • 【新薬展望2015】 (第III部)治療における最近の新薬の位置付け[薬効別] 新薬の広場 消化器癌治療薬
    裏川直樹, Kim Kiyonori, Kakeji Yoshihiro
    Jan. 2015, 医薬ジャーナル, 51(増刊) (増刊), 365 - 373, Japanese

  • 【食道・胃手術-合併症ゼロを目指した秘策-】 胃全摘後の各種再建法と合併症対策
    金治 新悟, Suzuki Satoshi, Nakamura Tetsu, 田中 賢一, 富永 正寛, Kakeji Yoshihiro
    Jan. 2015, 手術, 69(1号) (1号), 53 - 58, Japanese
    [Refereed]

  • 臨床経験 根治切除不能なStageIV大腸癌に対して原発巣切除を先行する意義
    奥本 龍雄, 横山 伸二, 野田 雅史, 松原 長秀, Kakeji Yoshihiro, 冨田 尚裕
    Dec. 2014, 外科, 76(13号) (13号), 1630 - 1635, Japanese
    [Refereed]
    Scientific journal

  • Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer
    Otowa Y, Nakamura Tetsu, Takiguchi G, Tomono A, Yamamoto M, Kanaji S, Imanishi Tatsuya, Suzuki Satoshi, Tanaka Kenichi, Itoh T, Kakeji Yoshihiro
    Dec. 2014, Dis Esophagus, English
    [Refereed]
    Scientific journal

  • 術前化学放射線療法により腹腔鏡下直腸切断術を施行した進行痔瘻癌の1例
    森川 剛志, Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 山本 将士, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    Nov. 2014, 癌と化学療法, 41(12号) (12号), 1875 - 1877, Japanese
    [Refereed]
    Scientific journal

  • Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study)
    Beppu T, Emi Y, Tokunaga S, Oki E, Shirabe K, Ueno S, Kuramoto M, Kabashima A, Takahashi I, Samura H, Eguchi S, Akagi Y, Natsugoe S, Ogata Y, Kakeji Yoshihiro, Baba H, Maehara Y, Kyushu Study, group of Clinical Cancer (KSC
    Nov. 2014, Anticancer Res, 34(11) (11), 6655 - 62, English
    [Refereed]
    Scientific journal

  • Otowa Y, Kim Kiyonori, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kuroda D, Kakeji Yoshihiro
    Nov. 2014, Surg Today, 44(11) (11), 2187 - 2190, English
    [Refereed]
    Scientific journal

  • Curable Resection in Gastric and Lymph Node Metastases from Melanoma
    Otowa Y, Suzuki Satoshi, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Sakaguchi M, Bito T, Kakeji Yoshihiro
    Nov. 2014, CRSLS MIS Case Reports, epub, English
    [Refereed]
    Scientific journal

  • Oshikiri T, Yasuda T, Harada H, Goto H, Oyama M, Hasegawa H, Ohara T, Sendo H, Nakamura Tetsu, Fujino Y, Tominaga M, Kakeji Yoshihiro
    Oct. 2014, Surg Endosc, 29(8) (8), 2442 - 2450, English
    [Refereed]
    Scientific journal

  • Kanaji S, Nakamura Tetsu, Nishi M, Yamamoto M, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki S, Tanaka K, Kakeji Yoshihiro
    Sep. 2014, World J Gastroenterol, 20(34) (34), 12341 - 12345, English
    [Refereed]
    Scientific journal

  • Fujinaka Y, Morita M, Ohga T, Kakeji Yoshihiro, Yano T, Maehara Y
    Sep. 2014, Int Surg, 99(4) (4), 640 - 644, English
    [Refereed]
    Scientific journal

  • Intratumoral lymphangiogenesis and prognostic significance of VEGFC expression in gastric cancer
    Ikeda K, Oki E, Saeki H, Ando K, Morita M, Oda Y, Imamura M, Kakeji Yoshihiro, Maehara Y
    Aug. 2014, Anticancer Res, 34(8) (8), 3911 - 5, English
    [Refereed]
    Scientific journal

  • Otowa Y, Sumi Yasuo, Kanaji S, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    Jul. 2014, World J Gastroenterol, 20(25) (25), 8317 - 8319, English
    [Refereed]
    Scientific journal

  • Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation
    Hasegawa H, Yamashita Kimihiro, Otubo D, Fujii S, Kamigaki T, Kuroda D, Kakeji Yoshihiro
    Jul. 2014, Anticancer Res, 34(7) (7), 3411 - 7, English
    [Refereed]
    Scientific journal

  • 【「キャッチフレーズ 図解」でさくさくわかる!消化器外科看護のための解剖生理・機能解剖】 胃 胃の解剖は?
    友野 絢子, Suzuki Satoshi, Kakeji Yoshihiro
    Jul. 2014, 消化器外科Nursing, 19(7号) (7号), 676 - 678, Japanese

  • 【「キャッチフレーズ 図解」でさくさくわかる!消化器外科看護のための解剖生理・機能解剖】 胃 胃のはたらきは?
    友野 絢子, Suzuki Satoshi, Kakeji Yoshihiro
    Jul. 2014, 消化器外科Nursing, 19(7号) (7号), 679 - 681, Japanese

  • Tsuchiya T, Sadahiro S, Sasaki K, Kondo K, Katsumata K, Nishimura G, Kakeji Yoshihiro, Baba H, Morita T, Koda K, Sato S, Matsuoka J, Yamaguchi Y, Usuki H, Hamada C, Kodaira S, Saji S
    Jun. 2014, Cancer Chemother Pharmacol, 73(6) (6), 1253 - 1261, English
    [Refereed]
    Scientific journal

  • 金治 新悟, Suzuki Satoshi, Nakamura Tetsu, 田中 賢一, Kakeji Yoshihiro
    Jun. 2014, 臨床外科, 69(6) (6), 674 - 679, Japanese
    [Refereed]

  • Wang Z, Uchida K, Ohnaka K, Morita M, Toyomura K, Kono S, Ueki T, Tanaka M, Kakeji Yoshihiro, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R
    May 2014, Scand J Gastroenterol, 49(5) (5), 581 - 588, English
    [Refereed]
    Scientific journal

  • Kanaji S, Nakamura Tetsu, Yamamoto M, Imanishi Tatsuya, Suzuki Satoshi, Tanaka Kenichi, Kuroda D, Kakeji Yoshihiro
    May 2014, Surg Today, 45(2) (2), 209 - 214, English
    [Refereed]
    Scientific journal

  • Imai K, Emi Y, Iyama KI, Beppu T, Ogata Y, Kakeji Yoshihiro, Samura H, Oki E, Akagi Y, Maehara Y, Baba H
    May 2014, Eur J Surg Oncol, 40(5) (5), 559 - 566, English
    [Refereed]
    Scientific journal

  • Kanaji S, Harada H, Nakayama S, Yasuda T, Oshikiri T, Kawasaki K, Yamamoto M, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Fujino Y, Tominaga M, Kakeji Yoshihiro
    Apr. 2014, Surg Endosc, 28(4) (4), 1250 - 1255, English
    [Refereed]
    Scientific journal

  • Kubo N, Morita M, Nakashima Y, Kitao H, Egashira A, Saeki H, Oki E, Kakeji Yoshihiro, Oda Y, Maehara Y
    Apr. 2014, Dis Esophagus, 27(3) (3), 285 - 293, English
    [Refereed]
    Scientific journal

  • Sumi Yasuo, Maehara R, Matsuda Y, Yamashita Kimihiro, Nakamura Tetsu, Suzuki Satoshi, Kuroda D, Kakeji Yoshihiro
    Apr. 2014, JSLS, 18(2) (2), 314 - 318, English
    [Refereed]
    Scientific journal

  • Sumi Yasuo, Yamashita K, Kanemitsu K, Kanaji S, Yamamoto M, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y
    Mar. 2014, SURGICAL SCIENCE, 5(1) (1), 122 - 127, English
    [Refereed]
    Scientific journal

  • Oki E, Emi Y, Kusumoto T, Sakaguchi Y, Yamamoto M, Sadanaga N, Shimokawa M, Yamanaka T, Saeki H, Morita M, Takahashi I, Hirabayashi N, Sakai K, Orita H, Aishima S, Kakeji Yoshihiro, Yamaguchi K, Yoshida K, Baba H, Maehara Y
    Mar. 2014, Ann Surg Oncol, 21(7) (7), 2340 - 2346, English
    [Refereed]
    Scientific journal

  • Honma K, Nakanishi R, Nakanoko T, Ando K, Saeki H, Oki E, Iimori M, Kitao H, Kakeji Yoshihiro, Maehara Y
    Mar. 2014, Surg Today, 44(3) (3), 454 - 461, English
    [Refereed]
    Scientific journal

  • Nakanoko T, Saeki H, Morita M, Nakashima Y, Ando K, Oki E, Ohga T, Kakeji Yoshihiro, Toh Y, Maehara Y
    Feb. 2014, Ann Surg Oncol, 21(2) (2), 597 - 604, English
    [Refereed]
    Scientific journal

  • Nakashima Y, Yoshinaga K, Kitao H, Ando K, Kimura Y, Saeki H, Oki E, Morita M, Kakeji Yoshihiro, Hirahashi M, Oda Y, Maehara Y
    Dec. 2013, Cancer Sci, 104(12) (12), 1718 - 1725, English
    [Refereed]
    Scientific journal

  • Sawada T, Yashiro M, Sentani K, Oue N, Yasui W, Miyazaki K, Kai K, Fujita H, Nakamura K, Maeda K, Kakeji Yoshihiro, Natsugoe S, Shirabe K, Nomura S, Shimada Y, Tomita N, Hirakawa K, Maehara Y
    Dec. 2013, Oncol Rep, 30(6) (6), 2609 - 2616, English
    [Refereed]
    Scientific journal

  • Thoracoscopic esophagectomy in the prone position for esophageal cancer with right aortic arch: case report
    Kanaji S, Nakamura T, Otowa Y, Yamamoto M, Yamashita Kimihiro, Imanishi T, Sumi Y, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    Oct. 2013, Anticancer Res, 33(10) (10), 4515 - 9, English
    [Refereed]
    Scientific journal

  • Nakanoko T, Saeki H, Morita M, Nakashima Y, Ando K, Oki E, Ohga T, Kakeji Yoshihiro, Toh Y, Maehara Y
    Oct. 2013, Ann Surg Oncol, 21(2) (2), 597 - 604, English
    [Refereed]
    Scientific journal

  • Shigeoka M, Urakawa N, Nakamura T, Nishio M, Watajima T, Kuroda D, Komori Takahide, Kakeji Yoshihiro, Semba Shuho, Yokozaki Hiroshi
    Aug. 2013, Cancer Sci, 104(8) (8), 1112 - 1119, English
    [Refereed]
    Scientific journal

  • Kasagi Y, Saeki H, Akahoshi T, Kawasaki J, Ando K, Oki E, Ohga T, Tomikawa M, Kakeji Yoshihiro, Shirabe K, Maehara Y
    Aug. 2013, Surg Today, 44(8) (8), 1573 - 1576, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Aug. 2013, Mol Carcinog, 52(8) (8), 619 - 626, English
    [Refereed]
    Scientific journal

  • Komori M, Asayama Y, Fujita N, Hiraka K, Tsurumaru D, Kakeji Yoshihiro, Honda H
    Aug. 2013, AJR Am J Roentgenol, 201(2) (2), 253 - 261, English
    [Refereed]
    Scientific journal

  • Wang ZJ, Ohnaka K, Morita M, Toyomura K, Kono S, Ueki T, Tanaka M, Kakeji Yoshihiro, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R
    May 2013, World J Gastroenterol, 19(17) (17), 2683 - 2690, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Apr. 2013, Int J Clin Oncol, 18(2) (2), 254 - 259, English
    [Refereed]
    Scientific journal

  • Ishiguro M, Kotake K, Nishimura G, Tomita N, Ichikawa W, Takahashi K, Watanabe T, Furuhata T, Kondo K, Mori M, Kakeji Yoshihiro, Kanazawa A, Kobayashi M, Okajima M, Hyodo I, Miyakoda K, Sugihara K
    Mar. 2013, BMC CANCER, 13, English
    [Refereed]
    Scientific journal

  • Akira Aso, Eikichi Ihara, Hiroaki Kubo, Takashi Osoegawa, Takamasa Oono, Kazuhiko Nakamura, Tetuhide Ito, Yoshihiro Kakeji, Osada Mikako, Hedetaka Yamamoto, Tatsuhiro Oishi, Yayoi Oishi, Yoichi Hachitanda, Ryoichi Takayanagi
    There have been no reports of gastric gastrointestinal stromal tumors (GISTs) <20 mm with distant metastasis. We report a case of a 15-mm gastric GIST with liver metastasis 1 year after surgical resection of the primary lesion. A 35-year-old man underwent routine esophagogastroduodenoscopy in July 2009. A submucosal tumor (SMT) <20 mm was incidentally detected at the posterior wall of the gastric body. Endoscopic ultrasound (EUS) indicated that it was a gastrointestinal mesenchymal tumor, including GIST, leiomyoma or schwannoma. He did not accept regular follow-up for this gastric SMT, therefore local laparoscopic excision was carried out in October 2009. The final pathological diagnosis after surgery was GIST, 15 mm in size, and a mitotic rate of 7/50 high-power fields, which did not indicate a high metastatic risk. The patient was followed up regularly without adjuvant chemotherapy. At 1 year after surgery, a space-occupying lesion ~15 mm was detected in the left lobe of the liver by abdominal ultrasound, where no mass lesion had been observed before surgery. To make a definite diagnosis of the hepatic mass lesion, EUS-guided fine-needle aspiration was performed, which demonstrated a metastatic liver tumor from a gastric GIST. Although this was a rare case, we should keep in mind that gastric GISTs do have a chance of malignant behavior, even if <20 mm.
    Feb. 2013, Clinical journal of gastroenterology, 6(1) (1), 29 - 32, English, Domestic magazine
    [Refereed]
    Scientific journal

  • Laparoscopic hemicolectomy in a patient with situs inversus totalis after open distal gastrectomy
    Sumi Yasuo, Tomono A, Suzuki Satoshi, Kuroda D, Kakeji Yoshihiro
    Feb. 2013, World J Gastrointest Surg, 5(2) (2), 22 - 6, English
    [Refereed]
    Research society

  • Kakeji Yoshihiro
    Feb. 2013, Int J Cancer, 132(4) (4), 951 - 958, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Feb. 2013, Int J Clin Oncol, 18(1) (1), 38 - 45, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    2013, Am J Pediatr Hematol Oncol, 84(4) (4), 233 - 239, English
    [Refereed]
    Scientific journal

  • Morita M, Yin G, Yoshimitsu S, Ohnaka K, Toyomura K, Kono S, Ueki T, Tanaka M, Kakeji Yoshihiro, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R
    2013, Asian Pac J Cancer Prev, 14(11) (11), 6249 - 6256, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Jan. 2013, Surg Endosc, 27(1) (1), 325 - 332, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Jan. 2013, Dis Esophagus, 26(1) (1), 50 - 56, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Jan. 2013, Surg Today, 43(1) (1), 73 - 80, English
    [Refereed]
    Scientific journal

  • Toshihiko Nakamura, Takashi Yao, Yoshihiro Kakeji, Hideaki Anai, Masaru Morita, Yoshinao Oda, Yoshihiko Maehara
    Jan. 2013, GASTRIC CANCER, 16(1) (1), 94 - 99, English
    [Refereed]
    Scientific journal

  • Rintaro Yoshida, Masaru Morita, Ryuichi Kumashiro, Keisuke Ikeda, Akinori Egashira, Hiroshi Saeki, Eiji Oki, Takefumi Ohga, Hideki Shiratsuchi, Junichi Fukushima, Torahiko Nakashima, Yoshihiro Kakeji, Yoshihiko Maehara
    Dec. 2012, ESOPHAGUS, 9(4) (4), 228 - 233, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Dec. 2012, Genes Cells, 17(12) (12), 962 - 970, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Nov. 2012, Int J Clin Oncol, 18(6) (6), 1042 - 1048, English
    [Refereed]
    Scientific journal

  • 新規抗癌剤治療を行ったS状結腸腺扁平上皮癌多発肝転移の1例
    Okuno Tatsuya, Fujishima Yoshimi, Yamashita Kimihiro, Sumi Yasuo, Yano Yoshihiko, Hara Shigeo, Kakeji Yoshihiro, Yokozaki Hiroshi, Azuma Takeshi
    Oct. 2012, 日本癌治療学会誌, 47(3号) (3号), 2304, Japanese
    Research society

  • Kakeji Yoshihiro
    Oct. 2012, Ann Surg Oncol, 19(11) (11), 3627 - 3635, English
    [Refereed]
    Scientific journal

  • Kazuhiro Nishikawa, Satoshi Morita, Takanori Matsui, Michiya Kobayashi, Yoji Takeuchi, Ikuo Takahashi, Seiji Sato, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Yoshihiro Kakeji, Hideo Baba
    Oct. 2012, GASTRIC CANCER, 15(4) (4), 363 - 369, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Aug. 2012, Surg Today, 42(8) (8), 734 - 740, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Aug. 2012, Surg Today, 42(8) (8), 752 - 758, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Aug. 2012, Nutr Cancer, 64(6) (6), 798 - 805, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Jul. 2012, Surg Today, 42(7) (7), 625 - 632, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Jun. 2012, Surg Today, 42(6) (6), 554 - 558, English
    [Refereed]
    Scientific journal

  • Phase II study of combination therapy with S-1 and cetuximab in patients with KRAS wild-type unresectable colorectal cancer who had previously received irinotecan, oxaliplatin, and fluoropyrimidines (KSCC0901).
    Kazuma Kobayashi, Yasunori Emi, Yoshihiro Kakeji, Takao Takahashi, Eiji Oki, Yoshito Akagi, Akihito Tsuji, Yasuhiro Kodera, Kazuhiro Yoshida, Hideo Baba, Mitsuo Shimada, Yutaka Ogata, Mototsugu Shimokawa, Shoji Tokunaga, Shoji Natsugoe, Yoshihiko Maehara
    May 2012, JOURNAL OF CLINICAL ONCOLOGY, 30(15) (15), English
    [Refereed]

  • Kakeji Yoshihiro
    May 2012, Ann Surg Oncol, 19(5) (5), 1499 - 1507, English
    [Refereed]
    Scientific journal

  • Yoshida D, Ikeda Y, Waki K, Shirabe K, Kakeji Yoshihiro, Tsujitani S, Maehara Y
    May 2012, Surg Today, 42(5) (5), 426 - 430, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Apr. 2012, Surg Today, 42(4) (4), 351 - 358, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Apr. 2012, Ann Surg Oncol, 19(4) (4), 1145 - 1152, English
    [Refereed]
    Scientific journal

  • Eriko Tokunaga, Satoko Okada, Nami Yamashita, Sayuri Akiyoshi, Hiroyuki Kitao, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara
    Apr. 2012, BREAST CANCER, 19(2) (2), 161 - 169, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Apr. 2012, J Gastroenterol, 47(4) (4), 351 - 358, English
    [Refereed]

  • Kakeji Yoshihiro
    Mar. 2012, DNA Repair (Amst), 11(3) (3), 247 - 258, English
    [Refereed]
    Scientific journal

  • Tsujitani S, Saito H, Wakatsuki T, Ikeguchi M, Shirabe K, Morita M, Kakeji Yoshihiro, Yano T, Maehara Y
    Feb. 2012, Surg Today, 42(3) (3), 225 - 232, English
    [Refereed]
    Scientific journal

  • 【胃癌診療のトピックス】 切除不能・再発胃癌の化学療法のup to date(解説/特集)
    Kakeji Yoshihiro
    Feb. 2012, 消化器外科, 35(2) (2), 201 - 207, Japanese
    [Invited]

  • Kakeji Yoshihiro
    2012, Genes Genet Syst, 87(4) (4), 265 - 272, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    2012, J Epidemiol, 22(1) (1), 64 - 71, English
    [Refereed]
    Scientific journal

  • Kakeji Yoshihiro
    Jan. 2012, Surg Today, 42(1) (1), 52 - 59, English
    [Refereed]
    Scientific journal

  • Maehara Y, Tsujitani S, Saeki H, Oki E, Yoshinaga K, Emi Y, Morita M, Kohnoe S, Kakeji Yoshihiro, Yano T, Baba H
    Jan. 2012, Surg Today, 42(1) (1), 8 - 28, English
    [Refereed]
    Scientific journal

  • 【手術助手にはこうしてほしい】 消化管領域 腹腔鏡下胃全摘術
    Kakeji Yoshihiro
    Jan. 2012, 外科, 74(1号) (1号), 31 - 36, Japanese

  • Kakeji Yoshihiro
    Jan. 2012, Surg Today, 42(2) (2), 111 - 120, English
    [Refereed]

  • Budhathoki S, Joshi AM, Ohnaka K, Yin G, Toyomura K, Kono S, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R
    Dec. 2011, Scandinavian Journal of Gastroenterology, 46(2) (2), 165 - 172, English
    [Refereed]
    Scientific journal

  • Ikeda T, Yonemura Y, Ueda N, Kabashima A, Shirabe K, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, Kakeji Y, Morita M, Tsujitani S, Maehara Y
    Dec. 2011, Surgery today, 41(12) (12), 1592 - 1598
    [Refereed]

  • Ando K, Oki E, Sugiyama M, Zhao Y, Kojima A, Yamamoto H, Yamashita Y, Saeki H, Taketomi A, Morita M, Kakeji Y, Tsujitani S, Maehara Y
    9, Sep. 2011, Surgery today, 41(9) (9), 1290 - 1293
    [Refereed]

  • Morita M, Nakanoko T, Kubo N, Fujinaka Y, Ikeda K, Egashira A, Saeki H, Uchiyama H, Ohga T, Kakeji Y, Shirabe K, Ikeda T, Tsujitani S, Maehara Y
    Sep. 2011, Annals of surgical oncology, 18(9) (9), 2613 - 2621
    [Refereed]

  • Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K, Maehara Y
    Jun. 2011, Annals of surgical oncology, 18(6) (6), 1757 - 1765
    [Refereed]

  • Constipation and colorectal cancer risk: the Fukuoka Colorectal Cancer Study
    Kakeji Yoshihiro
    2011, Asian Pac J Cancer Prev, 12(8) (8), 2025 - 30, English
    [Refereed]
    Scientific journal

  • Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S, Egashira A, Saeki H, Kakeji Y, Morita M, Sakaguchi Y, Okamura T, Maehara Y
    Apr. 2010, International journal of clinical oncology, 15(2) (2), 135 - 144
    [Refereed]

  • Ando K, Kakeji Y, Kitao H, Iimori M, Zhao Y, Yoshida R, Oki E, Yoshinaga K, Matumoto T, Morita M, Sakaguchi Y, Maehara Y
    Mar. 2010, Cancer science, 101(3) (3), 639 - 645
    [Refereed]

  • Fukuhara T, Egashira A, Imamura M, Ikegami T, Oki E, Soejima Y, Sadanaga N, Taketomi A, Yao T, Morita M, Kakeji Y, Tsuneyoshi M, Maehara Y
    1, 2009, Surgery today, 39(1) (1), 59 - 63
    [Refereed]

  • Yamamoto M, Yamanaka T, Baba H, Kakeji Y, Maehara Y
    Mar. 2008, Journal of surgical oncology, 97(3) (3), 231 - 235, English
    [Refereed]

  • Oki E, Kakeji Y, Taketomi A, Yamashita Y, Ohgaki K, Harada N, Iguchi T, Shibahara K, Sadanaga N, Morita M, Maehara Y
    1-4, 2008, Journal of gastrointestinal cancer, 39(1-4) (1-4), 82 - 85
    [Refereed]

  • Adenocarcinoma of the esophagogastric junction in Japan.
    Yamamoto M, Baba H, Egashira A, Oki E, Ikebe M, Kakeji Y, Maehara Y
    Jan. 2008, Hepato-gastroenterology, 55(81) (81), 103 - 107, English
    [Refereed]

  • Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S, Ohga T, Saeki H, Watanabe M, Kakeji Y, Morita M, Yamada T, Maehara Y
    Sep. 2007, Anticancer research, 27(5A) (5A), 3345 - 3353
    [Refereed]

  • Expression of p53 and p21 and the clinical response for hyperthermochemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Ishida M, Morita M, Saeki H, Ohga T, Sadanaga N, Watanabe M, Kakeji Y, Maehara Y
    Sep. 2007, Anticancer research, 27(5B) (5B), 3501 - 3506
    [Refereed]

  • [A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
    Oki E, Kakeji Y, Yoshida R, Ikeda K, Nishida K, Koga T, Egashira A, Tokunaga E, Morita M, Baba H, Maehara Y
    Jun. 2006, Gan to kagaku ryoho. Cancer & chemotherapy, 33 Suppl 1, 138 - 143, Japanese
    [Refereed]

  • Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
    Takahashi I, Emi Y, Kakeji Y, Tokunaga E, Ushiro S, Oki E, Watanabe M, Baba H, Maehara Y
    Apr. 2006, Oncology reports, 15(4) (4), 849 - 854
    [Refereed]

  • [Evaluation of positive cases with peritoneal lavage cytology in gastric cancer].
    Yamamoto M, Mashino K, Shibahara K, Oki E, Kakeji Y, Baba H, Maehara Y
    Oct. 2005, Gan to kagaku ryoho. Cancer & chemotherapy, 32(10) (10), 1389 - 1392, Japanese
    [Refereed]

  • [Current combination chemotherapy containing paclitaxel for advanced, recurrent gastric cancer].
    Emi Y, Kakeji Y, Baba H, Ishida T, Maehara Y
    Nov. 2004, Gan to kagaku ryoho. Cancer & chemotherapy, 31(12) (12), 1978 - 1981, Japanese
    [Refereed]

  • Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
    Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y
    Jan. 2004, Hepato-gastroenterology, 51(55) (55), 298 - 302, English
    [Refereed]

  • Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
    Kimura Y, Watanabe M, Ohga T, Saeki H, Kakeji Y, Baba H, Maehara Y
    Nov. 2003, Oncology reports, 10(6) (6), 1747 - 1751, English
    [Refereed]

  • Maehara Y, Kakeji Y, Koga T, Emi Y, Baba H, Akazawa K, Sugimachi K
    Jan. 2002, Surgery, 131(1 Suppl) (1 Suppl), S85 - 91, English
    [Refereed]
    Scientific journal

  • Gastric cancer with high telomerase activity shows rapid development and invasiveness.
    KAKEJI YOSHIHIRO
    2001, Oncology Reports, 8, 107 - 110, English
    [Refereed]
    Scientific journal

  • Thymidine Phosphorylase Activity and Angiogenesis in Gastric Cancer.
    KAKEJI YOSHIHIRO
    1999, Oncol Reports, 6, 995 - 999, English
    [Refereed]
    Scientific journal

  • Heterogeneity and clinical role of thymidine phospholyrase activity in gastric cancer.
    KAKEJI YOSHIHIRO
    1999, Oncol Reports, 6(6) (6), 1213 - 1216, English
    [Refereed]
    Scientific journal

  • Clinical significance of micrometastasis in bone marrow of patients with gastric cancer and its relation to angiogenesis.
    KAKEJI YOSHIHIRO
    1999, Gastric Cancer, 2, 46 - 51, English
    [Refereed]
    Scientific journal

  • KAKEJI YOSHIHIRO
    1998, Cancer, 82(12) (12), 2307 - 2311, English
    [Refereed]
    Scientific journal

  • KAKEJI YOSHIHIRO
    1997, Investigational New Drugs, 15(1) (1), 39 - 48, English
    [Refereed]
    Scientific journal

  • KAKEJI YOSHIHIRO
    1997, Int. J. Rad. Oncol. Biol. Phys, 37(5) (5), 1115 - 1123, English
    [Refereed]
    Scientific journal

  • Argyrophilic Nucleolar Organizer Region (AgNOR) in endoscopically biopsied tissues is an useful predictor of gastric malignancy.
    KAKEJI YOSHIHIRO
    1996, J Am Coll Surg, 182, 482 - 487, English
    [Refereed]
    Scientific journal

  • Surgical treatment for gastric carcinoma with duodenal invasion.
    KAKEJI YOSHIHIRO
    1995, J Surg Oncol, 59, 215 - 219, English
    [Refereed]
    Scientific journal

  • KAKEJI YOSHIHIRO
    1995, Br J Cancer, 71(1) (1), 191 - 195, English
    [Refereed]
    Scientific journal

  • Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
    KAKEJI YOSHIHIRO
    1994, Br J Cancer, 69, 749 - 753, English
    [Refereed]
    Scientific journal

  • Helix Pomatia Agglutinin binding activity and lymph node metastasis in patients with gastric cancer.
    KAKEJI YOSHIHIRO
    1994, Semin Surg Oncol, 10, 130 - 134, English
    [Refereed]
    Scientific journal

  • Prognostic significance of tumor-host interaction in clinical gastric cancer : relationship between DNA ploidy and dendritic cell infiltration.
    KAKEJI YOSHIHIRO
    1993, J Surg Oncol, 52(4) (4), 207 - 212, English
    [Refereed]
    Scientific journal

  • Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
    KAKEJI YOSHIHIRO
    1993, Br J Cancer, 67(3) (3), 589 - 593, English
    [Refereed]
    Scientific journal

  • Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer.
    KAKEJI YOSHIHIRO
    1991, Cancer Res, 51(7) (7), 3503 - 3506, English
    [Refereed]
    Scientific journal

  • Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma.
    KAKEJI YOSHIHIRO
    1991, Cancer, 68(11) (11), 2438 - 2442, English
    [Refereed]
    Scientific journal

  • Clinicopathologic features and prognostic significance of duodenal invasion in patients with distal gastric carcinoma.
    KAKEJI YOSHIHIRO
    1991, Cancer, 68(2) (2), 380 - 384, English
    [Refereed]
    Scientific journal

■ Books And Other Publications
  • がん治療YearBook Key Reference 2022-2023
    裏川 直樹, 金治 新悟, 掛地 吉弘
    胃癌, 株式会社へるす出版, Apr. 2024

  • 決定版!まるごと知りたい消化管 : 解剖生理も、最新の治療も、患者ケアも
    原田 仁, 掛地 吉弘
    (4章)しっかり消化!胃・十二指腸のすべて 疾患編 胃GIST, メディカ出版, Oct. 2023, Japanese, ISBN: 9784840480277

  • 決定版!まるごと知りたい消化管 : 解剖生理も、最新の治療も、患者ケアも
    原田 仁, 掛地 吉弘
    (4章)しっかり消化!胃・十二指腸のすべて 疾患編 胃がん, メディカ出版, Oct. 2023, Japanese, ISBN: 9784840480277

  • 内科学
    阿河 杏介, 掛地 吉弘
    11-5-15 腸閉塞（イレウス）, 朝倉書店, Mar. 2022, ISBN: 9784254322804

  • がん免疫ペディア 腫瘍免疫学・がん免疫療法の全てをまるごと理解！
    山下 公大, 掛地 吉弘
    Joint work, 2章がん微小環境 Keyword8 血管新生, 株式会社羊土社, Mar. 2022

  • 標準外科学
    掛地 吉弘
    Joint work, 第5章 無菌法（消毒法および減菌法), 株式会社医学書院, Mar. 2022

  • 専門医のための消化器病学 第3版
    瀧口 豪介, 掛地 吉弘
    食道上皮性良性腫瘍、食道粘膜下腫瘍, Nov. 2021

  • チーム医療のためのがんロコモハンドブック
    掛地 吉弘
    II．がんロコモ治療に必要ながん医療の基礎知識 2治療総論 2）手術治療, 総合医学社, Oct. 2021, Japanese, ISBN: 9784883787401

  • 標準外科学(第15版） / 無菌法（消毒法および滅菌法）
    北野正剛, 福島亮治, 織田成人, 山上裕機, 神野浩光, 永安武, 杉尾賢ニ, 竹政伊知朗, Kakeji Yoshihiro, 篠原尚, 若井俊文, 白石憲男, 佐野圭ニ, 渡部祐司, 袴田健一, 楠正人, 馬場秀夫, 竹内裕也, 守瀬善一, 島田英昭, 松原久裕, 佐々木章, 古川博之, 小野稔, 伊達洋至, 島田光生, 大段秀樹, 岩崎昭憲, 古川俊治, 岡本高宏, 井本滋, 臼田実男, 千田雅之, 池田徳彦, 宮地鑑, 益田宗孝, 安原洋, 大木隆生, 奥村明之進, 北川雄光, 田邊稔, 花崎和弘, 大辻英吾, 坂井義
    Others, 医学書院, Jan. 2019, Japanese
    Textbook

  • 改訂第2版 5年でマスター 消化器標準手術 消化器外科専門医への道 / 胃瘻造設術
    山崎悠太, Matsuda Yoshiko, Kakeji Yoshihiro
    Others, 株式会社メジカルビュー, Dec. 2018, Japanese
    Scholarly book

  • 先端医療シリーズ49 消化器疾患の最新医療 / National Clinical Databaseの役割
    Kakeji Yoshihiro
    Others, 寺田国際事務所/先端医療技術研究所, Aug. 2018, Japanese
    Scholarly book

  • 医療のあゆみBOOKS エビデンス 漢方診療 / 癌治療における漢方治療
    Kakeji Yoshihiro, Yamashita Kimihiro, Suzuki Satoshi
    Others, 医歯薬出版株式会社, Aug. 2018, Japanese
    Scholarly book

  • メディカ出版 / 考える外科 上部消化管外科の治療戦略
    Kakeji Yoshihiro
    Editor, 長谷川 素美, Jan. 2018, Japanese
    General book

  • Patient Surveillance After Cancer Treatment / Stomach Carcinoma Surveillance Counterpoint: Japan
    Kakeji Yoshihiro, Morita M, Maehara Y
    Others, Springer Science + Business Media, 2013, English
    Scholarly book

■ Lectures, oral presentations, etc.
  • The significance of conversion surgery following chemotherapy for clinical stage IV gastric cancer
    Harada H, Kanaji S, Sawada R, Koterazawa Y, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Kakeji Y
    第96回日本胃癌学会総会, English, 京都府立医科大学大学院医学研究科 消化器外科学, 京都市, Japan, Domestic conference
    Oral presentation

  • 当院における進行胃癌に対するロボット支援下胃切除術の工夫
    裏川 直樹、金治 新悟、原田 仁、澤田 隆一郎、小寺澤 康文、後藤 裕信、長谷川 寛、山下 公大、松田 武、掛地 吉弘
    第96回日本胃癌学会総会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都市, Japan, Domestic conference
    Oral presentation

  • 食道胃接合部腺癌に対する腹腔鏡下経裂孔的再建における左横隔膜開放法の有用性
    金治 新悟、裏川 直樹、原田 仁、澤田 隆一郎、小寺澤 康文、後藤 裕信、長谷川 寛、山下 公大、松田 武、掛地 吉弘
    第96回日本胃癌学会総会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都市, Japan, Domestic conference
    Public symposium

  • プレナリーセッション 1 胃癌学会施設認定制度について
    掛地 吉弘
    第96回日本胃癌学会総会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都市, Japan, Domestic conference
    Others

  • ランチョンセミナー 9 胃癌のバイオマーカー
    掛地 吉弘
    第96回日本胃癌学会総会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学・アステラス製薬株式会社, 京都市, Japan, Domestic conference
    Others

  • 胃癌学会の取り組み
    掛地 吉弘
    第96回日本胃癌学会総会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都市, Japan, Domestic conference
    Invited oral presentation

  • 特別講演「がん悪液質における集学的支持療法の重要性～チーム医療で”体重減少”に挑む」
    掛地 吉弘
    消化器がんエドルミズセミナー, Japanese, 小野薬品工業株式会社, 神戸/Weｂ, Japan, Domestic conference
    Others

  • 合同パネルディスカッション6「がん治療と栄養」
    掛地 吉弘
    第39回日本臨床栄養代謝学会学術集会, Japanese, 東邦大学医学部臨床支援室・東邦大学医療センター大森病院栄養治療センター, 横浜, Japan, Domestic conference
    Others

  • 術前化学療法を施行した食道癌における腫瘍マーカーと生存転帰の検討
    鳥越 陸矢、後藤 裕信、加藤 喬、小寺澤 康文、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第56回制癌剤適応研究会, Japanese, 藤田医科大学医学部消化器外科学講座 ばんたね病院外科, 下呂市, Japan, Domestic conference
    Oral presentation

  • 切除不能進行胃癌に対する conversion surgery の周術期化学療法の重要性及び治療成績
    横尾 拓樹、原田 仁、小寺澤 康文、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第56回制癌剤適応研究会, Japanese, 藤田医科大学医学部消化器外科学講座 ばんたね病院外科, 下呂市, Japan, Domestic conference
    Public symposium

  • 大腸癌腫瘍免疫微小環境における CD4+T 細胞に与える肥満の影響
    安藤 正恭、山田 康太、斎藤 雅史、山下 公大、安達 祐里、常城 宇生、阿部 智喜、向山 知佑、長谷川 寛、金治 新悟、松田 武、掛地 吉弘
    第56回制癌剤適応研究会, Japanese, 藤田医科大学医学部消化器外科学講座 ばんたね病院外科, 下呂市, Japan, Domestic conference
    Oral presentation

  • 鼠径リンパ節転移を伴う直腸・肛門管腺癌の術後成績；術前治療と選択的鼠径リンパ節郭清・直腸間膜全切除による治療戦略
    堀川 学、長谷川 寛、加藤 喬、澤田 隆一郎、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第56回制癌剤適応研究会, Japanese, 藤田医科大学医学部消化器外科学講座 ばんたね病院外科, 下呂市, Japan, Domestic conference
    Oral presentation

  • Clinical Significance of SUVmax on FDG-PET in Patients with Rectal Cancer Undergoing NACRT
    Tsuneki T, Matsuda T, Sawada R, Hasegawa H, Yamashita K, Koterazawa Y, Harada H, Urakawa N, Goto H, Kanaji S, Kakeji Y,
    The 19th Annual Academic Surgical Congress, English, Annual Academic Surgical Congress, Washington, D.C., United States, International conference
    Oral presentation

  • 高齢の胃癌患者に対する術前化学療法の安全性についての検討
    向山 知佑、金治 新悟、原田 仁、裏川 直樹、小寺澤 康文、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、掛地 吉弘
    第207回近畿外科学会, Japanese, 関西医科大学 外科学講座, 枚方市, Japan, Domestic conference
    Oral presentation

  • リンパ節郭清個数からみる MIE における上縦隔リンパ節郭清の重要性
    小寺澤 康文、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第207回近畿外科学会, Japanese, 関西医科大学 外科学講座, 枚方市, Japan, Domestic conference
    Oral presentation

  • 特別講演1 ロボット手術の次世代への継承～教育体制とテクノロジーの活用～
    掛地 吉弘
    第207回近畿外科学会, Japanese, 関西医科大学 外科学講座・インテュイティブサージカル合同会社, 枚方市, Japan, Domestic conference
    Others

  • 集学的治療における漢方薬の役割
    掛地 吉弘
    奈良県総合医療センター集学的がん治療セミナー, Japanese, 奈良県総合医療センター・株式会社ツムラ, 奈良市/Web, Japan, Domestic conference
    Invited oral presentation

  • 消化器領域のがんゲノム医療
    掛地 吉弘
    日本消化器病学会近畿支部第74回教育講演会, Japanese, 神戸大学大学院医学研究科外科学講座 肝胆膵外科学分野, 神戸, Japan, Domestic conference
    Others

  • 当院におけるTaTME併用大腸全摘術の手術成績
    澤田 隆一郎、松田 武、山下 公大、長谷川 寛、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、掛地 吉弘
    日本消化器病学会近畿支部第120回例会, Japanese, 神戸大学大学院医学研究科外科学講座 肝胆膵外科学分野, 神戸, Japan, Domestic conference
    Public symposium

  • アフタヌーンセミナー4「根治切除を視野に入れた食道癌治療戦略」～CAREからCUREを目指して
    掛地 吉弘
    日本消化器病学会近畿支部第120回例会, Japanese, 神戸大学大学院医学研究科外科学講座 肝胆膵外科学分野・MSD株式会社, 神戸, Japan, Domestic conference
    Others

  • 下部進行直腸癌に対する術前化学放射線療法＋選択的側方郭清の治療成績
    澤田 隆一郎、松田 武、山下 公大、長谷川 寛、加藤 喬、掛地 吉弘
    第100回大腸癌研究会学術集会, Japanese, 東京女子医科大学 消化器・一般外科, 東京, Japan, Domestic conference
    Poster presentation

  • 閉会の挨拶
    掛地 吉弘
    第12回若手消化器外科腹腔鏡セミナー, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野/肝胆膵外科学分野, 神戸, Japan, Domestic conference
    Others

  • 十二指腸表在性腫瘍に対する腹腔鏡内視鏡合同手術における結腸間膜尾側からの腹腔鏡アプローチの有用性の検討
    島田 淳司、金治 新悟、澤田 隆一郎、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、掛地 吉弘
    第194回兵庫県外科医会学術集会, Japanese, 兵庫県外科医会, 神戸, Japan, Domestic conference
    Oral presentation

  • 深層学習アルゴリズムに基づくイメージングサイトメトリーを用いた術前化学放射線療法後の直腸癌の新規予後因子の探索
    安達 祐里、山下 公大、長坂 暢、阿部 智喜、向山 知佑、常城 宇生、安藤 正恭、加藤 喬、小寺澤 康文、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、掛地 吉弘
    第36回日本バイオセラピィ学会学術集会総会, Japanese, 昭和大学医学部内科学講座腫瘍内科学部門, 東京, Japan, Domestic conference
    Oral presentation

  • 大腸癌腫瘍免疫微小環境における CD4＋T 細胞に与える肥満の影響
    常城 宇生、斎藤 雅史、山下 公大、阿部 智喜、向山 知佑、安藤 正恭、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、掛地 吉弘
    第36回日本バイオセラピィ学会学術集会総会, Japanese, 昭和大学医学部内科学講座腫瘍内科学部門, 東京, Japan, Domestic conference
    Oral presentation

  • 安全な Collard 変法吻合を目指した変革と短期成績
    加藤 喬、押切 太郎、小寺澤 康文、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Oral presentation

  • 下部進行直腸癌に対する TaTME 併用の有用性とラーニングカーブに関する検討
    澤田 隆一郎、松田 武、山下 公大、長谷川 寛、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Oral presentation

  • ロボット支援食道切除における上縦隔リンパ節郭清手技と短期成績
    小寺澤 康文、押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Oral presentation

  • ロボット支援胃切除術におけるリンパ節郭清時間の learning curve
    裏川 直樹、金治 新悟、小寺澤 康文、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Oral presentation

  • 多発リンパ節転移を伴う進行食道癌に対する Minimally invasive esophagectomy
    後藤 裕信、押切 太郎、加藤 喬、小寺澤 康文、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Oral presentation

  • 経肛門アプローチ併用による２チーム側方郭清の手術手技と手術成績
    松田 武、澤田 隆一郎、長谷川 寛、山下 公大、加藤 喬、小寺澤 康文、原田 仁、後藤 裕信、裏川 直樹、金治 新悟、押切 太郎、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Public symposium

  • 人間工学に基づく「鏡視下クロソイド・カーブ針」の開発
    松田 武、山下 公大、長谷川 寛、澤田 隆一郎、後藤 裕信、裏川 直樹、原田 仁、小寺澤 康文、金治 新悟、押切 太郎、掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Oral presentation

  • ワークショップ27 NCD 解析で判った内視鏡外科のエビデンス創出－ビックデータを如何使うか－
    掛地 吉弘
    第36回日本内視鏡外科学会総会, Japanese, 秋田大学大学院医学系研究科 腎泌尿器科学講座, 横浜, Japan, Domestic conference
    Others

  • どうするJSCASの今後
    掛地 吉弘
    第32回日本コンピュータ外科学会大会, Japanese, 鹿児島大学学術研究院医歯学域医学系 小児外科学分野, 鹿児島, Japan, Domestic conference
    Oral presentation

  • 開会の辞
    掛地 吉弘
    KOBEヘルニアセミナー, Japanese, コヴィディエンジャパン株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • 総合座長
    掛地 吉弘
    KOBEヘルニアセミナー, Japanese, コヴィディエンジャパン株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • 当院における腹腔鏡下スリーブ状胃切除術の短期治療成績の検討
    裏川 直樹、金治 新悟、原田 仁、澤田 隆一郎、小寺澤 康文、後藤 裕信、長谷川 寛、廣田 勇士、山下 公大、松田 武、掛地 吉弘
    第44回日本肥満学会・第41回日本肥満症治療学会学術集会, Japanese, 東北大学大学院医学系研究科 糖尿病代謝内科学分野・岩手医科大学医学部内科学講座 糖尿病・代謝・内分泌内科分野, 仙台, Japan, Domestic conference
    Poster presentation

  • 食道扁平上皮癌とマクロファージとの直接共培養により発現亢進するIFI16はIL-1αの分泌を介して腫瘍進展に関与する
    安積 佑樹、大森 將貴、鳥越 陸矢、横尾 拓樹、中西 崇、山中 啓太郎、石原 伸朗、塚本 修一、都 鍾智、浦上 聡、児玉 貴之、西尾 真理、重岡 学、狛 雄一朗、掛地 吉弘、横崎 宏
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Poster presentation

  • 消化器癌と腸内細菌
    掛地 吉弘
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野・ミヤリサン製薬株式会社, 高崎, Japan, Domestic conference
    Public discourse

  • CDX2低発現大腸癌の臨床学的予後と腫瘍生物学的特性についての解析
    向山 順子、山下 公大、板野 理、掛地 吉弘、板野 理、Piero Dalerba
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Public symposium

  • 深層学習アルゴリズムに基づくイメージングサイトメトリーを用いた術前化学放射線療法後の直腸癌の新規予後因子の探索
    安達 祐里、山下 公大、長坂 暢、澤田 隆一郎、長谷川 寛、松田 武、加藤 喬、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Public symposium

  • 脂肪細胞によるがん幹細胞性制御機構
    下野 洋平、後藤 秀彰、林 孝典、ハレディアンベフヌーシュ、前田 真男、渋谷 尚樹、河野 誠之、船越 洋平、掛地 吉弘、南 博信
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Poster presentation

  • 大腸癌手術前後における腸内細菌と代謝物の変化についての検討
    向山 知佑、山下 公大、安達 祐里、常城 宇生、阿部 智喜、安藤 正恭、斎藤 雅史、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Public symposium

  • 放射線治療において抗腫瘍効果に寄与する腫瘍内CD8+T細胞の動態
    阿部 智喜、山下 公大、向山 知佑、安藤 正恭、常城 宇生、安達 祐里、斎藤 雅史、加藤 喬、澤田 隆一郎、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Public symposium

  • シンポジウム2「一歩進んだ腫瘍免疫研究」
    掛地 吉弘
    第34回日本消化器癌発生学会総会, Japanese, 群馬大学大学院医学系研究科 総合外科学講座 肝胆膵外科学分野, 高崎, Japan, Domestic conference
    Others

  • 女性外科医がAcademic surgeonとして多方面で活躍するために 働き方改革を契機としたインセンティブ導入の提言
    向山 順子、篠田 昌宏、掛地 吉弘、板野 理
    第85回日本臨床外科学会総会, Japanese, 川崎医科大学総合医療センター, 岡山, Japan, Domestic conference
    Oral presentation

  • [総会特別企画10-2-1] 女性外科医がAcademic surgeon として多方面で活躍するために 働き方改革を契機としたインセンティブ導入の提言
    掛地 吉弘
    第85回日本臨床外科学会総会, Japanese, 川崎医科大学総合医療センター, 岡山, Japan, Domestic conference
    Others

  • リアルワールドデータを用いた食道扁平上皮癌に対する術前補助化学療法/化学放射線療法の治療成績比較
    岡村 明彦、渡邊 雅之、奥居 潤、松田 諭竹、竹村 亮、川久保 博文、竹内 裕也、武藤 学、掛地 吉弘、北川 雄光、土岐 祐一郎
    第74回日本気管食道科学会総会ならびに学術講演会, Japanese, 独立行政法人国立病院機構 九州がんセンター 消化管外科, 福岡, Japan, Domestic conference
    Oral presentation

  • 高齢者に対する食道切除後の腸瘻チューブ留置による栄養介入の重要性
    加藤 喬、押切 太郎、小寺澤 康文、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第74回日本気管食道科学会総会ならびに学術講演会, Japanese, 独立行政法人国立病院機構 九州がんセンター 消化管外科, 福岡, Japan, Domestic conference
    Oral presentation

  • ランチョンセミナー4 食道がん治療の最前線 ～経験を踏まえた治療戦略～
    掛地 吉弘
    第74回日本気管食道科学会総会ならびに学術講演会, Japanese, 独立行政法人国立病院機構 九州がんセンター 消化管外科, 福岡, Japan, Domestic conference
    Others

  • リンパ節郭清個数からみるMinimally invasive esophagectomyにおける上縦隔リンパ節郭清の重要性
    小寺澤 康文、加藤 喬、押切 太郎、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第74回日本気管食道科学会総会ならびに学術講演会, Japanese, 独立行政法人国立病院機構 九州がんセンター 消化管外科, 福岡, Japan, Domestic conference
    Oral presentation

  • 学会臨床研究発表会
    掛地 吉弘
    第74回日本気管食道科学会総会ならびに学術講演会, Japanese, 独立行政法人国立病院機構 九州がんセンター 消化管外科, 福岡, Japan, Domestic conference
    Others

  • 要望演題8 残胃癌
    掛地 吉弘
    第53回胃外科・術後障害研究会, Japanese, 埼玉医科大学国際医療センター消化器外科, 東京, Japan, Domestic conference
    Others

  • Opening Remarks
    掛地 吉弘
    オプジーボ胃癌一次治療 2周年記念講演会, Japanese, Web, Japan, Domestic conference
    Others

  • 特別講演「新規ロボット導入のコツとHybrid RAS」
    掛地 吉弘
    第3回兵庫胃ビデオカンファレンス, Japanese, コヴィディエンジャパン株式会社, 神戸, Japan, Domestic conference
    Others

  • session3 消化器癌パート「消化器疾患における腸内細菌叢のインパクト」
    掛地 吉弘
    シンバイオティクスセミナー～腸内細菌叢の基礎と臨床～, Japanese, 株式会社ヤクルト本社, Web, Japan, Domestic conference
    Others

  • 講演I 「敗血症における支持療法～DIC を中心に～」
    掛地 吉弘
    Asahi Web Meeting～集中治療から DIC 管理まで考える～, Japanese, 旭化成ファーマ株式会社, Web, Japan, Domestic conference
    Others

  • 切除不能Stage4大腸癌においてCDX2の発現低下は予後予測因子である
    向山 順子、山下 公大、篠田 昌宏、板野 理、掛地 吉弘
    第31回日本消化器関連学会週間（JDDW2023）, Japanese, 一般社団法人 日本消化器関連学会機構, 神戸/Web, Japan, Domestic conference
    Poster presentation

  • 招待講演(消化器外科学会) Science and art in colorectal surgery
    掛地 吉弘
    第31回日本消化器関連学会週間（JDDW2023）, Japanese, 一般社団法人 日本消化器関連学会機構, 神戸/Web, Japan, Domestic conference
    Others

  • 統合プログラム4（PD）(JDDW・消化器病学会・消化器内視鏡学会・肝臓学会・消化器外科学会・消化器がん検診学会) 臨床研究の支援体制と実施体制の強化
    掛地 吉弘
    第31回日本消化器関連学会週間（JDDW2023）, Japanese, 一般社団法人 日本消化器関連学会機構, 神戸/Web, Japan, Domestic conference
    Others

  • 十二指腸表在性腫瘍に対する腹腔鏡内視鏡合同⼿術における結腸間膜尾側からの腹腔鏡アプローチの有⽤性の検討
    原田 仁、金治 新悟、澤田 隆一郎、小寺澤 康文、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、掛地 吉弘
    第26回腹腔鏡内視鏡合同手術研究会, Japanese, 神戸大学 食道胃腸外科・神戸大学 国際がん医療・研究センター 消化器内科, 神戸, Japan, Domestic conference
    Oral presentation

  • Clinical Significance of SUVmax on FDG-PET to Predict Treatment Response and Outcomes in Patients with Rectal Cancer Undergoing NACRT
    Tsuneki T, Matsuda T, Sawada R, Hasegawa R, Yamashita K, Koterazawa Y, Harada H, Urakawa N, Goto H, Kanaji S, Kakeji Y
    IASGO-CME Advanced Post-Graduate Course in Kobe 2023, English, Department of Surgery, Hepato-Biliary-Pancreatic Surgery Division, Graduate School of Medicine, Kobe University, Kobe, Japan, International conference
    Poster presentation

  • The advantage of geriatric nutritional risk index as a prognostic indicator for elderly patients with early gastric cancer after noncurative endoscopic resection
    Shimada A, Harada H, Kanaji S, Sawada R, Koterazawa Y, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Kakeji Y
    IASGO-CME Advanced Post-Graduate Course in Kobe 2023, English, Department of Surgery, Hepato-Biliary-Pancreatic Surgery Division, Graduate School of Medicine, Kobe University, Kobe, Japan, International conference
    Poster presentation

  • Special Seminar 2 「Current Status of Robotic Surgery for Rectal Cancer in Japan and its future Prospects」
    Kakeji Y
    IASGO-CME Advanced Post-Graduate Course in Kobe 2023, English, Department of Surgery, Hepato-Biliary-Pancreatic Surgery Division, Graduate School of Medicine, Kobe University, Kobe, Japan, International conference
    Others

  • 【 JATS 】ワークショップ 食道2 食道癌手術の周術期管理を考える
    掛地 吉弘
    第76回日本胸部外科学会定期学術集会, Japanese, 東北大学大学院医学系研究科 心臓血管外科学分野, 仙台, Japan, Domestic conference
    Others

  • The significance of geriatric nutritional risk index as a prognostic factor for early gastric cancer in elderly patients after non-curative endoscopic resection
    Harada H, Kanaji S, Sawada R, Koterazawa Y, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    The 3rd International Congress of the Asian Oncology Society (AOS2023), English, Department of Urology, Keio University School of Medicin, Yokohama, Japan, International conference
    Oral presentation

  • Albumin and derived neutrophil-to-lymphocyte ratio is a novel prognostic factor for patients with esophageal squamous cell carcinoma
    Abe T, Oshikiri T, Goto H, Koterazawa Y, Kato T, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    The 3rd International Congress of the Asian Oncology Society (AOS2023), English, Department of Urology, Keio University School of Medicin, Yokohama, Japan, International conference
    Oral presentation

  • AOS Symposium1 AI oncology in Asian countries
    Kakeji Y
    The 3rd International Congress of the Asian Oncology Society (AOS2023), English, Department of Urology, Keio University School of Medicin, Yokohama, Japan, International conference
    Others

  • Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasised low rectal cancer
    Hasegawa H, Matsuda T, Yamashita K, Sawada R, Harada H, Urakawa N, Goto H, Kanaji S, Oshikiri T, Kakeji Y
    The 3rd International Congress of the Asian Oncology Society (AOS2023), English, Department of Urology, Keio University School of Medicin, Yokohama, Japan, International conference
    Oral presentation

  • 当院における食道癌術前 DCF 療法と術前 CF 療法の後方視的検討
    徳山 長裕、飛松 和俊、加藤 喬、後藤 裕信、押切 太郎、掛地 吉弘、児玉 裕三
    第61回日本癌治療学会学術集会, Japanese, 慶應義塾大学医学部 泌尿器科学教室, 横浜, Japan, Domestic conference
    Poster presentation

  • 臓器別ワークショップ8 食道癌・食道胃接合部癌 －世界と日本の治療は共存可能か？－
    掛地 吉弘
    第61回日本癌治療学会学術集会, Japanese, 慶應義塾大学医学部 泌尿器科学教室, 横浜, Japan, Domestic conference
    Others

  • 特別講演③ 「大腸癌薬物療法～DEEPER試験を踏まえて～」
    掛地 吉弘
    Colorectal Cancer Seminar ～大腸がん治療の最新情報～, Japanese, メルクバイオファーマ株式会社, 博多, Japan, Domestic conference
    Others

  • 胃癌に対する最新集学的治療2023
    掛地 吉弘
    神戸消化器癌フォーラム2023@Web, Japanese, 日本化薬株式会社, Web, Japan, Domestic conference
    Invited oral presentation

  • 右肺腺癌虫垂転移に対して腹腔鏡下回盲部切除術を施行した１例
    金城 敏之、山下 公大、松田 武、澤田 隆一郎、長谷川 寛、後藤 裕信、金治 新悟、押切 太郎、立原 素子、掛地 吉弘
    第36回近畿内視鏡外科研究会, Japanese, 近畿大学医学部外科学 下部消化管部門, 豊中, Japan, Domestic conference
    Oral presentation

  • 腹腔鏡下に切除し得た成人骨盤嚢胞性腫瘤の２例
    今井 理揮、松田 武、澤田 隆一郎、長谷川 寛、山下 公大、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第36回近畿内視鏡外科研究会, Japanese, 近畿大学医学部外科学 下部消化管部門, 豊中, Japan, Domestic conference
    Oral presentation

  • 下部直腸癌に対するTaTMEの有用性とラーニングカーブ
    澤田 隆一郎、松田 武、山下 公大、長谷川 寛、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第36回近畿内視鏡外科研究会, Japanese, 近畿大学医学部外科学 下部消化管部門, 豊中, Japan, Domestic conference
    Public symposium

  • リンパ節転移比率からみるMinimally invasive esophagectomyにおける上縦隔リンパ節郭清の重要性
    小寺澤 康文、押切 太郎、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第36回近畿内視鏡外科研究会, Japanese, 近畿大学医学部外科学 下部消化管部門, 豊中, Japan, Domestic conference
    Public symposium

  • 当院におけるロボット支援下結腸切除術の導入 10例の経験
    長谷川 寛、松田 武、澤田 隆一郎、山下 公大、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第36回近畿内視鏡外科研究会, Japanese, 近畿大学医学部外科学 下部消化管部門, 豊中, Japan, Domestic conference
    Public symposium

  • ランチョンセミナー5 「進化する胃癌薬物治療～臨床データを踏まえた胃癌1次治療の選択ポイント～」
    掛地 吉弘
    日本消化器病学会近畿支部第119回例会, Japanese, 和歌山県立医科大学第二内科, 大阪, Japan, Domestic conference
    Others

  • 特別講演「大腸癌治療のUP TO DATE ～Well-beingを目指した新しい消化器外科教育を含めて～」
    掛地 吉弘
    第39回兵庫大腸癌治療研究会, Japanese, 大鵬薬品工業株式会社・ミヤリサン製薬株式会社, Web, Japan, Domestic conference
    Others

  • The advantage of geriatric nutritional risk index as a prognostic indictor for elderly patients with early gastric cancer after non-curative endoscopic resection
    Imai M, Harada H, Kanaji S, Sawada R, Koterazawa Y, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    The Korea International Gastric Cancer Week 2023 (KINGCA WEEK 2023), English, The Korean Gastric Cancer Association, Seoul, Korea, Republic of, International conference
    Oral presentation

  • Efficacy of 18F-fluoro-2-deoxyglucose positron emission tomography as a predictor of treatment response to neoadjuvant chemotherapy for gastric cancer
    Yokoo H, Urakawa N, Kato T, Sawada R, Koterazawa Y, Harada H, Goto H, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    The Korea International Gastric Cancer Week 2023 (KINGCA WEEK 2023), English, The Korean Gastric Cancer Association, Seoul, Korea, Republic of, International conference
    Oral presentation

  • National Clinical Database in Japan
    Kakeji Y
    The Korea International Gastric Cancer Week 2023 (KINGCA WEEK 2023), English, The Korean Gastric Cancer Association, Seoul, Korea, Republic of, International conference
    Public symposium

  • 講師
    掛地 吉弘
    第2回～Anastomosis Master～, Japanese, ジョンソンエンドジョンソン株式会社, 神戸, Japan, Domestic conference
    Public discourse

  • 開会の挨拶
    掛地 吉弘
    第1回 Hanshin-GI, Japanese, 大鵬薬品工業株式会社, 大阪/Web, Japan, Domestic conference
    Others

  • 2レジメンの特徴を踏まえた、食道がん1次治療におけるこれからの治療戦略
    掛地 吉弘
    食道がん1次治療承認1周年記念講演会, Japanese, ブリストルマイヤーズスクイブ株式会社・小野薬品工業株式会社, 大阪/Web, Japan, Domestic conference
    Others

  • がん診療における漢方の役割
    掛地 吉弘
    Oncology&漢方 Hybrid Seminar, Japanese, 株式会社ツムラ, 大阪/Web, Japan, Domestic conference
    Others

  • HER2陽性胃癌の治療戦略
    掛地 吉弘
    Gastric Cancer Web Seminar, Japanese, 第一三共株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • 総合司会
    掛地 吉弘
    第3回神戸ラパロ道場, Japanese, コヴィディエンジャパン株式会社, 神戸, Japan, Domestic conference
    Others

  • 深層学習に基づくイメージサイトメトリーによる直腸癌の新規予後因子の探索
    山下 公大、長坂 暢、澤田 隆一郎、長谷川 寛、松田 武、小寺澤 康文、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第33回日本サイトメトリー学会学術集会, Japanese, 杏林大学大学院医学研究科 共同研究施設フロ−サイトメトリ−部門, Web, Japan, Domestic conference
    Poster presentation

  • 日本消化器外科学会のデータベース (DB) 事業の取り組み
    上野 秀樹、掛地 吉弘、若林 剛、今野 弘之、後藤 満一、北川 雄光
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Others

  • 術前補助療法後に原発巣 CR を達成した症例の予後因子解析; 多施設後ろ向き観察研究
    岡村 明彦、渡邊 雅之、奥居 潤、松田 諭、竹村 亮、川久保 博文、竹内 裕也、掛地 吉弘、北川 雄光、土岐 祐一郎
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Public symposium

  • 年齢と術前化学療法レジメンが術後合併症発生例の予後悪化に及ぼす影響 -85 施設による多施設共同研究
    松田 諭、北川 雄光、奥居 潤、岡村 明彦、川久保 博文、竹村 亮、掛地 吉弘、竹内 裕也、渡邊 雅之、土岐 祐一郎
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Public symposium

  • 消化器外科学会の挑戦～真の男女共同参画への道のりとマイルストーン～
    大越 香江、遠藤 英樹、野村 幸世、河野 恵美子、藤田 悠介、安福 至、肥田 侯矢、山本 博之、宮田 裕章、吉田 和弘、掛地 吉弘、調 憲、北川 雄光
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Others

  • 日本における男性外科医と女性外科医の手術修練格差
    河野 恵美子、五十棲 麗、野村 幸世、大越 香江、山本 博之、宮田 裕章、安福 至、前田 広道、坂本 純一 、内山 和久、掛地 吉弘、吉田 和弘、北川 雄光
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Others

  • 直腸癌の術前化学放射線療法への抵抗性における Wnt/β-catenin シグナル活性化の重要性
    都 鍾智、松田 武、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 高齢胃癌患者への内視鏡治療後非治癒切除症例における予後因子の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 当院における TaTME 併用大腸全摘術の手術成績の検討
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Public symposium

  • 術中診断にて漿膜浸潤以上の深達度であった進行胃癌に対する腹腔鏡下胃切除の安全性に関する検討
    金治 新悟、裏川 直樹、原田 仁、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Public symposium

  • 当院における進行胃癌に対するロボット支援下胃切除術の短期治療成績の検討
    裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 日本胃癌学会の NCD 利活用
    掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Others

  • 特別企画6 【データベース委員会】NCD研究の現状と展望
    掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Others

  • ASA 分類 Class 3 以上の大腸癌患者に対する腹腔鏡手術と開腹手術の比較検討
    常城 宇生、松田 武、山下 公大、長谷川 寛、澤田 隆一郎、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 高齢者食道癌患者に対する胸腔鏡下食道切除術
    安達 祐里、押切 太郎、後藤 裕信、加藤 喬、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 短期・長期成績からみた下部直腸癌に対するTaTME の有用性について
    松田 武、山下 公大、長谷川 寛、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 高齢者に対する胸腔鏡下食道切除後の経腸栄養は sarcopenia を予防できるか?
    加藤 喬、押切 太郎、後藤 裕信、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • パネルディスカッション 3 【上部】【 Challenges beyond borders 】高度進行胃癌に対する conversion surgery の現状と新たな治療戦略
    掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Others

  • ランチョンセミナー15 実践！胃癌一次治療におけるオプジーボ併用療法のエビデンスと臨床への活かし方
    掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座・小野薬品工業株式会社・ブリストルマイヤーズスクイブ株式会社, 函館, Japan, Domestic conference
    Others

  • 鼠経転移を伴う直腸肛門腺癌に対する術前治療と選択的側方郭清の治療成績
    長谷川 寛、松田 武、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 十二指腸浸潤を伴う胃癌に対する胃切除術の安全性の検討
    横尾 拓樹、金治 新悟、裏川 直樹、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • ロボット支援下食道切除術の術者育成
    後藤 裕信、押切 太郎、加藤 喬、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • AI 組織診断を用いた術前化学放射線療法後直腸癌の腫瘍 CD8+T 細胞の評価法の開発とその応用
    山下 公大、長坂 暢、阿河 杏介、阿部 智喜、澤田 隆一郎、長谷川 寛、松田 武、金治 新悟、押切 太郎、掛地 吉弘
    第78回日本消化器外科学会総会, Japanese, 弘前大学大学院医学研究科消化器外科学講座, 函館, Japan, Domestic conference
    Oral presentation

  • 作用機序からみた漢方と消化管治療
    掛地 吉弘
    第23回千葉消化管運動機能研究会, Japanese, 千葉消化管運動機能研究会・株式会社ツムラ, 千葉/Web, Japan, Domestic conference
    Others

  • 下部直腸癌に対するTaTMEの有用性とラーニングカーブ
    澤田 隆一郎、松田 武、山下 公大、長谷川 寛、小寺澤 康文、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第99回大腸癌研究会学術集会, Japanese, 関西労災病院 外科, 尼崎, Japan, Domestic conference
    Oral presentation

  • 日本胃癌学会合同企画シンポジウム 胃癌の最新トピックス～ピロリ菌感染診断、未感染胃癌、治療法の進歩
    掛地 吉弘
    第29回日本ヘリコバクター学会学術集会, Japanese, 杏林大学医学部感染症学教室, 東京/Web, Japan, Domestic conference
    Others

  • 高齢者に対する腹臥位胸腔鏡下食道切除術
    後藤 裕信、押切 太郎、加藤 喬、安達 祐里、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第77回日本食道学会学術集会, Japanese, 近畿大学医学部 外科学教室上部消化管部門, 大阪, Japan, Domestic conference
    Poster presentation

  • 全周性かつ表層拡大食道癌症例の特徴と手術治療成績
    加藤 喬、押切 太郎、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、掛地 吉弘
    第77回日本食道学会学術集会, Japanese, 近畿大学医学部 外科学教室上部消化管部門, 大阪, Japan, Domestic conference
    Poster presentation

  • 高齢者食道癌における術前化学療法、術後合併症の予後への影響
    松田 諭、北川 雄光、奥居 潤、岡村 明彦、川久保 博文、竹村 亮、掛地 吉弘、竹内 裕也、渡邊 雅之、土岐 祐一郎
    第77回日本食道学会学術集会, Japanese, 近畿大学医学部 外科学教室上部消化管部門, 大阪, Japan, Domestic conference
    Public symposium

  • 食道胃接合部癌に対する腹腔鏡下経裂孔的再建における左横隔膜開放法の有用性
    金治 新悟、裏川 直樹、原田 仁、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本食道学会学術集会, Japanese, 近畿大学医学部 外科学教室上部消化管部門, 大阪, Japan, Domestic conference
    Public symposium

  • 短期・長期成績からみたロボット支援食道切除術のエビデンス
    押切 太郎、後藤 裕信、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第77回日本食道学会学術集会, Japanese, 近畿大学医学部 外科学教室上部消化管部門, 大阪, Japan, Domestic conference
    Public symposium

  • MOAから考える長期生存効果の意義
    掛地 吉弘
    オプジーボ胃癌Web Liveセミナー, Japanese, 小野薬品工業株式会社・ブリストルマイヤーズスクイブ株式会社, Web, Japan, Domestic conference
    Others

  • 閉会の挨拶
    掛地 吉弘
    第11回若手消化器外科腹腔鏡セミナー, Japanese, 神戸大学大学院医学研究科外科学講座 食道胃腸外科学分野・肝胆膵外科学分野, 神戸, Japan, Domestic conference
    Others

  • 大腸癌腫瘍免疫微小環境におけるCD4＋T細胞に与える肥満の影響
    常城 宇生、斎藤 雅史、山田 康太、安藤 正恭、山下 公大、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第44回癌免疫外科研究会, Japanese, 千葉大学大学院医学研究院 先端応用外科, 千葉, Japan, Domestic conference
    Oral presentation

  • 化学放射線治療による腫瘍微小環境の変化～深層学習に基づくイメージサイトメトリーを用いた術前化学放射線療法後の直腸癌の新規予後因子の探索～
    安達 祐里、山下 公大、長坂 暢、澤田 隆一郎、長谷川 寛、松田 武、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第44回癌免疫外科研究会, Japanese, 千葉大学大学院医学研究院 先端応用外科, 千葉, Japan, Domestic conference
    Oral presentation

  • Neutrophil lymphocyte ratio and histological response correlate with prognosis of gastric cancer undergoing neoadjuvant chemotherapy
    Urakawa N, Kanaji S, Sawada R, Harada H, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Oral presentation

  • Luncheon Seminar 11 : Proximal gastrectomy: For better postoperative function
    Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Others

  • Practical use of National Clinical Database in gastric cancer treatment
    Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Oral presentation

  • Translational 1 : Artificial intelligence in the management of gastric cancer
    Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Others

  • Safety of laparoscopic gastrectomy for advanced gastric cancer with greater than serosal invasion depth
    Kanaji S, Urakawa N, Harada H, Kato T, Sawada R, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Oral presentation

  • The prognostic factors of early gastric cancer in elderly patients after non-curative endoscopic resection
    Harada H, Kanaji S, Sawada R, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Oral presentation

  • Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association
    Fukagawa T, Nunobe S, Ishikawa T, Kakeji Y
    The 15th International Gastric Cancer Congress (IGCC 2023), English, Department of Surgery, Keio University School of Medicine, Yokohama, Japan, Domestic conference
    Others

  • 難治性食道狭窄に対する腹腔鏡下食道バイパス術の工夫点と成績
    加藤 喬、押切 太郎、中村 哲、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第193回兵庫県外科医会学術集会, Japanese, 兵庫県外科医会, 神戸, Japan, Domestic conference
    Oral presentation

  • 高齢者食道癌患者に対する胸腔鏡下食道切除術
    安達 祐里、後藤 裕信、押切 太郎、加藤 喬、小寺澤 康文、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第66回関西胸部外科学会学術集会, Japanese, JCHO大阪病院, 大阪, Japan, Domestic conference
    Public symposium

  • 進行食道癌に対するロボット支援下食道切除
    後藤 裕信、押切 太郎、加藤 喬、小寺澤 康文、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第66回関西胸部外科学会学術集会, Japanese, JCHO大阪病院, 大阪, Japan, Domestic conference
    Public symposium

  • ランチョンセミナー5 「切除不能進行・再発胃癌に対する化学療法」
    掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科・日本イーライリリー株式会社, 横浜, Japan, Domestic conference
    Others

  • 食道切除 ・ 胸骨後再建後胃管切除に対する仰臥位胸腔鏡アプローチ
    鳥越 陸矢、掛地 吉弘、押切 太郎、松田 武、山下 公大、金治 新悟、長谷川 寛、後藤 裕信、裏川 直樹、原田 仁、澤田 隆一郎、加藤 喬
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Poster presentation

  • The mGPS is a significant oncological marker of rectal cancer patients undergoing NACRT.
    島田 淳司、松田 武、山下 公大、長谷川 寛、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Oral presentation

  • 切除不能進行胃癌に対する姑息的胃切除術の安全性に関する検討
    安積 佑樹、原田 仁、金治 新悟、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Oral presentation

  • 大量の難治性乳び腹水を伴う直腸間膜リンパ管嚢腫破裂に対して手術加療を施行した 1 例
    徳原 佳織、松田 武、山下 公大、長谷川 寛、澤田 隆一郎、王子 健太郎、加藤 喬、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Others

  • 当院における TaTME 併用による大腸全摘術、 回腸嚢肛門吻合術の手術成績
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Public symposium

  • 高齢胃癌患者の内視鏡治療後非治癒切除症例における予後因子の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Public symposium

  • 血行再建を伴う胸壁前有茎空腸再建術の有用性
    安達 祐里、押切 太郎、後藤 裕信、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、野村 正、榊原 俊介、寺師 浩人、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Public symposium

  • 膵臓側に位置する表在性非乳頭部十二指腸腫瘍に対する腹腔鏡内視鏡合同手術の工夫
    白神 直人、金治 新悟、原田 仁、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Public symposium

  • 自律神経を意識した腹臥位胸腔鏡下食道切除術
    雑賀 裕士、後藤 裕信、押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Public symposium

  • NACRT 後の直腸癌の腫瘍微小環境の変化～ AI を用いた新規予後因子の探索～
    阿部 智喜、山下 公大、長坂 暢、阿河 杏介、山田 康太、向山 知佑、安藤 正恭、澤田 隆一郎、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Public symposium

  • シンポジウム 3 「癌治療における術前術後集学的治療の現状と成績」
    掛地 吉弘
    第48回日本外科系連合学会学術集会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜, Japan, Domestic conference
    Others

  • 症例報告セッション
    掛地 吉弘
    第32回日本癌病態治療研究会, Japanese, 自治医科大学, さいたま, Japan, Domestic conference
    Others

  • 一般演題 「胃 5」
    掛地 吉弘
    第45回日本癌局所療法研究会, Japanese, 順天堂大学医学部・消化器外科学講座下部消化管外科, 東京, Japan, Domestic conference
    Others

  • 鼠径部転移を伴う直腸肛門腺癌に対する術前治療と選択的側方郭清の治療成績
    中西 崇、長谷川 寛、松田 武、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第45回日本癌局所療法研究会, Japanese, 順天堂大学医学部・消化器外科学講座下部消化管外科, 東京, Japan, Domestic conference
    Oral presentation

  • 消化器癌と腸内細菌
    掛地 吉弘
    第45回日本癌局所療法研究会, Japanese, 順天堂大学医学部・消化器外科学講座下部消化管外科・ミヤリサン製薬株式会社, 東京, Japan, Domestic conference
    Public discourse

  • 直腸癌の術前化学放射線療法への抵抗性における Wnt/ β -catenin シグナル活性化の重要性
    都 鍾智、松田 武、加藤 喬、清水 将来、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、押切 太郎、掛地 吉弘
    第45回日本癌局所療法研究会, Japanese, 順天堂大学医学部・消化器外科学講座下部消化管外科, 東京, Japan, Domestic conference
    Oral presentation

  • 兵庫県エリアセミナー：症例ディスカッション 食道がん１次治療におけるレジメン選択
    掛地 吉弘
    食道癌オプジーボWEBライブセミナー, Japanese, ブリストルマイヤーズスクイブ株式会社・小野薬品工業株式会社, 神戸, Japan, Domestic conference
    Others

  • 【賛助講演】 鼠径部ヘルニアの新NCD登録に対する要望と今後の日本ヘルニア学会に期待すること
    掛地 吉弘
    第21回日本ヘルニア学会学術集会, Japanese, 大阪府済生会吹田病院へルニアセンター, 大阪, Japan, Domestic conference
    Public symposium

  • 当科における全身合併症を伴う鼠径部ヘルニア手術の周術期管理の安全性の検討
    裏川 直樹、鍵山 大起、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第21回日本ヘルニア学会学術集会, Japanese, 大阪府済生会吹田病院へルニアセンター, 大阪, Japan, Domestic conference
    Public symposium

  • 胃癌の集学的治療戦略
    掛地 吉弘
    第５回サージカルフォーラム in Fukui, Japanese, 科研製薬株式会社, 福井, Japan, Domestic conference
    Others

  • Session2 ゲノム医療で変わる？大腸癌薬物療法
    掛地 吉弘
    第10回平成大腸癌カンファレンス, Japanese, 中外製薬株式会社, 神戸, Japan, Domestic conference
    Others

  • 難治性食道狭窄に対する腹腔鏡下食道バイパス術の工夫点と成績
    加藤 喬、押切 太郎、中村 哲、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第77回手術手技研究会, Japanese, 愛知医科大学 消化器外科, 名古屋, Japan, Domestic conference
    Public symposium

  • 当院における経肛門的アプローチ併用による大腸全摘出の手術手技
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第77回手術手技研究会, Japanese, 愛知医科大学 消化器外科, 名古屋, Japan, Domestic conference
    Public symposium

  • 当院におけるロボット支援下胃切除術のメインデバイスの変遷
    裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回手術手技研究会, Japanese, 愛知医科大学 消化器外科, 名古屋, Japan, Domestic conference
    Public symposium

  • 学術セミナー14 救急医療におけるチームマネジメント
    掛地 吉弘
    第38回日本臨床栄養代謝学会学術集会, Japanese, 神戸大学大学院医学研究科 外科系講座 災害・救急医学分野・旭化成ファーマ株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • 教育講演9 重症患者に対する栄養療法 その患者さんにタンパク制限はNGです！
    掛地 吉弘
    第38回日本臨床栄養代謝学会学術集会, Japanese, 神戸大学大学院医学研究科 外科系講座 災害・救急医学分野, 神戸/Web, Japan, Domestic conference
    Others

  • 外科学会における働き方改革の取り組み
    掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科・消化器外科女性医師の活躍を応援する会, 東京, Japan, Domestic conference
    Others

  • 貧血が直腸癌低位前方切除術後合併症に与える影響
    山田 岳史、遠藤 英樹、長谷川 寛、掛地 吉弘、山本 博之、宮田 裕章、大塚 幸喜、松田 明久、吉田 寛、北川 雄光
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • 外科医獲得にむけた外科学講座全体での取り組み
    小松 昇平、岡田 健次、掛地 吉弘、國久 智成、尾藤 祐子、眞庭 謙昌、福本 巧
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Others

  • 外科医で女性で子持ちで研究者は四重苦？ Physician scientist として「外科的治療だけでは難しい癌」を外科医が研究する意義
    向山 順子、篠田 昌宏、掛地 吉弘、板野 理
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Others

  • オープンソースの物体検出アルゴリズム YOLOv3 を用いた胸腔鏡下食道亜全摘術の手術動画解析
    押切 太郎、工藤 拓也、山崎 悠太、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • 知っておきたい外科学の最新トピックス 8 胃癌外科治療の最新トピックス
    掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Others

  • 下部進行直腸癌に対する術前化学放射線療法と選択的側方郭清の治療成績
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Poster presentation

  • 食道切除後長期の腸瘻での栄養管理はサルコペニアを予防する
    加藤 喬、押切 太郎、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • AI 病理診断システムを用いた直腸癌の新規予後因子の探索
    阿部 智喜、山下 公大、安藤 正恭、向山 知佑、阿河 杏介、山田 康太、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • 局所進行直腸癌術前療法における腫瘍内レジデントメモリー CD8+T 細胞の動態とその役割
    山下 公大、長坂 暢、阿河 杏介、阿部 智喜、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、高村 史記、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • Diversity からさらに未来へ～Diversity だけで十分ですか？ ～
    石田 苑子、中村 哲、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Others

  • 特別企画 2 女性外科医コンセプトから，より包括的ダイバーシティ推進へ
    掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Others

  • 経肛門アプローチによる側方郭清の標準化手術手技と手術成績
    松田 武、山下 公大、長谷川 寛、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • ランチョンセミナー（2） 胃癌・食道胃接合部癌に対する集学的治療の Best Practice
    掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科・日本イーライリリー株式会社, 東京, Japan, Domestic conference
    Others

  • 食道胃接合部癌に対する経裂孔的腹腔鏡下 y 字型食道胃管吻合の有用性
    金治 新悟、裏川 直樹、原田 仁、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • 当院における胃・食道胃接合部腺癌に対する術前化学療法の治療成績の検討
    裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • cStageIV 胃癌の conversion surgery における周術期化学療法の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第123回日本外科学会定期学術集会, Japanese, 東京慈恵会医科大学 外科学講座 血管外科, 東京, Japan, Domestic conference
    Public symposium

  • 進行・再発食道がん1次治療におけるオプジーボベースレジメンの特徴と位置づけ
    掛地 吉弘
    食道がんオプジーボWEBライブセミナー-周術期から進行・再発まで-, Japanese, 小野薬品工業株式会社・ブリストルマイヤーズスクイブ株式会社, Web, Japan, Domestic conference
    Others

  • 食道がん周術期におけるICIを用いた治療戦略
    掛地 吉弘
    食道がんオプジーボWEBライブセミナー-周術期から進行・再発まで-, Japanese, 小野薬品工業株式会社・ブリストルマイヤーズスクイブ株式会社, Web, Japan, Domestic conference
    Others

  • 特別講演 「大腸がん治療における最新のエビデンスと今後の展望」
    掛地 吉弘
    第38回兵庫大腸癌治療研究会, Japanese, ミヤリサン製薬株式会社・大鵬薬品工業株式会社, Web, Japan, Domestic conference
    Others

  • 特別講演 胃癌一次治療のベストプラクティス～最新情報と治療戦略～
    掛地 吉弘
    Gastric Cancer Update Seminar, Japanese, ブリストルマイヤーズスクイブ株式会社・小野薬品工業株式会社, Web, Japan, Domestic conference
    Others

  • Session 2：胃癌パート 長期フォローアップから見えてきたオプジーボ併用化学療法の真価
    掛地 吉弘
    Upper GI WEB ライブセミナー, Japanese, 小野薬品工業株式会社・ブリストルマイヤーズススクイブ株式会社, Web, Japan, Domestic conference
    Others

  • 閉会挨拶
    掛地 吉弘
    上部消化管内視鏡手術セミナー, Japanese, オリンパスマーケティング株式会社, Web, Japan, Domestic conference
    Others

  • 座長
    掛地 吉弘
    上部消化管内視鏡手術セミナー, Japanese, オリンパスマーケティング株式会社, Web, Japan, Domestic conference
    Others

  • 開会挨拶
    掛地 吉弘
    上部消化管内視鏡手術セミナー, Japanese, オリンパスマーケティング株式会社, Web, Japan, Domestic conference
    Others

  • 特別講演 当院におけるロボット手術の教育と取り組み
    掛地 吉弘
    神戸消化器外科手術手技セミナー, Japanese, テルモ株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • 司会
    掛地 吉弘
    第２回兵庫胃ビデオカンファレンス, Japanese, コヴィディエンジャパン株式会社, 神戸, Japan, Domestic conference
    Others

  • 胃癌治療戦略2023
    掛地 吉弘
    甲信がん Total Care Web Seminar, Japanese, 第一三共株式会社, Web, Japan, Domestic conference
    Oral presentation

  • がん診療における漢方の役割
    掛地 吉弘
    TSUMURA Surgery SEMINAR, Japanese, 株式会社ツムラ, Web, Japan, Domestic conference
    Others

  • Workshop2 Establishment of postoperative QOL evaluation method for gastric cancer
    Kakeji Y
    第95回日本胃癌学会総会, English, 静岡県立静岡がんセンター内視鏡科, Sapporo, Japan, Domestic conference
    Others

  • 残胃進行癌（幽門側胃切除後）の至適リンパ節郭清範囲
    片井 均、石川 卓、赤澤 宏平、深川 剛生、宮代 勲、布部 創也、鈴木 知志、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Public symposium

  • 切除不能進行胃癌に対する姑息的胃切除術の安全性に関する検討
    山田 康太、金治 新悟、原田 仁、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Public symposium

  • 高齢の胃癌患者に対する術前化学療法の安全性の検討
    向山 知佑、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Poster presentation

  • 当院におけるCY1を伴う進行胃癌に対する集学的治療戦略
    裏川 直樹、金治 新悟、原田 仁、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Poster presentation

  • 胃癌切除例におけるpoorly cohesive carcinomaの臨床病理学的特徴と予後に関する検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Public symposium

  • 新規半消化態栄養剤を用いた胃癌術後経口栄養療法の安全性に関する検討
    安積 佑樹、金治 新悟、原田 仁、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、押切 太郎、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Poster presentation

  • 腹腔鏡下経裂孔アプローチにおける左横隔膜開放法による下縦隔郭清・再建の安全性に関する検討
    金治 新悟、裏川 直樹、原田 仁、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Poster presentation

  • ランチョンセミナー7 HER2陽性胃癌の最適な治療シークエンスを考える
    掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科・第一三共株式会社, 札幌, Japan, Domestic conference
    Others

  • ランチョンセミナー3
    掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科・大鵬薬品工業株式会社, 札幌, Japan, Domestic conference
    Others

  • 胃癌学会の進路
    掛地 吉弘
    第95回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター内視鏡科, 札幌, Japan, Domestic conference
    Others

  • StageIV胃癌のconversion surgeryにおける周術期化学療法と予後の検討
    横尾 拓樹、原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第55回制癌剤適応研究会, Japanese, 横浜市立大学 消化器・腫瘍外科学, 鎌倉, Japan, Domestic conference
    Public symposium

  • 放射線治療による腫瘍微小環境の変化～ AI組織解析システムを用いた術前化学放射線療法後の直腸癌の新規予後因子の探索～
    阿部 智喜、山下 公大、長坂 暢、阿河 杏介、山田 康太、向山 知佑、安藤 正恭、澤田 隆一郎、長谷川 寛、松田 武、押切 太郎、掛地 吉弘
    第55回制癌剤適応研究会, Japanese, 横浜市立大学 消化器・腫瘍外科学, 鎌倉, Japan, Domestic conference
    Public symposium

  • シンポジウム3-3 Conversion surgery；適応のエビデンスとは？ 消化管
    掛地 吉弘
    第55回制癌剤適応研究会, Japanese, 横浜市立大学 消化器・腫瘍外科学, 鎌倉, Japan, Domestic conference
    Others

  • 漢方を使う消化管集学的治療
    掛地 吉弘
    守口門真漢方実践 病診薬連携セミナー, Japanese, 株式会社ツムラ, 守口, Japan, Domestic conference
    Others

  • The mGPS is a significant oncological marker of rectal cancer patients undergoing NACRT
    Shimada A, Matsuda T, Yamashita K, Hasegawa H, Sawada R, Harada H, Urakawa N, Goto H, Kanaji S, Oshikiri T, Kakeji Y
    The 18th Annual Academic Surgical Congress, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, Washington, DC, United States, Domestic conference
    Oral presentation

  • Risk factor for stricture after cervical triangular anastomosis in Minimally Invasive Esophagectomy
    Saiga H, Oshikiri T, Goto H, Kato T, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    The 18th Annual Academic Surgical Congress, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, Washington, DC, United States, Domestic conference
    Others

  • 胃癌・食道胃接合部癌の術前化学療法効果診断における組織学的効果判定および宿主免疫指標マーカーの有用性の検討
    裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第19回日本消化管学会総会学術集会, Japanese, 日本医科大学消化器内科学・日本医科大学付属病院消化器・肝臓内科, 東京, Japan, Domestic conference
    Public symposium

  • コアシンポジウム2 消化管腫瘍の新展開 【治療効果の診断と治療法選択】
    掛地 吉弘
    第19回日本消化管学会総会学術集会, Japanese, 日本医科大学消化器内科学・日本医科大学付属病院消化器・肝臓内科, 東京, Japan, Domestic conference
    Others

  • 当院における若年者大腸癌手術症例の検討
    阿部 智喜、長谷川 寛、澤田 隆一郎、山下 公大、松田 武、加藤 喬、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第98回大腸癌研究会学術集会, Japanese, 順天堂大学大学院医学研究科・人体病理病態学, 東京, Japan, Domestic conference
    Poster presentation

  • 胃癌治療戦略2023
    掛地 吉弘
    日本消化器病学会近畿支部第118回例会, Japanese, 京都府立医科大学大学院医学研究科消化器外科学・日本イーライリリー株式会社, 京都, Japan, Domestic conference
    Others

  • 食道胃接合部腺癌に対する当科の治療戦略
    裏川 直樹、金治 新悟、原田 仁、掛地 吉弘
    日本消化器病学会近畿支部第118回例会, Japanese, 京都府立医科大学大学院医学研究科消化器外科学, 京都, Japan, Domestic conference
    Public symposium

  • 気付いていますか？がん患者の体重減少
    掛地 吉弘
    エドルミズWEBライブセミナー, Japanese, 小野薬品工業株式会社, Web, Japan, Domestic conference
    Others

  • Opening Remarks
    掛地 吉弘
    Gastric Cancer Forum 2022, Japanese, 第一三共株式会社, 東京/Web, Japan, Domestic conference
    Others

  • Hybrid abdominal robotic approach with TaTME for low rectal cancer
    Matsuda T, Yamashita K, Hasegawa H, Sawada R, Urakawa N, Kanaji S, Oshikiri T, Kakeji Y
    Asian-Pacific Congress of Robotic Laparoscopic Surgery 2022 (ACRLS2022), English, Fujita Health University Hospital International Medical Center, Nagoya/web, Japan, Domestic conference
    Public symposium

  • Novel “Modified Bascule method” for lymphadenectomy along the left recurrent laryngeal nerve during robot-assisted minimally invasive esophagectomy
    Oshikiri T, Goto H, Kato T, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Kakeji Y
    Asian-Pacific Congress of Robotic Laparoscopic Surgery 2022 (ACRLS2022), English, Fujita Health University Hospital International Medical Center, Nagoya/web, Japan, Domestic conference
    Oral presentation

  • 胸腔鏡下食道悪性腫瘍手術における術中体位が術後肺炎発症に与える影響；NCD データ 9850 例の解析から
    岡村 明彦、渡邊 雅之、菊池 寛利、金治 新悟、森田 勝、掛地 吉弘、土岐 祐一郎、北川 雄光
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Public symposium

  • ロボット支援下食道切除術の胸腔鏡手術と比較した短期成績：NCD 解析結果
    錦織 達人、小濱 和貴、須田 康一、角田 茂、興田 幸恵、日景 允、柴崎 晋、田中 毅、寺島 雅典、掛地 吉弘、猪股 雅史、北川 雄光、酒井 義治、能城 浩和、宇山 一朗
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Public symposium

  • 難治性食道狭窄に対する腹腔鏡下食道バイパス術の工夫点と成績
    加藤 喬、押切 太郎、後藤 裕信、山崎 悠太、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、中村 哲、黒田 大介、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Oral presentation

  • 食道癌に対する腹臥位胸腔鏡下食道切除術の短期・長期成績
    後藤 裕信、押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Oral presentation

  • 一般演題（口演） 48 上部 高齢者
    掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Others

  • 腫瘍深達度が漿膜浸潤以上の進行胃癌に対する腹腔鏡下胃切除の安全性に関する検討
    金治 新悟、原田 仁、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Oral presentation

  • 直腸癌に対する Abdominal robotic approach 併用による Hybrid TaTME
    安藤 正恭、松田 武、山下 公大、長谷川 寛、澤田 隆一郎、原田 仁、後藤 裕信、裏川 直樹、金治 新悟、押切 太郎、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Oral presentation

  • Transanal アプローチ併用側方郭清の治療成績と安全に行うための工夫
    松田 武、山下 公大、長谷川 寛、澤田 隆一郎、裏川 直樹、原田 仁、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Oral presentation

  • 当科における残胃癌に対する腹腔鏡下残胃全摘術の手術成績と予後の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Public symposium

  • ロボット支援食道切除の短期成績 - 胸腔鏡手術との比較 -
    押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第35回日本内視鏡外科学会総会, Japanese, 藤田医科大学 先端ロボット・内視鏡手術学講座, 名古屋, Japan, Domestic conference
    Public symposium

  • 切除不能Stage4 大腸癌におけるマイクロRNA-221 の発現意義
    向山 順子、阿河 杏介、山下 公大、板野 理、掛地 吉弘
    第26回日本バイオ治療法学会学術集会, Japanese, 徳島大学大学院社会産業理工学研究部生物資源産業学域, 大阪, Japan, Domestic conference
    Oral presentation

  • AI 病理診断システムを用いた直腸癌の新規予後因子の探索
    阿部 智喜、山下 公大、長坂 暢、阿河 杏介、山田 康太、向山 知佑、安藤 正恭、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第26回日本バイオ治療法学会学術集会, Japanese, 徳島大学大学院社会産業理工学研究部生物資源産業学域, 大阪, Japan, Domestic conference
    Oral presentation

  • 肥満が大腸癌腫瘍微小環境のCD4陽性T細胞に及ぼす影響
    山田 康太、斎藤 雅史、山下 公大、安藤 正恭、阿部 智喜、向山 知佑、阿河 杏介、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、廣田 勇士、松田 武、押切 太郎、掛地 吉弘
    第43回日本肥満学会・第40回日本肥満症治療学会学術集会, Japanese, 琉球大学大学院 医学研究科 内分泌代謝・血液・膠原病内科学講座（第二内科）・大分大学医学部 消化器・小児外科学講座, 那覇, Japan, Domestic conference
    Oral presentation

  • COVID19 感染下における腹腔鏡下スリーブ状胃切除術の導入と短期治療成績
    裏川 直樹、向山 知佑、山田 康太、澤田 隆一郎、原田 仁、長谷川 寛、金治 新悟、廣田 勇士、松田 武、押切 太郎、掛地 吉弘
    第43回日本肥満学会・第40回日本肥満症治療学会学術集会, Japanese, 琉球大学大学院 医学研究科 内分泌代謝・血液・膠原病内科学講座（第二内科）・大分大学医学部 消化器・小児外科学講座, 那覇, Japan, Domestic conference
    Oral presentation

  • 大腸癌の腫瘍免疫微小環境における CD4 陽性T細胞に与える肥満の影響
    安藤 正恭、山田 康太、斎藤 雅史、山下 公大、阿部 智喜、向山 知佑、阿河 杏介、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第35回日本バイオセラピィ学会学術集会総会, Japanese, 福島県立医科大学 消化管外科学講座, 福島, Japan, Domestic conference
    Oral presentation

  • 放射線治療における腫瘍内 CD8+T細胞の動態
    向山 知佑、山下 公大、阿部 智喜、安藤 正恭、阿河 杏介、山田 康太、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第35回日本バイオセラピィ学会学術集会総会, Japanese, 福島県立医科大学 消化管外科学講座, 福島, Japan, Domestic conference
    Public symposium

  • AI イメージサイトメトリーを用いた直腸癌術前化学放射線療法の腫瘍 CD8+T 細胞の新たな評価法の開発
    山下 公大、長坂 暢、阿河 杏介、阿部 智喜、高村 史記、澤田 隆一郎、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第35回日本バイオセラピィ学会学術集会総会, Japanese, 福島県立医科大学 消化管外科学講座, 福島, Japan, Domestic conference
    Public symposium

  • パネルディスカッション 大腸癌薬物療法～抗GFR抗体の最適利用～
    掛地 吉弘
    大腸癌化学療法の学術講演会「Leader's Meeting in Kansai&Tokyo」, Japanese, メルクバイオファーマ株式会社, 大阪, Japan, Domestic conference
    Others

  • パネルディスカッション04 食道癌手術における周術期チーム医療について
    掛地 吉弘
    第84回日本臨床外科学会総会, Japanese, 久留米大学医学部外科学講座, 福岡, Japan, Domestic conference
    Others

  • 周術期チーム医療による腹臥位胸腔鏡下食道切除術
    後藤 裕信、押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第84回日本臨床外科学会総会, Japanese, 久留米大学医学部外科学講座, 福岡, Japan, Domestic conference
    Public symposium

  • 総合討論 臨床使用から出てくる疑問
    掛地 吉弘
    胃癌一次治療1周年記念講演会 オプジーボ+化学療法, Japanese, ブリストルマイヤーズスクイブ株式会社・小野薬品工業株式会社, 福岡/Web, Japan, Domestic conference
    Others

  • 残胃癌に対する腹腔鏡下残胃全摘術の手術成績の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第52回胃外科・術後障害研究会, Japanese, 静岡県立静岡がんセンター 胃外科, 沼津/Web, Japan, Domestic conference
    Public symposium

  • 幽門側胃切除後の残胃内容排出遅延に関する検討
    向山 知佑、金治 新悟、原田 仁、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第52回胃外科・術後障害研究会, Japanese, 静岡県立静岡がんセンター 胃外科, 沼津/Web, Japan, Domestic conference
    Public symposium

  • 術前欠損歯数が胃癌術後患者の予後に及ぼす影響についての検討
    安積 佑樹、金治 新悟、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第52回胃外科・術後障害研究会, Japanese, 静岡県立静岡がんセンター 胃外科, 沼津/Web, Japan, Domestic conference
    Oral presentation

  • 要望演題1-2 高齢者胃癌2
    掛地 吉弘
    第52回胃外科・術後障害研究会, Japanese, 静岡県立静岡がんセンター 胃外科, 沼津/Web, Japan, Domestic conference
    Others

  • 胃癌周術期治療戦略2022
    掛地 吉弘
    第6回胃癌周術期治療講演会, Japanese, 大鵬薬品工業株式会社, 大阪/Web, Japan, Domestic conference
    Public discourse

  • 大腸癌に対する最新集学的治療 2022
    掛地 吉弘
    神戸消化器癌フォーラム2022＠Web, Japanese, 日本化薬株式会社, Web, Japan, Domestic conference
    Others

  • 大腸癌のおけるCD4陽性T細胞の抗腫瘍免疫に及ぼす肥満の影響
    山田 康太、斎藤 雅史、山下 公大、安藤 正恭、阿部 智喜、向山 知佑、阿河 杏介、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第33回日本消化器癌発生学会総会, Japanese, 東京大学大学院医学系研究科消化管外科学, 東京/Web, Japan, Domestic conference
    Public symposium

  • 放射線治療において抗腫瘍効果に寄与する腫瘍内CD8+T細胞の動態
    阿河 杏介、山下 公大、阿部 智喜、安藤 正恭、向山 知佑、山田 康太、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第33回日本消化器癌発生学会総会, Japanese, 東京大学大学院医学系研究科消化管外科学, 東京/Web, Japan, Domestic conference
    Public symposium

  • シンポジウム2 臨床応用を意識した消化器癌研究
    掛地 吉弘
    第33回日本消化器癌発生学会総会, Japanese, 東京大学大学院医学系研究科消化管外科学, 東京/Web, Japan, Domestic conference
    Others

  • 閉会挨拶
    掛地 吉弘
    第21回兵庫胃がん治療研究会, Japanese, 大鵬薬品工業株式会社, Web, Japan, Domestic conference
    Others

  • Laparoscopic Endoscopic Cooperative Surgery Using Openwindow Suturing Technique for Treating Non-ampullary Superficial Duodenal Neoplasms Located on the Pancreatic Side
    Shirakami N, Kanaji S, Harada H, Urakawa N, Sawada R, Goto H, Hasegawa H, Yamashita K, Matsuda T,Oshikiri T,Kakeji Y
    Annual Congress of KSS 2022 & 74th Congress of the Korean Surgical Society, English, Korean Surgical Society, Seoul, Korea, Republic of, Domestic conference
    Oral presentation

  • Comparison of Laparoscopic Gastrectomy for Gastric Cancer with 3D and 2D Monitors
    Kanaji S, Harada H, Sawada R, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    Annual Congress of KSS 2022 & 74th Congress of the Korean Surgical Society, English, Korean Surgical Society, Seoul, Korea, Republic of, Domestic conference
    Public symposium

  • ランチョンセミナー①「集学的治療における漢方薬の役割」
    掛地 吉弘
    日本消化器病学会東海支部第137回例会, Japanese, 浜松医科大学第二外科・株式会社ツムラ, 浜松, Japan, Domestic conference
    Oral presentation

  • ワークショップ2 気管食道科領域の画像・AI診断
    掛地 吉弘
    第73回日本気管食道科学会総会, Japanese, 琉球大学 耳鼻咽喉・頭頸部外科学講座, 宜野湾, Japan, Domestic conference
    Others

  • 特別講演Ⅰ
    掛地 吉弘
    第19回神戸消化器外科懇話会学術講演会, Japanese, 神戸消化器外科懇話会・株式会社大塚製薬工場, 神戸, Japan, Domestic conference
    Others

  • 食道胃接合部に近接する胃消化管間質腫瘍に対する腹腔鏡下局所切除の安全性についての検討
    谷川 航平、金治 新悟、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    JDDW2022(第30回日本消化器関連学会週間), Japanese, 一般社団法人 日本消化器関連学会機構（JDDW）, 福岡/Web, Japan, Domestic conference
    Poster presentation

  • オープンソースの物体検出アルゴリズムYOLOv3を用いた胸腔鏡下食道亜全摘術の手術動画解析
    工藤 拓也、押切 太郎、金治 新悟、山崎 悠太、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、掛地 吉弘
    JDDW2022(第30回日本消化器関連学会週間), Japanese, 一般社団法人 日本消化器関連学会機構（JDDW）, 福岡/Web, Japan, Domestic conference
    Poster presentation

  • 当院における食道胃接合部腺癌に対する治療戦略
    裏川 直樹、金治 新悟、掛地 吉弘
    JDDW2022(第30回日本消化器関連学会週間), Japanese, 一般社団法人 日本消化器関連学会機構（JDDW）, 福岡/Web, Japan, Domestic conference
    Public symposium

  • 下部直腸癌に対するTaTMEの手術成績～Lap-TMEとの比較～
    松田 武、山下 公大、掛地 吉弘
    JDDW2022(第30回日本消化器関連学会週間), Japanese, 一般社団法人 日本消化器関連学会機構（JDDW）, 福岡/Web, Japan, Domestic conference
    Public symposium

  • パネルディスカッション8 食道胃接合部癌に対する集学的治療
    掛地 吉弘
    JDDW2022(第30回日本消化器関連学会週間), Japanese, 一般社団法人 日本消化器関連学会機構（JDDW）, 福岡/Web, Japan, Domestic conference
    Others

  • これまでに築かれてきた術後補助化学療法のエビデンス
    掛地 吉弘
    JDDW2022(第30回日本消化器関連学会週間), Japanese, 一般社団法人 日本消化器関連学会機構（JDDW）, 福岡/Web, Japan, Domestic conference
    Public symposium

  • 食道癌における術前 CF 療法に対する DCF 療法の有用性の検証 -85 施設 4048 例の検討
    松田 諭、北川 雄光、奥居 潤、岡村 明彦、川久保 博文、竹村 亮、武藤 学、掛地 吉弘、竹内 裕也、渡邊 雅之、土岐 祐一郎
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Oral presentation

  • 術前補助療法後の食道癌根治切除症例における再発予測ノモグラムの開発
    岡村 明彦、渡邊 雅之、奥居 潤、松田 諭、竹村 亮、川久保 博文、竹内 裕也、武藤 学、掛地 吉弘、北川 雄光、土岐 祐一郎
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Others

  • 全国がん登録の利活用に向けた学会研究体制の整備
    平田 公一、長谷川 潔、河野 浩二、藤 也寸志、掛地 吉弘、吉野 一郎、井本 滋、紫田 亜希子、竹政 伊知朗、増井 俊彦、海野 倫明、神野 哲弘、清家 正博、弦間 昭彦
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Public symposium

  • コロナ禍が消化器がん医療にもたらしたもの
    花崎 和弘、前田 広道、遠藤 英樹、山本 博之、宗景 匡哉、日比 泰造、掛地 吉弘、武富 紹信、北川 雄光、森 正樹、門田 守人
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Public symposium

  • 術前欠損歯数が胃癌術後患者の予後に及ぼす影響についての検討
    安積 佑樹、原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Oral presentation

  • cStageIV胃癌に対するconversion surgeryの手術成績と予後因子の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Public symposium

  • 鼠経リンパ節転移を伴う直腸癌に対する術前治療と選択的鼠経郭清の臨床的意義
    長谷川 寛、松田 武、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Poster presentation

  • 術前化学療法における Alb/ dNLR の推移は食道癌の予後に関与するか
    阿部 智喜、押切 太郎、後藤 裕信、加藤 喬、堀川 学、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Poster presentation

  • 直腸癌術前化学放射線療法の予後因子としての modified Glasgow Prognostic Score
    島田 淳司、松田 武、山下 公大、長谷川 寛、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Oral presentation

  • 直腸癌術前化学放射線療法における AI を用いた腫瘍組織 CD8+T 細胞の評価方法の検討
    阿河 杏介、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Oral presentation

  • FDG-PET/CTによる進行胃癌の病理学的病期の術前予測の有用性
    山田 康太、裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Poster presentation

  • National Clinical Database の利活用とがん医療
    掛地 吉弘、上野 秀樹、北川 雄光、瀬戸 泰之
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野, 神戸/Web, Japan, Domestic conference
    Public symposium

  • 学術セミナー38 胃癌1次治療オプジーボ＋化学療法の特徴：CheckMate 649 長期フォローデータから読み解く
    掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野、ブリストル・マイヤーズスクイブ株式会社、小野薬品工業株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • イブニングセミナー3 食道癌・大腸癌の治療最前線
    掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野、ミヤリサン製薬株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • 会長企画シンポジウム2 がん医療におけるAI－ここまで進んだ臨床応用－
    掛地 吉弘
    第60回日本癌治療学会学術集会, Japanese, 群馬大学大学院医学系研究科総合外科学講座 肝胆膵外科分野、ブリストル・マイヤーズスクイブ株式会社, 神戸/Web, Japan, Domestic conference
    Others

  • En-bloc Radical Lateral Pelvic Lymph Node Dissection Assisted By A Transanal Approach
    Matsuda T, Sawada R, Hasegawa H, Yamashita K, Kakeji Y
    American College of Surgeons Clinical Congress 2022, English, American College of Surgeons, San Diego,CA, United States, Domestic conference
    Public discourse

  • 講演2 キイトルーダ+FP療法のマネジメント～外来投与のTips～
    掛地 吉弘
    Oncologyインターネット講演会 食道癌 専門医向け, Japanese, MSD株式会社, 大阪/Web, Japan, Domestic conference
    Others

  • 講演1 自験例から考える食道癌1次治療としてのキイトルーダ+FP療法の可能性～外科医の立場から～
    掛地 吉弘
    Oncologyインターネット講演会 食道癌 専門医向け, Japanese, MSD株式会社, 大阪/Web, Japan, Domestic conference
    Others

  • 講演「胃癌一次治療におけるオプジーボ併用療法の適正使用」
    掛地 吉弘
    オプジーボワンポイントWEBレクチャー, Japanese, 小野薬品工業株式会社・ブリストルマイヤーズスクイブ株式会社, Web, Japan, Domestic conference
    Others

  • ワークショップ2 高齢者の肥満とサルコペニア・フレイル
    掛地 吉弘
    第44回日本臨床栄養学会総会・第43回日本臨床栄養協会総会・第20回大連合大会, Japanese, 岩手医科大学外科学講座・甲南女子大学医療栄養学部・ミヤリサン製薬株式会社, 盛岡, Japan, Domestic conference
    Others

  • ランチョンセミナー6 腸内細菌のリテラシー
    掛地 吉弘
    第44回日本臨床栄養学会総会・第43回日本臨床栄養協会総会・第20回大連合大会, Japanese, 岩手医科大学外科学講座・甲南女子大学医療栄養学部・ミヤリサン製薬株式会社, 盛岡, Japan, Domestic conference
    Others

  • 食道癌手術後の胃管癌の特性と重複癌の検討
    進 勇輝、山本 学、太田 光彦、池部 正彦、中島 雄一郎、森田 勝、掛地 吉弘、松原 久裕、土岐 祐一郎、藤 也寸志
    第75回日本胸部外科学会定期学術集会, Japanese, 東京大学医学部附属病院 呼吸器外科, 横浜/Web, Japan, Domestic conference
    Oral presentation

  • 腹臥位胸腔鏡下食道切除術における腹部操作アプローチの比較（LAP vs HALS）
    後藤 裕信、押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第75回日本胸部外科学会定期学術集会, Japanese, 東京大学医学部附属病院 呼吸器外科, 横浜/Web, Japan, Domestic conference
    Oral presentation

  • 進化する胃癌治療2022
    掛地 吉弘
    UTSUKUSHIMA G・I SEMINAR 2022, Japanese, 大鵬薬品工業株式会社, 福島/Web, Japan, Domestic conference
    Oral presentation

  • 閉会挨拶
    掛地 吉弘
    第23回神戸外科フォーラム, Japanese, 大鵬薬品工業株式会社, 神戸, Japan, Domestic conference
    Others

  • 特別講演Ⅱ 「わが国の医療環境と今後の取り組み～胃癌・大腸癌の治療におけるロンサーフⓇの役割～」
    掛地 吉弘
    第23回神戸外科フォーラム, Japanese, 大鵬薬品工業株式会社, 神戸, Japan, Domestic conference
    Others

  • がん診療におけるKAMPO
    掛地 吉弘
    日本消化器病学会東北支部 第24回教育講演会, Japanese, 株式会社ツムラ, Web, Japan, Domestic conference
    Others

  • Analyses of terminally differentiated normal cells guide the identification of cancer stem cell-suppressor microRNAs 正常最終分化細胞の解析によるがん幹細胞抑制性マイクロRNAの同定
    下野 洋平、久森 重夫 、向山 順子、林 孝典、前田 真男、磯部 大地、浅井 直也、掛地 吉弘
    第81回日本癌学会学術集会, Japanese, 東京大学医科学研究所 人癌病因遺伝子分野, 横浜/Web, Japan, Domestic conference
    Others

  • 閉会挨拶
    掛地 吉弘
    Kobe IBD Open Conference, Japanese, アッヴィ合同会社, 神戸/Web, Japan, Domestic conference
    Others

  • Comparison of Laparoscopic Surgeries With or Without Hand-Assisted Procedure in the Abdominal Phase of Thoracoscopic Esophagectomy in the Prone Position
    Goto H, Oshikiri T, Kato T, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    18th ISDE World Congress for Esophageal Diseases, English, International Society for Diseases of the Esophagus, Web, Japan, Domestic conference
    Poster presentation

  • 胃癌の免疫療法におけるbiomarker確立の必要性
    掛地 吉弘
    第42回分子腫瘍マーカー研究会, Japanese, 九州大学病院別府病院 外科, Web, Japan, Domestic conference
    Public symposium

  • NCDデータを用いた頸部食道癌手術における消化管再建臓器別の術後短期成績の検討
    宮脇 豊、立森 久照、中島 康晃、佐藤 弘、桜木 信一、島田 英昭、渡邊 雅之、掛地 吉弘、土岐 祐一郎、北川 雄光
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Poster presentation

  • 食道扁平上皮癌術前補助療法における治療前血清SCC抗原の意義
    岡村 明彦、奥居 潤、渡邊 雅之、松田 諭、川久保 博文、竹内 裕也、武藤 学、掛地 吉弘、北川 雄光、土岐 祐一郎
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Public symposium

  • ロボット支援食道切除術の利点と課題
    押切 太郎、加藤 喬、後藤 裕信、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Poster presentation

  • Albumin-derived NLR score is a novel prognostic marker for esophageal squamous cell carcinoma
    阿部 智喜、押切 太郎、後藤 裕信、加藤 喬、澤田 隆一郎、裏川 直樹、金治 新悟、松田 武、掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Poster presentation

  • 胸腔鏡下食道切除症例における栄養介入としての腸瘻チューブ留置期間の検討
    加藤 喬、押切 太郎、後藤 裕信、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Poster presentation

  • 腹臥位胸腔鏡下食道切除術における腹部操作アプローチの比較（LAP vs HALS）
    後藤 裕信、押切 太郎、加藤 喬、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Oral presentation

  • 低侵襲と合併症リスクの低減を目指した腹腔鏡下胸骨後経路作成の術後成績
    堀川 学、押切 太郎、後藤 裕信、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Oral presentation

  • ビデオシンポジウム3 胸部食道癌手術における腹部操作HALS or LAP
    掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Others

  • シンポジウム7 食道癌・接合部癌 治療における免疫チェックポイント阻害剤の適切な患者選択は？ CPS ？ TPS ？
    掛地 吉弘
    第76回日本食道学会学術集会, Japanese, 東邦大学大学院消化器外科学講座・臨床腫瘍学講座, 東京/Web, Japan, Domestic conference
    Others

  • 講師
    掛地 吉弘
    ～Anastomosis Master～, Japanese, ジョンソン・エンド・ジョンソン株式会社, 神戸, Japan, Domestic conference
    Public discourse

  • がん治療におけるKAMPO
    掛地 吉弘
    ONCOLOGY KAMPO SHORT LECTURE, Japanese, 株式会社ツムラ, Web, Japan, Domestic conference
    Public discourse

  • 当院における右側結腸癌に対する体腔内吻合の導入と治療成績
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第35回近畿内視鏡外科研究会, Japanese, 兵庫医科大学消化器外科学講座上部消化管外科, 西宮, Japan, Domestic conference
    Oral presentation

  • GASTRIC CANCER: CONTROVERSIES IN MANAGEMENT - EXTENT OF RESECTION, D1 VERSUS D2 LYMPH NODE DISSECTION, NEO-ADJUVANT AND ADJUVANT THERAPY
    Kakeji Y
    International Surgical Week ISW 2022-World's Congress of Surgery, English, International Society of Surgery, Vienna, Austria
    Public symposium

  • Session2 進行再発食道がん薬物療法のエビデンス
    掛地 吉弘
    食道がん1次治療承認記念講演会～オプジーボ+ヤーボイとオプジーボ+化学療法～, Japanese, ブリストルマイヤーズ スクイブ株式会社/小野薬品工業株式会社, Web, Japan
    Public discourse

  • がん診療における漢方の役割
    掛地 吉弘
    Oncology＆Kampo Web Seminar, Japanese, 府中病院・泉大津市立病院・株式会社ツムラ, Web, Japan
    Public discourse

  • 第一部 講演「原発巣占居部位による治療決定の歴史を振り返る」
    掛地 吉弘
    ベクティビックス全国講演会, Japanese, 武田薬品工業株式会社, Web, Japan
    Public discourse

  • 基調講演「食道がん手術の最前線」
    掛地 吉弘
    食道がん1次治療オプジーボ併用療法承認記念講演会in KOBE, Japanese, ブリストルマイヤーズ スクイブ株式会社・小野薬品工業株式会社, Web, Japan
    Public discourse

  • CDX2低発現大腸癌の腫瘍生物学的特徴の検討
    向山 順子、 篠田 昌宏、板野 理、掛地 吉弘、ダレルバ ピエロ
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 食道胃接合部に近接する胃GISTに対する腹腔鏡下局所切除の安全性についての検討
    谷川 航平、金治 新悟、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 術前サルコペニアの層別化による短期・長期リスク評価の有用性
    渡部 晃大、押切 太郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 80歳以上の大腸癌患者における腹腔鏡手術の有用性
    内海 昌子、松田 武、長谷川 寛、山下 公大、中西 崇、澤田 隆一郎、金治 新悟、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 下部直腸癌手術におけるTaTMEの有用性
    中西 崇、松田 武、山下 公大、長谷川 寛、澤田 隆一郎、内海 昌子、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • 胃癌におけるFDG-PET検査によるリンパ節SUVmax値を用いたリンパ節転移診断の有用性の検討
    山田 康太、金治 新悟、裏川 直樹、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 幽門側胃切除後の胃内容排出遅延の発症リスクと治療法に関する検討
    向山 知佑、金治 新悟、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 術前欠損歯数が胃癌術後患者の予後に及ぼす影響についての検討
    安積 佑樹、金治 新悟、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 抗凝固療法中の患者に対する胃切除術の安全性について
    工藤 拓也、金治 新悟、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 胸腔鏡下食道切除症例における腸瘻チューブ留置による栄養介入とその意義
    加藤 喬、押切 太郎、後藤 裕信、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • 当院における右側結腸癌に対する体腔内吻合の手術手技と短期成績
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • cStageⅣ胃癌に対するconversion surgeryの治療成績
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • 胃癌大弯側リンパ節郭清時に周囲リンパ節の郭清ラインとの連続性を意識した#4sb郭清手技の有用性
    裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • 低肺機能患者に対する腹臥位胸腔鏡下食道切除術
    後藤 裕信、押切 太郎、加藤 喬、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • 直腸悪性腫瘍に対するHybrid手術の短期成績に関する後ろ向き研究
    長谷川 寛、松田 武、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Oral presentation

  • Siewert II型食道胃接合部癌に対する偽His角・穹窿部を付加したy字様Overlap食道胃管吻合の有用性
    金治 新悟、原田 仁、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • 頭側アプローチによる腹腔鏡下結腸右半切除～術者経験を考慮した段階的導入と定型化～
    松田 武、山下 公大、長谷川 寛、澤田 隆一郎、内海 昌子、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • パネルディスカッション5 【下部】局所進行・再発大腸癌の手術適応に関するPrecision medicine
    掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public discourse

  • ランチョンセミナー4
    掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public discourse

  • 特別企画2 夢を語ろう：スーパーエクステンデッドサージャリーと周術期管理のはざま
    掛地 吉弘
    第77回日本消化器外科学会総会, Japanese, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public discourse

  • Laparoscopic retrosternal route creation for gastric conduit - efficacy and outcomes 腹腔鏡による胸骨後経路作成の工夫と術後成績
    Horikawa M, Oshikiri T, Goto H, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    第77回日本消化器外科学会総会, English, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • Development of a new method for evaluation of rectal cancer after neoadjuvant chemoradiotherapy 直腸癌術前化学放射線療法における腫瘍組織CD8+T細胞の新たな評価方法の開発
    Yamashita K, Matsuda T, Hasegawa H, Sawada R, Harada H, Goto H, Urakawa N, Kanaji S, Oshikiri T, Kakeji Y
    第77回日本消化器外科学会総会, English, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • A predictive nomogram model of therapeutic effect in neoadjuvant treatment for esophageal cancer 食道癌術前補助療法の奏効を予測するツールの開発;多施設共同後ろ向き観察研究
    Okamura A, Okui J, Watanabe M, Matsuda S, Takemura R, Kawakubo H, Takeuchi H, Kakeji Y, Kitagawa Y, Doki Y
    第77回日本消化器外科学会総会, English, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • The multicenter validation study of NAC response and recurrence patterns for esophageal cancer 切除可能進行食道癌における術前化学療法の奏効と再発形式の検証 -85施設3995例による多施設共同研究-
    Matsuda S, Kitagawa Y, Kawakubo H, Okamura A, Okui J, Takemura R, Kakeji Y, Takeuchi H, Watanabe M, Doki Y
    第77回日本消化器外科学会総会, English, 横浜市立大学消化器・腫瘍外科学, 横浜/Web, Japan
    Public symposium

  • 閉会挨拶
    掛地 吉弘
    第2回神戸ラパロ道場, Japanese, コヴィディエンジャパン株式会社, Web, Japan
    Public discourse

  • 総合司会
    掛地 吉弘
    第2回神戸ラパロ道場, Japanese, コヴィディエンジャパン株式会社, Web, Japan
    Public discourse

  • ガイドライン改訂を踏まえた大腸癌治療2022
    掛地 吉弘
    消化器癌治療フォーラム, Japanese, MSD株式会社, Web, Japan
    Public discourse

  • 大腸癌腹膜播種モデルでは、PMN-MDSCが病態を進行させる
    山下 公大、杉田 裕、斎藤 雅史、山田 康太、阿河 杏介、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第31回日本がん転移学会学術集会・総会, Japanese, 京都大学医学研究科, 京都/Web, Japan
    Poster presentation

  • 閉塞性大腸癌患者に対する腹腔鏡下手術の術前自己拡張型金属ステントの有用性
    常城 宇生、長谷川 寛、松田 武、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第97回大腸癌研究会学術集会, Japanese, 埼玉医科大学総合医療センター 消化管・一般外科, 東京/Web, Japan
    Oral presentation

  • 遠隔転移を有するHER2陽性進行胃癌に対しConversion Surgeryを施行し奏効を得た1例
    山田 康太、裏川 直樹、金治 新悟、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第44回日本癌局所療法研究会, Japanese, 独立行政法人 労働者健康安全機構 関西労災病院, 大阪, Japan
    Oral presentation

  • 食道癌に対するESD後の良性狭窄に対し食道バイパス手術によりQOL向上を得られた一例
    加藤 喬、押切 太郎、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第44回日本癌局所療法研究会, Japanese, 独立行政法人 労働者健康安全機構 関西労災病院, 大阪, Japan
    Oral presentation

  • 主題 4「QOL向上や症状緩和をめざした局所療法」
    掛地 吉弘
    第44回日本癌局所療法研究会, Japanese, 独立行政法人 労働者健康安全機構 関西労災病院, 大阪, Japan
    Public discourse

  • 術前化学療法における Alb-dNLR ratioの推移は食道癌の予後に関与するか
    阿部 智喜、押切 太郎、後藤 裕信、加藤 喬、堀川 学、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第31回日本癌病態治療研究会, Japanese, 徳島大学消化器 移植外科学, 鳴門/Web, Japan
    Poster presentation

  • 大腸癌免疫微小環境におけるCD4陽性T細胞に及ぼす肥満の影響
    山田 康太、斎藤 雅史、山下 公大、阿河 杏介、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第31回日本癌病態治療研究会, Japanese, 徳島大学消化器 移植外科学, 鳴門/Web, Japan
    Poster presentation

  • 放射線治療における腫瘍内 CD8+T 細胞の動態
    阿河 杏介、山下 公大、阿部 智喜、安藤 正恭、向山 知佑、山田 康太、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第31回日本癌病態治療研究会, Japanese, 徳島大学消化器 移植外科学, 鳴門/Web, Japan
    Public symposium

  • cStageIV胃癌に対するconversion surgeryの予後の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第31回日本癌病態治療研究会, Japanese, 徳島大学消化器 移植外科学, 鳴門/Web, Japan
    Poster presentation

  • 低侵襲治療を目指したロボット支援下胃切除術の導入と短期治療成績
    裏川 直樹、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第31回日本癌病態治療研究会, Japanese, 徳島大学消化器 移植外科学, 鳴門/Web, Japan
    Poster presentation

  • コーヒーブレイクセミナー1 大腸がん薬物療法 2022 ～一次治療がすべてをきめる～
    掛地 吉弘
    第31回日本癌病態治療研究会, Japanese, 徳島大学消化器 移植外科学, 鳴門/Web, Japan
    Public discourse

  • 胃癌集学的治療戦略2022
    掛地 吉弘
    第16回壬生Oncologyセミナー, Japanese, 中外製薬株式会社, 栃木/Web, Japan
    Invited oral presentation

  • 講演5「炎症性腸疾患の内科的治療の進歩と外科治療の変遷」
    掛地 吉弘
    日本消化器病学会近畿支部第69回教育講演会, Japanese, 神戸大学大学院医学研究科外科学講座肝胆膵外科学分野, 神戸, Japan
    Public discourse

  • 講演4「エビデンスに基づく食道癌の集学的治療」
    掛地 吉弘
    日本消化器病学会近畿支部第69回教育講演会, Japanese, 神戸大学大学院医学研究科外科学講座肝胆膵外科学分野, 神戸, Japan
    Public discourse

  • 食道切除・胸骨後再建後胃管癌に対する仰臥位胸腔鏡アプローチ
    鳥越 陸矢、堀江 和正、押切 太郎、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第65回関西胸部外科学会学術集会, Japanese, 浜松医科大学 外科学第一講座, 浜松, Japan
    Public symposium

  • Thoracic cavity-to-cage ratio is a predictor of technical difficulties in minimally invasive esophagectomy
    Abe T, Oshikiri T, Goto H, Kato T, Horikawa M, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    AOS 2022（2nd International Congress of ASIAN ONCOLOGY SOCIETY), English, Asian Oncology Society, Seoul/Web, Korea, Republic of
    Oral presentation

  • ジョイントセッション：日本外科系連合学会：環太平洋外科系学会日本支部会 1 Wada Award Session （English）1
    掛地 吉弘
    第47回日本外科系連合学会学術集会, Japanese, 岩手医科大学医学部外科学講座, 盛岡/Web, Japan
    Public discourse

  • NCDデータを利活用した外科治療への還元
    掛地 吉弘
    第47回日本外科系連合学会学術集会, Japanese, 岩手医科大学医学部外科学講座, 盛岡/Web, Japan
    Invited oral presentation

  • 実臨床におけるエドルミズ導入のポイント
    掛地 吉弘
    エドルミズWEBライブセミナー, Japanese, 小野薬品工業株式会社, Web, Japan
    Public discourse

  • 食道癌に対する集学的治療2022
    掛地 吉弘
    食道癌治療セミナーin奈良, Japanese, MSD株式会社, 橿原市/Web, Japan
    Public discourse

  • 腫瘍抗原導入樹状細胞にiNKT細胞リガンドを付加したワクチンは、抗原特異的な抗腫瘍免疫を効果的に誘導する
    阿部 智喜、山下 公大、渡部 晃大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第43回癌免疫外科研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都, Japan
    Public symposium

  • 大腸癌の腫瘍免疫微小環境におけるCD4陽性T細胞に及ぼす肥満の影響
    安藤 正恭、山田 康太、斎藤 雅史、山下 公大、向山 知佑、阿河 杏介、渡部 晃大、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第43回癌免疫外科研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都, Japan
    Public symposium

  • 放射線治療における腫瘍内CD8+T細胞の動態
    向山 知佑、山下 公大、安藤 正恭、阿河 杏介、山田 康太、渡部 晃大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第43回癌免疫外科研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都, Japan
    Public symposium

  • 【主題1-1】新規免疫療法への戦略とエビデンス1
    掛地 吉弘
    第43回癌免疫外科研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 京都, Japan
    Public discourse

  • 腹腔鏡による胸骨後経路作成の工夫と短期成績
    堀川 学、押切 太郎、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第76回手術手技研究会, Japanese, 佐賀大学医学部 一般・消化器外科, 佐賀/Web, Japan
    Public symposium

  • SF-20 胃4
    掛地 吉弘
    第76回手術手技研究会, Japanese, 佐賀大学医学部 一般・消化器外科, 佐賀/Web, Japan
    Public discourse

  • 講演「長期生存を目指した胃癌薬物療法～ニボルマブの登場で一次治療はどう変わるのか？～」
    掛地 吉弘
    オプジーボWEBライブセミナー～初夏のGC Week～, Japanese, 小野薬品工業株式会社・ブリストル・マイヤーズ スクイブ株式会社, Web, Japan
    Public discourse

  • 胃癌の集学的治療2022
    掛地 吉弘
    兵庫プロバイオティクス学術セミナー, Japanese, ミヤリサン製薬株式会社, Web, Japan
    Oral presentation

  • Sesson2「ゲノム医療で変わる！大腸癌薬物療法について」
    掛地 吉弘
    第9回平成大腸癌カンファレンス, Japanese, 中外製薬株式会社, Web, Japan
    Public discourse

  • 特別講演「大腸癌治療ガイドラインUpDateバイオマーカーを考慮した治療戦略」
    掛地 吉弘
    第36回兵庫大腸癌治療研究会, Japanese, ミヤリサン製薬株式会社、大鵬薬品工業株式会社, Web, Japan
    Public discourse

  • 集学的治療と漢方の役割
    掛地 吉弘
    手術手技と漢方を学ぶ会in愛知, Japanese, 株式会社ツムラ, 名古屋/Web, Japan
    Public discourse

  • 高齢者の外科医療品質向上に向けた高齢者リスクモデルの構築
    小船戸 康英、高橋 新、後藤 満一、掛地 吉弘、瀬戸 泰之、今野 弘之、隈丸 拓:、宮田 裕章、丸橋 繁
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Invited oral presentation

  • 肝胆膵領域におけるNCDデータ解析研究とACS-NSQIPから学ぶ外科医療成績向上へのステップ
    丸橋 繁、掛地 吉弘、上野 秀樹、北川 雄光、瀬戸 泰之、遠藤 格、宮田 裕章、今野 弘之、後藤 満一
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Invited oral presentation

  • リアルワールドにおけるロボット支援下食道切除術の安全性と有効性：National Clinical Databaseによる分析
    錦織 達人、隈丸 拓、小濱 和貴、須田 康一、寺島 雅典、能城 浩和、與田 幸恵、日景 允、柴崎 晋、角田 茂、猪股 雅史、掛地 吉弘、北川 雄光、宮田 裕章、坂井 義治、宇山 一朗
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 外科医獲得にむけた神戸大学外科学講座の取り組み
    小松 昇平、岡田 健次、掛地 吉弘、谷野 裕一、尾藤 祐子、眞庭 謙昌
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Invited oral presentation

  • 術前化学療法におけるAlb/dNLRの推移は食道癌の予後に関与するか
    阿部 智喜、押切 太郎、後藤 裕信、加藤 喬、堀川 学、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 術前欠損歯数が胃癌予後に及ぼす影響についての検討
    安積 佑樹、金治 新悟、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Poster presentation

  • 食道胃接合部に近接する胃GISTに対する腹腔鏡下局所切除の安全性についての検討
    谷川 航平、金治 新悟、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Poster presentation

  • サルコペニアの層別化によるリスク評価の有用性
    渡部 晃大、押切 太郎、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Poster presentation

  • MIE施行症例における術前血小板リンパ球比の予後予測因子としての有用性
    加藤 喬、押切 太郎、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 当科における下部進行直腸癌に対する治療戦略
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 高齢胃癌患者への内視鏡治療後非治癒切除症例における予後の検討
    原田 仁、金治 新悟、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Poster presentation

  • 胃・食道胃接合部癌術前化学療法における予後予測因子の検討
    裏川 直樹、原田 仁、澤田 隆一郎、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 2チームによるTaTMEは狭骨盤や肥満による腹腔鏡下直腸癌手術の困難さを緩和する
    長谷川 寛、松田 武、山下 公大、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public discourse

  • 直腸癌術前化学放射線療法における腫瘍内レジデントメモリーCD8+T細胞の動態とその予後
    山下 公大、阿河 杏介、松田 武、長谷川 寛、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 下部直腸癌に対するTaTMEと融合させたRobotic surgery
    松田 武、山下 公大、長谷川 寛、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • ロボット支援食道切除におけるlearning curveと手技の工夫
    押切 太郎、後藤 裕信、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public symposium

  • 消化管領域におけるNCD研究の利活用
    掛地 吉弘、丸橋 繁、上野 秀樹、北川 雄光、瀬戸 泰之、宮田 裕章、今野 弘之、後藤 満一
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Invited oral presentation

  • パネルディスカッション09 「進行胃癌に対する集学的治療の現状と展望」
    掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public discourse

  • ランチョンセミナー（7） フッ化ピリミジン系抗癌剤をサイエンスする
    掛地 吉弘
    第122回日本外科学会定期学術集会, Japanese, 熊本大学大学院 消化器外科学, 熊本市/Web, Japan
    Public discourse

  • Polymorphonuclear myeloid-derived suppressor cells reflect the status of peritoneal dissemination in colon cancer mouse model
    Saito M, Sugita Y, Yamashita K, Fujita M, Yamada K, Agawa K, Watanabe A, Fukuoka E, Kanaji S, Oshikiri T, Matsuda T, Kakeji Y
    AACR ANNUAL MEETING 2022, English, American Association for Cancer Research, New Orleans/Web, United States
    Poster presentation

  • 胃癌集学的治療戦略2022
    掛地 吉弘
    第14回消化器がん化学療法研究会, Japanese, 大鵬薬品工業株式会社, Web, Japan
    Invited oral presentation

  • Closing Remarks
    掛地 吉弘
    神戸消化器がんセミナー, Japanese, 中外製薬株式会社, Web, Japan
    Public discourse

  • SessionⅡ 「胃癌に対する外科手術の現況と展望」
    掛地 吉弘
    神戸消化器がんセミナー, Japanese, 中外製薬株式会社, Web, Japan
    Public discourse

  • 特別講演Ⅰ「横行結腸癌の腹腔鏡手術について」
    掛地 吉弘
    第30回近畿内視鏡下大腸手術研究会, Japanese, 近畿内視鏡下大腸手術研究会、株式会社ツムラ, 大阪/Web, Japan
    Public discourse

  • EBMに基づく抗EGFR抗体薬のリチャレンジ治療
    掛地 吉弘
    ベクティビックス全国Web講演会, Japanese, 武田薬品工業株式会社, Web, Japan
    Public discourse

  • 幽門側胃切除後の胃内容排出遅延の発症リスクと治療法に関する検討
    向山 知佑、金治 新悟、原田 仁、裏川 直樹、澤田 隆一郎、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第94回日本胃癌学会総会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Public symposium

  • 抗血栓療法中の患者に対する胃癌手術の安全性の検討
    工藤 拓也、金治 新悟、原田 仁、澤田 隆一郎、裏川 直樹、後藤 裕信、長谷川 寛、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第94回日本胃癌学会総会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Poster presentation

  • da Vinci Harmonicによるロボット支援下幽門側胃切除術の時間短縮効果と短期治療成績の検討
    裏川 直樹、澤田 隆一郎、原田 仁、後藤 裕信、長谷川 寛、金治 新悟、山下 公大、松田 武、押切 太郎、掛地 吉弘
    第94回日本胃癌学会総会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Oral presentation

  • イブニングセミナー3 HER2 陽性胃がんに対する薬物治療展開～エンハーツで繋ぐ～
    掛地 吉弘
    第94回日本胃癌学会総会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Public discourse

  • ランチョンセミナー9 胃癌薬物療法における最新の知見
    掛地 吉弘
    第94回日本胃癌学会総会, Japanese, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Public discourse

  • Phase Ⅱ study of neoadjuvant chemotherapy for locally advanced gastric cancer in elderly patients
    Matsuda Y, Ota M, Uehara H, Tsutsumi S, Kusumoto T, Yasui H, Ubukata Y, Yamaguchi S, Orita H, Izawa N, Kakizoe S, Shimokawa M, Kakeji Y, Oki E, Saeki H, Mori M
    第94回日本胃癌学会総会, English, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Public symposium

  • The Signicance of Surgical Intervention Following Chemotherapy for Stage IV Gastric Cancer
    Harada H, Kanaji S, Sawada R, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    第94回日本胃癌学会総会, English, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Oral presentation

  • Safety management of laparoscopic endoscopic cooperative surgery for duodenal tumor
    Kanaji S, Morita Y, Masumoto K, Kudo T, Harada H, Urakawa N, Takao T, Matsuda T, Oshikiri T, Toyonaga T, Kodama Y, Kakeji Y
    第94回日本胃癌学会総会, English, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Public symposium

  • Panel Discussion 2 New development for HER2 positive advanced gastric cancer
    Kakeji Y
    第94回日本胃癌学会総会, English, 横浜市立大学附属市民総合医療センター 消化器病センター 外科, 横浜/Web, Japan
    Public discourse

  • ロボット支援食道切除における反回神経麻痺低減の試み
    押切 太郎、後藤 裕信、加藤 喬、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第14回日本ロボット外科学会学術集会, Japanese, 鹿児島大学医学部産科婦人科, Web, Japan
    Public symposium

  • 一般口演25 胃③
    掛地 吉弘
    第14回日本ロボット外科学会学術集会, Japanese, 鹿児島大学医学部産科婦人科, Web, Japan
    Public discourse

  • 領域別シンポジウム9【小児・開発】
    掛地 吉弘
    第14回日本ロボット外科学会学術集会, Japanese, 鹿児島大学医学部産科婦人科, Web, Japan
    Public discourse

  • 癌幹細胞マーカーは食道扁平上皮癌に対する術前化学療法の治療効果予測に有用である
    安藤 正恭、山下 公大、阿河 杏介、中川 暁雄、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第54回制癌剤適応研究会, Japanese, 富山大学消化器・腫瘍・総合外科, Web/誌上開催, Japan
    Public symposium

  • 大腸癌腹膜播種モデルにおける骨髄由来免疫抑制細胞の機能
    向山 知佑、山下 公大、杉田 裕、澤田 隆一郎、原田 仁、裏川 直樹、後藤 裕信、長谷川 寛、金治 新悟、松田 武、押切 太郎、掛地 吉弘
    第54回制癌剤適応研究会, Japanese, 富山大学消化器・腫瘍・総合外科, Web/誌上開催, Japan
    Public symposium

  • 術前化学療法を施行した食道癌切除症例の予後を予測するバイオマーカーとしての血小板-リンパ球比の意義
    加藤 喬、押切 太郎、後藤 裕信、澤田 隆一郎、原田 仁、裏川 直樹、長谷川 寛、金治 新悟、山下 公大、松田 武、掛地 吉弘
    第54回制癌剤適応研究会, Japanese, 富山大学消化器・腫瘍・総合外科, Web/誌上開催, Japan
    Public symposium

  • 特別講演1 Society 5.0における大腸癌治療成績向上への取り組み〜multidisciplinary treatmentの発展：West meets East〜
    掛地 吉弘
    第54回制癌剤適応研究会, Japanese, 富山大学消化器・腫瘍・総合外科/日本イーライリリー株式会社, Web/誌上開催, Japan
    Public discourse

  • 進行再発大腸癌の個別化医療の展望
    掛地 吉弘
    ベクティビックス全国Web講演会, Japanese, 武田薬品工業株式会社, Web, Japan
    Public discourse

  • 癌関連線維芽細胞および癌細胞で発現する Metallothionein 2A は食道扁平上皮癌の進展に関与する
    清水 将来、塚本 修一、都 鍾智、安積 佑樹、北村 優、浦上 聡、谷川 航平、児玉 貴之、西尾 真理、重岡 学、狛 雄一朗、松田 武、押切 太郎、掛地 吉弘、横崎 宏
    第18回日本消化管学会総会学術集会, Japanese, 東京大学大学院医学系研究科消化管外科学, 東京/Web, Japan
    Public symposium

  • マクロファージとの相互作用により発現誘導される S100A8/A9 は Akt、p38 を介して食道扁平上皮癌細胞の運動能、浸潤能を亢進させる
    谷川 航平、塚本 修一、安積 佑樹、都 鍾智、北村 優、浦上 聡、清水 将来、児玉 貴之、西尾 真理、重岡 学、狛 雄一朗、松田 武、押切 太郎、掛地 吉弘、横崎 宏
    第18回日本消化管学会総会学術集会, Japanese, 東京大学大学院医学系研究科消化管外科学, 東京/Web, Japan
    Public symposium

  • コアシンポジウム2 消化管腫瘍の新展開【分子レベルから展開する診断・治療戦略】
    掛地 吉弘
    第18回日本消化管学会総会学術集会, Japanese, 東京大学大学院医学系研究科消化管外科学, 東京/Web, Japan
    Public discourse

  • 閉会の挨拶
    掛地 吉弘
    兵庫ヘルニアビデオカンファレンス, Japanese, コヴィディエンジャパン株式会社, Web, Japan
    Public discourse

  • 開会の挨拶
    掛地 吉弘
    兵庫ヘルニアビデオカンファレンス, Japanese, コヴィディエンジャパン株式会社, Web, Japan
    Public discourse

  • 総合司会
    掛地 吉弘
    兵庫ヘルニアビデオカンファレンス, Japanese, コヴィディエンジャパン株式会社, Web, Japan
    Public discourse

  • Assessing The Risk Factors for Delayed Gastric Emptying after Distal Gastrectomy for Gastric Cancer
    Mukoyama T, Kanaji S, Harada H, Urakawa N, Kato T, Sawada R, Gotoh H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y
    17th Annual Acasemic Surgical Congress, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, Florida/Web, United States
    Oral presentation

  • 消化器外科領域における漢方薬の役割～大建中湯・六君子湯・半夏瀉心湯～
    掛地 吉弘
    Fushimi Surgery Kampo Seminar, Japanese, 株式会社ツムラ, Web, Japan
    Invited oral presentation

  • Opening Remarks
    掛地 吉弘
    胃癌一次治療適応追加記念講演会～ A New Breath in Gastric Cancer～, Japanese, ブリストル・マイヤーズスクイブ株式会社, Web, Japan
    Public discourse

  • 総合司会
    掛地 吉弘
    第1回兵庫胃ビデオカンファレンス, Japanese, コヴィディエンジャパン株式会社, Web, Japan
    Public discourse

  • 当科における経肛門アプローチ併用による側方リンパ節郭清の手術成績
    澤田 隆一郎、松田 武、長谷川 寛、山下 公大、原田 仁、裏川 直樹、後藤 裕信、金治 新悟、押切 太郎、掛地 吉弘
    第96回大腸癌研究会, Japanese, 帝京大学医学部外科学講座, 東京/Web, Japan
    Oral presentation

  • 特別講演「胃癌・食道癌における集学的外科治療」
    掛地 吉弘
    第22回神戸外科WEBフォーラム 食道胃腸領域, Japanese
    Public discourse

  • 特別講演「低侵襲胃癌手術をより解像度を高めて考える」
    掛地 吉弘
    第190回兵庫県外科医会学術集会, Web開催/神戸, Domestic conference
    Others

  • CRT後の難治性食道狭窄に対する鏡視下食道バイパス術 (Postlethwait 法) の試み
    横尾 拓樹, 中村 哲, 西山 航平, 王子 健太郎, 佐伯 崇史, 山崎 悠太, 清水 貴, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 押切 太郎, 掛地 吉弘, 黒田 大介
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • 脾弯曲部癌におけるリンパ節転移領域と頻度に関する多施設共同コホート試験 (SP study)
    渡邉 純, 金光 幸秀, 諏訪 宏和, 掛地 吉弘, 石原 聡一郎, 神藤 英二, 小澤 平太, 須藤 剛, 川村 純一郎, 赤木 由人, 板橋 道朗, 大植 雅之, 池 秀之, 杉原 健一
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Public symposium

  • NCDを利用したロボット支援下胃切除の安全性・有効性に関する検討
    錦織 達人, 須田 康一, 小濱 和貴, 寺島 雅典, 能城 浩和, 與田 幸恵, 田中 毅, 日景 允, 柴崎 晋, 猪股 雅史, 掛地 吉弘, 北川 雄光, 坂井 義治, 宇山 一朗
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Public symposium

  • 低肺機能に対する腹臥位胸腔鏡下食道切除術
    阿部 智喜, 押切 太郎, 後藤 裕信, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • ロボット支援食道切除術においてenergy deviceが短期成績に及ぼす影響
    加藤 喬, 押切 太郎, 後藤 裕信, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Public symposium

  • 左結腸動脈処理に着目した腹腔鏡下左側結腸癌手術
    古出 隆大, 松田 武, 山下 公大, 長谷川 寛, 澤田 隆一郎, 原田 仁, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • 当院における右側結腸癌に対する体腔内吻合の導入と治療成績
    澤田 隆一郎, 松田 武, 長谷川 寛, 山下 公大, 原田 仁, 裏川 直樹, 後藤 裕信, 金治 新悟, 押切 太郎, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • 腹腔鏡下胃切除症例における周術期抗血栓療法の安全性の検討
    原田 仁, 金治 新悟, 工藤 拓也, 澤田 隆一郎, 裏川 直樹, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • 当院におけるロボット支援下幽門側胃切除術の手技定型化の確立と短期治療成績
    裏川 直樹, 金治 新悟, 澤田 隆一郎, 原田 仁, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • ロボット支援食道手術による反回神経麻痺の軽減に関する試み
    後藤 裕信, 押切 太郎, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • 直腸悪性腫瘍に対するHybird abdominal robotic approach with conventional TaTMEの導入
    長谷川 寛, 松田 武, 山下 公大, 澤田 隆一郎, 田代 志津, 大久保 愛子, 久徳 幸乃, 池田 健輔, 石黒 聖也, 岩﨑 一崇, 福永 涼, 水上 一也, 西林 優一, 押切 太郎, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Public symposium

  • 直腸癌手術におけるTransanal minimally invasive ISRの有用性と課題
    松田 武, 山下 公大, 長谷川 寛, 澤田 隆一郎, 原田 仁, 後藤 裕信, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Oral presentation

  • ロボット支援食道切除における至適剥離層
    押切 太郎, 後藤 裕信, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回日本内視鏡外科学会総会, Web開催/神戸, Domestic conference
    Public symposium

  • 癌間質および癌細胞で発現するMT2Aは食道扁平上皮癌の進展に関与する
    清水 将来, 佐藤 経雄, 塚本 修一, 都 鍾智, 安積 佑樹, 北村 優, 浦上 聡, 谷川 航平, 市原 有美, 児玉 貴之, 西尾 真里, 重岡 學, 狛 雄一朗, 掛地 吉弘, 横崎 宏
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • 腫瘍関連マクロファージ由来のCCL1はCCR8に作用し、Akt/PRAS40/mTORシグナルを介して食道扁平上皮癌の進展に寄与する
    藤川 正隆, 狛 雄一郎, 佐藤 経雄, 塚本 修一, 安積 佑樹, 都 鍾智, 浦上 聡, 北村 優, 清水 将来, 谷川 航平, 児玉 貴之, 西尾 真理, 重岡 學, 掛地 吉弘, 横崎 宏
    Web開催, Domestic conference
    Invited oral presentation

  • 直腸癌に対するAbdominal robotic approach併用によるHybrid TaTME
    安藤 正恭, 松田 武, 山下 公大, 長谷川 寛, 澤田 隆一郎, 内海 昌子, 原田 仁, 後藤 裕信, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • 大腸癌術後の早期再発のリスク因子
    山内 菜津子, 松田 武, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 山下 公大, 押切 太郎, 掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • 癌幹細胞マーカーは、食道扁平上皮癌に対する術前化学療法の治療効果予測に有用である
    阿河 杏介, 山下 公大, 中川 暁雄, 向山 知佑, 山田 康太, 渡部 晃大, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 松田 武, 押切 太郎, 掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • 腫瘍抗原導入樹状細胞にα-GalCerを付加したワクチンベクターの抗腫瘍効果
    渡部 晃大, 山下 公大, 向山 知佑, 阿河 杏介, 山田 康太, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 松田 武, 押切 太郎, 掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • 術前化学療法を施行した食道癌切除症例の予後を予測するバイオマーカーとしての血小板-リンパ球比の意義
    加藤 喬, 押切 太郎, 後藤 裕信, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • 当科におけるStageⅣ胃癌に対するconversion surgeryの治療成績
    原田 仁, 金治 新悟, 澤田 隆一郎, 裏川 直樹, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Poster presentation

  • シンポジウム1 Innovation in Clinical Technology and Basic Science
    掛地 吉弘
    第32回日本消化器癌発生学会総会/第10回国際消化器癌発生会議, Web開催, Domestic conference
    Others

  • 胸腔鏡下食道切除術における3D内視鏡システムは術後短期成績の改善に寄与する
    工藤 拓也, 押切 太郎, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第30回日本コンピュータ外科学会大会, Web開催/つくば, Domestic conference
    Oral presentation

  • ロボット支援食道切除手術におけるlearning curve
    加藤 喬, 押切 太郎, 後藤 裕信, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第30回日本コンピュータ外科学会大会, Web開催/つくば, Domestic conference
    Oral presentation

  • 3D/HDおよび2D/4Kモニターが術者技術レベルごとの手術操作にもたらす影響
    原田 仁, 金治 新悟, 澤田 隆一郎, 裏川 直樹, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第30回日本コンピュータ外科学会大会, Web開催/つくば, Domestic conference
    Oral presentation

  • 3D‒CT を用いた骨盤計測と直腸癌手術時間との関連―通常の腹腔鏡下手術と Transanal Total Mesorectal Excision との違い―
    長谷川 寛, 松田 武, 山下 公大, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 金治 新悟, 押切 太郎, 掛地 吉弘
    第30回日本コンピュータ外科学会大会, Web開催/つくば, Domestic conference
    Oral presentation

  • レチノイン酸レセプターγはヒトiPS細胞から食道上皮への分化誘導を促進する
    小寺澤 康文, 小柳 三千代, 押切 太郎, 掛地 吉弘, 青井 貴之
    第72回日本気管食道科学会総会ならびに学術講演会, Web開催, Domestic conference
    Public symposium

  • オープンソースの物体検出アルゴリズムYOLOv3を用いた胸腔鏡下食道亜全摘術の手術動画解析
    工藤 拓也, 押切 太郎, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第72回日本気管食道科学会総会ならびに学術講演会, Web開催, Domestic conference
    Public symposium

  • 胸腔鏡下食道切除術における嚥下性肺炎の予防
    後藤 裕信, 押切 太郎, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第72回日本気管食道科学会総会ならびに学術講演会, Web開催, Domestic conference
    Public symposium

  • ワークショップ2 人工知能・ビックデータを用いた研究
    掛地 吉弘
    第72回日本気管食道科学会総会ならびに学術講演会, Web開催, Domestic conference
    Others

  • 幽門側胃切除後の残胃内容排出遅延に関する検討
    向山 知佑, 金治 新悟, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第51回胃外科・術後障害研究会, Web開催, Domestic conference
    Oral presentation

  • 高齢者胃癌術後の肺炎併発が長期予後へ与える影響の検討
    裏川 直樹, 澤田 隆一郎, 原田 仁, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第51回胃外科・術後障害研究会, Web開催, Domestic conference
    Oral presentation

  • 要望演題4 高齢者胃癌手術-2
    掛地 吉弘
    第51回胃外科・術後障害研究会, Web開催, Domestic conference
    Others

  • 術中重大出血・周術期輸血量からみた急性汎発性腹膜炎手術における抗血栓薬の出血制御に与える影響 A nationwide study in Japan based on the National Clinical Database
    松岡 義, 小林 健二, 佐々木 淳一, 北川 雄光, 掛地 吉弘, 篠崎 浩治
    JDDW2021（第29回日本消化器関連学会週間）, Web開催/神戸, Domestic conference
    Poster presentation

  • 患者由来大腸癌オルガノイドを用いたバルプロ酸の新規治療薬としての有用性の検討
    堀江 和正, 堀川 学, 小柳 三千代, 松田 武, 掛地 吉弘, 青井 貴之
    JDDW2021（第29回日本消化器関連学会週間）, Web開催/神戸, Domestic conference
    Poster presentation

  • パネルディスカッション9 進行・再発消化器癌に対するconversion therapyの適応と限界
    掛地 吉弘
    JDDW2021（第29回日本消化器関連学会週間）, Web開催/神戸, Domestic conference
    Others

  • 膵臓側に位置する表在性非乳頭部十二指腸に対する腹腔鏡内視鏡合同手術の工夫
    金治 新悟, 森田 圭紀, 松本 慶, 工藤 拓也, 原田 仁, 裏川 直樹, 鷹尾 俊達, 松田 武, 押切 太郎, 豊永 高史, 児玉 裕三, 掛地 吉弘
    第22回腹腔鏡内視鏡合同研究会, Web開催
    Oral presentation

  • 大腸がんに対するゲノム医療
    掛地 吉弘
    市民公開講座「大腸がん 知れば安心！知れば納得！～専門医による治療最前線～」, 中外製薬株式会社、神戸新聞社, Web開催
    Public discourse

  • 本邦における高齢者直腸癌患者に対する腹腔鏡手術の安全性の検討
    清島 亮, 長谷川 博俊, 岡林 剛史, 茂田 浩平, 松井 信平, 宮田 裕章, 山下 裕一, 猪股 雅史, 若林 剛, 掛地 吉弘, 渡邊 昌彦, 北川 雄光
    第59回日本癌治療学会学術集会, Web開催/横浜, Domestic conference
    Invited oral presentation

  • TaTMEを軸とした近未来の下部直腸癌手術
    松田 武, 澤田 隆一郎, 長谷川 寛, 山下 公大, 原田 仁, 裏川 直樹, 後藤 裕信, 金治 新悟, 押切 太郎, 掛地 吉弘
    第59回日本癌治療学会学術集会, Web開催/横浜, Domestic conference
    Public symposium

  • ワークショップ17 切除不能消化器癌に対するconversion surgeryの適応とタイミング
    掛地 吉弘
    第59回日本癌治療学会学術集会, Web開催/横浜, Domestic conference
    Others

  • 臓器別シンポジウム6 局所進行食道がんに対する治療戦略
    掛地 吉弘
    第59回日本癌治療学会学術集会, Web開催/横浜, Domestic conference
    Others

  • 学術セミナー11 食道がん治療の現状と展望～周術期治療と薬物療法～
    掛地 吉弘
    第59回日本癌治療学会学術集会, Web開催/横浜, Domestic conference
    Others

  • スポンサードシンポジウム2 大腸癌個別化治療の現状と今後の展望
    掛地 吉弘
    第59回日本癌治療学会学術集会, Web開催/横浜, Domestic conference
    Others

  • 胃癌手術症例における欠損歯が予後に及ぼす影響について
    安積 佑樹, 金治 新悟, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    日本外科代謝栄養学会第58回学術集会, Web開催/神戸, Domestic conference
    Oral presentation

  • 食道癌患者における術前のサルコペニア予測サロゲートマーカーの開発
    渡部 晃大, 押切 太郎, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    日本外科代謝栄養学会第58回学術集会, Web開催/神戸, Domestic conference
    Oral presentation

  • ワークショップ4 重症感染症に対する治療～その理論と実践～
    掛地 吉弘
    日本外科代謝栄養学会第58回学術集会, Web開催/神戸, Domestic conference
    Others

  • Poster Discussion【B】 Esophagus/Stomach
    Kakeji Y
    International Association of Surgeons, Gastroenterologists and Oncologists(IASGO-CME 2021), Web開催, International conference
    Others

  • 大腸癌免疫微小環境におけるCD4陽性T細胞に及ぼす肥満の影響
    山田 康太, 斎藤 雅史, 山下 公大, 向山 知佑, 阿河 杏介, 渡部 晃大, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 松田 武, 押切 太郎, 掛地 吉弘
    第27回外科侵襲とサイトカイン研究会, Web開催/神戸, Domestic conference
    Public symposium

  • 胃・大腸癌に対する最新集学的治療2021
    掛地 吉弘
    神戸消化器癌フォーラム2021＠Web, Web開催
    Public discourse

  • オルガノイドの乳がん研究への展開
    下野 洋平, 西村 建徳, 河野 誠之, 渋谷 尚樹, 林 孝典, 柳 久乃, 渡辺 崇, 前田 真男, 掛地 吉弘, 河田 健司, 浅井 直也, 高尾 信太郎, 南 博信, 喜島 祐子, 鈴木 元, 後藤 典子
    第80回日本癌学会学術総会, Web開催/横浜, Domestic conference
    Public symposium

  • 大腸癌臨床検体のマイクロ RNA 網羅的解析による新規大腸癌幹細胞制御機構の解明
    向山 順子, 板野 理, 掛地 吉弘, 下野 洋平
    第80回日本癌学会学術総会, Web開催/横浜, Domestic conference
    Invited oral presentation

  • Prone Thoracoscopic Esophagectomy for Patients with Low Pulmonary Function
    Takiguchi G, Oshikiri T, Horikawa M, Kitamura Y, Horie K, Urakawa N, Hasegawa H, Yamamoto M, Shingo S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    17th ISDE World Congress for Esophageal Diseases(ISDE2021), Web開催, International conference

  • Laparoscopic creation of retrosternal route for gastric conduit reconstruction; safe and feasible procedure
    Horikawa M, Oshikiri T, Kitamura Y, Horie K, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    17th ISDE World Congress for Esophageal Diseases(ISDE2021), Web開催, International conference
    Oral presentation

  • A case of G-CSF(granulocyte-colony stimulating factor) producing esophageal cancer with enteroblastic differentiation
    Kitamura Y, Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    17th ISDE World Congress for Esophageal Diseases(ISDE2021), Web開催, International conference
    Poster presentation

  • Thoracoscopic retrosternal gastric conduit resection in the supine position for gastric tube cancer
    Horie K, Oshikiri T, Horikawa M, Kitamura Y, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    17th ISDE World Congress for Esophageal Diseases(ISDE2021), Web開催, International conference
    Oral presentation

  • Surgical techniques and potential of mediastinal lymphadenectomy in robotic surgery
    Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    17th ISDE World Congress for Esophageal Diseases(ISDE2021), Web開催, International conference
    Oral presentation

  • Current Status of Esophagectomy in Japanese National Clinical Database
    Kakeji Y, Takahashi A, Hasegawa H, Takiguchi G, Oshikiri T, Nakamura T, Miyata H, Kitagawa Y
    17th ISDE World Congress for Esophageal Diseases(ISDE2021), Web開催, International conference

  • ロボット支援食道切除術の短期成績と learning curve
    加藤 喬, 押切 太郎, 後藤 裕信, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回近畿内視鏡外科研究会, Web開催, Domestic conference
    Oral presentation

  • 腹臥位胸腔鏡下食道切除術における上縦隔郭清手技の工夫と定型化
    後藤 裕信, 押切 太郎, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回近畿内視鏡外科研究会, Web開催, Domestic conference
    Oral presentation

  • 当院における腹腔鏡下胃切除を安全に行うためのちょっとした工夫
    金治 新悟, 原田 仁, 裏川 直樹, 澤田 隆一郎, 後藤 裕信, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第34回近畿内視鏡外科研究会, Web開催, Domestic conference
    Public symposium

  • 直腸癌手術における Robotic TaTME の可能性
    松田 武, 山下 公大, 長谷川 寛, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 金治 新悟, 押切 太郎, 掛地 吉弘
    第34回近畿内視鏡外科研究会, Web開催, Domestic conference
    Nominated symposium

  • 当科におけるロボット支援食道手術の課題と可能性
    押切 太郎, 後藤 裕信, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第34回近畿内視鏡外科研究会, Web開催, Domestic conference
    Nominated symposium

  • 食道癌手術後の異時性胃癌（胃管癌）に対する全国実態調査
    太田 光彦, 池部 正彦, 中島 雄一郎, 山本 学, 森田 勝, 掛地 吉弘, 松原 久裕, 土岐 祐一郎, 藤 也寸志
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Oral presentation

  • 術前HbA1c値と食道癌術後合併症の関連；NCD データ15801例の解析から
    岡村 明彦, 山本 博之, 渡邊 雅之, 宮田 裕章, 金治 新悟, 神谷 欣志, 掛地 吉弘, 土岐 祐一郎, 北川 雄光
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Public symposium

  • Laparoscopic retrosternal route creation; short-term postoperative outcomes
    堀川 学, 押切 太郎, 後藤 裕信, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Poster presentation

  • Safety and validity of thoracoscopic esophagectomy for elderly patients
    渡部 晃大, 押切 太郎, 杉田 裕, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Public symposium

  • Established upper mediastinum lymphadenectomy in prone MIE improves outcomes
    後藤 裕信, 押切 太郎, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第75回日本食道学会学術集, Web開催/東京, Domestic conference
    Oral presentation

  • Validity of lymphadenectomy for No.106recL estimated by Efficacy Index
    押切 太郎, 後藤 裕信, 加藤 喬, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Public symposium

  • ワークショップ3 高齢者における食道癌手術の現状と課題
    掛地 吉弘
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Others

  • 食道癌の集学的治療戦略2021
    掛地 吉弘
    第75回日本食道学会学術集会, Web開催/東京, Domestic conference
    Public discourse

  • がん診療におけるKAMPO
    掛地 吉弘
    第11回高知和漢医薬セミナー, Web開催
    Public discourse

  • 直腸癌術後縫合不全は長期予後を悪化させるのか?マウスモデルと臨床研究で得られた結果からの考察
    島田 淳司, 長谷川 寛, 松田 武, 山下 公大, 澤田 隆一郎, 有本 聡, 原田 仁, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第30回消化器疾患病態治療研究会, Web開催, Domestic conference
    Oral presentation

  • FDG-PET検査によるリンパ節SUVmax値を用いた胃癌リンパ節転移診断の有用性の検討
    山田 康太, 裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第30回日本がん転移学会学術集会・総会, Web開催, Domestic conference
    Poster presentation

  • StageIV切除不能胃癌に対する外科治療
    金治 新悟, 松田 佳子, 山本 将士, 裏川 直樹, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第30回日本がん転移学会学術集会・総会, Web開催, Domestic conference
    Public symposium

  • 大腸癌腹膜播種モデルにおけるPMN-MDSCの役割
    山下 公大, 杉田 裕, 裏川 直樹, 長谷川 寛, 金治 新悟, 松田 武, 押切 太郎, 掛地 吉弘
    第30回日本がん転移学会学術集会・総会, Web開催, Domestic conference
    Poster presentation

  • シンポジウム2 チームで取り組むがん転移
    掛地 吉弘
    第30回日本がん転移学会学術集会・総会, Web開催, Domestic conference
    Others

  • NCDデータを用いた食道切除後再建ルートの術後合併症への影響の解析
    菊池 寛利, 遠藤 英樹, 山本 博之, 小澤 壯治, 宮田 裕章, 掛地 吉弘, 松原 久裕, 土岐 祐一郎, 北川 雄光, 竹内 裕也
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • Short-Term Outcomes of Robot-Assisted Minimally invasive esophagectomy
    Nakamura T, Takiguchi G, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Oshikiri T, Suzuki S, Kakeji Y
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • 長期予後予測因子GPSと術後短期成績に関するNCD解析研究
    平松 良浩, 隈丸 拓, 薄根 詩葉利, 森田 剛文, 木土 寛利, 神谷 欣志, 今野 弘之, 掛地 吉弘, 北川 雄光, 竹内 裕也
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • 飽和食塩溶液固定法を用いたCadaver Surgical Trainingの有用性
    都 鍾智, 押切 太郎, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • 腹腔鏡による胸骨後経路作成の工夫と短期成績
    堀川 学, 押切 太郎, 後藤 裕信, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Oral presentation

  • 食道癌患者における術前のサルコペニア予測サロゲートマーカーの開発と臨床的意義
    渡部 晃大, 押切 太郎, 裏川 直樹, 長谷川 寛, 金治 新悟, 山本 将士, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Oral presentation

  • 至適術前治療選択のためのバイオマーカーの重要性
    加藤 喬, 押切 太郎, 後藤 裕信, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Oral presentation

  • 当院における胃・食道胃接合部癌に対する術前化学療法の治療成績の検討
    裏川 直樹, 金治 新悟, 長谷川 寛, 山本 将士, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Oral presentation

  • Established upper mediastinum lymphadenectomy in prone MIE improves outcomes
    Goto H, Oshikiri T, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    Web開催/京都, Domestic conference
    Public symposium

  • 直腸癌術後縫合不全は長期予後を悪化させるか?マウスモデルと臨床多施設共同研究で得られた結果からの考察
    長谷川 寛, 松田 武, 山下 公大, 有本 聡, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • Simple and reliable transhiatal laparoscopic reconstruction for Siewert type II tumor
    Kanaji S, Suzuki S, Urakawa N, Yamamoto M, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • 直腸癌術前化学放射線療法におけるCD8+T細胞の誘導とその予後
    山下 公大, 松田 武, 阿河 杏介, 長谷川 寛, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Oral presentation

  • taTMEを安全に行うための工夫と手術成績，そして今後の展望
    松田 武, 山下 公大, 長谷川 寛, 内海 昌子, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • Potential of robotic surgery surpassing conventional thoracoscopic esophagectomy
    Oshikiri T, Goto H, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public symposium

  • Educational Lecture 5 Surgery based on digital information: focusing on gastric cancer surgery
    掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Others

  • NCDデータを利活用した消化器外科領域臨床研究
    掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Public discourse

  • ランチョンセミナー8 がんゲノム医療時代における大腸癌薬物療法のトピックス
    掛地 吉弘
    第76回日本消化器外科学会総会, Web開催/京都, Domestic conference
    Others

  • 放射線治療における腫瘍内CD8⁺T細胞の動態
    阿河 杏介, 山下 公大, 向山 知佑, 山田 康太, 渡部 晃大, 裏川 直樹, 長谷川 寛, 金治 新悟, 松田 武, 押切 太郎, 掛地 吉弘
    第31回日本サイトメトリー学会学術集会, Web開催, Domestic conference
    Oral presentation

  • 大腸癌腹膜播腫モデルにおける骨髄由来免疫抑制細胞の機能
    山田 康太, 山下 公大, 杉田 裕, 向山 知佑, 阿河 杏介, 渡部 晃大, 澤田 隆一郎, 原田 仁, 裏川 直樹, 後藤 裕信, 長谷川 寛, 金治 新悟, 松田 武, 押切 太郎, 掛地 吉弘
    第31回日本サイトメトリー学会学術集会, Web開催, Domestic conference
    Oral presentation

  • 招聘シンポジウム 固形腫瘍の病態と最新の研究
    掛地 吉弘
    第31回日本サイトメトリー学会学術集会, Web開催, Domestic conference
    Others

  • Abdominal robotic approach 併用によるHybrid taTMEの安全性
    安藤 正恭, 松田 武, 山下 公大, 長谷川 寛, 内海 昌子, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第46回日本外科系連合学会学術集会, Web開催/東京, Domestic conference
    Public symposium

  • 当院におけるロボット支援下幽門側胃切除術の短期治療成績と定型化に向けた取り組み
    裏川 直樹, 金治 新悟, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第46回日本外科系連合学会学術集会, Web開催/東京
    Public symposium

  • 食道癌術後患者においてcomprehensive complication indexが予後に及ぼす影響
    工藤 拓也, 押切 太郎, 瀧口 豪介, 裏川 直樹, 山本 将士, 長谷川 寛, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第46回日本外科系連合学会学術集会, Web開催/東京, Domestic conference
    Public symposium

  • パネルディスカッション3 外科系各科におけるがん免疫療法
    掛地 吉弘
    第46回日本外科系連合学会学術集会, Web開催/東京, Domestic conference
    Others

  • 高齢食道癌患者に対する胸腔鏡下食道切除術の安全性と妥当性
    渡部 晃大, 押切 太郎, 杉田 裕, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第64回関西胸部外科学会学術集会, Web開催, Domestic conference
    Oral presentation

  • 右水腎症を伴う進行直腸癌に対し術前化学療法を施行し、病理学的完全奏功を得た1例
    岡本 柊志, 山下 公大, 松田 武, 長谷川 寛, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第43回日本癌局所療法研究会, Web開催, Domestic conference
    Oral presentation

  • 主題 4-1 高齢者 下部消化管、肝胆膵
    掛地 吉弘
    第43回日本癌局所療法研究会, Web開催, Domestic conference
    Others

  • 大腸癌薬物療法 Right test, Right time, Right patient
    掛地 吉弘
    ベクティビックス全国Web講演会, Web開催
    Others

  • 食道切除・胸骨後再建後胃管癌に対する仰臥位胸腔鏡アプローチ
    堀江 和正, 押切 太郎, 加藤 喬, 後藤 裕信, 澤田 隆一郎, 原田 仁, 裏川 直樹, 長谷川 寛, 金治 新悟, 山下 公大, 松田 武, 掛地 吉弘
    第75回手術手技研究会, Web開催/三島, Domestic conference
    Oral presentation

  • taTMEの手術成績と手技の工夫
    岡本 柊志, 松田 武, 山下 公大, 長谷川 寛, 内海 昌子, 裏川 直樹, 金治 新悟, 押切 太郎, 掛地 吉弘
    第75回手術手技研究会, Web開催/三島, Domestic conference
    Poster presentation

  • 十二指腸乳頭に近接する表在型腫瘍に対する乳頭損傷予防として膵管ステントを用いた腫瘍切除術式の検討
    金治 新悟, 鈴木 知志, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第75回手術手技研究会, Web開催/三島, Domestic conference
    Poster presentation

  • Antigen electroporated DC loaded with NKT-cell ligand induces the antigen specific antitumor immunity
    Watanabe A, Yamashita K, Arimoto A, Yamada K, Agawa K, Kamigaki T, Takimioto R, Kakeji Y
    AACR ANNUAL MEETING 2021, Web開催, International conference
    Poster presentation

  • NCDを用いた虫垂炎研究：虫垂炎手術における手術関連死ゼロを目指して
    山田 岳史, 遠藤 英樹, 長谷川 寛, 木村 聡元, 掛地 吉弘, 石田 秀行, 幸田 圭史, 坂本 一博, 平田 敬冶, 山本 博之, 宮田 裕章, 松田 明久, 吉田 寛, 北川 雄光
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Oral presentation

  • 急性汎発性腹膜炎手術における抗血栓薬の術中出血量・周術期出血/血栓合併症に対する影響～A nationwide study in Japan based on the National Clinical Database～
    松岡 義, 小林 健二, 佐々木 淳一, 北川 雄光, 掛地 吉弘, 篠崎 浩治
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Public symposium

  • 食道神経内分泌細胞癌治療の現状と予後予測因子の検討
    宗田 真, 桑野 博行, 宮崎 達也, 酒井 真, 掛地 吉弘, 藤 也寸志, 土岐 祐一郎, 松原 久裕, 佐伯 浩司
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Public symposium

  • 膵管内乳頭粘液性癌に対する亜全胃温存膵頭十二指腸切除術後に細胆管癌を発症し、肝切除後胆汁瘻を合併した１例
    山内 沙耶, 蔵満 薫, 宗 慎一, 寺井 祥雄, 木戸 正浩, 田中 基文, 小松 昇平, 津川 大介, 権 英寿, 浦出 剛史, 石田 潤, 白川 幸代, 山下 博成, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 掛地 吉弘, 福本 巧
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Poster presentation

  • 低肺機能食道癌患者に対する腹臥位胸腔鏡下食道切除術の安全性
    瀧口 豪介, 押切 太郎, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Oral presentation

  • 高齢者の胃癌ESD後追加外科切除に関する検討
    山本 将士, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Poster presentation

  • 当科におけるcStageIV胃癌に対するconversion surgeryの治療成績
    松田 佳子, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    Web開催
    Poster presentation

  • FDG-PET検査によるリンパ節SUVmax値を用いた胃癌リンパ節転移診断の有用性の検討
    山田 康太, 裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Public symposium

  • 直腸癌NACRT症例におけるサルコペニアの影響
    堀江 和正, 松田 武, 山下 公大, 長谷川 寛, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Public symposium

  • 食道癌におけるcomprehensive complication indexと長期予後の関係
    工藤 拓也, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Oral presentation

  • リンパ節転移比率はMinimally invasive esophagectomy（MIE）を施行した食道扁平上皮癌患者の独立予後因子である
    北村 優, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Oral presentation

  • 術前化学療法を施行した食道癌切除症例の予後を予測するバイオマーカーとしての好中球-リンパ球比の意義
    加藤 喬, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Poster presentation

  • 当科における胃腺癌・食道胃接合部腺癌に対する術前化学療法の治療成績
    裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Poster presentation

  • 最新内視鏡システムが腹腔鏡下胃癌手術にもたらすもの
    金治 新悟, 山崎 悠太, 工藤 拓也, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Public symposium

  • 大腸癌腹膜播腫モデルにおける PD-L1 耐性とその克服
    山下 公大, 杉田 裕, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Oral presentation

  • 直腸癌におけるtransperineal minimally invasive APRの有用性：手術成績と定型化について
    松田 武, 山下 公大, 長谷川 寛, 内海 昌子, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Oral presentation

  • 胃がん登録の現状とNCDへの実装
    掛地 吉弘, 小寺 泰弘
    第121回日本外科学会定期学術集会, Web開催
    Others

  • 当科で行っている胸管温存，反回神経非遊離のen-bloc 縦隔郭清
    押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催
    Oral presentation

  • 特別企画6 各疾患登録とNCDの課題と将来
    掛地 吉弘
    第121回日本外科学会定期学術集会, Web開催, Domestic conference
    Others

  • Session3 【パネルディスカッション】
    掛地 吉弘
    第30回近畿GIST研究会, Japanese, 近畿GIST研究会、ファイザー株式会社, web開催, Japan, Domestic conference
    Others

  • 一般演題 食道癌に対するMIEの現状と教育
    掛地 吉弘
    第4回神戸消化器学術講演会, Japanese, ミヤリサン製薬株式会社, web開催, Japan, Domestic conference
    Others

  • 開会のあいさつ
    掛地 吉弘
    第4回神戸消化器学術講演会, Japanese, ミヤリサン製薬株式会社, web開催, Japan, Domestic conference
    [Invited]
    Others

  • 胃癌薬物療法のベストシークエンスとは～ニボルマブ～のベストポジションを考える
    掛地 吉弘
    オプジーボ WEBライブセミナー, Japanese, 小野薬品工業株式会社、ブリストル・マイヤーズ・スクイブ株式会社, web開催, Japan, Domestic conference
    Public discourse

  • Computer-based video analysis of device usage in laparoscopic gastrectomy.
    Yamasazaki Y, Kanaji S, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Matsuda Y, Yamashita K, Oshikiri T, Matsuda T, Nanakmura T, Suzuki S, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Public symposium

  • Prone thoracoscopic esophagectomy for patients with low respiratory function
    Takiguchi G, Oshikiri T, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamutra T, Suzuki S, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Oral presentation

  • Robot-assisted gastrectomy: short-term outcomes and procedural standardization at a single hospital
    Urakawa N, Kanaji S, Takiguchi G, Hasegawa H, Yamamoto M, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Oral presentation

  • How much operative time does transanal approach reduce for male patients with rectal cancer?
    Hasegawa H, Matsuda T, Yamashita K, Utsumi M, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Public symposium

  • Laparoscopic vs. open right hemicolectomy: the Japanese National Clinical Database analysis
    Matsuda T, Endo H, Inomata M, Hasegawa H, Kumamaru H, Miyata H, Sakai Y, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Public symposium

  • Transanal vs. laparoscopic TME for low rectal cancer: clinical outcomes and technical tips
    Matsuda T, Yamashita K, Hasegawa H, Utsumi M, Takiguchi G, Urakawa N, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Public symposium

  • Which surgical position is beneficial for thoracoscopic esophagectmoy?-Prone or lateral position-
    Nakamura T,Takiguchi, Miura S, Otsubo D, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Suzuki S, Kakeji Y
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Poster presentation

  • NCDによるReal Worldデータが胃癌における手術手技を変える可能性
    比企 直樹, 吉田 和弘, 本多 通孝, 衛藤 剛, 井田 智, 隈丸 拓, 小寺 泰弘, 掛地 吉弘, 今野 弘之, 宮田 裕章, 瀬戸 康之, 牛久 秀樹, 新原 正大, 細田 桂, 山下 継史
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Invited oral presentation

  • National Clinical Databaseから見えてくる内視鏡外科手術の実像
    掛地 吉弘, 北川 雄光, 瀬戸 泰之
    第33回日本内視鏡外科学会総会, Japanese, 大分大学医学部消化器・小児外科学講座, 横浜/web開催, Japan, Domestic conference
    Invited oral presentation

  • 内科領域の現状と展望
    田邉 聡, 小野 裕之, 鈴木 晴久, 石川 卓, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Oral presentation

  • 抗血栓療法中の患者に対する胃癌手術の安全性の検討
    工藤 拓也, 金治 新悟, 瀧口 豪介, 裏川 直樹, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Oral presentation

  • 当院におけるロボット支援下幽門側胃切除術の短期治療成績と定型化に向けた取り組み
    裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Oral presentation

  • 高齢者に対する胃癌ESD後追加手術
    山本 将士, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Public symposium

  • 高齢進行胃・接合部癌患者に対する術前化学療法の安全性と有用性の検討
    金治 新悟, 鈴木 知志, 松田 佳子, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Public symposium

  • 術前化学療法を行いpCRを得られた6症例の検討
    松田 佳子, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Poster presentation

  • 高齢者の胃癌に対する胃切除範囲の予後に及ぼす影響
    鈴木 知志, 裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Oral presentation

  • パネルディスカッション2 胃癌周術期薬物治療の挑戦
    掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Others

  • プレナリーセッション3 胃癌登録事業について
    掛地 吉弘
    第93回日本胃癌学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科, web開催, Japan, Domestic conference
    [Invited]
    Public discourse

  • 当番世話人の挨拶 閉会
    掛地 吉弘
    第27回日本がんチーム医療研究会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学分野、NPO法人堺臨床研究支援センター、日本がんチーム医療研究会, 大阪/web開催, Japan, Domestic conference
    Others

  • 特別シンポジウム『COVID-19 蔓延下のがん診療』
    掛地 吉弘
    第27回日本がんチーム医療研究会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学分野、NPO法人堺臨床研究支援センター、日本がんチーム医療研究会, 大阪/web開催, Japan, Domestic conference
    Others

  • 当番世話人の挨拶 開会
    掛地 吉弘
    第27回日本がんチーム医療研究会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学分野、NPO法人堺臨床研究支援センター、日本がんチーム医療研究会, 大阪/web開催, Japan, Domestic conference
    Others

  • 5Ｇ世代の胃癌手術
    掛地 吉弘
    第1回5四金会, Japanese, 5四金会、科研製薬株式会社, 神戸/web開催, Japan, Domestic conference
    Invited oral presentation

  • 胃原発混合神経内分泌非神経内分泌腫瘍(MiNEN)の全エクソームシークエンスによる解析
    工藤 拓也, 石田 苑子, 中村 哲, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 鈴木 知志, 全 陽, 掛地 吉弘
    第8回日本神経内分泌腫瘍研究会学術集会, Japanese, 横浜市立大学大学院医学研究科 がん総合医科学, web開催, Japan, Domestic conference
    Oral presentation

  • 基調講演「当科における大腸外科医育成」
    掛地 吉弘
    兵庫県消化器外科研究会, Japanese, 兵庫県消化器外科研究会・小野薬品工業株式会社, web開催, Japan, Domestic conference
    [Invited]
    Oral presentation

  • Confirmed three-year RFS and OS of the randomized trial of adjuvant S-1 versus S-1 plus docetaxel after curative resection of pStage III gastric cancer (JACCRO GC-07).
    Yoshida K, Kodera Y, Kochi M, Sano T, Kakeji Y, Ichikawa W, Kurahashi S, Yamaguchi H, Toyokawa T, Nakamura M, Fujitani K, Mochizuki Y, Ota M, Hihara J, Makari Y, Takeno A, Takeuchi M, Fujii M
    Gastrointestinal Cancers Symposium（ASCO GI 2021）, English, ASCO, web開催, International conference
    Oral presentation

  • National clinical databaseによる膵全摘術の術後重症合併症リスクモデル
    橋本 大輔, 水間 正道, 隈丸 拓, 宮田 裕章, 近本 亮, 五十嵐 久人, 糸井 隆夫, 江川 新一, 児玉 裕三, 里井 壯平, 濱田 晋, 水元 一博, 山上 祐機, 山本 雅一, 掛地 吉弘, 瀬戸 康之, 馬場 秀夫, 海野 倫明, 下瀬川 徹, 岡崎 和一
    第51回日本膵臓学会大会, Japanese, 近畿大学医学部外科学教室 肝胆膵部門, 神戸/web開催, Japan, Domestic conference
    Invited oral presentation

  • 女性外科医のキャリア・アップを目指した一歩踏み込んだサポート体制
    石田 苑子, 中村 哲, 内海 昌子, 永田 真知子, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第45回日本外科系連合学会学術集会, Japanese, 久留米大学病院 腫瘍センター, web開催, Japan, Domestic conference
    Public symposium

  • シンポジウム6 分子標的剤で変ったがん集学的治療
    掛地 吉弘
    第45回日本外科系連合学会学術集会, Japanese, 久留米大学病院 腫瘍センター, web開催, Japan, Domestic conference
    Others

  • 消化器外科領域でのNCDへの取り組みについて
    掛地 吉弘
    第108回日本泌尿器科学会総会, Japanese, 神戸大学大学院医学研究科 腎泌尿器科学分野, 神戸/Web開催, Japan, Domestic conference
    Public discourse

  • Standardization of upper mediastinal lymphadenectomy in prone thoracoscopic esophagectomy（腹臥位胸腔鏡下食道切除術における上縦隔郭清の定型化）
    Takiguchi G, Oshikiri T, Urakawa N, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • Surgical outcomes and technical tips of transanal total mesorectal excision for low rectal cancer （下部直腸癌に対するtaTMEの手術成績（vs. lap TME）と安全に行うための工夫）
    Matsuda T, Yamashita K, Hasegawa H, Urakawa N, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • Feasibility of thoracic duct preservation in esophageal SCC: a propensity score matchied-cohort study（食道扁平上皮癌に対する食道切除における胸管温存の妥当性～傾向スコアを用いた後ろ向きコホート研究～）
    Oshikiri T, Nakamura T, Takiguchi G, kanaji S, Yamashita K, Matsuda T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • Standardization of the robotic esophagectomy based on standardized minimally invasive esophagectomy（胸腔鏡手術との互換性から考えるロボット支援下食道切除術への移行と定型化）
    Nakamura T, Takiguchi G, Urakawa N, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Oshikiri T, Suzuki S, Kakeji Y
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • Workshop14 Future perspectives of cancer genomic medicine in gastroenterological surgery
    Kakeji Y
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Others

  • 腹腔鏡手術の安全性に注目した、本邦での高齢者に対する大腸手術成績の検討～NCDデータを用いて～
    清島 亮, 長谷川 博俊, 岡林 剛史, 宮田 裕章, 山下 裕一, 猪股 雅史, 若林 剛, 掛地 吉弘, 渡邊 昌彦, 北川 雄光
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • 腹腔鏡下胃切除術動画における手術器具自動認識システムの開発と臨床研究への応用
    山崎 悠太, 金治 新悟, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • 高齢食道癌患者に対する胸腔鏡下手術の有用性
    杉田 裕, 中村 哲, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • 腹腔鏡による安全な胸骨後経路作成の工夫
    堀川 学, 押切 太郎, 瀧口 豪介, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Oral presentation

  • 当院におけるロボット支援下胃切除術の短期治療成績と定型化に向けた取り組み
    裏川 直樹, 金治 新悟, 瀧口 豪介, 山本 将士, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Oral presentation

  • 臨床的側方リンパ節転移陽性直腸癌に対する術前化学放射線療法に伴う直腸癌手術後の再発リスクの検討
    長谷川 寛, 松田 武, 山下 公大, 有本 聡, 内海 昌子, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • 胃癌ESD後の追加外科切除に関する検討
    山本 将士, 金治 新悟, 裏川 直樹, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 森田 圭紀, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Oral presentation

  • 局所進行胃癌に対する術前化学療法著効症例において術後補助化学療法は省略可能か
    松田 佳子, 裏川 直樹, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Oral presentation

  • 腹膜播種における骨髄由来免疫抑制性細胞の働きとその治療応用
    山下 公大, 杉田 裕, 長谷川 寛, 山本 将士, 金治 新悟, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Oral presentation

  • 高度進行胃癌に対するConversion surgeryの検討
    鈴木 知志, 金治 新悟, 裏川 直樹, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • ランチョンセミナー4
    掛地 吉弘
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    [Invited]
    Public discourse

  • Comparison of 3D and 4K for laparoscopic gastrectomy for gastric cancer（腹腔鏡下胃癌手術の手術成績に関する内視鏡画像システム（3Ｄvs4Ｋ）のランダム化比較試験）
    Kanaji S, Yamazaki Y, Suzuki S, Yamamoto M, Urakawa N, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y
    第75回日本消化器外科学会総会, Japanese, 和歌山県立医科大学外科学第2講座, 和歌山/Web開催, Japan, Domestic conference
    Public symposium

  • 食道裂孔ヘルニア・胃食道逆流症の外科治療の全国実態調査
    小澤 壯治, 小村 伸朗, 小柳 和夫, 小熊 潤也, 數野 暁人, 北川 雄光, 掛地 吉弘, 藤 也寸志, 松原 久裕
    第74回日本食道学会学術集会, Japanese, 徳島大学大学院医歯薬学研究部 胸部・内分泌・腫瘍外科学分野, 徳島/Web開催, Japan, Domestic conference
    Public symposium

  • Established upper mediastinum lymphadenectomy in prone MIE improves outcomes
    瀧口 豪介, 押切 太郎, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本食道学会学術集会, Japanese, 徳島大学大学院医歯薬学研究部 胸部・内分泌・腫瘍外科学分野, 徳島/Web開催, Japan, Domestic conference
    Public symposium

  • Feasibility of lymphadenectomy with thoracic duct preservation in esophageal SCC
    押切 太郎, 中村 哲, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 鈴木 知志, 掛地 吉弘
    第74回日本食道学会学術集会, Japanese, 徳島大学大学院医歯薬学研究部 胸部・内分泌・腫瘍外科学分野, 徳島/Web開催, Japan, Domestic conference
    Public symposium

  • 表在型食道癌（pMM/SM1）に対する胸腔鏡下食道切除術の治療成績
    中村 哲, 瀧口 豪介, 金治 新悟, 松田 武, 鈴木 知志, 掛地 吉弘
    第74回日本食道学会学術集会, Japanese, 徳島大学大学院医歯薬学研究部 胸部・内分泌・腫瘍外科学分野, 徳島/Web開催, Japan, Domestic conference
    Public symposium

  • ワークショップ3 初回治療後の病期診断の現況とブレークスルー（領域横断的セッション）
    掛地 吉弘
    Japanese, 徳島大学大学院医歯薬学研究部 胸部・内分泌・腫瘍外科学分野, 徳島/Web開催, Japan, Domestic conference
    Others

  • 食道癌術前化学療法の効果予測因子における癌幹細胞マーカーの有用性に関する検討
    阿河 杏介, 山下 公大, 中川 暁雄, 山田 康太, 渡部 晃大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第24回バイオ治療法研究会学術集会, Japanese, 福岡大学医学部産科婦人科学講座、福岡がん総合クリニック, web開催, Japan, Domestic conference
    Oral presentation

  • 腹膜播種における腹腔内MDSCの役割
    山下 公大, 杉田 裕, 山田 康太, 阿河 杏介, 渡部 晃大, 福岡 英志, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第24回バイオ治療法研究会学術集会, Japanese, 福岡大学医学部産科婦人科学講座、福岡がん総合クリニック, web開催, Japan, Domestic conference
    Oral presentation

  • 特別講演「ロボット胃がん手術：安全に行うためのコツと今後の可能性」
    掛地 吉弘
    第21回神戸外科WEBフォ－ラム, Japanese, 大鵬薬品工業株式会社, web開催, Japan, Domestic conference
    Others

  • SESSION2 Clinical Question の治療戦略を考える
    掛地 吉弘
    ESOPHAGEAL CANCER EXPERT FORUM, Japanese, 小野薬品工業株式会社、Bristol Myers Squibb, web開催, Japan, Domestic conference
    Others

  • NACRT 施行後腹会陰式直腸切断術における大網充填術の有用性
    永田 真知子, 松田 武, 長谷川 寛, 山下 公大, 内海 昌子, 山本 将士, 松田 佳子, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第33回日本外科感染症学会総会学術集会, Japanese, 防衛医科大学校 外科学講座, web開催, Japan, Domestic conference
    Poster presentation

  • 高齢者胃癌切除後の肺炎併発による長期予後への影響の検討
    山田 康太, 鈴木 知志, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 晢, 掛地 吉弘
    第33回日本外科感染症学会総会学術集会, Japanese, 防衛医科大学校 外科学講座, web開催, Japan, Domestic conference
    Public symposium

  • 直腸癌術後縫合不全は長期予後を悪化させるのか？
    長谷川 寛, 松田 武, 山下 公大, 内海 昌子, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第33回日本外科感染症学会総会学術集会, Japanese, 防衛医科大学校 外科学講座, web開催, Japan, Domestic conference
    Poster presentation

  • NCD データから見る、高齢者に対する腹腔鏡下直腸手術と SSI 発生の関連について
    清島 亮, 宮田 裕章, 岡林 剛史, 長谷川 博俊, 鶴田 雅士, 茂田 浩平, 山下 裕一, 猪股 雅史, 若林 剛, 掛地 吉弘, 北川 雄光, 渡邊 昌彦
    第33回日本外科感染症学会総会学術集会, Japanese, 防衛医科大学校 外科学講座, web開催, Japan, Domestic conference
    Public symposium

  • 挨拶
    掛地 吉弘
    第188回 兵庫県外科医会学術集会, Japanese, 兵庫県外科医会、コヴィディエンジャパン株式会社, 姫路/Web開催, Japan, Domestic conference
    [Invited]
    Others

  • 直腸癌に対するTa-TME併用直腸切除術の手術手技と手術成績
    山内 沙耶, 松田 武, 山下 公大, 長谷川 寛, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Public symposium

  • 鼠経リンパ節転移陽性直腸癌に対する治療戦略
    加藤 喬, 松田 武, 長谷川 寛, 山下 公大, 内海 昌子, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Oral presentation

  • 大腸癌腹膜播種の病勢に骨髄由来免疫抑制細胞が及ぼす影響とその治療応用
    山田 康太, 山下 公大, 杉田 裕, 阿河 杏介, 渡部 晃大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学, web開催, Japan, Domestic conference
    Public symposium

  • 放射線治療は、腫瘍内CD8+T細胞の増加とサイトカイン産生を増強し、抗腫瘍効果に寄与する
    阿河 杏介, 山下 公大, 山田 康太, 渡部 晃大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院医学研究科 消化器外科, web開催, Japan, Domestic conference
    Public symposium

  • 腫瘍関連マクロファージ由来のCCL1はCCR8を介して食道扁平上皮癌の運動能・浸潤能を亢進させる
    藤川 正隆, 佐藤 経雄, 藤田 知樹, 浦上 聡, 北村 優, 児玉 貴之, 清水 将来, 谷川 航平, 坂本 浩輝, 西尾 真理, 重岡 學, 狛 雄一朗, 掛地 吉弘, 横崎
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院医学研究科 消化器外科, web開催, Japan, Domestic conference
    Oral presentation

  • 癌関連線維芽細胞はPAI-1の分泌を介して食道扁平上皮癌の進展に寄与する
    坂本 浩輝, 佐藤 経雄, 藤田 知樹, 浦上 聡, 北村 優, 谷川 航平, 清水 将来, 児玉 貴之, 藤川 正隆, 西尾 真理, 重岡 學, 狛 雄一朗, 掛地 吉弘, 横崎 宏
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院医学研究科 消化器外科, web開催, Japan, Domestic conference
    Oral presentation

  • 当院における胃・食道胃接合部腺癌に対する術前化学療法の治療成績の検討
    裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院医学研究科 消化器外科, web開催, Japan, Domestic conference
    Public symposium

  • 共催セミナー4 消化器癌におけるオキサリプラチンの臨床的意義
    掛地 吉弘
    第31回日本消化器癌発生学会総会, Japanese, 大阪市立大学大学院医学研究科 消化器外科, web開催, Japan, Domestic conference
    [Invited]
    Public discourse

  • 胃癌に対する最新集学的治療
    掛地 吉弘
    神戸消化器癌フォーラム2020＠web, Japanese, 日本化薬株式会社, web開催, Japan, Domestic conference
    [Invited]
    Invited oral presentation

  • 当科における胃癌および食道胃接合部癌に対する術前化学療法の治療成績
    山本 将士, 金治 新悟, 松田 佳子, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第50回胃外科・術後障害研究会, Japanese, 帝京大学医学部外科学講座, web開催, Japan, Domestic conference
    Public symposium

  • 胃癌治療の目指すもの
    掛地 吉弘
    第50回胃外科・術後障害研究会, Japanese, 帝京大学医学部外科学講座, web開催, Japan, Domestic conference
    Public discourse

  • 主題1-2 「化学療法後の胃癌手術」
    掛地 吉弘
    第50回胃外科・術後障害研究会, Japanese, 帝京大学医学部外科学講座, web開催, Japan, Domestic conference
    Others

  • 完全腹腔鏡下幽門側胃切除における点墨による胃切離線決定法の有用性
    山崎 悠太, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan
    Poster presentation

  • NACRT施行後腹会陰式直腸切断術における大網充填術の有用性
    永田 真知子, 松田 武, 長谷川 寛, 山下 公大, 内海 昌子, 山本 将士, 松田 佳子, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Poster presentation

  • 低肺機能に対する腹臥位胸腔鏡下食道切除術
    瀧口 豪介, 押切 太郎, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Poster presentation

  • 食道胃接合部癌Siewert2型におけるリンパ節転移の予後への影響
    裏川 直樹, 鈴木 知志, 金治 新悟, 瀧口 豪介, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Poster presentation

  • StageⅣ胃癌に対するconversion surgery
    山本 将士, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Poster presentation

  • 十二指腸乳頭に近接する表在型腫瘍に対する乳頭損傷予防として膵管ステントを用いた腫瘍切除術式の検討
    金治 新悟, 鈴木 知志, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Poster presentation

  • 高齢者の胃癌手術における腎機能障害度の合併症発生に及ぼす影響
    鈴木 知志, 金治 新悟, 掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Public symposium

  • ランチョンセミナー63 ニボルマブが変える食道癌薬物治療戦略
    掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    [Invited]
    Public discourse

  • ワークショップ13 消化器悪性疾患に対するconversion surgery
    掛地 吉弘
    JDDW2020（第28回日本消化器関連学会週間）, Japanese, 一般社団法人日本消化器関連学会機構, 神戸/web開催, Japan, Domestic conference
    Others

  • 飽和食塩溶液固定法を用いた腹臥位胸腔鏡下食道切除術のCadaver Surgical Training
    瀧口 豪介, 押切 太郎, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第73回日本胸部外科学会定期学術集会, Japanese, 名古屋大学大学院医学系研究科 心臓外科学, web開催, Japan, Domestic conference
    Invited oral presentation

  • 大動脈食道瘻の治療戦略－消化器外科の観点から－
    中村 哲, 瀧口 豪介, 山中 勝弘, 大村 篤史, 押切 太郎, 井上 武, 岡田 健次, 掛地 吉弘
    第73回日本胸部外科学会定期学術集会, Japanese, 名古屋大学大学院医学系研究科 心臓外科学, web開催, Japan, Domestic conference
    Public symposium

  • 総会特別企画09 5G時代の遠隔医療－システム構築と外科治療－
    掛地 吉弘
    第82回日本臨床外科学会総会, Japanese, 大阪医科大学 外科学講座 一般・消化器外科, web開催, Japan, Domestic conference
    Others

  • 胃がんにおける抗HER2抗体による術前治療および免疫チェックポイント阻害薬の展望
    掛地 吉弘
    第58回日本癌治療学会学術集会, Japanese, 日本医科大学大学院医学研究科 呼吸器内科学分野, 京都/web開催, Japan, Domestic conference
    Public symposium

  • 学術セミナー42 消化器癌免疫療法におけるバイオマーカーと治療戦略
    掛地 吉弘
    第58回日本癌治療学会学術集会, Japanese, 日本医科大学大学院医学研究科 呼吸器内科学分野、MSD株式会社, 京都/Web開催, Japan, Domestic conference
    Public discourse

  • 特別講演「癌治療と栄養学を考える」
    掛地 吉弘
    第11回神戸栄養研究会, Japanese, 神戸大学医学部附属病院 栄養輸液サポートチーム（NEST）、アボットジャパン合同会社, web開催, Japan
    Others

  • Special Lecture『ゲノム診療の時代に改めて抗EGFR抗体薬治療を考える』
    掛地 吉弘
    Leader's Meeting in Kansai & Tokyo, Japanese, メルクバイオファーマ株式会社, 大阪, Japan
    Others

  • サージカルフォーラム 胃１
    掛地 吉弘
    第74回手術手技研究会, Japanese, 大阪大学大学院 消化器外科学, 松江, Japan, Domestic conference
    Others

  • 特別講演『大腸ステントの現状と将来展望』
    掛地 吉弘
    第33回兵庫大腸癌治療研究会, Japanese, 兵庫大腸癌治療研究会、兵庫県がん診療連携協議会、大鵬薬品工業株式会社、ミヤリサン製薬株式会社, web開催, Japan
    Others

  • 潜在転移ヒト乳がん幹細胞のマイクロRNAプロファイル
    下野 洋平, 渋谷 尚樹, 西村 建徳, 後藤 典子, 掛地 吉弘
    第79回日本癌学会学術総会, Japanese, 広島大学大学院医系化学研究科 分子病理学, 広島, Japan, Domestic conference
    Invited oral presentation

  • 放射線治療は新たに浸潤するCD8+T細胞を増強し、腫瘍内CD8+T細胞の増加と抗腫瘍効果に寄与する。
    山下 公大, 福岡 英志, 渡部 晃大, 阿河 杏介, 山田 康太, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第79回日本癌学会学術総会, Japanese, 広島大学大学院医系化学研究科 分子病理学, 広島, Japan, Domestic conference
    Poster presentation

  • Killian-Jamieson 憩室内に発生した食道癌の一例
    堀川 学, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第203回近畿外科学会, Japanese, 大阪市立大学大学院医学研究科 消化器外科、乳腺・内分泌外科学, webおよび誌上開催, Japan, Domestic conference
    Oral presentation

  • Ta-TME併用による腹会陰式直腸切断術の手術手技と手術成績
    山内 沙耶, 松田 武, 山下 公大, 長谷川 寛, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第203回近畿外科学会, Japanese, 大阪市立大学大学院医学研究科 消化器外科、乳腺・内分泌外科学, webおよび誌上開催, Japan, Domestic conference
    Oral presentation

  • 当科における下部直腸癌に対するtaTMEの手術手技と手術成績
    内海 昌子, 松田 武, 山下 公大, 長谷川 寛, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第33回近畿内視鏡外科研究会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学 乳腺・内分泌外科学, web開催, Japan, Domestic conference
    Public symposium

  • 低肺機能食道患者に対する腹臥位胸腔鏡下食道切除術
    瀧口 豪介, 押切 太郎, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第33回近畿内視鏡外科研究会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学 乳腺・内分泌外科学, web開催, Japan, Domestic conference
    Oral presentation

  • 腹臥位胸腔鏡下食道切除における上縦隔郭清の工夫
    押切 太郎, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第33回近畿内視鏡外科研究会, Japanese, 大阪市立大学大学院 医学研究科 消化器外科学 乳腺・内分泌外科学, web開催, Japan, Domestic conference
    Public symposium

  • プロローグ
    掛地 吉弘
    食道癌免疫療法セミナー, Japanese, 小野薬品工業株式会社、ブリストル・マイヤーズスクイブ株式会社, web開催, Japan
    Others

  • Session2 【手術】胃癌に対するロボット手術
    掛地 吉弘
    Gastric Cancer Cross-Clinical Seminar In KOBE, Japanese, 大鵬薬品工業株式会社、７大学連携個別化がん医療, web開催, Japan
    Others

  • 大腸がんの治療戦略 リキッドバイオプシーをどう生かすか
    掛地 吉弘
    大腸がんWEBセミナー ＝Kobe Program＝, Japanese, 武田薬品工業株式会社, web開催, Japan
    Others

  • Session2 大腸がん化学療法について伝えたい３つの事柄
    掛地 吉弘
    第7回平成大腸癌カンファレンス, Japanese, 中外製薬株式会社, web開催, Japan
    Others

  • ACS-NSQIPに学ぶ, 外科医療成績向上に向けた取り組み
    丸橋 繁, 掛地 吉弘, 宮田 裕章, 瀬戸 泰之, 北川 雄光, Lina Hu, Clifford Ko, 後藤 満一
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Invited oral presentation

  • 食道癌手術における術前の歯牙欠損と術後の予後との関係
    三浦 晋, 中村 哲, 瀧口 豪介, 押切 太郎, 裏川 直樹, 長谷川 寛, 山本 将士, 金冶 新悟, 松田 佳子, 山下 公大, 松田 武, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • 胸部食道癌術後にsevereな体重減少を認める症例は予後不良であり、周術期に短期的な経腸栄養を行っても改善しない
    小寺澤 康文, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • 間葉系幹細胞由来のCXCL16は胃癌細胞においてSTAT3経路を介してRor1の発現を誘導し増殖と遊走を促進する
    池田 太郎, 西田 満, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 南 康博, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • 食道亜全摘術の再建経路選択におけるICG蛍光観察法の有用性
    工藤 拓也, 押切 太郎, 瀧口 豪介, 裏川 直樹, 松田 佳子, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • オープンソースの物体検出アルゴリズムを用いた腹腔鏡下胃癌手術ビデオにおける手術器具自動認識システムの開発と利用
    山崎 悠太, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Invited oral presentation

  • 食道癌手術における術後合併症予測因子及び長期予後予測因子としてのSurgical Apgar Scoreの有用性
    瀧口 豪介, 中川 暁雄, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • 食道胃接合部癌 Siewert2 型におけるリンパ節転移の予後への影響
    裏川 直樹, 金治 新悟, 鈴木 知志, 瀧口 豪介, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • 直腸癌術後縫合不全は長期予後を悪化させるのか？
    長谷川 寛, 松田 武, 山下 公大, 有本 聡, 西 将康, 細野 雅義, 阿部 紘一郎, 前田 詠理, 川﨑 健太郎, 藤野 泰宏, 富永 正寛, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • 当院における腹腔鏡下胃全摘術の安全性と有用性
    山本 将士, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • 表在性非乳頭部十二指腸腫瘍に対する腹腔鏡内視鏡合同手術～腫瘍局在に応じた外科手技の工夫と治療成績～
    金治 新悟, 森田 圭紀, 鈴木 知志, 山本 将士, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 豊永 高史, 中村 哲, 児玉 裕三, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • 術後腹膜炎が転移を促進させる-マウス腹膜炎モデルにおける肺転移への影響
    山下 公大, 有本 聡, 渡部 晃大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • 「外側先行剥離」による新しいTaTME手技
    松田 武, 山下 公大, 長谷川 寛, 有本 聡, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • ロボット支援手術における上縦隔郭清手技とその可能性
    押切 太郎, 中村 哲, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • 食道癌に対する胸腔鏡下手術の治療成績
    中村 哲, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • 食道胃接合部腺癌に対する術前補助化学療法の検討
    鈴木 知志, 金治 新悟, 裏川 直樹, 山本 将士, 松田 佳子, 有本 聡, 瀧口 豪介, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Poster presentation

  • イブニングセミナー（8） 「大腸癌化学療法～Late Lineの治療戦略～」
    掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室、バイエル薬品株式会社, web開催, Japan, Domestic conference
    Public discourse

  • ワークショップ（19）「上部消化管機能温存術式のエビデンス」
    掛地 吉弘
    第120回日本外科学会定期学術集会, Japanese, 慶応義塾大学医学部外科学教室, web開催, Japan, Domestic conference
    Public symposium

  • Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer:JACCRO GC-07
    Kochi M, Yoshida K, Kodera Y, Ichikawa W, Kakeji Y, Sano T, Takeuchi M, Fujii M, Takayama T
    第92回日本胃癌学会総会, Japanese, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Public symposium

  • Treatment choices after recurrence in patients with stage III gastric cancer in JACCRO GC-07 study
    Ishida H, Ichikawa W, Yoshida K, Kodera Y, Kochi M, Kakeji Y, Sano T, Takeuchi M, Fujii M
    第92回日本胃癌学会総会, Japanese, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • Feasibility of laparoscopic gastrectomy for patients with poor physical status: a NCD-based study
    Inokuchi M, Kumamaru K, Nakagawa M, Miyata H, Kakeji Y, Kojima K, Seto Y
    第92回日本胃癌学会総会, Japanese, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • NCDデータを用いた胃全摘術後合併症に対するHospital Volumeの影響
    岩槻 政晃, 掛地 吉弘, 吉田 和弘, 今野 弘之, 瀬戸 泰之, 馬場 秀夫
    第92回日本胃癌学会総会, Japanese, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • Preoperative endoscopic tattooing using India ink for totally laparoscopic distal gastrectomy
    Yamazaki Y, Kanaji S, Takiguchi G, Urakawa N, Yamamoto M, Matsuda Y, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Domestic conference
    Oral presentation

  • Conversion surgery following chemotherapy for Stage Ⅳ gastric cancer
    Yamamoto M, Kanaji S, Takiguchi G, Urakawa N, Hasegawa H, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki, Kakeji Y
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference

  • Perspective of newer treatments of Schirrus-Type gastric cancer or peritoneal dissemination
    Kakeji Y
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Public symposium

  • リンパ節転移を伴う早期胃癌の予後に関する検討
    杉田 裕, 鈴木 知志, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 掛地 吉弘
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • 抗血栓療法中患者に対する胃切除術における周術期抗血栓療法の検討
    裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Poster presentation

  • 高齢者局所進行胃癌に対する術前化学療法の有効性と安全性
    松田 佳子, 杉田 裕, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • Siewert Ⅱ型食道胃接合部癌に対する偽His角・fornix形成食道胃管再建
    金治 新悟, 鈴木 知志, 山本 将士, 裏川 直樹, 瀧口 豪介, 長谷川 寛, 松田 佳子, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 掛地 吉弘
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Poster presentation

  • 食道胃接合部腺癌に対する術前補助化学療法の有用性
    鈴木 知志, 金治 新悟, 裏川 直樹, 山本 将士, 松田 佳子, 有本 聡, 瀧口 豪介, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • 口演25 合併症/術後障害3
    掛地 吉弘
    第92回日本胃癌学会総会, English, 国立がん研究センター 先端医療開発センター, web開催, Japan, Domestic conference
    Oral presentation

  • 腹膜播種の病勢に腹腔内骨髄由来抑制細胞が及ぼす影響と、治療標的としての可能性
    山田 康太, 山下 公大, 杉田 裕, 渡部 晃大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第41回癌免疫外科研究会, Japanese, 大阪大学大学院医学系研究科 臨床腫瘍免疫学, 大阪, Japan, Domestic conference
    Oral presentation

  • NKT細胞ワクチンベクターの抗原特異的T細胞の活性化
    阿河 杏介, 山下 公大, 渡部 晃大, 山田 康太, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第41回癌免疫外科研究会, Japanese, 大阪大学大学院医学系研究科 臨床腫瘍免疫学, 大阪, Japan, Domestic conference
    Oral presentation

  • 一般口演１ 局所微小環境1
    掛地 吉弘
    第41回癌免疫外科研究会, Japanese, 大阪大学大学院医学系研究科 臨床腫瘍免疫学, 大阪, Japan, Domestic conference
    Oral presentation

  • Antigen specific antitumor effect induced by antigen-electroporated, natural killer T cell ligand-loaded dendritic cells
    Watanabe A, Yamashita K, Arimoto A, Sugita Y, Fukuoka E, Kamigaki T, Takimoto R, Kakeji Y
    AACR Annual Meeting 2020, English, web開催, International conference
    Poster presentation

  • Radiationtherapy for tumors enhances newly-infiltrating CD8⁺T cells and contributes to the increase of intratumor CD8⁺T cells and anti-tumor effects.
    Yamashita K, Fukuoka E, Sugita Y, Arimoto A, Watanabe A, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    AACR Annual Meeting 2020, English, web開催, International conference
    Poster presentation

  • 食道癌治療の新時代～ニボルマブをどう使いこなすか？～
    掛地 吉弘
    オプジーボWEBライブセミナー, Japanese, ブリストル・マイヤーズ スクイブ株式会社、小野薬品工業株式会社, web開催, Japan
    Public discourse

  • 胃がんの最新治療
    掛地 吉弘
    Next TV Symposium -胃がんのトータルマネジメント-, Japanese, 第一三共株式会社・アストラゼネカ株式会社, Japan, Domestic conference
    Public discourse

  • 対策型胃内視鏡検診の導入と課題 －AIによる診断支援の可能性ー
    掛地 吉弘
    Next TV Symposium -胃がんのトータルマネジメント-, Japanese, 第一三共株式会社・アストラゼネカ株式会社, Japan, Domestic conference
    Public discourse

  • 高齢食道癌患者に対する胸腔鏡下手術の意義と適応
    杉田 裕, 中村 哲, 押切 太郎, 掛地 吉弘
    日本消化器病学会近畿支部第112回例会, Japanese, 京都府立医科大学大学院医学研究科消化器内科学, 誌上開催, Japan, Domestic conference
    Public symposium

  • 当科における鼠径リンパ節転移陽性直腸癌に治療成績
    安達 祐里, 松田 武, 山下 公大, 長谷川 寛, 有本 聡, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    日本消化器病学会近畿支部第112回例会, Japanese, 京都府立医科大学大学院医学研究科消化器内科学, 誌上開催, Japan, Domestic conference
    Oral presentation

  • 当科における鼠径リンパ節転移陽性直腸癌の治療戦略
    阿河 杏介, 松田 武, 山下 公大, 長谷川 寛, 有本 聡, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第53回制癌剤適応研究会, 京都府立医科大学大学院医学研究科 消化器外科学, 滋賀, Japan, Domestic conference
    Poster presentation

  • 局所進行直腸癌に対する術前化学放射線療法における治療成績の比較検討
    永田 真知子, 松田 武, 有本 聡, 長谷川 寛, 山下 公大, 山本 将士, 松田 佳子, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第53回制癌剤適応研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 滋賀, Japan, Domestic conference
    Poster presentation

  • 当院における高頻度マイクロサテライト不安定性大腸癌のスクリーニング方法の検討
    高井 亮, 山下 公大, 須藤 洋崇, 豊田 昌徳, 船越 洋平, 清田 尚臣, 井上 潤, 田中 心和, 松田 武, 児玉 裕三, 南 博信, 掛地 吉弘
    第53回制癌剤適応研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 滋賀, Japan, Domestic conference
    Public symposium

  • 食道扁平上皮癌術前化学療法によるPD-L1発現とCD8陽性腫瘍浸潤リンパ球の誘導
    福岡 英志, 山下 公大, 有本 聡, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第53回制癌剤適応研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 滋賀, Japan, Domestic conference
    Public symposium

  • ランチョンセミナー
    掛地 吉弘
    第53回制癌剤適応研究会, Japanese, 京都府立医科大学大学院医学研究科 消化器外科学, 滋賀, Japan, Domestic conference
    Public discourse

  • 漢方を使う消化管集学的治療
    掛地 吉弘
    岐阜外科漢方フォーラム, Japanese, 株式会社ツムラ, 岐阜, Japan, Domestic conference
    Public discourse

  • Ｇ－ＣＳＦ（granulicyte-colony stimulating factor）産生胎児消化管上皮類似食道癌の１例
    北村 優, 押切 太郎, 瀧口 豪介, 中村 哲, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 鈴木 知志, 掛地 吉弘
    Japanese, 名古屋市立大学大学院 医学研究科 次世代医療開発学, 姫路, Japan, Domestic conference
    Oral presentation

  • 輸血依存の重症再生不良性貧血経過中に大腸癌術後の穿通性吻合部潰瘍を発症し周術期管理が奏効した1例
    岡本 大輝, 松田 武, 長谷川 寛, 金治 新悟, 松田 佳子, 山下 公大, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第16回日本消化管学会総会学術集会, Japanese, 名古屋市立大学大学院 医学研究科 次世代医療開発学, 姫路, Japan, Domestic conference
    Oral presentation

  • Contribution of 3-dimensional system in advance of Minimally Invasive Esophagectomy.
    Kudo T, Oshikiri T, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    15th ANNUAL ACADEMIC SURGICAL CONGRESS, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, Florida, United States, International conference
    Oral presentation

  • Influence of Lymphatic Metastasis on the Recurrence of Adenocarcinoma of the Esophagogastric Junction
    Urakawa N, Suzuki S, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y
    15th ANNUAL ACADEMIC SURGICAL CONGRESS, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, Florida, United States, International conference
    Oral presentation

  • がん診療におけるKAMPO
    掛地 吉弘
    第１回おかやま地域医療連携講演会, Japanese, 株式会社ツムラ, 岡山, Japan, Domestic conference
    [Invited]
    Invited oral presentation

  • がん治療におけるKAMPO
    掛地 吉弘
    おかやま地域医療連携講演会, Japanese, 株式会社ツムラ, 岡山, Japan, Domestic conference
    Public discourse

  • 特別講演
    掛地 吉弘
    神戸消化器外科Seminar, Japanese, テルモ株式会社, 神戸, Japan, Domestic conference
    Invited oral presentation

  • StageⅢ大腸癌術後補助化学療法の検討
    内海 昌子, 永田 真知子, 松田 武, 長谷川 寛, 山下 公大, 有本 聡, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第96回大腸癌研究会, Japanese, 広島大学大学院医系科学研究科 内視鏡医学, 広島, Japan, Domestic conference
    Oral presentation

  • Mesenchymal Stromal Cell-derived CXCL16 Promotes Proliferation and Migration of Gastric Cancer Cells by Inducing STAT3-mediated Expression of Ror1
    Ikeda T, Nishita M, Kakeji Y, Minami Y
    ASCB EMBO 2019 meeting, English, Stanford University,Harvard Medical School and Dana Farber Cancer Institute, Ｗashington, United States, International conference
    Oral presentation

  • ミラーイメージの克服についての工夫と検討、左右差について
    三浦 晋, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 松田 佳子, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Oral presentation

  • 完全腹腔鏡下幽門側胃切除術における点墨による病変マーキングの有用性
    山崎 悠太, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Oral presentation

  • ASA class 3,4 のhigh risk 大腸癌患者における腹腔鏡手術の有用性
    福岡 英志, 松田 武, 裏川 直樹, 瀧口 豪介, 長谷川 寛, 山本 将士, 松田 佳子, 金治 新悟, 山下 公大, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Oral presentation

  • 低肺機能に対する腹臥位胸腔鏡下食道切除術
    瀧口 豪介, 押切 太郎, 北村 優, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • 腹腔鏡下噴門側胃切除後の食道胃管再建に関する検討
    裏川 直樹, 金治 新悟, 山本 将士, 瀧口 豪介, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Oral presentation

  • 評価型外科縫合シミュレーターを活用した研修医・専攻医に対する腹腔鏡縫合結紮トレーニング
    長谷川 寛, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Oral presentation

  • 吻合を用いた腹腔鏡下胃全摘の検討
    山本 将士, 金治 新悟, 瀧口 豪介, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Oral presentation

  • ロボット支援Minimally invasive esophagectomy の可能性
    押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • 腹腔鏡下結腸右半切除D3 郭清における頭側アプローチの有用性
    松田 武, 山下 公大, 長谷川 寛, 有本 聡, 瀧口 豪介, 裏川 直樹, 山本 将士, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • 外側先行剥離によるTa-TME の標準化
    松田 武, 山下 公大, 長谷川 寛, 有本 聡, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • 施設内定型化郭清手技による反回神経麻痺の低減
    中村 哲, 押切 太郎, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 鈴木 知志, 掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • Educational Lecture 20
    掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • Surgical Forum76
    掛地 吉弘
    第32回日本内視鏡外科学会総会, Japanese, 東海大学医学部消化器外科, 横浜, Japan, Domestic conference
    Public symposium

  • α-ガラクトシルセラミドを付加し、腫瘍抗原を導入した樹状細胞ワクチンベクターの抗腫瘍効果
    渡部 晃大, 山下 公大, 有本 聡, 西 将康, 福岡 英志, 杉田 裕, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第23回バイオ治療法研究会学術集会, Japanese, 新潟薬科大学 健康・自立総合研究機構, 新潟, Japan, Domestic conference
    Oral presentation

  • When should esophagectomy be performed to non-curative superficial esophageal cancer after endoscopic resection?
    Ishida S, Nakamura T, Koterazawa Y, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Suzuki S, Kakeji Y
    7th FACO Academic Conference, English, Chinese Society of Clinical Oncology, Shanghai, China, International conference
    Poster presentation

  • Treatment Strategy for Rectal Cancer Patients With Inguinal Lymph Node Metastasis
    Utsumi M, Matsuda T, Yamashita K, Hasegawa H, Arimoto A, Yamamoto M, Kanaji Shingo, Matsuda Y, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    7th FACO Academic Conference, English, Chinese Society of Clinical Oncology, Shanghai, China, International conference
    Poster presentation

  • Safety of preoperative chemotherapy for elderly gastric cancer patients
    Matsuda Y, Sugita Y, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    7th FACO Academic Conference, English, Chinese Society of Clinical Oncology, Shanghai, China, International conference
    Poster presentation

  • 一般演題
    掛地 吉弘
    第3回神戸消化器学術講演会, Japanese, ミヤリサン製薬株式会社, 神戸, Japan, Domestic conference
    Oral presentation

  • 物体検出アルゴリズムを用いた鉗子軌道解析法の開発
    山崎 悠太, 金治 新悟, 山本 将士, 松田 佳子, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第28回日本コンピューター外科学会大会, Japanese, 東京大学医学部附属病院 心臓外科, 東京, Japan, Domestic conference
    Oral presentation

  • 消化器がん患者におけるサルコペニア対策について
    掛地 吉弘
    JDDW2019, Japanese, 兵庫医科大学 内科学消化管科, 神戸, Japan, Domestic conference
    Public symposium

  • 消化器癌集学的治療と漢方
    掛地 吉弘
    第3回日本先制臨床医学会学術大会, Japanese, 一般社団法人日本先制臨床学会, 神戸, Japan, Domestic conference
    Invited oral presentation

  • 第23回 臨床研究セミナー 第1部 臨床研究の基礎講座
    掛地 吉弘
    第81回日本臨床外科学会総会, Japanese, 高知大学外科学講座外科１, 高知, Japan, Domestic conference
    Public discourse

  • シンポジウム02 消化管外科手術における縫合不全対策について考える1
    掛地 吉弘
    第81回日本臨床外科学会総会, Japanese, 高知大学外科学講座外科１, 高知, Japan, Domestic conference
    Public symposium

  • α-ガラクトシルセラミドを付加し、 腫瘍抗原を導入した樹状細胞ワクチンベクターの抗腫瘍効果
    渡部 晃大, 山下 公大, 有本 聡, 西 将康, 杉田 裕, 福岡 英志, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉
    第30回日本消化器癌発生学会総会, Japanese, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Public symposium

  • 当院における高頻度マイクロサテライト不安定性大腸癌のスクリーニング方法の検討
    高井 亮, 山下 公大, 須藤 洋崇, 豊田 昌徳, 船越 洋平, 今村 善宣, 清田 尚臣, 井上 潤, 田中 心和, 松田 武, 児玉 裕三, 南 博信, 掛地 吉弘
    第30回日本消化器癌発生学会総会, Japanese, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Public symposium

  • 当科における鼠径リンパ節転移陽性直腸癌の治療戦略と成績
    堀江 和正, 松田 武, 山下 公大, 長谷川 寛, 有本 聡, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第30回日本消化器癌発生学会総会, Japanese, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Poster presentation

  • 食道扁平上皮癌術前化学療法によるPD-L1発現とCD8陽性腫瘍浸潤リンパ球の誘導
    福岡 英志, 山下 公大, 田中 智子, 澤田 隆一郎, 有本 聡, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第30回日本消化器癌発生学会総会, Japanese, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Public symposium

  • 腹膜播種における腹腔内腫瘍免疫微小環境の解析
    杉田 裕, 山下 公大, 福岡 英志, 渡部 晃大, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第30回日本消化器癌発生学会総会, Japanese, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Public symposium

  • 胸部食道癌に対し予防的頸部リンパ節郭清は省略可能か
    小寺澤 康文, 押切 太郎, 高橋 理彦, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第30回日本消化器癌発生学会総会, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Public symposium

  • 理事長講演 日本消化器癌発生学会の「創始と継志」–次の10年
    掛地 吉弘
    第30回日本消化器癌発生学会総会, Japanese, 一般社団法人 日本消化器癌発生学会, 横浜, Japan, Domestic conference
    Keynote oral presentation

  • セッションⅠ内視鏡
    掛地 吉弘
    第18回兵庫胃がん治療研究会, Japanese, 兵庫胃がん治療研究会、兵庫県がん診療連携協議会、大鵬薬品工業㈱, 神戸, Japan, Domestic conference
    Oral presentation

  • Closing Remarks
    掛地 吉弘
    Millennial Seminar of GI Cancer, Japanese, 中外製薬株式会社, 神戸, Japan, International conference
    Others

  • 特別講演2
    掛地 吉弘
    Millennial Seminar of GI Cancer, Japanese, 中外製薬株式会社, 神戸, Japan, Domestic conference
    Invited oral presentation

  • 高齢者の胃癌切除後における炎症に基づく予後予測スコアの有用性
    多田羅 敬, 鈴木 知志, 金治 新悟, 山本 将士, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第49回胃外科・術後障害研究会, Japanese, 鹿児島大学大学院 消化器・乳腺甲状腺外科学, 鹿児島, Japan, Domestic conference
    Public symposium

  • 完全腹腔鏡下幽門側胃切除術における点墨による病変マーキングの有用性
    山崎 悠太, 金治 新悟, 瀧口 豪介, 裏川 直樹, 山本 将士, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第49回胃外科・術後障害研究会, Japanese, 鹿児島大学大学院 消化器・乳腺甲状腺外科学, 鹿児島, Japan, Domestic conference
    Poster presentation

  • 早期胃癌に対するESD後追加外科切除例の検討
    裏川 直樹, 金治 新悟, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第49回胃外科・術後障害研究会, Japanese, 鹿児島大学大学院 消化器・乳腺甲状腺外科学, 鹿児島, Japan, Domestic conference
    Public symposium

  • 食道胃接合部に近接するGISTに対する噴門機能を温存した腹腔鏡下局所切除の安全性に関する検討
    金治 新悟, 山本 将士, 裏川 直樹, 鈴木 知志, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第49回胃外科・術後障害研究会, Japanese, 鹿児島大学大学院 消化器・乳腺甲状腺外科学, 鹿児島, Japan, Domestic conference
    Public symposium

  • シンポジウム4-2 [切られる胃1-2]
    掛地 吉弘
    第49回胃外科・術後障害研究会, Japanese, 鹿児島大学大学院 消化器・乳腺甲状腺外科学, 鹿児島, Japan, Domestic conference
    Others

  • 特別講演Ⅰ
    掛地 吉弘
    第17回神戸消化器外科懇話会, Japanese, 神戸消化器外科懇話会、株式会社大塚製薬工業、イーエヌ大塚製薬株式会社, 神戸, Japan, Domestic conference
    Oral presentation

  • 特別講演Ⅰ
    掛地 吉弘
    第20回神戸外科フォーラム, Japanese, 大鵬薬品工業株式会社, 神戸, Japan, Domestic conference
    [Invited]
    Others

  • 開会の挨拶
    掛地 吉弘
    第20回神戸外科フォーラム, Japanese, 大鵬薬品工業株式会社, 神戸, Japan, Domestic conference
    Others

  • 令和の胃癌集学的治療戦略
    掛地 吉弘
    第12回大分消化器癌治療研究会, Japanese, 大鵬薬品工業株式会社, 大分, Japan, Domestic conference
    Public symposium

  • 5-ALAを用いた胃癌審査腹腔鏡検査の光線力学診断を検討する医師主導検証治験
    高橋 剛, 大森 健, 田中 達也, 並川 努, 藤谷 和正, 西川 和宏, 藤原 義之, 永野 浩昭, 大辻 英吾, 掛地 吉弘, 黒川 幸典, 山﨑 誠, 瀧口 修司
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public symposium

  • 歯牙欠損は食道癌術後の予後を悪化させる
    三浦 晋, 中村 哲, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金冶 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Oral presentation

  • 食道扁平上皮癌術前化学療法によるPD-L1発現とCD8陽性腫瘍浸潤リンパ球の誘導
    福岡 英志, 山下 公大, 有本 聡, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Oral presentation

  • 下部進行直腸癌に対する術前化学放射線療法と選択的側方郭清の治療成績
    前原 律子, 松田 武, 山下 公大, 長谷川 寛, 有本 聡, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public symposium

  • 局所進行胃癌に対するneoadjuvant cheterapyとしてのSOX療法の安全性
    杉田 裕, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Poster presentation

  • 抗血栓薬内服患者に対する胃切除術における周術期抗血栓療法の検討
    裏川 直樹, 金治 新悟, 原田 仁, 瀧口 豪介, 有本 聡, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public symposium

  • 食道癌手術治療に対するエノキサパリンによる静脈血栓塞栓症予防
    瀧口 豪介, 中村 哲, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Poster presentation

  • 鼠径リンパ節転移を伴う直腸癌に対する術前化学放射線療法
    長谷川 寛, 松田 武, 山下 公大, 植田 康司, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Oral presentation

  • StageⅣ胃癌に対するconversion surgeryの検討
    山本 将士, 金治 新悟, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Oral presentation

  • 内視鏡治療後非治癒切除症例に対する食道切除術の意義と適応
    中村 哲, 小寺澤 康文, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 田中 心和, 金治 新悟, 松田 佳子, 山下 公大, 森田 圭紀, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public symposium

  • NCDを活用した消化器外科診療
    掛地 吉弘, 宮田 裕章, 瀬戸 泰之
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public symposium

  • 胃がんの最新治療
    掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public symposium

  • ワークショップ13 ビッグデータを生かしたがんの診療と研究
    掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Others

  • 大腸がん個別化治療を上手に使いこなす〜プレシジョンメディシンの実践〜
    掛地 吉弘
    第57回日本癌治療学会学術集会, Japanese, 岐阜大学大学院医学系研究科 脳腫瘍制御学講座 腫瘍外科学分野, 福岡, Japan, Domestic conference
    Public discourse

  • National Clinical Database(NCD)の現状と展望について
    掛地 吉弘
    第57回癌治療に関する医療統計勉強会, Japanese, 癌治療に関する医療統計勉強会、中外製薬株式会社, 大阪, Japan, Domestic conference
    Others

  • 腹腔鏡下に切除し得た副腎腫瘤を合併した家族性大腸ポリポーシスの１例
    趙 良, 松田 武, 内海, 工藤 拓也, 山下 公大, 長谷川 寛, 瀧口 豪介, 裏川 直樹, 山本 将士, 松田 佳子, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    日本消化器病学会近畿支部第111回例会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 胸腔鏡下核出術を施行した食道神経鞘腫の一例
    神尾 翼, 押切 太郎, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    日本消化器病学会近畿支部第111回例会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 術前化学療法中にＧ-ＣＳＦ（granulocyte-colony stimulating factor）産生腫瘍の診断を得た進行食道腺癌
    北村 優, 瀧口 豪介, 押切 太郎, 中村 哲, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 鈴木 知志, 掛地 吉弘
    日本消化器病学会近畿支部第111回例会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 早期胃癌に対するＥＳＤ後の追加外科切除奨励の検討
    池田 太郎, 金治 新悟, 鈴木 知志, 掛地 吉弘
    日本消化器病学会近畿支部第111回例会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学, 大阪, Japan, Domestic conference
    Public symposium

  • 十二指腸病変に対する腹腔鏡内視鏡合同手術の検討
    山本 将士, 金治 新悟, 掛地 吉弘, 森田 圭紀
    日本消化器病学会近畿支部第111回例会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学, 大阪, Japan, Domestic conference
    Public symposium

  • 外側先行剥離による安全なＴａ-ＴＭＥ手技の確立
    松田 武, 山下 公大, 長谷川 寛, 掛地 吉弘
    日本消化器病学会近畿支部第111回例会, Japanese, 神戸大学大学院医学研究科 外科学講座 食道胃腸外科学, 大阪, Japan, Domestic conference
    Public symposium

  • ヒト乳がん異種移植モデルの微小転移がん幹細胞で発現低下しているマイクロRNA-93の解析
    渋谷 尚樹, 下野 洋平, 南 博信, 掛地 吉弘, 鈴木 聡
    第78回日本癌学会学術総会, Japanese, 京都大学大学院 生命科学研究科, 京都, Japan, Domestic conference
    Poster presentation

  • 間葉系間質細胞由来のCXCL16は胃癌細胞においてRor1の発現を誘導し増殖と遊走を促進する
    池田 太郎, 西田 満, 掛地 吉弘, 南 康弘
    第78回日本癌学会学術総会, Japanese, 京都大学大学院 生命科学研究科, 京都, Japan, Domestic conference
    Poster presentation

  • 食道がん：病態・治療戦略
    掛地 吉弘
    第78回日本癌学会学術総会, Japanese, 京都大学大学院 生命科学研究科, 京都, Japan, Domestic conference
    Others

  • 完全内臓逆位を伴うＳ状結腸癌に対して腹腔鏡下Ｓ状結腸切除を施行した一例
    工藤 拓也, 松田 武, 山下 公大, 長谷川 寛, 内海 昌子, 有本 聡, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第202回近畿外科学会, Japanese, 大阪大学大学院医学系研究科 外科学講座 消化器外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 炎症による反復性幽門狭窄をきたした胃異所性膵に対して腹腔鏡下幽門側胃切除術を行った1例
    山田 康太, 裏川 直樹, 金治 新悟, 瀧口 豪介, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第202回近畿外科学会, Japanese, 大阪大学大学院医学系研究科 外科学講座 消化器外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 後縦隔経路再建胃管癌に対する腹臥位胸腔鏡下胃管全摘術の２例
    北村 優, 中村 哲, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 掛地 吉弘
    第202回近畿外科学会, Japanese, 大阪大学大学院医学系研究科 外科学講座 消化器外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 鼠径リンパ節転移陽性直腸癌に対する治療戦略
    内海 昌子, 松田 武, 山下 公大, 長谷川 寛, 工藤 拓也, 有本 聡, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第202回近畿外科学会, Japanese, 大阪大学大学院医学系研究科 外科学講座 消化器外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 大動脈十二指腸瘻の治療経験
    瀧口 豪介, 中村 哲, 後竹 康子, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 岡田 健次, 掛地 吉弘
    第202回近畿外科学会, Japanese, 大阪大学大学院医学系研究科 外科学講座 消化器外科学, 大阪, Japan, Domestic conference
    Oral presentation

  • 頭側アプローチによる腹腔鏡下右半結腸切除
    内海 昌子, 松田 武, 有本 聡, 長谷川 寛, 山下 公大, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回近畿内視鏡外科研究会, Japanese, 大阪大学大学院医学系研究科 産科学婦人科学教室, 大阪, Japan, Domestic conference
    Public symposium

  • 腹臥位胸腔鏡下食道切除における上縦隔郭清の定形化
    押切 太郎, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第32回近畿内視鏡外科研究会, Japanese, 大阪大学大学院医学系研究科 産科学婦人科学教室, 大阪, Japan, Domestic conference
    Public symposium

  • ワークショップ5 手術教育 教える側の努力、工夫
    掛地 吉弘
    第32回近畿内視鏡外科研究会, Japanese, 大阪大学大学院医学系研究科 産科学婦人科学教室, 大阪, Japan, Domestic conference
    Public symposium

  • 大腸癌に対する最新集学的治療
    掛地 吉弘
    第１回神戸消化器癌フォーラム, Japanese, 日本化薬株式会社, 神戸, Japan, Domestic conference
    [Invited]
    Invited oral presentation

  • 消化管集学的治療における漢方薬の役割
    掛地 吉弘
    第25回関西がんチーム医療研究会, Japanese, 田附興風会医学研究所 北野病院、関西がんチーム医療研究所, 大阪, Japan, Domestic conference
    Nominated symposium

  • オープニングリマークス
    掛地 吉弘
    兵庫ＤＫＴフォーラム, Japanese, 株式会社ツムラ 神戸支店, 神戸, Japan, Domestic conference
    Others

  • 胃管癌に対する低侵襲治療
    堀江 和正, 中村 哲, 小寺澤 康文, 三浦 晋, 瀧口 豪介, 長谷川 寛, 松田 佳子, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第28回消化器疾患病態治療研究会, Japanese, 愛知医科大学 消化管内科, 名古屋, Japan, Domestic conference
    Oral presentation

  • 当院における胃SMT に対する腹腔鏡手術に関する検討
    山本 将士, 金治 新悟, 瀧口 豪介, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第28回消化器疾患病態治療研究会, Japanese, 愛知医科大学 消化管内科, 名古屋, Japan, Domestic conference
    Oral presentation

  • Safety and effectiveness of laparoscopic colorectomy for elderly patients: A propensity-score matching analysis
    Arimoto A, Kakeji Y, Suzuki S, Nakamura T, Oshikiro T, Matsuda Y, Kanaji S, Yamamoto M, Urakawa N, Takiguchi G, Matsuda T, Yamashita K, Hasegawa H
    日本・モンゴル国際消化器がんシンポジウム, Japanese, Ulaanbaatar, Mongolia, International conference
    Oral presentation

  • Transanal total mesorectal excision for rectal cancer by two-surgeon team
    Hasegawa H, Kakeji Y, Suzuki S, Tetsu N, Oshikiri T, Matsuda Y, Kanaji S, Yamamoto M, Urakawa N, Takiguchi G, Arimoto S, Yamashita K, Matsuda T
    日本・モンゴル国際消化器がんシンポジウム, English, Ulaanbaatar, Mongolia, International conference
    Oral presentation

  • Laparoscopic surgery for gastric GIST
    Suzuki S, Kakeji Y, Nakamura T, Oshikiri T, Matsuda T, Yamamoto K, Matsuda Y, Hasegawa H, Takiguchi G, Yamamoto M, Urakawa N
    日本・モンゴル国際消化器がんシンポジウム, Japanese, Ulaanbaatar, Mongolia, International conference
    Oral presentation

  • 大腸癌における外科治療
    第6回平成大腸癌カンファレンス, Japanese, 中外製薬株式会社, 神戸, Japan, Domestic conference
    Others

  • 漢方を使う消化管集学的治療
    掛地 吉弘
    第20回 千葉消化管運動機能研究会, Japanese, 千葉大学大学院医学研究院 先端応用科学, 千葉, Japan, Domestic conference
    Public discourse

  • 胃管癌に対する胸腔鏡手術の導入
    堀江 和正, 中村 哲, 押切 太郎, 瀧口 豪介, 三浦 晋, 山本 将士, 金治 新悟, 松田 武, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 腹腔鏡下胃切除術における術前後の大腰筋断面積変化の検討
    山崎 悠太, 金治 新悟, 瀧口 豪介, 山本 将士, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Poster presentation

  • 胸部食道癌に対し予防的頸部リンパ節郭清は全例に必要か；予防的頸部郭清省略の検討
    小寺澤 康文, 押切 太郎, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 食道癌に対する胸腔鏡下食道切除術、propensity scoreを用いた腹臥位と左側臥位の予後の比較
    三浦 晋, 中村 哲, 押切 太郎, 瀧口 豪介, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Poster presentation

  • 胸壁前有茎空腸再建術の工夫と有用性
    瀧口 豪介, 中村 哲, 三浦 晋, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 腹腔鏡下噴門即胃切除後の食道胃管再建に関する検討
    山本 将士, 金治 新悟, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference, Co-authored internationally
    Poster presentation

  • 胃癌に対する腹腔鏡下脾動脈近位即郭清における画像によるシミュレーションと左外側アプローチの有用性
    金治 新悟, 鈴木 知志, 池田 太郎, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Poster presentation

  • 当科で術前化学療法を施行した腎機能障害を有する胃癌症例の検討
    松田 佳子, 杉田 裕, 山本 将士, 金治 新悟, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Poster presentation

  • αガラクトシルセラミド付加した抗原導入した樹状細胞抗腫瘍ベクターの抗腫瘍効果
    山下 公大, 有本 聡, 長谷川 寛, 山本 将士, 金治 新悟, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 進行横行結腸癌に対する発生解剖に基づいた鏡視下手術：頭側アプローチのコツと工夫
    松田 武, 山下 公大, 長谷川 寛, 瀧口 豪介, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 食道がんに対する内視鏡下手術の進歩
    押切 太郎, 瀧口 豪介, 三浦 晋, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 消化器外科医に求められる大動脈食道瘻の手術治療戦略
    中村 哲, 瀧口 豪介, 三浦 晋, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Oral presentation

  • 慢性腎臓病（CKD）の胃癌切除後の合併症発生に及ぼす影響
    鈴木 知志, 金治 新悟, 山本 将士, 瀧口 豪介, 三浦 晋, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Public symposium

  • Study of morbidity and mortality in pancreaticoduodenectomy: Collaborative projects of NCD and NSQIP
    Marubashi S, Miyata H, Kakeji Y, Seto Y, Gotoh M
    第74回日本消化器外科学会総会, English, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Public symposium

  • Safety of laparoscopic gastrectomy for gastric cancer in prospective cohort study using NCD registry
    Hiki N, Honda M, Kumamaru H, Miyata H, Yoshida K, Kodera Y, Kakeji Y, Inomata M, Seto Y
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Public symposium

  • The utilization of 'Big Date' in gastroenterologocal surgery
    掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学, 東京, Japan, Domestic conference
    Others

  • ランチョンセミナー1 ゲノム医療で始まる大腸癌治療の新時代 ～外科医はどのように対処するのか～
    掛地 吉弘
    第74回日本消化器外科学会総会, Japanese, 東京慈恵会医科大学/武田薬品工業株式会社, 東京, Japan, Domestic conference
    Others

  • 進行胃がんに対する集学的治療 ～ロボット手術から術後栄養管理まで～
    掛地 吉弘
    神戸消化器外科懇話会分科会, Japanese, 株式会社大塚製薬工場/イーエヌ大塚製薬株式会社, 神戸, Japan, Domestic conference
    Others

  • 当院における大腸NETの手術治療成績
    有本 聡, 松田 武, 長谷川 寛, 山下 公大, 瀧口 豪介, 裏川 直樹, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第91回大腸癌研究会, Japanese, がん・感染症センター 都立駒込病院 外科, 東京, Japan, Domestic conference
    Poster presentation

  • 示説Ⅰ-6 大腸癌肝転移の治療戦略
    掛地 吉弘
    第91回大腸癌研究会, Japanese, がん・感染症センター 都立駒込病院 外科, 東京, Japan, Domestic conference
    Others

  • モーニングセミナーＡ（MSA） 大腸がん補助療法の最新情報
    掛地 吉弘
    第91回大腸癌研究会, Japanese, がん・感染症センター 都立駒込病院 外科, 東京, Japan, Domestic conference
    Others

  • 術後腹膜炎が肺転移の予後に及ぼす影響とその免疫学的検討
    渡部 晃大, 山下 公大, 有本 聡, 杉田 裕, 福岡 英志, 瀧口 豪介, 裏川 直樹, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第26回外科侵襲とサイトカイン研究会, Japanese, 神戸大学大学院医学研究科外科系講座 災害・救急医学分野, 神戸, Japan, Domestic conference
    Public symposium

  • 開会の挨拶
    掛地 吉弘
    第15回近畿腹腔鏡下胃切除セミナー, Japanese, 近畿腹腔鏡下胃切除セミナー／コヴィディエンジャパン株式会社, 大阪, Japan, Domestic conference
    Others

  • 直腸癌手術における術中内視鏡検査による吻合部評価の有用性
    渋谷 尚樹, 松田 武, 山下 公大, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 角 泰雄, 掛地 吉弘
    第28回日本癌病態治療研究会, Japanese, 埼玉医科大学総合医療センター 消化管・一般外科/ゲノム診療科, 川越, Japan, Domestic conference
    Poster presentation

  • 食道癌における術前化学療法症例による免疫微小環境の変化
    福岡 英志, 山下 公大, 田中 智子, 澤田 隆一郎, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第28回日本癌病態治療研究会, Japanese, 埼玉医科大学総合医療センター 消化管・一般外科/ゲノム診療科, 川越, Japan, Domestic conference
    Public symposium

  • 胸部食道癌に対し予防的頸部リンパ節郭清は全例に必要か
    小寺澤 康文, 押切 太郎, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第28回日本癌病態治療研究会, Japanese, 埼玉医科大学総合医療センター 消化管・一般外科/ゲノム診療科, 川越, Japan, Domestic conference
    Public symposium

  • 大腸癌病態からみた最新治療
    掛地 吉弘
    第28回日本癌病態治療研究会, Japanese, 埼玉医科大学総合医療センター 消化管・一般外科/ゲノム診療科, 川越, Japan, Domestic conference
    Others

  • 最新のエビデンスをどの様に解釈し臨床へ応用するか
    掛地 吉弘
    Colorectal Cancer Seminar～大腸がん治療の最新情報～, Japanese, メルクバイオファーマ株式会社, 福岡, Japan, Domestic conference
    Nominated symposium

  • 3Dモニターが手術操作にもたらす影響に関する術者技術レベルごとの検討
    原田 仁, 金治 新悟, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Public symposium

  • 術前化学療法として SOX 療法を施行した進行食道胃接合部癌の 4 例
    髙井 亮, 松田 佳子, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Oral presentation

  • 女性外科医から始める働き方改革
    石田 苑子, 中村 哲, 永田 真知子, 三浦 由紀子, 前原 律子, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Public symposium

  • 高齢者の胃癌切除におけるCONUT scoreによるフレイル判定の有用性
    杉田 裕, 鈴木 知志, 裏川 直樹, 金治 新悟, 山本 将士, 松田 佳子, 瀧口 豪介, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Public symposium

  • 3ステップ法による腹腔鏡下結腸脾弯曲授動
    有本 聡, 松田 武, 山下 公大, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Public symposium

  • 胸腔鏡下食道癌手術におけるエノキサパリンによる静脈血栓塞栓症予防
    瀧口 豪介, 中村 哲, 三浦 晋, 高瀬 信尚, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Oral presentation

  • ワークショップ1「高難度手術チームの立ち上げ方」
    掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Others

  • ランチョンセミナー2
    掛地 吉弘
    第44回日本外科系連合学会学術集会, Japanese, 金沢医科大学 一般・消化器外科学, 金沢, Japan, Domestic conference
    Others

  • Three-dimensional laparoscopic vision improves forceps motion more in the depth direction than in the horizontal direction
    Yamazaki Y, Kanaji S, Takiguchi G, Yamamoto M, Matsuda Y, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    Computer Assisted Radiology and Surgery(CARS2019), English, Rennes, France, International conference
    Poster presentation

  • 虫垂腺癌術後の吻合部再発と診断され、神経内分泌癌と診断された1手術例
    渡部 晃大, 山下 公大, 三浦 晋, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第41回日本癌局所療法研究会, Japanese, 川崎医科大学臨床腫瘍学, 岡山, Japan, Domestic conference
    Oral presentation

  • 高齢者の胃癌切除症例における術前末梢血中リンパ球数の臨床的意義
    多田羅 敬, 鈴木 知志, 金治 新悟, 山本 将士, 松田 佳子, 長谷川 寛, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第41回日本癌局所療法研究会, Japanese, 川崎医科大学臨床腫瘍学, 岡山, Japan, Domestic conference
    Oral presentation

  • ランチョンセミナー 大腸癌治療へのMolecular Subtype〜MSIを含めて
    掛地 吉弘
    第41回日本癌局所療法研究会, Japanese, 川崎医科大学臨床腫瘍学, 岡山, Japan, Domestic conference
    Public discourse

  • 主題1 「がん局所療法とゲノム医療」
    掛地 吉弘
    第41回日本癌局所療法研究会, Japanese, 川崎医科大学臨床腫瘍学, 岡山, Japan, Domestic conference
    Others

  • A new technique for lymph node dissection along proximal splenic artery during laparoscopic gastrectomy for gastric cancer: Left-lateral approach.
    Kanaji S, Suzuki S, Yamamoto M, Takiguchi G, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y
    27th European Association for Endoscopic Surgery (EAES2019), English, Seville, Spain, International conference
    Public symposium

  • All-trans-レチノイン酸はヒトiPS細胞から食道上皮への分化誘導を促進する
    小寺澤 康文, 押切 太郎, 中村 哲, 小柳 美千代, 掛地 吉弘, 青井 貴之
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Poster presentation

  • 食道切除再建術における経腸栄養tube留置の意義
    瀧口 豪介, 押切 太郎, 小寺澤 康文, 三浦 晋, 山本 将士, 金治 新悟, 松田 佳子, 中村 哲, 鈴木 知志, 掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Poster presentation

  • 高齢食道癌患者に対する胸腔鏡手術の妥当性
    杉田 裕, 押切 太郎, 澤田 隆一郎, 三浦 晋, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Poster presentation

  • ロボット支援下食道切除術の導入と初期治療成績
    中村 哲, 小寺澤 康文, 青木 丈明, 瀧口 豪介, 三浦 晋, 山本 将士, 金治 新悟, 松田 武, 鈴木 知志, 掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Poster presentation

  • 食道癌に対する胸腔鏡下食道切除術、腹臥位と左側臥位の予後の比較
    三浦 晋, 中村 哲, 瀧口 豪介, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Poster presentation

  • 当科での腹臥位胸腔鏡下食道切除術における上縦隔郭清手技と成績
    押切 太郎, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Poster presentation

  • ランチョンセミナー 8 食道胃接合部癌治療を考える ―よい手術、集学的治療と栄養管理―
    掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Others

  • 27476例の食道切除術を用いた機能集約シミュレーション：NCDを活用した医療政策提言
    錦織 達人, 高橋 新, 市原 直昭, 角田 茂, 藤 也寸志, 渡邊 雅之, 松原 久裕, 掛地 吉弘, 瀬戸 泰之
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Public symposium

  • 術後再発食道扁平上皮癌の転移巣に対する外科的切除の意義に関する全国実態調査
    工藤 健介, 佐伯 浩司, 中島 雄一郎, 沖 英次, 森 正樹, 下川 元継, 掛地 吉弘, 藤 也寸志, 松原 久裕
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Public symposium

  • “Seed and Soil”セッション5 研究推進の「土壌作り」に向けた食道学会の役割
    掛地 吉弘
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Others

  • 化学・放射線療法の習得と集学的治療の実践
    掛地 吉弘, 瀧口 豪介, 三浦 晋, 押切 太郎, 中村 哲
    第73回日本食道学会学術集会, Japanese, 独立行政法人国立病院機構 九州がんセンター, 福岡, Japan, Domestic conference
    Public symposium

  • 令和の胃癌治療戦略
    掛地 吉弘
    Nagoya GI symposium ～Final Circular～, Japanese, 日本イーライリリー株式会社, 名古屋, Japan, Domestic conference
    Public discourse

  • αガラクトシルセラミド付加した抗原導入した樹状細胞ベクターの抗腫瘍効果
    渡部 晃大, 山下 公大, 有本 聡, 西 将康, 杉田 裕, 福岡 英志, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第29回日本サイトメトリー学会学術集会, Japanese, 順天堂大学医学部内科学血液学講座, 東京, Japan, Domestic conference
    Oral presentation

  • 腹膜播種マウスモデルにおける腹腔内骨髄由来抑制細胞（MDSC）の検討
    杉田 裕, 山下 公大, 渡部 晃大, 福岡 英志, 有本 聡, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第29回日本サイトメトリー学会学術集会, Japanese, 順天堂大学医学部内科学血液学講座, 東京, Japan, Domestic conference
    Oral presentation

  • Ta-TME における「外側先行剥離」による安全な手術手技
    松田 武, 山下 公大, 長谷川 寛, 有本 聡, 瀧口 豪介, 山本 将士, 金治 新悟, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第73回手術手技研究会, Japanese, 上尾中央総合病院 外科, 東京, Japan, Domestic conference
    Oral presentation

  • 胃1
    掛地 吉弘
    第73回手術手技研究会, Japanese, 上尾中央総合病院 外科, 東京, Japan, Domestic conference
    Public discourse

  • 日本における胃癌の周術期治療の新たな進歩
    掛地 吉弘
    2019日中胃がん治療フォーラム, Japanese, 大鵬薬品工業株式会社, Beijing, China, International conference
    Others

  • 消化器癌患者の末梢血T細胞におけるimmunological synapseの評価
    杉田 裕, 山下 公大, 田中 智子, 渡部 晃大, 福岡 英志, 有本 聡, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第40回癌免疫外科研究会, Japanese, 金沢大学 消化器・腫瘍・再生外科学, 金沢, Japan, Domestic conference
    Oral presentation

  • 直腸癌術前化学放射線療法における腫瘍免疫因子の発現動態の解析
    福岡 英志, 山下 公大, 中川 暁雄, 長谷川 寛, 松田 武, 山本 将士, 金治 新悟, 松田 佳子, 瀧口 豪介, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第40回癌免疫外科研究会, Japanese, 金沢大学 消化器・腫瘍・再生外科学, 金沢, Japan, Domestic conference
    Oral presentation

  • タンパク抗原を導入したNKT細胞活性化樹状細胞ワクチンベクターの抗腫瘍効果
    山下 公大, 有本 聡, 西 将康, 福岡 英志, 杉田 裕, 渡部 晃大, 長谷川 寛, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第40回癌免疫外科研究会, Japanese, 金沢大学 消化器・腫瘍・再生外科学, 金沢, Japan, Domestic conference
    Oral presentation

  • 要望演題8 炎症・癌局所微小環境（2）
    掛地 吉弘
    第40回癌免疫外科研究会, Japanese, 金沢大学 消化器・腫瘍・再生外科学, 金沢, Japan, Domestic conference
    Others

  • ニボルマブの効果を引き出すためのベストプラクティス
    掛地 吉弘
    胃癌WEBライブセミナーin HYOGO, Japanese, プリストル・マイヤーズ スクイブ株式会社、小野薬品工業株式会社, 神戸, Japan, Domestic conference
    Public discourse

  • Effect of hospital and surgeon volume on postoperative outcomes after total gastrectomy for gastric cancer based on Japanese nationwide database
    Baba H, Iwatsuki M, Kakeji Y, Yoshida K, Konno H, Seto Y
    IGCC 2019 第13回国際胃癌学会議, English, Prague, Czech Republic, International conference
    Public symposium

  • Prediction of the dorsal landmark using 3D-CT during laparoscopic lymph node dissection along the proximal splenic artery in gastric cancer
    Ikeda T, Kanaji S, Takiguchi G, Takase N, Hasegawa H, Yamamoto M, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y
    IGCC 2019 第13回国際胃癌学会議, English, Prague, Czech Republic, International conference
    Poster presentation

  • Impact of Lymphatic Metastasis for the Recurrence of Adenocarcinoma of the Esophagogastric Junction
    Urakawa U, Suzuki S, Kanaji S, Ikeda T, Yamamoto M, Matsuda Y, Oshikiri T, Nakamura T, Kakeji Y
    IGCC 2019 第13回国際胃癌学会議, English, Prague, Czech Republic, International conference
    Poster presentation

  • The long-term impact of postoperative pneumonia after curative gastrectomy for elderly gastric cancer patients
    Suzuki S, Ikeda T, Urakawa N, Kanaji S, Yamamoto M, Matsuda Y, Kakeji Y
    IGCC 2019 第13回国際胃癌学会議, English, Prague, Czech Republic, International conference
    Poster presentation

  • Comparison of two- and three-dimensional display for performance of laparoscopic total gastrectomy for gastric cancer
    Kakeji Y, Kanaji S, Suzuki S, Yamamoto M, Matsuda Y
    IGCC 2019 第13回国際胃癌学会議, English, Prague, Czech Republic, International conference
    Poster presentation

  • Phase III study of laparoscopic distal gastrectomy for advanced gastric cancer in Japan (JLSSG0901): results of short term outcomes
    Etoh T, Tsuji T, Lee W S, Sakuramoto S, Yoshida K, Kubo N, Nishizaki M, Noshiro H, Ikeda O, Shibata R, Ohuchida K, Kuwabara S, Yoshida T, Kakeji Y, Kitano S, Japanese Laparoscopic Surgery Study G
    IGCC 2019 第13回国際胃癌学会議, English, Prague, Czech Republic, International conference
    Poster presentation

  • Routine Placement of Feeding Jejunostomy Tube during Thoracoscopic Esophagectomy Increases Postoperative Complications and Does Not Improve Postoperative Malnutrition
    Koterazawa Y, Oshikiri T, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y
    第44回 KSELS & 国際シンポジウム, English, The Korean Society of Endoscopic & Laparoscopic Surgeons, Seoul, Korea, Republic of, International conference
    Poster presentation

  • 胸部食道癌手術において経腸栄養tube は全例に必要か？
    小寺澤 康文, 押切 太郎, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Poster presentation

  • ミラーイメージの克服についての工夫 モニターの位置とカメラの角度についての検討
    三浦 晋, 押切 太郎, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Poster presentation

  • 局所進行直腸癌に対する術前化学放射線療法と画像診断に基づく選択的側方郭清の治療
    高瀬 信尚, 松田 武, 山下 公大, 長谷川 寛, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Poster presentation

  • 時代にマッチした若手消化器外科腹腔鏡トレーニングコースの開催
    長谷川 寛, 田中 基文, 押切 太郎, 中村 哲, 外山 博近, 木戸 正浩, 上野 公彦, 鈴木 知志, 味木 徹夫, 福本 巧, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Poster presentation

  • 局所進行胃癌に対する術前化学療法におけるSOX 療法の安全性と有効性
    松田 佳子, 杉田 裕, 高瀬 信尚, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Poster presentation

  • 肺への浸潤を伴う食道癌に対する胸腔鏡下食道切除術の試み
    中村 哲, 三浦 晋, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 山下 公大, 押切 太郎, 松田 武, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Poster presentation

  • 本邦における高齢者食道癌手術後に発生する手術関連死亡リスクの因子の解析-National Clinical Databaseを用いて-
    村上 健太郎, 松原 久裕, 宮田 裕章, 阿久津 泰典, 藤 也寸志, 掛地 吉弘, 瀬戸 泰之
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • Collaborative projects of NCD and NSQIP for quality improvement of gastroenterological surgery
    小船戸 康英, 丸橋 繁, 宮田 裕章, Ko Cliffor, 掛地 吉弘, 瀬戸 泰之, 後藤 満和
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • 腹腔鏡下胃切除術における術後大腰筋断面積変化の検討
    山崎 悠太, 金治 新悟, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • Ta-TMEにおける安全な神経血管束温存と直腸尿道筋切離のための工夫
    松田 武, 長谷川 寛, 山下 公大, 高瀬 信尚, 瀧口 豪介, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • 高齢者胃癌後の肺炎併発による長期予後への影響の検討
    鈴木 知志, 金治 新悟, 山本 将士, 高瀬 信尚, 三浦 晋, 瀧口 豪介, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • National Clinical Database (NCD) 膵癌登録の第1回予後調査
    水間 正道, 海野 倫明, 隈丸 拓, 宮田 裕章, 五十嵐 久人, 糸井 隆夫, 江川 新一, 児玉 裕三, 里井 壮平, 濱田 晋, 水元 一博, 掛地 吉弘, 瀬戸 泰之, 下瀬川 徹, 岡崎 和一
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • NCDを活用した外科領域の医療政策エビデンスの発信～食道切除術の機能集約に向けて～
    錦織 達人, 高橋 新, 一原 直昭, 角田 茂, 藤 也寸志, 渡邊 雅之, 松原 久裕, 掛地 吉弘, 瀬戸 泰之, 宮田 裕章, 酒井 義治
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • National clinical database (NCD) による膵全摘出の術後合併症リスクモデル
    橋本 大輔, 水間 正道, 隈丸 拓, 宮田 裕章, 近本 亮, 五十嵐 久人, 糸井 隆夫, 江川 新一, 児玉 裕三, 里井 壮平, 濱田 晋, 水本 一博, 山上 裕機, 山本 雅一, 掛地 吉弘, 瀬戸 泰之, 馬場 秀夫, 海野 倫明, 下瀬川 徹, 岡崎 和一
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Nominated symposium

  • 3D-CTを用いた脾動脈幹近位リンパ節背側境界の術前シミュレーションの有用性
    池田 太郎, 金治 新悟, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 山本 将士, 松田 佳子, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • 十二指腸腫瘍に対する腹腔鏡内視鏡合同手術の安全性に関する検討
    金治 新悟, 森田 圭紀, 鈴木 知志, 山本 将士, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 豊永 高史, 中村 哲, 児玉 裕三, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • 直腸癌術前化学放射線療法の免疫微小環境の変化とその予後因子の検討
    山下 公大, 松田 武, 中川 暁雄, 福岡 英志, 高瀬 信尚, 瀧口 豪介, 長谷川 寛, 山本 将士, 金治 新悟, 松田 佳子, 押切 太郎, 鈴木 知志, 掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Public symposium

  • ワークショップ（18） 高齢者上部消化管癌に対する治療戦略
    掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Nominated symposium

  • ランチョンセミナー（1） 大腸がん治療の潮流～忙しい外科医が押さえておくポイント～
    掛地 吉弘
    第119回日本外科学会定期学術集会, Japanese, 一般社団法人日本外科学会, 大阪, Japan, Domestic conference
    Others

  • 術前化学放射線療法後に切除し得た直腸癌術後骨盤内再発の1例
    有本 聡, 松田 武, 山下 公大, 長谷川 寛, 掛地 吉弘
    第31回兵庫大腸癌治療研究会, Japanese, 兵庫大腸癌治療研究会、ミヤリサン製薬株式会社、大鵬薬品株式会社, 神戸, Japan, Domestic conference
    Oral presentation

  • 特別講演 胃癌手術において合併症を限りなく0にするための方法
    掛地 吉弘
    神戸消化器外科 Seminar, Japanese, テルモ株式会社, 神戸, Japan, Domestic conference
    Others

  • 術前化学療法を行った進行胃癌症例での再発例の検討
    松田 佳子, 杉田 裕, 長谷川 寛, 山本 将士, 金治 新悟, 山下 公大, 押切 太郎, 松田 武, 中村 哲, 鈴木 知志, 掛地 吉弘
    第91回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター 胃外科, 静岡, Japan, Domestic conference
    Poster presentation

  • SiewertⅡ型食道胃接合部癌に対する偽His角・Fornix形成食道胃管再建
    金治 新悟, 山本 将士, 三浦 晋, 瀧口 豪介, 高瀬 信尚, 長谷川 寛, 松田 佳子, 山下 公大, 松田 武, 押切 太郎, 中村 哲, 鈴木 知志, 掛地 吉弘
    第91回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター 胃外科, 静岡, Japan, Domestic conference
    Poster presentation

  • NCDデータベースを用いた胃切除術後合併症に与えるhospital and surgeon volumeの影響
    岩槻 政晃, 掛地 吉弘, 吉田 和弘, 今野 弘之, 瀬戸 泰之, 馬場 秀夫
    第91回日本胃癌学会総会, Japanese, 静岡県立静岡がんセンター 胃外科, 静岡, Japan, Domestic conference
    Nominated symposium

  • 免疫チェックポイント阻害薬の適用からみたマイクロサテライト不安定性検査の在り方
    須藤 洋崇, 豊田 昌徳, 船越 洋平, 今村 善宣, 清田 尚臣, TAKASE NOBUHISA, HASEGAWA HIROSHI, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO, 南 博信
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Public symposium

  • 末梢血myeloid derived suppressor cells（MDSC）は腫瘍の再発を反映する
    田中 智子, YAMASHITA KIMIHIRO, 杉田 裕, 福岡 英志, 有本 聡, KAKEJI YOSHIHIRO
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Others

  • 腹膜播種マウスモデルにおける腹腔内骨髄由来抑制細胞（MDSC）の検討
    杉田 裕, YAMASHITA KIMIHIRO, 田中 智子, 渡部 晃大, 福岡 英志, 有本 聡, HASEGAWA HIROSHI, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Oral presentation

  • 乳癌センチネルリンパ節におけるprogrammed death −1 発現に関する検討
    多田羅 敬, 向原 徹, 下野 洋平, 山崎 隆, 今村 善宣, 船越 洋平, 豊田 昌徳, 清田 尚臣, 河野 誠之, 高尾 信太郎, KAKEJI YOSHIHIRO, 南 博信
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Others

  • 直腸癌術前化学放射線療法の腫瘍免疫因子の発現動態の解析
    福岡 英志, YAMASHITA KIMIHIRO, 中川 暁雄, HASEGAWA HIROSHI, MATSUDA TAKERU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Oral presentation

  • 食道扁平上皮癌における酸化ヌクレオチド浄化因子MTH1 発現の検討
    秋山 真吾, 佐伯 浩司, 北尾 洋之, OSHIKIRI TARO, NAKAMURA TETSU, 岩崎 武, KAKEJI YOSHIHIRO
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Oral presentation

  • 高齢進行胃癌患者における術前化学療法の安全性
    MATSUDA YOSHIKO, TAKASE NOBUHISA, TAKIGUCHI GOSUKE, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Oral presentation

  • ポスター発表 癌幹細胞他（座長）
    KAKEJI YOSHIHIRO
    第18回日本再生医療学会総会, Mar. 2019, Japanese, 鳥取大学大学院医学系研究科 機能再生医科学専攻 遺伝子医療学部門, 神戸, Domestic conference
    Others

  • SOX2 陰性食道扁平上皮癌はSOX2 プロモーター領域のメチル化を伴う高悪性組織亜型である
    前原 律子, 全 陽, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第52回制癌剤適応研究会, Mar. 2019, Japanese, 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野, 神戸, Domestic conference
    Oral presentation

  • 本邦における胃癌に対する腹腔鏡下手手術成績に関する後ろ向き調査研究
    KAKEJI YOSHIHIRO
    第91回日本胃癌学会総会, Feb. 2019, Japanese, 静岡県立静岡がんセンター 胃外科, 沼津, Domestic conference
    Others

  • パネルディスカッション4 高齢者に対する胃癌治療（座長）
    KAKEJI YOSHIHIRO
    第91回日本胃癌学会総会, Feb. 2019, Japanese, 静岡県立静岡がんセンター 胃外科, 沼津, Domestic conference
    Others

  • Superiority of esophageal reconstruction by pedicled jejunal flap with microvascular augmentation.
    Gosuke Takiguchi, Tetsu Nakamura, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Shingo Kanaji, Kimihiro Yamashita, Taro Oshikiri, Takeru Matsuda, Satoshi Suzuki, Yoshihiro Kakeji
    14TH ANNUAL ACADEMIC SURGICAL CONGRESS, Feb. 2019, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, ヒューストン, International conference
    Oral presentation

  • Skeletal muscle loss in laparoscopic gastrectomy: differences between laparoscopic procedures.
    Yuta Yamazaki, Shingo Kanaji, Gosuke Takiguchi, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Taro Oshikiri, Takeru Matsuda, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    14TH ANNUAL ACADEMIC SURGICAL CONGRESS, Feb. 2019, English, Academic Surgical Congress · Association for Academic Surgery · Society of University Surgeons, ヒューストン, International conference
    Oral presentation

  • 末梢Ｔ細胞のIS形成能の測定法の確立
    YAMASHITA KIMIHIRO, 田中 智子, 杉田 裕, 渡部 晃大, 福岡 英志, 有本 聡, TAKIGUCHI GOSUKE, TAKASE NOBUHISA, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第22回バイオ治療法研究会, Dec. 2018, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 東京, Domestic conference
    Oral presentation

  • 腹腔鏡下胃切除症例における周術期抗血栓療法の安全性の検討
    原田 仁, KANAJI SHINGO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 腹腔鏡下胃癌手術における術前CTを用いた難易度予測
    池田 太郎, KANAJI SHINGO, 後藤 裕信, 大坪 大, YAMAMOTO MASASHI, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, 藤野 泰宏, 富永 正寛, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 腹臥位食道癌手術における気管分岐部郭清
    三浦 晋, OSHIKIRI TARO, NAKAMURA TETSU, TAKIGUCHI GOSUKE, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 腹臥位胸腔鏡下食道亜全摘術において食道・気管の位置関係が左上縦隔郭清手技に及ぼす影響
    TAKIGUCHI GOSUKE, OSHIKIRI TARO, NAKAMURA TETSU, 堀江 和正, 三浦 晋, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 特別講演2 進行再発大腸癌治療におけるBevacizumabの意義（座長）
    KAKEJI YOSHIHIRO
    Millennaial Seminar of GI Cancer, Dec. 2018, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • 当科における十二指腸腫瘍に対する腹腔鏡内視鏡合同手術
    KANAJI SHINGO, SUZUKI SATOSHI, YAMAMOTO MASASHI, HASEGAWA HIROSHI, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Public symposium

  • 進行胃癌に対する最適な集学的治療
    KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Public discourse

  • 食道切除・胸骨後再建後の胃管癌に対して胸腔鏡下に胃管切除術を施行した１例
    堀江 和正, OSHIKIRI TARO, NAKAMURA TETSU, TAKIGUCHI GOSUKE, 三浦 晋, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 消化器癌における術前療法による癌免疫微小環境の変化
    福岡 英志, YAMASHITA KIMIHIRO, 中川 暁雄, HASEGAWA HIROSHI, MATSUDA TAKERU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第22回バイオ治療法研究会, Dec. 2018, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 東京, Domestic conference
    Oral presentation

  • 胸腔鏡下食道切除術に対する3D内視鏡の導入は術後合併症を減少させるか？
    NAKAMURA TETSU, OSHIKIRI TARO, 山崎 悠太, 三浦 晋, TAKIGUCHI GOSUKE, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 基礎および臨床データが示す腹腔鏡下胃全摘術における3D内視鏡システムの有用性
    山崎 悠太, KANAJI SHINGO, TAKIGUCHI GOSUKE, HASEGAWA HIROSHI, YAMAMOTO MASASHI, MATSUDA YOSHIKO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • 一般演題146 食道悪性 郭清（司会）
    KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Others

  • 安全なTa-TMEの確立を目指して～当科の手術成績と工夫～
    MATSUDA TAKERU, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Oral presentation

  • マウス腹膜播種モデルにおける腹腔内骨髄由来免疫抑制細胞（MDSC)の推移
    杉田 裕, YAMASHITA KIMIHIRO, 福岡 英志, 田中 智子, 有本 聡, TAKIGUCHI GOSUKE, TAKASE NOBUHISA, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第22回バイオ治療法研究会, Dec. 2018, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 東京, Domestic conference
    Oral presentation

  • ICGR15分値に基づく肝予備能からみた肝切除の術式・安全性評価：NCDデータを用いた解析
    青木 琢, 窪田 敬一, 隈丸 拓, 白木 孝之, 宮田 裕章, 瀬戸 泰之, KAKEJI YOSHIHIRO, 山本 雅一
    第31回日本内視鏡外科学会総会, Dec. 2018, Japanese, 一般社団法人日本内視鏡外科学会, 福岡, Domestic conference
    Public symposium

  • Closing Remarks
    KAKEJI YOSHIHIRO
    Millennaial Seminar of GI Cancer, Dec. 2018, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • 閉会の挨拶
    KAKEJI YOSHIHIRO
    第19回神戸外科フォーラム, Nov. 2018, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Others

  • 腹膜播種モデルにおける腹腔内骨骨髄由来抑制細胞(MDSC)の推移
    杉田 裕, YAMASHITA KIMIHIRO, 福岡 英志, 田中 智子, 有本 聡, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第29回日本消化器癌発生学会総会, Nov. 2018, Japanese, 一般社団法人日本消化器癌発生学会, 東京, Domestic conference
    Oral presentation

  • 腹腔鏡下胃切除術における術前後の大腰筋断面積変化の検討
    山崎 悠太, KANAJI SHINGO, TAKIGUCHI GOSUKE, YAMAMOTO MASASHI, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    第48回 胃外科・術後障害研究会, Nov. 2018, Japanese, 胃外科・術後障害研究会, 金沢, Domestic conference
    Poster presentation

  • 内視鏡手術による技術レベルごとの3D画像の影響
    山崎 悠太, KANAJI SHINGO, TAKIGUCHI GOSUKE, HASEGAWA HIROSHI, YAMAMOTO MASASHI, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第27回日本コンピューター外科学会大会, Nov. 2018, Japanese, 一般社団法人日本コンピューター外科学会, 奈良, Domestic conference
    Others

  • 内視鏡治療後非治癒切除症例に対する食道切除術の適応
    NAKAMURA TETSU, 小寺澤 康文, KAKEJI YOSHIHIRO
    JDDW2018（第26回日本消化器関連学会週間）, Nov. 2018, Japanese, 一般社団法人 日本消化器関連学会機構, 神戸, Domestic conference
    Others

  • 特別講演Ⅱ 食道がん、食道胃接合部がん治療の展望～世界の趨勢とアジアの位置付け～（座長）
    KAKEJI YOSHIHIRO
    第16回神戸消化器外科懇話会, Nov. 2018, Japanese, 神戸消化器外科懇話会/株式会社大塚製薬工業/イーエヌ大塚製薬株式会社, 神戸, Domestic conference
    Others

  • 特別講演Ⅱ 上部消化器癌治療と栄養(司会）
    KAKEJI YOSHIHIRO
    第19回神戸外科フォーラム, Nov. 2018, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Others

  • 第9郡 食道癌(座長）
    KAKEJI YOSHIHIRO
    第70回日本気管食道科学総会ならびに学術講演会, Nov. 2018, Japanese, 特定非営利活動法人 日本気管食道科学会, 東京, Domestic conference
    Others

  • 食道扁平上皮癌微小環境におけるFAP陽性癌関連線維芽細胞の役割
    東野 展英, KOMA YUICHIRO, 坂本 浩輝, 藤川 正隆, 細野 雅義, 小平 日実子, NISHIO MARI, SHIGEOKA MANABU, KAKEJI YOSHIHIRO, YOKOZAKI HIROSHI
    第29回日本消化器癌発生学会総会, Nov. 2018, Japanese, 日本消化器癌発生学会, 東京都, Domestic conference
    Poster presentation

  • 食道癌患者におけるT細胞表面分子集簇による機能評価
    YAMASHITA KIMIHIRO, 田中 智子, 杉田 裕, 福岡 英志, 有本 聡, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第29回日本消化器癌発生学会総会, Nov. 2018, Japanese, 一般社団法人日本消化器癌発生学会, 東京, Domestic conference
    Poster presentation

  • 残胃癌に対する残胃亜全摘術の栄養状態の変化を含めた短期・長期成績に関する検討
    後藤 裕信, KANAJI SHINGO, 大坪 大, YAMAMOTO MASASHI, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, 藤野 泰宏, 富永 正寛, KAKEJI YOSHIHIRO
    第48回 胃外科・術後障害研究会, Nov. 2018, Japanese, 胃外科・術後障害研究会, 金沢, Domestic conference
    Others

  • 根治を目指すための胃がんの集学的治療
    KAKEJI YOSHIHIRO
    神戸消化器がん免疫療法セミナー, Nov. 2018, Japanese, ブリストル・マイヤーズ スクイブ株式会社/小野薬品工業株式会社, 神戸, Domestic conference
    Others

  • 胃癌に対するニボルマルの有用性～ATTRACTION-2試験の長期フォローアップデータを踏まえて～(座長）
    KAKEJI YOSHIHIRO
    オプジーボWEBライブセミナー, Nov. 2018, Japanese, ブリストル・マイヤーズ スクイブ株式会社/小野薬品工業株式会社, ＷＥＢセミナー, Domestic conference
    Others

  • ランチョンセミナー1 QOLを見据えた大腸癌化学療法～ポートポンプリー治療の実態～
    KAKEJI YOSHIHIRO
    第29回 日本消化器癌発生学会総会, Nov. 2018, Japanese, 一般社団法人日本消化器癌発生学会, 東京, Domestic conference
    Others

  • パネルディスカッション25 LECS～現在から未来へ～(司会）
    KAKEJI YOSHIHIRO
    第80回日本臨床外科学会総会, Nov. 2018, Japanese, 日本臨床外科学会, 東京, Domestic conference
    Others

  • セッションⅢ/画像2,ナビゲーション1,境界領域1(座長）
    KAKEJI YOSHIHIRO
    第27回日本コンピューター外科学会大会, Nov. 2018, Japanese, 一般社団法人日本コンピューター外科学会, 奈良, Domestic conference
    Others

  • International Session(Symposium)6 ロボットが切り開く消化器外科の未来 (司会）
    KAKEJI YOSHIHIRO
    JDDW2018（第26回日本消化器関連学会週間）, Nov. 2018, Japanese, 一般社団法人 日本消化器関連学会機構, 神戸, Domestic conference
    Others

  • ICGR15分値に基づく肝予備能からみた肝切除の術式・安全性評価：NCDデータを用いた解析
    青木 琢, 窪田 敬一, 隈丸 拓, 白木 孝之, 宮田 裕章, 瀬戸 泰之, KAKEJI YOSHIHIRO, 山本 雅一
    第80回日本臨床外科学会総会, Nov. 2018, Japanese, 日本臨床外科学会, 東京, Domestic conference
    Public symposium

  • 兵庫県の消化器診療の再編と展望
    KAKEJI YOSHIHIRO
    神戸医療連携懇話会, Oct. 2018, Japanese, バイエル薬品株式会社, 神戸, Domestic conference
    Others

  • 特別講演Ⅱ 直腸癌に対するロボット手術(座長）
    KAKEJI YOSHIHIRO
    第25回近畿内視鏡下大腸手術研究会, Oct. 2018, Japanese, 近畿内視鏡下大腸手術研究会/ジョンソンエンドジョンソン株式会社, 神戸, Domestic conference
    Others

  • 特別企画シンポジウム 癌治療-Made in Japan 世界にはばたく日本発の癌治療- 次世代を担う免疫療法を目指して(司会）
    KAKEJI YOSHIHIRO
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Others

  • 高齢者胃癌の外科治療
    SUZUKI SATOSHI, KANAJI SHINGO, YAMAMOTO MASASHI, TAKASE NOBUHISA, TAKIGUCHI GOSUKE, 三浦 晋, HASEGAWA HIROSHI, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Oral presentation

  • 学術セミナー34 大腸癌における最適な治療戦略(司会）
    KAKEJI YOSHIHIRO
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Others

  • 化学療法後に胃切除術を行った進行胃癌症例における予後因子の検討
    杉田 裕, SUZUKI SATOSHI, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • 胃癌治療の新潮流
    KAKEJI YOSHIHIRO
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • パネルディスカッション 患者さんの生活スタイル・嗜好を取り入れた治療選択
    KAKEJI YOSHIHIRO
    Chugai Colorectal Cancer Symposium in HYOGO, Oct. 2018, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • シンポジウム3 胃癌の集学的治療(司会）
    KAKEJI YOSHIHIRO
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Others

  • がん診療ガイドラインの将来ー臓器がん登録の質と医療の質の向上を目指してー
    平田 公一, 今村 将史, 竹政 伊知朗, 古川 俊治, 後藤 満一, 袴田 健一, 石黒 めぐみ, KAKEJI YOSHIHIRO, 鶴間 哲弘, 森 正樹, 佐藤 雅美, 横井 公平, 柴田 亜希子, 海野 倫明, 西山 正彦
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Others

  • Stage III結腸癌に対する術後補助化学療法C-SOX療法の効果・安全性の検討（KSCC1303）
    椛島 章, 江見 泰徳, 宮成 信友, 辻 晃仁, 境 健爾, 澤井 照光, 今村 博, 盛 真一郎, 徳永 章二, 沖 英次, 佐伯 浩司, KAKEJI YOSHIHIRO, 赤木 由人, 馬場 秀夫, 前原 喜彦
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Oral presentation

  • StageIII胃癌における術後補助化療S-1+Docetaxel療法とS-1単独療法の第III相試験
    高金 明典, 小寺 泰弘, 吉田 和弘, 東風 貢, 市川 度, KAKEJI YOSHIHIRO, 佐野 武, 石黒 敦, 深井 康幸, 柴田 勇, 武者 信行, 出口 智宙, 木村 泰生, 竹内 正弘, 藤井 雅志
    第56回日本癌治療学会学術集会, Oct. 2018, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Oral presentation

  • 本邦での大腸癌患者におけるマイクロサテライト不安定性検査の有用性についての検討
    須藤 洋崇, TOYODA MASANORI, 後藤 秀彰, FUNAKOSHI YOUHEI, YAMASHITA KIMIHIRO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO, MINAMI HIRONOBU
    第77回日本癌学会学術集会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Poster presentation

  • 腹臥位胸腔鏡下食道切除術における縦隔郭清の工夫と定型化
    TAKIGUCHI GOSUKE, OSHIKIRI TARO, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回近畿内視鏡外科研究会, Sep. 2018, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Public symposium

  • 肥満症例に対する腹腔鏡下胃切除術～何が手術の難易度を規定するのか？～
    後藤 裕信, KANAJI SHINGO, 大坪 大, YAMAMOTO MASASHI, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, 藤野 泰宏, 富永 正寛, KAKEJI YOSHIHIRO
    第31回近畿内視鏡外科研究会, Sep. 2018, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Public symposium

  • 当科におけるTa-TMEの導入と定型化
    MATSUDA TAKERU, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回近畿内視鏡外科研究会, Sep. 2018, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Public symposium

  • 直腸癌術前化学放射線療法によるCD８+T細胞とPD-L1陽性免疫細胞の誘導
    福岡 英志, YAMASHITA KIMIHIRO, 中川 暁雄, 田中 智子, 有本 聡, 杉田 裕, HASEGAWA HIROSHI, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第77回日本癌学会学術総会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Oral presentation

  • 食道閉塞をきたし早期手術をおこなった酸性洗剤飲用による腐食性食道炎の一例
    石田 苑子, OSHIKIRI TARO, NAKAMURA TETSU, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    日本消化器病学会近畿支部第109回例会, Sep. 2018, Japanese, 日本消化器病学会, 大阪, Domestic conference
    Oral presentation

  • 食道切除・胸骨後再建後の胃管癌に対して胸腔鏡下に胃管切除術を施行した１例
    堀江 和正, OSHIKIRI TARO, 三浦 晋, TAKIGUCHI GOSUKE, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第31回近畿内視鏡外科研究会, Sep. 2018, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Oral presentation

  • 腫瘍抗原導入DCGによる抗原特異的抗腫瘍免疫活性化
    有本 聡, YAMASHITA KIMIHIRO, 西 将康, 杉田 裕, 福岡 英志, 田中 智子, KAKEJI YOSHIHIRO
    第77回日本癌学会学術総会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Poster presentation

  • 一般講演(座長）
    KAKEJI YOSHIHIRO
    第11回神戸消化器癌勉強会, Sep. 2018, Japanese, 株式会社ヤクルト本社, 神戸, Domestic conference
    Others

  • ランチョンセミナー18 ニューテクノロジーへの期待、がん免疫療法への予感(座長）
    KAKEJI YOSHIHIRO
    第77回日本癌学会学術集会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Others

  • ヒト乳がん異種移植モデルの微小転移がん幹細胞で発現低下しているマイクロRNA-25の解析
    渋谷尚樹, 下野洋平, MINAMI HIRONOBU, KAKEJI YOSHIHIRO, SUZUKI AKIRA
    第77回日本癌学会学術集会, Sep. 2018, Japanese, 大阪, Domestic conference
    Poster presentation

  • セッションⅡ 化学療法 「胃癌治療のUp to Date」(司会）
    KAKEJI YOSHIHIRO
    第17回兵庫胃がん治療研究会, Sep. 2018, Japanese, 大鵬薬品工業株式会社/兵庫胃がん治療研究会/兵庫県がん診療連携協議会, 神戸, Domestic conference
    Others

  • スポンサードセッション2 ロボット手術を導入して～腹腔鏡との違いはこのポイント～(座長）
    KAKEJI YOSHIHIRO
    第31回近畿内視鏡外科研究会, Sep. 2018, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Others

  • シンポジウム1 消化管診療の最前線(司会）
    KAKEJI YOSHIHIRO
    日本消化器病学会近畿支部第109回例会, Sep. 2018, Japanese, 日本消化器病学会, 大阪, Domestic conference
    Others

  • T細胞刺激後免疫シナプス様表面分子の集簇反応の評価
    YAMASHITA KIMIHIRO, 田中 智子, 岡 祐馬, 森田 愛梨, 柳田 匡俊, 杉田 裕, 福岡 英志, 有本 聡, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第77回日本癌学会学術総会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Poster presentation

  • Symposia on Specific Tumors 消化管がん治療の新展開(座長）
    KAKEJI YOSHIHIRO
    第77回日本癌学会学術集会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Others

  • StagedPedicled Jejunal after Aortoesophagectomy for Aortoesophageal Fistula.
    Tetsu Nakamura, Sonoko Ishida, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Yasuo Sumi, Satoshi Suzuki, Yoshihiro Kakeji
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Poster presentation

  • Reliable Surgical Techniques for Lymphadenectomy along the Left Recurrent Laryngeal Nerve during Thoracoscipic Esophagectomy Iin the Prone Position.
    Taro Oshikiri, Tetsu Nakamura, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Satoshi Suzuki, Yoshihiro Kakeji
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Others

  • Pseudodiverticulosis-Related Esophageal Mass with Intense Fdg Uptake
    Ryuichiro Sawada, Taro Oshikiri, Tetsu Nakamura, Yukiko Miura, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Yasuo Sumi, Satoshi Suzuki, Yoshihiro Kakeji
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Poster presentation

  • Prone Position in Thoracoscopic Esophagectomy Improves Postoperative Oxygenation and Reduces Pulmonary Complications
    Yoshihiro Kakeji, Dai Otsubo, Gosuke Takiguchi, Taro Oshikiri, Tetsu Nakamura
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Poster presentation

  • Plenary Session XII: New Horizons of Immuno-Oncology in Esophageal Cancer: Where We Are Now(座長）
    Yoshihiro Kakeji
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Oral presentation

  • IFT20は微小管ダイナミックスを制御することで大腸癌細胞の浸潤能亢進に寄与する
    青木 丈明, 西田 満, KAKEJI YOSHIHIRO, 南 康博
    第77回日本癌学会学術総会, Sep. 2018, Japanese, 日本癌学会, 大阪, Domestic conference
    Poster presentation

  • Comparison of the clinical outcomes of esophagectomy  and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma
    Yasufumi Koterazawa, Tetsu Nakamura, Taro Oshikiri, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Satoshi Suzuki, Yoshihiro Kakeji
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Oral presentation

  • Clinical Impact of Surgical Apgar Score in Predicting Postoperative Complications and Long-Term Prognosis after Esophagectomy.
    Sonoko Ishida, Akio Nakagawa, Tetsu Nakamura, Taro Oshikiri, HIroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Yasuo Sumi, Satoshi Suzuki, Yoshihiro Kakeji
    The international society for Diseases of the Esophagus (ISDE), Sep. 2018, English, International Society for Diseases of the Esophagus, Vienna, International conference
    Poster presentation

  • 特別講演 抗血栓薬（抗凝固薬、抗血小板薬）をどう扱うか？～非循環器科医の先生方に知っておいていただきたい事～(座長）
    KAKEJI YOSHIHIRO
    地域医療連携を考える会, Aug. 2018, Japanese, 第一三共株式会社, 神戸, Domestic conference
    Others

  • 消化器癌患者におけるT細胞の刺激応答性の評価方法の検討
    田中 智子, YAMASHITA KIMIHIRO, 岡 祐馬, 柳田 匡俊, 杉田 裕, 福岡 英志, 有本 聡, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第22回日本がん免疫学会総会, Aug. 2018, Japanese, 日本がん免疫学会, 岡山, Domestic conference
    Poster presentation

  • 要望演題3 重症感染症に対する至適栄養管理とは？(座長）
    KAKEJI YOSHIHIRO
    日本外科代謝栄養学会第55回学術集会, Jul. 2018, Japanese, 日本外科代謝栄養学会, 大阪, Domestic conference
    Others

  • 閉塞性大腸癌に対する術前大腸ステント留置の有用性の検討
    細野 雅義, MATSUDA TAKERU, HASEGAWA HIROSHI, YAMASHITA KIMIHIRO, SUMI YASUO, KANAJI SHINGO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Others

  • 腹腔鏡下側方リンパ節郭清を安全に行うための2つの筋膜を意識した手術手技
    SUMI YASUO, HASEGAWA HIROSHI, YAMASHITA KIMIHIRO, MATSUDA TAKERU, YAMAMOTO MASASHI, KANAJI SHINGO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 腹腔鏡下胃全摘術におけるOverlap法の工夫と検討
    三浦 晋, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 腹臥位胸腔鏡下食道切除術のlearning curveが術後合併症に及ぼす影響と今後の展望
    OSHIKIRI TARO, NAKAMURA TETSU, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 難治性腹水に対する改良型腹水濾過濃縮再静注法(KM-CART療法)の治療効果
    金 英植, 前原 律子, SUMI YASUO, AJIKI TETSUO, 譜久山 仁, 譜久山 剛, 吉田 優子, 高橋 毅, 長谷川 恭久, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 特別講演Ⅱ がん治療革命：遺伝子診療時代における外科治療(座長）
    KAKEJI YOSHIHIRO
    第30回神戸臨床腫瘍研究会, Jul. 2018, Japanese, 神戸臨床腫瘍研究会/中外製薬会社, 神戸, Domestic conference
    Others

  • 特別講演 進行食道癌に対する総合的治療戦略(座長）
    KAKEJI YOSHIHIRO
    兵庫県消化器外科研究会2018, Jul. 2018, Japanese, 兵庫県消化器外科研究会/小野薬品工業株式会社, 神戸, Domestic conference
    Others

  • 当院における腹腔鏡下胃全摘術についての検討
    YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 男性直腸癌Hartmann術後人工肛門閉鎖(再吻合)において術中内視鏡を活用し腹腔鏡手術を行った1例
    HASEGAWA HIROSHI, MATSUDA TAKERU, YAMASHITA KIMIHIRO, SUMI YASUO, YAMAMOTO MASASHI, KANAJI SHINGO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 切除可能進行胃癌における術前補助化学療法の予後因子の検討
    杉田 裕, MATSUDA TAKERU, SUZUKI SATOSHI, NAKAMURA TETSU, SUMI YASUO, OSHIKIRI TARO, 藤田 敏忠, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 食道癌術前化学療法の効果予測因子としての癌幹細胞マーカーの有用性に関する検討
    中川 暁雄, YAMASHITA KIMIHIRO, NAKAMURA TETSU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, 藤田 敏忠, OSHIKIRI TARO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 消化器癌患者におけるT細胞表面分子集簇による機能評価
    YAMASHITA KIMIHIRO, 田中 智子, 杉田 裕, 福岡 英志, 有本 聡, YAMAMOTO MASASHI, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 術前抗血栓療法中の胃切除患者に対する周術期抗血栓療法の検討
    原田 仁, KANAJI SHINGO, YAMAMOTO MASASHI, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 術後腹膜炎が肺転移の予後に及ぼす影響とその免疫学的検討
    有本 聡, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, 杉田 裕, 福岡 英志, 田中 智子, KANAJI SHINGO, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第27回日本がん転移学会学術集会・総会, Jul. 2018, Japanese, 日本がん転移学会, 横浜, Domestic conference
    Public symposium

  • 高齢者の胃癌治癒切除後の予後予測におけるCONUT scoreの有用性
    SUZUKI SATOSHI, KANAJI SHINGO, YAMAMOTO MASASHI, MATSUDA YOSHIKO, 杉田 裕, HASEGAWA HIROSHI, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    日本外科代謝栄養学会第55回学術集会, Jul. 2018, Japanese, 日本外科代謝栄養学会, 大阪, Domestic conference
    Oral presentation

  • 高齢者における術前化学療法の安全性と栄養評価
    杉田 裕, MATSUDA YOSHIKO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    日本外科代謝栄養学会第55回学術集会, Jul. 2018, Japanese, 日本外科代謝栄養学会, 大阪, Domestic conference
    Oral presentation

  • 後期高齢者進行胃癌患者に対する術前化学療法の安全性
    MATSUDA YOSHIKO, 杉田 裕, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 局所進行直腸癌に対する術前化学療法のランダム化Phase II試験とその免疫関連マーカーの解析 (KSCC1301A)
    沖 英次, 安藤 幸滋, 中西 良太, 是久 翔太郎, 中島 雄一郎, 佐伯 浩司, 赤木 由人, KAKEJI YOSHIHIRO, 馬場 秀夫, 前原 喜彦
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 胸部食道癌手術において経腸栄養tube留置は省略できるか?
    小寺澤 康文, OSHIKIRI TARO, NAKAMURA TETSU, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • 教育セミナー 消化器がん治療における漢方の役割(座長）
    KAKEJI YOSHIHIRO
    日本外科代謝栄養学会第55回学術集会, Jul. 2018, Japanese, 日本外科代謝栄養学会, 大阪, Domestic conference
    Others

  • 胃癌術後の合併症発生の予測因子としてのeGFRの有用性
    SUZUKI SATOSHI, KANAJI SHINGO, YAMAMOTO MASASHI, HASEGAWA HIROSHI, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • StageIII治癒切除胃癌に対する術後補助化学療法としてのS-1+Docetaxel併用療法とS-1単独療法のランダム化比較第III相試験
    國枝 克行, 小寺 泰弘, 吉田 和弘, 東風 貢, 市川 度, KAKEJI YOSHIHIRO, 佐野 武, 後藤 昌弘, 芝原 一繁, 寺本 仁, 中山 裕史, 竹内 正弘, 藤井 雅志
    第16回日本臨床腫瘍学会学術集会, Jul. 2018, Japanese, 公益社団法人 日本臨床腫瘍学会, 神戸, Domestic conference
    Others

  • Session2 大腸癌治療の最前線～2018 Update～(座長）
    KAKEJI YOSHIHIRO
    第5回平成大腸癌カンファレンス, Jul. 2018, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • pT4b症例における腹腔鏡手術の治療成績
    青木 丈明, MATSUDA TAKERU, SUZUKI SATOSHI, NAKAMURA TETSU, SUMI YASUO, OSHIKIRI TARO, 藤田 敏忠, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Others

  • KM-CARTにより原発性胆汁性胆管炎による難治性腹水の減少を認めた1例
    前原 律子, 金 英植, SUMI YASUO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, 味木 徹夫, KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Poster presentation

  • Flow cytometric measurement of erythrocyte membrane-bound IgG: A potential diagnostic method for colorectal carcinoma
    北尾 章人, 川本 晋一郎, 早川 郁代, 倉田 啓史, 山崎 隆, 松岡 広, SUMI YASUO, KAKEJI YOSHIHIRO, 亀崎 豊美, 南 博信
    第16回日本臨床腫瘍学会学術集会, Jul. 2018, Japanese, 公益社団法人 日本臨床腫瘍学会, 神戸, Domestic conference
    Poster presentation

  • cT1大腸癌におけるESD穿孔症例の検討
    前原 律子, MATSUDA TAKERU, HASEGAWA HIROSHI, YAMASHITA KIMIHIRO, SUMI YASUO, 石田 司, 田中 心和, 森田 圭紀, 豊永 高史, 梅垣 英次, KAKEJI YOSHIHIRO
    第89回大腸癌研究会, Jul. 2018, Japanese, 大腸癌研究会, 新潟, Domestic conference
    Poster presentation

  • 50周年特別企画2 春夏秋冬 心技の継承 胃
    KAKEJI YOSHIHIRO
    第73回日本消化器外科学会総会, Jul. 2018, Japanese, 一般社団法人 日本消化器外科学会, 鹿児島, Domestic conference
    Others

  • 鼠径リンパ節転移を伴う進行直腸癌に対する術前化学放射線療法と手術の制御効果
    植田 康司, MATSUDA TAKERU, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, OSHIKIRI TARO, 藤田 敏忠, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第43回日本外科系連合学会学術集会, Jun. 2018, Japanese, 一般社団法人 学会支援機構内日本外科系連合学会事務局, 東京, Domestic conference
    Oral presentation

  • 食道破裂の全国実態調査
    宗田 真, 桑野 博行, 酒井 真, 宮崎 達也, KAKEJI YOSHIHIRO, 藤 也寸志, 松原 久裕
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • 食道原発神経内分泌腫瘍の病態に関わる全国調査
    宮崎 達也, 桑野 博行, 宗田 真, 酒井 真, 松原 久裕, KAKEJI YOSHIHIRO, 藤 也寸志
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • 食道癌術前化学療法のchemoresistance markerとしてのCD24、CD44、CD133の有用性
    中川 暁雄, YAMASHITA KIMIHIRO, NAKAMURA TETSU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Poster presentation

  • 食道Gastrointestinal stromal tumor(GIST)の病態に関わる全国調査
    新井 冨生, 桑野 博行, 宮崎 達也, 酒井 真, 宗田 真, 根本 哲生, 藤 也寸志, KAKEJI YOSHIHIRO, 松原 久裕
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • 消化器外科におけるNCD登録とデータの利活用
    KAKEJI YOSHIHIRO
    第16回日本ヘルニア学会学術集会, Jun. 2018, Japanese, 日本ヘルニア学会, 札幌, Domestic conference
    Public discourse

  • 高齢者胃癌患者における術後肺炎併発の長期予後への影響
    杉田 裕, SUZUKI SATOSHI, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    第43回日本外科系連合学会学術集会, Jun. 2018, Japanese, 一般社団法人 学会支援機構内日本外科系連合学会事務局, 東京, Domestic conference
    Public symposium

  • 研究推進委員会報告(司会）
    KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • 胸部食道癌手術において経腸栄養tubeは全例に必要か？
    小寺澤 康文, OSHIKIRI TARO, NAKAMURA TETSU, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Poster presentation

  • 胸腔鏡下食道切除術後の合併症の予後
    NAKAMURA TETSU, 三浦 由紀子, HASEGAWA HIROSHI, YAMAMOTO MASASHI, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Poster presentation

  • ランチョンセミナー6 酸関連疾患の四半世紀の変遷、 今後の胃酸分泌抑制剤の戦略(座長）
    KAKEJI YOSHIHIRO
    第43回日本外科系連合学会学術集会, Jun. 2018, Japanese, 一般社団法人 学会支援機構内日本外科系連合学会事務局, 東京, Domestic conference
    Others

  • マルチライフ～女性外科医と家庭の真の両立を目指して～
    石田 苑子, NAKAMURA TETSU, OSHIKIRI TARO, 永田 真知子, 田中 智子, 三浦 由紀子, 前原 律子, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第43回日本外科系連合学会学術集会, Jun. 2018, Japanese, 一般社団法人 学会支援機構内日本外科系連合学会事務局, 東京, Domestic conference
    Public symposium

  • ビデオシンポジウム 新たなMIEを求めて～3D手術の進歩～(司会）
    KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • ビデオシンポジウム5 明日から活かせる腹腔鏡下胃全摘後の再建術(座長）
    KAKEJI YOSHIHIRO
    第43回日本外科系連合学会学術集会, Jun. 2018, Japanese, 一般社団法人 学会支援機構内日本外科系連合学会事務局, 東京, Domestic conference
    Others

  • パネルディスカッション 最新のエビデンスをどの様に解釈し臨床へ応用するか(司会）
    KAKEJI YOSHIHIRO
    Colorectal Cancer Seminar～大腸がん治療の最新情報～, Jun. 2018, Japanese, メルクセローノ株式会社, 福岡, Domestic conference
    Others

  • QOLに考慮した有茎空腸再建術の工夫
    TAKIGUCHI GOSUKE, NAKAMURA TETSU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA TAKERU, OSHIKIRI TARO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • MIEにおいて3D内視鏡システムは反回神経麻痺を減少させるか？
    OSHIKIRI TARO, NAKAMURA TETSU, 三浦 由紀子, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回日本食道学会学術集会, Jun. 2018, Japanese, 特定非営利活動法人 日本食道学会, 宇都宮, Domestic conference
    Others

  • A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
    Yasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, Wataru Ichikawa, Yoshihiro Kakeji, Takeshi Sano, Narutoshi Nagao, Masazumi Takahashi, Akinori Takagane, Masanori Nakamura, Masahide Kaji, Hiroshi Okitsu, Takashi Nomura, Takanori Matsui, Takaki Yoshikawa, Jin Matsuyama, Makoto Yamada, Yuichi Ito, Masahiro Takeuchi, Masashi Fujii
    2018 ASCO Annual Meeting, Jun. 2018, English, 2019アメリカ臨床腫瘍学会（ASCO), Chicago, International conference
    Oral presentation

  • 3D/HDおよび2D/4Kモニターが内視鏡外科医の手術手技にもたらす効果
    原田 仁, KANAJI SHINGO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第43回日本外科系連合学会学術集会, Jun. 2018, Japanese, 一般社団法人 学会支援機構内日本外科系連合学会事務局, 東京, Domestic conference
    Public symposium

  • 放射線がもたらす腫瘍微小環境の変化の解析
    福岡 英志, YAMASHITA KIMIHIRO, 中川 暁雄, HASEGAWA HIROSHI, MATSUDA TAKERU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第6回がんと代謝研究会, May 2018, Japanese, がんと代謝研究会, 奄美大島, Domestic conference
    Poster presentation

  • 肺への浸潤を伴う食道癌に対する胸腔鏡下食道切除術
    NAKAMURA TETSU, HASEGAWA HIROSHI, YAMAMOTO MASASHI, MATSUDA YOSHIKO, KANAJI SHINGO, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Others

  • 当科におけるTa-TMEの手術手技と手術成績
    MATSUDA TAKERU, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Others

  • 当院における十二指腸LECSの検討
    渡部 晃大, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, MATSUDA YOSHIKO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第201回近畿外科学会, May 2018, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Oral presentation

  • 直腸癌術前化学療法の腫瘍免疫因子の発現動態の解析
    福岡 英志, YAMASHITA KIMIHIRO, 中川 暁雄, HASEGAWA HIROSHI, MATSUDA TAKERU, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第27回日本癌病態治療研究会, May 2018, Japanese, NPO法人 日本癌病態治療研究会事務局, 千葉, Domestic conference
    Public symposium

  • 直腸癌手術における術中内視鏡検査と経肛門ドレーンの有効性
    渋谷 尚樹, MATSUDA TAKERU, SUMI YASUO, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Others

  • 進化する胃癌治療
    KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Public discourse

  • 消化器癌患者におけるT細胞の刺激応答性の新規評価方法
    田中 智子, YAMASHITA KIMIHIRO, 岡 祐馬, 森田 愛梨, 柳田 匡俊, 杉田 裕, 福岡 英志, 有本 聡, HASEGAWA HIROSHI, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第28回日本サイトメトリー学会学術集会, May 2018, Japanese, 一般社団法人日本サイトメトリー学会, 東京, Domestic conference
    Poster presentation

  • 十二指腸腫瘍に対す腹腔鏡内視鏡合同手術について
    YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Poster presentation

  • 腫瘍再発モデルにおける末梢血中の骨髄由来抑制細胞(MDSC)の推移
    杉田 裕, YAMASHITA KIMIHIRO, 田中 智子, 福岡 英志, 有本 聡, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第39回癌免疫外科研究会, May 2018, Japanese, 癌免疫外科研究会, 岐阜, Domestic conference
    Oral presentation

  • 腫瘍再発モデルにおける末梢血中の骨髄由来抑制細胞(MDSC)の推移
    杉田 裕, YAMASHITA KIMIHIRO, 田中 智子, 福岡 英志, 有本 聡, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第6回がんと代謝研究会, May 2018, Japanese, がんと代謝研究会, 奄美大島, Domestic conference
    Poster presentation

  • 主題Ⅱ Precision Medicineの幕開け(司会）
    KAKEJI YOSHIHIRO
    第39回癌免疫外科研究会, May 2018, Japanese, 癌免疫外科研究会, 岐阜, Domestic conference
    Poster presentation

  • 酸性洗剤飲用により完全閉塞をきたした腐食性食道炎の一例
    石田 苑子, NAKAMURA TETSU, OSHIKIRI TARO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第201回近畿外科学会, May 2018, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Oral presentation

  • 左結腸動脈温存D３郭清の定型化：当院での試み
    前原 律子, SUMI YASUO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第201回近畿外科学会, May 2018, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Oral presentation

  • 癌患者におけるT細胞の刺激応答性の評価
    YAMASHITA KIMIHIRO, 田中 智子, 杉田 裕, 福岡 英志, 有本 聡, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, MATSUDA TAKERU, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第27回日本癌病態治療研究会, May 2018, Japanese, NPO法人 日本癌病態治療研究会事務局, 千葉, Domestic conference
    Others

  • 開腹Hartmann術後の人工肛門形成状態に対する腹腔鏡下人工肛門閉鎖術の有効性
    HASEGAWA HIROSHI, MATSUDA TAKERU, YAMASHITA KIMIHIRO, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Poster presentation

  • イブニングセミナー マイクロRNAの臨床応用を目指して
    KAKEJI YOSHIHIRO
    第27回日本癌病態治療研究会, May 2018, Japanese, NPO法人 日本癌病態治療研究会事務局, 千葉, Domestic conference
    Others

  • Surgical Forum14 食道②(司会）
    KAKEJI YOSHIHIRO
    第72回手術手技研究会, May 2018, Japanese, 手術手技研究会事務局, 徳島, Domestic conference
    Others

  • FDGの高度集積を認めた食道偽憩室に起因する食道腫瘤の一例
    澤田 隆一郎, OSHIKIRI TARO, 三浦 由紀子, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, NAKAMURA TETSU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第201回近畿外科学会, May 2018, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Oral presentation

  • 腹壁瘢痕ヘルニアinlay-meshにおける腹腔鏡手術と開腹手術の比較
    HASEGAWA HIROSHI, MATSUDA TAKERU, YAMASHITA KIMIHIRO, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Poster presentation

  • 腹臥位での胸腔鏡手術による食道癌根治術
    OSHIKIRI TARO, NAKAMURA TETSU, 三浦 由紀子, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Oral presentation

  • 第2部 第5回「臨床研究助成」及び「若手外科医のための臨床研究助成」授賞式(司会）
    KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • 多施設共同観察研究による食道扁平上皮癌術前治療における効果予測分子バイオマーカーの同定（KSCC1307）
    佐伯 浩司, 中司 悠, 城後 友望子, 藤原 美奈子, 徳永 章二, 馬場 祥史, 中村 哲, 岩田 直樹, 江頭 明典, 田中 善宏, 工藤 健介, 中西 良太, 久保 信英, 安藤 幸滋, 中島 雄一郎, 沖 英次, 森田 勝, 江見 泰徳, KAKEJI YOSHIHIRO, 馬場 秀夫, 前原 喜彦
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Public symposium

  • 食道癌内視鏡的粘膜下層剥離術後非治療切除症例に対する追加治療例の検討
    小寺澤 康文, NAKAMURA TETSU, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • 食道癌手術における合併症および長期予後予測因子としてのSurgical Apgar Score
    中川 暁雄, NAKAMURA TETSU, OSHIKIRI TARO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Public symposium

  • 高齢者進行胃癌に対する術前化学療法の安全性
    MATSUDA YOSHIKO, 三浦 由紀子, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Poster presentation

  • 高齢者の胃癌治癒切除後の予後予測因子におけるCONUT scoreの有用性
    SUZUKI SATOSHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMAMOTO MASASHI, HASEGAWA HIROSHI, YAMASHITA KIMIHIRO, OSHIKIRI TARO, MATSUDA TAKERU, SUMI YASUO, NAKAMURA TETSU, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Public symposium

  • 胸腔鏡下食道切除術に対する３Ｄ内視鏡の導入と治療成績
    NAKAMURA TETSU, 小寺澤 康文, 澤田 隆一郎, 池田 太郎, 渋谷 尚樹, 青木 丈明, 三浦 由紀子, 原田 仁, 中川 暁雄, 西 将康, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, YAMASHITA KIMIHIRO, MATSUDA TAKERU, OSHIKIRI TARO, SUMI YASUO, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • 下部進行直腸癌に対する術前化学放射線療法＋選択的側方郭清の治療成績
    MATSUDA TAKERU, SUMI YASUO, YAMASHITA KIMIHIRO, HASEGAWA HIROSHI, YAMAMOTO MASASHI, KANAJI SHINGO, MATSUDA YOSHIKO, OSHIKIRI TARO, NAKAMURA TETSU, SUZUKI SATOSHI, KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • ワークショップ（3） 胃切除後障害に対する対策（司会）
    KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • ランチョンセミナー（27） 胃癌に対する手術と化学療法の新展開(司会）
    KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • ランチョンセミナー（11） がん免疫療法が切り開く外科医の未来(司会）
    KAKEJI YOSHIHIRO
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • The induction of PD-L1 positive immune cells and CD8-positive T lymphocytes by neoadjuvant chemoradiotherapy for rectal cancer
    Kimihiro Yamashita, Akio Nakagawa, Tomoko Tanaka, Akira Arimoto, Eiji Fukuoka, Yutaka Sugita, Junko Mukohyama, Piero Dalerba, Hiroshi Hasegawa, Takeru Matsuda, Satoshi Suzuki, Yoshihiro Kakeji
    AACR Annual Meeting 2018, Apr. 2018, English, American Association for Cancer Research, Chicago, International conference
    Poster presentation

  • Surgical strategy for splenic flexure cancer.
    Takeru Matsuda, Yasuo Sumi, Kimihiro Yamashita, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
    SAGES2018, Apr. 2018, English, Society of American Gastrointestinal and Endoscopic Surgeons, Washington, International conference
    Others

  • NCDによるReal Wordデータが腹腔鏡下幽門側胃切除の実臨床を変える可能性
    比企 直樹, 本多 通孝, 衛藤 剛, 吉田 和弘, 隈丸 拓, 小寺 泰弘, KAKEJI YOSHIHIRO, 宮田 裕章, 今野 弘之, 瀬戸 泰之, 猪股 雅史, 北野 正剛
    第118回日本外科学会定期学術集会, Apr. 2018, Japanese, 一般社団法人日本外科学会, 東京, Domestic conference
    Others

  • Flow cytometric measurement of increased erythrocyte bound IgG: A potential screening method for colorectal cancer
    Akihito Kitao, Shinichiro Kawamoto, Keiji Kurata, Ikuyo Hayakawa, Hiroshi Matsuoka, Yasuo Sumi, Yoshihiro Kakeji, Toyomi Kamesaki, Hironobu Minami
    AACR Annual Meeting 2018, Apr. 2018, English, American Association for Cancer Research, Chicago, International conference
    Poster presentation

  • Epigenetic regulation of colorectal cancer stem cells by the miR-221/QKI5 axis.
    Junko Mukohyama, Yohei Shimono, Piero Dalerba, Taichi Isobe, Qingjiang Hu, Debashis Sahoo, Naoki Shibuya, Hironobu Minami, Koshi Mimori, Yoshihiro Kakeji, Akira Suzuki
    AACR Annual Meeting 2018, Apr. 2018, English, American Association for Cancer Research, Chicago, International conference
    [Invited]
    Invited oral presentation

  • Electroporation as a feasible method for antigen delivering into vectors loaded with NKT cell ligand
    Akira Arimoto, Masayasu Nishi, Kimihiro Yamashita, Yutaka Sugita, Eiji Fukuoka, Tomoko Tanaka, Takashi Kamigaki, Rishu Takimoto, Yoshihiro Kakeji
    AACR Annual Meeting 2018, Apr. 2018, English, American Association for Cancer Research, Chicago, International conference
    Poster presentation

  • A new method for evaluating T cell response after stimulation on gastrointestinal cancer patients
    Tomoko Tanaka, Kimihiro Yamashita, Yutaka Sugita, Eiji Fukuoka, Akira Arimoto, Yoshihiro Kakeji
    AACR Annual Meeting 2018, Apr. 2018, English, American Association for Cancer Research, Chicago, International conference
    Poster presentation

  • 乳癌センチネルリンパ節におけるprogrammed death-1発現に関する検討
    多田羅 敬, 向原 徹, Shimono Yohei, 山崎 隆, Toyoda Masanori, Kiyota Naomi, Kono Seishi, 高尾 信太郎, Kakeji Yoshihiro, Minami Hironobu
    第51回制癌剤適応研究会, Mar. 2018, Japanese, 制癌剤適応研究会, 下呂, Domestic conference
    Oral presentation

  • 特別講座
    Kakeji Yoshihiro
    神戸 消化器外科 Seminar, Mar. 2018, Japanese, テルモ株式会社, 神戸, Domestic conference
    Others

  • 当科での腹腔鏡下胃全摘術における食道空腸吻吻合の短期成績に関する検討
    三浦 晋, 後藤 裕信, 大坪 大, Kanaji Shingo, 今西 達也, 山岸 農, 池田 公治, 吉田 佐智子, 吉田 俊彦, 大山 正人, 松本 拓, 柿木 啓太郎, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Poster presentation

  • 当院における残胃癌に対する腹腔鏡手術の検討
    Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Poster presentation

  • 神経内分泌細胞成分を伴う胃癌に対する集学的治療の有用性
    杉田 裕, Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Poster presentation

  • 術前化学放射線療法を施行した進行直腸癌におけるmodified Glassgow Prognostic Scoreを用いた治療効果予測
    福岡 英志, Yamashita Kimihiro, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, Yamamoto Masashi, 藤田 敏忠, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第51回制癌剤適応研究会, Mar. 2018, Japanese, 制癌剤適応研究会, 下呂, Domestic conference
    Oral presentation

  • 高齢者食道癌における術前補助化学療法についての検討
    Yamamoto Masashi, Nakamura Tetsu, Matsuda Yoshiko, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第51回制癌剤適応研究会, Mar. 2018, Japanese, 制癌剤適応研究会, 下呂, Domestic conference
    Oral presentation

  • 高齢者の胃癌切除症例における術前末梢血の総リンパ球数の臨床的意義
    多田羅 敬, Suzuki Satoshi, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Oral presentation

  • 高齢者の胃癌切除後の予後予測における血小板/リンパ球比の有用性
    Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Oral presentation

  • 口演4 高齢者胃癌
    Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Others

  • 局所進行直腸癌における術前化学放射線療法後の免疫細胞の解析
    Yamashita Kimihiro, 中川 暁雄, Matsuda Takeru, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第51回制癌剤適応研究会, Mar. 2018, Japanese, 制癌剤適応研究会, 下呂, Domestic conference
    Oral presentation

  • 化学療法後に胃切除術を行った進行胃癌症例の検討
    Matsuda Yoshiko, 杉田 裕, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第51回制癌剤適応研究会, Mar. 2018, Japanese, 制癌剤適応研究会, 下呂, Domestic conference
    Oral presentation

  • 胃癌における免疫チェックポイント阻害薬（仮）
    Kakeji Yoshihiro
    神戸胃がん免疫療法セミナー, Mar. 2018, Japanese, ブリストル・マイヤーズ スクイズ株式会社,小野薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • ワークショップ5 新しい胃癌取扱い規約（15版）に基づいた補助化学療法の成績
    Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Others

  • StageIV胃癌に対するconversion surgeryの適応と予後の検討
    原田 仁, Suzuki Satoshi, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第51回制癌剤適応研究会, Mar. 2018, Japanese, 制癌剤適応研究会, 下呂, Domestic conference
    Oral presentation

  • 80歳以上の胃癌患者に対する術前補助化学療法の経験
    Matsuda Yoshiko, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第90回日本胃癌学会総会, Mar. 2018, Japanese, 日本胃癌学会, 横浜, Domestic conference
    Poster presentation

  • 発生と解剖に基づいた脾弯曲癌に対する腹腔鏡下結腸間膜全切除
    Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第14回日本消化管学会総会学術集会, Feb. 2018, Japanese, 日本消化管学会, 東京, Domestic conference
    Public symposium

  • 当科における噴門部GISTの手術成績と治療戦略の検討
    池田 太郎, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第14回日本消化管学会総会学術集会, Feb. 2018, Japanese, 日本消化管学会, 東京, Domestic conference
    Public symposium

  • 大腸癌薬物療法の新展開
    Kakeji Yoshihiro
    第14回日本消化管学会総会学術集会, Feb. 2018, Japanese, 日本消化管学会, 東京, Domestic conference
    Others

  • 大腸癌集学的治療の展開
    Kakeji Yoshihiro
    兵庫大腸癌治療フォーラム2018, Feb. 2018, Japanese, 武田薬品工業株式会社, 神戸, Domestic conference
    Others

  • 大腸癌がん化学療法の新潮流2018
    Kakeji Yoshihiro
    Chugai Colorectal Cancer Symposium in Kobe, Feb. 2018, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 神経内分泌細胞成分を含む胃癌に対する集学的治療の有用性
    杉田 裕, Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第14回日本消化管学会総会学術集会, Feb. 2018, Japanese, 日本消化管学会, 東京, Domestic conference
    Public symposium

  • 下部消化管癌に対する内視鏡外科手術
    Kakeji Yoshihiro
    第14回日本消化管学会総会学術集会, Feb. 2018, Japanese, 日本消化管学会, 東京, Domestic conference
    Others

  • がん免疫療法の有効性と使いこなすための工夫～肺癌治療の経験から～
    Kakeji Yoshihiro
    消化器がん免疫療法セミナー, Feb. 2018, Japanese, 小野薬品株式会社,ブリストル・マイヤーズ スクイブ株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 特別講演I 消化器癌におけるPD-L1発現調整と免疫療法
    Kakeji Yoshihiro
    第17回神戸がん研究会, Jan. 2018, Japanese, 神戸がん研究会,日本イーライリリー株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 講演I、講演II
    Kakeji Yoshihiro
    Cancer VTEセミナー～がんと静脈血栓塞栓症～, Jan. 2018, Japanese, 第一三共株式会社, 神戸, Domestic conference
    Public discourse

  • 開会の辞
    Kakeji Yoshihiro
    第37回兵庫臨床栄養研究会, Jan. 2018, Japanese, 兵庫臨床栄養研究会,ＥＡファーマ株式会社,株式会社陽進堂, 神戸, Domestic conference
    Others

  • 『胃がん周術期の管理を支える栄養の役割』
    Kakeji Yoshihiro
    第37回兵庫臨床栄養研究会, Jan. 2018, Japanese, 兵庫臨床栄養研究会,ＥＡファーマ株式会社,株式会社陽進堂, 神戸, Domestic conference
    Others

  • 腹臥位食道癌手術における左右上縦隔郭清
    Oshikiri Taro, Nakamura Tetsu, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Yoshiko, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第30回日本内視鏡外科学会総会, Dec. 2017, Japanese, 日本内視鏡外科学会, 京都, Domestic conference
    Public symposium

  • 進行胃癌に対する腹腔鏡下胃切除術の短期、長期成績 開腹術との比較
    Kanaji Shingo, Suzuki Satoshi, 池田 太郎, Yamamoto Masashi, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第30回日本内視鏡外科学会総会, Dec. 2017, Japanese, 日本内視鏡外科学会, 京都, Domestic conference
    Public symposium

  • 術後腹膜炎が肺転移の予後に及ぼす影響とその免疫学的検討
    有本 聡, Hasegawa Hiroshi, Yamashita Kimihiro, 杉田 裕, 福岡 英志, 田中 智子, 西 将康, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第21回バイオ治療法研究会学術集会, Dec. 2017, Japanese, バイオ治療研究会, 福岡, Domestic conference
    Oral presentation

  • 腫瘍抗原導入DCGを用いた抗原特異的抗腫瘍免疫活性化
    西 将康, Yamashita Kimihiro, Hasegawa Hiroshi, 田中 智子, 有本 聡, 杉田 裕, 福岡 英志, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第21回バイオ治療法研究会学術集会, Dec. 2017, Japanese, バイオ治療研究会, 福岡, Domestic conference
    Oral presentation

  • 高齢者食道癌に対する胸腔鏡下手術成績の検討
    澤田 隆一郎, Nakamura Tetsu, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第30回日本内視鏡外科学会総会, Dec. 2017, Japanese, 日本内視鏡外科学会, 京都, Domestic conference
    Poster presentation

  • 外国人患者受入れ医療機関認証制度と患者用クリニカルパス
    Takaoka Yutaka, Yano Ikuko, 中町 祐司, 日下 亜紀子, 山本 育子, ウィリアムソン 彰子, 輪野 透, Kakeji Yoshihiro, Nishi Shinichi, Itoh Tomoo
    第17回日本クリニカルパス学会, Dec. 2017, Japanese, 日本クリニカルパス学会, 大阪, Domestic conference
    Poster presentation

  • 外国人患者受入れ医療機関認証制度と患者用クリニカルパス
    Takaoka Yutaka, Yano Ikuko, 中町 祐司, 日下 亜紀子, 山本 育子, ウィリアムソン 彰子, 輪野 透, Kakeji Yoshihiro, Nishi Shinichi, Itoh Tomoo
    第18回日本クリニカルパス学会学術集会, Dec. 2017, Japanese, 日本クリニカルパス学会, 大阪, Domestic conference
    Oral presentation

  • 横行結腸癌に対する腹腔鏡下手術における発生学的観点からみた至適切除範囲とアプローチ法について
    Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第30回日本内視鏡外科学会総会, Dec. 2017, Japanese, 日本内視鏡外科学会, 京都, Domestic conference
    Poster presentation

  • 胃がん治療の方向性
    Kakeji Yoshihiro
    Millennnial Seminar of GI Cancer, Dec. 2017, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • ヒト大腸上皮の分化過程における腫瘍抑制的マイクロRNAの協調的発現上昇
    Shimono Yohei, 久森 重夫, Piero Dalerba, 磯部 大地, 向山 順子, 渋谷 尚樹, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira
    2017年度生命科学系学会合同年次大会ConBio, Dec. 2017, English, 日本分子生物学会、日本生化学会, 兵庫（神戸）, Domestic conference
    Poster presentation

  • Closing Remarks
    Kakeji Yoshihiro
    Millennnial Seminar of GI Cancer, Dec. 2017, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • 理事直轄プロジェクト
    Kakeji Yoshihiro
    第28回日本消化器癌発生学会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Others

  • 理事直轄プロジェクト
    Kakeji Yoshihiro
    神戸外科フォーラム, Nov. 2017, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Others

  • 直腸癌術前化学放射線療法の腫瘍免疫因子の発現動態の解析
    Yamashita Kimihiro, 中川 暁雄, Matsuda Takeru, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第79回日本臨床外科学会総会, Nov. 2017, Japanese, 日本臨床外科学会, 東京, Domestic conference
    [Invited]
    Nominated symposium

  • 大腸癌化学療法 Late lineを再考する
    Kakeji Yoshihiro
    神戸大腸癌治療セミナー, Nov. 2017, Japanese, バイエル薬品株式会社, 神戸, Domestic conference
    Others

  • 食道扁平上皮癌微小環境におけるFAP陽性癌関連線維芽細胞の役割
    東野展英, 細野雅義, 岡本真生子, 土井雅之, 池田千浦子, 小平日実子, 市原有美, Nishio Mari, Shigeoka Manabu, Koma Yuichiro, Kakeji Yoshihiro, Yokozaki Hiroshi
    第28回日本消化器癌発生学会総会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Poster presentation

  • 食道・胃癌術前補助療法CR症例［手術 vs 経過観察］
    Kakeji Yoshihiro
    第79回日本臨床外科学会総会, Nov. 2017, Japanese, 日本臨床外科学会, 東京, Domestic conference
    [Invited]
    Nominated symposium

  • 上部胃癌に対する至適な切除術式と再建法
    Kakeji Yoshihiro
    第47回胃外科・術後障害研究会, Nov. 2017, Chinese, 胃外科・術後研究会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • 消化器癌患者におけるT細胞の刺激応答性の評価方法の検討
    田中 智子, Yamashita Kimihiro, 岡 祐馬, 森田 愛梨, 柳田 匡俊, 杉田 裕, 福岡 英志, 有本 聡, 西 将康, Hasegawa Hiroshi, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本消化器癌発生学会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Oral presentation

  • 術後腹膜炎が肺転移の予後に及ぼす影響とその免疫学的検討
    有本 聡, Hasegawa Hiroshi, Yamashita Kimihiro, 杉田 裕, 福岡 英志, 田中 智子, 西 将康, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本消化器癌発生学会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Oral presentation

  • 腫瘍再発モデルにおける末梢血中の骨髄由来抑制細胞（MDSC）の推移
    杉田 裕, 田中 智子, Yamashita Kimihiro, 福岡 英志, 有本 聡, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本消化器癌発生学会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Oral presentation

  • 腫瘍抗原導入DCGを用いた抗腫瘍免疫活性化の検討
    福岡 英志, Yamashita Kimihiro, 西 将康, 田中 智子, 有本 聡, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本消化器癌発生学会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Oral presentation

  • 高齢者進行胃癌症例治療成績からみた戦略
    Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第47回胃外科・術後障害研究会, Nov. 2017, Japanese, 胃外科・術後研究会, 横浜, Domestic conference
    Poster presentation

  • 高齢者の胃癌切除後における炎症に基づく予後予測スコアの有用性
    Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第79回日本臨床外科学会総会, Nov. 2017, Japanese, 日本臨床外科学会, 東京, Domestic conference
    Oral presentation

  • Experience of Neoadjuvant Chemoradiotherapy for locally advanced rectal cancer
    井上 由子, Yoshida Kenji, Miyawaki Daisuke, Uezono Haruka, Ishihara Takeaki, 西川 遼, 妹尾 悟史, Kakeji Yoshihiro, Sasaki Ryohei
    日本放射線腫瘍学会第30回学術大会, Nov. 2017, Japanese, 日本放射線腫瘍学会, 大阪, Domestic conference
    Oral presentation

  • 癌微小環境における腫瘍関連マクロファージ由来のCXCL8はヒト食道扁平上皮癌の運動能および浸潤能を促進する
    細野雅義, 東野展英, 岡本真生子, 土井雅之, 小平日実子, 市原有美, Nishio Mari, Shigeoka Manabu, 狛雄一郎, Yokozaki Hiroshi, Kakeji Yoshihiro
    第28回日本消化器癌発生学会, Nov. 2017, Japanese, 日本消化器癌発生学会, 熊本, Domestic conference
    Others

  • CXCL8 derived from TAMs promotes cell migration and invasion of human esophageal cancer cells
    細野雅義, 東野展英, 岡本真生子, 土井雅之, 小平日実子, 市原有美, Nishio Mari, Shigeoka Manabu, Koma Yuichiro, Yokozaki Hiroshi, Kakeji Yoshihiro
    第28回日本消化器癌発生学会総会, Nov. 2017, English, 日本消化器癌発生学会, 熊本, Domestic conference
    [Invited]
    Invited oral presentation

  • 開会挨拶
    Kakeji Yoshihiro
    第1回神戸消化器学術講演会, Nov. 2017, Japanese, ミヤリサン製薬株式会社, 神戸, Domestic conference
    Others

  • 『大腸癌鏡視下手術における発生と解剖に基づいたアプローチ』
    Kakeji Yoshihiro
    第1回神戸消化器学術講演会, Nov. 2017, Japanese, ミヤリサン製薬株式会社, 神戸, Domestic conference
    Others

  • Stage IV胃癌に対するconversion surgeryの適応と治療成績
    原田 仁, Kanaji Shingo, 鈴木, 知志, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第79回日本臨床外科学会総会, Nov. 2017, Japanese, 日本臨床外科学会, 東京, Domestic conference
    Public symposium

  • 閉塞性大腸癌に対する術前大腸ステント留置の有用性の検討
    前原 律子, Sumi Yasuo, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 内視鏡的粘膜下層剥離術後非治癒切除症例に対する食道切除の意義とその役割
    小寺澤 康文, Nakamura Tetsu, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • 大腸ESD後穿孔症例に対するクリッピング閉鎖の有効性について
    杉田 裕, Hasegawa Hiroshi, Matsuda Takeru, Yamashita Kimihiro, Sumi Yasuo, 前原 律子, 東野 展英, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 早期胃癌に対するESD後の追加外科切除症例の検討
    秋山 真吾, Kanaji Shingo, 石田 諒, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 進化する胃癌周術期化学療法
    Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    [Invited]
    Invited oral presentation

  • 食道切除術におけるSurgical Apgar Scoreの有用性の検討
    中川 暁雄, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 十二指腸腫瘍に対する腹腔鏡内視鏡合同手術の手術成績の検討
    永田 真知子, Kanaji Shingo, Morita Yoshinori, 音羽 泰則, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Toyonaga Takashi, Suzuki Satoshi, Azuma Takeshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 高齢者食道癌における術前補助化学療法の検討
    澤田 隆一郎, Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • 高齢者食道癌における胸腔鏡下手術に関する検討（優秀演題）
    澤田 隆一郎, Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 高齢者胃癌の術後合併症発生の予測因子としてのCONUT scoreの有用性
    Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 高齢者の胃癌切除症例における術前末梢血の白血球系細胞数の臨床的意義
    多田羅 敬, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 高齢者の胃癌切除後における炎症に基づく予後予測スコアの有用性
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Hasegawa Hiroshi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Oral presentation

  • 回腸双孔式人工肛門閉鎖における創部線状縫合閉鎖と巾着縫合閉鎖の比較
    Hasegawa Hiroshi, Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • 医師主導臨床試験グループが果たす役割：KSCCにおける取り組み
    沖 英次, 佐伯 浩司, 牧山 明資, 坂本 佐奈枝, Kakeji Yoshihiro, 赤木 由人, 馬場 秀夫, 前原 喜彦
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • 胃癌腹膜播種に対しての化学療法
    Kakeji Yoshihiro
    第55回日本癌治療学会学術集会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • 胃がん治療のパラダイムシフト ～がん免疫療法の到来～
    Kakeji Yoshihiro
    第55回日本癌治療学会学術集会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Public discourse

  • 『大腸癌のOS延長を目指した最適な治療戦略とは?（仮）』
    Kakeji Yoshihiro
    Chugai Colorectal Cancer Symposium in HYOGO, Oct. 2017, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • Stage IV胃癌への新たな治療戦略
    Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • Stage IV胃癌に対するconversion surgeryの適応と治療成績
    原田 仁, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, Japanese, 日本消化器関連学会機構, 福岡, Domestic conference
    Poster presentation

  • HER2陽性胃癌に対するトラスツズマブ併用療法の多施設共同コホート研究(KSCC1105)
    岩槻 政晃, 牧山 明資, 柏田 知美, 高橋 郁雄, 江見 泰徳, 楠本 哲也, 山本 一治, 石川 啓, 根来 裕二, 下瀬 堯之, 沖 英次, 佐伯 浩司, Kakeji Yoshihiro, 馬場 秀夫, 前原 喜彦
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • cStageII/III胃癌に対する術前化学療法の有用性
    Matsuda Yoshiko, 三浦 由紀子, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • Clinical outcomes of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for lower rectal cancer
    Matsuda Takeru, Sumi Yasuo, Kakeji Yoshihiro
    JDDW2017, Oct. 2017, English, 日本消化器関連学会機構, 福岡, Domestic conference
    Public symposium

  • 70歳以上の結腸・直腸癌患者に対するTFTD(TAS-102)とBevacizumabの第II相臨床試験
    沖 英次, 佐伯 浩司, 牧山 明資, 中西 良太, Kakeji Yoshihiro, 赤木 由人, 馬場 秀夫, 前原 喜彦
    第55回日本癌治療学会学術総会, Oct. 2017, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Public discourse

  • 膵臓側に局在が及ぶ十二指腸腫瘍に対する腹腔鏡・内視鏡合同手術
    永田 真知子, Kanaji Shingo, Morita Yoshinori, 河原 史朗, Yamamoto Masashi, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第30回近畿内視鏡外科研究会, Sep. 2017, Japanese, 近畿内視鏡外科研究会, 大阪, Domestic conference
    Public symposium

  • 閉会の挨拶
    Kakeji Yoshihiro
    大腸癌フォーラム in Hyogo 2017, Sep. 2017, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Others

  • 腹腔鏡下食道亜全摘術を施行した食道炎症性腫瘤の1例
    澤田 隆一郎, Oshikiri Taro, 小寺澤 康文, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第30回近畿内視鏡外科研究会, Sep. 2017, Japanese, 近畿内視鏡外科研究会, 大阪, Domestic conference
    Oral presentation

  • 腹腔鏡下胃切除後にPetersen's herniaをきたした3例
    岡本 柊志, Yamamoto Masashi, Kanaji Shingo, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第30回近畿内視鏡外科研究会, Sep. 2017, Japanese, 近畿内視鏡外科研究会, 大阪, Domestic conference
    Oral presentation

  • 特別講演 進行再発大腸癌の化学療法～マネージメントのコツ～
    Kakeji Yoshihiro
    第10回神戸消化器癌勉強会, Sep. 2017, Japanese, 株式会社ヤクルト, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 当科におけるTAMIS併用直腸癌手術の経験と今後の課題
    Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第30回近畿内視鏡外科研究会, Sep. 2017, Japanese, 近畿内視鏡外科研究会, 大阪, Domestic conference
    Public symposium

  • 低酸素環境におけるMCM7 ｍRNA発現レベルの乖離
    Shimono Yohei, 近藤 弘基, 向山 順子, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira
    第76回日本癌学会学術総会, Sep. 2017, Japanese, 日本癌学会, 横浜, Domestic conference
    Poster presentation

  • 術前診断し腹腔鏡下小腸部分切除術をおこなった小腸血管腫の1例
    石田 苑子, Hasegawa Hiroshi, Matsuda Takeru, Yamashita Kimihiro, 福岡 裕貴, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第200回近畿外科学会, Sep. 2017, Japanese, 近畿外科学会, 京都, Domestic conference
    Oral presentation

  • 術前化学放射線療法を施行した局所進行肛門管癌に対して有茎腹直筋皮弁再建が有用であった1例
    池田 太郎, Matsuda Takeru, 福岡 英志, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第200回近畿外科学会, Sep. 2017, Japanese, 近畿外科学会, 京都, Domestic conference
    Oral presentation

  • 開会挨拶
    Kakeji Yoshihiro
    第16回兵庫胃がん治療研究会, Sep. 2017, Japanese, 兵庫胃がん治療,兵庫県がん診療連携協議会,大鵬薬品株式会社, 神戸, Domestic conference
    Others

  • 回腸ストマ閉鎖における創部環状閉鎖と線上閉鎖との比較
    Hasegawa Hiroshi, Matsuda Takeru, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第200回近畿外科学会, Sep. 2017, Japanese, 近畿外科学会, 京都, Domestic conference
    Oral presentation

  • 炎症性食道腫瘤の1例
    澤田 隆一郎, Oshikiri Taro, 小寺澤 康文, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第200回近畿外科学会, Sep. 2017, Japanese, 近畿外科学会, 京都, Domestic conference
    Oral presentation

  • 「観察性能の進化がもたらす最新の手術手技～腹腔鏡下消化管手術のUp to Date～」
    Kakeji Yoshihiro
    第30回近畿内視鏡外科研究会, Sep. 2017, Japanese, 近畿内視鏡外科研究会, 大阪, Domestic conference
    [Invited]
    Invited oral presentation

  • ヒト上皮分化プログラムの解析に基づく癌幹細胞抑制マイクロRNAの固定
    久森 重夫, 磯部 大地, 向山 順子, 渋谷 尚樹, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira
    第76回日本癌学会学術総会, Sep. 2017, Japanese, 日本癌学会, 横浜, Domestic conference
    Oral presentation

  • イレウス症状を呈し腹腔鏡下に切除した小腸神経内分泌腫瘍の1例
    福岡 裕貴, Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, 福岡 英志, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第30回近畿内視鏡外科研究会, Sep. 2017, Japanese, 近畿内視鏡外科研究会, 大阪, Domestic conference
    Oral presentation

  • アフタヌーンセミナー「進歩する胃がんの治療」
    Kakeji Yoshihiro
    第200回近畿外科学会, Sep. 2017, Japanese, 近畿外科学会, 京都, International conference
    [Invited]
    Invited oral presentation

  • miR-221-QKI5経路による大腸癌幹細胞の制御機構の解明
    Shimono Yohei, 磯部 大地, 渋谷 尚樹, 胡 慶江, Yamashita Kimihiro, 三森 功士, Minami Hironobu, Kakeji Yoshihiro, Suzuki Akira
    第76回日本癌学会学術総会, Sep. 2017, Japanese, 日本癌学会, 横浜, Domestic conference
    Oral presentation

  • miR-221-QKI5 axis regulates tumorigenicity of human colorectal cancer stem cells
    向山 順子, Shimono Yohei, 磯部 大地, Qingjiang Hu, 渋谷 尚樹, Yamashita Kimihiro, 三森 功士, Minami Hironobu, Kakeji Yoshihiro, Suzuki Akira
    第76回日本癌学会学術総会, Sep. 2017, Japanese, 日本癌学会, 神奈川（横浜）, Domestic conference
    Oral presentation

  • Identification of cancer-stem-cell-suppressor microRNAs through the analyses of human epithelial differentiation program
    Shimono Yohei, 久森 重夫, 磯部 大地, 向山 順子, 渋谷 尚樹, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira
    第76回日本癌学会学術総会, Sep. 2017, English, 日本癌学会, 神奈川（横浜）, Domestic conference
    Oral presentation

  • Discordance of MCM7 mRNA and its intronic microRNA levels under hypoxia
    渋谷 尚樹, Shimono Yohei, 近藤 弘基, 向山 順子, 田中 康照, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira
    第76回日本癌学会学術総会, Sep. 2017, Japanese, 日本癌学会, 神奈川（横浜）, Domestic conference
    Poster presentation

  • Closing Lecture
    Kakeji Yoshihiro
    兵庫大腸癌治療フォーラム, Sep. 2017, Japanese, 武田薬品, 神戸, Domestic conference
    Others

  • 右側結腸癌に対するReduced port Surgeryの短期成績について
    Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    6th Reduced Port Surgery Forum 2017 in Oita、第11回 単孔式内視鏡手術研究会、第17回 Needlescopic Surgery Meeting, Aug. 2017, Japanese, 単孔式内視鏡手術研究会, 大分, Domestic conference
    Oral presentation

  • Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer
    E.Fukuoka, Matsuda Yoshiko, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, M.Yamamoto, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, T.Nakamura, Suzuki Satoshi, Kakeji Yoshihiro
    日本・モンゴル国際消化器がんシンポジウム, Aug. 2017, English, 中山がん研究所, ウランバートル, モンゴル, International conference
    Oral presentation

  • Laparoscopic complete mesocolic excision for splenic flexure cancer based on embryology
    Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, M.Yamamoto, Y.Mastuda, Kanaji Shingo, Oshikiri Taro, T.Nakamura, Suzuki Satoshi, Kakeji Yoshihiro
    日本・モンゴル国際消化器がんシンポジウム, Aug. 2017, English, 中山がん研究所, ウランバートル, モンゴル, International conference
    Oral presentation

  • Comparison of two-and three-dimensional display for performance of laparoscopic total gastrectomy for gastric cancer
    Kanaji Shingo, Suzuki Satoshi, M.Yamamoto, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, T.Nakamura, Kakeji Yoshihiro
    日本・モンゴル国際消化器がんシンポジウム, Aug. 2017, English, 中山がん研究所, ウランバートル, モンゴル, Domestic conference
    Oral presentation

  • 要望演題19(1) 消化器疾患に関する最新の臨床研究1
    Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Others

  • 本邦における胃癌に対する腹腔鏡下手術成績に関する後ろ向き調査研究
    吉田 和弘, 隈丸 拓, 小寺 泰弘, Kakeji Yoshihiro, 今野 弘之, 宮田 裕章, 後藤 満一, 瀬戸 泰之
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    [Invited]
    Invited oral presentation

  • 閉塞性大腸癌に対するステント留置の有用性
    前原 律子, Sumi Yasuo, Hasegawa Hiroshi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 腹腔鏡下幽門側胃切除術における術前CT画像を用いた手術時間を予測する簡便な指標に関する検討
    安田 貴志, Kanaji Shingo, Oshikiri Taro, Yamamoto Masashi, Nakamura Tetsu, Suzuki Satoshi, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 特別講演「胃癌治療の最近の話題と今後の展望」
    Kakeji Yoshihiro
    Meet the Professor on Gastric Cancer, Jul. 2017, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • 当院における進行下部直腸癌に対する側方リンパ節郭清について
    Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Public symposium

  • 大腸癌に対する周術期化学療法
    Kakeji Yoshihiro
    第4回平成大腸癌カンファレンス, Jul. 2017, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • 大腸ESD後穿孔症例に対するクリッピング閉鎖の有効性の検討
    前原 律子, Matsuda Takeru, Hasegawa Hiroshi, Yamashita Kimihiro, Sumi Yasuo, Kakeji Yoshihiro
    第87回大腸癌研究会, Jul. 2017, Japanese, 大腸癌研究会, 四日市, Domestic conference
    Oral presentation

  • 食道癌手術におけるSurgical Apgar Scoreと合併症予測因子
    中川 暁雄, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Public symposium

  • 食道癌cStageII/IIIで術前補助化学療法を施行した症例におけるCRP/Albの有用性
    音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 消化器外科関連分野のNCDの現状と展望
    宮田 裕章, Kakeji Yoshihiro, 今野 弘之, 後藤 満一, 岩中 督, 瀬戸 泰之
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    [Invited]
    Invited oral presentation

  • 消化器外科におけるNCDを活用した研究課題の成果と今後の展開
    Kakeji Yoshihiro, 後藤 満一, 今野 弘之, 宮田 裕章, 瀬戸 泰之
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    [Invited]
    Invited oral presentation

  • 術前抗血栓療法中の胃切除患者に対する周術期抗血栓療法の検討
    原田 仁, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 術前化学放射線療法施行直腸癌における免疫関連因子の発現動態の検討
    中川 暁雄, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第87回大腸癌研究会, Jul. 2017, Japanese, 大腸癌研究会, 四日市, Domestic conference
    Oral presentation

  • 周術期腹膜炎に伴う免疫抑制メカニズムの解明と治療:マウスモデルでの検討
    Hasegawa Hiroshi, 有本 聡, Yamashita Kimihiro, Kanaji Shingo, 西 将康, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 高齢者胃癌手術後の予後予測におけるCONUT scoreの有効性
    Suzuki Satoshi, Kanaji Shingo, Matsuda Yoshiko, Yamamoto Masashi, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 血管吻合付有茎空腸再建術の工夫と治療成績
    Nakamura Tetsu, Matsuda Yoshiko, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Public symposium

  • 局所進行直腸癌における術前化学放射線療法後のPD-L1発現の変化
    Yamashita Kimihiro, 中川 暁雄, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 胸腔鏡下食道切除術における術後合併症と予後との検討
    三浦 由紀子, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • The role of cancer microenvironment in growth, invasion, and metastasis of cancer
    細野雅義, 東野展英, Nishio Mari, Shigeoka Manabu, Koma Yuichiro, Yokozaki Hiroshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, English, 日本消化器外科学会, 金沢, Domestic conference
    [Invited]
    Nominated symposium

  • 癌微小環境における腫瘍関連マクロファージ由来のIL-8はヒト食道扁平上皮癌の運動能および浸潤能を促進する
    細野雅義, 東野展英, Nishio Mari, Shigeoka Manabu, KOMA YUICHIRO, Yokozaki Hiroshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 化学療法施行後に手術を行った高度進行胃癌の検討
    Matsuda Yoshiko, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 胃GISTに対するLECS(laparoscopy and endoscopy cooperative surgery)により切除された胃壁長の検討
    Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    Oral presentation

  • 「患者負担の少ない癌手術と化学療法へのサポーティブケア」
    Kakeji Yoshihiro
    第72回日本消化器外科学会総会, Jul. 2017, Japanese, 日本消化器外科学会, 金沢, Domestic conference
    [Invited]
    Invited oral presentation

  • ランチョンセミナー 胃癌・大腸癌における血管新生のメカニズムと治療
    Kakeji Yoshihiro
    第26回日本がん転移学会学術集会・総会, Jul. 2017, Japanese, 日本がん転移学会, 大阪, Domestic conference
    [Invited]
    Invited oral presentation

  • ポスター Colorectal Cancer3 大腸3
    Kakeji Yoshihiro
    第15回日本臨床腫瘍学会学術集会, Jul. 2017, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference
    Others

  • Expression of programmed death-1 (PD-1) in sentinel lymph nodes of breast cancer
    多田羅 敬, Shimono Yohei, 山崎 隆, Toyoda Masanori, Kiyota Naomi, 高尾 信太朗, Kono Seishi, Kakeji Yoshihiro, Minami Hironobu
    第15回日本臨床腫瘍学会学術集会, Jul. 2017, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference
    Oral presentation

  • 腹腔鏡下食道癌手術手技の施設内統一と成績
    Oshikiri Taro, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本食道学会学術集会, Jun. 2017, Japanese, 日本食道学会, 軽井沢, Domestic conference
    Poster presentation

  • 内視鏡的粘膜下層剥離術後非治療切除症例に対する食道切除の意義とその役割
    小寺澤 康文, Nakamura Tetsu, 福岡 英志, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第26回癌病態治療研究会, Jun. 2017, Japanese, 日本癌病態治療研究会, 横浜, Domestic conference
    Public symposium

  • 大腸がん幹細胞におけるマイクロRNA-221の特異的発現
    渋谷 尚樹, 向山 順子, 磯部 大地, 近藤 弘基, 向原 徹, Kakeji Yoshihiro, Minami Hironobu, Shimono Yohei, Suzuki Akira
    第27回日本サイトメトリー学会学術集会, Jun. 2017, Japanese, 日本サイトメトリー学会, 神戸, Domestic conference
    Oral presentation

  • 人工癌幹細胞と癌オルガノイドを用いた癌幹細胞研究
    Aoi Takashi, 石田 諒, Ogawa Hiroyuki, Aoi Michiyo, Kakeji Yoshihiro, Maniwa Yoshimasa
    第27回日本サイトメトリー学会学術集会, Jun. 2017, Japanese, 日本サイトメトリー学会, 神戸, Domestic conference
    [Invited]
    Nominated symposium

  • 食道非上皮性腫瘍の術前診断とその有用性
    青木 丈明, Nakamura Tetsu, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本食道学会学術集会, Jun. 2017, Japanese, 日本食道学会, 軽井沢, Domestic conference
    Public symposium

  • 食道癌同時性重複癌症例に対する同時手術治療症例の検討
    Nakamura Tetsu, 音羽 泰則, 澤田 隆一郎, 青木 丈明, Kanaji Shingo, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本食道学会学術集会, Jun. 2017, Japanese, 日本食道学会, 軽井沢, Domestic conference
    Poster presentation

  • 食道癌手術における呼吸器合併症の低減を目指したmultidisciplinary team manegement
    渋谷 尚樹, Nakamura Tetsu, Oshikiri Taro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第42回日本外科系連合学会学術集会, Jun. 2017, Japanese, 日本外科系連合学会, 徳島, Domestic conference
    Public symposium

  • 術前化学放射線療法を施行した進行直腸癌におけるmodified Glasgow Prognostic Scoreを用いた治療効果予測
    福岡 英志, Yamashita Kimihiro, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回癌病態治療研究会, Jun. 2017, Japanese, 日本癌病態治療研究会, 横浜, Domestic conference
    Public symposium

  • 腫瘍抗原導入DCGを用いた抗腫瘍免疫活性化の検討
    西 将康, Yamashita Kimihiro, Hasegawa Hiroshi, 田中 智子, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本サイトメトリー学会学術集会, Jun. 2017, Japanese, 日本サイトメトリー学会, 神戸, Domestic conference
    Oral presentation

  • 主題「再発癌に対する局所療法」
    Kakeji Yoshihiro
    第39回日本癌局所療法研究会, Jun. 2017, Japanese, 日本癌局所療法研究会, 京都, Domestic conference
    Others

  • 高齢者食道癌に対する腹腔鏡下手術の治療成績の検討
    澤田 隆一郎, Nakamura Tetsu, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本食道学会学術集会, Jun. 2017, Japanese, 日本食道学会, 軽井沢, Domestic conference
    Poster presentation

  • 高齢者食道癌に対する鏡視下手術の役割
    Kakeji Yoshihiro
    第60回関西胸部外科学会学術集会, Jun. 2017, Japanese, 日本胸部外科学会, 大阪, Domestic conference
    Others

  • 高齢者食道癌に対する胸腔鏡下手術の治療成績の検討
    澤田 隆一郎, Nakamura Tetsu, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第60回関西胸部外科学会学術集会, Jun. 2017, Japanese, 日本胸部外科学会, 大阪, Domestic conference
    Public symposium

  • 局所進行直腸癌術前化学放射線療法の免疫チェクポイント分子の変化
    Yamashita Kimihiro, 中川 暁雄, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回癌病態治療研究会, Jun. 2017, Japanese, 日本癌病態治療研究会, 横浜, Domestic conference
    Public symposium

  • 教育講演「個別化がん医療に向けたヒト腫瘍モデルの新たな展開」
    Kakeji Yoshihiro
    第27回日本サイトメトリー学会学術集会, Jun. 2017, Japanese, 日本サイトメトリー学会, 神戸, Domestic conference
    Public discourse

  • 一般演題 口演1 頭頸部食道癌の治療
    Kakeji Yoshihiro
    第71回日本食道学会学術集会, Jun. 2017, Japanese, 日本食道学会, 軽井沢, Domestic conference
    Others

  • 「Conversion surgeryの適応と治療成績」
    Kakeji Yoshihiro
    第26回癌病態治療研究会, Jun. 2017, Japanese, 日本癌病態治療研究会, 横浜, Domestic conference
    Others

  • ワークショップ4 多施設共同研究を進めるためのチームネットワーク
    Kakeji Yoshihiro
    第42回日本外科系連合学会学術集会, Jun. 2017, Japanese, 日本外科系連合学会, 徳島, Domestic conference
    Others

  • Tmab+XP療法が著効しConversion surgeryを施行した胃癌腹膜播種の一例
    松田 佑輔, Suzuki Satoshi, Matsuda Yoshiko, Kanaji Shingo, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第39回日本癌局所療法研究会, Jun. 2017, Japanese, 日本癌局所療法研究会, 京都, Domestic conference
    Oral presentation

  • Stage IV胃癌に対するConversion surgeryの適応と治療成績
    原田 仁, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第26回癌病態治療研究会, Jun. 2017, Japanese, 日本癌病態治療研究会, 横浜, Domestic conference
    Public symposium

  • Single incision laparoscopic colectomy for colon cancer in a patient with situs inversus totalis;A case report
    Tanaka.T.Sumi.Y, Yamamoto.M, Hasegawa Hiroshi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura.T, Suzuki Satoshi, Kakeji Yoshihiro
    第25回欧州内視鏡外科会議（EAES）, Jun. 2017, English, EAES, フランクフルト, ドイツ, International conference
    Poster presentation

  • S-1/CDDP療法後に手術を施行し長期予後を得ている腹膜播種陽性胃癌の1例
    Matsuda Yoshiko, Nakamura Tetsu, 植田 康司, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第39回日本癌局所療法研究会, Jun. 2017, Japanese, 日本癌局所療法研究会, 京都, Domestic conference
    Oral presentation

  • Next generation laparoscopic surgery using EMARO（Endoscopic Manipulator Robot）and a 3D endoscope system
    Sumi Yasuo, Matsuda Takeru, Hasegawa Hiroshi, Yamashita Kimihiro, Miura Yasushi, Yamamoto.M, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, Nakamura.T, Suzuki Satoshi, Kakeji Yoshihiro
    第25回欧州内視鏡外科会議（EAES）, Jun. 2017, English, EAES, フランクフルト, ドイツ, International conference
    Poster presentation

  • Embryological consideration of laparoscopic complete
    Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Sumi Yasuo, Yamamoto.M, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura.T, Suzuki Satoshi, Kakeji Yoshihiro
    第25回欧州内視鏡外科会議（EAES）, Jun. 2017, English, EAES, フランクフルト, ドイツ, International conference
    Oral presentation

  • Comparison of operative skill using two -and three-dimensional monitor during laparoscopic phantom tasks by the position tracker
    Nishi.M, Kanaji Shingo, Harada.H, Hasegawa Hiroshi, Yamamoto.M, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura.T, Suzuki Satoshi, Kakeji Yoshihiro
    第25回欧州内視鏡外科会議（EAES）, Jun. 2017, English, EAES, フランクフルト, ドイツ, International conference
    Poster presentation

  • B16F10細胞を用いた再発モデルにおける末梢血中MDSCの経時的測定の有用性
    田中 智子, Yamashita Kimihiro, 有本 聡, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本サイトメトリー学会学術集会, Jun. 2017, Japanese, 日本サイトメトリー学会, 神戸, Domestic conference
    Oral presentation

  • A randomized phase II study evaluating efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy for patients with resectable rectal cancer(KSCC1301).(abstract3549)
    M.Sugiyama, H.murakami, Hasegawa Hiroshi, Mori Shunpei, G.Nakayama, H.Saeki, M.Shimokawa, Kakeji Yoshihiro, Baba Hisamitsu, Y.Akagi, Y.Maehara
    ASCO2017 ANNUAL MEETING, Jun. 2017, Japanese, ASCO, シカゴ, アメリカ, Domestic conference
    Poster presentation

  • 鉗子操作の3次元軌跡解析を用いた内視鏡外科手術の適正評価法の開発と技術評価が学習効果に及ぼす影響に関する研究
    Kanaji Shingo, 原田 仁, 西 将康, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第71回手術手技研究会, May 2017, Japanese, 手術手技研究会, 名古屋, Domestic conference
    Others

  • 腹腔鏡下胃癌手術～術後化学療法の実践まで
    Kakeji Yoshihiro
    Gastric Cancer Symposium in Kobe, May 2017, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Others

  • 特別講演「九州大学第二外科における臨床と研究」
    Kakeji Yoshihiro
    神戸大腸がんセミナー, May 2017, Japanese, メルクセローノ株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 直腸癌における腫瘍免疫関連因子の発現動態と化学療法前後の腫瘍浸潤CD8陽性T細胞の発現の変化と組織学的効果判定の関連の検討
    中川 暁雄, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第38回癌免疫外科研究会, May 2017, Japanese, 癌免疫外科研究会, 倉敷, Domestic conference
    Oral presentation

  • 胆癌状態における腫瘍誘導性骨髄由来抑制細胞（MDSC）を与える影響
    田中 智子, Yamashita Kimihiro, 有本 聡, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第38回癌免疫外科研究会, May 2017, Japanese, 癌免疫外科研究会, 倉敷, Domestic conference
    Oral presentation

  • 大動脈食道瘻手術における消化器外科医の役割‐食道切除と再建を中心に‐
    Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    第71回手術手技研究会, May 2017, Japanese, 手術手技研究会, 名古屋, Domestic conference
    Oral presentation

  • 穿孔性腹膜炎が肺転移の予後に及ぼす影響とその免疫学的検討
    有本 聡, 西 将康, Hasegawa Hiroshi, 田中 智子, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第38回癌免疫外科研究会, May 2017, Japanese, 癌免疫外科研究会, 倉敷, Domestic conference
    Oral presentation

  • 進行横行結腸癌に対する頭側アプローチによる腹腔鏡下拡大結腸右半切除術
    Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回手術手技研究会, May 2017, Japanese, 手術手技研究会, 名古屋, Domestic conference
    Oral presentation

  • 上部消化管の高悪性度神経内分泌腫瘍 26例の検討
    友野 絢子, Suzuki Satoshi, 裏川 直樹, 松本 晶子, 大坪 出, 美田 良保, 光辻 理顕, 佐溝 政広, 和田 隆宏, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, May 2017, Japanese, 日本外科学会, 神戸, Domestic conference
    Others

  • 十二指腸腫瘍に対する腹腔鏡内視鏡合同手術‐当科における手技の工夫と治療成績‐
    三浦 由紀子, Kanaji Shingo, Morita Yoshinori, 音羽 泰則, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, 富永 高史, Suzuki Satoshi, Azuma Takeshi, Kakeji Yoshihiro
    第71回手術手技研究会, May 2017, Japanese, 手術手技研究会, 名古屋, Domestic conference
    Oral presentation

  • 腫瘍抗原導入DCGを用いた抗原特異的な抗腫瘍免疫活性化
    西 将康, Yamashita Kimihiro, Hasegawa Hiroshi, 田中 智子, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第38回癌免疫外科研究会, May 2017, Japanese, 癌免疫外科研究会, 倉敷, Domestic conference
    Oral presentation

  • 癌局所微小環境（主題II）
    Kakeji Yoshihiro
    第38回癌免疫外科研究会, May 2017, Japanese, 癌免疫外科研究会, 倉敷, Domestic conference
    [Invited]
    Nominated symposium

  • Closing Remarks
    Kakeji Yoshihiro
    神戸大学消化器癌セミナー, May 2017, Japanese, 日本イーライリリー株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 腹腔鏡下幽門側胃切除術における簡便な手術難易度を示す指標に関する検討
    後藤 裕信, 安田 貴志, Kanaji Shingo, Oshikiri Taro, Yamamoto Masashi, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 腹腔鏡下右側結腸切除術においてReduced Port Surgeryをいかに教育するか?
    Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, 三浦 由紀子, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 腹腔鏡下S状結腸・直腸癌における下腸間膜動脈high ligationの重要性
    Hasegawa Hiroshi, Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, 山下 博成, 大山 正人, 大村 典子, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, 藤野 泰宏, 富永 正寛, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 動作解析システムを用いた3D腹腔鏡下での手術手技の検討
    西 将康, Kanaji Shingo, 原田 仁, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 当院における腹腔鏡下胃全摘術における食道空腸吻合法の検討
    多田羅 敬, Kanaji Shingo, Suzuki Satoshi, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 直腸癌の術前化学放射線療法施行例における免疫関連因子の検討
    中川 暁雄, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 担癌状態におけるmyeloid derived suppressor cellsの治療による変化と治療成績への影響
    田中 智子, Yamashita Kimihiro, 有本 聡, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 大腸ESD後穿孔症例に対するクリッピング閉鎖の有用性について
    前原 律子, Sumi Yasuo, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Tanaka Shinwa, 森田 佳紀, 富永 高史, Umegaki Eiji, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 大腸ESD後穿孔症例に対するクリッピング閉鎖の有効性について
    前原 律子, Sumi Yasuo, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Tanaka Shinwa, 森田 佳紀, Toyonaga Takashi, Umegaki Eiji, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 食道癌手術のパラダイム・シフト－側臥位から腹臥位へ－
    大坪 大, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, 安田 貴志, 今西 達也, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, 千堂 宏義, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 食道胃接合部癌Siewert II型に対する下縦隔立体構造を意識した腹腔鏡下リンパ節郭清と逆流防止を意識した偽His角・fornix形成を伴う食道胃管吻合法
    裏川 直樹, Kanaji Shingo, 音羽 泰則, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 食道・胃接合部癌の集学的治療
    Kakeji Yoshihiro, Kanaji Shingo, 原田 仁, 裏川 直樹, Yamamoto Masashi, Suzuki Satoshi
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Others

  • 消化器外科医からみた大動脈食道瘻の治療戦略
    Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, 高橋 宏明, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Inoue Takeshi, Suzuki Satoshi, Sumi Yasuo, Tanaka Hiroshi, Okita Yutaka, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 根治切除を施行したpStageII-III胃癌に対するS-1術後補助化学療法
    Matsuda Yoshiko, 三浦 由紀子, 松田 佑輔, 後藤 裕信, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 高齢者食道癌に対する術前補助化学療法の治療成績
    澤田 隆一郎, Nakamura Tetsu, 三浦 由紀子, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 呼吸器合併症低減をめざした食道癌手術とmultidisciplinary team management
    渋谷 尚樹, Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 血流に配慮した食道再建術の工夫
    瀧口 豪介, Nakamura Tetsu, 三浦 由紀子, 松田 佑輔, 後藤 裕信, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 胸腔鏡下食道癌手術症例における術後合併症の発生と予後の検討
    三浦 由紀子, Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 患者左右から攻略する腹腔鏡下膵上縁D2郭清
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 下部直腸癌の鼠径リンパ節転移に対する術前化学放射線療法の有用性
    Yamashita Kimihiro, Sumi Yasuo, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 胃癌肝転移の外科治療の問題点
    Suzuki Satoshi, 金光 聖哲, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, 後藤 裕信, 松田 佑輔, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 胃癌ESD後の腹腔鏡下胃切除による追加治療
    石田 諒, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 胃・十二指腸腫瘍に対するLECS(laparoscopy and endoscopy cooperative surgery)
    Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • 胃GISTに対する腹腔鏡下胃切除の有用性
    古出 隆大, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • ランチョンセミナー（30）胃癌薬物療法の課題と展望
    Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Others

  • ディベート（3）cStageI上部胃癌の術式選択－噴門部胃切除 vs 胃全摘－
    Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Others

  • Stage IV胃癌に対するConversion surgeryの適応
    音羽 泰則, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, 原田 仁, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Poster presentation

  • Detection of EBV BamHI W region in surgical cancer specimens is a useful method to evaluate the risk of lymphomagenesis inpatient derived-tumor xenograft.
    Junko Mukohyama, Dai Iwakiri, Zen Yoh, Toru Mukohara, Minami Hironobu, Kakeji Yoshihiro, Shimono Yohei
    Annual Meeting of the American Association for Cancer Research 2017, Apr. 2017, English, American Association for Cancer Research, Washington DC, USA, International conference
    Poster presentation

  • 3Dモニターが初心者の内視鏡外科修練にもたらす影響
    原田 仁, Kanaji Shingo, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第117回日本外科学会定期学術集会, Apr. 2017, Japanese, 日本外科学会, 横浜, Domestic conference
    Oral presentation

  • 3D culture may better represent trastuzumab resistance associated with PIK3CA mutation than 2D culture.
    Takashi Tatara, Toru Mukohara, Rina Tanaka, Shimono Yohei, Toyoda Masanori, Kiyota Naomi, Hirai Midori, Kakeji Yoshihiro, Minami Hironobu
    Annual Meeting of the American Association for Cancer Research 2017, Apr. 2017, English, American Association for Cancer Research, Washington DC, USA, International conference
    Poster presentation

  • 直接接触相互作用によるスキルス胃癌細胞の浸潤と間質線維芽細胞の増殖促進
    東野展英, Koma Yuichiro, 細野雅義, 高瀬信尚, 小平日実子, 岡本真生子, 土井雅之, Shigeoka Manabu, Nishio Mari, 八代正和, 平川弘聖, 栁原五吉, Kakeji Yoshihiro, Yokozaki Hiroshi
    第89回日本胃癌学会総会, Mar. 2017, Japanese, Japanese Gastric Cancer Association, 広島, Domestic conference
    Poster presentation

  • 大腸癌肝転移に対する術前化学療法の効果とその予後
    福岡 英志, Yamashita Kimihiro, 金光 聖哲, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Ku Yonson, Kakeji Yoshihiro
    第50回制癌剤適応研究会, Mar. 2017, Japanese, 制癌剤適応研究会, 徳島, Domestic conference
    Oral presentation

  • 局所進行直腸癌における術前化学放射線療法の免疫関連因子への影響
    Yamashita Kimihiro, 中川 暁雄, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第50回制癌剤適応研究会, Mar. 2017, Japanese, 制癌剤適応研究会, 徳島, Domestic conference
    Public symposium

  • The significance of surgery following chemotherapy for stage IV gastric cancer （StageIV胃癌に対する化学療法後の外科切除の意義）
    原田 仁, Suzuki Satoshi, 音羽 泰則, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, English, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • The laparoscopic lymphadenectomy along proximal splenic artery from patient's left side（患者左から攻略する腹腔鏡下脾動脈近位側郭清）
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Others

  • The cancer-stromal interaction in scirrhous-type gastric carcinoma（直接接触相互作用によるスキルス胃癌細胞の浸潤と間質線維芽細胞の増殖促進）
    東野展英, Koma Yuichiro, 細野雅義, 高瀬信尚, 小平日実子, 岡本真生子, 土井雅之, Shigeoka Manabu, Nishio Mari, 八代正和, 平川弘聖, 柳原五吉, Kakeji Yoshihiro, Yokozaki Hiroshi
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • Surveillance and treatment for gastric cancer after radical esophagectomy（当科における食道切除後再建胃管癌の検討）
    Matsuda Yoshiko, Nakamura Tetsu, 三浦 由紀子, 松田 佑輔, 後藤 裕信, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • Postoperative pneumonia after gastrectomy for elderly gastric cancer patients（高齢者胃癌の術後肺炎の長期予後に及ぼす影響）
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, 後藤 裕信, 松田 佑輔, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • Lecture Series 2 Genome and epigenome
    Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Others

  • LECS(laparoscopy and endoscopy cooperative surgery) for gastric GIST（胃・十二指腸腫瘍に対するLECS(laparoscopy and endoscopy cooperative surgery)
    Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Oral presentation

  • HER2陽性乳癌細胞株を用いたPIK3CA変異によるtrastuzumab耐性機構に関する2次元、3次元培養の比較
    多田羅 敬, Mukohara Toru, 田中 里奈, Shimono Yohei, Toyoda Masanori, Kiyota Naomi, Hirai Midori, Kakeji Yoshihiro, Minami Hironobu
    第50回制癌剤適応研究会, Mar. 2017, Japanese, 制癌剤適応研究会, 徳島, Domestic conference
    Public symposium

  • Early gastric cancer accompanied by Menetrier's disease with difficulty in pueoperative diagnosis（術前進行度診断が困難であったMenetrier病合併早期胃癌の一例）
    杉田 裕, Suzuki Satoshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, 大澤 正人, 中本 光春, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • Clinicopathologic Study of Gastric Stump Cancer after Proximal Gastrectomy（噴門側胃切除術後の残胃の癌の特徴）
    三浦 由紀子, Suzuki Satoshi, 大坪 大, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, 安田 貴志, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第89回日本胃癌学会総会, Mar. 2017, Japanese, 一般社団法人 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 主題1-1 Ｈ.pylori 陰性・除菌後胃癌の特徴と治療
    Kakeji Yoshihiro
    第49回胃病態機能研究会, Feb. 2017, Japanese, 胃病態機能研究会, 名古屋, Domestic conference
    Others

  • 高齢者の胃癌切除症例における術前末梢血の白血球系細胞数の臨床的意義
    多田羅 敬, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    第49回胃病態機能研究会, Feb. 2017, Japanese, 胃病態機能研究会, 名古屋, Domestic conference
    Oral presentation

  • 後期高齢者の胃癌切除術後の呼吸器合併症発生の危険因子についての検討
    Suzuki Satoshi, 松田 佑輔, 多田羅 敬, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    第49回胃病態機能研究会, Feb. 2017, Japanese, 胃病態機能研究会, 名古屋, Domestic conference
    Oral presentation

  • 一般演題1 食道（治療）
    Kakeji Yoshihiro
    第13回日本消化管学会総会学術集会, Feb. 2017, Japanese, 日本消化管学会, 名古屋, Domestic conference
    Others

  • HER2陽性胃癌に対するTrastuzumabを併用した集学的治療
    原田 仁, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第13回日本消化管学会総会学術集会, Feb. 2017, Japanese, 日本消化管学会, 名古屋, Domestic conference
    Public symposium

  • 腹腔鏡下直腸低位前方切除術を安全に施行するための工夫
    Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, 三浦 由紀子, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第86回大腸癌研究会, Jan. 2017, Japanese, 大腸癌研究会, 盛岡, Domestic conference
    Oral presentation

  • ロボット支援幽門側胃切除術における助手ポートからの超音波凝固切開装置使用の有用性
    田中 智子, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第9回日本ロボット外科学会学術集会, Jan. 2017, Japanese, J-robo 日本ロボット外科学会 事務局, 佐賀, Domestic conference
    Oral presentation

  • EMARO(Endoscope Manipulate Robot)と3D内視鏡による次世代の腹腔鏡下手術について
    Sumi Yasuo, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, 三浦 由紀子, Matsuda Yoshiko, Yamamoto Masashi, Kanaji Shingo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第9回日本ロボット外科学会学術集会, Jan. 2017, Japanese, J-robo 日本ロボット外科学会 事務局, 佐賀, Domestic conference
    Oral presentation

  • 腹腔鏡下直腸癌手術における3D内視鏡の有用性
    Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Oral presentation

  • 腹腔鏡下中結腸動静脈郭清における出血をさせないための工夫
    Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Oral presentation

  • 高齢者胃癌に対する腹腔鏡下胃切除術の手術成績の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Matsuda Yoshiko, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Oral presentation

  • 胸腔鏡下食道切除術に対する3D内視鏡の有用性と治療成績
    Nakamura Tetsu, 原田 仁, 西 将康, 三浦 由紀子, 後藤 裕信, Hasegawa Hiroshi, Matsuda Yoshiko, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Oral presentation

  • 外科切除のmyeloid derived suppressor cellsに対する影響と臨床的意義
    田中 智子, Yamashita Kimihiro, 有本 聡, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第20回バイオ治療法研究会学術集会, Dec. 2016, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 博多, Domestic conference
    Oral presentation

  • 【消化器外科 上部消化管】こだわりの手術手技～出血はしない、させない、ひろげない～2
    Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Others

  • Siewert TypeII型食道胃接合部腺癌に対するロボット支援下経裂孔的下縦隔郭清の有用性
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Hasegawa Hiroshi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Public symposium

  • 3ステップ法による腹腔鏡下脾弯曲授動の定型化
    青木 丈明, Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第29回日本内視鏡外科学会総会, Dec. 2016, Japanese, 一般社団法人 日本内視鏡外科学会, 横浜, Domestic conference
    Oral presentation

  • 発生学的観点から見た横行結腸切除の特殊性・困難性と、安全・確実に腹腔鏡下D3横行結腸切除を行うための工夫
    Matsuda Takeru, 岩崎 武, Kakeji Yoshihiro
    第24回日本消化器関連学会週間（JDDW2016）, Nov. 2016, Japanese, JDDW 2016 運営委員会, 神戸, Domestic conference
    Public symposium

  • 直腸癌の術前化学放射線療法の免疫関連因子の検討
    Yamashita Kimihiro, 中川 暁雄, Sumi Yasuo, Hasegawa Hiroshi, Matsuda Takeru, 向山 順子, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本大腸肛門病学会学術集会, Nov. 2016, Japanese, 日本大腸肛門病学会事務局, 三重, Domestic conference
    Oral presentation

  • 超高齢者胃癌に対する胃切除術の適応
    Suzuki Satoshi, Kanaji Shingo, 原田 仁, 三浦 由紀子, 松田 佑輔, 高瀬 信尚, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第78回日本臨床外科学会総会, Nov. 2016, Japanese, 日本臨床外科学会 事務局, 東京, Domestic conference
    Public symposium

  • 大腸癌肝転移切除後の再発例に対する再発巣切除の意義
    金光 聖哲, 吉川 卓郎, 前田 哲生, 阿河 杏介, 松永 隆史, 得居 龍, 田村 太一, 宗 慎一, 若原 智之, 芦谷 博史, 土田 忍, 植野 望, Kakeji Yoshihiro, Ku Yonson, 豊川 晃弘
    第78回日本臨床外科学会総会, Nov. 2016, Japanese, 日本臨床外科学会 事務局, 東京, Domestic conference
    Oral presentation

  • 進行食道疣状扁平上皮癌の1例
    高瀬 信尚, Suzuki Satoshi, Nakamura Tetsu, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Kakeji Yoshihiro
    第78回日本臨床外科学会総会, Nov. 2016, Japanese, 日本臨床外科学会 事務局, 東京, Domestic conference
    Oral presentation

  • 食道癌術後胃管壊死により胃管気管支瘻を来した1例
    Tanaka Yugo, 内田 孝宏, 大隈 宏通, 奥田 祐亮, Shimizu Nahoko, Ogawa Hiroyuki, 田根 慎也, Hokka Daisuke, Nakamura Tetsu, Kakeji Yoshihiro, 真庭 謙昌
    第68回日本気管食道科学会, Nov. 2016, Japanese, 日本食道科学会, 東京, Domestic conference
    Oral presentation

  • 十二指腸乳頭部癌におけるKRAS遺伝子変異の臨床病理組織学的意義
    前原 律子, Zen Yoh, Ajiki Tetsuo, Ku Yonson, Kakeji Yoshihiro
    第24回日本消化器関連学会週間（JDDW2016）, Nov. 2016, Japanese, JDDW 2016 運営委員会, 神戸, Domestic conference
    Poster presentation

  • ランチタイムセミナー10 Evidenceを考慮した進行再発大腸癌の治療戦略
    Kakeji Yoshihiro
    第71回日本大腸肛門病学会学術集会, Nov. 2016, Japanese, 日本大腸肛門病学会事務局, 三重, Domestic conference
    Others

  • ビデオワークショップ08 胃全摘空腸パウチ再建術の有用性とコツ
    Kakeji Yoshihiro
    第78回日本臨床外科学会総会, Nov. 2016, Japanese, 日本臨床外科学会 事務局, 東京, Domestic conference
    Others

  • シンポジウム8 腹腔下手術とロボット手術《ビデオ》
    Kakeji Yoshihiro
    第24回日本消化器関連学会週間（JDDW2016）, Nov. 2016, Japanese, JDDW 2016 運営委員会, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • サテライトシンポジウム90 エビデンスから実臨床へ－胃癌二次治療におけるRAM+PTX療法の経験から－
    Kakeji Yoshihiro
    第24回日本消化器関連学会週間（JDDW2016）, Nov. 2016, Japanese, JDDW 2016 運営委員会, 神戸, Domestic conference
    Others

  • SOX2-negative squamous cell carcinoma of the esophagus: A rare variant with aggressive clinical courses
    前原 律子, Zen Yoh, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第24回日本消化器関連学会週間（JDDW2016）, Nov. 2016, Japanese, JDDW 2016 運営委員会, 神戸, Domestic conference
    Poster presentation

  • NCDから見えてくる消化器外科医療
    Kakeji Yoshihiro
    第78回日本臨床外科学会総会, Nov. 2016, Japanese, 日本臨床外科学会 事務局, 東京, Domestic conference
    [Invited]
    Invited oral presentation

  • Digital Poster,Lower GI "Neoplasia 1"
    Kakeji Yoshihiro
    2016年アジア太平洋消化器週間（APDW 2016）, Nov. 2016, English, 一般社団法人 日本消化器外科学会, 神戸, Domestic conference
    Others

  • Current Status and Future Directions for Gastric Cancer Treatment Strategy
    Kakeji Yoshihiro
    2016年アジア太平洋消化器週間（APDW 2016）, Nov. 2016, English, 一般社団法人 日本消化器外科学会, 神戸, Domestic conference
    Public discourse

  • 3D映像が内視鏡外科手術トレーニングに及ぼす影響の検討
    Kanaji Shingo, 原田 仁, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第78回日本臨床外科学会総会, Nov. 2016, Japanese, 日本臨床外科学会 事務局, 東京, Domestic conference
    Oral presentation

  • 術前抗血栓療法中の胃切除患者に対する周術期抗血栓療法の検討
    Kanaji Shingo, 原田 仁, Yamamoto Masashi, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第46回胃外科・術後障害研究会, Oct. 2016, Japanese, 胃外科・術後障害研究会, 米子, Domestic conference
    Oral presentation

  • 高齢者の胃癌切除後の呼吸器合併症への予後への影響についての検討
    Suzuki Satoshi, Kanaji Shingo, 原田 仁, 松田 佑輔, 後藤 裕信, Yamamoto Masashi, Oshikiri Taro, Nakamura Tetsu, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Kakeji Yoshihiro
    第54回日本癌治療学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Public symposium

  • 後期高齢者に対する胃癌切除術後の呼吸器合併症発生の危険因子の検討
    松田 佑輔, Suzuki Satoshi, Kanaji Shingo, 後藤 裕信, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    第46回胃外科・術後障害研究会, Oct. 2016, Japanese, 胃外科・術後障害研究会, 米子, Domestic conference
    Oral presentation

  • 学術セミナー20 CVポート、インフューーザーポンプ自由自在
    Kakeji Yoshihiro
    第54回日本癌治療学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Others

  • 一般演題10〔高度進行・再発胃癌の治療〕
    Kakeji Yoshihiro
    第46回胃外科・術後障害研究会, Oct. 2016, English, 胃外科・術後障害研究会, 米子, Domestic conference
    Others

  • ミニシンポジウム27 胃6：胃がんにおける新たな予後因子の探索
    Kakeji Yoshihiro
    第54回日本癌治療学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Others

  • StageIV胃癌に対する外科切除例の予後規定因子に関する検討
    原田 仁, Kanaji Shingo, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第54回日本癌治療学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本癌治療学会, 横浜, Domestic conference
    Public symposium

  • Selectively upregulated miR-221 regulates the clonogenicity of human colon cancer stem cells(選択的に発現上昇しているマイクロ RNA-221 がヒト大腸がん幹細胞のクローン原性を制御する)
    渋谷 尚樹, 向山 順子, 磯部 大地, 近藤 弘基, Mukohara Toru, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira, Shimono Yohei
    第75回日本癌学会学術総会, Oct. 2016, Japanese, 日本癌学会, 横浜, Domestic conference
    Poster presentation

  • Selectively upregulated miR-221 regulates the clonogenicity of human colon cancer stem cells.
    Naoki Shibuya, Junko Mukohyama, Taichi Isobe, Hiroki Kondo, Mukohara Toru, Kakeji Yoshihiro, Minami Hironobu, Suzuki Akira, Shimono Yohei
    第75回日本癌学会学術総会シンポジウムS12 Advances in cancer animal model: from mechanisms to clinical output がん動物モデルの新展開：メカニズムから臨床応用まで, Oct. 2016, English, 日本癌学会, 横浜, Domestic conference
    Poster presentation

  • Selectively upregulated miR-221 regulates the clonogenicity of human colon cancer stem cells.
    Naoki Shibuya, Junko Mukohyama, Taichi Isobe, Hiroki Kondo, Mukohara Toru, Kakeji Yoshihiro, Hironobu Minam, Suzuki Akira, Shimono Yohei
    The 75th Annual Meeting of the Japanese Cancer Association, Oct. 2016, English, The Japanese Cancer Association, 神奈川(横浜）, Domestic conference
    Poster presentation

  • Flt1/VEGFR1 heterozygosity causes transient embryonic edema in mice
    Hirashima Masanori, 音羽泰則, 森脇一将, 佐野圭吾, 白壁正規, 米村重信, 澁谷正史, Janet Rossant, 須田年生, Kakeji Yoshihiro
    第15回日本心臓血管発生研究会, Oct. 2016, Japanese, 日本心臓血管発生研究会, 吹田, 血管内皮増殖因子（VEGF-A）は血管新生や血管透過性亢進に重要な役割を果たす。VEGF-Aヘテロ欠損（VEGF-A+/-）マウスやVEGF-A過剰発現マウスは血管や心臓の形成異常で胎生致死となることから、VEGF-Aの量的変化が個体発生に影響を与えることが知られている。VEGF-Aには二つのチロシンキナーゼ型受容体があり、Flk1が主要なシグナルを伝えるのに対して、Flt1はVEGF-Aの局所濃度を負に制御するデコイ受容体である。我々は、Flt1+/-マウスが一過性の胎仔浮腫をきたすことを見出し、胎生期の脈管形成及び体液恒常性維持におけるFlt1の制御的役割について解析した。Flt1のチロシンキナーゼ領域が欠損しているマウス胎仔は浮腫を示さず、Flt1+/-マウス胎仔ではFlk1のチロシンリン酸化が亢進していた。このことからFlt1シグナルではなく, Domestic conference
    Oral presentation

  • Evaluation of the risk of lymphomagenesis in xenografts by the detection of EBV BamHI W region in patient specimens.(患者検体からのEBウイルスBamHI W 領域の検出によるヒト腫瘍異種移植マウスのリンパ腫形成リスクの評価）
    向山 順子, Mukohara Toru, Minami Hironobu, Kakeji Yoshihiro, Shimono Yohei
    第75回日本癌学会学術総会, Oct. 2016, Japanese, 日本癌学会, 横浜, Domestic conference
    Oral presentation

  • Evaluation of the risk of lymphomagenesis in xenografts by the detection of EBV BamHI W region in patient specimens
    Junko Mukohyama, Mukohara Toru, Minami Hironobu, Kakeji Yoshihiro, Shimono Yohei
    The 75th Annual Meeting of the Japanese Cancer Association, Oct. 2016, Japanese, The Japanese Cancer Association, 神奈川(横浜）, Domestic conference
    Oral presentation

  • Biomarker of esophageal cancer 食道癌のバイオマーカー
    Kakeji Yoshihiro
    第75回日本癌学会学術総会, Oct. 2016, Japanese, 日本癌学会, 横浜, Domestic conference
    Others

  • Advances of diagnosis&treatment in gastrointestinal surgery
    Kakeji Yoshihiro
    40th World Congress of the International College of Surgeons/62nd Annual Congress of the International College of Surgeons Japan Section(第40回国際外科学会・第62回国際外科学会日本部会総会), Oct. 2016, English, 国際外科学会日本部会, 京都, International conference
    Others

  • 80歳以上の高齢者胃癌に対する腹腔鏡下胃切除術の手術成績の検討
    Suzuki Satoshi, Kanaji Shingo, 松田 佑輔, 後藤 裕信, Yamamoto Masashi, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Kakeji Yoshihiro
    第46回胃外科・術後障害研究会, Oct. 2016, Japanese, 胃外科・術後障害研究会, 米子, Domestic conference
    Oral presentation

  • 腹臥位食道癌手術における左上縦隔郭清の定型化
    池田 太郎, Oshikiri Taro, Nakamura Tetsu, 古出 隆大, Yamamoto Masashi, Hasegawa Hiroshi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第29回近畿内視鏡外科研究会, Sep. 2016, Japanese, 近畿内視鏡外科研究会事務局, 京都, Domestic conference
    Public symposium

  • 直腸癌の術前化学放射線療法施行例における免疫関連因子の検討
    中川 暁雄, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • 担癌状態における骨髄由来抑制細胞(MDSC)の治療による変化とその治療成績への影響
    田中 智子, Yamashita Kimihiro, 有本 聡, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • 神経内分泌細胞成分を伴う胃癌に対する集学的治療の有用性
    原田 仁, Suzuki Satoshi, 友野 絢子, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Kanaji Shingo, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Sumi Yasuo, Kakeji Yoshihiro
    第25回消化器疾患病態治療研究会, Sep. 2016, Japanese, 消化器疾患病態治療研究会, 高崎市, International conference
    Oral presentation

  • 食道扁平上皮癌における酸化ヌクレオチド浄化因子MTH1発現の意義
    秋山 真吾, 佐伯 浩司, 北尾 洋之, 是久翔太郎, 谷口 大介, 枝廣圭太郎, 工藤 健介, 堤 亮介, 中司 悠, 西村 章, 田尻 裕匡, 中西 良太, 杉山 雅彦, 中島雄一郎, 沖 英次, Kakeji Yoshihiro, 前原 喜彦
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Poster presentation

  • 手術治療をおこなった食道GISTの2例
    青木 丈明, Nakamura Tetsu, Oshikiri Taro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • 癌微小環境における腫瘍関連マクロファージ由来のIL-8はヒト食道扁平上皮癌の運動能および浸潤能を促進する
    細野雅義, 高瀬信尚, 東野展英, 土井雅之, 岡本真生子, 小平日実子, 市原有美, Nishio Mari, Shigeoka Manabu, Koma Yuichiro, Yokozaki Hiroshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • 胃GIST に対するLECS（laparoscopy and endoscopy cooperative surgery）の検討
    Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第25回消化器疾患病態治療研究会, Sep. 2016, Japanese, 消化器疾患病態治療研究会, 高崎市, International conference
    Oral presentation

  • 胃GISTに対するLECS(laparoscopy and endoscopy cooperative surgery)症例の検討
    松田 佑輔, Kanaji Shingo, Yamamoto Masashi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第29回近畿内視鏡外科研究会, Sep. 2016, Japanese, 近畿内視鏡外科研究会事務局, 京都, Domestic conference
    Public symposium

  • ランチョンセミナー4 胃癌の病因の治療戦略
    Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Public discourse

  • ランチョンセミナー1 腹腔鏡下大腸切除について
    Kakeji Yoshihiro
    第29回近畿内視鏡外科研究会, Sep. 2016, Japanese, 近畿内視鏡外科研究会事務局, 京都, Domestic conference
    Others

  • HER2陽性胃癌に対するTrastuzumab併用化学療法後の外科切除の安全性と有効性
    後藤 裕信, Kanaji Shingo, Yamamoto Masashi, Hasegawa Hiroshi, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • DOGにおけるCD40-CD40L interaction の抗腫瘍効果への影響
    有本 聡, Yamashita Kimihiro, Hasegawa Hiroshi, 西 将康, 田中 智子, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • Allogeneic DCGを用いた抗腫瘍免疫活性化の検討
    西 将康, Yamashita Kimihiro, Hasegawa Hiroshi, 田中 智子, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第27回日本消化器癌発生学会総会, Sep. 2016, Japanese, 日本消化器癌発生学会, 鹿児島, Domestic conference
    Oral presentation

  • 3ステップ法による腹腔鏡下結腸脾弯曲授動
    青木 丈明, Matsuda Takeru, Sumi Yasuo, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第29回近畿内視鏡外科研究会, Sep. 2016, Japanese, 近畿内視鏡外科研究会事務局, 京都, Domestic conference
    Oral presentation

  • 3Dモニターが初心者の内視鏡外科トレーニングにもたらす影響
    原田 仁, Kanaji Shingo, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Matsuda Yoshiko, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第29回近畿内視鏡外科研究会, Sep. 2016, Japanese, 近畿内視鏡外科研究会事務局, 京都, Domestic conference
    Public symposium

  • 右側結腸癌に対する単孔式腹腔鏡下手術の有用性について
    Sumi Yasuo, Matsuda Takeru, Yamashita Kimihiro, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第10回単孔式内視鏡手術研究会/第14回 Needlescopic Surgery Meeting, Aug. 2016, Japanese, 単孔式内視鏡手術研究会事務局, 大阪, Domestic conference
    Oral presentation

  • 鉗子軌跡解析による3D 映像の内視鏡手術における有用性の検討と今後の展開
    Kanaji Shingo, 西 将康, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 大竹 義人, 佐藤 嘉伸, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Public symposium

  • 末梢血骨髄由来抑制細胞（MDSC）による再発予測
    田中 智子, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 兵庫県における腹腔鏡下大腸癌手術の現状・兵庫大腸がん治療研究会のアンケート結果より
    川崎 健太郎, 安積 靖友, 藤原 英利, 廣吉 基己, 石井 正之, 野田 雅史, Kakeji Yoshihiro, 冨田 尚裕
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 噴門側胃切除術における偽His角・Fornix形成を行った食道胃管Overlap吻合法の有用性
    音羽 泰則, Kanaji Shingo, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 腹臥位食道癌手術におけるlearning curveと次世代の術者教育
    Oshikiri Taro, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第70回日本食道学会学術集会, Jul. 2016, Japanese, 特定非営利活動法人 日本食道学会, 東京, Domestic conference
    Poster presentation

  • 当院における大腸ESD穿孔後の外科的治療の検討
    前原 律子, Yamashita Kimihiro, 金光 聖哲, Sumi Yasuo, Nakamura Tetsu, Morita Yoshinori, Tanaka Shinwa, 豊永 高志, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 担癌状態における腫瘍誘導性骨髄由来抑制細胞(MDSC)の与える影響と治療による変化
    田中 智子, Yamashita Kimihiro, 西 将康, Hasegawa Hiroshi, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Matsuda Takeru, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回日本サイトメトリー学会学術集会, Jul. 2016, Japanese, 日本サイトメトリー学会, 福岡, Domestic conference
    Oral presentation

  • 大腸癌内視鏡切除後の追加外科切除例におけるリンパ節転移のリスク因子
    金光 聖哲, Sumi Yasuo, Yamashita Kimihiro, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 進行直腸癌におけるmodified Glasgow Prognostic Scoreを用いた治療効果予測
    Yamashita Kimihiro, Sumi Yasuo, 金光 聖哲, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 食道扁平上皮癌における酸化ヌクレオチド浄化因子MTH1発現の意義の検討
    秋山 真吾, 佐伯 浩司, 北尾 洋之, 中島 雄一郎, 杉山 雅彦, 園田 英人, 大垣 吉平, 沖 英次, Kakeji Yoshihiro, 前原 喜彦
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 食道非上皮性腫瘍の診断と手術治療の検討
    青木 丈明, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第70回日本食道学会学術集会, Jul. 2016, Japanese, 特定非営利活動法人 日本食道学会, 東京, Domestic conference
    Public symposium

  • 消化器外科医からみた大動脈食道瘻の治療戦略 －その食道切除術と再建術－
    Nakamura Tetsu, 今西 達也, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Public symposium

  • 術前抗血栓療法中の患者に対する胃切除症例の検討
    原田 仁, Kanaji Shingo, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 腫瘍に対する外科的切除の腫瘍誘導性骨髄由来抑制細胞(MDSC)に対する影響とその臨床的意義
    Yamashita Kimihiro, 田中 智子, 西 将康, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第25回日本がん転移学会学術集会・総会, Jul. 2016, Japanese, 日本がん転移学会事務局, 米子, Domestic conference
    Poster presentation

  • 合併症提低減と根治性を目指した胸腔鏡下食道切除術の現況
    Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第70回日本食道学会学術集会, Jul. 2016, Japanese, 特定非営利活動法人 日本食道学会, 東京, Domestic conference
    Poster presentation

  • 高齢者胃癌に対する胃切除後の呼吸器合併症の予後に及ぼす影響
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 高齢者Stage III進行大腸癌に対する補助化学療法における腹腔鏡手術の有用性
    植田 康司, 金光 聖哲, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 後期高齢者大腸癌に対する腹腔鏡手術の有用性
    Hasegawa Hiroshi, Sumi Yasuo, 大山 正人, Matsuda Takeru, Yamashita Kimihiro, 前原 律子, 植田 康司, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第85回大腸癌研究会, Jul. 2016, Japanese, 大腸癌研究会, 大阪, Domestic conference
    Oral presentation

  • 胸壁前経路有茎空腸再建術の有用性
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Public symposium

  • 教育企画5 匠の技の継承「胃」
    Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Others

  • 画像診断による腹腔鏡下側方リンパ節郭清の適応と神経筋膜を意識した郭清手技について
    Sumi Yasuo, 金光 聖哲, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Oral presentation

  • 一般演題2「癌幹細胞/細胞増殖・転移浸潤マーカー」
    Kakeji Yoshihiro
    第26回日本サイトメトリー学会学術集会, Jul. 2016, Japanese, 日本サイトメトリー学会, 福岡, Domestic conference
    Others

  • 胃GISTに対するLECS(laparoscopy and endoscopy cooperative surgery)により余剰切除された胃壁長の検討
    Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 【アフタヌーンセミナーB】大腸癌化学療法～10年間の歩みと今後の展望～
    Kakeji Yoshihiro
    第85回大腸癌研究会, Jul. 2016, Japanese, 大腸癌研究会, 大阪, Domestic conference
    Others

  • ワークショップ3「食道非上皮性腫瘍の治療」
    Kakeji Yoshihiro
    第70回日本食道学会学術集会, Jul. 2016, Japanese, 特定非営利活動法人 日本食道学会, 東京, Domestic conference
    Others

  • ランチョンセミナー5 胃がん周術期化学療法 -最新の知見と展望-
    Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Others

  • パネルディスカッション1 胃切除後の食道再建術式
    Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Others

  • Upregulation of Oncogenic miR-221 in Human Colon Cancer Stem Cells
    Junko Mukohyama, Shimono Yohei, Toru Mukohaya, Kakeji Yoshihiro, Minami Hironobu
    The Japanese Society of Medical Oncology 2016 Annual Meeting, Jul. 2016, Japanese, The Japanese Society of Medical Oncology, 兵庫（神戸）, Domestic conference
    [Invited]
    Nominated symposium

  • Oral Session 2-10 Gastric Cancer (2)
    Kakeji Yoshihiro
    第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference
    Others

  • NCDを活用した消化器外科医療の展開
    Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    [Invited]
    Invited oral presentation

  • alpha-galactosylceramideによるNKT細胞活性化と肝傷害
    Hasegawa Hiroshi, Yamashita Kimihiro, 西 将康, 田中 智子, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回日本サイトメトリー学会学術集会, Jul. 2016, Japanese, 日本サイトメトリー学会, 福岡, Domestic conference
    Oral presentation

  • Allogeneic DCG療法を用いた抗腫瘍免疫活性化の検討
    西 将康, Yamashita Kimihiro, Hasegawa Hiroshi, 田中 智子, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Matsuda Yoshiko, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回日本サイトメトリー学会学術集会, Jul. 2016, Japanese, 日本サイトメトリー学会, 福岡, Domestic conference
    Oral presentation

  • Allogeneic DCG療法を用いたNKT細胞の活性化に伴う抗腫瘍降下の検討
    西 将康, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第71回日本消化器外科学会総会, Jul. 2016, Japanese, 一般社団法人 日本消化器外科学会, 徳島, Domestic conference
    Poster presentation

  • 分子標的薬による胃癌の個別化治療
    Kakeji Yoshihiro, Kanaji Shingo, Yamamoto Masashi, Suzuki Satoshi
    第25回日本癌病態治療研究会, Jun. 2016, Japanese, NPO法人 日本癌病態治療研究会事務局, 東京, Domestic conference
    Public symposium

  • 腹腔鏡下直腸切除術における縫合不全対策について －当科での工夫－
    有本 聡, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 腹腔鏡下胃癌手術における層構造を意識した脾動脈近位側リンパ節郭清
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 腹臥位食道癌手術におけるエネルギーデバイスの使い分けとコツ
    青木 丈明, Oshikiri Taro, Nakamura Tetsu, Yamamoto Masashi, Hasegawa Hiroshi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 当科における腹腔鏡下直腸切除術における使用エネルギーデバイスについて
    Sumi Yasuo, 金光 聖哲, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 直腸癌化学放射線療法後の腹会陰式直腸切断術における骨盤大網形成術の有用性
    Yamashita Kimihiro, Sumi Yasuo, 金光 聖哲, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 直腸癌の術前治療の現状と今後における癌免疫関連因子の検討
    中川 暁雄, Yamashita Kimihiro, 三浦 由紀子, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第25回日本癌病態治療研究会, Jun. 2016, Japanese, NPO法人 日本癌病態治療研究会事務局, 東京, Domestic conference
    Poster presentation

  • 大腸癌肝転移切除後の再発巣に対する切除の意義
    東野 展英, 金光 聖哲, Yamashita Kimihiro, Sumi Yasuo, 三浦 由紀子, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • 食道癌手術における気管支動脈3D-CT術前ナビゲーションの有用性
    渋谷 尚樹, Nakamura Tetsu, 青木 丈明, 古出 隆大, 植田 康司, 原田 仁, 中川 暁雄, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, 今西 達也, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 食道癌に対するMinimally Invasive Esophagectomy
    Oshikiri Taro, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Public symposium

  • 高齢者大腸癌患者に対する腹腔鏡下手術の有用性の検討
    前原 律子, Sumi Yasuo, 金光 聖哲, Yamashita Kimihiro, 三浦 由紀子, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • 高齢者の胃癌切除後の予後規定因子の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • 高齢者 Stage III進行大腸癌に対する補助化学療法の腹腔鏡手術における有用性
    植田 康司, 金光 聖哲, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • 下部直腸癌・肛門管癌に対する術前化学放射線療法施行後リンパ節郭清の治療成績
    植田 康司, Yamashita Kimihiro, Sumi Yasuo, 金光 聖哲, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Sasaki Ryohei, Kakeji Yoshihiro
    第38回日本癌局所療法研究会, Jun. 2016, Japanese, 日本癌局所療法研究会, 東京, Domestic conference
    Oral presentation

  • 一般演題 胃1
    Kakeji Yoshihiro
    第38回日本癌局所療法研究会, Jun. 2016, Japanese, 日本癌局所療法研究会, 東京, Domestic conference
    Others

  • 胃GISTに対する単孔式腹腔鏡下胃部分切除術の手術成績と手技の工夫
    多田羅 敬, Kanaji Shingo, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Others

  • 胃GISTに対するLECS(laparoscoopy and endoscopy cooperative surgery)の検討
    Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Matsuda Takeru, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • スポンサードシンポジウム(2) 外科学 各診療科の低侵襲手術の最前線
    Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Others

  • Stage IV胃癌に対する外科切除例の予後規定因子に関する検討
    原田 仁, Kanaji Shingo, 音羽 泰則, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • Laparoscopic right hemicolectomy using a cranial approach: Technical tips
    Matsuda Takeru, Iwasaki T, Hirata Ken-ichi, Tsugawa D, Sugita Y, Ishida S, Sumi Yasuo, Kakeji Yoshihiro
    24th International congress of the European Association for Endoscopic Surgery, Jun. 2016, English, The European Association for Endoscopic Surgery, Amsterdam, The Netherlands, International conference
    Oral presentation

  • ESD治療後の胃癌に対する腹腔鏡下胃切除症例の検討
    石田 諒, Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第41回日本外科系連合学会学術集会, Jun. 2016, Japanese, 日本外科系連合学会, 大阪, Domestic conference
    Poster presentation

  • 腹腔鏡下直腸低位前方切除術における基本手技の積み重ねによる定型化への取り組み
    Sumi Yasuo, Yamashita Kimihiro, 金光 聖哲, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第70回 手術手技研究会, May 2016, Japanese, 手術手技研究会事務局, 品川, Domestic conference
    Public symposium

  • 第24回日本外科学会生涯教育セミナー 「胃癌」 病因論
    Kakeji Yoshihiro
    第199回近畿外科学会, May 2016, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Public discourse

  • 腫瘍に対する外科的切除の腫瘍誘導性骨髄由来抑制細胞(MDSC)に対する影響とその臨床的意義
    田中 智子, Yamashita Kimihiro, 西 将康, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第37回癌免疫外科研究会, May 2016, Japanese, 癌免疫外科研究会, 川越, Domestic conference
    Public symposium

  • 一般演題（口演）6 新規免疫療法
    Kakeji Yoshihiro
    第37回癌免疫外科研究会, May 2016, Japanese, 癌免疫外科研究会, 川越, Domestic conference
    Others

  • リンパ節転移の過程で神経内分泌分化を示した直腸癌の一例
    東野 展英, Sumi Yasuo, 金光 聖哲, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第199回近畿外科学会, May 2016, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Oral presentation

  • イレウスを繰り返したNSAIDs起因性多発小腸潰瘍の1例
    渡部 晃大, Yamashita Kimihiro, 金光 聖哲, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第199回近畿外科学会, May 2016, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Oral presentation

  • 大腸癌血行性転移切除後の再発に対する再切除の意義
    金光 聖哲, Sumi Yasuo, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Poster presentation

  • 側方リンパ節転移を伴う進行直腸癌に対する腹腔鏡下側方リンパ節郭清術について
    Sumi Yasuo, Yamashita Kimihiro, 金光 聖哲, 三浦 由紀子, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Poster presentation

  • 切除不能胃癌の集学的治療における外科手術介入の意義
    音羽 泰則, Suzuki Satoshi, Kanaji Shingo, 田中 智子, 瀧口 豪介, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Poster presentation

  • 新しい外科学の価値の創造（1） 化学療法と外科
    Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Others

  • 食道扁平上皮癌における酸化ヌクレオチド浄化因子MTH1発現の生物学的意義と治療標的としての可能性
    秋山 真吾, 佐伯 浩司, 北尾 洋之, 枝廣 圭太郎, 是久 翔太郎, 谷口 大介, 工藤 健介, 堤 亮介, 中司 悠, 西村 章, 田尻 裕匡, 堤 智崇, 由茅 隆文, 笠木 勇太, 杉山 雅彦, 中島 雄一郎, 大垣 吉平, 園田 英人, 沖 英次, Kakeji Yoshihiro, 前原 喜彦
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Oral presentation

  • 食道癌根治切除術のリンパ節再発に対するSalvage CRT
    Yamamoto Masashi, 今西 達也, Kanaji Shingo, Yamashita Kimihiro, 金光 聖哲, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro, 奥野 達也
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Poster presentation

  • 左反回神経浸潤が疑われる#106recL転移リンパ節に対する胸腔鏡下神経温存郭清
    Oshikiri Taro, Nakamura Tetsu, 三浦 由紀子, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Yamashita Kimihiro, Sumi Yasuo, 藤野 泰宏, 富永 正寛, Suzuki Satoshi, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Oral presentation

  • 高齢者胃癌の術後合併症発生の危険因子の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Oral presentation

  • 局所進行直腸癌に対する術前化学放射線療法の治療成績とその工夫
    Yamashita Kimihiro, Sumi Yasuo, 金光 聖哲, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Poster presentation

  • 胸腔鏡下食道切除術に対する3D内視鏡の導入
    Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, 金光 聖哲, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Poster presentation

  • ランチョンセミナー 結腸癌に対する術後補助化学療法 現在、過去、未来
    Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Others

  • ディベート（4）幽門側胃切除の再建 －温故知新－Billroth-I法 vs Roux-en-Y法
    Kakeji Yoshihiro
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Others

  • NCDを基盤とした消化器外科領域の前向き研究への課題
    後藤 満一, Kakeji Yoshihiro, 宮田 裕章, 瀬戸 泰之
    第116回日本外科学会定期学術集会, Apr. 2016, Japanese, 一般社団法人日本外科学会, 大阪, Domestic conference
    Others

  • 閉塞性大腸癌に対する大腸ステントによる術前減圧の有用性
    細野 雅義, Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, Kanaji Shingo, Yamamoto Masashi, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第52回日本腹部救急医学会総会, Mar. 2016, Japanese, 日本腹部救急医学会, 東京, Domestic conference
    Oral presentation

  • 当院におけるLECS症例の検討
    Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Poster presentation

  • 食道胃接合部位癌の異時性肺転移切除により長期生存を得た1例
    田中 智子, Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Poster presentation

  • 高齢者の胃癌切除後の予後規定因子の研究
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Poster presentation

  • 完全内臓逆位に合併した胃癌に対し完全腹腔鏡下胃全摘を行った一例
    原田 仁, Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Poster presentation

  • 胃癌術後補助化学療法の展開2016
    Kakeji Yoshihiro
    第49回制癌剤適応研究会, Mar. 2016, Japanese, 制癌剤適応研究会, 会津若松, Domestic conference
    [Invited]
    Invited oral presentation

  • リンパ節を細分化して行う安定した脾動脈近位側リンパ節(No.11p)郭清
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Poster presentation

  • ポスター 2-31 Predictive factor 7
    Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Others

  • プレナリーセッション2 胃癌臨床試験：世界の試験総覧
    Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Others

  • StageIV胃癌の集学的治療における外科手術の意義
    音羽 泰則, Suzuki Satoshi, Kanaji Shingo, 田中 智子, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, 藤島 佳未, Ikeda Atsuki, Kakeji Yoshihiro
    第88回日本胃癌学会学術総会, Mar. 2016, Japanese, 一般社団法人 日本胃癌学会, 別府, Domestic conference
    Poster presentation

  • 大腸がん内視鏡切除後の追加外科切除例の検討
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, 有本 聡, Kanaji Shingo, Yamamoto Masashi, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第12回日本消化管学会総会学術集会, Feb. 2016, Japanese, 日本消化管学会, 東京, Domestic conference
    Public symposium

  • 一般演題2 手術(2)
    Kakeji Yoshihiro
    第48回胃病態機能研究会, Feb. 2016, Japanese, 胃病態機能研究会, 東京, Domestic conference
    Others

  • Comparison of two- and three-dimensional display for performance of laparoscopic total gastrectomy
    Kanaji Shingo, 西 将康, 原田 仁, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    11th Annual Academic Surgical Congress, Feb. 2016, English, Society of University Surgeons, Association for Academic Surgery, Jacksonville, Florida, International conference
    Public symposium

  • 治癒切除不能stageIV大腸癌に対する原発巣切除の意義
    向山 順子, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第84回大腸癌研究会, Jan. 2016, Japanese, 大腸癌研究会, 熊本, Domestic conference
    Poster presentation

  • 慢性閉塞性肺疾患を合併した高齢者胃癌に対する腹腔鏡下胃切除術の安全性の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Oral presentation

  • 腹腔鏡補助下・後縦隔経路再建術の手技と工夫
    青木 丈明, Nakamura Tetsu, 有本 聡, 古出 隆大, 原田 仁, 瀧口 豪介, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Oral presentation

  • 腹腔鏡下側方リンパ節郭清を安全に施行するために
    Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    [Invited]
    Nominated symposium

  • 腹臥位食道癌手術の利点と可能性
    Oshikiri Taro, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    [Invited]
    Nominated symposium

  • 新しい3次元動作解析システムを用いた内視鏡手術の技術分析 - 3Dと2Dモニターにおける鉗子操作の比較検討 -
    西 将康, Kanaji Shingo, 原田 仁, 音羽 泰則, 瀧口 豪介, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Public symposium

  • 左側閉塞性大腸癌に対しステント留置後に腹腔鏡下手術を施行した4例
    前原 律子, Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, 三浦 由紀子, Yamamoto Masashi, Kanaji Shingo, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Oral presentation

  • 胸腔鏡下食道切除術の治療成績の検討
    Nakamura Tetsu, 青木 丈明, 有本 聡, 古出 隆大, 原田 仁, 瀧口 豪介, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Oral presentation

  • 胃GISTに対する単孔式腹腔鏡下胃部分切除の手術成績と手技の工夫
    多田羅 敬, Kanaji Shingo, Nakamura Tetsu, Suzuki Satoshi, Yamamoto Masashi, 今西 達也, 田中 賢一, Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Oral presentation

  • ヒト大腸がん幹細胞のマイクロRNA発現に継代回数と移植部位がおよぼす影響
    向山 順子, Shimono Yohei, Yamashita Kimihiro, Minami Hironobu, Kakeji Yoshihiro
    第19回バイオ治療法研究会学術集会, Dec. 2015, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 東京, Domestic conference
    Oral presentation

  • パネルディスカッション22 腹腔鏡下幽門保存胃切除：究極の機能温存手術への飛躍
    Kakeji Yoshihiro
    第28回日本内視鏡外科学会総会, Dec. 2015, Japanese, 一般社団法人 日本内視鏡外科学会, 大阪, Domestic conference
    Others

  • iNKT細胞活性化療法における肝障害
    長谷川 寛, Yamashita Kimihiro, 大坪 大, 西田 勝浩, Kakeji Yoshihiro
    第19回バイオ治療法研究会学術集会, Dec. 2015, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 東京, Domestic conference
    Oral presentation

  • DCG療法におけるCD40-CD40L interactionの抗腫瘍降下への影響
    Yamashita Kimihiro, 長谷川 寛, 西 将康, 田中 智子, 有本 聡, Kim Kiyonori, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 神垣 隆, Kakeji Yoshihiro
    第19回バイオ治療法研究会学術集会, Dec. 2015, Japanese, 特定非営利活動法人環瀬戸内自然免疫ネットワーク, 東京, Domestic conference
    Oral presentation

  • 大腸癌に対する術後補所化学療法
    Kakeji Yoshihiro
    第26回日本消化器癌発生学会総会, Nov. 2015, Japanese, 日本消化器癌発生学会, 米子, Domestic conference
    Public discourse

  • 切除不能胃癌に対する外科切除例の予後規定因子に関する検討
    原田 仁, Kanaji Shingo, 音羽 泰則, Yamamoto Masashi, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第45回胃外科・術後障害研究会, Nov. 2015, Japanese, 胃外科・術後障害研究会, 名古屋, Domestic conference
    Oral presentation

  • 食道癌術後胃管気管支瘻を来した1例
    Tanaka Yugo, 内田 孝宏, 大隈 宏通, 奥田 祐亮, 清水 奈保子, 小川 裕行, Tane Shinya, Hokka Daisuke, Nakamura Tetsu, Kakeji Yoshihiro, 真庭 謙昌
    第67回日本気管食道科学会総会ならびに学術講演会, Nov. 2015, Japanese, 日本気管食道科学会, 福島, Domestic conference
    Oral presentation

  • 腫瘍誘導性骨髄由来抑制細胞（MDSC）に対する早期治療は肺転移を抑制する
    Yamashita Kimihiro, 西 将康, 田中 智子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回日本消化器癌発生学会総会, Nov. 2015, Japanese, 日本消化器癌発生学会, 米子, Domestic conference
    [Invited]
    Nominated symposium

  • アロ樹状細胞を用いた抗腫瘍免疫活性化の検討
    西 将康, Yamashita Kimihiro, 田中 智子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第26回日本消化器癌発生学会総会, Nov. 2015, Japanese, 日本消化器癌発生学会, 米子, Domestic conference
    Poster presentation

  • NCAMとFGFRの相互作用はヒト食道扁平上皮癌における腫瘍関連マクロファージの生存能および遊走能に関与する
    高瀬 信尚, Koma Yuichiro, 荒井 慎明, 小平 日美子, 細野 雅義, 市原 有美, 西尾 真理, 重岡 学, Kakeji Yoshihiro, Yokozaki Hiroshi
    第26回日本消化器癌発生学会総会, Nov. 2015, Japanese, 日本消化器癌発生学会, 米子, Domestic conference
    Oral presentation

  • NCAMとFGFRの相互作用はヒト食道癌における腫瘍関連マクロファージの生存能および遊走能に関与する
    高瀬 信尚, Koma Yuichiro, 荒井 慎明, 小平 日実子, 細野雅義, 市原 有美, 西尾 真理, 重岡 学, Kakeji Yoshihiro, Yokozaki Hiroshi
    第26回日本消化器癌発生学会, Nov. 2015, Japanese, The Japanese Society for Gastroenterological Carcinogenesis, 米子, Domestic conference
    Oral presentation

  • 3D内視鏡を用いた腹腔鏡下胃全摘術の有用性
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, 安田 貴志, Nakamura Tetsu, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第45回胃外科・術後障害研究会, Nov. 2015, Japanese, 胃外科・術後障害研究会, 名古屋, Domestic conference
    Oral presentation

  • 優秀ビデオセッション
    Kakeji Yoshihiro
    第68回日本胸部外科学会定期学術集会, Oct. 2015, Japanese, 特定非営利活動法人 日本胸部外科学会, 神戸, Domestic conference
    Others

  • 腹臥位食道癌手術における左上縦隔郭清の工夫
    Oshikiri Taro, Nakamura Tetsu, 瀧口 豪介, Kakeji Yoshihiro
    第68回日本胸部外科学会定期学術集会, Oct. 2015, Japanese, 特定非営利活動法人 日本胸部外科学会, 神戸, Domestic conference
    [Invited]
    Nominated symposium

  • 早期胃癌に対するESD後非治癒症例のリンパ節転移とESD後腫瘍遺残の危険因子の検討
    Kanaji Shingo, 石田 諒, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, 田中 賢一, Kakeji Yoshihiro
    第23回日本消化器関連学会週間(JDDW 2015), Oct. 2015, Japanese, JDDW 2015 運営委員会, 東京, Domestic conference
    Poster presentation

  • 食道扁平上皮癌におけるMTH1発現の意義の検討
    秋山 真吾, 佐伯 浩司, 北尾 洋之, 中司 悠, 田尻 裕匡, 堤 智崇, 由茅 隆文, 笠木 勇太, 杉山 雅彦, 中島 雄一郎, 大垣 吉平, 園田 英人, 沖 英次, Kakeji Yoshihiro
    第53回日本癌治療学会学術集会, Oct. 2015, Japanese, 一般社団法人 日本癌治療学会, 京都, Domestic conference
    Public symposium

  • 食道切除後の胸壁前経路有茎空腸再建術の有用性
    瀧口 豪介, Nakamura Tetsu, 向山 順子, 西 将康, 石田 諒, 音羽 泰則, 高瀬 信尚, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第68回日本胸部外科学会定期学術集会, Oct. 2015, Japanese, 特定非営利活動法人 日本胸部外科学会, 神戸, Domestic conference
    Public symposium

  • 食道癌に対する腹腔鏡補助下胃管作成・後縦隔再建術
    青木 丈明, Nakamura Tetsu, Oshikiri Taro, Kakeji Yoshihiro
    第68回日本胸部外科学会定期学術集会, Oct. 2015, Japanese, 特定非営利活動法人 日本胸部外科学会, 神戸, Domestic conference
    Oral presentation

  • 食道外科医からみた大動脈食道瘻の手術治療
    Nakamura Tetsu, 瀧口 豪介, 今西 達也, Oshikiri Taro, 山里 隆浩, Matsumori Masamichi, Okita Yutaka, Kakeji Yoshihiro
    第68回日本胸部外科学会定期学術集会, Oct. 2015, Japanese, 特定非営利活動法人 日本胸部外科学会, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 教育シンポジウム5: 医工連携と癌治療
    Kakeji Yoshihiro
    第53回日本癌治療学会学術集会, Oct. 2015, Japanese, 一般社団法人 日本癌治療学会, 京都, Domestic conference
    Others

  • 右鎖骨動脈起始異常を伴う食道癌に対する腹臥位胸腔鏡下食道切除術
    古出 隆大, Nakamura Tetsu, Kanaji Shingo, Suzuki Satoshi, Kakeji Yoshihiro
    第68回日本胸部外科学会定期学術集会, Oct. 2015, Japanese, 特定非営利活動法人 日本胸部外科学会, 神戸, Domestic conference
    Oral presentation

  • ヒト大腸直腸がん幹細胞のマイクロRNA発現に異種移植部位がおよぼす影響
    向山 順子, Shimono Yohei, 船越 洋平, Mukohara Toru, Kakeji Yoshihiro, Minami Hironobu
    第74回日本癌学会学術集会, Oct. 2015, Japanese, 日本癌学会, 名古屋, Domestic conference
    Oral presentation

  • ヒト大腸癌のがん幹細胞のマイクロRNA発現に異種移植部位がおよぼす影響
    向山 順子, Shimono Yohei, 船越 洋平, Mukohara Toru, Kakeji Yoshihiro, Minami Hironobu
    第74回日本癌学会学術総会, Oct. 2015, Japanese, 日本癌学会, 名古屋, Domestic conference
    Poster presentation

  • デジタルポスターセッション 胃-免疫・内分泌、その他（研究）1
    Kakeji Yoshihiro
    第23回日本消化器関連学会週間(JDDW 2015), Oct. 2015, Japanese, JDDW 2015 運営委員会, 東京, Domestic conference
    Others

  • Tips of laparoscopic lateral lymph node dissection for rectal cancer
    音羽 泰則, 向山 順子, 前原 律子, 植田 康司, 有本 聡, 細野 雅義, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第53回日本癌治療学会学術集会, Oct. 2015, Japanese, 一般社団法人 日本癌治療学会, 京都, Domestic conference
    Oral presentation

  • StageIII胃癌に対する術後補所化学療法DS vs S-1第III相試験(JACCRO GC-07)
    Kakeji Yoshihiro
    第53回日本癌治療学会学術集会, Oct. 2015, Japanese, 一般社団法人 日本癌治療学会, 京都, Domestic conference
    [Invited]
    Invited oral presentation

  • Stage II, III大腸癌に対する腹腔鏡下手術の有効性
    植田 康司, Kim Kiyonori, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第23回日本消化器関連学会週間(JDDW 2015), Oct. 2015, Japanese, JDDW 2015 運営委員会, 東京, Domestic conference
    Poster presentation

  • FACO Surgery Session 3 "Esophagus"
    Kakeji Yoshihiro
    第53回日本癌治療学会学術集会, Oct. 2015, Japanese, 一般社団法人 日本癌治療学会, 京都, Domestic conference
    Others

  • Effect of the xenotransplantation site on the microRNA expression of human colorectal cancer stem cells
    Junko Mukohyama, Shimono Yohei, Yohei Funakoshi, Mukohara Toru, Kakeji Yoshihiro, Minami Hironobu
    The 74th Annual Meeting of the Japanese Cancer Association, Oct. 2015, English, Japanese Cancer Association, 名古屋, Domestic conference
    Poster presentation

  • Combined thoracoscopic esophagectomy and pedicled jejunal transfer for esophageal cancer
    青木 丈明, Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Suzuki Satoshi, Kakeji Yoshihiro
    第53回日本癌治療学会学術集会, Oct. 2015, Japanese, 一般社団法人 日本癌治療学会, 京都, Domestic conference
    Oral presentation

  • 腹臥位食道癌手術におけるエネルギーデバイスの使い分けとコツ
    原田 仁, Oshikiri Taro, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, 音羽 泰則, 瀧口 豪介, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    第28回近畿内視鏡外科研究会, Sep. 2015, Japanese, 近畿内視鏡外科研究会事務局, 和歌山, Domestic conference
    Public symposium

  • 当教室における内視鏡外科技術認定（大腸）取得を目指す取り組み（弟子の立場から）
    有本 聡, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第28回近畿内視鏡外科研究会, Sep. 2015, Japanese, 近畿内視鏡外科研究会事務局, 和歌山, Domestic conference
    Oral presentation

  • 胃GISTに対する単孔式腹腔鏡下胃部分切除術の手術成績と手技の工夫
    多田羅 敬, Kanaji Shingo, Nakamura Tetsu, Suzuki Satoshi, Yamamoto Masashi, 今西 達也, 田中 賢一, Kakeji Yoshihiro
    第28回近畿内視鏡外科研究会, Sep. 2015, Japanese, 近畿内視鏡外科研究会事務局, 和歌山, Domestic conference
    Oral presentation

  • 腹腔鏡下直腸切除術においていかに縫合不全を減らすか － 当科での工夫 －
    Kim Kiyonori, Yamashita Kimihiro, Kanaji Shingo, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 特定因子の導入による人工大腸癌幹細胞の誘導
    石田 諒, 大嶋 野歩, Kakeji Yoshihiro, Aoi Takashi
    第25回日本サイトメトリー学会学術集会, Jul. 2015, Japanese, 日本サイトメトリー学会, 東京, Domestic conference
    Oral presentation

  • 大腸癌肝転移切除後の再発巣に対する切除の意義
    Kim Kiyonori, Sumi Yasuo, 有本 聡, 植田 康司, 向山 順子, Yamashita Kimihiro, Suzuki Satoshi, Kakeji Yoshihiro
    第83回大腸癌研究会, Jul. 2015, Japanese, 大腸癌研究会, 久留米, Domestic conference
    Oral presentation

  • 大腸癌イレウスに対する術前減圧後の腹腔鏡下切除術の有用性
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, Kanaji Shingo, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 食道切除術施行患者における経腸栄養の有用性
    今西 達也, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 食道切除後の胸壁前経路有茎空腸再建術の有用性
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, 裏川 直樹, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 食道癌手術における静脈血栓塞栓症予防 - エノキサパリンの安全性とVTEリスク因子の検討 -
    中川 暁雄, 音羽 泰則, 瀧口 豪介, 友野 絢子, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Poster presentation

  • 食道癌根治切除後の局所再発に対するSalvage CRTに関する検討
    Yamamoto Masashi, 今西 達也, Kanaji Shingo, Yamashita Kimihiro, Kim Kiyonori, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro, 奥野 達哉
    第37回日本癌局所療法研究会, Jul. 2015, Japanese, 日本癌局所療法研究会, 千葉, Domestic conference
    Oral presentation

  • 重複癌を有する食道切除術の意義
    音羽 泰則, Nakamura Tetsu, 瀧口 豪介, Yamamoto Masashi, 今西 達也, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 腫瘍誘導性骨髄由来抑制細胞(MDSC)に対する早期治療は肺の転移を抑制する
    西 将康, Yamashita Kimihiro, 木村 裕, 大坪 大, 田中 智子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Oshikiri Taro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第25回日本サイトメトリー学会学術集会, Jul. 2015, Japanese, 日本サイトメトリー学会, 東京, Domestic conference
    Oral presentation

  • 手術合併症危険因子からみた残胃癌外科治療の検討
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Nakamura Tetsu, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 主題III-4 遠隔転移を伴う症例に対する局所療法の意義
    Kakeji Yoshihiro
    第37回日本癌局所療法研究会, Jul. 2015, Japanese, 日本癌局所療法研究会, 千葉, Domestic conference
    Others

  • 再建臓器血流を勘考した再建・吻合方法の選択と成績
    瀧口 豪介, Nakamura Tetsu, 中川 暁雄, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Poster presentation

  • 合併症低減に向けた胸部食道癌手術
    Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 高齢者食道癌における術前補助化学療法について
    Yamamoto Masashi, Nakamura Tetsu, Kanaji Shingo, Yamashita Kimihiro, Kim Kiyonori, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 高齢者胃癌に対する胃切除術の予後規定因子の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 嫌気性菌感染により広範な食道壁内解離をきたした下部食道癌の1例
    原田 仁, Nakamura Tetsu, 友野 絢子, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Poster presentation

  • 局所進行癌に対する術前化学放射線療法を中心とした集学的治療
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 胸腔鏡下食道切除術の低侵襲性と根治性の両立を目指して
    Nakamura Tetsu, 瀧口 豪介, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Poster presentation

  • 一般演題 ポスター50 「術前化学療法2」
    Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Others

  • 一般演題 ポスター20 「合併症（狭窄・腸閉塞）」
    Nakamura Tetsu, 秋山 真吾, 向山 順子, 石田 諒, 西 将康, 高瀬 信尚, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Others

  • 一般演題1「サイトカイン・免疫（1）」
    Kakeji Yoshihiro
    第25回日本サイトメトリー学会学術集会, Jul. 2015, Japanese, 日本サイトメトリー学会, 東京, Domestic conference
    Others

  • クローン病長期寛解後に同時性二重大腸癌を発症した一例
    裏川 直樹, Yamashita Kimihiro, Kim Kiyonori, 今西 達也, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第37回日本癌局所療法研究会, Jul. 2015, Japanese, 日本癌局所療法研究会, 千葉, Domestic conference
    Oral presentation

  • NKT細胞活性化の抗腫瘍効果におけるアロ樹状細胞の有用性
    Yamashita Kimihiro, 西 将康, 田中 智子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第24回日本がん転移学会学術集会・総会, Jul. 2015, Japanese, 日本がん転移学会事務局, 大阪, Domestic conference
    Poster presentation

  • NCDデータを活用した腹腔鏡下胃切除術に関する臨床試験の展開
    Kakeji Yoshihiro, 吉田 和弘, 比企 直樹, 小寺 泰弘, 衛藤 剛, 本田 通孝, 山下 裕一, 佐々木 章, 若林 剛, 宮田 裕章
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    [Invited]
    Invited oral presentation

  • International Video Symposium3 [English] : Colorectum
    Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Others

  • ALBとCRP値を用いた術前補助化学療法の効果と術後合併症の予測
    音羽 泰則, Nakamura Tetsu, 瀧口 豪介, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回日本食道学会学術集会, Jul. 2015, Japanese, 特定非営利活動法人 日本食道学会, 横浜, Domestic conference
    Poster presentation

  • 80歳以上の超高齢者大腸癌患者に対する腹腔鏡下手術の有用性について
    前原 律子, Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第70回日本消化器外科学会, Jul. 2015, Japanese, 一般社団法人 日本消化器外科学会, 浜松, Domestic conference
    Oral presentation

  • 3D内視鏡下での単孔式腹腔鏡下横行結腸切除術について
    Sumi Yasuo, 有本 聡, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Oshikiri Taro, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第9回単孔式内視鏡手術研究会, Jul. 2015, Japanese, 単孔式内視鏡手術研究会事務局, 秋田, Domestic conference
    [Invited]
    Invited oral presentation

  • 当院における食道癌患者に対するNEST介入について
    Yamamoto Masashi, Nakamura Tetsu, Kanaji Shingo, Yamashita Kimihiro, Kim Kiyonori, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro, 戸田 明代, Takahashi Michiko, Usami Makoto
    第40回日本外科系連合学会学術集会, Jun. 2015, Japanese, 日本外科系連合学会, 東京, Domestic conference
    Public symposium

  • 招請講演4 食道癌に対する胸腔鏡下食道切除術の現状と展望
    Kakeji Yoshihiro
    第58回関西胸部外科学会学術集会, Jun. 2015, Japanese, 関西胸部外科学会事務局, 岡山, Domestic conference
    Others

  • 高齢者胃癌に対する異説叙述後合併症の予後に及ぼす影響
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, 田中 賢一, Kakeji Yoshihiro
    第40回日本外科系連合学会学術集会, Jun. 2015, Japanese, 日本外科系連合学会, 東京, Domestic conference
    Public symposium

  • 形成外科との連携による微小血管吻合を用いた食道再建術の現状
    植田 康司, Nakamura Tetsu, Hashikawa Kazunobu, 原田 仁, Yamamoto Masashi, Kanaji Shingo, 今西 達也, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第40回日本外科系連合学会学術集会, Jun. 2015, Japanese, 日本外科系連合学会, 東京, Domestic conference
    Public symposium

  • ワークショップ2 バイオマーカーと遺伝子
    Kakeji Yoshihiro
    第24回日本癌病態治療研究会, Jun. 2015, Japanese, NPO法人 日本癌病態治療研究会事務局, 日光, Domestic conference
    Others

  • シンポジウム1 高齢者手術の周術期管理の工夫 －各領域のメディカルスタッフの立場から
    Kakeji Yoshihiro
    第40回日本外科系連合学会学術集会, Jun. 2015, Japanese, 日本外科系連合学会, 東京, Domestic conference
    Others

  • Outcome of Laparoscopic Colorectal Resection for Cancer in Elderly People at least 85 Years Old
    前原 律子, Sumi Yasuo, 向山 順子, 友野 絢子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    23rd International congress of the European Association for Endoscopic Surgery (EAES), Jun. 2015, English, The European Association for Endoscopic Surgery, Bucharest, International conference
    Oral presentation

  • Laparoscopic Surgery for the Patients with Gastric Cancer and Situs Inversus Totalis
    友野 絢子, 原田 仁, 前原 律子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    23rd International congress of the European Association for Endoscopic Surgery (EAES), Jun. 2015, English, The European Association for Endoscopic Surgery, Bucharest, International conference
    Poster presentation

  • Laparoscopic Ileocecal Resection Can Be Applied for Appendiceal Cancer with a Fistula to the Ileum.
    向山 順子, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    23rd International congress of the European Association for Endoscopic Surgery (EAES), Jun. 2015, English, The European Association for Endoscopic Surgery, Bucharest, International conference
    Poster presentation

  • A Comparison of Laparoscopic Surgery and Open Surgery for Advanced Rectal Cancer
    Sumi Yasuo, 前原 律子, 向山 順子, 友野 絢子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    23rd International congress of the European Association for Endoscopic Surgery (EAES), Jun. 2015, English, The European Association for Endoscopic Surgery, Bucharest, International conference
    Poster presentation

  • 85歳以上の超高齢者大腸癌患者に対する腹腔鏡手術の有用性の検討
    前原 律子, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第40回日本外科系連合学会学術集会, Jun. 2015, Japanese, 日本外科系連合学会, 東京, Domestic conference
    Public symposium

  • 3D映像が内視鏡外科手術にもたらす効果の検討
    西 将康, Kanaji Shingo, 原田 仁, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第24回日本癌病態治療研究会, Jun. 2015, Japanese, NPO法人 日本癌病態治療研究会事務局, 日光, Domestic conference
    Public symposium

  • 腹腔鏡下直腸切除術における簡便な綿テープ牽引法を用いた術野展開の工夫について
    Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, Kanaji Shingo, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回手術手技研究会, May 2015, Japanese, 手術手技研究会事務局, 高崎, Domestic conference
    [Invited]
    Nominated symposium

  • 直腸癌に対する腹開陰式直腸切断術における骨盤大網形成術による感染対策
    Kakeji Yoshihiro, Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, Nakamura Tetsu, Suzuki Satoshi
    第69回手術手技研究会, May 2015, Japanese, 手術手技研究会事務局, 高崎, Domestic conference
    Keynote oral presentation

  • 大腸(1)
    Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, 向山 順子, 前原 律子, 多田羅 敬, 古出 隆大, 細野 雅義, 中川 暁雄, Kanaji Shingo, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第197回近畿外科学会, May 2015, Japanese, 近畿外科学会事務局, 大阪, Domestic conference
    Others

  • 臓器血流に配慮した食道再建術の工夫
    古出 隆大, Nakamura Tetsu, 原田 仁, 瀧口 豪介, 音羽 泰則, 友野 絢子, 裏川 直樹, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回手術手技研究会, May 2015, Japanese, 手術手技研究会事務局, 高崎, Domestic conference
    Public symposium

  • 食道癌手術における3D-CTによる気管支動脈走行の術前ナビゲーション
    今西 達也, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第69回手術手技研究会, May 2015, Japanese, 手術手技研究会事務局, 高崎, Domestic conference
    Public symposium

  • 腫瘍誘導性骨髄由来抑制細胞(MDSC)に対する治療は肺の転移を抑制する
    西 将康, Yamashita Kimihiro, 長谷川 寛, 木村 裕, 田中 智子, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第36回癌免疫外科研究会, May 2015, Japanese, 癌免疫外科研究会, 奄美, Domestic conference
    Oral presentation

  • 一般口演5「マーカー」
    Kakeji Yoshihiro
    第36回癌免疫外科研究会, May 2015, Japanese, 癌免疫外科研究会, 奄美, Domestic conference
    Others

  • αGalCer-NKT細胞活性化の抗腫瘍効果におけるアロ樹状細胞の有用性
    田中 智子, Yamashita Kimihiro, 西 将康, 長谷川 寛, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Sumi Yasuo, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第36回癌免疫外科研究会, May 2015, Japanese, 癌免疫外科研究会, 奄美, Domestic conference
    Oral presentation

  • ヒト乳がん手術検体異種移植腫瘍の増殖抑制に関わるNK細胞浸潤機構の検討
    向山 順子, Shimono Yohei, Yamashita Kimihiro, Minami Hironobu, Kakeji Yoshihiro
    第36回癌免疫外科研究会, May 2015, Japanese, 癌免疫外科研究会, 奄美, Domestic conference
    Oral presentation

  • ReGISTry Study of High Risk GIST Patients After Complete Resection:The adjuvant therapy and pathological diagnosis in Japan.
    Toshirou Nishida, Yuko Kitagawa, Yukinori Kurokawa, Yoshito Komatsu, Chikashi Ishioka, Toshihiko Doi, Yasuhide Yamada, Masato Ozaka, Haruhiko Cho, Tetsuo Kanda, Toshiro Sugiyama, Akira Sawaki, Kakeji Yoshihiro, Toshihiro Hirai, Shinji Hato, Hideo Baba, Kuniaki Shirao, Seiichi Hirota, Tatsuo Kagimura
    2015 ASCO Annual Meeting, May 2015, English, American Society of Clinical Oncology, Chicago, Illinois, International conference
    Poster presentation

  • Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07).
    Kakeji Yoshihiro, Yasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, Masazumi Takahashi, Takayuki Kii, Atsushi Ishiguro, Kiyoshi Ishigure, Akinori Takagane, Takanori Matsui, Masahide Kaji, Wataru Ichikawa, Takeshi Sano, Masahiro Takeuchi, Masashi Fujii, Toshifusa Nakajima
    2015 ASCO Annual Meeting, May 2015, English, American Society of Clinical Oncology, Chicago, Illinois, International conference
    Others

  • A central review of liver resectability and pathological tumor response after chemotherapy in patients with initially unresectable colorectal cancer liver metastases: Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802), and SOX (S-1 and oxaliplatin) p
    Eiji Oki, Yasunori Emi, Hiroshi Saeki, Shoji Tokunaga, Toru Beppu, Ken Shirabe, Mitsuhisa Takatsuki, Shinji Uchida, Masahiko Sakoda, Susumu Eguchi, Masafumi Inomata, Yoshito Akagi, Shoji Natsugoe, Yutaka Ogata, Kakeji Yoshihiro, Hideo Baba, Kenichi Iyama, Yoshihiko Maehara
    2015 ASCO Annual Meeting, May 2015, English, American Society of Clinical Oncology, Chicago, Illinois, International conference
    Others

  • 反回神経麻痺の低減を目指した胸腔鏡下食道切術の定型化と工夫
    Nakamura Tetsu, 秋山 真吾, 向山 順子, 石田 諒, 西 将康, 高瀬 信尚, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 当施設における女性外科医のリクルートと支援
    Kido Masahiro, Fukumoto Takumi, Takebe Atsushi, Tanaka Motofumi, Kinoshita Hisoka, Kuramitsu Kaori, Ajiki Tetsuo, Toyama Hirochika, Asari Sadaki, Goto Tadahiro, Matsumoto Taku, Kakeji Yoshihiro, Ku Yonson
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 日本外科学会, 名古屋, Domestic conference
    [Invited]
    Invited oral presentation

  • 直腸癌に対する腹腔鏡下手術の有用性について
    Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, 向山 順子, 前原 律子, 多田羅 敬, 古出 隆大, 細野 雅義, 中川 暁雄, Kanaji Shingo, Yamamoto Masashi, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 大腸癌治療戦略最前線
    Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Public discourse

  • 大腸癌の両葉多発肝転移に対する術前化学療法の安全性と有用性
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, 高井 亮, 前原 律子, 古出 隆大, 多田羅 敬, 細野 雅義, 中川 暁雄, 友野 絢子, Kanaji Shingo, Yamamoto Masashi, 森川 剛志, 今西 達也, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Ku Yonson, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 食道切除後の胸壁前経路有茎空腸再建術の有用性
    瀧口 豪介, Nakamura Tetsu, 向山 順子, 西 将康, 石田 諒, 音羽 泰則, 裏川 直樹, 友野 絢子, 高瀬 信尚, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 食道癌手術におけるエノキサパリンの安全性及び投与下におけるVTE リスク因子の検討
    中川 暁雄, 高井 亮, 前原 律子, 古出 隆大, 多田羅 敬, 細野 雅義, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, 森川 剛志, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 治癒切除不能大腸癌に対する原発巣切除の意義
    向山 順子, Yamashita Kimihiro, Kim Kiyonori, 今西 達也, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 高齢者胃癌に対する安全な術式選択
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Nakamura Tetsu, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 化学放射線療法後の進行直腸癌に対する腹腔鏡下手術の有用性の検討
    前原 律子, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, 今西 達也, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • Siewert II 型食道胃接合部癌に対する下縦隔立体構造を意識した腹腔鏡下リンパ節郭清と簡便な偽His角・fornix 形成食道胃管吻合法
    Kanaji Shingo, Suzuki Satoshi, Nakamura Tetsu, 裏川 直樹, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 75 歳以上高齢者食道癌に対する術前化学療法と手術の安全性
    Yamamoto Masashi, Nakamura Tetsu, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, 今西 達也, Sumi Yasuo, Suzuki Satoshi, 田中 賢一, Kakeji Yoshihiro
    第115回日本外科学会定期学術集会, Apr. 2015, Japanese, 一般社団法人日本外科学会, 名古屋, Domestic conference
    Oral presentation

  • 噴門側胃切除後の残胃癌について
    Yamamoto Masashi, Suzuki Satoshi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 特別講演2
    Kakeji Yoshihiro
    第2回神戸外科手術・感染症セミナー, Mar. 2015, Japanese, 大正富山医薬品株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 短期予後からみた高齢者胃癌に対する外科治療の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Public symposium

  • 神経内分泌細胞成分を伴う胃癌に対する集学的治療の有用性
    友野 絢子, Suzuki Satoshi, Yamamoto Masashi, 音羽 泰則, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro, Itoh Tomoo
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 食道胃接合部腺癌におけるリンパ節転移分布および再発形式からみた縦隔リンパ節郭清範囲の検討
    裏川 直樹, Suzuki Satoshi, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Public discourse

  • 高度進行胃癌に対するconversion surgeryの意義と時期について
    音羽 泰則, Suzuki Satoshi, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 教室における胃肝癌症例の検討
    Nakamura Tetsu, 西 将康, 瀧口 豪介, 音羽 泰則, 友野 絢子, 裏川 直樹, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 遠位側胃切除後に発生した残胃癌に対する手術成績の検討
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 胃GISTに対する腹腔鏡下胃切除の有用性
    古出 隆大, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • パネルディスカッション7 高齢者に対する術後補所化学療法の問題点と工夫
    Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    [Invited]
    Nominated symposium

  • ESD治療後の胃癌に対する腹腔鏡下胃切除症例の検討
    石田 諒, Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第87回日本胃癌学会総会, Mar. 2015, Japanese, 日本胃癌学会, 広島, Domestic conference
    Poster presentation

  • 当院における食道癌根治切除後の局所再発に対するSalvage CRTに関する検討
    Yamamoto Masashi, Imanishi Tatsuya, Tanaka Kenichi, Kakeji Yoshihiro
    日本消化器病学会近畿支部 第102回例会, Feb. 2015, Japanese, 日本消化器病学会, 京都, Domestic conference
    Oral presentation

  • 症例報告ディスカッション
    Kakeji Yoshihiro
    神戸大学外科創傷セミナー（SSIに対する新たなる挑戦）, Jan. 2015, Japanese, KCI, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 教育講演
    Kakeji Yoshihiro
    神戸大学外科創傷セミナー（SSIに対する新たなる挑戦）, Jan. 2015, Japanese, KCI, 神戸, Domestic conference
    Oral presentation

  • 特別講演 ロボット支援胃切除術の導入経験と今後の展望
    Kakeji Yoshihiro
    第4回神戸Robotic Surgeryセミナー, Dec. 2014, Japanese, コヴィディエンジャパン, 神戸, Domestic conference
    Public discourse

  • 特別講演II 大腸癌肝転移に対する化学療法の意義と効果判定の新しい考え方
    Kakeji Yoshihiro
    Chugai Colorectal Cancer Symposium in HYOGO, Nov. 2014, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Public discourse

  • 転移性肺腫瘍に対する治療標的としての腫瘍誘導性骨髄由来抑制細胞
    Yamashita Kimihiro, 木村 裕, 西 将康, 大坪 大, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第25回日本消化器癌発生学会総会, Nov. 2014, Japanese, 日本消化器癌発生学会, 福岡, Domestic conference
    Oral presentation

  • 大腸癌 基礎
    Kakeji Yoshihiro
    第69回日本大腸肛門病学会学術集会, Nov. 2014, Japanese, 日本大腸肛門病学会, 横浜, Domestic conference
    Public discourse

  • 腫瘍関連マクロファージが分泌するGDF15は食道扁平上皮癌の腫瘍増殖、進展に関与する
    裏川 直樹, 宇都宮 壮顕, 荒井 慎明, 市原 有美, 高瀬 信尚, 西尾 真理, 重岡 学, Kakeji Yoshihiro, Koma Yuichiro, Yokozaki Hiroshi
    第25回日本消化器癌発生学会総会, Nov. 2014, Japanese, 日本消化器癌発生学会, 福岡, Domestic conference
    Oral presentation

  • 気道狭窄をきたした食道神経鞘腫の1例
    Tane Shinya, 大隈 宏通, 小川 裕行, Hokka Daisuke, Tanaka Yugo, 友野 絢子, Kanaji Shingo, Nakamura Tetsu, Kakeji Yoshihiro, Maniwa Yoshimasa
    第66回日本気管食道科学会, Nov. 2014, Japanese, 日本気管食道科学会, 高知, Domestic conference
    Oral presentation

  • ポスター14 症例報告（2）
    Kakeji Yoshihiro
    第25回日本消化器癌発生学会総会, Nov. 2014, Japanese, 日本消化器癌発生学会, 福岡, Domestic conference
    [Invited]
    Invited oral presentation

  • セツキシマブの特徴を活かした大腸癌治療戦略
    Kakeji Yoshihiro
    第2回北大阪大腸癌化学療法カンファレンス, Nov. 2014, Japanese, Bristol-Myers Squibb、Merck Serono, 大阪, Domestic conference
    Public discourse

  • Stage IV胃癌に対する外科治療
    Kakeji Yoshihiro
    第76回日本臨床外科学会総会, Nov. 2014, Japanese, 日本臨床外科学会, 郡山, Domestic conference
    [Invited]
    Invited oral presentation

  • Allogeneoc DCGを用いたNKT細胞活性化と抗腫瘍効果の検討
    西 将康, Yamashita Kimihiro, 長谷川 寛, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第25回日本消化器癌発生学会総会, Nov. 2014, Japanese, 日本消化器癌発生学会, 福岡, Domestic conference
    Oral presentation

  • 要望演題（ビデオ）1 研修医・専門医によるビデオ（吻合・縫合）1
    Kakeji Yoshihiro
    第27回内視鏡外科学会総会, Oct. 2014, Japanese, 内視鏡外科学会, 盛岡, Domestic conference
    [Invited]
    Invited oral presentation

  • 腹腔鏡下大腸全摘出術における小切開を置かない回腸嚢作成方法について
    前原 律子, Sumi Yasuo, Kakeji Yoshihiro, Tanaka Kenichi, Suzuki Satoshi, Nakamura Tetsu, Imanishi Tatsuya, Yamashita Kimihiro, Kim Kiyonori, Kanaji Shingo, Yamamoto Masashi
    第27回内視鏡外科学会総会, Oct. 2014, Japanese, 内視鏡外科学会, 盛岡, Domestic conference
    Oral presentation

  • 特別講演I 腹腔鏡でみる進行直腸癌手術に役立つ骨盤解剖
    Kakeji Yoshihiro
    神戸消化器外科カンファレンス, Oct. 2014, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • 特別講演I 食道癌集学的治療における個別化とsalvage surgery
    Kakeji Yoshihiro
    第12回神戸消化器外科懇話会学術講演会, Oct. 2014, Japanese, 神戸消化器外科懇話会、株式会社大塚製薬工場、イーエヌ大塚製薬株式会社, 神戸, Domestic conference
    Public discourse

  • 当院における高齢者大腸癌腹腔鏡手術成績
    Tanaka Kenichi, 三浦 由紀子, 前原 律子, 古出 隆大, 細野 雅義, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, 森川 剛志, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    第27回内視鏡外科学会総会, Oct. 2014, Japanese, 内視鏡外科学会, 盛岡, Domestic conference
    Oral presentation

  • 食道癌に対する胸腔鏡下手術の長期成績
    Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, 高瀬 信尚, 友野 絢子, 裏川 直樹, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第27回内視鏡外科学会総会, Oct. 2014, Japanese, 内視鏡外科学会, 盛岡, Domestic conference
    Oral presentation

  • 根治切除不能なStage4大腸癌に対して、原発巣切除を先行する意義
    奥本 龍夫, 横山 伸二, 野田 雅史, 松原 長秀, Kakeji Yoshihiro, 富田 尚裕
    JDDW 2014 (Japan Digestive Disease Week 2014)第22回日本消化器関連学会週間, Oct. 2014, Japanese, JDDW, 神戸, Domestic conference
    Poster presentation

  • 高齢者胃癌に対する腹腔鏡補助下幽門側胃切除の安全性の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第27回内視鏡外科学会総会, Oct. 2014, Japanese, 内視鏡外科学会, 盛岡, Domestic conference
    Oral presentation

  • ランチョンセミナー53 集学的治療としての鏡視下手術の役割
    Kakeji Yoshihiro
    JDDW 2014 (Japan Digestive Disease Week 2014)第22回日本消化器関連学会週間, Oct. 2014, Japanese, JDDW, 神戸, Domestic conference
    Public discourse

  • デジタルポスターセッション 胃6
    Kakeji Yoshihiro
    JDDW 2014 (Japan Digestive Disease Week 2014)第22回日本消化器関連学会週間, Oct. 2014, Japanese, JDDW, 神戸, Domestic conference
    [Invited]
    Nominated symposium

  • 3Dハイビジョン映像システムによって腹腔鏡下大腸切除術はどう変わるか
    Sumi Yasuo, 前原 律子, 古出 隆大, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第27回内視鏡外科学会総会, Oct. 2014, Japanese, 内視鏡外科学会, 盛岡, Domestic conference
    Oral presentation

  • 閉塞性大腸癌に対する術前減圧後の腹腔鏡下切除術の有用性
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, 森川 剛志, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第6回日本Acute Care Surgery学会学術集会, Sep. 2014, Japanese, 日本Acute Care Surgery 学会学術, 青森, Domestic conference
    Oral presentation

  • 噴門GISTに対する腹腔鏡下局所切除における手技の工夫と治療成績
    裏川 直樹, Kanaji Shingo, Suzuki Satoshi, Nakamura Tetsu, Yamamoto Masashi, Imanishi Tatsuya, Tanaka Kenichi, Kakeji Yoshihiro
    第27回近畿内視鏡外科研究会, Sep. 2014, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Oral presentation

  • 特別講演II 消化器がん克服を目指した探索的医療開発
    Kakeji Yoshihiro
    第10回神戸がん研究会, Sep. 2014, Japanese, 神戸がん研究会, 神戸, Domestic conference
    Public discourse

  • Clinicopathological significance of GDF15 in the microenvironment of human esophageal squamous cell carcinoma
    裏川 直樹, 宇都宮 壮顕, 荒井 慎明, 市原 有美, 高瀬 信尚, 西尾 真理, 重岡 学, Koma Yuichiro, Kakeji Yoshihiro, Yokozaki Hiroshi
    The 73rd Annual Meeting of the Japanese Cancer Association, Sep. 2014, Japanese, Japanese Cancer Association, 横浜, Domestic conference
    Poster presentation

  • 呼吸困難にて発症した食道脂肪肉腫の1例
    瀧口 豪介, Nakamura Tetsu, Kakeji Yoshihiro
    第6回日本Acute Care Surgery学会学術集会, Sep. 2014, Japanese, 日本Acute Care Surgery 学会学術, 青森, Domestic conference
    Oral presentation

  • 右鎖骨下動脈起始異常を伴う食道癌に対する腹臥位腔鏡下食道切除術の経験
    古出 隆大, Nakamura Tetsu, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第27回近畿内視鏡外科研究会, Sep. 2014, Japanese, 近畿内視鏡外科研究会, 神戸, Domestic conference
    Oral presentation

  • Effect of natural killer cell infiltration on the growth of the mouse xenografts tumors of human breast cancers.
    向山 順子, Shimono Yohei, 船越 洋平, Mukohara Toru, Matsuoka Hiroshi, Kakeji Yoshihiro, Minami Hironobu
    The 73rd Annual Meeting of the Japanese Cancer Association, Sep. 2014, Japanese, Japanese Cancer Association, 横浜, Domestic conference
    Poster presentation

  • Effect of natural killer cell infiltration on the growth of the mouse xenografts tumors of human breast cancers.
    Junko Mukohyama, Shimono Yohei, Yohei Funakoshi, Mukohara Toru, Matsuoka Hiroshi, Kakeji Yoshihiro, Minami Hironobu
    The 73rd Annual Meeting of the Japanese Cancer Association, Sep. 2014, English, Japanese Cancer Association, 横浜, Domestic conference
    Poster presentation

  • ASCO、ESMOGI後の大腸癌治療を考える
    Kakeji Yoshihiro
    CRC Core Meeting in KOBE, Sep. 2014, Japanese, Bristol-Myers Squibb、Merck Serono, 神戸, Domestic conference
    Public discourse

  • 縫合不全に対し単孔式腹腔鏡下回瘻増設術を施行した3例
    Sumi Yasuo, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    3rd Reduced Port Surgery Forum 2014 in Fukui, Aug. 2014, Japanese, 単孔式内視鏡手術研究会, 福井, Domestic conference
    Oral presentation

  • 食道癌に対する手術治療の最前線
    Kakeji Yoshihiro
    第52回日本癌治療学会学術集会, Aug. 2014, Japanese, 日本癌治療学会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • 食道がん
    Kakeji Yoshihiro
    第52回日本癌治療学会学術集会, Aug. 2014, Japanese, 日本癌治療学会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • 高齢者大腸癌に対する腹腔胸手術の有用性について
    前原 律子, Kim Kiyonori, Sumi Yasuo, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第52回日本癌治療学会学術集会, Aug. 2014, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • 胃癌における機能温存手術
    Suzuki Satoshi, Kanaji Shingo, Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Tanaka Kenichi, Kakeji Yoshihiro
    第52回日本癌治療学会学術集会, Aug. 2014, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Oral presentation

  • シンポジウム04 胃がん治療戦略のUp to Date
    Kakeji Yoshihiro
    第52回日本癌治療学会学術集会, Aug. 2014, Japanese, 日本癌治療学会, 横浜, Domestic conference
    [Invited]
    Nominated symposium

  • 有茎空腸再建術における手技の工夫-良好な血流と挙上性を確保するコツ-
    Nakamura Tetsu, 瀧口 豪介, Yamamoto Masashi, Kanaji Shingo, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 腹腔鏡下側方リンパ節郭清のコツ～2つの膜を意識して～
    Sumi Yasuo, Yamashita Kimihiro, Kim Kiyonori, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 腹腔鏡下胃癌手術における合併症危険因子と治療成績向上にむけた対策
    Kanaji Shingo, Suzuki Satoshi, 原田 仁, 安田 貴志, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, 藤野 泰宏, 富永 正浩, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 大腸癌肝転移術前化学療法における新しい組織学的効果判定基準mTRGの有用性
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, 豊川 晃弘, 富永 正寛, Ku Yonson, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器病学会, 福島, Domestic conference
    Keynote oral presentation

  • 大腸癌肝転移に対する治療の現況
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第23回がん転移学会学術集会・総会, Jul. 2014, Japanese, がん転移学会, 金沢, Domestic conference
    Public symposium

  • 食道癌術後合併症対策-当科における取り組み
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 食道癌術後胃管気管瘻に対し、大胸筋皮弁を用いた修復術を行った1例
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第68回日本食道学会学術集会, Jul. 2014, Japanese, 日本食道学会, 東京, Domestic conference
    Poster presentation

  • 食道Liposarcomaの1例
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, 友野 絢子, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第68回日本食道学会学術集会, Jul. 2014, Japanese, 日本食道学会, 東京, Domestic conference
    Poster presentation

  • 術前補助化学療法を施行した食道癌cStageII/IIIにおけるmGPSの意義
    音羽 泰則, Nakamura Tetsu, Yamashita Kimihiro, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第68回日本食道学会学術集会, Jul. 2014, Japanese, 日本食道学会, 東京, Domestic conference
    Poster presentation

  • 術前化学放射線療法を用いた側方リンパ節転移陽性進行直腸癌の治療成績
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 骨髄由来抑制細胞(MDSC)の癌転移に対する治療的意義
    Yamashita Kimihiro, 木村 裕, 西 将康, Yamamoto Masashi, 大坪 大, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第23回がん転移学会学術集会・総会, Jul. 2014, Japanese, がん転移学会, 金沢, Domestic conference
    Oral presentation

  • 高齢者大腸癌症例の手術適応
    Tanaka Kenichi, 西 将康, 向山 順子, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Nakamura Tetsu, Imanishi Tatsuya, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 高齢者食道癌に対する術前化学療法+鏡視下手術は標準治療となりうる
    Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 高齢者胃癌に対する腹腔鏡補助下幽門側胃切除の安全性の検討
    Suzuki Satoshi, Kanaji Shingo, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Oral presentation

  • 抗EGFR抗体を用いた治療戦略ASC最新報告活かす最新治療戦略2014
    Kakeji Yoshihiro
    新時代の切除不能進行・再発大腸癌治療を考える, Jul. 2014, Japanese, 武田薬品工業株式会社, 姫路, Domestic conference
    Public discourse

  • 抗EGFR抗体を用いた治療戦略ASC最新報告
    Kakeji Yoshihiro
    大腸がん治療を高めるためにIN HIROSAKI, Jul. 2014, Japanese, 武田薬品工業株式会社, 弘前, Domestic conference
    Public discourse

  • 抗EGFR抗体を活かす最新治療戦略2014
    Kakeji Yoshihiro
    大腸癌 Meeting～生存期間の延長を目指して～, Jul. 2014, Japanese, 武田薬品工業株式会社, 加古川, Domestic conference
    Public discourse

  • 胸部食道癌に対する胸腔鏡下食道切除術の遠隔治療成績の検討
    Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, 裏川 直樹, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第68回日本食道学会学術集会, Jul. 2014, Japanese, 日本食道学会, 東京, Domestic conference
    Oral presentation

  • 気道狭窄を呈した食道神経鞘腫の一例
    友野 絢子, Nakamura Tetsu, 瀧口 豪介, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第68回日本食道学会学術集会, Jul. 2014, Japanese, 日本食道学会, 東京, Domestic conference
    Poster presentation

  • 一般演題 癌 ポスター61 予測因子3
    Kakeji Yoshihiro
    第68回日本食道学会学術集会, Jul. 2014, Japanese, 日本食道学会, 東京, Domestic conference
    Oral presentation

  • ランチョンセミナー OS延長を目指す新時代の抗EGFR抗体薬の使い方
    Kakeji Yoshihiro
    第69回日本消化器外科学会総会, Jul. 2014, Japanese, 日本消化器外科学会, 郡山, Domestic conference
    Public discourse

  • SessionII 静岡がんセンターでの直腸癌手術への取り組み
    Kakeji Yoshihiro
    平成大腸癌カンファレンス, Jul. 2014, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    [Invited]
    Nominated symposium

  • SessionII消化器がんの臨床と研究 up to date
    Kakeji Yoshihiro
    兵庫県消化器外科研究会2014, Jul. 2014, Japanese, 小野薬品工業株式会社, 青森, Domestic conference
    Public discourse

  • Session 2 パネルディスカッション
    Kakeji Yoshihiro
    Chugai Colorectal Cancer Symposium in HYOGO, Jul. 2014, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    [Invited]
    Nominated symposium

  • 特別講演I 非代償性肝硬変患者の浮腫・腹水における新しい治療戦略～バソプレシンV2受容体拮抗剤～
    Kakeji Yoshihiro
    水利尿カンファレンス, Jun. 2014, Japanese, 大塚製薬, 神戸, Domestic conference
    Public discourse

  • 術前化学放射線療法により直腸切除術を施行した進行痔瘻癌の一例
    森川 剛志, Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第36回日本癌局所療法研究会, Jun. 2014, Japanese, 日本癌局所療法研究会, 八尾, Domestic conference
    Oral presentation

  • 胸部食道癌術後に胃管気管瘻を生じ、大胸筋皮弁による修復術を行った1例
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第23回近畿過大侵襲研究会, Jun. 2014, Japanese, -, 大阪, Domestic conference
    Oral presentation

  • 胸腔鏡手術は術直後の酸素化能が保たれており、開胸手術と同等の根治性を有する
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第57回関西胸部外科学会, Jun. 2014, Japanese, -, 大阪, Domestic conference
    Oral presentation

  • 何を、どう使う?分子標的薬の治療戦略2014
    Kakeji Yoshihiro
    Chugai Colorectal Cancer Seminar, Jun. 2014, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 胃10
    Kakeji Yoshihiro
    第36回日本癌局所療法研究会, Jun. 2014, Japanese, 日本癌局所療法研究会, 八尾, Domestic conference
    [Invited]
    Nominated symposium

  • シンポジウム4 胸部領域の鏡視下手術 －手術の工夫と安全対策 -
    Kakeji Yoshihiro
    第39回日本外科系連合学会学術集会, Jun. 2014, Japanese, -, 東京, Domestic conference
    [Invited]
    Nominated symposium

  • アロ樹状細胞を用いたNKT細胞活性化と抗腫瘍効果の検討
    西 将康, Yamashita Kimihiro, 長谷川 寛, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Sumi Yasuo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第23回日本癌病態治療研究会, Jun. 2014, Japanese, 日本癌病態研究会, 岐阜, Domestic conference
    Oral presentation

  • アロ樹状細胞を用いたCTL誘導の試み
    Yamashita Kimihiro, 西 将康, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第24回日本サイトメトリー学会学術集会, Jun. 2014, Japanese, 日本サイトメトリー学会, 枚方, Domestic conference
    [Invited]
    Nominated symposium

  • Experience of totally laparoscopic partial resection for hemangioma in the third portion of the duodenum
    西 将康, Kanaji Shingo, Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 60th Annual Congress of International College of Surgeons Japan Section, Jun. 2014, English, Department of General Surgical science, 高崎, International conference
    Oral presentation

  • Case Presentation Awards: 食道疾患
    Kakeji Yoshihiro
    第57回関西胸部外科学会, Jun. 2014, Japanese, -, 大阪, Domestic conference
    [Invited]
    Invited oral presentation

  • 分子標的薬を使いこなす（1） 胃癌・大腸癌
    Kakeji Yoshihiro, 水田 直美, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Minami Hironobu
    第25回日本在宅医療学会学術集会, May 2014, Japanese, 日本在宅医療学会, 倉敷, Domestic conference
    [Invited]
    Invited oral presentation

  • 腹腔鏡下直腸低位前方切除術における術野展開の工夫について
    Sumi Yasuo, Kim Kiyonori, Yamashita Kimihiro, Kanaji Shingo, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第68回手術手技研究会, May 2014, Japanese, 日本大学医学部消化器外科, 東京, Domestic conference
    Oral presentation

  • 腹腔鏡下胃癌手術における層構造を意識した脾動脈近位側リンパ説郭清
    Kanaji Shingo, Suzuki Satoshi, Nakamura Tetsu, Yamamoto Masashi, Imanishi Tatsuya, Tanaka Kenichi, Kakeji Yoshihiro
    第68回手術手技研究会, May 2014, Japanese, 日本大学医学部消化器外科, 東京, Domestic conference
    Oral presentation

  • 肺転移における骨髄由来抑制細胞の影響と治療的意義
    Yamashita Kimihiro, 木村 裕, 大坪 大, 長谷川 寛, 裏川 直樹, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第35回癌免疫外科研究会, May 2014, Japanese, -, 大阪, Domestic conference
    Oral presentation

  • 敗血症性DICに対する治療戦略～抗凝固療法の現状と今後の展望～
    Kakeji Yoshihiro
    第2回外科感染症セミナーin Kobe, May 2014, Japanese, 旭化成ファーマ株式会社、ファイザー株式会社, 神戸, Domestic conference
    Public discourse

  • 特別講演 食道胃接合部癌に対する治療戦略
    Kakeji Yoshihiro
    第46回兵庫県手術手技研究会, May 2014, Japanese, 持田製薬株式会社, 神戸, Domestic conference
    Oral presentation

  • 抗EGFR抗体の意義-RAS解析に基づくOS延長を見据えた大腸癌治療戦略-
    Kakeji Yoshihiro
    嶺南化学療法研究会, May 2014, Japanese, 武田薬品工業株式会社, 敦賀, Domestic conference
    [Invited]
    Invited oral presentation

  • 教育講演（総論） 消化器外科領域におけるSSIの現状とその対策
    Kakeji Yoshihiro
    V.A.C Summit関西, May 2014, Japanese, KCI, 神戸, Domestic conference
    Public discourse

  • 一般演題（口演）7「micro-RNA・予後因子」
    Kakeji Yoshihiro
    第35回癌免疫外科研究会, May 2014, Japanese, -, 大阪, Domestic conference
    Oral presentation

  • ESDを契機に発症したと考えられる急性虫垂炎の一例
    杉田 裕, Sumi Yasuo, Yamashita Kimihiro, Kim Kiyonori, Kanaji Shingo, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第195回近畿外科学会, May 2014, Japanese, 近畿外科学会, 天王寺, Domestic conference
    Oral presentation

  • 腹臥位食道切除術による術後酸素化能維持と肺合併症減少
    Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, 黒田 大介, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Poster presentation

  • 特別講演
    Kakeji Yoshihiro
    第3回神戸Robotic Surgeryセミナー, Apr. 2014, Japanese, コヴィディエンジャパン, 神戸, Domestic conference
    Public discourse

  • 当院における大腸癌肺転移切除症例の検討
    Tanaka Kenichi, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, 向山 順子, 西 将康, 石田 諒, 秋山 真吾, 瀧口 豪介, 音羽 泰則, 裏川 直樹, 友野 絢子, 高瀬 信尚, Yamamoto Masashi, Kanaji Shingo, 森川 剛志, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Maniwa Yoshimasa, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Poster presentation

  • Outcome of endoscopic therapy in superficial Barrett's esophageal carcinoma
    Ishida Tsukasa, Morita Yoshinori, Toyonaga Takashi, Tanaka Shinwa, 河原 史明, 小原 佳子, 吉崎 哲也, Kakeji Yoshihiro, Yokozaki Hiroshi, Azuma Takeshi
    The 87th congress of the Japan gastroenterological endoscopy society, Apr. 2014, Japanese, the Japan gastroenterological endoscopy society, 福岡, Domestic conference
    Poster presentation

  • 直腸癌側方リンパ節転移症例に対する術前化学放射線療法による治療効果
    音羽 泰則, Yamashita Kimihiro, Kim Kiyonori, Sumi Yasuo, 秋山 真吾, 石田 諒, 西 将康, 向山 順子, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Oral presentation

  • 大腸癌肝転移切除後の再発巣に対する再切除の意義
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, 向山 順子, 石田 諒, 西 将康, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Poster presentation

  • 食道扁平上皮癌に浸潤する腫瘍組織内CD204陽性マクロファージは腫瘍増殖、進展に関与する
    裏川 直樹, 宇都宮 壮顕, 綿島 健人, 高瀬 信尚, 西尾 真理, 重岡 学, Koma Yuichiro, 仙波 秀峰, Kakeji Yoshihiro, Yokozaki Hiroshi
    第103回日本病理学会総会, Apr. 2014, Japanese, 日本病理学会, 広島, Domestic conference
    Poster presentation

  • 食道切除術施行患者における経腸栄養の有用性
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Poster presentation

  • 術前化学放射線療法を施行した下部直腸癌に対する腹腔鏡下手術の有用性
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 石田 諒, 向山 順子, 音羽 泰則, Yamamoto Masashi, Kanaji Shingo, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Oral presentation

  • 腫瘍関連マクロファージで高発現する接着分子や細胞外基質の機能解析
    高瀬 信尚, Koma Yuichiro, 宇都宮 壮顕, 西尾 真理, 裏川 直樹, 重岡 学, 綿島 健人, 仙波 秀峰, Kakeji Yoshihiro, Yokozaki Hiroshi
    第103回日本病理学会総会, Apr. 2014, Japanese, 日本病理学会総会, 広島, Domestic conference
    Poster presentation

  • 高齢者食道癌に対する術前補助化学療法の検討
    Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Poster presentation

  • 胃癌肝転移に対する化学療法および手術療法の成績からみた治療戦略
    Suzuki Satoshi, 寒原 芳浩, Yamamoto Masashi, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, 原田 仁, 富永 正寛, Fukumoto Takumi, Ku Yonson, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Poster presentation

  • みんなで取り組む大腸がん治療
    Kakeji Yoshihiro
    大腸がんと言われた時～専門医による治療の最前線～, Apr. 2014, Japanese, 神戸新聞社, 神戸, Domestic conference
    Public discourse

  • Session5 神戸サイト企画: Q&A
    Kakeji Yoshihiro
    大腸癌治療ガイドライン講座-ガイドライン改定特別番組-, Apr. 2014, Japanese, 中外製薬株式会社, 神戸, Domestic conference
    Public discourse

  • Linear Stapler再建による完全鏡視下幽門側胃切除から胃全摘への安全確実なStep up
    Kanaji Shingo, Suzuki Satoshi, Yamamoto Masashi, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, Japanese, 一般社団法人日本外科学会, 京都, Domestic conference
    Oral presentation

  • International Session (10) Upper gastrointestinal tract surgery
    Kakeji Yoshihiro
    第114回日本外科学会定期学術集会, Apr. 2014, English, 一般社団法人日本外科学会, 京都, Domestic conference
    [Invited]
    Nominated symposium

  • 特別講演 外来治療におけスチバーガの使い方～愛知県がんセンター中央病院での取り組み～
    Kakeji Yoshihiro
    スチバーガ承認1周年記念講演会, Mar. 2014, Japanese, バイエル薬品株式会社, 神戸, Domestic conference
    Public discourse

  • 特別講演 S-1：5-FU最終兵器
    Kakeji Yoshihiro
    Colorectal Cancer Experts Meeting, Mar. 2014, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • 特別講演1 敗血症性ショックの病態と治療～2014MEIDAIバンドルM13S6～
    Kakeji Yoshihiro
    神戸外科手術・感染症セミナー, Mar. 2014, Japanese, 大正富山医薬品株式会社, 神戸, Domestic conference
    Public discourse

  • 当科における胃神経内分泌細胞癌8例の検討
    Yamamoto Masashi, Suzuki Satoshi, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 86th Annual Meeting of Japanese Gastric Association, Mar. 2014, Japanese, Meeting of Japanese Gastric Association, 横浜, Domestic conference
    Oral presentation

  • 大腸癌肝転移conversion例の検討、新しい組織学的効果判定基準、modified Tumor Regression Grade (mTRG)の再発予測における有用性
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, 友野 絢子, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, 豊川 晃弘, 富永 正寛, Ku Yonson, Kakeji Yoshihiro
    The 47th Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, Mar. 2014, Japanese, Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, 名古屋, Domestic conference
    Oral presentation

  • 主題関連演題2 上部消化官術後合併症の診断と治療
    Kakeji Yoshihiro
    第50回日本腹部救急医学会総会, Mar. 2014, Japanese, 日本腹部救急医学会, 新宿, Domestic conference
    Public discourse

  • 高齢者食道癌に対するNAC＋手術治療の現状と課題
    Yamamoto Masashi, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 47th Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, Mar. 2014, Japanese, Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, 名古屋, Domestic conference
    Oral presentation

  • 継続と展開 胃癌集学的治療戦略2014
    Kakeji Yoshihiro
    The 47th Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, Mar. 2014, Japanese, Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, 名古屋, Domestic conference
    Oral presentation

  • 経鼻、経肛門的チューブ減圧後に切除された閉寒性大腸癌症例の検討
    西 将康, Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 50th Annual Congress of Japanese Society for Abdominal Emergency Medicine, Mar. 2014, Japanese, Japanese Society for Abdominal Emergency Medicine, 東京, Domestic conference
    Oral presentation

  • 開会の辞
    Kakeji Yoshihiro
    神戸外科手術・感染症セミナー, Mar. 2014, Japanese, 大正富山医薬品株式会社, 神戸, Domestic conference
    Public discourse

  • 胃癌肝転移に対する治療戦略-肝切除の意義と役割-
    Suzuki Satoshi, 寒原 芳浩, Yamamoto Masashi, 金治 新悟, Kim Kiyonori, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Okuno Tatsuya, 藤島 佳未, 原田 仁, 富永 正寛, Fukumoto Takumi, Ku Yonson, Kakeji Yoshihiro
    The 86th Annual Meeting of Japanese Gastric Association, Mar. 2014, Japanese, Meeting of Japanese Gastric Association, 横浜, Domestic conference
    Oral presentation

  • 胃GISTに対する腹腔鏡下胃局所切除の有用性
    金治 新悟, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 86th Annual Meeting of Japanese Gastric Association, Mar. 2014, Japanese, Meeting of Japanese Gastric Association, 横浜, Domestic conference
    Oral presentation

  • 特別講演 直腸癌治療の最前線 ～ロボット手術を含めて～
    Kakeji Yoshihiro
    大腸癌治療セミナー in Kobe, Feb. 2014, Japanese, 大鵬薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • 特別講演I 胃癌化学療法のトピックス：術後補助化学療法の二次治療
    Kakeji Yoshihiro
    第16回神戸外科フォーラム, Feb. 2014, Japanese, 神戸外科フォーラム、 大薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • 当科におけるロボット支援腹腔鏡下直腸低位前方切除術の導入について
    Sumi Yasuo, Suzuki Satoshi, 金治 新悟, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 6th Annual Congress of Japan Robotic Surgery Society, Feb. 2014, Japanese, JAPAN ROBOTIC SURGERY SOCIETY, 福岡, Domestic conference
    Oral presentation

  • Modified Glasgow Prognostic Score Predicts Histological Respose of Neoadjuvant Chemotherapy in cStage II or III Esoph-ageal Cancer
    Nakamura Tetsu, Kanaji Shingo, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    9th Annual Academic Surgical Congress, Feb. 2014, English, Academic Surgical Congress, San Diego, The United States, International conference
    [Invited]
    Oral presentation

  • Modified Glasgow Prognostic Score Predicts Histological Response of Neoadjuvant Chemotherapy in cStage II or III Esophageal Cancer
    音羽 泰則, Nakamura Tetsu, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    9th Annual Academic Surgical Congress, Feb. 2014, English, Academic Surgical Congress, サンディエゴ, USA, International conference
    Oral presentation

  • Current State and Results of Treatment for Liver Metastases from Colorectal Cancer
    Kim Kiyonori, Sumi Yasuo, Yamashita Kimihiro, Yamamoto Masashi, 金治 新悟, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    9th Annual Academic Surgical Congress, Feb. 2014, English, Academic Surgical Congress, サンディエゴ, USA, International conference
    Oral presentation

  • 進行下部直腸癌治療における腹腔鏡下手術の意義
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 石田 諒, 向山 順子, 秋山 真吾, Yamamoto Masashi, 金治 新悟, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 80th Meeting of Japanese Society for Cancer of the Colon and Rectum, Jan. 2014, Japanese, 東京, Domestic conference
    Oral presentation

  • 新たなステージを迎えた大腸がん治療戦略-抗EGFR抗体の意義を考える-
    Kakeji Yoshihiro
    mCRC Expert Meeting in Yokkaichi 2014, Jan. 2014, Japanese, Takeda Pharmaceutical Company Limited, YOKKAICHI MEDICAL ASSOCIATION, 四日市, Domestic conference
    Public discourse

  • Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells
    Naoki Urakawa, Nobuhisa Takase, Manabu Shigeoka, Mari Nishio, Taketo Watajima, Souken Utsunomiya, Masakazu Yashiro, Hirakawa Kose, Koma Yuichiro, Semba Shuho, Kazuyoshi Yanagihara, Suzuki Satoshi, Kakeji Yoshihiro, Yokozaki Hiroshi
    The 4th JCA-AACR Special Joint Conference:The Latest Advances in Gastric Cancer Research:, Dec. 2013, English, JCA-AACR, Urayasu, gastric cancer, fibroblast, International conference
    Poster presentation

  • 閉寒性大腸癌に対する経肛門イレウスチューブ減圧後の腹腔鏡下手術例の検討
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, 金治 新悟, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    THE 26TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ENDPSCOPIC SURGERY, Nov. 2013, Japanese, JAPAN SOCIETY FOR ENDOSCOPIC SURGERY, 福岡, Domestic conference
    Oral presentation

  • 腹腔鏡下手術における簡便なセプラフィルム貼付法
    石田 諒, Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 金治 新悟, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    THE 26TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ENDPSCOPIC SURGERY, Nov. 2013, Japanese, JAPAN SOCIETY FOR ENDOSCOPIC SURGERY, 福岡, Domestic conference
    Oral presentation

  • 腹臥位鏡視下食道切除における術後酸素化能の改善
    Nakamura Tetsu, 瀧口 豪介, 音羽 泰則, 高瀬 信尚, 友野 絢子, 裏川 直樹, Yamamoto Masashi, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    THE 26TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ENDPSCOPIC SURGERY, Nov. 2013, Japanese, JAPAN SOCIETY FOR ENDOSCOPIC SURGERY, 福岡, Domestic conference
    Oral presentation

  • 特別講演 8、静脈血栓寒栓症
    Kakeji Yoshihiro
    The 75th Annual Congress of Japan Surgical Association, Nov. 2013, Japanese, Annual Congress of Japan Surgical Association, 名古屋, Domestic conference
    Oral presentation

  • 当科におけるロボット支援腹腔鏡下直腸低位前方切除術について
    Sumi Yasuo, 金治 新悟, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    THE 26TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ENDPSCOPIC SURGERY, Nov. 2013, Japanese, JAPAN SOCIETY FOR ENDOSCOPIC SURGERY, 福岡, Domestic conference
    [Invited]
    Invited oral presentation

  • 大腸癌に対する集学的治療戦略～いかに手術に持っていくか？～
    Kakeji Yoshihiro
    第15回近畿内視鏡下大腸手術研究会, Nov. 2013, Japanese, 近畿内視鏡下大腸手術研究会, 大阪, Domestic conference
    Keynote oral presentation

  • 食道胃接合部に近接する胃粘膜下腫瘍に対する腹腔鏡下胃部分切除の手術成績と手技の工夫
    金治 新悟, Nakamura Tetsu, Suzuki Satoshi, Yamamoto Masashi, Imanishi Tatsuya, Tanaka Kenichi, 藤野 泰宏, 富永 正寛, Kakeji Yoshihiro
    THE 26TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ENDPSCOPIC SURGERY, Nov. 2013, Japanese, JAPAN SOCIETY FOR ENDOSCOPIC SURGERY, 福岡, Domestic conference
    Oral presentation

  • 上気道・上部消化管5重複癌の一例
    音羽 泰則, Nakamura Tetsu, 瀧口 豪介, 友野 絢子, 裏川 直樹, 高瀬 信尚, Yamamoto Masashi, 金治 新悟, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 75th Annual Congress of Japan Surgical Association, Nov. 2013, Japanese, Annual Congress of Japan Surgical Association, 名古屋, Domestic conference
    [Invited]
    Invited oral presentation

  • 残胃癌に対する腹腔鏡補助下残胃全摘術の検討
    Suzuki Satoshi, 金治 新悟, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro, 黒田 大介
    THE 26TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ENDPSCOPIC SURGERY, Nov. 2013, Japanese, JAPAN SOCIETY FOR ENDOSCOPIC SURGERY, 福岡, Domestic conference
    Oral presentation

  • 胸腔鏡併用咽頭喉頭食道全摘術の治療成績
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, 友野 絢子, 裏川 直樹, 高瀬 信尚, Yamamoto Masashi, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 75th Annual Congress of Japan Surgical Association, Nov. 2013, Japanese, Annual Congress of Japan Surgical Association, 名古屋, Domestic conference
    Oral presentation

  • Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells
    裏川 直樹, 高瀬 信尚, 重岡 学, 西尾 真理, 綿島 健人, 宇都宮 壮顕, Koma Yuichiro, Semba Shuho, Suzuki Satoshi, Kakeji Yoshihiro, Yokozaki Hiroshi
    The Latest Advances in Gastric Cancer Research, Nov. 2013, Japanese, 東京, Domestic conference
    Oral presentation

  • 分子標的薬を活かす胃癌治療最前線
    Kakeji Yoshihiro
    Gastric Cancer Conference in Amagasaki, Oct. 2013, Japanese, CHUGAI PHARMACEUTICAL CO.,LTD., 兵庫, Domestic conference
    [Invited]
    Invited oral presentation

  • 腹臥位食道切除術と術後肺酸素化に与える影響
    Nakamura Tetsu, 高瀬 信尚, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, Yamamoto Masashi, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 66th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery, Oct. 2013, Japanese, THE JAPANESE ASSOCIATION FOR THORACIC SURGERY, 仙台, Domestic conference
    Oral presentation

  • 当科における食道GIST切除症例の検討
    Yamamoto Masashi, Imanishi Tatsuya, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, 黒田 大介, Kakeji Yoshihiro, 廣田 誠一
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Poster presentation

  • 当院における食道癌術後局所再発症例に対するSalvage化学放射線療法(CRT)の治療成績
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, 金治 新悟, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, 奥野 達也, 黒田 大介, Kakeji Yoshihiro
    The 51st Annual Meeting of Japan Society of Clinical Oncology, Oct. 2013, Japanese, Japan Society of Clinical Oncology, 京都, Domestic conference
    Oral presentation

  • 当院における食道癌術後局所再発症例に対するSalvage化学放射線療法(CRT)の治療成績
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Okuno Tatsuya, 黒田 大介, Kakeji Yoshihiro
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Poster presentation

  • 大腸癌内視鏡切除後の追加外科切除例の検討
    Kim Kiyonori, Yamashita Kimihiro, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, Yamamoto Masashi, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Poster presentation

  • 切除不能大腸癌症例に対する手術介入の有用性
    藤島 佳未, Okuno Tatsuya, Kakeji Yoshihiro, Azuma Takeshi
    第51回日本癌治療学会学術集会, Oct. 2013, Japanese, 日本癌治療学会, 京都, 【目的】切除不能大腸癌患者に対する全身化学療法の治療成績は、FOLFIRI/FOLFOXと分子標的治療薬を併用する事で飛躍的に向上し、腫瘍縮小後に手術介入を行うことで、主に肝肺転移症例で長期生存が得られる事が報告されている。只、経過中、治癒切除適応と言えなくても手術介入を希望される症例も存在するため、手術介入の意義は明らかではない。今回、全身化学療法開始後に手術介入を行った症例を抽出し、この治療戦略の意義と有用性を検討した。【方法】1999年7月より2011年4 月まで、切除不能大腸癌と判断され、当科で化学療法を先行した134症例を対象とし、化学療法開始後に手術介入（RFA含む）を試みた症例の背景および治療成績を後方視的に検討した。【成績】全134症例の背景は男性/女性92/42、年齢中央値64（28-83）歳、PS0-1/2-3 125/9例、進行, Domestic conference
    Oral presentation

  • 進行下部直腸癌症例に対する術前・術後補助化学療法の現状
    西 将康, Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 51st Annual Meeting of Japan Society of Clinical Oncology, Oct. 2013, Japanese, Japan Society of Clinical Oncology, 京都, Domestic conference
    Oral presentation

  • 新たなステージを迎えた大腸癌治療戦略-抗EGFR抗体の意義を考える-
    Kakeji Yoshihiro
    大腸癌治療を考える2013 in Kyoto ～OSの延長を目指して～, Oct. 2013, Japanese, Takeda Pharmaceutical Company Limited, 京都, Domestic conference
    [Invited]
    Invited oral presentation

  • 新たなステージを迎えた大腸癌治療戦略-抗EGFR抗体の意義を考える-
    Kakeji Yoshihiro
    colorectal cancer meeting in Fukushima, Oct. 2013, Japanese, Takeda Pharmaceutical Company Limited, 福島, Domestic conference
    [Invited]
    Invited oral presentation

  • 食道癌に対する化学放射線療法の現状と展望
    Kakeji Yoshihiro
    The 51st Annual Meeting of Japan Society of Clinical Oncology, Oct. 2013, Japanese, Japan Society of Clinical Oncology, 京都, Domestic conference
    Oral presentation

  • 食道癌におけるCD204陽性腫瘍関連マクロファージの臨床病理学的検討
    裏川 直樹, 宇都宮 壮顕, 綿島 健人, 高瀬 信尚, 西尾 真理, 重岡 学, Koma Yuichiro, Semba Shuho, Kakeji Yoshihiro, Yokozaki Hiroshi
    The 72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013, Japanese, JAPANESE CANCER ASSOCIATION, 横浜, Domestic conference
    Poster presentation

  • 術前化学放射線療法を行った下部直腸癌の術後補助化学療法の現状と問題点
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 高瀬 信尚, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Poster presentation

  • 残胃癌手術症例の検討
    Suzuki Satoshi, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 高瀬 信尚, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Poster presentation

  • 鏡視下手術とVTE対策
    Kakeji Yoshihiro
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Oral presentation

  • 基礎疾患を有する大腸癌手術症例の検討
    Tanaka Kenichi, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Nakamura Tetsu, Imanishi Tatsuya, Yamamoto Masashi, 金治 新悟, 高瀬 信尚, 裏川 直樹, 友野 絢子, 音羽 泰則, 瀧口 豪介, Kakeji Yoshihiro
    The 11th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Oct. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 東京, Domestic conference
    Poster presentation

  • StageIV切除不能胃癌に対する化学療法後切除症例の検討
    金治 新悟, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 51st Annual Meeting of Japan Society of Clinical Oncology, Oct. 2013, Japanese, Japan Society of Clinical Oncology, 京都, Domestic conference
    Oral presentation

  • OS延長を目指した治療戦略
    Kakeji Yoshihiro
    The 51st Annual Meeting of Japan Society of Clinical Oncology, Oct. 2013, Japanese, Japan Society of Clinical Oncology, 京都, Domestic conference
    [Invited]
    Invited oral presentation

  • 当科における腹腔鏡下側方リンパ節郭清について
    Sumi Yasuo, Yamashita Kimihiro, Kim Kiyonori, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 26th Annual Meeting of the Kinki Society for Endoscopic Surgery, Sep. 2013, Japanese, Kinki Society for Endoscopic Surgery, 奈良, Domestic conference
    Oral presentation

  • 切除不能大腸癌症例に対する手術介入の有用性
    藤島 佳未, Okuno Tatsuya, Kakeji Yoshihiro, Azuma Takeshi
    日本消化器病学会近畿支部第99回例会, Sep. 2013, Japanese, 日本消化器病学会近畿支部, 大阪, 【目的】切除不能大腸癌患者に対する全身化学療法の治療成績は、FOLFIRI/FOLFOXと分子標的治療薬を併用する事で飛躍的に向上し、腫瘍縮小後に手術介入を行うことで、主に肝肺転移症例で長期生存が得られる事が報告されている。只、経過中、治癒切除適応と言えなくても手術介入を希望される症例も存在するため、手術介入の意義は明らかではない。今回、全身化学療法開始後に手術介入を行った症例を抽出し、この治療戦略の意義と有用性を検討した。【方法】1999年7月より2011年4 月まで、切除不能大腸癌と判断され、当科で化学療法を先行した134症例を対象とし、化学療法開始後に手術介入（RFA含む）を試みた症例の背景および治療成績を後方視的に検討した。【成績】全134症例の背景は男性/女性92/42、年齢中央値64（28-83）歳、PS0-1/2-3 125/9例、進行, Domestic conference
    Public symposium

  • 新たなステージを迎えた大腸癌治療戦略-抗EGFR抗体の意義を考える-
    Kakeji Yoshihiro
    大腸癌治療を考える会 in Autumu, Sep. 2013, Japanese, Takeda Pharmaceutical Company Limited, 名古屋, Domestic conference
    [Invited]
    Invited oral presentation

  • 新たなステージを迎えた大腸癌治療戦略-抗EGFR抗体の意義を考える-
    Kakeji Yoshihiro
    ベクティビックス発売3周年記念講演会, Sep. 2013, Japanese, 長野, Domestic conference
    [Invited]
    Invited oral presentation

  • 消化管領域のロボット支援手術
    Suzuki Satoshi, Nakamura Tetsu, Sumi Yasuo, Tanaka Kenichi, 黒田 大介, Kakeji Yoshihiro
    メルクセローノセミナー, Sep. 2013, Japanese, 神戸, Domestic conference
    Public discourse

  • 化学放射線療法により完全奏功を得た食道小細胞癌の1例
    裏川 直樹, Suzuki Satoshi, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    1st Japan NeuroEndocrine Tumor Society(JNETS), Sep. 2013, Japanese, Japan NeuroEndocrine Tumor Society(JNETS), 京都, Domestic conference
    Poster presentation

  • 当科における右側結腸癌に対する単孔式腹腔鏡下手術の導入について
    Sumi Yasuo, 金治 新悟, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    2nd Reduced Port Surgery Forum, Aug. 2013, Japanese, 岩手, Domestic conference
    [Invited]
    Invited oral presentation

  • 外科療法
    Kakeji Yoshihiro
    The 11th Annual Meeting of Japanese Society of Medical Oncology, Aug. 2013, Japanese, Japan Society of Medical Oncology, 宮崎, Domestic conference
    [Invited]
    Invited oral presentation

  • 臨床診断Ｔ3直腸癌に対する術前化学放射線療法の有用性
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 要望ビデオ33
    Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 腹腔鏡下直腸低位前方切除術における定型化への試み
    Sumi Yasuo, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 腹腔鏡下横行結腸癌手術におけるリンパ節郭清の工夫
    Tanaka Kenichi, Yamashita Kimihiro, Kim Kiyonori, Sumi Yasuo, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 腹臥位および側臥位食道癌切除における術後呼吸機能への影響についての検討
    大坪 大, Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 当科におけるMinimally invasive esophagectomyへの取り組み
    Nakamura Tetsu, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 大腸癌肝転移切除症例における術前化学療法の意義
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, 金治 新悟, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 79th Meeting of Japanese Society for Cancer of the Colon and Rectum, Jul. 2013, Japanese, Japan Society for Cancer of the Colon and Rectum, 大阪, Domestic conference
    Oral presentation

  • 大腸ESD穿孔後の外科的治療の検討
    音羽 泰則, Yamashita Kimihiro, Kim Kiyonori, Sumi Yasuo, Suzuki Satoshi, Morita Yoshinori, Tanaka Shinwa, Toyonaga Takashi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 食道癌術後肺合併症対策-当科における取り組み
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, 大坪 大, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 食道胃接合部癌に対する外科治療の検討
    裏川 直樹, Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Sumi Yasuo, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    [Invited]
    Invited oral presentation

  • 今後のGIST治療に関して
    Kakeji Yoshihiro
    The 8th KOBE GIST Seminar, Jul. 2013, Japanese, NOVARTIS, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 高齢者胃癌に対する外科治療
    Suzuki Satoshi, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 鏡視下手術とVTE対策
    Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    [Invited]
    Invited oral presentation

  • StageIV大腸癌の原発巣切除におけるリンパ節廓清度、手術アプローチの後治療に与える影響
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 68th General Meeting of the Japanese Society of Gastronterological Surgery, Jul. 2013, Japanese, The Japanese Society of Gastroenterological Surgery, 宮崎, Domestic conference
    Oral presentation

  • 2013ASCO-GI/ASCO後の抗EGFR抗体による大腸癌治療戦略
    Kakeji Yoshihiro
    ベクティビックス発売3周年記念講演会, Jul. 2013, Japanese, Takeda Pharmaceutical Company Limited, 山形, Domestic conference
    [Invited]
    Invited oral presentation

  • 2013ASCO-GI/ASCO後の抗EGFR抗体による大腸癌治療戦略
    Kakeji Yoshihiro
    Expert Meeting「進行・再発大腸癌における1次療法としてのパニツムマブの意義を考える」, Jul. 2013, Japanese, Takeda Pharmaceutical Company Limited, 熊本, Domestic conference
    [Invited]
    Invited oral presentation

  • 肺転移における骨髄由来抑制性細胞の役割
    Yamashita Kimihiro, 大坪 大, 長谷川 寛, 裏川 直樹, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 22nd Annual Meeting of Japanese Society of Strategies for Cancer Research and Therapy, Jun. 2013, Japanese, 東京, Domestic conference
    Oral presentation

  • 当科における腹臥位食道切除術の定型化と術後酸素化に及ぼす影響
    Nakamura Tetsu, 瀧口 豪介, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 67th Annual Meeting of the Japan Esophageal Society, Jun. 2013, Japanese, Annual Meeting of the Japan Esophageal Society, 大阪, Domestic conference
    Oral presentation

  • 専門医が注目するASCO2013最新の話題
    Kakeji Yoshihiro
    ベクティビックス全国TV/Web講演会ASCO2013 消化器癌治療のトピックス, Jun. 2013, Japanese, 神戸, Domestic conference
    Oral presentation

  • 食道扁平上皮癌の増殖、進展と腫瘍組織内CD204陽性マクロファージの関連
    裏川 直樹, 重岡 学, Nakamura Tetsu, 西尾 真理, 綿島 健人, Semba Shuho, Kakeji Yoshihiro, Yokozaki Hiroshi
    第102回日本病理学会総会, Jun. 2013, Japanese, 日本病理学会, 札幌, Domestic conference
    Poster presentation

  • 食道癌手術における3D-CTによる気管支動脈走行の術前ナビゲーション
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, 大坪 大, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 67th Annual Meeting of the Japan Esophageal Society, Jun. 2013, Japanese, Annual Meeting of the Japan Esophageal Society, 大阪, Domestic conference
    Oral presentation

  • 食道胃腸外科の集学的治療の現状と展望
    Kakeji Yoshihiro
    第210回大分県外科医会例会, Jun. 2013, Japanese, 大分県外科医会, 大分, Domestic conference
    [Invited]
    Invited oral presentation

  • 胃癌に対するコンピューター支援手術
    Kakeji Yoshihiro
    第13回播州消化器癌手術手技研究会, Jun. 2013, Japanese, 播州消化器癌手術手技研究会、中外製薬株式会社, 姫路, Domestic conference
    [Invited]
    Invited oral presentation

  • STEP-BY-STEP INTRODUCTION OF REDUCED-PORT LAPAROSCOPIC RIGHT HEMICOLECTOMY-FINAL STAGE-SINGLE INCISION PLUS ONE PUNCTURE LAPAROSCOPIC SURGERY-
    Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 大坪 大, 高瀬 信尚, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    21st International Congress of the European Association for Endoscopic Surgery, Jun. 2013, English, Vienna, Austria, International conference
    Poster presentation

  • S-1/CDDPによるdown staging後根治切除をし得た切除不能進行胃癌の1例
    音羽 泰則, Kim Kiyonori, Suzuki Satoshi, 瀧口 豪介, 高瀬 信尚, Yamamoto Masashi, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 38th Annual Congress of Japanese College of Surgeons, Jun. 2013, Japanese, 東京, Domestic conference
    Poster presentation

  • 膜性腎症合併早期胃がんに対するＥＳＤ後、狭窄を来たし、外科的バイパス術を要した1例
    Ishida Tsukasa, Morita Yoshinori, Toyonaga Takashi, 吉崎 哲也, 河原 史明, 坂井 文, Tanaka Shinwa, Azuma Takeshi, Nakamura Tetsu, Kakeji Yoshihiro
    第85回日本消化器内視鏡学会総会, May 2013, Japanese, 日本消化器内視鏡学会, 京都, Domestic conference
    Poster presentation

  • 分子標的薬を用いた大腸癌治療戦略2013
    Kakeji Yoshihiro
    大腸癌治療カンファレンス in 川越, May 2013, Japanese, 埼玉, Domestic conference
    [Invited]
    Invited oral presentation

  • 直腸低位前方切除術においてda Vinci surgical systemを用いたsingle stapling techniqueによる吻合
    Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 大坪 大, 高瀬 信尚, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 67th Annual Meeting of Japanese Society for Advancement of Surgical techniques, May 2013, Japanese, Japanese Society for Advancement of Surgical Techniques, 北海道, Domestic conference
    [Invited]
    Invited oral presentation

  • 大腸癌肝転移に対する切除前化学療法施行の検討
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 高瀬 健太, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, 豊川 晃弘, 富永 正寛, Ku Yonson, Kakeji Yoshihiro
    The 35th annual meeting of Japanese Scociety for Resarch of Loco-Regional Cancer Therapy, May 2013, Japanese, Japanese Society for Research of Loco-Regional Cancer Therapy, 神戸, Domestic conference
    Oral presentation

  • 食道癌術前補助化学療法におけるmGPSの意義
    音羽 泰則, Nakamura Tetsu, 瀧口 豪介, 高瀬 信尚, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 35th annual meeting of Japanese Scociety for Resarch of Loco-Regional Cancer Therapy, May 2013, Japanese, Japanese Society for Research of Loco-Regional Cancer Therapy, 神戸, Domestic conference
    Oral presentation

  • 化学療法にて手術可能となった切除不能胃癌の4例
    Yamamoto Masashi, Imanishi Tatsuya, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro, 藤野 佳未, Okuno Tatsuya, Azuma Takeshi
    The 35th annual meeting of Japanese Scociety for Resarch of Loco-Regional Cancer Therapy, May 2013, Japanese, Japanese Society for Research of Loco-Regional Cancer Therapy, 神戸, Domestic conference
    Oral presentation

  • 腹腔鏡下横行結腸癌手術におけるリンパ節郭清の工夫
    Tanaka Kenichi, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 腹会陰式直腸切断術に対する腹腔鏡下大網形成術の有用性/直腸癌の術前化学放射線療法後の合併症対策として
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 腹臥位胸腔鏡下食道切除術におけるトラブルシューティング
    Imanishi Tatsuya, 黒田 大介, Nakamura Tetsu, Yamamoto Masashi, 瀧口 豪介, 音羽 泰則, 友野 絢子, 裏川 直樹, 大坪 大, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 肺転移における骨髄由来抑制細胞(MDSC)の役割について
    大坪 大, Yamashita Kimihiro, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, Yamamoto Masashi, Kim Kiyonori, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 超高齢者胃癌の外科治療の問題点と可能性
    Suzuki Satoshi, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 大腸癌領域における分子標的治療薬の最新情報
    Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 大腸癌肝転移症例における、化学療法後の肝切除術の有用性
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, 豊川 晃弘, 長谷川 寛, 富永 正寛, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 大腸がんとは
    Kakeji Yoshihiro
    市民公開講座「がんに負けないためには」, Apr. 2013, Japanese, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 食道切除後の胸壁前経路有茎空腸再建術の有用性
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 食道癌手術治療における静脈血栓寒栓症予防対策の確立
    Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 食道癌手術における3D-CTによる気管支動脈走行形態ナビゲーションの有用性
    Yamamoto Masashi, Imanishi Tatsuya, 大坪 大, 友野 絢子, 裏川 直樹, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 食道癌に対する腹腔鏡補助下胃管再建術の治療成績
    裏川 直樹, Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 食道癌cStageII/IIIで術前補助化学療法を施行した症例におけるModified Glasgow Prognostic Score（mGPS）の有用性
    音羽 泰則, Nakamura Tetsu, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Poster presentation

  • 消化器外科領域における臨床研究の現状
    Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 簡便性と安全性を追求した腹腔鏡下直腸切除術-当科での工夫と定型化への試み-
    Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • 胃癌腹膜播腫に対する治療と展開
    Kakeji Yoshihiro
    The 113th Annual Congress of Japan Surgical Society, Apr. 2013, Japanese, Japan Surgical Society, 福岡, Domestic conference
    Oral presentation

  • PRONE THORACOSCOPIC ESOPHAGECTOMY AND IMPROVEMENT OF POSTOPERATIVE PULMONARY OXYGENATION
    Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    THE 21ST ANNUAL MEETING OF THE ASIAN SOCIETY FOR CARDIOVASCULAR AND THORACIC SURGERY(ASCVTS), Apr. 2013, Japanese, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • PRONE THORACOSCOPIC ESOPHAGECTOMY AND IMPROVEMENT OF POSTOPERATIVE PULMONARY OXYGENATION
    Nakamura Tetsu, 大坪 大, 瀧口 豪介, 音羽 泰則, 高瀬 信尚, 裏川 直樹, 友野 絢子, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    THE 21ST ANNUAL MEETING OF THE ASIAN SOCIETY FOR CARDIOVASCULAR AND THORACIC SURGERY, Apr. 2013, Japanese, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • GIST新ガイドラインに基づいた集学的治療
    Kakeji Yoshihiro
    GIST forum 2013, Apr. 2013, Japanese, 福島, Domestic conference
    [Invited]
    Invited oral presentation

  • 腹腔鏡下回盲部切除術にて治療できた腸腰筋膿瘍を形成した虫垂炎の一例
    音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 49th Annual Congress of Japanese Society for Abdominal Emergency Medicine, Mar. 2013, Japanese, Japanese Society for Abdominal Emergency Medicine, 福岡, Domestic conference
    Oral presentation

  • 特別講演会、animal Labによる技術指導
    Kakeji Yoshihiro
    第11回神戸内視鏡外科手術手技研究会, Mar. 2013, Japanese, Kobe University Hospital Medical, 神戸, Domestic conference
    Public discourse

  • 大腸癌術後補助化学療法の変遷に関する調査～多施設アンケートをもとに
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 46th Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, Mar. 2013, Japanese, Japan Research Society for Appropriate Cancer Chemotherapy, 軽井沢, Domestic conference
    Oral presentation

  • 大腸癌治療の新展開-Cureを目指したフロントライン治療戦略のエビデンス-
    Kakeji Yoshihiro
    これからの大腸癌治療～ベクティビックス全例調査結果を受けて～, Mar. 2013, Japanese, Takeda Pharmaceutical Company Limited, 尼崎, Domestic conference
    Public discourse

  • 大腸癌治療における抗EGFR抗体を用いた治療戦略
    Kakeji Yoshihiro
    北大阪大腸がん化学療法カンファレンス, Mar. 2013, Japanese, Merck Serono, 大阪, Domestic conference
    Public discourse

  • 食道穿孔に対する胸腔鏡下食道切除術
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, 友野 絢子, 裏川 直樹, 大坪 大, Yamamoto Masashi, 金光 聖哲, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 49th Annual Congress of Japanese Society for Abdominal Emergency Medicine, Mar. 2013, Japanese, Japanese Society for Abdominal Emergency Medicine, 福岡, Domestic conference
    Oral presentation

  • 手術：No,16郭清～私はこうしている～
    Kakeji Yoshihiro
    第9回兵庫胃がん治療研究会, Mar. 2013, Japanese, 兵庫胃がん治療研究会、兵庫県がん診療連携協議会、大鵬薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • 高齢者におけるStageIII大腸癌に対する術後補助化学療法の現況
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 46th Annual Meeting of Japan Research Society for Appropriate Cancer Chemotherapy, Mar. 2013, Japanese, Japan Research Society for Appropriate Cancer Chemotherapy, 軽井沢, Domestic conference
    Oral presentation

  • 経口抗癌剤を用いた大腸癌術後補助化学療法
    Kakeji Yoshihiro
    第20回近畿大腸肛門疾患カンファレンス, Mar. 2013, Japanese, 近畿大腸肛門疾患カンファレンス、大鵬薬品工業株式会社, 大阪, Domestic conference
    Public discourse

  • 一時治療から見た当科における胃癌化学療法患者の治療成績について―手術転換例を中心に―
    藤島 佳未, Okuno Tatsuya, 坂井 文, 池田 篤紀, Suzuki Satoshi, Tanaka Kenichi, 田村 孝雄, Kakeji Yoshihiro, Azuma Takeshi
    第99回日本消化器病学会総会, Mar. 2013, Japanese, 日本消化器病学会, 鹿児島, 切除不能再発・進行胃癌患者の当科における化学療法の成績を一次治療から検討し、その中で手術転換を行い得た症例を後方視的に評価した。2000年6月～2010年11月までの予後評価可能108症例を対象とし、全生存成績は342日、10例以上の治療経験レジメンは一次治療別レジメン（S-1/5FU/CPT-11+CDDP/S-1+CDDP/S-1+DTX）では大きな差を認めなかった。手術転換症例は4例、加療前非治癒因子は肺転移1/#16リンパ節転移2/BulkyN2転移1であった。R0切除後無再発生存が2例（#16リンパ節転移とBulkyN2）、どちらもS-1＋αレジメンであった。現行の2剤併用レジメンで手術転換が可能となり、救済できたのは高度リンパ節転移例に限られており、現在3剤併用のDCSの手術転換率を検証する臨床試験の結果が期待される。, Domestic conference
    Poster presentation

  • 胃癌周術期補助化学療法の進歩～Ｓ-1＋αの可能性～
    Kakeji Yoshihiro, Suzuki Satoshi, Tanaka Kenichi
    The 99th General Meeting of the Japanese Society of Gastroenterology, Mar. 2013, Japanese, The Japanese Society of Gastroenterology, 鹿児島, Domestic conference
    Oral presentation

  • 胃・十二指腸潰瘍穿孔の治療法 -手術or保存療法-
    Kakeji Yoshihiro
    The 49th Annual Congress of Japanese Society for Abdominal Emergency Medicine, Mar. 2013, Japanese, Japanese Society for Abdominal Emergency Medicine, 福岡, Domestic conference
    Others

  • ー
    Kakeji Yoshihiro
    第9回兵庫胃がん治療研究会, Mar. 2013, Japanese, 兵庫胃がん治療研究会、兵庫県がん診療連携協議会、大鵬薬品工業株式会社, 神戸, Domestic conference
    Public discourse

  • Cureを目指したフロントラインからの大腸癌治療戦略
    Kakeji Yoshihiro
    大腸がん副作用マネジメント勉強会, Mar. 2013, Japanese, Takeda Pharmaceutical Company Limited, 埼玉, Domestic conference
    Public discourse

  • --
    Kakeji Yoshihiro
    神戸大腸癌術後補助化学療法フォーラム, Mar. 2013, Japanese, 神戸, Domestic conference
    Public discourse

  • 病理病期II，IIIA，IIIB進行胃癌術後補助化学療法Docetaxel/S-1併用療法の安全確認試験-予後追跡調査-
    江見 泰徳, 佐伯 浩司, 沖 英二, 森田 勝, 楠本 哲也, Kakeji Yoshihiro, 馬場 秀夫, 前原 喜彦
    The 85th Annual Meeting of Japanese Gastric Cancer Association, Feb. 2013, Japanese, Japanese Gastric Cancer Association, 大阪, Domestic conference
    Oral presentation

  • 当院における後期高齢者食道癌の内科的及び外科的治療の展開
    池田 篤紀, Okuno Tatsuya, Kakeji Yoshihiro, Azuma Takeshi
    日本消化器病学会近畿支部第98回例会, Feb. 2013, Japanese, 日本消化器病学会近畿支部, 神戸, Domestic conference
    Public symposium

  • 大腸癌治療の新展開-Cureを目指したフロントライン治療戦略のエビデンス-
    Kakeji Yoshihiro
    胃癌・大腸癌検診部会定例講演会, Feb. 2013, Japanese, 明石医師会、武田薬品工業株式会社, 明石, Domestic conference
    Public discourse

  • 大腸癌治療の新展開-Cureを目指したフロントライン治療戦略-
    Kakeji Yoshihiro
    第2回最新の大腸癌治療を考える会, Feb. 2013, Japanese, Takeda Pharmaceutical Company Limited, 大阪, Domestic conference
    Keynote oral presentation

  • 大腸癌治療の新展開-Cureを目指したフロントライン治療戦略-
    Kakeji Yoshihiro
    ベクティビックス講演会 ～切除不能大腸癌フロントライン治療におけるベクティビックスの位置づけ～, Feb. 2013, Japanese, Takeda Pharmaceutical Company Limited, 福岡, Domestic conference
    Public discourse

  • 大腸癌の最新集学的治療戦略
    Kakeji Yoshihiro
    第17回消化器癌フォーラム, Feb. 2013, Japanese, TAIHO PHARMACEUTICAL CO, 大阪, Domestic conference
    Public discourse

  • 高齢者の早期胃癌に対する腹腔鏡補助下幽門側胃切除術の検討
    Suzuki Satoshi, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Tanaka Kenichi, Kakeji Yoshihiro
    The 85th Annual Meeting of Japanese Gastric Cancer Association, Feb. 2013, Japanese, Japanese Gastric Cancer Association, 大阪, Domestic conference
    Oral presentation

  • 胸腔鏡下食道癌手術後胃管癌の2切除例の報告
    瀧口 豪介, Nakamura Tetsu, 音羽 泰則, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 85th Annual Meeting of Japanese Gastric Cancer Association, Feb. 2013, Japanese, Japanese Gastric Cancer Association, 大阪, Domestic conference
    Poster presentation

  • 一次治療から見た当科における胃癌化学療法患者の治療成績について-手術転換例を中心に-
    藤島 佳未, Okuno Tatsuya, 坂井 文, 池田 篤紀, Suzuki Satoshi, Tanaka Kenichi, 田村 孝雄, Kakeji Yoshihiro, Azuma Takeshi
    第85回日本胃癌学会総会, Feb. 2013, Japanese, 日本胃癌学会, 大阪, 切除不能再発・進行胃癌患者の当科における化学療法の成績を一次治療から検討し、その中で手術転換を行い得た症例を後方視的に評価した。2000年6月～2010年11月までの予後評価可能108症例を対象とし、全生存成績は342日、10例以上の治療経験レジメンは一次治療別レジメン（S-1/5FU/CPT-11+CDDP/S-1+CDDP/S-1+DTX）では大きな差を認めなかった。手術転換症例は4例、加療前非治癒因子は肺転移1/#16リンパ節転移2/BulkyN2転移1であった。R0切除後無再発生存が2例（#16リンパ節転移とBulkyN2）、どちらもS-1＋αレジメンであった。現行の2剤併用レジメンで手術転換が可能となり、救済できたのは高度リンパ節転移例に限られており、現在3剤併用のDCSの手術転換率を検証する臨床試験の結果が期待される。, Domestic conference
    Oral presentation

  • 胃GISTに対する単孔式腹腔鏡下手術
    Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 85th Annual Meeting of Japanese Gastric Cancer Association, Feb. 2013, Japanese, Japanese Gastric Cancer Association, 大阪, Domestic conference
    Oral presentation

  • ー
    Kakeji Yoshihiro
    大腸癌治療セミナー, Feb. 2013, Japanese, Yakult Honsha Co, 神戸, Domestic conference
    Public discourse

  • ー
    Kakeji Yoshihiro
    阪神消化管治療研究会, Feb. 2013, Japanese, TAIHO PHARMACEUTICAL CO, 神戸, Domestic conference
    Public discourse

  • 大腸癌治療の新展開-Cureを目指したフロントライン治療戦略-
    Kakeji Yoshihiro
    臨床研究を考える会, Jan. 2013, Japanese, Takeda Pharmaceutical Company Limited, 横浜, Domestic conference
    Public discourse

  • 大腸癌治療の新展開-Cureを目指したフロントライン治療戦略-
    Kakeji Yoshihiro
    ベクティビックス講演会 大腸癌治療を適正に実施するために, Jan. 2013, Japanese, Takeda Pharmaceutical Company Limited, 福島, Domestic conference
    Public discourse

  • 局所進行直腸癌治療と腹会陰式直腸切除術会陰部創管理における大網形成術の有用性
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The 78th Meeting of Japanese Society For Cancer of the Colon and Recturm, Jan. 2013, Japanese, Japanese Society For Cancer of the Colon and Recturm, 東京, Domestic conference
    Oral presentation

  • ロボット支援幽門側胃切除術における3Ｄ-ＨＤ映像と多関節機能の活用
    Suzuki Satoshi, Nakamura Tetsu, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Tanaka Kenichi, Kakeji Yoshihiro
    The 5th Annual Congress of Japan Robotic Surgery Society, Jan. 2013, Japanese, Japan Robotic Surgery Society, 名古屋, Domestic conference
    Oral presentation

  • 腹臥位食道切除術における術中体位の問題点-神経障害を中心として-
    Nakamura Tetsu, 瀧口 豪介, 音羽 泰則, 友野 絢子, 裏川 直樹, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 25th Annual Meeting of the Japan Society for Endoscopic Surgery, Dec. 2012, Japanese, Japan Society for Endoscopic Surgery, 横浜, Domestic conference
    Oral presentation

  • 腹臥位胸腔鏡下食道切除術における縦隔郭清の工夫と手術成績
    黒田 大介, Nakamura Tetsu, Imanishi Tatsuya, Yamamoto Masashi, Kim Kiyonori, 大坪 大, 裏川 直樹, 友野 絢子, 音羽 泰則, 瀧口 豪介, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    The 25th Annual Meeting of the Japan Society for Endoscopic Surgery, Dec. 2012, Japanese, Japan Society for Endoscopic Surgery, 横浜, Domestic conference
    Oral presentation

  • 当科における腹腔鏡下側方リンパ節郭清について
    Sumi Yasuo, Imanishi Tatsuya, Yamashita Kimihiro, Kim Kiyonori, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 大坪 大, Yamamoto Masashi, Nakamura Tetsu, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 25th Annual Meeting of the Japan Society for Endoscopic Surgery, Dec. 2012, Japanese, Japan Society for Endoscopic Surgery, 横浜, Domestic conference
    Oral presentation

  • 高齢者に対する腹腔鏡補助下幽門側胃切除術の検討
    Suzuki Satoshi, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, 黒田 大介, Kakeji Yoshihiro
    The 25th Annual Meeting of the Japan Society for Endoscopic Surgery, Dec. 2012, Japanese, Japan Society for Endoscopic Surgery, 横浜, Domestic conference
    Oral presentation

  • ー
    Kakeji Yoshihiro
    第15回神戸外科フォーラム, Dec. 2012, Japanese, 神戸外科フォーラム、大鵬薬品工業株式会社, 横浜, Domestic conference
    Public discourse

  • ＳｔａｇｅIV大腸癌の原発巣切除に対する腹腔鏡下手術の有用性
    Kim Kiyonori, Yamashita Kimihiro, 裏川 直樹, 黒田 大介, Kakeji Yoshihiro
    The 67th Annual Meeting of the Japan Society of Coloproctology, Nov. 2012, Japanese, Japan Society of Coloproctology, 福岡, Domestic conference
    Oral presentation

  • 頸部食道choristomaの一例
    宮内 玄徳, Nakamura Tetsu, 宗 慎一, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The192st Annual Conference of Kinki Surgical Association, Nov. 2012, Japanese, Kinki Surgical Association, 大阪, Domestic conference
    Oral presentation

  • 腹腔鏡下胃全摘術・噴門切除術とその再建術式2
    Kakeji Yoshihiro
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Others

  • 当科における食道GISTの治療経験
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, 大坪 大, 裏川 直樹, 友野 絢子, 瀧口 豪介, 音羽 泰則, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Oral presentation

  • 当科における残胃癌に対する手術成績の検討
    Suzuki Satoshi, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, 黒田 大介, Kakeji Yoshihiro
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Oral presentation

  • 当科において経験した食道GIST切除症例の検討
    Imanishi Tatsuya, Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 23th Annual Meeting of Japanese Society for Gastroenterological Carcinogenesis, Nov. 2012, Japanese, Japanese Society for Gastroenterological Carcinogenesis, 徳島, Domestic conference
    Oral presentation

  • 大腸癌治療の今～Cureを目指したフロントライン治療戦略～
    Kakeji Yoshihiro
    The 46th Annual Meeting of Nagoya Colorectal Cancer Seminar, Nov. 2012, Japanese, Nagoya Colorectal Cancer Seminar、Takeda Pharmaceutical Company Limited, 名古屋, Domestic conference
    Public discourse

  • 大腸癌の最新治療戦略
    Kakeji Yoshihiro
    第10回神戸消化器外科懇話会, Nov. 2012, Japanese, 兵庫医科大学肝胆膵外科、神戸消化器外科懇話会、大塚製薬株式会社、イーエヌ大塚製薬株式会社, 神戸, Domestic conference
    [Invited]
    Invited oral presentation

  • 多施設アンケート調査による大腸癌補助化学療法の変遷の評価～兵庫大腸癌治療研究会
    Yamashita Kimihiro, 川崎 健太郎, 梅木 雅彦, Sumi Yasuo, 黒田 大介, 今西 築, Kakeji Yoshihiro, 富田 尚裕
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Oral presentation

  • 診断に難渋した原発性虫垂癌の一例
    荒尾 真道, 竹中 完, 酒井 新, 松木 信之, Shiomi Hideyuki, Masuda Atsuhiro, Arisaka Yoshifumi, Hayakumo Takanobu, Azuma Takeshi, Kim Kiyonori, Kakeji Yoshihiro, 友野 絢子, Sakai Yasuhiro, Itoh Tomoo
    日本消化器内視鏡学会近畿支部第89会支部例会, Nov. 2012, Japanese, 日本消化器内視鏡学会近畿支部, 大阪, Domestic conference
    Oral presentation

  • 出血を来した小腸滑膜肉腫の1例
    Yamashita Kimihiro, Kim Kiyonori, 裏川 直樹, 黒田 大介, Kakeji Yoshihiro
    The 67th Annual Meeting of the Japan Society of Coloproctology, Nov. 2012, Japanese, Japan Society of Coloproctology, 福岡, Domestic conference
    Poster presentation

  • 胸腔鏡下食道切除術をおこなった右鎖骨下動脈起始異常を伴う食道癌の一例
    Yamamoto Masashi, Imanishi Tatsuya, 黒田 大介, Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Kakeji Yoshihiro
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Oral presentation

  • 回腸癌の術前診断で切除術を施行した虫垂癌回腸浸潤の一例
    村上 優, Kim Kiyonori, Yamashita Kimihiro, 友野 絢子, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, Kakeji Yoshihiro
    The192st Annual Conference of Kinki Surgical Association, Nov. 2012, Japanese, Kinki Surgical Association, 大阪, Domestic conference
    Oral presentation

  • 下部消化管穿孔症例におけるincisional SSIの予防に対するＪ-ＶＡＣ Drainage Systemの効果について
    Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 友野 絢子, 裏川 直樹, 大坪 大, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Oral presentation

  • 胃領域リンパ節に転移を認めた悪性黒色腫胃転移の1切除例
    音羽 泰則, Suzuki Satoshi, 瀧口 豪介, Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, 黒田 大介, Kakeji Yoshihiro
    The 74th Annual Congress of Japan Surgical Association, Nov. 2012, Japanese, Japan Surgical Association, 東京, Domestic conference
    Oral presentation

  • 胃癌のRobotic Surgery
    Kakeji Yoshihiro
    神戸消化器外科手術フォーラム, Nov. 2012, Japanese, Chugai Pharmaceutical Co, 神戸, Domestic conference
    Public discourse

  • マウス膵癌細胞を用いた制御性T細胞除去と樹状細胞ワクチン併用療法の抗腫瘍効果に関する検討
    Yamamoto Masashi, Kim Kiyonori, Yamashita Kimihiro, Imanishi Tatsuya, Sumi Yasuo, Nakamura Tetsu, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 23th Annual Meeting of Japanese Society for Gastroenterological Carcinogenesis, Nov. 2012, Japanese, Japanese Society for Gastroenterological Carcinogenesis, 徳島, Domestic conference
    Oral presentation

  • ヒトアロ樹状細胞を用いたCTL誘導の試み
    Yamashita Kimihiro, Yamamoto Masashi, 大坪 大, 長谷川 寛, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, Kim Kiyonori, Imanishi Tatsuya, Nakamura Tetsu, Sumi Yasuo, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 23th Annual Meeting of Japanese Society for Gastroenterological Carcinogenesis, Nov. 2012, Japanese, Japanese Society for Gastroenterological Carcinogenesis, 徳島, Domestic conference
    Oral presentation

  • The Optimal Treatment of Aggressive approach
    Kakeji Yoshihiro
    Challenges for the Future of Colorectal Cancer, Nov. 2012, Japanese, Takeda Pharmaceutical Company Limited, 東京, Domestic conference
    Public discourse

  • Oncosurgical approachとsurvival benefit
    Kakeji Yoshihiro
    Challenges for the Future of Colorectal Cancer, Nov. 2012, Japanese, Takeda Pharmaceutical Company Limited, 東京, Domestic conference
    Public discourse

  • -
    Kakeji Yoshihiro
    The 67th Annual Meeting of the Japan Society of Coloproctology, Nov. 2012, Japanese, Japan Society of Coloproctology, 福岡, Domestic conference
    Others

  • -
    Kakeji Yoshihiro
    The 23th Annual Meeting of Japanese Society for Gastroenterological Carcinogenesis, Nov. 2012, Japanese, Japanese Society for Gastroenterological Carcinogenesis, 徳島, Domestic conference
    Others

  • -
    Kakeji Yoshihiro
    神戸消化器外科手術フォーラム, Nov. 2012, Japanese, Chugai Pharmaceutical Co, 神戸, Domestic conference
    Public discourse

  • 特別講演・内視鏡外科手術 Hands on seminar
    Kakeji Yoshihiro
    第10回神戸内視鏡外科手術手技研究会, Oct. 2012, Japanese, Kobe University Hospital Medical Information Network, 神戸, Domestic conference
    Public discourse

  • 直腸癌における側方リンパ節に対する術前化学放射線療法の治療効果
    Yamashita Kimihiro, Kim Kiyonori, Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 50th Annual Meeting of Japan Society of Clinical Oncology, Oct. 2012, Japanese, Japan Society of Clinical Oncology, 横浜, Domestic conference
    Oral presentation

  • 大腸癌術後補助化学療法の現状
    Kakeji Yoshihiro
    第4回四国消化器癌フォーラム, Oct. 2012, Japanese, 四国消化器癌フォーラム、株式会社ヤクルト本社、徳島大学病院がん診療連携センター, 徳島, Domestic conference
    Public discourse

  • 進行再発大腸癌のCetuximab単剤・併用療法例の効果、安全性および早期効果予測の検討
    池田 篤紀, Okuno Tatsuya, 藤島 佳未, Yamashita Kimihiro, Sumi Yasuo, 黒田 大介, Kakeji Yoshihiro, Azuma Takeshi
    第50回日本癌治療学会学術集会, Oct. 2012, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • 進行再発大腸癌に対する薬剤による組織学的的効果と治療戦略-大腸外科の立場から-
    Kakeji Yoshihiro, Sumi Yasuo, Yamashita Kimihiro, Kim Kiyonori, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, Tanaka Kenichi, 黒田 大介
    The 50th Annual Meeting of Japan Society of Clinical Oncology, Oct. 2012, Japanese, Japan Society of Clinical Oncology, 横浜, Domestic conference
    Oral presentation

  • 新規抗癌剤治療を行ったS状結腸腺扁平上皮癌多発肝転移の1例
    Okuno Tatsuya, 池川 卓也, 鎮西 亮, 池田 篤紀, 藤島 佳未, Yamashita Kimihiro, Sumi Yasuo, Yano Yoshihiko, Hara Shigeo, 黒田 大介, Kakeji Yoshihiro, Yokozaki Hiroshi, Azuma Takeshi
    第50回日本癌治療学会学術集会, Oct. 2012, Japanese, 日本癌治療学会, 横浜, Domestic conference
    Poster presentation

  • 治癒を目指す大腸癌術後補助化学療法2012
    Kakeji Yoshihiro
    第4回四国消化器癌フォーラム, Oct. 2012, Japanese, 四国消化器癌フォーラム、株式会社ヤクルト本社、徳島大学病院がん診療連携センター, 徳島, Domestic conference
    Public discourse

  • StagelV大腸癌原発巣切除例の検討
    Kim Kiyonori, Yamashita Kimihiro, Sumi Yasuo, 音羽 泰則, 瀧口 豪介, 裏川 直樹, 友野 絢子, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    The 50th Annual Meeting of Japan Society of Clinical Oncology, Oct. 2012, Japanese, Japan Society of Clinical Oncology, 横浜, Domestic conference
    Oral presentation

  • -
    Kakeji Yoshihiro
    The 50th Annual Meeting of Japan Society of Clinical Oncology, Oct. 2012, Japanese, Japan Society of Clinical Oncology, 横浜, Domestic conference
    Others

  • -
    Kakeji Yoshihiro
    The 20st Annual Meeting of Japan Digestive Disease Week, Oct. 2012, Japanese, Japan Digestive Disease Week, 神戸, Domestic conference
    Others

  • -
    Kakeji Yoshihiro
    神戸消化器癌フォーラム, Oct. 2012, Japanese, TAIHO PHARMACEUTICAL CO, 神戸, Domestic conference
    Public discourse

  • 腹臥位胸腔鏡下食道切除におけるトラブルシューティング
    Imanishi Tatsuya, 黒田 大介, Nakamura Tetsu, Yamamoto Masashi, Kim Kiyonori, 大坪 大, 裏川 直樹, 友野 絢子, 音羽 泰則, 瀧口 豪介, Yamashita Kimihiro, Sumi Yasuo, Suzuki Satoshi, Kakeji Yoshihiro
    The 25th Anuual Meeting of the Kinki Society for Endoscopic Surgery, Sep. 2012, Japanese, the Kinki Society for Endoscopic Surgery, 京都, Domestic conference
    Oral presentation

  • 同時多発癌を合併したCrohn病の一例
    山本 恭孝, Okuno Tatsuya, Yoshie Tomoo, 平野 仁崇, 池田 篤紀, 孝橋 道敬, 神澤 真紀, Ooi Makoto, Ikehara Nobunao, Yamashita Kimihiro, 大林 千穂, Yoshida Masaru, 黒田 大介, 藤田 剛, Kakeji Yoshihiro, Yokozaki Hiroshi, Azuma Takeshi
    日本消化器病学会近畿支部第97回例会, Sep. 2012, Japanese, 日本消化器病学会近畿支部, 京都, Domestic conference
    Oral presentation

  • 大腸がん治療における抗EGFR抗体を用いた治療戦略
    Kakeji Yoshihiro
    第2回 M:I Meeting with surgeon & Oncologist, Sep. 2012, Japanese, Merck Serono, 神戸, Domestic conference
    Public discourse

  • 消化器がんの分子標的治療薬
    Kakeji Yoshihiro
    The 71st Annual Meeting of the Japanese Cancer Association, Sep. 2012, Japanese, the Japanese Cancer Association, 北海道, Domestic conference
    Others

  • 患者にやさしい大腸がん化学療法
    Kakeji Yoshihiro
    広畑・癌治療・化学療法セミナー, Sep. 2012, Japanese, ONO PHARMACEUTICAL CO, 姫路, Domestic conference
    Public discourse

  • トリプルネガティブ乳癌におけるBRCA1プロモーターメチル化の臨床的意義
    山下 奈真, 徳永 えり子, 北尾 洋之, Kakeji Yoshihiro, 前原 喜彦
    The 71st Annual Meeting of the Japanese Cancer Association, Sep. 2012, Japanese, the Japanese Cancer Association, 北海道, Domestic conference
    Oral presentation

  • 1次治療から見た当科における胃癌化学療法患者の治療成績について-手術転換例を中心に-
    藤島 佳未, Okuno Tatsuya, Kakeji Yoshihiro, Azuma Takeshi
    日本消化器病学会近畿支部第97回例会, Sep. 2012, Japanese, 日本消化器病学会近畿支部, 京都, 切除不能再発・進行胃癌患者の当科における化学療法の成績を一次治療から検討し、その中で手術転換を行い得た症例を後方視的に評価した。2000年6月～2010年11月までの予後評価可能108症例を対象とし、全生存成績は342日、10例以上の治療経験レジメンは一次治療別レジメン（S-1/5FU/CPT-11+CDDP/S-1+CDDP/S-1+DTX）では大きな差を認めなかった。手術転換症例は4例、加療前非治癒因子は肺転移1/#16リンパ節転移2/BulkyN2転移1であった。R0切除後無再発生存が2例（それぞれ#16リンパ節転移とBulkyN2）、どちらもS-1＋αレジメンであった。現行の2剤併用レジメンで手術転換が可能となり、救済できたのは高度リンパ節転移例に限られており、現在3剤併用のDCSの手術転換率を検証する臨床試験の結果が期待される。, Domestic conference
    Public symposium

  • 1次治療から見た当科における胃癌化学療法患者の治療成績について-手術転換例を中心に-
    藤島 佳未, Okuno Tatsuya, Azuma Takeshi, Kakeji Yoshihiro
    The 97st Annual Meeting of THE JAPANESE SOCIETY OF GASTROENTEROLOGY, Sep. 2012, Japanese, THE JAPANESE SOCIETY OF GASTROENTEROLOGY, 京都, Domestic conference
    Public symposium

  • -
    Kakeji Yoshihiro
    Colorectal Cancer Symposium in KOBE 2012, Sep. 2012, Japanese, Yakult Honsha Co, 神戸, Domestic conference
    Public discourse

  • 内視鏡外科手術体験コース
    Kakeji Yoshihiro
    神戸大学連携授業, Aug. 2012, Japanese, Kobe University Hospital Medical, 神戸, Domestic conference
    Public discourse

  • Luncheon Satellite Symposium
    Kakeji Yoshihiro
    2012 World Congress on Gastrointestinal Cancer:Asian Perspectives, Aug. 2012, English, Imedex, 中国, Domestic conference
    Oral presentation

  • 21世紀のロボット手術
    Kakeji Yoshihiro
    神戸大学連携授業, Aug. 2012, Japanese, Kobe University Hospital Medical, 神戸, Domestic conference
    Public discourse

  • -
    Kakeji Yoshihiro
    大腸癌治療 Update in Kobe, Aug. 2012, Japanese, Yakult Honsha Co, 神戸, Domestic conference
    Public discourse

  • -
    Kakeji Yoshihiro
    Covidien Japan Hand-on Training, Aug. 2012, Japanese, Covidien company, 神戸, Domestic conference
    Public discourse

  • 大腸癌肝転移における完全腹腔鏡下肝切除および大腸同時切除術
    沖 英次, 池田 哲夫, Kakeji Yoshihiro, 安藤 幸滋, 佐伯 浩司, 大賀 丈史, 辻谷 俊一, 鴻江 俊冶, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    [Invited]
    Invited oral presentation

  • 大腸癌におけるDNA修腹因子FANCJ発現と5-FU感受性
    中西 良太, 北尾 洋之, 藤中 良彦, 安藤 幸滋, 佐伯 浩司, 大賀 丈史, 徳永 えり子, 沖 英次, Kakeji Yoshihiro, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    [Invited]
    Invited oral presentation

  • 大腸癌StageIVにおけるFanconi貧血経路およびミスマッチ修復経路活性化の意義
    中西 良太, 北尾 洋之, 安藤 幸滋, 佐伯 浩司, 沖 英次, 徳永 えり子, 大賀 丈史, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊治, 前原 喜彦
    The75th Annual Congress of Japanese Society for Cancer of the Colon and Rectum, Jul. 2012, Japanese, Japanese Society for Cancer of the Colon and Rectum, 東京, Domestic conference
    Oral presentation

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略2012
    Kakeji Yoshihiro
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略
    Kakeji Yoshihiro
    Vectibix発売2周年記念Symposium in NAHA, Jul. 2012, Japanese, Takeda Pharmaceutical Company Limited, 沖縄, Domestic conference
    Public discourse

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略
    Kakeji Yoshihiro
    TAKEDA大腸がんセミナー～Panitumumabの位置づけを考える～, Jul. 2012, Japanese, Takeda Pharmaceutical Company Limited, 岩手, Domestic conference
    Public discourse

  • 新たに開発した直腸圧排鉤を用いた腹腔鏡下直腸吻合方法″Push法、Push & Pull法゛の検討
    日高 元, 池田 哲夫, 安藤 幸滋, 佐伯 浩司, 沖 英次, 大賀 丈史, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊冶, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • 食道癌におけるDNA修復遺伝子FANCJ発現の意義
    河野 浩幸, 北尾 洋之, 安藤 幸滋, 佐伯 浩司, 沖 英次, 大賀 丈史, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊治, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Oral presentation

  • 食道癌Salvage手術の検証からの治療戦略
    大賀 丈史, 安藤 幸滋, 佐伯 浩司, 沖 英次, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊治, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • 完全腹腔鏡下幽門側胃切除における三角吻合(Book Binding法)の工夫
    安藤 幸滋, 佐伯 浩司, 池田 哲夫, 神代 竜一, 沖 英次, 大賀 丈史, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊治, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • 胃癌腹膜播種に対する審査腹腔鏡の有用性とS-1+Docetaxel術前化学療法による集学的治療戦略
    江見 泰徳, Kakeji Yoshihiro, 久松 雄一, 安藤 幸滋, 佐伯 浩司, 沖 英次, 大賀 丈史, 辻谷 俊一, 鴻江 俊冶, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Oral presentation

  • 胃癌のHER2診断における問題点の検証
    鴻江 俊冶, 久松 雄一, 神代 竜一, 中西 良太, 安藤 幸滋, 佐伯 浩司, 沖 英次, Kakeji Yoshihiro, 相島 慎一, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • 胃癌における染色体不安定性に対するMad2過剰発現の影響
    久松 雄一, 飯森 真人, 北尾 洋之, 安藤 幸滋, 佐伯 浩司, 大賀 丈史, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊治, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Oral presentation

  • 胃癌における細胞周期の制御因子Plk1過剰発現と染色体不安定性の関連
    大津 甫, 安藤 幸滋, 佐伯 浩司, 大賀 丈史, 沖 英次, Kakeji Yoshihiro, 辻谷 俊一, 鴻江 俊冶, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Oral presentation

  • 胃・大腸癌組織におけるCXCL12/CXCR4発現による浸潤転移の分子機序とその制御
    Kakeji Yoshihiro, 増田 隆伸, 安藤 幸滋, 佐伯 浩司, 沖 英次, 大賀 丈史, 辻谷 俊一, 鴻江 俊冶, 米満 吉和, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • ー
    Kakeji Yoshihiro
    The 77th Annual Congress of, Jul. 2012, Japanese, Japanese Society for Cancer of the Colon and Rectum, 東京, Domestic conference
    Others

  • ワークショップ1-2B：臨床応用に向かう消化器外科領域基礎研究(消化管)
    Kakeji Yoshihiro
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • ハイパースペクトルカメラを用いた大腸病変における酸化ヘモグロビンの濃度変化に関する検討
    神代 竜一, 赤星 朋比古, 長尾 吉泰, 佐伯 浩司, 沖 英次, 大賀 丈史, 富川 盛雅, Kakeji Yoshihiro, 前原 喜彦, 橋爪 誠
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Oral presentation

  • コンピューター診断支援システムNewVESを応用した消化器外科領域の治療シミュレーション
    富川 盛雅, 小田 昌宏, 神代 竜一, 赤星 朋比古, 橋本 直隆, 長尾 吉泰, Kakeji Yoshihiro, 森 健策, 前原 喜彦, 橋爪 誠
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • WT1およびMUC1がん抗原ペプチドを用いた進行膵癌に対する樹状細胞ワクチン療法
    辻谷 俊一, 岡本 正人, 木村 幸乃, 本間 定, 小井戸 薫雄, 高橋 秀徳, Kakeji Yoshihiro, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Others

  • HER2検査を導入した胃癌治療の最前線～HER2 陰性症例～
    Kakeji Yoshihiro
    第36回京大外科関連施設癌研究会, Jul. 2012, Japanese, 京大外科関連施設癌研究会、中外製薬株式会社, 京都, Domestic conference
    Public discourse

  • GIST治療の将来展望
    Kakeji Yoshihiro
    第7回神戸GISTセミナー, Jul. 2012, Japanese, Novartis Pharma, 神戸, Domestic conference
    Public discourse

  • 80歳以上高齢者胃癌に対する外科治療・成績と術後栄養状態の評価
    中ノ子 智徳, Kakeji Yoshihiro, 安藤 幸滋, 佐伯 浩司, 大賀 丈史, 辻谷 俊一, 鴻江 俊冶, 前原 喜彦
    The 67th General Meeting of the Japanese Society of Gastroenterological Surgery, Jul. 2012, Japanese, The Japanese Society of Gastroenterological Surgery, 富山, Domestic conference
    Oral presentation

  • -
    Kakeji Yoshihiro
    The 10th Annual Meeting of Japanese Society of Medical Oncology, Jul. 2012, Japanese, Japanese Society of Medical Oncology, 大阪, Domestic conference
    Others

  • laparoscopic harvest of perineal omentplasty wtih rectal resection for rectal cancer
    Yamashita Kimihiro, Sumi Yasuo, Kim Kiyonori, 裏川 直樹, 音羽 泰則, 瀧口 豪介, 友野 絢子, 大坪 大, Yamamoto Masashi, Imanishi Tatsuya, Nakamura Tetsu, Suzuki Satoshi, 黒田 大介, Kakeji Yoshihiro
    the 20th International Congress of the European Association for Endoscopic Surgery (EAES) in Brussels, Jun. 2012, Japanese, ベルギー, International conference
    Others

  • -
    Kakeji Yoshihiro
    The 66th Annual Meeting of The Japan Esophageal Society, Jun. 2012, Japanese, The Japan Esophageal Society, 軽井沢, Domestic conference
    Others

  • -
    Kakeji Yoshihiro
    市民公開講座 もし大腸がんになったら～これだけ知ればもう安心～, Jun. 2012, Japanese, EAES, 神戸, Domestic conference
    Public discourse

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略
    Kakeji Yoshihiro
    第三回ベクティビックス適生使用勉強会, May 2012, Japanese, Takeda Pharmaceutical Company Limited, 長崎, Domestic conference
    Public discourse

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略
    Kakeji Yoshihiro
    the193st Annual Conference of Fukuyama Surgical Association, May 2012, Japanese, Fukuoka Surgical Association, 福山, Domestic conference
    Public discourse

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略
    Kakeji Yoshihiro
    ベクティビックス講演会, May 2012, Japanese, Takeda Pharmaceutical Company Limited, 北海道, Domestic conference
    Public discourse

  • 進行・再発大腸癌におけるCureを目指したフロントライン治療戦略
    Kakeji Yoshihiro
    Vectibix発売2周年記念講演会, May 2012, Japanese, Takeda Pharmaceutical Company Limited, 鹿児島, Domestic conference
    Public discourse

  • 結腸癌術後化学療法の新たな選択肢と治療選択
    Kakeji Yoshihiro
    Chugai Colorectal Cancer Symposium in KOBE, May 2012, Japanese, Chugai Pharmaceutical Co, 神戸, Domestic conference
    Public discourse

  • クローン病発症から23年を経て同時性多発大腸癌を併発した1例
    Yamashita Kimihiro, Ooi Makoto, Yoshie Tomoo, Kim Kiyonori, Sumi Yasuo, Suzuki Satoshi, 黒田 大介, Yoshida Tsuyoshi, Azuma Takeshi, Kakeji Yoshihiro
    兵庫IBDカンファレンス, May 2012, Japanese, 神戸, Domestic conference
    Public discourse

  • -
    Kakeji Yoshihiro
    The 66th Annual Meeting of Japanese Society for Advanvemem of Suegical Techniques, May 2012, Japanese, Japanese Society for Advanvemem of Suegical Techniques, 福岡, Domestic conference
    Others

  • -
    Kakeji Yoshihiro
    the 51st Annual Conference of Japanese Society for Medical and Biological Engineering, May 2012, Japanese, Japanese Society for Medical and Biological Engineering, 福岡, Domestic conference
    Others

  • 進化するGIST集学的治療戦略
    Kakeji Yoshihiro
    Japanese Study Group on GIST, Apr. 2012, Japanese, Japanese Study Group on GIST, 大阪, Domestic conference
    Public discourse

  • 特別講演「本当に膵液瘻がゼロになる！サーモグラフィーで考える腹腔鏡下胃切除術」
    掛地 吉弘
    第15回近畿腹腔鏡下胃切除セミナー, Japanese, 近畿腹腔鏡下胃切除セミナー／コヴィディエンジャパン株式会社, 大阪, Domestic conference
    Others

■ Affiliated Academic Society
  • American Society for Clinical Oncology (ASCO)

  • American Association for Cancer Research (AACR)

  • 日本胃癌学会

  • American Society of Clinical Oncology (ASCO)

  • 日本コンピュ−タ外科学会

  • 日本内視鏡外科学会

  • 日本消化器癌発生学会

  • 日本食道学会

  • 日本サイトメトリー学会

  • American Association for Cancer Research (AACR)

  • 日本消化器内視鏡学会

  • 日本癌学会

  • 日本癌治療学会

  • 日本消化器外科学会

  • 日本外科学会

■ Research Themes
TOP